Citrus Sinensis ID: 021771
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 308 | 2.2.26 [Sep-21-2011] | |||||||
| O81906 | 849 | G-type lectin S-receptor- | yes | no | 0.980 | 0.355 | 0.633 | 1e-108 | |
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.983 | 0.452 | 0.584 | 1e-108 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.983 | 0.359 | 0.611 | 1e-107 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.983 | 0.357 | 0.611 | 1e-106 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.970 | 0.366 | 0.615 | 1e-105 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.980 | 0.358 | 0.590 | 1e-103 | |
| Q9LDQ3 | 669 | Putative cysteine-rich re | no | no | 0.983 | 0.452 | 0.576 | 1e-103 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.983 | 0.449 | 0.568 | 1e-103 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.886 | 0.403 | 0.626 | 1e-103 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.983 | 0.359 | 0.577 | 1e-103 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 392 bits (1008), Expect = e-108, Method: Compositional matrix adjust.
Identities = 194/306 (63%), Positives = 233/306 (76%), Gaps = 4/306 (1%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DG+EIAVKRLS SGQG+ EFKNE+ LIAKLQH+NLVRL GCC E E +L+YEY
Sbjct: 545 KGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEY 604
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLD FLFD T+ +DWK R SII GIARGLLYLH DSRL+IIHRDLK SNVLL+
Sbjct: 605 MPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDA 664
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
EMNPKISDFGMARIFGGNQ+EANT R+VGTYGYM+PEYAMEGLFSVKSDV+SFGVLLLEI
Sbjct: 665 EMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEI 724
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
+SGK+NT SE G SL+ Y W L+ G + EL++P ++ +C E L+ IH+ +LCVQ
Sbjct: 725 VSGKRNTSLRSSEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQ 783
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQF---SSGAEVCSVNEVTL 302
+A+RP M+SV++ML SDT TL P +P F+ R + F SS + S NE+T
Sbjct: 784 DSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITS 843
Query: 303 SNVTPR 308
+ V R
Sbjct: 844 TVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 391 bits (1005), Expect = e-108, Method: Compositional matrix adjust.
Identities = 179/306 (58%), Positives = 238/306 (77%), Gaps = 3/306 (0%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L+DG E+AVKRLS++SGQG EFKNEV L+AKLQH+NLVRL G CL+ E +L+YEY
Sbjct: 364 KGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEY 423
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+PNKSLD FLFD + QLDW RR II G+ARG+LYLH+DSRL IIHRDLKASN+LL+
Sbjct: 424 VPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDA 483
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+MNPKI+DFGMARIFG +Q+E NT+RIVGTYGYM+PEYAM G +S+KSDV+SFGVL+LEI
Sbjct: 484 DMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEI 543
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
ISGKKN+ FY ++ L+SY W LW G LEL++P + ++C E+++ +HIGLLCVQ
Sbjct: 544 ISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQ 603
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVAR---PGQFSSGAEVCSVNEVTL 302
D A+RPT+S++V+ML S+TVTLP P +P + + +S + + SV++ ++
Sbjct: 604 EDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASI 663
Query: 303 SNVTPR 308
+++ PR
Sbjct: 664 TDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (994), Expect = e-107, Method: Compositional matrix adjust.
Identities = 189/309 (61%), Positives = 231/309 (74%), Gaps = 6/309 (1%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G+L DGKEIAVKRLS+ S QG EF NEV LIAKLQH NLVRL GCC+++ E +LIYEY
Sbjct: 535 KGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEY 594
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ N SLD LFD TRS L+W++R IINGIARGLLYLH+DSR +IIHRDLKASNVLL+
Sbjct: 595 LENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDK 654
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
M PKISDFGMARIFG ++EANT R+VGTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEI
Sbjct: 655 NMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEI 714
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV----LKQSCVAAELLKFIHIGL 241
ISGK+N GFY S +LL + W+ W EG LE+++P+ L E+L+ I IGL
Sbjct: 715 ISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGL 774
Query: 242 LCVQADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGA--EVCSVNE 299
LCVQ + DRP MSSV+VML S+T +PQP P F +GR+ SS + C+VN+
Sbjct: 775 LCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQ 834
Query: 300 VTLSNVTPR 308
+TLS + R
Sbjct: 835 ITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 383 bits (984), Expect = e-106, Method: Compositional matrix adjust.
Identities = 189/309 (61%), Positives = 229/309 (74%), Gaps = 6/309 (1%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DGKEIAVKRLS+ S QG EF NEV LIAKLQH NLVRL GCC+++ E +LIYEY
Sbjct: 539 KGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEY 598
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ N SLD LFD TRS L+W++R IINGIARGLLYLH+DSR +IIHRDLKASNVLL+
Sbjct: 599 LENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDK 658
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
M PKISDFGMARIFG ++EANT R+VGTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEI
Sbjct: 659 NMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEI 718
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV----LKQSCVAAELLKFIHIGL 241
ISGK+N GFY S +LL + W+ W EG+ LE+++P+ L E+L+ I IGL
Sbjct: 719 ISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGL 778
Query: 242 LCVQADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGR--NVARPGQFSSGAEVCSVNE 299
LCVQ + DRP MSSV+VML S+T +PQP P F VGR + + C+VN+
Sbjct: 779 LCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQ 838
Query: 300 VTLSNVTPR 308
VTLS + R
Sbjct: 839 VTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 382 bits (980), Expect = e-105, Method: Compositional matrix adjust.
Identities = 187/304 (61%), Positives = 238/304 (78%), Gaps = 5/304 (1%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+GKL DG+EIAVKRLS SGQG++EFKNEV LIAKLQH+NLVRL GCC++ E +LIYEY
Sbjct: 516 KGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEY 575
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLD F+FD RS +LDWK+R++IING+ARG+LYLH+DSRL+IIHRDLKA NVLL++
Sbjct: 576 MPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDN 635
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+MNPKISDFG+A+ FGG+QSE++TNR+VGTYGYM PEYA++G FSVKSDVFSFGVL+LEI
Sbjct: 636 DMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEI 695
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEG-EALELMEPVLKQSCVAAELLKFIHIGLLCV 244
I+GK N GF ++ +LL + WK+W E E E L+++ V E+L+ IH+ LLCV
Sbjct: 696 ITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCV 755
Query: 245 QADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSN 304
Q DRPTM+SVV+M SD+ +LP PT+P F RNV SS + S NEV+++
Sbjct: 756 QQKPEDRPTMASVVLMFGSDS-SLPHPTQPGFFTNRNVP---DISSSLSLRSQNEVSITM 811
Query: 305 VTPR 308
+ R
Sbjct: 812 LQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 376 bits (966), Expect = e-103, Method: Compositional matrix adjust.
Identities = 179/303 (59%), Positives = 225/303 (74%), Gaps = 1/303 (0%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G ++G+EIAVKRLS S QGL+EFKNE+ LIAKLQH+NLVRL GCC+E+NE +L+YEY
Sbjct: 541 KGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEY 600
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLD FLFD ++ LDW++R +I GIARGLLYLH DSRLKIIHRDLKASN+LL+
Sbjct: 601 MPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDT 660
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
EMNPKISDFGMARIF Q ANT R+VGTYGYMAPEYAMEG+FS KSDV+SFGVL+LEI
Sbjct: 661 EMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEI 720
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
+SG+KN F ++ G SL+ Y W LW +G+ E+++P++K + E ++ IH+G+LC Q
Sbjct: 721 VSGRKNVSFRGTDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQ 779
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
RP M SV++ML S T LP P +P F N G +V SVN+VT + +
Sbjct: 780 DSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVASVNDVTFTTI 839
Query: 306 TPR 308
R
Sbjct: 840 VGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 376 bits (965), Expect = e-103, Method: Compositional matrix adjust.
Identities = 178/309 (57%), Positives = 237/309 (76%), Gaps = 6/309 (1%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+GKL+ G E+AVKRLS+TSGQG +EFKNE L++KLQHKNLVRL G CLE E +L+YE+
Sbjct: 361 RGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEF 420
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+PNKSLD FLFD + +LDW RR +II GIARG+LYLH+DSRL IIHRDLKASN+LL+
Sbjct: 421 VPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 480
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+MNPKI+DFGMARIFG +QS+ANT RI GT+GYM+PEYAM G FS+KSDV+SFGVL+LEI
Sbjct: 481 DMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEI 540
Query: 186 ISGKKNTGFY-LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCV 244
ISGKKN+ FY + + G +L+++ W+LW G LEL++P + +S ++E + IHI LLCV
Sbjct: 541 ISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCV 600
Query: 245 QADSADRPTMSSVVVMLASDTVTLPQPTEPAFSV-GRNVARPG----QFSSGAEVCSVNE 299
Q D ADRP + ++++ML S T TL P P F + GR++ + G + +S + S+N+
Sbjct: 601 QEDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSIND 660
Query: 300 VTLSNVTPR 308
+++ PR
Sbjct: 661 ASITEFYPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 375 bits (963), Expect = e-103, Method: Compositional matrix adjust.
Identities = 175/308 (56%), Positives = 239/308 (77%), Gaps = 5/308 (1%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G ++GKE+AVKRLS+ S QG EFK EV ++AKLQH+NLVRL G L+ E +L+YEY
Sbjct: 367 KGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEY 426
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLD LFD T+ +QLDW +R +II GIARG+LYLH+DSRL IIHRDLKASN+LL+
Sbjct: 427 MPNKSLDCLLFDPTKQIQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 486
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
++NPKI+DFGMARIFG +Q++ NT+RIVGTYGYMAPEYAM G FS+KSDV+SFGVL+LEI
Sbjct: 487 DINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEI 546
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
ISG+KN+ F S+ Q LL++ W+LW +AL+L++P++ ++C +E+++ IHIGLLCVQ
Sbjct: 547 ISGRKNSSFGESDGAQDLLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQ 606
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVG-RNVARP----GQFSSGAEVCSVNEV 300
D A RP +S+V +ML S+TVTLP P +P F + R V P ++ + S+++
Sbjct: 607 EDPAKRPAISTVFMMLTSNTVTLPVPRQPGFFIQCRAVKDPLDSDQSTTTKSFPASIDDE 666
Query: 301 TLSNVTPR 308
+++++ PR
Sbjct: 667 SITDLYPR 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 375 bits (962), Expect = e-103, Method: Compositional matrix adjust.
Identities = 171/273 (62%), Positives = 221/273 (80%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G ++GKE+AVKRLS+ S QG EFK EV ++AKLQH+NLVRL G L+ E +L+YEY
Sbjct: 369 KGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEY 428
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLD LFD T+ QLDW +R +II GIARG+LYLH+DSRL IIHRDLKASN+LL+
Sbjct: 429 MPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 488
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
++NPKI+DFGMARIFG +Q++ NT+RIVGTYGYMAPEYAM G FS+KSDV+SFGVL+LEI
Sbjct: 489 DINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEI 548
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
ISG+KN+ F S+ Q LL++TW+LW AL+L++P++ +C +E+++ IHIGLLCVQ
Sbjct: 549 ISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQ 608
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSV 278
D A RPT+S+V +ML S+TVTLP P +P F +
Sbjct: 609 EDPAKRPTISTVFMMLTSNTVTLPVPRQPGFFI 641
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 374 bits (960), Expect = e-103, Method: Compositional matrix adjust.
Identities = 175/303 (57%), Positives = 225/303 (74%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+GKL +G+EIAVKRLSR SGQGL+E NEV +I+KLQH+NLV+L GCC+E E +L+YEY
Sbjct: 540 KGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEY 599
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MP KSLD +LFD + LDWK R +I+ GI RGLLYLH DSRLKIIHRDLKASN+LL+
Sbjct: 600 MPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDE 659
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+NPKISDFG+ARIF N+ EANT R+VGTYGYM+PEYAMEG FS KSDVFS GV+ LEI
Sbjct: 660 NLNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEI 719
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
ISG++N+ + E +LL+Y WKLW +GEA L +P + C E+ K +HIGLLCVQ
Sbjct: 720 ISGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVFDKCFEKEIEKCVHIGLLCVQ 779
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
+ DRP +S+V+ ML ++ ++L P +PAF V R + ++ S+N+V+L+ V
Sbjct: 780 EVANDRPNVSNVIWMLTTENMSLADPKQPAFIVRRGASEAESSDQSSQKVSINDVSLTAV 839
Query: 306 TPR 308
T R
Sbjct: 840 TGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 308 | ||||||
| 224113927 | 381 | predicted protein [Populus trichocarpa] | 0.980 | 0.792 | 0.768 | 1e-135 | |
| 224076400 | 666 | predicted protein [Populus trichocarpa] | 0.980 | 0.453 | 0.778 | 1e-134 | |
| 255555021 | 686 | ATP binding protein, putative [Ricinus c | 0.980 | 0.440 | 0.749 | 1e-131 | |
| 356554939 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.983 | 0.457 | 0.689 | 1e-125 | |
| 356510387 | 647 | PREDICTED: cysteine-rich receptor-like p | 0.983 | 0.468 | 0.702 | 1e-123 | |
| 225462833 | 399 | PREDICTED: G-type lectin S-receptor-like | 0.977 | 0.754 | 0.712 | 1e-123 | |
| 356546303 | 662 | PREDICTED: cysteine-rich receptor-like p | 0.983 | 0.457 | 0.679 | 1e-123 | |
| 358346817 | 626 | Cysteine-rich receptor-like protein kina | 0.983 | 0.484 | 0.689 | 1e-123 | |
| 358346648 | 573 | Cysteine-rich receptor-like protein kina | 0.983 | 0.528 | 0.689 | 1e-123 | |
| 357515489 | 670 | S-locus lectin protein kinase family pro | 0.993 | 0.456 | 0.697 | 1e-122 |
| >gi|224113927|ref|XP_002316616.1| predicted protein [Populus trichocarpa] gi|222859681|gb|EEE97228.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1249), Expect = e-135, Method: Compositional matrix adjust.
Identities = 233/303 (76%), Positives = 268/303 (88%), Gaps = 1/303 (0%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DGKE+AVKRLSRTSGQG +EF NEV LIA+LQH+NLVRL GCCLE+NE LLIYEY
Sbjct: 80 RGTLEDGKEVAVKRLSRTSGQGQREFLNEVVLIARLQHRNLVRLLGCCLEKNEKLLIYEY 139
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLDV LF S+ V LDW+RR+SIINGIARGLLYLHEDSRL+IIHRDLK SN+LL++
Sbjct: 140 MPNKSLDVILFGSSNGVLLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKTSNILLDY 199
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM GLFSVKSDVFSFGVLLLEI
Sbjct: 200 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMVGLFSVKSDVFSFGVLLLEI 259
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
ISG+KN GF+LSE G+SLL++ WKLW +G+ LELM+P+L++S VA E+L+ IHIGLLCVQ
Sbjct: 260 ISGEKNVGFHLSEEGESLLTFAWKLWSDGQGLELMDPMLEKSGVATEVLRCIHIGLLCVQ 319
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
D ADRPTMSSV+ MLASDT+TLP P +PAFS+GR VA GQ SS +VCS NE+T+S +
Sbjct: 320 EDPADRPTMSSVLHMLASDTITLPIPKQPAFSIGRFVAMEGQ-SSNQKVCSSNELTISVL 378
Query: 306 TPR 308
+PR
Sbjct: 379 SPR 381
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076400|ref|XP_002304937.1| predicted protein [Populus trichocarpa] gi|222847901|gb|EEE85448.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 484 bits (1246), Expect = e-134, Method: Compositional matrix adjust.
Identities = 236/303 (77%), Positives = 265/303 (87%), Gaps = 1/303 (0%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G + DGKEIAVKRLSRTSGQGL+EF NEV LIA+LQH+NLV+L GCCLE+NE LL+YEY
Sbjct: 365 KGVMEDGKEIAVKRLSRTSGQGLREFMNEVNLIARLQHRNLVKLLGCCLEKNEKLLVYEY 424
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLDVFLFDS VQLDW+RR+SIINGIARGLLYLHEDSRL+IIHRDLKASN+LL++
Sbjct: 425 MPNKSLDVFLFDSAMRVQLDWQRRLSIINGIARGLLYLHEDSRLRIIHRDLKASNILLDY 484
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
EMNPKISDFGMARIFGGN SEANTNRIVGTYGYMAPEYAMEGL SVKSDVFSFGVL+LEI
Sbjct: 485 EMNPKISDFGMARIFGGNHSEANTNRIVGTYGYMAPEYAMEGLSSVKSDVFSFGVLMLEI 544
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
ISGK+N GF+LSE G+SLL++TWKLW EG+ LELM+ +L++S VA E+LK IHIGLLCVQ
Sbjct: 545 ISGKRNGGFHLSEEGKSLLNFTWKLWSEGKGLELMDSLLEKSSVATEVLKCIHIGLLCVQ 604
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
D DRPTMSSVVVMLA D +P PT+PAFSVGR VA SS V SVN+VTLSNV
Sbjct: 605 EDPVDRPTMSSVVVMLAGDNFKIPIPTKPAFSVGRIVAEETT-SSNQRVSSVNKVTLSNV 663
Query: 306 TPR 308
PR
Sbjct: 664 LPR 666
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555021|ref|XP_002518548.1| ATP binding protein, putative [Ricinus communis] gi|223542393|gb|EEF43935.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 474 bits (1220), Expect = e-131, Method: Compositional matrix adjust.
Identities = 227/303 (74%), Positives = 266/303 (87%), Gaps = 1/303 (0%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DGKEIAVKRLSRTSGQGL EF NEVTLI KLQH+NLVRL GCCLE++E LLIYEY
Sbjct: 385 KGTLPDGKEIAVKRLSRTSGQGLPEFMNEVTLIFKLQHRNLVRLLGCCLEKSEKLLIYEY 444
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLDVFLFDS V+LDW+RR+SII+GIARGLLYLHEDSRL+IIHRDLKASN+LL++
Sbjct: 445 MPNKSLDVFLFDSHMGVRLDWQRRLSIISGIARGLLYLHEDSRLRIIHRDLKASNILLDY 504
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+MNPKISDFGMARIFGGN S++ TNRIVGTYGYM+PEYAMEGLFS+KSD+FSFGVLLLEI
Sbjct: 505 DMNPKISDFGMARIFGGNDSKS-TNRIVGTYGYMSPEYAMEGLFSMKSDIFSFGVLLLEI 563
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
ISG++N FY+ E G+SLL++ WKLW + + LEL++P + S VA E+LK +HIGLLCVQ
Sbjct: 564 ISGRRNNRFYVEEEGESLLTFAWKLWNKDQGLELLDPAVVNSSVAIEVLKCVHIGLLCVQ 623
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
D A+RPTMSSVVVMLASDT+TLPQP +PAFS+G+ VAR SS +V SVN+VTLSNV
Sbjct: 624 DDPAERPTMSSVVVMLASDTITLPQPRKPAFSIGQFVARSATSSSNPKVSSVNQVTLSNV 683
Query: 306 TPR 308
+PR
Sbjct: 684 SPR 686
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356554939|ref|XP_003545798.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 453 bits (1166), Expect = e-125, Method: Compositional matrix adjust.
Identities = 209/303 (68%), Positives = 252/303 (83%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DG++IAVKRLS+ SGQG +EFKNEV IAKLQH+NLVRL CCLEENE +L+YEY
Sbjct: 360 KGILPDGRQIAVKRLSQASGQGSEEFKNEVMFIAKLQHRNLVRLLACCLEENEKILVYEY 419
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ N SL+ LFD + QLDWK R+SIINGIARG+LYLHEDSRL++IHRDLKASNVLL+H
Sbjct: 420 LSNASLNFHLFDDEKKKQLDWKLRLSIINGIARGILYLHEDSRLRVIHRDLKASNVLLDH 479
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+MNPKISDFG+AR F Q +ANTNR++GTYGYMAPEYAMEGLFSVKSDVFSFGVL+LEI
Sbjct: 480 DMNPKISDFGLARAFSKGQKQANTNRVMGTYGYMAPEYAMEGLFSVKSDVFSFGVLVLEI 539
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
I GKKN+GFYLSE GQ LL Y WK+WC G+ LEL++PVL++SC+ +E++K IHIGLLCVQ
Sbjct: 540 ICGKKNSGFYLSECGQGLLLYAWKIWCAGKFLELLDPVLEESCIESEVVKCIHIGLLCVQ 599
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
D+ADRP MS+VVVMLASDT+ LP+P PAFSVGR S + S+N++T+SN+
Sbjct: 600 EDAADRPNMSTVVVMLASDTMVLPKPNRPAFSVGRMALGDASTSKSSNKHSINDITISNI 659
Query: 306 TPR 308
PR
Sbjct: 660 LPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510387|ref|XP_003523920.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 448 bits (1153), Expect = e-123, Method: Compositional matrix adjust.
Identities = 213/303 (70%), Positives = 255/303 (84%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DG++IAVKRLS+TS QG++EFKNEV LIAKLQH+NLVRL CC+E+NE LL+YE+
Sbjct: 345 KGVLPDGRQIAVKRLSKTSVQGVEEFKNEVILIAKLQHRNLVRLLACCIEQNEKLLVYEF 404
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPN SLD LFD + L+WK R++IINGIA+GLLYLHEDSRL++IHRDLKASN+LL+H
Sbjct: 405 MPNSSLDFHLFDMEKGEHLEWKNRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNILLDH 464
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
EMNPKISDFG+AR FGG+Q +ANT R+VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI
Sbjct: 465 EMNPKISDFGLARTFGGDQKQANTIRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 524
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
ISGK+++ FYLS+ GQSLL Y W LWCE + LELM+P++++SCV +E+LK +HIGLLCVQ
Sbjct: 525 ISGKRSSKFYLSDQGQSLLIYAWNLWCERKGLELMDPIIEKSCVRSEVLKCMHIGLLCVQ 584
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
D+ADRP MSSVV MLASDTV+L PT PAFSVGR V S+ + SVNE T+S V
Sbjct: 585 EDAADRPKMSSVVHMLASDTVSLSVPTRPAFSVGRAVTERECSSNTSMHYSVNEATVSEV 644
Query: 306 TPR 308
PR
Sbjct: 645 IPR 647
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225462833|ref|XP_002269514.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 448 bits (1152), Expect = e-123, Method: Compositional matrix adjust.
Identities = 216/303 (71%), Positives = 257/303 (84%), Gaps = 2/303 (0%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G LADG+EIAVKRLSRTSGQGL+EFKNEVTLIA+LQH+NLVRL GCCLE NESLLIYEY
Sbjct: 99 RGTLADGREIAVKRLSRTSGQGLEEFKNEVTLIARLQHRNLVRLLGCCLEGNESLLIYEY 158
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLDVFLFDST S QLDWK R++IINGIARG+ YLHEDSRL+IIHRDLK SNVLL+
Sbjct: 159 MPNKSLDVFLFDSTTSAQLDWKTRLNIINGIARGISYLHEDSRLRIIHRDLKPSNVLLDS 218
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+MNPKISDFGMARIF G+++ NT RIVG+YGYMAPEYAMEGL+S+KSDV+SFGV+LLEI
Sbjct: 219 DMNPKISDFGMARIFAGSENGTNTARIVGSYGYMAPEYAMEGLYSIKSDVYSFGVVLLEI 278
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
I+G+KN GF+LS +G SLLS+ W+ W EG+ LELM+P+L SC E L+ HIGLLCVQ
Sbjct: 279 ITGRKNAGFHLSGMGPSLLSHAWQSWNEGKGLELMDPLLGDSCCPDEFLRCYHIGLLCVQ 338
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
D++DRPTMSSV+VML S++V+L QP PAFSVGR+ + + +SG+ SVN +T S
Sbjct: 339 EDASDRPTMSSVIVMLKSESVSLRQPERPAFSVGRSTNQH-ETASGSS-SSVNGLTASIA 396
Query: 306 TPR 308
PR
Sbjct: 397 LPR 399
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356546303|ref|XP_003541568.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 447 bits (1149), Expect = e-123, Method: Compositional matrix adjust.
Identities = 206/303 (67%), Positives = 252/303 (83%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DG++IAVKRLS+ SGQG +EFKNEV IAKLQH NLVRL CCLE E +L+YEY
Sbjct: 360 KGTLPDGRQIAVKRLSQASGQGSEEFKNEVMFIAKLQHCNLVRLLACCLEGKEKILVYEY 419
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ N SLD LFD + QLDW R+SIINGIA+GLLYLHEDSRLK+IHRDLKASN+LL+
Sbjct: 420 LSNASLDFHLFDERKKRQLDWNLRLSIINGIAKGLLYLHEDSRLKVIHRDLKASNILLDD 479
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
EMNPKISDFG+AR F Q++ANTNR++GTYGYM+PEYAMEGLFSVKSDVFS+GVL+LEI
Sbjct: 480 EMNPKISDFGLARAFEKGQNQANTNRVMGTYGYMSPEYAMEGLFSVKSDVFSYGVLVLEI 539
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
I GKKN+GFYLSE GQSL Y WK+WC G++LELM+PVL++SC+ +E++K IHIGLLCVQ
Sbjct: 540 ICGKKNSGFYLSECGQSLTLYAWKIWCAGKSLELMDPVLEKSCIESEVMKCIHIGLLCVQ 599
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
D+ADRPTMS+VVVMLASD ++LP+P +PAFSVGR S ++ S+N+VT++N+
Sbjct: 600 EDAADRPTMSTVVVMLASDKMSLPEPNQPAFSVGRMTLEGASTSKSSKNLSINDVTVTNI 659
Query: 306 TPR 308
PR
Sbjct: 660 LPR 662
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346817|ref|XP_003637461.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503396|gb|AES84599.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1148), Expect = e-123, Method: Compositional matrix adjust.
Identities = 209/303 (68%), Positives = 248/303 (81%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DG E+A+KRLS TSGQG +EFKNEV IAKLQH+NLVRL GCC+E+NE LL+YEY
Sbjct: 324 KGNLVDGTEVAIKRLSITSGQGSEEFKNEVIFIAKLQHRNLVRLLGCCIEDNEKLLVYEY 383
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPN SLD LFD + LDWK R++IINGIA+GLLYLHEDSRL++IHRDLKASNVLL+
Sbjct: 384 MPNSSLDFHLFDEEKRKLLDWKLRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNVLLDQ 443
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
EMNPKISDFG+AR F +Q + NT R+VGTYGYMAPEYAMEGL+SVKSDVFSFGVLLLEI
Sbjct: 444 EMNPKISDFGLARAFEKDQCQENTRRVVGTYGYMAPEYAMEGLYSVKSDVFSFGVLLLEI 503
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
I G++N GFYL+E GQSLL Y+W LWCE ++LEL++P+LK + E++K IHIGLLCVQ
Sbjct: 504 ICGRRNGGFYLAEHGQSLLVYSWNLWCEDKSLELLDPILKNTYTTNEVIKCIHIGLLCVQ 563
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
D+ DRPTMS+VVVMLASDT+TLP P PAFSVGR V S + SVNEVT++N+
Sbjct: 564 EDAVDRPTMSNVVVMLASDTMTLPNPNHPAFSVGRKVVEGESTSKASNDPSVNEVTVTNI 623
Query: 306 TPR 308
PR
Sbjct: 624 LPR 626
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358346648|ref|XP_003637378.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355503313|gb|AES84516.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1146), Expect = e-123, Method: Compositional matrix adjust.
Identities = 209/303 (68%), Positives = 248/303 (81%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DG E+A+KRLS TSGQG +EFKNEV IAKLQH+NLVRL GCC+E+NE LL+YEY
Sbjct: 271 KGNLVDGTEVAIKRLSITSGQGSEEFKNEVIFIAKLQHRNLVRLLGCCIEDNEKLLVYEY 330
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPN SLD LFD + LDWK R++IINGIA+GLLYLHEDSRL++IHRDLKASNVLL+
Sbjct: 331 MPNSSLDFHLFDEEKRKLLDWKLRLNIINGIAKGLLYLHEDSRLRVIHRDLKASNVLLDQ 390
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
EMNPKISDFG+AR F +Q + NT R+VGTYGYMAPEYAMEGL+SVKSDVFSFGVLLLEI
Sbjct: 391 EMNPKISDFGLARAFEKDQCQENTRRVVGTYGYMAPEYAMEGLYSVKSDVFSFGVLLLEI 450
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
I G++N GFYL+E GQSLL Y+W LWCE ++LEL++P+LK + E++K IHIGLLCVQ
Sbjct: 451 ICGRRNGGFYLAEHGQSLLVYSWNLWCEDKSLELLDPILKNTYTTNEVIKCIHIGLLCVQ 510
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
D+ DRPTMS+VVVMLASDT+TLP P PAFSVGR V S + SVNEVT++N+
Sbjct: 511 EDAVDRPTMSNVVVMLASDTMTLPNPNHPAFSVGRKVVEGESTSKASNDPSVNEVTVTNI 570
Query: 306 TPR 308
PR
Sbjct: 571 LPR 573
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357515489|ref|XP_003628033.1| S-locus lectin protein kinase family protein [Medicago truncatula] gi|355522055|gb|AET02509.1| S-locus lectin protein kinase family protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1143), Expect = e-122, Method: Compositional matrix adjust.
Identities = 214/307 (69%), Positives = 257/307 (83%), Gaps = 1/307 (0%)
Query: 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62
S +G L DG++IAVKRLSRTSGQG +EFKNEV IAKLQH+NLVRL CCLE NE LL+
Sbjct: 349 SVYKGILPDGRQIAVKRLSRTSGQGSEEFKNEVMFIAKLQHRNLVRLLACCLEGNEKLLV 408
Query: 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
YE+MPN SLD LFD+ + +L+WK +SIINGIA+GLLYLHEDSRL++IHRDLKASNVL
Sbjct: 409 YEFMPNASLDFHLFDNEKRKELNWKLSLSIINGIAKGLLYLHEDSRLRVIHRDLKASNVL 468
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
L+HEMNPKISDFG+AR F Q++ANT RI+GTYGYMAPEYAMEG+FSVK+DVFSFGVL+
Sbjct: 469 LDHEMNPKISDFGLARAFDIGQNQANTRRIMGTYGYMAPEYAMEGVFSVKTDVFSFGVLV 528
Query: 183 LEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA-ELLKFIHIGL 241
LEIISGKKNTGFYLSE GQSLL YTWK WCEG LE+M+ VL +SC+ E+++ I+IGL
Sbjct: 529 LEIISGKKNTGFYLSEHGQSLLLYTWKKWCEGTCLEIMDSVLGKSCIDDNEVVRCINIGL 588
Query: 242 LCVQADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVT 301
LCVQ D+ADRPTMS+VVVMLASDT+TLP+P +PAFS+GR + S + S+N+VT
Sbjct: 589 LCVQEDAADRPTMSTVVVMLASDTMTLPKPKQPAFSIGRMTSTDSSSSKSFKDPSINDVT 648
Query: 302 LSNVTPR 308
+SN+ PR
Sbjct: 649 VSNILPR 655
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 308 | ||||||
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.980 | 0.355 | 0.633 | 1.3e-98 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.970 | 0.366 | 0.618 | 5.8e-98 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.983 | 0.359 | 0.611 | 8.4e-97 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.983 | 0.357 | 0.618 | 1.1e-96 | |
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.983 | 0.452 | 0.588 | 4.7e-96 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.980 | 0.358 | 0.590 | 3.8e-94 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.983 | 0.452 | 0.576 | 7.8e-94 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.983 | 0.469 | 0.575 | 1.9e-92 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.983 | 0.356 | 0.579 | 2.1e-91 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.886 | 0.403 | 0.626 | 2.1e-91 |
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 1.3e-98, P = 1.3e-98
Identities = 194/306 (63%), Positives = 233/306 (76%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DG+EIAVKRLS SGQG+ EFKNE+ LIAKLQH+NLVRL GCC E E +L+YEY
Sbjct: 545 KGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEY 604
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLD FLFD T+ +DWK R SII GIARGLLYLH DSRL+IIHRDLK SNVLL+
Sbjct: 605 MPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDA 664
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
EMNPKISDFGMARIFGGNQ+EANT R+VGTYGYM+PEYAMEGLFSVKSDV+SFGVLLLEI
Sbjct: 665 EMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEI 724
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
+SGK+NT SE G SL+ Y W L+ G + EL++P ++ +C E L+ IH+ +LCVQ
Sbjct: 725 VSGKRNTSLRSSEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQ 783
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQF---SSGAEVCSVNEVTL 302
+A+RP M+SV++ML SDT TL P +P F+ R + F SS + S NE+T
Sbjct: 784 DSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITS 843
Query: 303 SNVTPR 308
+ V R
Sbjct: 844 TVVLGR 849
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 973 (347.6 bits), Expect = 5.8e-98, P = 5.8e-98
Identities = 188/304 (61%), Positives = 241/304 (79%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+GKL DG+EIAVKRLS SGQG++EFKNEV LIAKLQH+NLVRL GCC++ E +LIYEY
Sbjct: 516 KGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEY 575
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLD F+FD RS +LDWK+R++IING+ARG+LYLH+DSRL+IIHRDLKA NVLL++
Sbjct: 576 MPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDN 635
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+MNPKISDFG+A+ FGG+QSE++TNR+VGTYGYM PEYA++G FSVKSDVFSFGVL+LEI
Sbjct: 636 DMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEI 695
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV-LKQSCVAAELLKFIHIGLLCV 244
I+GK N GF ++ +LL + WK+W E +E+ E L+++ V E+L+ IH+ LLCV
Sbjct: 696 ITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCV 755
Query: 245 QADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSN 304
Q DRPTM+SVV+M SD+ +LP PT+P F RNV P SS + S NEV+++
Sbjct: 756 QQKPEDRPTMASVVLMFGSDS-SLPHPTQPGFFTNRNV--P-DISSSLSLRSQNEVSITM 811
Query: 305 VTPR 308
+ R
Sbjct: 812 LQGR 815
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 962 (343.7 bits), Expect = 8.4e-97, P = 8.4e-97
Identities = 189/309 (61%), Positives = 231/309 (74%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G+L DGKEIAVKRLS+ S QG EF NEV LIAKLQH NLVRL GCC+++ E +LIYEY
Sbjct: 535 KGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEY 594
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ N SLD LFD TRS L+W++R IINGIARGLLYLH+DSR +IIHRDLKASNVLL+
Sbjct: 595 LENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDK 654
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
M PKISDFGMARIFG ++EANT R+VGTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEI
Sbjct: 655 NMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEI 714
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV----LKQSCVAAELLKFIHIGL 241
ISGK+N GFY S +LL + W+ W EG LE+++P+ L E+L+ I IGL
Sbjct: 715 ISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGL 774
Query: 242 LCVQADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGA--EVCSVNE 299
LCVQ + DRP MSSV+VML S+T +PQP P F +GR+ SS + C+VN+
Sbjct: 775 LCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQ 834
Query: 300 VTLSNVTPR 308
+TLS + R
Sbjct: 835 ITLSVIDAR 843
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
Identities = 191/309 (61%), Positives = 231/309 (74%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L DGKEIAVKRLS+ S QG EF NEV LIAKLQH NLVRL GCC+++ E +LIYEY
Sbjct: 539 KGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEY 598
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ N SLD LFD TRS L+W++R IINGIARGLLYLH+DSR +IIHRDLKASNVLL+
Sbjct: 599 LENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDK 658
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
M PKISDFGMARIFG ++EANT R+VGTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEI
Sbjct: 659 NMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEI 718
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV----LKQSCVAAELLKFIHIGL 241
ISGK+N GFY S +LL + W+ W EG+ LE+++P+ L E+L+ I IGL
Sbjct: 719 ISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGL 778
Query: 242 LCVQADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGA--EVCSVNE 299
LCVQ + DRP MSSV+VML S+T +PQP P F VGR+ SS + C+VN+
Sbjct: 779 LCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQ 838
Query: 300 VTLSNVTPR 308
VTLS + R
Sbjct: 839 VTLSVIDAR 847
|
|
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 955 (341.2 bits), Expect = 4.7e-96, P = 4.7e-96
Identities = 180/306 (58%), Positives = 239/306 (78%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L+DG E+AVKRLS++SGQG EFKNEV L+AKLQH+NLVRL G CL+ E +L+YEY
Sbjct: 364 KGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEY 423
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+PNKSLD FLFD + QLDW RR II G+ARG+LYLH+DSRL IIHRDLKASN+LL+
Sbjct: 424 VPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDA 483
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+MNPKI+DFGMARIFG +Q+E NT+RIVGTYGYM+PEYAM G +S+KSDV+SFGVL+LEI
Sbjct: 484 DMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEI 543
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
ISGKKN+ FY ++ L+SY W LW G LEL++P + ++C E+++ +HIGLLCVQ
Sbjct: 544 ISGKKNSSFYQTDGAHDLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQ 603
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVAR-P--GQFSSGAEVCSVNEVTL 302
D A+RPT+S++V+ML S+TVTLP P +P + + P +S + + SV++ ++
Sbjct: 604 EDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASI 663
Query: 303 SNVTPR 308
+++ PR
Sbjct: 664 TDIHPR 669
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 937 (334.9 bits), Expect = 3.8e-94, P = 3.8e-94
Identities = 179/303 (59%), Positives = 225/303 (74%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G ++G+EIAVKRLS S QGL+EFKNE+ LIAKLQH+NLVRL GCC+E+NE +L+YEY
Sbjct: 541 KGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEY 600
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLD FLFD ++ LDW++R +I GIARGLLYLH DSRLKIIHRDLKASN+LL+
Sbjct: 601 MPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDT 660
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
EMNPKISDFGMARIF Q ANT R+VGTYGYMAPEYAMEG+FS KSDV+SFGVL+LEI
Sbjct: 661 EMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEI 720
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
+SG+KN F ++ G SL+ Y W LW +G+ E+++P++K + E ++ IH+G+LC Q
Sbjct: 721 VSGRKNVSFRGTDHG-SLIGYAWHLWSQGKTKEMIDPIVKDTRDVTEAMRCIHVGMLCTQ 779
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSNV 305
RP M SV++ML S T LP P +P F N G +V SVN+VT + +
Sbjct: 780 DSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDGHDVASVNDVTFTTI 839
Query: 306 TPR 308
R
Sbjct: 840 VGR 842
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 7.8e-94, P = 7.8e-94
Identities = 178/309 (57%), Positives = 237/309 (76%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+GKL+ G E+AVKRLS+TSGQG +EFKNE L++KLQHKNLVRL G CLE E +L+YE+
Sbjct: 361 RGKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEF 420
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+PNKSLD FLFD + +LDW RR +II GIARG+LYLH+DSRL IIHRDLKASN+LL+
Sbjct: 421 VPNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 480
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+MNPKI+DFGMARIFG +QS+ANT RI GT+GYM+PEYAM G FS+KSDV+SFGVL+LEI
Sbjct: 481 DMNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEI 540
Query: 186 ISGKKNTGFY-LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCV 244
ISGKKN+ FY + + G +L+++ W+LW G LEL++P + +S ++E + IHI LLCV
Sbjct: 541 ISGKKNSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCV 600
Query: 245 QADSADRPTMSSVVVMLASDTVTLPQPTEPAFSV-GRNVARPG----QFSSGAEVCSVNE 299
Q D ADRP + ++++ML S T TL P P F + GR++ + G + +S + S+N+
Sbjct: 601 QEDPADRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSIND 660
Query: 300 VTLSNVTPR 308
+++ PR
Sbjct: 661 ASITEFYPR 669
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 921 (329.3 bits), Expect = 1.9e-92, P = 1.9e-92
Identities = 175/304 (57%), Positives = 228/304 (75%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G L+ G ++AVKRLS+TSGQG +EF+NEV ++AKLQH+NLV+L G CLE E +L+YE+
Sbjct: 342 KGTLSSGLQVAVKRLSKTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEF 401
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+PNKSLD FLFDST ++LDW RR II GIARG+LYLH+DSRL IIHRDLKA N+LL+
Sbjct: 402 VPNKSLDHFLFDSTMKMKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDD 461
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+MNPKI+DFGMARIFG +Q+EA T R+VGTYGYM+PEYAM G FS+KSDV+SFGVL+LEI
Sbjct: 462 DMNPKIADFGMARIFGMDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEI 521
Query: 186 ISGKKNTGFY-LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCV 244
ISG KN+ Y + E +L++YTW+LW G EL++P + +E+ + IHI LLCV
Sbjct: 522 ISGMKNSSLYQMDESVGNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCV 581
Query: 245 QADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVNEVTLSN 304
Q D+ DRPTMSS+V ML + + L +P P F + G + CSV+E +++
Sbjct: 582 QEDAEDRPTMSSIVQMLTTSLIALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEASITR 641
Query: 305 VTPR 308
VTPR
Sbjct: 642 VTPR 645
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 2.1e-91, P = 2.1e-91
Identities = 179/309 (57%), Positives = 233/309 (75%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+GKL DG+E+AVKRLS+TS QG EFKNEV LIA+LQH NLVRL CC++ E +LIYEY
Sbjct: 542 KGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEY 601
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ N SLD LFD +R+ +L+W+ R IINGIARGLLYLH+DSR +IIHRDLKASN+LL+
Sbjct: 602 LENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDK 661
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
M PKISDFGMARIFG +++EANT ++VGTYGYM+PEYAM+G+FS+KSDVFSFGVLLLEI
Sbjct: 662 YMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEI 721
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA---ELLKFIHIGLL 242
IS K+N GFY S+ +LL W+ W EG+ LE+++P++ S E+L+ I IGLL
Sbjct: 722 ISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLL 781
Query: 243 CVQADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPGQFSSGA---EVCSVNE 299
CVQ + DRPTMS V++ML S++ T+PQP P + + R++ SS E +VN+
Sbjct: 782 CVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQ 841
Query: 300 VTLSNVTPR 308
+T+S + R
Sbjct: 842 ITVSVLDAR 850
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 911 (325.7 bits), Expect = 2.1e-91, P = 2.1e-91
Identities = 171/273 (62%), Positives = 221/273 (80%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G ++GKE+AVKRLS+ S QG EFK EV ++AKLQH+NLVRL G L+ E +L+YEY
Sbjct: 369 KGTFSNGKEVAVKRLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEY 428
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
MPNKSLD LFD T+ QLDW +R +II GIARG+LYLH+DSRL IIHRDLKASN+LL+
Sbjct: 429 MPNKSLDCLLFDPTKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDA 488
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
++NPKI+DFGMARIFG +Q++ NT+RIVGTYGYMAPEYAM G FS+KSDV+SFGVL+LEI
Sbjct: 489 DINPKIADFGMARIFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEI 548
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
ISG+KN+ F S+ Q LL++TW+LW AL+L++P++ +C +E+++ IHIGLLCVQ
Sbjct: 549 ISGRKNSSFDESDGAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQ 608
Query: 246 ADSADRPTMSSVVVMLASDTVTLPQPTEPAFSV 278
D A RPT+S+V +ML S+TVTLP P +P F +
Sbjct: 609 EDPAKRPTISTVFMMLTSNTVTLPVPRQPGFFI 641
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 308 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-32 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-21 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-16 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-13 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 3e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-51
Identities = 86/253 (33%), Positives = 119/253 (47%), Gaps = 30/253 (11%)
Query: 14 EIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
E+AVK L S Q ++EF E ++ KL H N+V+L G C EE ++ EYM L
Sbjct: 30 EVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLL 89
Query: 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
+L +L +S IARG+ YL IHRDL A N L+ + KIS
Sbjct: 90 SYL--RKNRPKLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKIS 144
Query: 133 DFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-G 188
DFG++R + + + R G +MAPE EG F+ KSDV+SFGVLL EI + G
Sbjct: 145 DFGLSR----DLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 200
Query: 189 KKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADS 248
++ Y + +L Y G L +C + + L C D
Sbjct: 201 EQ---PYPGMSNEEVLEYLKN----GYRLPQPP-----NCPP----ELYDLMLQCWAEDP 244
Query: 249 ADRPTMSSVVVML 261
DRPT S +V +L
Sbjct: 245 EDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-51
Identities = 91/253 (35%), Positives = 125/253 (49%), Gaps = 29/253 (11%)
Query: 14 EIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
E+AVK L S Q ++EF E ++ KL H N+V+L G C EE +++ EYMP L
Sbjct: 30 EVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLL 89
Query: 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
+L R +L +S IARG+ YL IHRDL A N L+ + KIS
Sbjct: 90 DYLRK-NRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKIS 145
Query: 133 DFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-G 188
DFG++R + + + ++ G +MAPE EG F+ KSDV+SFGVLL EI + G
Sbjct: 146 DFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 189 KKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADS 248
++ Y +L Y K G L +C EL K + L C D
Sbjct: 202 EE---PYPGMSNAEVLEYLKK----GYRLPKPP-----NCP-PELYKLM---LQCWAEDP 245
Query: 249 ADRPTMSSVVVML 261
DRPT S +V +L
Sbjct: 246 EDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 2e-50
Identities = 66/178 (37%), Positives = 100/178 (56%), Gaps = 10/178 (5%)
Query: 11 DGKEIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
GK++A+K + + S L+E E+ ++ KL H N+V+L+G +EN L+ EY
Sbjct: 17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMN 128
SL L + +L + I+ I GL YLH IIHRDLK N+LL+
Sbjct: 77 SLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGK 131
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-YAMEGLFSVKSDVFSFGVLLLEI 185
K++DFG++++ ++S T IVGT YMAPE +G +S KSD++S GV+L E+
Sbjct: 132 VKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-49
Identities = 92/268 (34%), Positives = 127/268 (47%), Gaps = 31/268 (11%)
Query: 5 LQGKLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
L+GK E+AVK L S + ++F E ++ KL H N+VRL G C EE L+
Sbjct: 16 LKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVL 75
Query: 64 EYMPNKSLDVFL------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
EYM L +L F S L K +S IA+G+ YL K +HRDL
Sbjct: 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLA 132
Query: 118 ASNVLLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVF 176
A N L+ ++ KISDFG++R ++ + T + +MAPE +G+F+ KSDV+
Sbjct: 133 ARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVW 191
Query: 177 SFGVLLLEIIS-GKK-NTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234
SFGVLL EI + G G E+ + L +G L E EL
Sbjct: 192 SFGVLLWEIFTLGATPYPGLSNEEVLEYLR--------KGYRLPKPE------YCPDELY 237
Query: 235 KFIHIGLLCVQADSADRPTMSSVVVMLA 262
+ + L C Q D DRPT S +V L
Sbjct: 238 ELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-47
Identities = 77/254 (30%), Positives = 107/254 (42%), Gaps = 21/254 (8%)
Query: 8 KLADGKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
GK +AVK L + Q + E+ ++ +L H N+VRL +++ L+ EY
Sbjct: 20 HKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEY 79
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
L +L L I I RGL YLH IIHRDLK N+LL+
Sbjct: 80 CEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHS---NGIIHRDLKPENILLDE 133
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-YAMEGLFSVKSDVFSFGVLLLE 184
KI+DFG+A+ + S T VGT YMAPE + K DV+S GV+L E
Sbjct: 134 NGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYE 191
Query: 185 IISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCV 244
+++GK F + L L L K S + E I L
Sbjct: 192 LLTGK--PPFSGENILDQLQLIRRILGP-----PLEFDEPKWSSGSEEAKDLIK-KCLNK 243
Query: 245 QADSADRPTMSSVV 258
D + RPT ++
Sbjct: 244 --DPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-46
Identities = 85/254 (33%), Positives = 121/254 (47%), Gaps = 31/254 (12%)
Query: 14 EIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
++AVK L S + +EF E +++ KL H N+VRL G C + ++ EYMP L
Sbjct: 30 KVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLL 89
Query: 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
FL + L + + IA+G+ YL +HRDL A N L+ + KIS
Sbjct: 90 DFLRKHGEKLTLKDL--LQMALQIAKGMEYLES---KNFVHRDLAARNCLVTENLVVKIS 144
Query: 133 DFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN 191
DFG++R I+ + + +MAPE +G F+ KSDV+SFGVLL EI +
Sbjct: 145 DFGLSRDIYEDDYYRKRGGGKL-PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFT---- 199
Query: 192 TGFYLSELGQSLLSYTWKLWCEGEALELME--PVLKQ--SCVAAELLKFIHIGLLCVQAD 247
LG+ Y E LEL+E L + +C EL + + L C D
Sbjct: 200 -------LGEQ--PYPGMSNE--EVLELLEDGYRLPRPENC-PDELYELM---LQCWAYD 244
Query: 248 SADRPTMSSVVVML 261
DRPT S +V L
Sbjct: 245 PEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 8e-45
Identities = 70/244 (28%), Positives = 111/244 (45%), Gaps = 23/244 (9%)
Query: 11 DGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
GK +A+K + + + +E E+ ++ KL+H N+VRL+ +E++ L+ EY
Sbjct: 23 TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGG 82
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
L L + D R + I L YLH I+HRDLK N+LL+ + +
Sbjct: 83 DLFDLL-KKRGRLSEDEAR--FYLRQILSALEYLHS---KGIVHRDLKPENILLDEDGHV 136
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
K++DFG+AR + VGT YMAPE + + D++S GV+L E+++GK
Sbjct: 137 KLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
Query: 190 KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA 249
F G L +K + + P S A +L++ LL D
Sbjct: 194 --PPFP----GDDQLLELFKKIGKPK-PPFPPPEWDISPEAKDLIR----KLLVK--DPE 240
Query: 250 DRPT 253
R T
Sbjct: 241 KRLT 244
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 76/258 (29%), Positives = 123/258 (47%), Gaps = 46/258 (17%)
Query: 11 DGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCL-EENESLLIY-EYM 66
G+ +AVK LS S + L+ + E+ +++ LQH N+VR +G EE +L I+ EY+
Sbjct: 24 TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83
Query: 67 PNKSLDVFL--FDS---------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRD 115
SL L F TR I GL YLH I+HRD
Sbjct: 84 SGGSLSSLLKKFGKLPEPVIRKYTRQ--------------ILEGLAYLH---SNGIVHRD 126
Query: 116 LKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDV 175
+K +N+L++ + K++DFG A+ G ++ T + GT +MAPE + +D+
Sbjct: 127 IKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADI 186
Query: 176 FSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235
+S G ++E+ +GK SELG + ++ +K+ GE E+ P ++ E
Sbjct: 187 WSLGCTVIEMATGKPP----WSELG-NPMAALYKIGSSGEPPEI--P----EHLSEEAKD 235
Query: 236 FIHIGLLCVQADSADRPT 253
F+ C++ D RPT
Sbjct: 236 FL---RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 54/180 (30%), Positives = 97/180 (53%), Gaps = 10/180 (5%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
GKE+A+K + S + ++ NE+ ++ K +H N+V+ +G L+++E ++ E+ S
Sbjct: 24 TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS 83
Query: 71 LDVFLFDSTRSVQLDWKRRIS-IINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
L L + +++ I+ + + +GL YLH IIHRD+KA+N+LL +
Sbjct: 84 LKDLLKSTNQTLTESQ---IAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEV 137
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
K+ DFG++ N +VGT +MAPE + K+D++S G+ +E+ GK
Sbjct: 138 KLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-33
Identities = 72/257 (28%), Positives = 121/257 (47%), Gaps = 22/257 (8%)
Query: 12 GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPN 68
G+++AVK L+ + Q +F+ E+ ++ L H+N+V+ G C + LI EY+P+
Sbjct: 33 GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
SL +L Q++ KR + + I +G+ YL + IHRDL A N+L+ E
Sbjct: 93 GSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDL 147
Query: 129 PKISDFGMARIFGGNQSE----ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
KISDFG+A++ + + + Y APE FS SDV+SFGV L E
Sbjct: 148 VKISDFGLAKVL--PEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYE 204
Query: 185 IIS-GKKNTGFYLSELGQSLLSYTWKLWCEG--EALELMEPVLKQSCVAAELLKFIHIGL 241
+ + G + S + L LEL++ + + + +
Sbjct: 205 LFTYGDPS----QSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMK 260
Query: 242 LCVQADSADRPTMSSVV 258
LC +A+ DRP+ + ++
Sbjct: 261 LCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 9e-32
Identities = 71/252 (28%), Positives = 112/252 (44%), Gaps = 36/252 (14%)
Query: 11 DGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
GK A+K++ + ++ E+ + + +V+ +G +E E ++ EYM
Sbjct: 25 TGKIYALKKIHVDGDEEFR--KQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82
Query: 68 NKSLDVFLFDSTRSVQLDWKRRI--SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
SL D + V + I I +GL YLH ++ IIHRD+K SN+L+N
Sbjct: 83 GGSLA----DLLKKVGK-IPEPVLAYIARQILKGLDYLH--TKRHIIHRDIKPSNLLINS 135
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ KI+DFG++++ + NT VGT YM+PE +S +D++S G+ LLE
Sbjct: 136 KGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPERIQGESYSYAADIWSLGLTLLEC 193
Query: 186 ISGKKNTGFYLSELGQ----SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL 241
GK F GQ L+ C+G L + E FI
Sbjct: 194 ALGK----FPFLPPGQPSFFELMQAI----CDGPPPSLPA-----EEFSPEFRDFIS--- 237
Query: 242 LCVQADSADRPT 253
C+Q D RP+
Sbjct: 238 ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 74/255 (29%), Positives = 115/255 (45%), Gaps = 41/255 (16%)
Query: 11 DGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
GK +AVK + + +Q + E+ ++ K +V +G + + EYM
Sbjct: 25 TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG 84
Query: 70 SLDVFLFDSTRSVQLDWKRRI--SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
SLD L + VQ RI I + +GL YLHE KIIHRD+K SN+L+N
Sbjct: 85 SLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRG 138
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
K+ DFG++ S A T VGT YMAPE +SVKSD++S G+ L+E+ +
Sbjct: 139 QIKLCDFGVSGQL--VNSLAKTF--VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT 194
Query: 188 GKKNTGFYLSELGQSLLSYTWKLWCEGEA--LELME-------PVLKQSCVAAELLKFIH 238
G+ + + + EL++ P L + + F++
Sbjct: 195 GR----------------FPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238
Query: 239 IGLLCVQADSADRPT 253
LC+ D +RP+
Sbjct: 239 ---LCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 65/178 (36%), Positives = 97/178 (54%), Gaps = 14/178 (7%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
G+++AVK L S Q F E +++ L+H NLV+L G L+ N ++ EYM SL
Sbjct: 29 GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
+L R+V + +++ + G+ YL E +HRDL A NVL++ ++ K+
Sbjct: 88 VDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKV 143
Query: 132 SDFGMARIFGGNQSEANTNRIVGTY--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
SDFG+A+ EA+ + G + APE E FS KSDV+SFG+LL EI S
Sbjct: 144 SDFGLAK-------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 63/182 (34%), Positives = 95/182 (52%), Gaps = 6/182 (3%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G + +A+K L Q+F+ EV + +L+HK+L+ LF C +I E
Sbjct: 24 EGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
M SL FL V L I + +A G+ YL E IHRDL A N+L+
Sbjct: 84 MEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGE 139
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
++ K++DFG+AR+ + ++ +I Y + APE A G FS KSDV+SFG+LL E+
Sbjct: 140 DLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEM 197
Query: 186 IS 187
+
Sbjct: 198 FT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 62/188 (32%), Positives = 97/188 (51%), Gaps = 19/188 (10%)
Query: 15 IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+A+K L + QEF+ E L++ LQH N+V L G C +E + +++EY+ + L
Sbjct: 38 VAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE 97
Query: 74 FLF-----------DSTRSVQ--LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
FL +V+ LD + I IA G+ YL S +HRDL A N
Sbjct: 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARN 154
Query: 121 VLLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
L+ + KISDFG++R I+ + + ++ +M PE + G F+ +SD++SFG
Sbjct: 155 CLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR-WMPPEAILYGKFTTESDIWSFG 213
Query: 180 VLLLEIIS 187
V+L EI S
Sbjct: 214 VVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-29
Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 28/190 (14%)
Query: 11 DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
G +A+K++S + L+ E+ L+ L+H N+V+ G + +I EY N
Sbjct: 24 TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83
Query: 69 KSLDVFLFDSTRSVQLDWKRR--------ISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
SL R + K+ + + +GL YLHE +IHRD+KA+N
Sbjct: 84 GSL--------RQII---KKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAAN 129
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-YAMEGLFSVKSDVFSFG 179
+L + K++DFG+A + + +VGT +MAPE M G S SD++S G
Sbjct: 130 ILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSGA-STASDIWSLG 186
Query: 180 VLLLEIISGK 189
++E+++G
Sbjct: 187 CTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 6e-29
Identities = 54/184 (29%), Positives = 94/184 (51%), Gaps = 18/184 (9%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
A GKE+A+K++ R Q + NE+ ++ +H N+V + L +E ++ EYM
Sbjct: 42 ATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100
Query: 70 SL----DVFLFDSTRSVQLDWKRRIS-IINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
SL +I+ + + +GL YLH +IHRD+K+ N+LL+
Sbjct: 101 SLTDIITQNFVRMNEP-------QIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLS 150
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
+ + K++DFG A +S+ N+ +VGT +MAPE + K D++S G++ +E
Sbjct: 151 KDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
Query: 185 IISG 188
+ G
Sbjct: 209 MAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 62/177 (35%), Positives = 93/177 (52%), Gaps = 12/177 (6%)
Query: 14 EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
++AVK L + + F E ++ KL+H LV+L+ C EE ++ EYM SL
Sbjct: 32 KVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90
Query: 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISD 133
FL +L + + + IA G+ YL IHRDL A N+L+ + KI+D
Sbjct: 91 FLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIAD 146
Query: 134 FGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
FG+AR+ ++ A G + APE A G F++KSDV+SFG+LL EI++
Sbjct: 147 FGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (277), Expect = 5e-28
Identities = 70/261 (26%), Positives = 114/261 (43%), Gaps = 21/261 (8%)
Query: 11 DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQH-KNLVRLFGCCLEENESLLIYEYM 66
D K +A+K L++ + ++ F E+ ++A L H N+V+L+ +E L+ EY+
Sbjct: 21 DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
SL+ L R L + I+ I L YLH IIHRD+K N+LL+ +
Sbjct: 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRD 137
Query: 127 MN-PKISDFGMARIFGGNQSEAN----TNRIVGTYGYMAPEYAMEGLF---SVKSDVFSF 178
K+ DFG+A++ S ++ + VGT GYMAPE + S SD++S
Sbjct: 138 GRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197
Query: 179 GVLLLEIISGKK-NTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237
G+ L E+++G G S L +L + L S
Sbjct: 198 GITLYELLTGLPPFEGEKNSSATSQTLKIILEL-----PTPSLASPLSPSNPELISKAAS 252
Query: 238 HIGLLCVQADSADRPTMSSVV 258
+ + D +R + SS +
Sbjct: 253 DLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 8 KLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+ +DGK +K LS S + ++ NEV ++ KL H N+++ + E+ + ++ EY
Sbjct: 21 RKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80
Query: 66 MPNKSLDVFLFDSTRSVQ-------LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
L + + + LDW ++ + L YLH KI+HRD+K
Sbjct: 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL------ALKYLHSR---KILHRDIKP 131
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSF 178
N+ L K+ DFG++++ A T +VGT Y++PE ++ KSD++S
Sbjct: 132 QNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKPYNYKSDIWSL 189
Query: 179 GVLLLEIISGKK 190
G +L E+ + K
Sbjct: 190 GCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 59/177 (33%), Positives = 90/177 (50%), Gaps = 12/177 (6%)
Query: 14 EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+AVK L + ++F E ++ KL+H L++L+ C E ++ E M SL
Sbjct: 32 PVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE 90
Query: 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISD 133
+L L + I + +A G+ YL + IHRDL A NVL+ K++D
Sbjct: 91 YLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVAD 146
Query: 134 FGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
FG+AR+ + EA G + APE A+ FS+KSDV+SFG+LL EI++
Sbjct: 147 FGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-27
Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 33/191 (17%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY----- 65
G+ +A+K + LQE E++++ + +V+ +G + + ++ EY
Sbjct: 27 TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84
Query: 66 ------MPNKSLDVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKA 118
+ NK+L + I+ I +GL YLH K IHRD+KA
Sbjct: 85 VSDIMKITNKTLT--------------EEEIAAILYQTLKGLEYLH---SNKKIHRDIKA 127
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSF 178
N+LLN E K++DFG++ ++ NT ++GT +MAPE E ++ K+D++S
Sbjct: 128 GNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNNKADIWSL 185
Query: 179 GVLLLEIISGK 189
G+ +E+ GK
Sbjct: 186 GITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 66/214 (30%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 4 CLQGKLADGKEI-AVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
C + + KE+ AVK L T+ ++ F+ E L+ QH+N+V+ +G C E + ++
Sbjct: 26 CYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM 85
Query: 62 IYEYMPNKSLDVFLF----DSTRSV-------QLDWKRRISIINGIARGLLYLHEDSRLK 110
++EYM + L+ FL D+ +L + + I IA G++YL +
Sbjct: 86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL---ASQH 142
Query: 111 IIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTN---RIVGT----YGYMAPEY 163
+HRDL N L+ +++ KI DFGM+R + T R+ G +M PE
Sbjct: 143 FVHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYYRVGGHTMLPIRWMPPES 195
Query: 164 AMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLS 197
M F+ +SDV+SFGV+L EI + K + LS
Sbjct: 196 IMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-27
Identities = 63/174 (36%), Positives = 98/174 (56%), Gaps = 7/174 (4%)
Query: 14 EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
++A+K L + S + F E L+ +LQH LVRL+ +E +I EYM N SL
Sbjct: 32 KVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVD 89
Query: 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISD 133
FL + ++L + I + IA G+ ++ R IHRDL+A+N+L++ + KI+D
Sbjct: 90 FL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIAD 145
Query: 134 FGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
FG+AR+ N+ A + APE G F++KSDV+SFG+LL EI++
Sbjct: 146 FGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 80/265 (30%), Positives = 130/265 (49%), Gaps = 39/265 (14%)
Query: 8 KLADGKEI--AVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
KL KEI A+K L S + +F E +++ + H N++RL G + ++I E
Sbjct: 26 KLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
YM N SLD FL + + + ++ GIA G+ YL S + +HRDL A N+L+N
Sbjct: 86 YMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMNYVHRDLAARNILVN 140
Query: 125 HEMNPKISDFGMARIFGGNQSEANTN--RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ K+SDFG++R +++ T +I + APE F+ SDV+SFG+++
Sbjct: 141 SNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRKFTSASDVWSFGIVM 198
Query: 183 LEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALE----LMEPVLKQSCVAAELLKFI 237
E++S G++ Y Q ++ A+E L P+ C +A +
Sbjct: 199 WEVMSYGERP---YWDMSNQDVIK----------AVEDGYRLPPPM---DCPSA-----L 237
Query: 238 H-IGLLCVQADSADRPTMSSVVVML 261
+ + L C Q D +RPT S +V L
Sbjct: 238 YQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 82/269 (30%), Positives = 114/269 (42%), Gaps = 42/269 (15%)
Query: 8 KLADGKEI--AVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
+ GKE+ AVK L + G +EF E +++A+L H +VRL G C E +L+ E
Sbjct: 17 LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-PLMLVME 75
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIIN------GIARGLLYLHEDSRLKIIHRDLKA 118
P L +L +R I + + +A G+ YL +HRDL A
Sbjct: 76 LAPLGPLLKYLKK---------RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAA 123
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY--GYMAPEYAMEGLFSVKSDVF 176
NVLL + KISDFGM+R G S+ G + + APE G FS KSDV+
Sbjct: 124 RNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVW 182
Query: 177 SFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235
S+GV L E S G K Y G E + ++E + +
Sbjct: 183 SYGVTLWEAFSYGAKP---YGEMKGA-------------EVIAMLESGERLPRPEECPQE 226
Query: 236 FIHIGLLCVQADSADRPTMSSVVVMLASD 264
I L C + DRPT S + D
Sbjct: 227 IYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 15/195 (7%)
Query: 15 IAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
+AVK L S Q+F+ E L+ LQH+++VR +G C E L+++EYM + L+ F
Sbjct: 38 VAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97
Query: 75 L---------FDSTRSV---QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
L V QL + ++I + IA G++YL + L +HRDL N L
Sbjct: 98 LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCL 154
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ + KI DFGM+R R + +M PE + F+ +SD++SFGV+L
Sbjct: 155 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214
Query: 183 LEIISGKKNTGFYLS 197
EI + K + LS
Sbjct: 215 WEIFTYGKQPWYQLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 5e-26
Identities = 74/271 (27%), Positives = 116/271 (42%), Gaps = 52/271 (19%)
Query: 14 EIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
+A+K ++ + EF NE +++ + ++VRL G +L++ E M L
Sbjct: 38 RVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLK 97
Query: 73 VFLFDSTRSVQ-----LDWKRRISIIN---GIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
+L S R L I IA G+ YL K +HRDL A N ++
Sbjct: 98 SYL-RSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVA 153
Query: 125 HEMNPKISDFGMAR-IFGGNQSEANTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFG 179
++ KI DFGM R I+ E + R G +MAPE +G+F+ KSDV+SFG
Sbjct: 154 EDLTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFG 208
Query: 180 VLLLEIIS-------GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232
V+L E+ + G N + +L + +G L+L E +
Sbjct: 209 VVLWEMATLAEQPYQGLSN---------EEVLKFV----IDGGHLDLPE------NCPDK 249
Query: 233 LLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263
LL+ + +C Q + RPT +V L
Sbjct: 250 LLELM---RMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 65/174 (37%), Positives = 94/174 (54%), Gaps = 6/174 (3%)
Query: 14 EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
++AVK L + +Q F E L+ LQH LVRL+ +E +I EYM SL
Sbjct: 32 KVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD 90
Query: 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISD 133
FL S ++ + I IA G+ Y+ R IHRDL+A+NVL++ + KI+D
Sbjct: 91 FL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIAD 146
Query: 134 FGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
FG+AR+ N+ A + APE G F++KSDV+SFG+LL EI++
Sbjct: 147 FGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 9e-26
Identities = 65/193 (33%), Positives = 95/193 (49%), Gaps = 17/193 (8%)
Query: 7 GKLADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
G+ D E+ V + S Q +F E +++K H+N+VRL G E ++
Sbjct: 29 GRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL 88
Query: 64 EYMPNKSLDVFLFDS----TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
E M L FL ++ R L K + +A+G YL E+ IHRD+ A
Sbjct: 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAAR 145
Query: 120 NVLLNHEMNP----KISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSD 174
N LL + P KI+DFGMAR I+ + R + +M PE ++G+F+ K+D
Sbjct: 146 NCLLTCK-GPGRVAKIADFGMARDIYRASYYRKG-GRAMLPIKWMPPEAFLDGIFTSKTD 203
Query: 175 VFSFGVLLLEIIS 187
V+SFGVLL EI S
Sbjct: 204 VWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 64/194 (32%), Positives = 103/194 (53%), Gaps = 14/194 (7%)
Query: 1 MESCLQGKLAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--E 56
+E C L D G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V+ G C
Sbjct: 20 VELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79
Query: 57 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL 116
L+ EY+P SL +L +LD ++ + + I +G+ YL + +HRDL
Sbjct: 80 RNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYL---GSKRYVHRDL 134
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG---TYGYMAPEYAMEGLFSVKS 173
N+L+ E KI DFG+ ++ ++ E R G + Y APE E FSV S
Sbjct: 135 ATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESLTESKFSVAS 192
Query: 174 DVFSFGVLLLEIIS 187
DV+SFGV+L E+ +
Sbjct: 193 DVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 56/183 (30%), Positives = 100/183 (54%), Gaps = 16/183 (8%)
Query: 14 EIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
+A+K L + + +E +E ++A + H ++VRL G CL + LI + MP L
Sbjct: 38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLL 96
Query: 73 VFLFDSTRSVQ----LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
++ + ++ L+W +I A+G+ YL E+ RL +HRDL A NVL+ +
Sbjct: 97 DYVRNHKDNIGSQYLLNWCVQI------AKGMSYL-EEKRL--VHRDLAARNVLVKTPQH 147
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS- 187
KI+DFG+A++ ++ E + +MA E + +++ KSDV+S+GV + E+++
Sbjct: 148 VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF 207
Query: 188 GKK 190
G K
Sbjct: 208 GAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 62/177 (35%), Positives = 89/177 (50%), Gaps = 12/177 (6%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY-EYMPNKS 70
G ++AVK + + Q F E +++ +L+H NLV+L G +EE L I EYM S
Sbjct: 29 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
L +L RSV L + + + YL ++ +HRDL A NVL++ + K
Sbjct: 87 LVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAK 142
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+SDFG+ + Q + APE E FS KSDV+SFG+LL EI S
Sbjct: 143 VSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-25
Identities = 62/192 (32%), Positives = 100/192 (52%), Gaps = 13/192 (6%)
Query: 5 LQGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
+G +G E + VK L +T + LQ EF+ E+ + KL HKN+VRL G C E +
Sbjct: 26 AKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM 85
Query: 62 IYEYMPNKSLDVFL------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRD 115
I EY L FL + + L K+++++ IA G+ +L S + +HRD
Sbjct: 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRD 142
Query: 116 LKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDV 175
L A N L++ + K+S +++ ++ N ++ ++APE E FS KSDV
Sbjct: 143 LAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPEAVQEDDFSTKSDV 201
Query: 176 FSFGVLLLEIIS 187
+SFGVL+ E+ +
Sbjct: 202 WSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 1e-24
Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 12/164 (7%)
Query: 30 EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR 89
+F E ++ KL H NLV+L+G C ++ ++ EYM N L +L + + +W
Sbjct: 45 DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--L 102
Query: 90 ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149
+ + + + + YL + IHRDL A N L+ + K+SDFG+AR +Q ++
Sbjct: 103 LDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159
Query: 150 NRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 190
GT + PE FS KSDV+SFGVL+ E+ S K
Sbjct: 160 ----GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-24
Identities = 60/185 (32%), Positives = 100/185 (54%), Gaps = 14/185 (7%)
Query: 10 ADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
AD + A+K+ LS+ + + +E +E ++AKL ++R + L++ + ++ EY
Sbjct: 23 ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82
Query: 68 NKSLDVFL---FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
N L L W+ I I+ G+A +LH KI+HRD+K+ N+ L+
Sbjct: 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----HLHSK---KILHRDIKSLNLFLD 135
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
N KI D G+A++ N + ANT IVGT Y++PE + ++ KSDV++ GV+L E
Sbjct: 136 AYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYE 193
Query: 185 IISGK 189
+GK
Sbjct: 194 CCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 4e-24
Identities = 55/174 (31%), Positives = 91/174 (52%), Gaps = 6/174 (3%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
+AVK L + ++EF E ++ +++H NLV+L G C E +I E+M +L
Sbjct: 31 SLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
+L + R +++ + + I+ + YL + + IHRDL A N L+ K+
Sbjct: 90 LDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKV 145
Query: 132 SDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+DFG++R+ G+ A+ + APE FS+KSDV++FGVLL EI
Sbjct: 146 ADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 8e-24
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 13/186 (6%)
Query: 8 KLADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIY 63
K GK A+K L + + ++ E +++++ H +V+L + E L L+
Sbjct: 14 KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH-YAFQTEEKLYLVL 72
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
EY P L + R I L YLH L II+RDLK N+LL
Sbjct: 73 EYAPGGEL-FSHLSKEGRFSEERARFY--AAEIVLALEYLH---SLGIIYRDLKPENILL 126
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
+ + + K++DFG+A+ S NT GT Y+APE + + D +S GVLL
Sbjct: 127 DADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLY 184
Query: 184 EIISGK 189
E+++GK
Sbjct: 185 EMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-23
Identities = 63/193 (32%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 9 LADGKE---IAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
L G +AVK L + + Q +EF E L++ H N+V+L G CL +I E
Sbjct: 20 LGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79
Query: 65 YMPNKSLDVFLFD----STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
M L +L D L K + I +A+G +YL ++ IHRDL A N
Sbjct: 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARN 136
Query: 121 VLLNHEMNP-----KISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSD 174
L++ + KI DFG+AR I+ + ++ +MAPE ++G F+ +SD
Sbjct: 137 CLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR-WMAPESLLDGKFTTQSD 195
Query: 175 VFSFGVLLLEIIS 187
V+SFGVL+ EI++
Sbjct: 196 VWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 60/192 (31%), Positives = 89/192 (46%), Gaps = 22/192 (11%)
Query: 8 KLADGKEI-AVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLL--IY 63
+L + I A+K ++ LQ + E+ + + +V+ +G L+E+ S +
Sbjct: 21 RLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLK 117
EY SLD S RI I + +GL YLH KIIHRD+K
Sbjct: 81 EYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIK 132
Query: 118 ASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177
SN+LL + K+ DFG++ S A T GT YMAPE +S+ SDV+S
Sbjct: 133 PSNILLTRKGQVKLCDFGVSGELV--NSLAGT--FTGTSFYMAPERIQGKPYSITSDVWS 188
Query: 178 FGVLLLEIISGK 189
G+ LLE+ +
Sbjct: 189 LGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 2e-23
Identities = 57/187 (30%), Positives = 95/187 (50%), Gaps = 13/187 (6%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
G + +++A+K + R ++F E ++ KL H LV+L+G C E + L++E+M
Sbjct: 23 GYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
+ L +L + + + + + + G+ YL + +IHRDL A N L+
Sbjct: 82 EHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGEN 136
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
K+SDFGM R +Q ++T GT + +PE +S KSDV+SFGVL+
Sbjct: 137 QVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMW 192
Query: 184 EIISGKK 190
E+ S K
Sbjct: 193 EVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 49/159 (30%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 91
E+ L+ KL+H N+VRL + +++EYM + D+ + V+ +
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKC 104
Query: 92 IINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151
+ + GL YLH + I+HRD+K SN+L+N++ K++DFG+AR + S TNR
Sbjct: 105 YMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR 161
Query: 152 IVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 189
++ T Y PE + + + D++S G +L E+ GK
Sbjct: 162 VI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-23
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 25/194 (12%)
Query: 15 IAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+AVK L S +F+ E L+A+ H N+V+L G C L++EYM L+
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97
Query: 74 FLFDST-------------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 114
FL + + L ++ I +A G+ YL E K +HR
Sbjct: 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHR 154
Query: 115 DLKASNVLLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKS 173
DL N L+ M KI+DFG++R I+ + +A+ N + +M PE ++ +S
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR-WMPPESIFYNRYTTES 213
Query: 174 DVFSFGVLLLEIIS 187
DV+++GV+L EI S
Sbjct: 214 DVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-23
Identities = 59/184 (32%), Positives = 92/184 (50%), Gaps = 6/184 (3%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
+G L E+AVK T L ++F E ++ + H N+V+L G C+++ ++ E
Sbjct: 13 KGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME 72
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
+P SL FL + +L K+ + + A G+ YL +S+ IHRDL A N L+
Sbjct: 73 LVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIHRDLAARNCLVG 127
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
KISDFGM+R G + + APE G ++ +SDV+S+G+LL E
Sbjct: 128 ENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWE 187
Query: 185 IISG 188
S
Sbjct: 188 TFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 4e-23
Identities = 58/182 (31%), Positives = 87/182 (47%), Gaps = 16/182 (8%)
Query: 15 IAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
IA+K + + +Q E+ L + L+H+N+V+ G E + E +P SL
Sbjct: 36 IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL 95
Query: 75 LFDSTRSVQLDWKRRISIIN----GIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEMNP 129
L RS K I I GL YLH+ +I+HRD+K NVL+N +
Sbjct: 96 L----RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVV 148
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIIS 187
KISDFG ++ G T GT YMAPE +G + +D++S G ++E+ +
Sbjct: 149 KISDFGTSKRLAGINPCTET--FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT 206
Query: 188 GK 189
GK
Sbjct: 207 GK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-23
Identities = 77/268 (28%), Positives = 130/268 (48%), Gaps = 44/268 (16%)
Query: 8 KLADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
K+ KE+AV + G + Q+F +E +++ + H N++RL G + +++I E
Sbjct: 27 KMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86
Query: 65 YMPNKSLDVFLFDST---RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
YM N +LD +L D S QL + ++ GIA G+ YL S + +HRDL A N+
Sbjct: 87 YMENGALDKYLRDHDGEFSSYQL-----VGMLRGIAAGMKYL---SDMNYVHRDLAARNI 138
Query: 122 LLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDV 175
L+N + K+SDFG++R+ E + T G + APE F+ SDV
Sbjct: 139 LVNSNLECKVSDFGLSRVL-----EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDV 193
Query: 176 FSFGVLLLEIISGKKNTGFYLS--ELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233
+SFG+++ E++S + + +S E+ +++ + L P+ S V +
Sbjct: 194 WSFGIVMWEVMSFGERPYWDMSNHEVMKAI----------NDGFRLPAPMDCPSAVYQLM 243
Query: 234 LKFIHIGLLCVQADSADRPTMSSVVVML 261
L+ C Q D A RP +V +L
Sbjct: 244 LQ-------CWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 9e-23
Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 34/207 (16%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQEFK-----NEVTLIAKL-QHKNLVRLFGCCLEENESL- 60
+ KE A+K L + Q ++E K E ++ +L H +++L+ ++ E+L
Sbjct: 22 EKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY-YTFQDEENLY 78
Query: 61 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
+ EY PN L ++ + LD K I L YLH IIHRDLK N
Sbjct: 79 FVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPEN 132
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSE------------------ANTNRIVGTYGYMAPE 162
+LL+ +M+ KI+DFG A++ N S VGT Y++PE
Sbjct: 133 ILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPE 192
Query: 163 YAMEGLFSVKSDVFSFGVLLLEIISGK 189
E SD+++ G ++ ++++GK
Sbjct: 193 LLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-22
Identities = 57/179 (31%), Positives = 101/179 (56%), Gaps = 11/179 (6%)
Query: 13 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
K+I V+++++ Q NE ++ L H N++ + LE+ +++ EY P +L
Sbjct: 31 KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA 87
Query: 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEMNPKI 131
++ S+ LD +I++ + LL LH I+HRDLK N+LL+ H+M KI
Sbjct: 88 EYIQKRCNSL-LDED---TILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKI 143
Query: 132 SDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 190
DFG+++I ++S+A T +VGT Y++PE ++ KSD+++ G +L E+ S K+
Sbjct: 144 GDFGISKIL-SSKSKAYT--VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-22
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 21/163 (12%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-- 91
E++L+ +L+H N+V+L E + L++EY + L +L + + + I
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 92 IINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151
++ G+A Y H S +I+HRDLK N+L+N + K++DFG+AR F G T+
Sbjct: 107 LLRGLA----YCH--SH-RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHE 158
Query: 152 IVGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 189
+V T Y APE L K D++S G + E+I+GK
Sbjct: 159 VV-TLWYRAPEI----LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-22
Identities = 60/175 (34%), Positives = 99/175 (56%), Gaps = 9/175 (5%)
Query: 14 EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
++AVK L + + F E ++ KL+H LV+L+ EE ++ EYM SL
Sbjct: 32 KVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE-PIYIVTEYMSKGSLLD 89
Query: 74 FLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
FL D R+++L + + +A G+ Y+ R+ IHRDL+++N+L+ + KI+
Sbjct: 90 FLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIA 144
Query: 133 DFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
DFG+AR+ N+ A + APE A+ G F++KSDV+SFG+LL E+++
Sbjct: 145 DFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 61/186 (32%), Positives = 91/186 (48%), Gaps = 20/186 (10%)
Query: 15 IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+AVK L S ++F EV ++++L N+ RL G C + +I EYM N L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 74 FL--------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
FL + S L + + + IA G+ YL L +HRDL N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGT----YGYMAPEYAMEGLFSVKSDVFSFGVL 181
KI+DFGM+R N ++ R+ G +MA E + G F+ KSDV++FGV
Sbjct: 166 NYTIKIADFGMSR----NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 182 LLEIIS 187
L EI++
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-22
Identities = 75/264 (28%), Positives = 127/264 (48%), Gaps = 36/264 (13%)
Query: 8 KLADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
KL +EI V + +G + ++F +E +++ + H N++ L G + +++ E
Sbjct: 26 KLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
YM N SLD FL Q + + ++ GIA G+ YL S + +HRDL A N+L+N
Sbjct: 86 YMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILVN 140
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSF 178
+ K+SDFG++R+ + A T R G + APE F+ SDV+S+
Sbjct: 141 SNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRWTAPEAIAYRKFTSASDVWSY 195
Query: 179 GVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238
G+++ E++S + + +S Q ++ E L P+ C AA +H
Sbjct: 196 GIVMWEVMSYGERPYWEMSN--QDVIKAI------EEGYRLPAPM---DCPAA-----LH 239
Query: 239 IGLL-CVQADSADRPTMSSVVVML 261
+L C Q D +RP +V +L
Sbjct: 240 QLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 80/265 (30%), Positives = 123/265 (46%), Gaps = 45/265 (16%)
Query: 15 IAVKRLSRTSGQGLQEFKNEVTLIAKL----QHKNLVRLFGCCLEENESLLIYEYMPNKS 70
+AVK L + + ++ + V+ + + +HKN++ L G C +E ++ EY + +
Sbjct: 45 VAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGN 102
Query: 71 LDVFL-----------FDSTRSV--QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
L FL D R L K +S +ARG+ +L S+ K IHRDL
Sbjct: 103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL--ASK-KCIHRDLA 159
Query: 118 ASNVLL--NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDV 175
A NVL+ +H M KI+DFG+AR T +MAPE + +++ +SDV
Sbjct: 160 ARNVLVTEDHVM--KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDV 217
Query: 176 FSFGVLLLEIIS--GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233
+SFGVLL EI + G G + EL +KL EG +E +P Q+C
Sbjct: 218 WSFGVLLWEIFTLGGSPYPGIPVEEL--------FKLLKEGYRME--KP---QNCT---- 260
Query: 234 LKFIHIGLLCVQADSADRPTMSSVV 258
+ H+ C + RPT +V
Sbjct: 261 QELYHLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 3e-22
Identities = 59/194 (30%), Positives = 100/194 (51%), Gaps = 15/194 (7%)
Query: 15 IAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
+AVK L S ++F E L+ LQH+++V+ +G C+E + ++++EYM + L+ F
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97
Query: 75 L----------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
L + R +L + + I IA G++YL + +HRDL N L+
Sbjct: 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVG 154
Query: 125 HEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
+ KI DFGM+R ++ + + ++ +M PE M F+ +SDV+S GV+L
Sbjct: 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLW 213
Query: 184 EIISGKKNTGFYLS 197
EI + K + LS
Sbjct: 214 EIFTYGKQPWYQLS 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 4e-22
Identities = 74/256 (28%), Positives = 124/256 (48%), Gaps = 40/256 (15%)
Query: 9 LADGKEIAVKRLS-----RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
L DG AVK +S +T + +++ + E+ L++KLQH N+V+ G EE ++L I+
Sbjct: 22 LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-DNLYIF 80
Query: 64 -EYMPNKSLDVFL--FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
E +P SL L + S + R I GL YLH+ +HRD+K +N
Sbjct: 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHDR---NTVHRDIKGAN 132
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEAN--TNRIVGTYGYMAPEYAM-EGLFSVKSDVFS 177
+L++ K++DFGMA+ Q G+ +MAPE +G + + +D++S
Sbjct: 133 ILVDTNGVVKLADFGMAK-----QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWS 187
Query: 178 FGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237
G +LE+ +GK S+L ++ +K+ E + + ++ E FI
Sbjct: 188 LGCTVLEMATGKPP----WSQLEG--VAAVFKIGRSKELPPIPDH------LSDEAKDFI 235
Query: 238 HIGLLCVQADSADRPT 253
L C+Q D + RPT
Sbjct: 236 ---LKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-22
Identities = 75/262 (28%), Positives = 122/262 (46%), Gaps = 24/262 (9%)
Query: 12 GKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENES--LLIYEYMPN 68
G+ +AVK L R GQ +K E+ ++ L H+N+V+ GCC E+ LI EY+P
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
SL +L + L + + I G+ YLH IHRDL A NVLL+++
Sbjct: 93 GSLRDYL--PKHKLNL--AQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRL 145
Query: 129 PKISDFGMAR-IFGGNQ----SEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
KI DFG+A+ + G++ E + + + A E E FS SDV+SFGV L
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WYAVECLKENKFSYASDVWSFGVTLY 201
Query: 184 EIISGKKNTGFYLSELGQ--SLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL 241
E+++ + S + ++ +EL+E ++ C + +
Sbjct: 202 ELLT---HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMK 258
Query: 242 LCVQADSADRPTMSSVVVMLAS 263
C + ++ RPT S++ +L
Sbjct: 259 NCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 8e-22
Identities = 53/166 (31%), Positives = 98/166 (59%), Gaps = 10/166 (6%)
Query: 28 LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK 87
L E+ L+ +LQH+N+V+ G L+ + + EY+P S+ L ++ + +
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLV 108
Query: 88 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGN--QS 145
R + + I +GL YLH +R IIHRD+K +N+L++++ KISDFG+++ N +
Sbjct: 109 R--NFVRQILKGLNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST 163
Query: 146 EANTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+ N R + G+ +MAPE + ++ K+D++S G L++E+++GK
Sbjct: 164 KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-21
Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 18/197 (9%)
Query: 15 IAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
+AVK L + ++F+ E L+ LQH+++V+ +G C + + ++++EYM + L+ F
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97
Query: 75 LF----DSTRSV---------QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
L D+ V +L + + I + IA G++YL + +HRDL N
Sbjct: 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNC 154
Query: 122 LLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
L+ + KI DFGM+R ++ + + ++ +M PE M F+ +SDV+SFGV
Sbjct: 155 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGV 213
Query: 181 LLLEIISGKKNTGFYLS 197
+L EI + K F LS
Sbjct: 214 ILWEIFTYGKQPWFQLS 230
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-21
Identities = 77/270 (28%), Positives = 120/270 (44%), Gaps = 54/270 (20%)
Query: 15 IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+AVK L + + +F E+ ++++L++ N++RL G C+ ++ +I EYM N L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 74 FLFDSTRSVQLDWKRR-----ISIIN------GIARGLLYLHEDSRLKIIHRDLKASNVL 122
FL S R ++ + +SI N IA G+ YL + L +HRDL N L
Sbjct: 107 FL--SQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ + KI+DFGM+R R V +MA E + G F+ SDV++FGV L
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 183 LEIISGKK--------------NTG-FYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS 227
E+ + K NTG F+ ++ Q LS T C +LM
Sbjct: 222 WEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQT--PLCPSPVFKLM------- 272
Query: 228 CVAAELLKFIHIGLLCVQADSADRPTMSSV 257
+ C D DRPT + +
Sbjct: 273 -------------MRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-21
Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 25/195 (12%)
Query: 15 IAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+AVK L + L++ +E L+ ++ H ++++L+G C ++ LLI EY SL
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92
Query: 74 FLFDSTR----SVQLDWKRRISIING-----------------IARGLLYLHEDSRLKII 112
FL +S + + D R S ++ I+RG+ YL E +K++
Sbjct: 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLV 149
Query: 113 HRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVK 172
HRDL A NVL+ KISDFG++R S ++ +MA E + +++ +
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ 209
Query: 173 SDVFSFGVLLLEIIS 187
SDV+SFGVLL EI++
Sbjct: 210 SDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-21
Identities = 58/188 (30%), Positives = 100/188 (53%), Gaps = 20/188 (10%)
Query: 12 GKEIAVKR-----LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY-EY 65
G+E+AVK+ S + + + + E+ L+ LQH+ +V+ +G CL ++E+L I+ EY
Sbjct: 27 GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEY 85
Query: 66 MPNKSLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
MP S+ L T +V + R+ I G+ YLH + I+HRD+K +N+L
Sbjct: 86 MPGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYLHSN---MIVHRDIKGANIL 136
Query: 123 LNHEMNPKISDFGMA-RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
+ N K+ DFG + R+ S + GT +M+PE + K+DV+S G
Sbjct: 137 RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCT 196
Query: 182 LLEIISGK 189
++E+++ K
Sbjct: 197 VVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 49/179 (27%), Positives = 95/179 (53%), Gaps = 10/179 (5%)
Query: 12 GKEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
+ +A+K + + +++ + E+ +++ + + + +G L+ ++ +I EY S
Sbjct: 26 NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85
Query: 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
D + +LD I+ + GL YLHE+ IHRD+KA+N+LL+ E + K
Sbjct: 86 C----LDLLKPGKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVK 138
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
++DFG++ S+ NT VGT +MAPE + + K+D++S G+ +E+ G+
Sbjct: 139 LADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-21
Identities = 57/174 (32%), Positives = 94/174 (54%), Gaps = 7/174 (4%)
Query: 14 EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+A+K L + + F E ++ KL+H+ LV+L+ EE ++ EYM SL
Sbjct: 32 RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLD 89
Query: 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISD 133
FL L + + + IA G+ Y+ R+ +HRDL+A+N+L+ + K++D
Sbjct: 90 FLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 145
Query: 134 FGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
FG+AR+ N+ A + APE A+ G F++KSDV+SFG+LL E+ +
Sbjct: 146 FGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-21
Identities = 65/184 (35%), Positives = 98/184 (53%), Gaps = 15/184 (8%)
Query: 5 LQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
LQG+ G+++AVK + Q F E ++ KL HKNLVRL G L N ++ E
Sbjct: 23 LQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVME 78
Query: 65 YMPNKSLDVFLFDSTRS-VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
M +L FL R+ V + + S+ +A G+ YL K++HRDL A N+L+
Sbjct: 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KLVHRDLAARNILV 133
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
+ + K+SDFG+AR+ + +++ + APE FS KSDV+S+GVLL
Sbjct: 134 SEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWSYGVLLW 188
Query: 184 EIIS 187
E+ S
Sbjct: 189 EVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-21
Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 9/186 (4%)
Query: 11 DGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLFG-CCLEENESLLIY-EYM 66
DGK + K + + + Q+ +EV ++ +L+H N+VR + N++L I EY
Sbjct: 24 DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83
Query: 67 PNKSLDVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLH--EDSRLKIIHRDLKASNVLL 123
L + + + ++ + I+ + L H D ++HRDLK +N+ L
Sbjct: 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL 143
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
+ N K+ DFG+A+I G + S A T VGT YM+PE + KSD++S G L+
Sbjct: 144 DANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIY 201
Query: 184 EIISGK 189
E+ +
Sbjct: 202 ELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 48/188 (25%), Positives = 98/188 (52%), Gaps = 13/188 (6%)
Query: 4 CLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
C+ + G+++AVK++ Q + NEV ++ QH N+V ++ L +E ++
Sbjct: 36 CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
E++ +L D +++ ++ ++ + + L +LH +IHRD+K+ ++LL
Sbjct: 96 EFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILL 148
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
+ K+SDFG F S+ R +VGT +MAPE + + D++S G++
Sbjct: 149 TSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 204
Query: 182 LLEIISGK 189
++E++ G+
Sbjct: 205 VIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-21
Identities = 62/192 (32%), Positives = 106/192 (55%), Gaps = 17/192 (8%)
Query: 15 IAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+A+K L+ T+G + EF +E ++A + H +LVRL G CL L + + MP+ L
Sbjct: 39 VAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLD 97
Query: 74 FLFDSTRSVQ----LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
++ + ++ L+W +I A+G++YL E +++HRDL A NVL+ +
Sbjct: 98 YVHEHKDNIGSQLLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHV 148
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-- 187
KI+DFG+AR+ G++ E N + +MA E F+ +SDV+S+GV + E+++
Sbjct: 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208
Query: 188 GKKNTGFYLSEL 199
GK G E+
Sbjct: 209 GKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-21
Identities = 62/189 (32%), Positives = 94/189 (49%), Gaps = 20/189 (10%)
Query: 15 IAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+A+K L + Q EF+ E +L+A+L H N+V L G +E +++EY+ L
Sbjct: 37 VAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHE 96
Query: 74 FLF--------------DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
FL D T LD + I IA G+ YL S +H+DL A
Sbjct: 97 FLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAAR 153
Query: 120 NVLLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSF 178
N+L+ +++ KISD G++R I+ + ++ +M PE M G FS SD++SF
Sbjct: 154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSF 212
Query: 179 GVLLLEIIS 187
GV+L EI S
Sbjct: 213 GVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-21
Identities = 57/186 (30%), Positives = 100/186 (53%), Gaps = 11/186 (5%)
Query: 8 KLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
KL +EI A+K L S + + ++F +E +++ + H N++ L G + ++I E
Sbjct: 26 KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
+M N +LD FL Q + + ++ GIA G+ YL E + +HRDL A N+L+N
Sbjct: 86 FMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVN 140
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVG---TYGYMAPEYAMEGLFSVKSDVFSFGVL 181
+ K+SDFG++R + S+ +G + APE F+ SDV+S+G++
Sbjct: 141 SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIV 200
Query: 182 LLEIIS 187
+ E++S
Sbjct: 201 MWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-21
Identities = 53/182 (29%), Positives = 98/182 (53%), Gaps = 14/182 (7%)
Query: 12 GKEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQH---KNLVRLFGCCLEENESLLIYEYMP 67
G+ +A+K ++ T + + + EV L+++L+ N+ + +G L+ +I EY
Sbjct: 26 GRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
S+ + ++ + K II + L Y+H+ +IHRD+KA+N+L+ +
Sbjct: 86 GGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTG 138
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEII 186
N K+ DFG+A + N S+ +T VGT +MAPE EG + K+D++S G+ + E+
Sbjct: 139 NVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196
Query: 187 SG 188
+G
Sbjct: 197 TG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-21
Identities = 59/190 (31%), Positives = 99/190 (52%), Gaps = 19/190 (10%)
Query: 13 KEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
+ +A+K L + G +EFK+E + ++LQH N+V L G +E +I+ Y + L
Sbjct: 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 72 DVFLF-------------DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
FL D T L+ + I+ IA G+ +L S ++H+DL
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLAT 152
Query: 119 SNVLLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177
NVL+ ++N KISD G+ R ++ + + N ++ +M+PE M G FS+ SD++S
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWS 211
Query: 178 FGVLLLEIIS 187
+GV+L E+ S
Sbjct: 212 YGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-21
Identities = 58/175 (33%), Positives = 94/175 (53%), Gaps = 9/175 (5%)
Query: 14 EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
++AVK + + ++ F E ++ LQH LV+L +E +I E+M SL
Sbjct: 32 KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLD 89
Query: 74 FL-FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
FL D L + I IA G+ ++ + + IHRDL+A+N+L++ + KI+
Sbjct: 90 FLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIA 144
Query: 133 DFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
DFG+AR+ N+ A + APE G F++KSDV+SFG+LL+EI++
Sbjct: 145 DFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 83/264 (31%), Positives = 125/264 (47%), Gaps = 37/264 (14%)
Query: 15 IAVKRLS-RTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
+AVK L + + L + +E+ L+ + +HKN++ L G C +E +I EY +L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 73 VFL-----------FDSTRSV--QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
FL FD T+ QL +K +S +ARG+ YL +SR + IHRDL A
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAAR 163
Query: 120 NVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
NVL+ + KI+DFG+AR T+ +MAPE + +++ +SDV+SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 180 VLLLEI--ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237
+L+ EI + G G + EL +KL EG ++ K S EL +
Sbjct: 224 ILMWEIFTLGGSPYPGIPVEEL--------FKLLREGHRMD------KPSNCTHELYMLM 269
Query: 238 HIGLLCVQADSADRPTMSSVVVML 261
C A RPT +V L
Sbjct: 270 R---ECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-20
Identities = 63/263 (23%), Positives = 120/263 (45%), Gaps = 26/263 (9%)
Query: 2 ESCLQGKLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES 59
E+ L + D + K L+R S + ++ NE+ +++ LQH N++ + +++N
Sbjct: 15 EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL 74
Query: 60 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
L+ EY +L + + + + + + I + Y+H+ I+HRD+K
Sbjct: 75 LIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTL 130
Query: 120 NVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
N+ L K+ DFG+++I G S A T +VGT YM+PE ++ KSD+++ G
Sbjct: 131 NIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALG 188
Query: 180 VLLLEIISGKKN-TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238
+L E+++ K+ L ++ + PV+ ++EL+ +H
Sbjct: 189 CVLYELLTLKRTFDATNPLNLVVKIVQGNY------------TPVVSV--YSSELISLVH 234
Query: 239 IGLLCVQADSADRPTMSSVVVML 261
+Q D RPT V+
Sbjct: 235 ---SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-20
Identities = 58/174 (33%), Positives = 95/174 (54%), Gaps = 7/174 (4%)
Query: 14 EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
++A+K L + + F E ++ KL+H LV L+ EE ++ E+M SL
Sbjct: 32 KVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLD 89
Query: 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISD 133
FL + L + + + IA G+ Y+ R+ IHRDL+A+N+L+ + KI+D
Sbjct: 90 FLKEGDGK-YLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIAD 145
Query: 134 FGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
FG+AR+ N+ A + APE A+ G F++KSDV+SFG+LL E+++
Sbjct: 146 FGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-20
Identities = 58/187 (31%), Positives = 97/187 (51%), Gaps = 14/187 (7%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
GK ++A+K + S EF E ++ KL H+ LV+L+G C ++ ++ EYM
Sbjct: 23 GKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
N L +L + + Q + + + + G+ YL + IHRDL A N L++ +
Sbjct: 82 SNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQ 136
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
K+SDFG++R ++ ++ VG+ + PE + FS KSDV++FGVL+
Sbjct: 137 GCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMW 192
Query: 184 EIIS-GK 189
E+ S GK
Sbjct: 193 EVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-20
Identities = 76/261 (29%), Positives = 109/261 (41%), Gaps = 41/261 (15%)
Query: 15 IAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+AVK L + +F E ++ L H+NL+RL+G L +++ E P SL
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH-PLMMVTELAPLGSL-- 82
Query: 74 FLFDSTRSVQLD-------WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
D R L + I NG+ YL + IHRDL A N+LL +
Sbjct: 83 --LDRLRKDALGHFLISTLCDYAVQIANGMR----YLESK---RFIHRDLAARNILLASD 133
Query: 127 MNPKISDFGMARIFGGNQS--EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
KI DFG+ R N+ + V + + APE FS SDV+ FGV L E
Sbjct: 134 DKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRTFSHASDVWMFGVTLWE 192
Query: 185 IISGKKNTGFYLSE--LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL 242
+ + Y E G S K+ EGE LE P ++C ++ L
Sbjct: 193 MFT-------YGEEPWAGLSGSQILKKIDKEGERLE--RP---EACP----QDIYNVMLQ 236
Query: 243 CVQADSADRPTMSSVVVMLAS 263
C + ADRPT +++ L
Sbjct: 237 CWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-20
Identities = 48/144 (33%), Positives = 77/144 (53%), Gaps = 9/144 (6%)
Query: 46 LVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 105
+V +G L EN + E+M SLD ++ + ++ +I + GL YL+
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGKI--AVAVVEGLTYLYN 121
Query: 106 DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM 165
R I+HRD+K SN+L+N K+ DFG++ G + + VGT YM+PE
Sbjct: 122 VHR--IMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQ 175
Query: 166 EGLFSVKSDVFSFGVLLLEIISGK 189
G ++VKSDV+S G+ ++E+ GK
Sbjct: 176 GGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 8e-20
Identities = 62/179 (34%), Positives = 92/179 (51%), Gaps = 12/179 (6%)
Query: 14 EIAVKRLSRTSGQGLQE-FKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
++AVK L T+ +E +E+ +++ L H+N+V L G C L+I EY L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
FL R L + +S +A+G+ +L + IHRDL A NVLL H KI
Sbjct: 127 LNFL-RRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKI 182
Query: 132 SDFGMAR-IFGGNQ--SEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
DFG+AR I + + N V +MAPE +++ +SDV+S+G+LL EI S
Sbjct: 183 CDFGLARDIMNDSNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 69/233 (29%), Positives = 103/233 (44%), Gaps = 46/233 (19%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD-------VFLFDSTRSVQLDW 86
E+ ++ + H N+V+ E ++ E+M SL+ FL D R
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ----- 176
Query: 87 KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146
I++GIA YLH R I+HRD+K SN+L+N N KI+DFG++RI Q+
Sbjct: 177 -----ILSGIA----YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTM 222
Query: 147 ANTNRIVGTYGYMAPEYAMEGLFSVK-----SDVFSFGVLLLEIISGKKNTGFYLSELGQ 201
N VGT YM+PE L D++S GV +LE G+ F + G
Sbjct: 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR--FPFGVGRQGD 280
Query: 202 SLLSYTW-KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 253
W L C A+ + +P + + E FI C+Q + A R +
Sbjct: 281 ------WASLMC---AICMSQPPEAPATASREFRHFIS---CCLQREPAKRWS 321
|
Length = 353 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-19
Identities = 60/193 (31%), Positives = 96/193 (49%), Gaps = 26/193 (13%)
Query: 15 IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+AVK L + +F EV ++++L+ N++RL G C++E+ +I EYM N L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 74 FLFDSTRSVQ------------------LDWKRRISIINGIARGLLYLHEDSRLKIIHRD 115
FL S+ + + + + + IA G+ YL S L +HRD
Sbjct: 109 FL--SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRD 163
Query: 116 LKASNVLLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSD 174
L N L+ + KI+DFGM+R ++ G+ R V +MA E + G F+ SD
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASD 222
Query: 175 VFSFGVLLLEIIS 187
V++FGV L EI+
Sbjct: 223 VWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-19
Identities = 57/187 (30%), Positives = 103/187 (55%), Gaps = 11/187 (5%)
Query: 9 LADGKEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
L + +++A+KR+ + E + EV +++ H N+V+ + + +E L+ Y+
Sbjct: 23 LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82
Query: 68 NKS-LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
S LD+ R LD +++ + +GL YLH + + IHRD+KA N+LL +
Sbjct: 83 GGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGED 138
Query: 127 MNPKISDFGM-ARIF-GGNQSEANTNRIVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLL 182
+ KI+DFG+ A + GG+++ VGT +MAPE ME + + K+D++SFG+
Sbjct: 139 GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITA 197
Query: 183 LEIISGK 189
+E+ +G
Sbjct: 198 IELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 51/183 (27%), Positives = 88/183 (48%), Gaps = 14/183 (7%)
Query: 13 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
KEI ++ + ++E +E+ ++ L+H NLV+ +G + + + EY +L+
Sbjct: 31 KEIRIQDNDPKT---IKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLE 87
Query: 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
L + R + R + + GL YLH I+HRD+K +N+ L+H K+
Sbjct: 88 ELL-EHGRILDEHVIRVYT--LQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLG 141
Query: 133 DFGMARIFGGNQSEANT--NRIVGTYGYMAPEYAMEGLFSVK---SDVFSFGVLLLEIIS 187
DFG A N + + GT YMAPE G +D++S G ++LE+ +
Sbjct: 142 DFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT 201
Query: 188 GKK 190
GK+
Sbjct: 202 GKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 57/181 (31%), Positives = 99/181 (54%), Gaps = 11/181 (6%)
Query: 12 GKEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES--LLIYEYMPN 68
G+++AVK L + G + + K E+ ++ L H+N+V+ G C E+ + LI E++P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
SL +L + + L + + ++ I +G+ YL SR + +HRDL A NVL+ E
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--GSR-QYVHRDLAARNVLVESEHQ 147
Query: 129 PKISDFGMARIFGGNQS--EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
KI DFG+ + ++ + + Y APE ++ F + SDV+SFGV L E++
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELL 206
Query: 187 S 187
+
Sbjct: 207 T 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-19
Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 18/177 (10%)
Query: 15 IAVKRLS---RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
+A+K++S + S + Q+ EV + KL+H N ++ GC L E+ + L+ EY +
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSAS 102
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
D+ L ++ +G +GL YLH + +IHRD+KA N+LL+ K+
Sbjct: 103 DLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKL 156
Query: 132 SDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEI 185
DFG A I A N VGT +MAPE + EG + K DV+S G+ +E+
Sbjct: 157 GDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 76/261 (29%), Positives = 120/261 (45%), Gaps = 37/261 (14%)
Query: 15 IAVKRLS-RTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
+AVK L + + L + +E+ ++ + +HKN++ L G C ++ +I EY +L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 73 VFL-----------FDSTR--SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
+L +D R Q+ +K +S +ARG+ YL + K IHRDL A
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 120 NVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
NVL+ KI+DFG+AR T +MAPE + +++ +SDV+SFG
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 180 VLLLEI--ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237
VL+ EI + G G + EL +KL EG ++ K + EL +
Sbjct: 227 VLMWEIFTLGGSPYPGIPVEEL--------FKLLKEGHRMD------KPANCTNELYMMM 272
Query: 238 HIGLLCVQADSADRPTMSSVV 258
C A + RPT +V
Sbjct: 273 RD---CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 65/256 (25%), Positives = 112/256 (43%), Gaps = 33/256 (12%)
Query: 12 GKEIAVKR--LSRTSGQGLQE--------FKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
G+ +AVK+ L T ++E+ + L H N+V+ G E L
Sbjct: 26 GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF-ETTEEYLS 84
Query: 62 IY-EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
I+ EY+P S+ L + + + + GL YLH I+HRDLKA N
Sbjct: 85 IFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADN 138
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE--YAMEGLFSVKSDVFSF 178
+L++ + KISDFG+++ + G+ +MAPE ++ +S K D++S
Sbjct: 139 LLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSL 198
Query: 179 GVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ-SCVAAELLKFI 237
G ++LE+ +G++ + ++ +KL + A + V S VA + L
Sbjct: 199 GCVVLEMFAGRRPWS------DEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLN-- 250
Query: 238 HIGLLCVQADSADRPT 253
C + +RPT
Sbjct: 251 ----ACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-19
Identities = 57/183 (31%), Positives = 94/183 (51%), Gaps = 14/183 (7%)
Query: 15 IAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+AVK L + + + +F E+ ++++L+ N++RL C+ + +I EYM N L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 74 FL--------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
FL + V + + I + IA G+ YL S L +HRDL N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 126 EMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
KI+DFGM+R ++ G+ R V +M+ E + G F+ SDV++FGV L E
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQ-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 185 IIS 187
I++
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-19
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 19/190 (10%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
GK ++A+K + ++F E ++ KL H LV+L+G C ++ ++ E+M
Sbjct: 23 GKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
N L +L R +L +S+ + G+ YL +S IHRDL A N L++
Sbjct: 82 ENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSST 136
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGV 180
K+SDFGM R ++ + G + PE +S KSDV+SFGV
Sbjct: 137 GVVKVSDFGMTRYVLDDE-------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189
Query: 181 LLLEIISGKK 190
L+ E+ + K
Sbjct: 190 LMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 79/256 (30%), Positives = 117/256 (45%), Gaps = 40/256 (15%)
Query: 12 GKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQH-KNLVRLFGCCLEENESLLIYEYMPNK 69
G +AVKR+ T + Q ++ ++ + +V+ +G E + + E M +
Sbjct: 29 GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM-DI 87
Query: 70 SLDVFLFDSTRSVQLDWKRRI--SIINGIA----RGLLYLHEDSRLKIIHRDLKASNVLL 123
SLD F + V K I I+ IA + L YL E+ LKIIHRD+K SN+LL
Sbjct: 88 SLDKF----YKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILL 141
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE----YAMEGLFSVKSDVFSFG 179
+ N K+ DFG I G R G YMAPE A +G + V+SDV+S G
Sbjct: 142 DRNGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPSARDG-YDVRSDVWSLG 197
Query: 180 VLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS---CVAAELLKF 236
+ L E+ +GK + S Q L+ K G+ P+L S + + F
Sbjct: 198 ITLYEVATGKFPYPKWNSVFDQ--LTQVVK----GDP-----PILSNSEEREFSPSFVNF 246
Query: 237 IHIGLLCVQADSADRP 252
I+ LC+ D + RP
Sbjct: 247 IN---LCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-19
Identities = 71/267 (26%), Positives = 115/267 (43%), Gaps = 39/267 (14%)
Query: 8 KLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+L+D + A+K L S + ++ NE+ ++A + H N++ L+ N+ ++ EY
Sbjct: 21 RLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80
Query: 66 MPNKSLDVFLFDSTRSV-----QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
P L + + Q W+ I + RGL LHE KI+HRDLK++N
Sbjct: 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQL----LRGLQALHE---QKILHRDLKSAN 133
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
+LL KI D G++++ N A T +GT YMAPE +S KSD++S G
Sbjct: 134 ILLVANDLVKIGDLGISKVLKKNM--AKTQ--IGTPHYMAPEVWKGRPYSYKSDIWSLGC 189
Query: 181 LLLEIISGKKN-TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239
LL E+ + + +L + + P+ + +L FI
Sbjct: 190 LLYEMATFAPPFEARSMQDLRYKVQRGKY------------PPI--PPIYSQDLQNFIR- 234
Query: 240 GLLCVQADSADRPTMSSVVVMLASDTV 266
+Q RP + LAS V
Sbjct: 235 --SMLQVKPKLRPNCDKI---LASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-19
Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 18/194 (9%)
Query: 7 GKLADGKEIAVKRLS------RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL 60
G G+ IAVK++ + + ++ + EV L+ L+H N+V+ G CL++N
Sbjct: 19 GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78
Query: 61 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRI-SIINGIARGLLYLHEDSRLKIIHRDLKAS 119
+ E++P S+ L + + + I++G+A YLH + ++HRD+K +
Sbjct: 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNNC---VVHRDIKGN 131
Query: 120 NVLLNHEMNPKISDFGMAR---IFGGNQSEANTNRIV-GTYGYMAPEYAMEGLFSVKSDV 175
NV+L K+ DFG AR G + + +N + + GT +MAPE E + KSD+
Sbjct: 132 NVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDI 191
Query: 176 FSFGVLLLEIISGK 189
+S G + E+ +GK
Sbjct: 192 WSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 7e-19
Identities = 57/181 (31%), Positives = 91/181 (50%), Gaps = 18/181 (9%)
Query: 15 IAVKRLS---RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
+A+K++S + S + Q+ EV + +++H N + GC L E+ + L+ EY +
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSAS 112
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
D+ L +I +G +GL YLH + +IHRD+KA N+LL K+
Sbjct: 113 DLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKL 166
Query: 132 SDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISG 188
+DFG A I + N VGT +MAPE + EG + K DV+S G+ +E+
Sbjct: 167 ADFGSASIA------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 220
Query: 189 K 189
K
Sbjct: 221 K 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-19
Identities = 78/262 (29%), Positives = 127/262 (48%), Gaps = 39/262 (14%)
Query: 15 IAVKRLSR-TSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
+AVK L + + L + +E+ ++ + +HKN++ L G C ++ ++ EY +L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 73 VFL-----------FDSTR--SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
+L FD+ + QL +K +S +ARG+ YL + K IHRDL A
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 120 NVLLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSF 178
NVL+ + KI+DFG+AR + + + TN + +MAPE + +++ +SDV+SF
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSF 222
Query: 179 GVLLLEIIS--GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236
GVLL EI + G G + EL +KL EG ++ K + EL
Sbjct: 223 GVLLWEIFTLGGSPYPGIPVEEL--------FKLLKEGHRMD------KPANCTHELYMI 268
Query: 237 IHIGLLCVQADSADRPTMSSVV 258
+ C A + RPT +V
Sbjct: 269 MR---ECWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 7e-19
Identities = 59/179 (32%), Positives = 97/179 (54%), Gaps = 22/179 (12%)
Query: 15 IAVKRLSRTSGQGLQEFKN---EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
+A+K++S + Q +++++ EV + +L+H N + GC L E+ + L+ EY +
Sbjct: 43 VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSAS 102
Query: 72 DVF--LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
D+ + V++ +I +G +GL YLH + IHRD+KA N+LL
Sbjct: 103 DILEVHKKPLQEVEI-----AAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTV 154
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPE--YAM-EGLFSVKSDVFSFGVLLLEI 185
K++DFG A + S AN+ VGT +MAPE AM EG + K DV+S G+ +E+
Sbjct: 155 KLADFGSASL----VSPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-19
Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 18/181 (9%)
Query: 15 IAVKRLSRTSGQ---GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
+AVK++S + Q Q+ EV + +L+H N + GC L+E+ + L+ EY +
Sbjct: 49 VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSAS 108
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
D+ L +I +G +GL YLH + +IHRD+KA N+LL K+
Sbjct: 109 DLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKL 162
Query: 132 SDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISG 188
+DFG A S AN+ VGT +MAPE + EG + K DV+S G+ +E+
Sbjct: 163 ADFGSASK----SSPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216
Query: 189 K 189
K
Sbjct: 217 K 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-18
Identities = 49/162 (30%), Positives = 90/162 (55%), Gaps = 9/162 (5%)
Query: 28 LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK 87
+++ + E+T++++ + R +G L+ + +I EY+ S D + L+
Sbjct: 46 IEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEET 101
Query: 88 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA 147
+I+ I +GL YLH + + IHRD+KA+NVLL+ + + K++DFG+A Q +
Sbjct: 102 YIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158
Query: 148 NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
NT VGT +MAPE + + K+D++S G+ +E+ G+
Sbjct: 159 NT--FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 80/263 (30%), Positives = 125/263 (47%), Gaps = 39/263 (14%)
Query: 14 EIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
++AVK L S + + L + +E+ ++ + +HKN++ L G C ++ +I EY +L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 72 DVFLF-------------DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
+L QL +K +S +ARG+ YL + K IHRDL A
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168
Query: 119 SNVLLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177
NVL+ + KI+DFG+AR I + + TN + +MAPE + +++ +SDV+S
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWS 227
Query: 178 FGVLLLEI--ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235
FGVLL EI + G G + EL +KL EG ++ K S EL
Sbjct: 228 FGVLLWEIFTLGGSPYPGVPVEEL--------FKLLKEGHRMD------KPSNCTNELYM 273
Query: 236 FIHIGLLCVQADSADRPTMSSVV 258
+ C A + RPT +V
Sbjct: 274 MMRD---CWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-18
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 30/202 (14%)
Query: 8 KLADGKEIAV-KRLSRTSGQ--GLQEFK------------NEVTLIAKLQHKNLVRLFGC 52
KL +G V K +RT+G+ L+E E++L+ +L+H+N+VRL
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 53 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQ--LDWKRRISIINGIARGLLYLHEDSRLK 110
EN+ +L++EYM D+ + T V+ LD S + +G+ + HE+ +
Sbjct: 67 IHTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---R 120
Query: 111 IIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT--NRIVGTYGYMAPEYAMEG- 167
++HRDLK N+L+N K++DFG+AR FG NT N +V T Y AP+ +
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVLLGSR 176
Query: 168 LFSVKSDVFSFGVLLLEIISGK 189
+S D++S G ++ E+I+G+
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 62/183 (33%), Positives = 95/183 (51%), Gaps = 11/183 (6%)
Query: 11 DGKEI--AVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCL-EENESLLIYEYM 66
DG++I AVK L+R T + +++F E ++ H N++ L G CL E L++ YM
Sbjct: 20 DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
+ L F+ T + + K I +A+G+ YL K +HRDL A N +L+
Sbjct: 80 KHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDES 134
Query: 127 MNPKISDFGMAR-IFGGN-QSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
K++DFG+AR I+ S N +MA E F+ KSDV+SFGVLL E
Sbjct: 135 FTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 194
Query: 185 IIS 187
+++
Sbjct: 195 LMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 21/155 (13%)
Query: 45 NLVRLFGCCLEENESLLIYEYMPNKSLDVF---LFDSTRSVQLDWKRRISIINGIARGLL 101
V +G E + + E M + SLD F ++D ++ D +I++ I + L
Sbjct: 61 YTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV--SIVKALE 117
Query: 102 YLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGN--QSEANTNRIVGTYGYM 159
YLH +L +IHRD+K SNVL+N K+ DFG++ G S A T G YM
Sbjct: 118 YLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDA-GCKPYM 170
Query: 160 APE-----YAMEGLFSVKSDVFSFGVLLLEIISGK 189
APE +G + VKSDV+S G+ ++E+ +G+
Sbjct: 171 APERINPELNQKG-YDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 52/160 (32%), Positives = 87/160 (54%), Gaps = 14/160 (8%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL---FDSTRSVQLDWKRRI 90
E++L+ +L H N+VRL EN+ L++E+ LD+ L DS+ LD
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIK 102
Query: 91 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTN 150
S + + +G+ Y H S +++HRDLK N+L++ E K++DFG+AR F G T+
Sbjct: 103 SYLYQLLQGIAYCH--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTH 158
Query: 151 RIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGK 189
+V T Y APE + +S D++S G + E+++ +
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 57/199 (28%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 3 SCLQGK-LADGKEIAVKRLS---RTSGQG---LQEFKNEVTLIAKLQHKNLVRLFGCCLE 55
SC Q + + G +AVK+++ TS + ++ + E+ L+A+L H +++R+ G E
Sbjct: 15 SCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE 74
Query: 56 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI--INGIARGLLYLHEDSRLKIIH 113
++ L E+M S+ L +K + I + RGL YLHE+ +IIH
Sbjct: 75 DSHFNLFVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN---QIIH 126
Query: 114 RDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEAN--TNRIVGTYGYMAPEYAMEGLFS 170
RD+K +N+L++ +I+DFG A + A +++GT +MAPE +
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG 186
Query: 171 VKSDVFSFGVLLLEIISGK 189
DV+S G +++E+ + K
Sbjct: 187 RSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-18
Identities = 68/230 (29%), Positives = 110/230 (47%), Gaps = 30/230 (13%)
Query: 14 EIAVKRLSRTSGQG-LQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
+ A+KR+ + + ++F E+ ++ KL H N++ L G C L EY P+ +L
Sbjct: 36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 95
Query: 72 DVFLFDS-------------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
FL S + + L ++ + +ARG+ YL S+ + IHRDL A
Sbjct: 96 LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAA 152
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG--YMAPEYAMEGLFSVKSDVF 176
N+L+ KI+DFG++R E + +G +MA E +++ SDV+
Sbjct: 153 RNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW 207
Query: 177 SFGVLLLEIIS--GKKNTGFYLSELGQSL-LSYTWK--LWCEGEALELME 221
S+GVLL EI+S G G +EL + L Y + L C+ E +LM
Sbjct: 208 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMR 257
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 52/165 (31%), Positives = 86/165 (52%), Gaps = 13/165 (7%)
Query: 29 QEFKNEVTLIAKLQHK----NLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQL 84
+N++ K+ H+ +V +G + E + E+M SLD L +
Sbjct: 40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPE 98
Query: 85 DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQ 144
+ +ISI + RGL YL E + KI+HRD+K SN+L+N K+ DFG++ G
Sbjct: 99 NILGKISI--AVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQL 150
Query: 145 SEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
++ N VGT YM+PE ++V+SD++S G+ L+E+ G+
Sbjct: 151 IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-18
Identities = 50/176 (28%), Positives = 91/176 (51%), Gaps = 14/176 (7%)
Query: 16 AVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75
A K + S + L++F E+ ++++ +H N+V L+ EN+ ++ E+ +LD +
Sbjct: 34 AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIM 93
Query: 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFG 135
+ R + R + + L +LH K+IHRDLKA N+LL + + K++DFG
Sbjct: 94 LELERGLTEPQIRYVC--RQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFG 148
Query: 136 MARIFGGNQSEANT-NRIVGTYGYMAPEYAMEGLFS-----VKSDVFSFGVLLLEI 185
++ N+S + +GT +MAPE F K+D++S G+ L+E+
Sbjct: 149 VS---AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-18
Identities = 49/162 (30%), Positives = 91/162 (56%), Gaps = 9/162 (5%)
Query: 28 LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK 87
+++ + E+T++++ + + +G L+ + +I EY+ S D R+ D
Sbjct: 46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEF 101
Query: 88 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA 147
+ +++ I +GL YLH + K IHRD+KA+NVLL+ + + K++DFG+A Q +
Sbjct: 102 QIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158
Query: 148 NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
NT VGT +MAPE + + K+D++S G+ +E+ G+
Sbjct: 159 NT--FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 7e-18
Identities = 51/183 (27%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
G+ +A+K++ E+ L+ +L H N+++L + + L++E+M
Sbjct: 23 TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-- 80
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
D++ R L S + + +GL + H I+HRDLK N+L+N E
Sbjct: 81 -DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGV 136
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE--YAMEGLFSVKSDVFSFGVLLLEII 186
K++DFG+AR FG T+ +V T Y APE +G +S D++S G + E++
Sbjct: 137 LKLADFGLARSFGS-PVRPYTHYVV-TRWYRAPELLLGDKG-YSTPVDIWSVGCIFAELL 193
Query: 187 SGK 189
S +
Sbjct: 194 SRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-18
Identities = 49/187 (26%), Positives = 98/187 (52%), Gaps = 11/187 (5%)
Query: 4 CLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
C+ + G+++AVK + Q + NEV ++ QH+N+V ++ L E ++
Sbjct: 38 CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
E++ +L D +L+ ++ ++ + + L YLH +IHRD+K+ ++LL
Sbjct: 98 EFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILL 150
Query: 124 NHEMNPKISDFGM-ARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ K+SDFG A+I ++ +VGT +MAPE + + D++S G+++
Sbjct: 151 TLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMV 207
Query: 183 LEIISGK 189
+E++ G+
Sbjct: 208 IEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-18
Identities = 51/159 (32%), Positives = 91/159 (57%), Gaps = 11/159 (6%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF-DSTRSVQ-LDWKRRIS 91
E++L+ +LQH N+V L ++E+ LI+E++ S+D+ + DS Q +D + S
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKS 105
Query: 92 IINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151
+ I +G+L+ H +++HRDLK N+L++++ K++DFG+AR F G T+
Sbjct: 106 YLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHE 161
Query: 152 IVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGK 189
+V T Y APE + +S D++S G + E+ + K
Sbjct: 162 VV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 8e-18
Identities = 50/181 (27%), Positives = 97/181 (53%), Gaps = 9/181 (4%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+A G+E+A+K+++ + NE+ ++ +L++ N+V L +E ++ EY+
Sbjct: 41 VATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
SL D +D + ++ + L +LH + ++IHRD+K+ NVLL + +
Sbjct: 101 GSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGS 153
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
K++DFG QS+ +T +VGT +MAPE + K D++S G++ +E++ G
Sbjct: 154 VKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
Query: 189 K 189
+
Sbjct: 212 E 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 66/254 (25%), Positives = 118/254 (46%), Gaps = 24/254 (9%)
Query: 9 LADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
L DG+ +A+K++ + Q+ E+ L+ +L H N+++ +E NE ++ E
Sbjct: 24 LLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRI-SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
L + + +L +R I + L ++H +I+HRD+K +NV +
Sbjct: 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFIT 140
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
K+ D G+ R F + A++ +VGT YM+PE E ++ KSD++S G LL E
Sbjct: 141 ATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
Query: 185 IISGKKNTGFYLSELGQSLLSYTWKL-WCEGEALELMEPVLKQSCVAAELLKFIHIGLLC 243
+ + + + FY ++ +L S K+ C+ P L + EL + C
Sbjct: 199 MAALQ--SPFYGDKM--NLYSLCKKIEKCD-------YPPLPADHYSEELRDLVSR---C 244
Query: 244 VQADSADRPTMSSV 257
+ D RP +S V
Sbjct: 245 INPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-17
Identities = 59/184 (32%), Positives = 89/184 (48%), Gaps = 9/184 (4%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
+G L D +AVK Q L+ +F +E ++ + H N+V+L G C + ++ E
Sbjct: 13 KGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
+P D F + +L K+ + A G+ YL + IHRDL A N L+
Sbjct: 73 LVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVG 127
Query: 125 HEMNPKISDFGMARIF-GGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
KISDFGM+R G S + +I + APE G +S +SDV+S+G+LL
Sbjct: 128 ENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSESDVWSYGILLW 185
Query: 184 EIIS 187
E S
Sbjct: 186 ETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 49/163 (30%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 11 DGKEIAVKRL--SRTSGQGL-QEFKNEVTLIAKLQHKNLVRLFGCCLEENESL--LIYEY 65
DGKE A+K+ + G+ Q E+ L+ +L+H+N+V L LE + L+++Y
Sbjct: 26 DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85
Query: 66 MPNKSLDVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
+ + F + V + S++ I G+ YLH + ++HRDLK +N+L+
Sbjct: 86 AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVM 142
Query: 125 HEMNP----KISDFGMARIFGGN-QSEANTNRIVGTYGYMAPE 162
E KI D G+AR+F + A+ + +V T Y APE
Sbjct: 143 GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 52/188 (27%), Positives = 92/188 (48%), Gaps = 22/188 (11%)
Query: 15 IAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES------LLIYEYM 66
+AVK +L + ++EF +E + H N+++L G C E + ++I +M
Sbjct: 30 VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFM 89
Query: 67 PNKSLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
+ L FL S +L + + + IA G+ YL S IHRDL A N +L
Sbjct: 90 KHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCML 146
Query: 124 NHEMNPKISDFGMAR-IFGGN---QSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
+M ++DFG+++ I+ G+ Q + ++A E + +++ KSDV++FG
Sbjct: 147 REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV----KWIAIESLADRVYTSKSDVWAFG 202
Query: 180 VLLLEIIS 187
V + EI +
Sbjct: 203 VTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 54/187 (28%), Positives = 85/187 (45%), Gaps = 17/187 (9%)
Query: 12 GKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
G A+K + + + + E ++++ Q +V+L+ + L+ EY+P
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77
Query: 69 KSLDVF-LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
D+ L ++ S+ D R I I L YLH IIHRDLK N+L++
Sbjct: 78 G--DLASLLENVGSLDEDVAR--IYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNG 130
Query: 128 NPKISDFG------MARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
+ K++DFG + R N E RIVGT Y+APE + S D +S G +
Sbjct: 131 HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCI 190
Query: 182 LLEIISG 188
L E + G
Sbjct: 191 LYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 21/164 (12%)
Query: 33 NEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS- 91
NE ++ +L H LV L+ ++ E++ Y+ +D+ L R L K + S
Sbjct: 49 NERRILQELNHPFLVNLWYS-FQDEENM----YL---VVDLLLGGDLR-YHLSQKVKFSE 99
Query: 92 -----IINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146
I I L YLH IIHRD+K N+LL+ + + I+DF +A +
Sbjct: 100 EQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154
Query: 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 190
T GT GYMAPE +SV D +S GV E + GK+
Sbjct: 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-17
Identities = 50/178 (28%), Positives = 95/178 (53%), Gaps = 10/178 (5%)
Query: 13 KEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
K +A+K + + +++ + E+T++++ + + +G L++ + +I EY+ S
Sbjct: 30 KVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 89
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
D LD + +I+ I +GL YLH + + IHRD+KA+NVLL+ K+
Sbjct: 90 ----LDLLEPGPLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKL 142
Query: 132 SDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+DFG+A ++ N VGT +MAPE + + K+D++S G+ +E+ G+
Sbjct: 143 ADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-17
Identities = 69/257 (26%), Positives = 113/257 (43%), Gaps = 45/257 (17%)
Query: 9 LADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
L + +AVK + LQ + +E+ ++ K ++ +G EN + E+M
Sbjct: 23 LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
SLDV+ R + RI++ + +GL YL LKI+HRD+K SN+L+N
Sbjct: 83 GGSLDVY-----RKIPEHVLGRIAV--AVVKGLTYLWS---LKILHRDVKPSNMLVNTRG 132
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
K+ DFG++ S A T VGT YMAPE + + SDV+S G+ +E+
Sbjct: 133 QVKLCDFGVSTQL--VNSIAKT--YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL 188
Query: 188 GK-------KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC----VAAELLKF 236
G+ KN G + L+L++ ++ + V KF
Sbjct: 189 GRFPYPQIQKNQGSLM-------------------PLQLLQCIVDEDPPVLPVGQFSEKF 229
Query: 237 IHIGLLCVQADSADRPT 253
+H C++ +RP
Sbjct: 230 VHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 53/151 (35%), Positives = 76/151 (50%), Gaps = 14/151 (9%)
Query: 42 QHKNLVRLFGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGL 100
+H L +L C + + L + EY+ L +F RS + D R I GL
Sbjct: 54 KHPFLTQLH-SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGL 109
Query: 101 LYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIVGTYGY 158
+LHE II+RDLK NVLL+ E + KI+DFGM + I GG T+ GT Y
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT----TSTFCGTPDY 162
Query: 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+APE + D ++ GVLL E+++G+
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-17
Identities = 57/185 (30%), Positives = 97/185 (52%), Gaps = 18/185 (9%)
Query: 14 EIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENES----LLIYEY 65
++AVK +++ + +++F +E + + H N++RL G CL+ E+E ++I +
Sbjct: 28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87
Query: 66 MPNKSLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
M + L FL S L + + + IA G+ YL S IHRDL A N +
Sbjct: 88 MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCM 144
Query: 123 LNHEMNPKISDFGMA-RIFGGNQSEANTNRIVGT-YGYMAPEYAMEGLFSVKSDVFSFGV 180
LN MN ++DFG++ +I+ G+ RI ++A E + +++ KSDV+SFGV
Sbjct: 145 LNENMNVCVADFGLSKKIYNGDYYR--QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGV 202
Query: 181 LLLEI 185
+ EI
Sbjct: 203 TMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 54/183 (29%), Positives = 92/183 (50%), Gaps = 9/183 (4%)
Query: 10 ADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
+D + +K + T + + K EV L+AK++H N+V F E ++ EY
Sbjct: 23 SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE- 126
L + + R V + +S I+ GL ++H+ KI+HRD+K+ N+ L+
Sbjct: 83 GGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNG 138
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
M K+ DFG+AR + A T VGT Y++PE ++ K+D++S G +L E+
Sbjct: 139 MVAKLGDFGIARQLNDSMELAYT--CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELC 196
Query: 187 SGK 189
+ K
Sbjct: 197 TLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 54/185 (29%), Positives = 97/185 (52%), Gaps = 19/185 (10%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
G LA K I K S + L+++ E+ ++A H +V+L G + + ++ E+
Sbjct: 37 GALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
P ++D + + R + + +I +I + L YLH +KIIHRDLKA NVLL
Sbjct: 92 PGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTL 145
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM-----EGLFSVKSDVFSFGV 180
+ + K++DFG++ ++ + +GT +MAPE M + + K+D++S G+
Sbjct: 146 DGDIKLADFGVSA--KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 203
Query: 181 LLLEI 185
L+E+
Sbjct: 204 TLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-17
Identities = 52/190 (27%), Positives = 100/190 (52%), Gaps = 12/190 (6%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+A G+E+A+K+++ + NE+ ++ + +H N+V L +E ++ EY+
Sbjct: 41 VATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
SL D +D + ++ + L +LH + ++IHRD+K+ N+LL + +
Sbjct: 101 GSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGS 153
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
K++DFG QS+ +T +VGT +MAPE + K D++S G++ +E++ G
Sbjct: 154 VKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
Query: 189 KKNTGFYLSE 198
+ YL+E
Sbjct: 212 EPP---YLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 48/187 (25%), Positives = 99/187 (52%), Gaps = 11/187 (5%)
Query: 4 CLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
C+ + GK +AVK++ Q + NEV ++ QH+N+V ++ L +E ++
Sbjct: 37 CIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 96
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
E++ +L D +++ ++ ++ + + L LH +IHRD+K+ ++LL
Sbjct: 97 EFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILL 149
Query: 124 NHEMNPKISDFGM-ARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
H+ K+SDFG A++ ++ +VGT +MAPE + + D++S G+++
Sbjct: 150 THDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMV 206
Query: 183 LEIISGK 189
+E++ G+
Sbjct: 207 IEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 63/185 (34%), Positives = 89/185 (48%), Gaps = 11/185 (5%)
Query: 7 GKL-ADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
G+L AD +AVK T L+ +F E ++ + H N+VRL G C ++ ++ E
Sbjct: 14 GRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 73
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
+ FL T +L K I ++ A G+ YL IHRDL A N L+
Sbjct: 74 LVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVT 128
Query: 125 HEMNPKISDFGMAR--IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ KISDFGM+R G S +I + APE G +S +SDV+SFG+LL
Sbjct: 129 EKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYSSESDVWSFGILL 186
Query: 183 LEIIS 187
E S
Sbjct: 187 WEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 6e-17
Identities = 62/187 (33%), Positives = 92/187 (49%), Gaps = 22/187 (11%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAK------LQHKNLVRLFGCCLEENESLL-IY 63
G+ AVK L + LQ+ E T+ K H L +L+ CC + + L +
Sbjct: 19 SGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQLY-CCFQTPDRLFFVM 75
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
E++ L +F +S + D R I L++LH+ II+RDLK NVLL
Sbjct: 76 EFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLL 129
Query: 124 NHEMNPKISDFGMAR--IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
+HE + K++DFGM + IF G T+ GT Y+APE E L+ D ++ GVL
Sbjct: 130 DHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVL 185
Query: 182 LLEIISG 188
L E++ G
Sbjct: 186 LYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 59/235 (25%), Positives = 112/235 (47%), Gaps = 20/235 (8%)
Query: 33 NEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 92
+E+ + KLQH N+V+L G C E + LI+EY+ K+L L + L W+RR I
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKI 785
Query: 93 INGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152
GIA+ L +LH ++ +L ++++ + P + +
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKC 838
Query: 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC 212
+ Y+APE + KSD++ FG++L+E+++GK + S++ W +C
Sbjct: 839 FISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHGSIVE--WARYC 895
Query: 213 EGEA-LEL-MEPVLKQ--SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263
+ L++ ++P ++ S E+++ +++ L C D RP + V+ L S
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 7e-17
Identities = 51/188 (27%), Positives = 98/188 (52%), Gaps = 13/188 (6%)
Query: 4 CLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
C+ + GK++AVK++ Q + NEV ++ H+N+V ++ L +E ++
Sbjct: 39 CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
E++ +L D +++ ++ ++ + R L YLH +IHRD+K+ ++LL
Sbjct: 99 EFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILL 151
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
+ K+SDFG F S+ R +VGT +MAPE + + D++S G++
Sbjct: 152 TSDGRIKLSDFG----FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207
Query: 182 LLEIISGK 189
++E+I G+
Sbjct: 208 VIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-17
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I GL +LH + +I++RDLK NVLL+ N +ISD G+A G + GT
Sbjct: 104 IICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGT 157
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
GYMAPE ++ D F+ G L E+I+G+
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 64/261 (24%), Positives = 124/261 (47%), Gaps = 32/261 (12%)
Query: 9 LADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
L DG +A+K++ + + E+ L+ +L H N+++ + +E+NE ++ E
Sbjct: 24 LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83
Query: 66 MPNKSLDVFL--FDSTRSV---QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
L + F + + + WK + + + + H SR +++HRD+K +N
Sbjct: 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE------HMHSR-RVMHRDIKPAN 136
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
V + K+ D G+ R F + A++ +VGT YM+PE E ++ KSD++S G
Sbjct: 137 VFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGC 194
Query: 181 LLLEIISGKKNTGFYLSELGQSLLSYTWKL-WCEGEALELMEPVLKQSCVAAELLKFIHI 239
LL E+ + + + FY ++ +L S K+ C+ P L + EL + ++
Sbjct: 195 LLYEMAALQ--SPFYGDKM--NLYSLCKKIEQCD-------YPPLPSDHYSEELRQLVN- 242
Query: 240 GLLCVQADSADRPTMSSVVVM 260
+C+ D RP ++ V +
Sbjct: 243 --MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 32/180 (17%)
Query: 30 EFKNEVTLIAKL-QHKNLVRLFGCCL------EENESLLIYEYMPNKSLDVFLFDSTRSV 82
E K E ++ K H N+ +G + +++ L+ E S+ T V
Sbjct: 48 EIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-------TDLV 100
Query: 83 Q--LDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134
+ +R+ I+ RGL YLHE+ K+IHRD+K N+LL K+ DF
Sbjct: 101 KGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157
Query: 135 GMARIFGGNQSEANTNRIVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVLLLEIISGK 189
G++ NT +GT +MAPE + + +SDV+S G+ +E+ GK
Sbjct: 158 GVSAQLDSTLGRRNT--FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 58/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 2 ESCLQGKLADGKE--IAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENE 58
E +G + D E +A+K ++ + + EF NE +++ + ++VRL G +
Sbjct: 24 EGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83
Query: 59 SLLIYEYMPNKSLDVFLFDSTRSVQLD-----------WKRRISIINGIARGLLYLHEDS 107
+L+I E M L +L RS++ + K+ I + IA G+ YL+ +
Sbjct: 84 TLVIMELMTRGDLKSYL----RSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN- 138
Query: 108 RLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG 167
K +HRDL A N ++ + KI DFGM R + + +M+PE +G
Sbjct: 139 --KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 196
Query: 168 LFSVKSDVFSFGVLLLEI 185
+F+ SDV+SFGV+L EI
Sbjct: 197 VFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 50/156 (32%), Positives = 86/156 (55%), Gaps = 9/156 (5%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E+ ++ + +V +G + E + E+M SLD L ++ R + + ++SI
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI- 110
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
+ RGL YL E + +I+HRD+K SN+L+N K+ DFG++ G ++ N V
Sbjct: 111 -AVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFV 163
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
GT YM+PE +SV+SD++S G+ L+E+ G+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 56/177 (31%), Positives = 87/177 (49%), Gaps = 13/177 (7%)
Query: 15 IAVKRLSRTSGQGLQE--FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
+A+ L R Q F E + + H N+VRL G N +++ EYM N +LD
Sbjct: 36 VAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
FL QL + + ++ G+A G+ YL E + +H+ L A VL+N ++ KIS
Sbjct: 95 SFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKIS 149
Query: 133 DFGMARIFGGNQSEA--NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
F + ++SEA T + APE FS SDV+SFG+++ E++S
Sbjct: 150 GFRRLQ---EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-16
Identities = 50/176 (28%), Positives = 92/176 (52%), Gaps = 14/176 (7%)
Query: 16 AVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75
A K + S + L+++ E+ ++A H N+V+L EN ++ E+ ++D +
Sbjct: 34 AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVM 93
Query: 76 FDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134
+ R + + +I ++ L YLHE+ KIIHRDLKA N+L + + K++DF
Sbjct: 94 LELERPLT---EPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADF 147
Query: 135 GMARIFGGNQSEANTNRIVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVLLLEI 185
G++ ++ + +GT +MAPE M + + K+DV+S G+ L+E+
Sbjct: 148 GVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 29 QEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST-------- 79
++F E+ ++ KL H N++ L G C + EY P +L FL S
Sbjct: 47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAF 106
Query: 80 -----RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134
+ L ++ + + +A G+ YL E + IHRDL A NVL+ + KI+DF
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADF 163
Query: 135 GMARIFGGNQSEANTNRIVGTYG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKK 190
G++R E + +G +MA E +++ KSDV+SFGVLL EI+S G
Sbjct: 164 GLSR-----GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
Query: 191 NTGFYLSELGQSL---LSYTWKLWCEGEALELME 221
G +EL + L C+ E ELM
Sbjct: 219 YCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMR 252
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 53/177 (29%), Positives = 98/177 (55%), Gaps = 13/177 (7%)
Query: 15 IAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+A+K L TS + +E +E ++A + + ++ RL G CL L I + MP L
Sbjct: 39 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLD 97
Query: 74 FLFDSTRSVQLDWKRRISIIN---GIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
++ + ++ + ++N IA+G+ YL E+ RL +HRDL A NVL+ + K
Sbjct: 98 YVREHKDNIGSQY-----LLNWCVQIAKGMNYL-EERRL--VHRDLAARNVLVKTPQHVK 149
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
I+DFG+A++ G ++ E + +MA E + +++ +SDV+S+GV + E+++
Sbjct: 150 ITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 52/184 (28%), Positives = 98/184 (53%), Gaps = 20/184 (10%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+A G+ +A+K + G + + E++++ + +H N+V FG L ++ ++ EY
Sbjct: 25 IATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84
Query: 69 KSLDVFLFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
SL ++ TR +Q+ + R ++ +GL YLHE IHRD+K +N+LL
Sbjct: 85 GSLQD-IYQVTRGPLSELQIAYVCRETL-----KGLAYLHE---TGKIHRDIKGANILLT 135
Query: 125 HEMNPKISDFGM-ARIFGGNQSEANTNRIVGTYGYMAPEYA---MEGLFSVKSDVFSFGV 180
+ + K++DFG+ A++ + A +GT +MAPE A +G + K D+++ G+
Sbjct: 136 EDGDVKLADFGVSAQLT---ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192
Query: 181 LLLE 184
+E
Sbjct: 193 TAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-16
Identities = 51/183 (27%), Positives = 90/183 (49%), Gaps = 9/183 (4%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
GK+ K++ KRL + SG+ + + E+ + K+ +V L + L+ M
Sbjct: 18 GKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNLAYAFESKTHLCLVMSLM 75
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
L +++ L+ +R I I G+L+LH + I++RD+K NVLL+ +
Sbjct: 76 NGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQ 131
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
N ++SD G+A ++ + GT GYMAPE E +S D F+ G + E++
Sbjct: 132 GNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV 188
Query: 187 SGK 189
+G+
Sbjct: 189 AGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 5e-16
Identities = 48/181 (26%), Positives = 96/181 (53%), Gaps = 9/181 (4%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+A G+E+A+K+++ + NE+ ++ + ++ N+V L +E ++ EY+
Sbjct: 41 IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
SL D +D + ++ + L +LH + ++IHRD+K+ N+LL + +
Sbjct: 101 GSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGS 153
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
K++DFG QS+ +T +VGT +MAPE + K D++S G++ +E++ G
Sbjct: 154 VKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
Query: 189 K 189
+
Sbjct: 212 E 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 7e-16
Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 29 QEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST-------- 79
++F E+ ++ KL H N++ L G C L EY P+ +L FL S
Sbjct: 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 99
Query: 80 -----RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134
+ L ++ + +ARG+ YL + + IHRDL A N+L+ KI+DF
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 156
Query: 135 GMARIFGGNQSEANTNRIVGTYG--YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKK 190
G++R E + +G +MA E +++ SDV+S+GVLL EI+S G
Sbjct: 157 GLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
Query: 191 NTGFYLSELGQSLLSYTWKLW----CEGEALELM 220
G +EL + L ++L C+ E +LM
Sbjct: 212 YCGMTCAELYEK-LPQGYRLEKPLNCDDEVYDLM 244
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-16
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 30 EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLD---- 85
EF NE +++ ++VRL G + +L++ E M + L +L RS++ +
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENN 110
Query: 86 -------WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR 138
+ I + IA G+ YL+ K +HRDL A N ++ H+ KI DFGM R
Sbjct: 111 PGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
Query: 139 IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+ + +MAPE +G+F+ SD++SFGV+L EI S
Sbjct: 168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 9 LADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
G+ +A+K+ L R G + E+ + QH +V+L + +L+ EYM
Sbjct: 22 RETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
P+ L L D R + + + + +G+ Y+H I+HRDLK +N+L++ +
Sbjct: 82 PS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGIMHRDLKPANLLISAD 135
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE 162
KI+DFG+AR+F + +++ V T Y APE
Sbjct: 136 GVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 54/177 (30%), Positives = 93/177 (52%), Gaps = 13/177 (7%)
Query: 15 IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMPNKSLD 72
+A+K + R+ Q QE + + + L H +VRL G C SL L+ + P SL
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSL- 95
Query: 73 VFLFDSTRSVQ--LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
D R + LD +R ++ IA+G+ YL E +++HR+L A N+LL + +
Sbjct: 96 ---LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQ 149
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
I+DFG+A + + + + +MA E + G ++ +SDV+S+GV + E++S
Sbjct: 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 57/189 (30%), Positives = 98/189 (51%), Gaps = 20/189 (10%)
Query: 12 GKEIAVKRL-----SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE-SLLIY-E 64
G+E+A K++ S + + + + E+ L+ LQH+ +V+ +GC + E +L I+ E
Sbjct: 27 GRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86
Query: 65 YMPNKSLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
YMP S+ L T SV + R+I G+ YLH + I+HRD+K +N+
Sbjct: 87 YMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYLHSN---MIVHRDIKGANI 137
Query: 122 LLNHEMNPKISDFGMA-RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
L + N K+ DFG + R+ S + GT +M+PE + K+DV+S G
Sbjct: 138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGC 197
Query: 181 LLLEIISGK 189
++E+++ K
Sbjct: 198 TVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 53/181 (29%), Positives = 95/181 (52%), Gaps = 11/181 (6%)
Query: 14 EIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
++A+K L + + ++ E E ++ +L + +VR+ G C E +L+ E L+
Sbjct: 24 DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLN 82
Query: 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
FL S + ++ + +++ ++ G+ YL + +HRDL A NVLL ++ KIS
Sbjct: 83 KFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKIS 137
Query: 133 DFGMARIFGGNQSEANTNRIVGTY--GYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GK 189
DFG+++ G + S R G + + APE FS +SDV+S+G+ + E S G+
Sbjct: 138 DFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQ 196
Query: 190 K 190
K
Sbjct: 197 K 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 52/157 (33%), Positives = 85/157 (54%), Gaps = 11/157 (7%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR-SVQLDWKRRISI 92
E+ ++ + +V +G + E + E+M SLD L + R Q+ K I++
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 93 INGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152
I +GL YL E + KI+HRD+K SN+L+N K+ DFG++ G ++ N
Sbjct: 113 I----KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSF 162
Query: 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
VGT YM+PE +SV+SD++S G+ L+E+ G+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 3e-15
Identities = 47/181 (25%), Positives = 95/181 (52%), Gaps = 9/181 (4%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+A G+E+A+++++ + NE+ ++ + ++ N+V L +E ++ EY+
Sbjct: 42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
SL D +D + ++ + L +LH + ++IHRD+K+ N+LL + +
Sbjct: 102 GSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGS 154
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
K++DFG QS+ + +VGT +MAPE + K D++S G++ +E+I G
Sbjct: 155 VKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
Query: 189 K 189
+
Sbjct: 213 E 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-15
Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 37 LIAKLQHKNLVRLFGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIING 95
L +H L LF C + E L + EY+ L +F S + D R
Sbjct: 49 LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAE 104
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIV 153
I GL +LH+ II+RDLK NVLL+ + + KI+DFGM + + G E +
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
GT Y+APE ++ D +SFGVLL E++ G+
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-15
Identities = 54/189 (28%), Positives = 100/189 (52%), Gaps = 24/189 (12%)
Query: 11 DGKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMP 67
DGK+ +K + S+ S + +E + EV +++ ++H N+V + EEN +L ++ +Y
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV-QYQESFEENGNLYIVMDYCE 82
Query: 68 NKSLDVF-LFDSTRSVQ------LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
D++ ++ R V LDW +I + L ++H+ KI+HRD+K+ N
Sbjct: 83 GG--DLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHDR---KILHRDIKSQN 131
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
+ L + K+ DFG+AR+ A T +GT Y++PE ++ KSD+++ G
Sbjct: 132 IFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYYLSPEICENRPYNNKSDIWALGC 189
Query: 181 LLLEIISGK 189
+L E+ + K
Sbjct: 190 VLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-15
Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL---FDSTRSVQLDWKRRI 90
E++L+ ++QH N+VRL E L++EY LD+ L DS+ + +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIK 105
Query: 91 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP-KISDFGMARIFGGNQSEANT 149
+ + I RG+ Y H +++HRDLK N+L++ N K++DFG+AR F G T
Sbjct: 106 TYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFT 161
Query: 150 NRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 189
+ +V T Y APE + +S D++S G + E+++ K
Sbjct: 162 HEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-15
Identities = 50/185 (27%), Positives = 92/185 (49%), Gaps = 17/185 (9%)
Query: 9 LADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
L D K +A+K++ + Q+ E+ L+ +L H N+++ +E+NE ++ E
Sbjct: 24 LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83
Query: 66 MPNKSLD--VFLFDSTRSV---QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
L + F + + + WK + + + + H SR +++HRD+K +N
Sbjct: 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE------HMHSR-RVMHRDIKPAN 136
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
V + K+ D G+ R F + A++ +VGT YM+PE E ++ KSD++S G
Sbjct: 137 VFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGC 194
Query: 181 LLLEI 185
LL E+
Sbjct: 195 LLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 7e-15
Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 40/199 (20%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLF-----GCCLEEN 57
G+++A+K++S F + E+ L+ L+H+N++ L + N
Sbjct: 25 GRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77
Query: 58 ESLLIYEYMP---NKSLDVFLFDSTRSVQLDWKRRIS-IINGIARGLLYLHEDSRLKIIH 113
+ ++ E M +K + S + + D I + I RGL YLH +IH
Sbjct: 78 DVYIVTELMETDLHK-----VIKSPQPLTDD---HIQYFLYQILRGLKYLH---SANVIH 126
Query: 114 RDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN--TNRIVGTYGYMAPEYAMEGL-FS 170
RDLK SN+L+N + KI DFG+AR ++ E T +V T Y APE + ++
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYT 185
Query: 171 VKSDVFSFGVLLLEIISGK 189
D++S G + E+++ K
Sbjct: 186 KAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 8e-15
Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 18/161 (11%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-- 91
EV ++ +L+H+N+V L + L++EY+ L++ L S + D R
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLEL-LEASPGGLPPDAVRSYIWQ 108
Query: 92 IINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151
++ IA Y H IIHRD+K N+L++ K+ DFG AR + T+
Sbjct: 109 LLQAIA----YCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD- 160
Query: 152 IVGTYGYMAPE----YAMEGLFSVKSDVFSFGVLLLEIISG 188
V T Y APE G V DV++ G ++ E++ G
Sbjct: 161 YVATRWYRAPELLVGDTNYG-KPV--DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-15
Identities = 41/96 (42%), Positives = 56/96 (58%), Gaps = 9/96 (9%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIV 153
IA GL +LH II+RDLK NV+L+ E + KI+DFGM + IFGG T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
GT Y+APE + D ++FGVLL E+++G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E L+ + H +++R+ + + ++ +P+ S D++ + + RS L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
I GL YLH +IIHRD+K N+ +N I D G A+ +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
GT APE ++ K+D++S G++L E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 47/157 (29%), Positives = 87/157 (55%), Gaps = 8/157 (5%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E++L+ +L H N+V+L EN+ L++E++ ++ L F+ D++ + S +
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYL 106
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
+ +GL + H +++HRDLK N+L+N E K++DFG+AR F G T+ +V
Sbjct: 107 FQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV 162
Query: 154 GTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 189
T Y APE + +S D++S G + E+++ +
Sbjct: 163 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 55/201 (27%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 2 ESCLQGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES 59
E+ L+ + +++AVK L S ++EF E + + H N+++L G L
Sbjct: 17 EAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAK 76
Query: 60 ------LLIYEYMPNKSLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLK 110
++I +M + L FL S L + + + IA G+ YL S
Sbjct: 77 GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYL---SSKN 133
Query: 111 IIHRDLKASNVLLNHEMNPKISDFGMAR-IFGGN---QSEANTNRIVGTYGYMAPEYAME 166
IHRDL A N +LN M ++DFG+++ I+ G+ Q A+ + ++A E +
Sbjct: 134 FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV----KWLALESLAD 189
Query: 167 GLFSVKSDVFSFGVLLLEIIS 187
+++ SDV++FGV + EI++
Sbjct: 190 NVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 18/185 (9%)
Query: 11 DGKEIAVKRLSRTS--GQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYM 66
+ A+K + + G QE +E ++ + H +V+L+ ++ + + ++ EY
Sbjct: 17 KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY-RTFKDKKYIYMLMEYC 75
Query: 67 PNKSLDVFLFDSTRSVQL--DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
L + R L ++ R I + YLH II+RDLK N+LL+
Sbjct: 76 LGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLH---NRGIIYRDLKPENLLLD 127
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
K+ DFG A+ Q T GT Y+APE + + D +S G+LL E
Sbjct: 128 SNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYE 184
Query: 185 IISGK 189
+++G+
Sbjct: 185 LLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 56/189 (29%), Positives = 99/189 (52%), Gaps = 20/189 (10%)
Query: 12 GKEIAVKRL-----SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-ENESLLIY-E 64
G+E+AVK++ S+ + + + + E+ L+ L+H +V+ +GC + E + L I+ E
Sbjct: 27 GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86
Query: 65 YMPNKSLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
YMP S+ L T +V + R+I +G+ YLH + I+HRD+K +N+
Sbjct: 87 YMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGVSYLHSN---MIVHRDIKGANI 137
Query: 122 LLNHEMNPKISDFGMA-RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
L + N K+ DFG + RI S + GT +M+PE + K+DV+S
Sbjct: 138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVAC 197
Query: 181 LLLEIISGK 189
++E+++ K
Sbjct: 198 TVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 49/167 (29%), Positives = 87/167 (52%), Gaps = 18/167 (10%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESL----------LIYEYMPNKSLDVFLFDSTRSVQ 83
E+ ++ +L H+N+V L ++ ++L L++EYM + D+ + V
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESGLVH 112
Query: 84 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGN 143
S + + GL Y H+ + L HRD+K SN+LLN++ K++DFG+AR++
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 144 QSEANTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 189
+S TN+++ T Y PE + E + DV+S G +L E+ + K
Sbjct: 170 ESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 51/164 (31%), Positives = 87/164 (53%), Gaps = 17/164 (10%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENES-LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 92
E L+ L H+N++ + C+E+ E ++Y YM +L +FL R + + + +S
Sbjct: 58 ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC-RLGEANNPQALST 116
Query: 93 IN------GIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR-IFGGNQS 145
IA G+ YLH + +IH+D+ A N +++ E+ KI+D ++R +F +
Sbjct: 117 QQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH 173
Query: 146 --EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
N NR V +MA E + +S SDV+SFGVLL E+++
Sbjct: 174 CLGDNENRPVK---WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 52/183 (28%), Positives = 91/183 (49%), Gaps = 15/183 (8%)
Query: 11 DGKEIAVKRLSRTS-GQGLQEFK-NEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+ +A+KR+ +G+ E+ L+ +L+HKN+VRL+ + + L++EY +
Sbjct: 24 THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-D 82
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
+ L + FDS +D + S + + +GL + H ++HRDLK N+L+N
Sbjct: 83 QDLKKY-FDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGE 137
Query: 129 PKISDFGMARIFG--GNQSEANTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEI 185
K++DFG+AR FG A V T Y P+ L+S D++S G + E+
Sbjct: 138 LKLADFGLARAFGIPVRCYSAE----VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
Query: 186 ISG 188
+
Sbjct: 194 ANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 16/152 (10%)
Query: 46 LVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 105
+V +G E + EYM SLD + + I + +GL +L E
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 106 DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGN--QSEANTNRIVGTYGYMAPEY 163
+ IIHRD+K +NVL+N K+ DFG++ GN S A TN +G YMAPE
Sbjct: 121 E--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTN--IGCQSYMAPER 172
Query: 164 ------AMEGLFSVKSDVFSFGVLLLEIISGK 189
++V+SDV+S G+ +LE+ G+
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-14
Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 18/195 (9%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEEN------E 58
+G+ ++A ++ +G +E K E+ ++ K H+N+ +G +++N +
Sbjct: 24 KGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83
Query: 59 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
L+ E+ S+ L +T+ L + I I RGL +LH+ K+IHRD+K
Sbjct: 84 LWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKG 139
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM-----EGLFSVKS 173
NVLL K+ DFG++ +++ N +GT +MAPE + + KS
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKS 197
Query: 174 DVFSFGVLLLEIISG 188
D++S G+ +E+ G
Sbjct: 198 DLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEY 65
GKL K++ KRL + +G + E ++AK+ + +V L + L L+
Sbjct: 18 GKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL-AYAFQTKTDLCLVMTI 74
Query: 66 MPNKSLDVFLFD-STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
M L +++ + R I GL +LH+ +II+RDLK NVLL+
Sbjct: 75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLD 131
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
++ N +ISD G+A QS+ T GT G+MAPE + D F+ GV L E
Sbjct: 132 NDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYE 189
Query: 185 IISGK 189
+I+ +
Sbjct: 190 MIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 36/196 (18%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKN-----------EVTLIAKLQHKNLVRLFGCCLEENES 59
G+ +A+K++ L E K E+ L+ +L+H N++ L ++
Sbjct: 24 TGRIVAIKKIK------LGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNI 77
Query: 60 LLIYEYMPNKSLDVFLFD-STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
L++E+M L+ + D S D K S + RGL YLH I+HRDLK
Sbjct: 78 NLVFEFMET-DLEKVIKDKSIVLTPADIK---SYMLMTLRGLEYLH---SNWILHRDLKP 130
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKS----- 173
+N+L+ + K++DFG+AR F G+ + T+++V T Y APE LF +
Sbjct: 131 NNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYRAPEL----LFGARHYGVGV 184
Query: 174 DVFSFGVLLLEIISGK 189
D++S G + E++
Sbjct: 185 DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 49/153 (32%), Positives = 79/153 (51%), Gaps = 7/153 (4%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISI 92
E L++KL H +V+ LE + +I EY + LD L + + + L +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 93 INGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152
+ G+ Y+H+ +I+HRDLKA N+ L + + KI DFG++R+ G+ A T
Sbjct: 112 FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--F 165
Query: 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
GT YM+PE + KSD++S G +L E+
Sbjct: 166 TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 6e-14
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 46/199 (23%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLFGCCLEENESLLI 62
G+ +A+K+LSR F+N E+ L+ + HKN++ L
Sbjct: 41 GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83
Query: 63 YEYMPNKSLDVF--------LFDST--RSVQ--LDWKRRISIINGIARGLLYLHEDSRLK 110
+ P KSL+ F L D+ + +Q LD +R ++ + G+ +LH
Sbjct: 84 --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138
Query: 111 IIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFS 170
IIHRDLK SN+++ + KI DFG+AR G + T +V Y Y APE + +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYK 195
Query: 171 VKSDVFSFGVLLLEIISGK 189
D++S G ++ E+I G
Sbjct: 196 ENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-14
Identities = 58/185 (31%), Positives = 93/185 (50%), Gaps = 17/185 (9%)
Query: 13 KEIAVKRLSRTSGQGL--QEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
K +AVK L + E E ++ +L + +VR+ G C E+ +L+ E
Sbjct: 23 KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAES-WMLVMELAELGP 81
Query: 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
L+ FL ++ + K +++ ++ G+ YL E + +HRDL A NVLL + K
Sbjct: 82 LNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAK 135
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL----FSVKSDVFSFGVLLLEII 186
ISDFG+++ G ++ N + + YA E + FS KSDV+SFGVL+ E
Sbjct: 136 ISDFGLSKALG---ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192
Query: 187 S-GKK 190
S G+K
Sbjct: 193 SYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-14
Identities = 67/249 (26%), Positives = 115/249 (46%), Gaps = 30/249 (12%)
Query: 15 IAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+A+K L TS + +E +E ++A + + RL G CL L + + MP L
Sbjct: 39 VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCL-- 95
Query: 74 FLFDSTRSVQ--LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
D R + + + ++ IA+G+ YL E ++++HRDL A NVL+ + KI
Sbjct: 96 --LDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKI 150
Query: 132 SDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GK 189
+DFG+AR+ +++E + + +MA E + F+ +SDV+S+GV + E+++ K
Sbjct: 151 TDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAK 210
Query: 190 KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA 249
G E+ + LE E L Q + + I + C DS
Sbjct: 211 PYDGIPAREI--------------PDLLEKGER-LPQPPICTIDVYMIMVK--CWMIDSE 253
Query: 250 DRPTMSSVV 258
RP +V
Sbjct: 254 CRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 98 RGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157
G+ +LH++ I+HRDLK SN+LLN+ KI DFG+AR +G ++V T
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLW 171
Query: 158 YMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 189
Y APE + +S D++S G + E+++ K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 18/171 (10%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEE-----NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR 88
E+ ++ KL+H N+V L +E + +Y P D+ SV+L +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 89 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIF-------- 140
+ + G+ YLHE+ I+HRD+KA+N+L++++ KI+DFG+AR +
Sbjct: 117 IKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 141 -GGNQSEANTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 189
GG +V T Y PE + E ++ D++ G + E+ + +
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 49/151 (32%), Positives = 76/151 (50%), Gaps = 14/151 (9%)
Query: 42 QHKNLVRLFGCCLEENESLL-IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGL 100
+H L L+ C + E+L + EY+ L +F + D R I GL
Sbjct: 54 EHPFLTHLY-CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGL 109
Query: 101 LYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIVGTYGY 158
+LH I++RDLK N+LL+ + + KI+DFGM + + G +A T GT Y
Sbjct: 110 QFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFCGTPDY 162
Query: 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+APE + ++ D +SFGVLL E++ G+
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 52/186 (27%), Positives = 96/186 (51%), Gaps = 14/186 (7%)
Query: 12 GKEIAVKRL-----SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL--IYE 64
G+E+AVK++ S + + + + E+ L+ L H+ +V+ +GC + E L E
Sbjct: 27 GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
+MP S+ L S ++ + R+ + I G+ YLH + I+HRD+K +N+L +
Sbjct: 87 HMPGGSIKDQL-KSYGALTENVTRKYT--RQILEGVSYLHSN---MIVHRDIKGANILRD 140
Query: 125 HEMNPKISDFGMA-RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
N K+ DFG + R+ S + GT +M+PE + K+D++S G ++
Sbjct: 141 SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVV 200
Query: 184 EIISGK 189
E+++ K
Sbjct: 201 EMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 56/176 (31%), Positives = 85/176 (48%), Gaps = 45/176 (25%)
Query: 34 EVTLIAKLQHKNLVRL---------------FGCCLEENESLLIYEYMPNKSLDVFLFDS 78
E+TL+ L+H N+V L C ++ SLL + MP F S
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTP------F-S 106
Query: 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR 138
V+ ++ + RGL YLHE+ IIHRDLK SN+LL + KI+DFG+AR
Sbjct: 107 ESQVK-------CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
Query: 139 IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 189
+ G ++ T ++V T Y APE L + D+++ G +L E+++ K
Sbjct: 157 TY-GLPAKPMTPKVV-TLWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 51/187 (27%), Positives = 95/187 (50%), Gaps = 18/187 (9%)
Query: 9 LADGKEIAVKRLS-RTSGQGL-QEFKNEVTLIAKLQ---HKNLVRLFGCCL-----EENE 58
L G+ +A+K++ S +G+ E+ L+ +L+ H N+VRL C E +
Sbjct: 21 LNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80
Query: 59 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
L++E++ ++ L +L L + ++ + RG+ +LH +I+HRDLK
Sbjct: 81 LTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKP 135
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSF 178
N+L+ + KI+DFG+ARI+ + +V T Y APE ++ ++ D++S
Sbjct: 136 QNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSV 192
Query: 179 GVLLLEI 185
G + E+
Sbjct: 193 GCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 39/92 (42%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
+ARG+ +L SR K IHRDL A N+LL+ KI DFG+AR +
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+MAPE + +++ +SDV+SFGVLL EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 14 EIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
+AVK + ++E F E ++ + H ++V+L G EN ++ E P L
Sbjct: 36 AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELR 94
Query: 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
+L LD I ++ L YL + +HRD+ A NVL++ K+
Sbjct: 95 SYL--QVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLG 149
Query: 133 DFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKK 190
DFG++R + + +A+ ++ +MAPE F+ SDV+ FGV + EI+ G K
Sbjct: 150 DFGLSRYLEDESYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-13
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 23/202 (11%)
Query: 12 GKEIAVKRLSR--TSGQGLQEFKNEVTLIAKLQHKNLVRL---FGCCLEENESLLIYEYM 66
G+++A+K+LSR S + E+TL+ +QH+N++ L F + +E Y M
Sbjct: 40 GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
P D+ L + ++ + GL Y+H IIHRDLK N+ +N +
Sbjct: 100 PYMQTDL---QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNED 153
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEI 185
KI DFG+AR ++A V T Y APE + + ++ D++S G ++ E+
Sbjct: 154 CELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
Query: 186 ISGKKNTGF----YLSELGQSL 203
++GK T F YL +L Q L
Sbjct: 209 LTGK--TLFKGKDYLDQLTQIL 228
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 52/188 (27%), Positives = 96/188 (51%), Gaps = 18/188 (9%)
Query: 12 GKEIAVKRLS-RTSGQGLQ-EFKNEVTLIAKLQ---HKNLVRLFGCCL-----EENESLL 61
G+ +A+KR+ +T +G+ EV ++ L+ H N+VRLF C E + L
Sbjct: 27 GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86
Query: 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
++E++ ++ L +L D + + ++ + RGL +LH +++HRDLK N+
Sbjct: 87 VFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNI 141
Query: 122 LLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
L+ K++DFG+ARI+ + +V T Y APE ++ ++ D++S G +
Sbjct: 142 LVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198
Query: 182 LLEIISGK 189
E+ K
Sbjct: 199 FAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 51/180 (28%), Positives = 91/180 (50%), Gaps = 12/180 (6%)
Query: 13 KEIAVKRLS-----RTSGQGLQEFKNEVTLIAK-LQHKNLVRLFGCCLEENESLLIYEYM 66
KEI V + R + + + +EVT+I + L+H N+VR + LE + ++ + +
Sbjct: 32 KEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLI 91
Query: 67 PNKSL-DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
L + F + + +R +I + L YLH++ R I+HRDL +N++L
Sbjct: 92 EGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGE 149
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ I+DFG+A+ Q E+ +VGT Y PE + K+DV++FG +L ++
Sbjct: 150 DDKVTITDFGLAK---QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 48/157 (30%), Positives = 83/157 (52%), Gaps = 9/157 (5%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
EV+L+ L+H N+V L E L++EY+ +K L +L D S+ + + +
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--L 110
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
+ RGL Y H R K++HRDLK N+L+N K++DFG+AR ++ +N +V
Sbjct: 111 FQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVV 166
Query: 154 GTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 189
T Y P+ + +S + D++ G + E+ +G+
Sbjct: 167 -TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 33/173 (19%)
Query: 28 LQEFKNEVTLIAKLQHKNLVRLFGCCLEENES--LLIYEYMPNKSLDVFLFDSTRSVQLD 85
LQE + H N+V+L EN+ L++EYM + L R+ L+
Sbjct: 60 LQELGD---------HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILE 105
Query: 86 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS 145
+ I+ + + L Y+H S +IHRDLK SN+LLN + K++DFG+AR
Sbjct: 106 DVHKRYIMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL-SELE 161
Query: 146 EANTNRI----VGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 189
E N + V T Y APE L D++S G +L E++ GK
Sbjct: 162 ENPENPVLTDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 39/192 (20%)
Query: 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIF 140
+ LD + +S +A+G+ +L + IHRDL A N+LL H KI DFG+AR
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-- 262
Query: 141 GGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195
++N +V +MAPE +++ +SDV+S+G+LL EI S
Sbjct: 263 ---DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS-------- 311
Query: 196 LSELGQS------LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA 249
LG S + S +K+ EG ++ P C +E+ + C AD
Sbjct: 312 ---LGSSPYPGMPVDSKFYKMIKEG--YRMLSP----ECAPSEMYDIMKS---CWDADPL 359
Query: 250 DRPTMSSVVVML 261
RPT +V ++
Sbjct: 360 KRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 50/183 (27%), Positives = 93/183 (50%), Gaps = 19/183 (10%)
Query: 12 GKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMP 67
G+ +A+K++ + T + ++ E+ L+ L+H+N++ L + E + + E +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
D+ ++R ++ + + + I RGL Y+H ++HRDLK SN+L+N
Sbjct: 93 --GTDLHRLLTSRPLEKQFIQ--YFLYQILRGLKYVHSAG---VVHRDLKPSNILINENC 145
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEII 186
+ KI DFG+ARI + V T Y APE + + V+ D++S G + E++
Sbjct: 146 DLKICDFGLARI-----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
Query: 187 SGK 189
GK
Sbjct: 201 EGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-12
Identities = 53/188 (28%), Positives = 92/188 (48%), Gaps = 18/188 (9%)
Query: 12 GKEIAVKRLSRTSGQ-GLQ-EFKNEVTLIAKLQ---HKNLVRLFGCCL-----EENESLL 61
G +A+K + + + GL EV L+ +L+ H N+VRL C E + L
Sbjct: 25 GHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84
Query: 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
++E++ ++ L +L D L + ++ RGL +LH + I+HRDLK N+
Sbjct: 85 VFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENI 139
Query: 122 LLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
L+ K++DFG+ARI+ + +V T Y APE ++ ++ D++S G +
Sbjct: 140 LVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 196
Query: 182 LLEIISGK 189
E+ K
Sbjct: 197 FAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 29/197 (14%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
K +AVK++ T Q ++ E+ +I +L H N+V+++ L
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL------TEDVG 83
Query: 72 DVFLFDSTRSVQ--LDWKRRISIING-------------IARGLLYLHEDSRLKIIHRDL 116
+ +S VQ ++ + G + RGL Y+H + ++HRDL
Sbjct: 84 SLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDL 140
Query: 117 KASNVLLNHE-MNPKISDFGMARIFGGNQSEAN--TNRIVGTYGYMAPEYAMEGLFSVKS 173
K +NV +N E + KI DFG+ARI + S + +V + Y +P + K+
Sbjct: 141 KPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKA 199
Query: 174 -DVFSFGVLLLEIISGK 189
D+++ G + E+++GK
Sbjct: 200 IDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 36/196 (18%)
Query: 12 GKEIAVKRLS---------RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGC----CLEE-N 57
G ++A+K++S RT L+E K ++ + +H+N++ + E N
Sbjct: 30 GVKVAIKKISPFEHQTFCQRT----LREIK----ILRRFKHENIIGILDIIRPPSFESFN 81
Query: 58 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
+ ++ E M L+ ++ L + I RGL Y+H + ++HRDLK
Sbjct: 82 DVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLK 133
Query: 118 ASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI---VGTYGYMAPEYAMEGLFSVKS- 173
SN+LLN + KI DFG+ARI + +T + V T Y APE + K+
Sbjct: 134 PSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAI 191
Query: 174 DVFSFGVLLLEIISGK 189
D++S G +L E++S +
Sbjct: 192 DIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 42/140 (30%), Positives = 73/140 (52%), Gaps = 18/140 (12%)
Query: 34 EVTLIAKLQHKNLVRLFGCC----LEENES----LLIYEYMPNKSLDVFLFDSTRSVQLD 85
E+ ++ L+H+N+V L C N L++E+ + D+ S ++V+
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH---DLAGLLSNKNVKFT 117
Query: 86 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS 145
++ + GL Y+H R KI+HRD+KA+N+L+ + K++DFG+AR F +++
Sbjct: 118 LSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 146 EAN---TNRIVGTYGYMAPE 162
TNR+V T Y PE
Sbjct: 175 SKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 19/162 (11%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD-----STRSVQLDWKR 88
EV+L+ L+H N+V L + L++EY+ +K L ++ D S +V++
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI---- 108
Query: 89 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN 148
+ I RGL Y H R K++HRDLK N+L+N K++DFG+AR ++
Sbjct: 109 ---FLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTY 161
Query: 149 TNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 189
+N +V T Y P+ + +S + D++ G + E+ SG+
Sbjct: 162 SNEVV-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I RGL YLH I+HRD+K N+L+N KI DFG+AR+ ++S+ T +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 156 YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGK 189
Y Y APE M ++ D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 53/170 (31%), Positives = 85/170 (50%), Gaps = 21/170 (12%)
Query: 30 EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR 89
F +L+++L HK+LV+L+G C+ + E++++ EY+ LDVFL +V L WK
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWK-- 103
Query: 90 ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL-----NHEMNP--KISDFGMARIFGG 142
+ + +A L YL + K++H ++ N+L+ N P K+SD G+
Sbjct: 104 LDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL- 159
Query: 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKS--DVFSFGVLLLEIISGKK 190
E RI ++APE G S+ D +SFG LLEI S +
Sbjct: 160 -SREERVERI----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 38/195 (19%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
G +AVK+LSR Q + K E+ L+ ++H+N++ L + P
Sbjct: 42 GLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPA 88
Query: 69 KSL----DVFLFDSTRSVQLDWKRRIS---------IINGIARGLLYLHEDSRLKIIHRD 115
+SL DV+L L+ + +I I RGL Y+H IIHRD
Sbjct: 89 RSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRD 145
Query: 116 LKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSD 174
LK SN+ +N + KI DFG+AR ++ V T Y APE + + ++ D
Sbjct: 146 LKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVD 200
Query: 175 VFSFGVLLLEIISGK 189
++S G ++ E+++G+
Sbjct: 201 IWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 28/189 (14%)
Query: 13 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
+ +A+K+LSR F+N+ AK ++ LV L C +N L+ + P KSL+
Sbjct: 50 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 73 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
F L D+ ++LD +R ++ + G+ +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
+++ + KI DFG+AR G S T +V Y Y APE + + D++S G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 181 LLLEIISGK 189
++ E+I G
Sbjct: 214 IMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 32 KNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 91
K + L AK H L L C ++ + EY+ L +F RS + D R
Sbjct: 46 KRILALAAK--HPFLTALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRF 100
Query: 92 IINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANT 149
+ L++LH R +I+RDLK N+LL+ E + K++DFGM + I G T
Sbjct: 101 YAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TT 153
Query: 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
GT Y+APE E + D ++ GVL+ E+++G+
Sbjct: 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 58/192 (30%), Positives = 95/192 (49%), Gaps = 32/192 (16%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
G ++A+K+L R F++E L AK ++ L RL EN L+ + P+ SL
Sbjct: 40 GAKVAIKKLYRP-------FQSE--LFAKRAYREL-RLLKHMKHENVIGLLDVFTPDLSL 89
Query: 72 DVFL-------FDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKA 118
D F F T +L ++S ++ + +GL Y+H IIHRDLK
Sbjct: 90 DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKP 146
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFS 177
N+ +N + KI DFG+AR Q+++ V T Y APE + + ++ D++S
Sbjct: 147 GNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWS 201
Query: 178 FGVLLLEIISGK 189
G ++ E+++GK
Sbjct: 202 VGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 58/169 (34%), Positives = 80/169 (47%), Gaps = 23/169 (13%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
+ARG+ +L SR K IHRDL A N+LL+ KI DFG+AR +
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNTGFYLSE-LGQSLLSYTWKLWC 212
+MAPE + +++ +SDV+SFGVLL EI S G ++E Q L T
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT----- 294
Query: 213 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 261
A E P + + I L C Q D +RPT S++V +L
Sbjct: 295 RMRAPENATPEIYR------------IMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 41/113 (36%), Positives = 61/113 (53%), Gaps = 21/113 (18%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
+A+G+ +L + IHRD+ A NVLL KI DFG+AR ++N +V
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKG 272
Query: 156 YG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKK-------NTGFY 195
+MAPE + +++V+SDV+S+G+LL EI S GK N+ FY
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 59/193 (30%), Positives = 93/193 (48%), Gaps = 36/193 (18%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
G +AVK+LSR F+N+ AK ++ LV L C +N L+ + P KSL
Sbjct: 46 GINVAVKKLSRP-------FQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQKSL 95
Query: 72 DVF--------LFDSTRS----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
+ F L D+ ++LD +R ++ + G+ +LH IIHRDLK S
Sbjct: 96 EEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPS 152
Query: 120 NVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY----GYMAPEYAMEGLFSVKSDV 175
N+++ + KI DFG+AR A TN ++ Y Y APE + + D+
Sbjct: 153 NIVVKSDCTLKILDFGLART-------ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDI 205
Query: 176 FSFGVLLLEIISG 188
+S G ++ E++ G
Sbjct: 206 WSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 64/249 (25%), Positives = 105/249 (42%), Gaps = 47/249 (18%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISI 92
E+ ++ +L+H+NLV L + L++E++ + LD D + LD R
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKY 105
Query: 93 INGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152
+ I RG+ + H + IIHRD+K N+L++ K+ DFG AR E T+
Sbjct: 106 LFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-Y 160
Query: 153 VGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISG----------------------- 188
V T Y APE + + + D+++ G L+ E+++G
Sbjct: 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL 220
Query: 189 --KKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQA 246
+ F + L + K E E LE P K S + +L K C++
Sbjct: 221 IPRHQEIFQKNPLFAGMRLPEVK---EIEPLEKRFP--KLSGLVLDLAK------QCLRI 269
Query: 247 DSADRPTMS 255
D DRP+ S
Sbjct: 270 DPDDRPSSS 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 27/169 (15%)
Query: 29 QEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR 88
Q NE ++ ++ H ++RLF ++ ++ EY+P L +L +S
Sbjct: 46 QHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS---------G 96
Query: 89 RISIINGIAR--------GLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIF 140
R S N L YLH +I++RDLK N+LL+ E + K++DFG A+
Sbjct: 97 RFS--NSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-- 149
Query: 141 GGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+ T + GT Y+APE + D ++ G+L+ E++ G
Sbjct: 150 ---KLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-12
Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 21/190 (11%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLE------ENESLLIYE 64
G+ A+K + T + +E K E+ ++ K H+N+ +G ++ +++ L+ E
Sbjct: 41 GQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99
Query: 65 YMPNKSL-DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
+ S+ D+ +++ DW I I RGL +LH K+IHRD+K NVLL
Sbjct: 100 FCGAGSVTDLVKNTKGNALKEDWIAYIC--REILRGLAHLHAH---KVIHRDIKGQNVLL 154
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM-----EGLFSVKSDVFSF 178
K+ DFG++ +++ N +GT +MAPE + + +SD++S
Sbjct: 155 TENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSL 212
Query: 179 GVLLLEIISG 188
G+ +E+ G
Sbjct: 213 GITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-12
Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 26/188 (13%)
Query: 13 KEIAVKRLSRTSGQGLQEFKN--EVTLIAKLQHKNLVRLF-----GCCLEE-NESLLIYE 64
+++AVK+LSR + + E+ L+ ++H+N++ L +E NE L+
Sbjct: 41 QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100
Query: 65 YMPNKSLDVFLFD--STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
M ++ S VQ +I + RGL Y+H IIHRDLK SNV
Sbjct: 101 LMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLKYIHSAG---IIHRDLKPSNVA 150
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVL 181
+N + +I DFG+AR Q++ V T Y APE + + ++ D++S G +
Sbjct: 151 VNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205
Query: 182 LLEIISGK 189
+ E++ GK
Sbjct: 206 MAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 41/113 (36%), Positives = 63/113 (55%), Gaps = 8/113 (7%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR-IVG 154
I+ GL +LH II+RDLK NV+L+ E + KI+DFGM + + + T R G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163
Query: 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-TGFYLSELGQSLLSY 206
T Y+APE + D +++GVLL E+++G+ G EL QS++ +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 50/183 (27%), Positives = 89/183 (48%), Gaps = 15/183 (8%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
L G+ AVK + G + E+ ++ + +H N+V FG L + + EY
Sbjct: 30 NLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89
Query: 68 NKSL-DVFLFDSTRS-VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
SL D++ S +Q+ + R ++ +GL YLH ++ HRD+K +N+LL
Sbjct: 90 GGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM---HRDIKGANILLTD 141
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLL 182
+ K++DFG+A + A +GT +MAPE A G ++ D+++ G+
Sbjct: 142 NGDVKLADFGVAAKI--TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITA 199
Query: 183 LEI 185
+E+
Sbjct: 200 IEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 48/157 (30%), Positives = 79/157 (50%), Gaps = 8/157 (5%)
Query: 32 KNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 91
K E ++A++ H +V+L E + LI +++ L L + D K ++
Sbjct: 46 KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 92 IINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151
+A L +LH L II+RDLK N+LL+ E + K++DFG+++ E
Sbjct: 106 ---ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYS 157
Query: 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
GT YMAPE + +D +SFGVL+ E+++G
Sbjct: 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 45/165 (27%), Positives = 77/165 (46%), Gaps = 26/165 (15%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E ++ + H ++++L G + LI +P D++ + L KR I+I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCY-------LAAKRNIAIC 182
Query: 94 NGIA------RGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA 147
+ +A R + YLHE+ IIHRD+KA N+ +NH + + DFG A +
Sbjct: 183 DILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF----PVDI 235
Query: 148 NTNRIVGTYGYMA---PEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
N N+ G G +A PE + D++S G++L E+ +
Sbjct: 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 9e-12
Identities = 57/192 (29%), Positives = 95/192 (49%), Gaps = 30/192 (15%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN-----EVTLIAKLQH--KNLVRLFGCCLEENESLLIYE 64
G +AVK++ RT + +E K +V L H +V+ +G + +++ + E
Sbjct: 40 GHVMAVKQMRRTGNK--EENKRILMDLDVVL---KSHDCPYIVKCYGYFITDSDVFICME 94
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRI--SIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
M + LD L + +Q I + I + L YL E +IHRD+K SN+L
Sbjct: 95 LM-STCLDKLL----KRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNIL 147
Query: 123 LNHEMNPKISDFGMA-RIFGGNQSEANTNRIVGTYGYMAPEY----AMEGLFSVKSDVFS 177
L+ N K+ DFG++ R+ S+A T R G YMAPE + +++DV+S
Sbjct: 148 LDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPERIDPPDPNPKYDIRADVWS 203
Query: 178 FGVLLLEIISGK 189
G+ L+E+ +G+
Sbjct: 204 LGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-12
Identities = 37/93 (39%), Positives = 55/93 (59%), Gaps = 9/93 (9%)
Query: 99 GLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIVGTY 156
GL +LH II+RDLK NV+L+ + + KI+DFGM + +FG N++ GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST----FCGTP 160
Query: 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
Y+APE ++ D +SFGVLL E++ G+
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-12
Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 16/188 (8%)
Query: 5 LQGKLADGKEIAVKRLSRTSGQGLQEFKN----EVTLIAKLQHKNLVRLFGCCLEENESL 60
L K + G A+K L ++ + N ++ + + + +L+ ++
Sbjct: 14 LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLY 73
Query: 61 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
L+ EY+ L + + DW ++ I + G+ LH+ IIHRD+K N
Sbjct: 74 LVMEYLNGGDCAS-LIKTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPEN 127
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
+L++ + K++DFG++R N+ + VGT Y+APE + SD +S G
Sbjct: 128 LLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 181 LLLEIISG 188
++ E + G
Sbjct: 182 VIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-12
Identities = 47/147 (31%), Positives = 72/147 (48%), Gaps = 8/147 (5%)
Query: 43 HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLY 102
H LV L C E+ + EY+ L +F R +L + I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 103 LHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE 162
LHE II+RDLK NVLL+ E + K++D+GM + G + T+ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 166
Query: 163 YAMEGLFSVKSDVFSFGVLLLEIISGK 189
+ D ++ GVL+ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 55/183 (30%), Positives = 91/183 (49%), Gaps = 11/183 (6%)
Query: 11 DGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP- 67
DGK+ +K+L+ S + + + E L+++L+H N+V E E L+Y M
Sbjct: 24 DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESW--EGEDGLLYIVMGF 81
Query: 68 NKSLDVFLFDSTRSVQLDWKRRI-SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
+ D++ + +L + ++ IA L YLHE I+HRDLK NV L
Sbjct: 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRT 138
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
K+ D G+AR+ A+T ++GT YM+PE ++ KSDV++ G + E+
Sbjct: 139 NIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196
Query: 187 SGK 189
+ K
Sbjct: 197 TLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 3/92 (3%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
+A+G+ +L SR K IHRDL A N+LL+ KI DFG+AR +
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+MAPE + +++++SDV+SFGVLL EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 49/156 (31%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 39 AKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL------DVFLFDSTRSVQLDWKRRISI 92
+H LV LF C E+ + EY L DVF R +
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF----------SEPRAVFY 106
Query: 93 INGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152
+ GL YLHE+ KI++RDLK N+LL+ E KI+DFG+ + G +T
Sbjct: 107 AACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--F 161
Query: 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
GT ++APE E ++ D + GVL+ E++ G
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT--NRIV 153
+ RGL Y+H +IHRDLK SN+L+N + +I DFGMAR + +E V
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 154 GTYGYMAPE--YAMEGLFSVKSDVFSFGVLLLEII 186
T Y APE ++ ++ D++S G + E++
Sbjct: 173 ATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 90 ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149
+S +ARG+ +L + +HRDL A NVLL KI DFG+AR + + +
Sbjct: 240 LSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+MAPE + L++ SDV+S+G+LL EI S
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 50/183 (27%), Positives = 88/183 (48%), Gaps = 9/183 (4%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
GK+ K++ KR+ + G+ + NE ++ K+ + +V L ++ L+ M
Sbjct: 25 GKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
L ++ + + R + I GL LH++ +I++RDLK N+LL+
Sbjct: 83 NGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDH 138
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
+ +ISD G+A Q+ VGT GYMAPE ++ D ++ G LL E+I
Sbjct: 139 GHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 195
Query: 187 SGK 189
+G+
Sbjct: 196 AGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 1e-11
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 41/172 (23%)
Query: 32 KNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 90
NE ++ ++H LV L+G +++ +L L+ EY+P L F R R
Sbjct: 49 LNEKRILQSIRHPFLVNLYGS-FQDDSNLYLVMEYVPGGEL----FSHLRKS-----GRF 98
Query: 91 SIINGIAR--------GLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142
+AR L YLH L I++RDLK N+LL+ + KI+DFG A+ G
Sbjct: 99 P--EPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153
Query: 143 NQSEANTNRIVGTYGYMAPE------YAMEGLFSVKSDVFSFGVLLLEIISG 188
T + GT Y+APE Y +V D ++ G+L+ E+++G
Sbjct: 154 -----RTYTLCGTPEYLAPEIILSKGYGK----AV--DWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 48/180 (26%), Positives = 91/180 (50%), Gaps = 17/180 (9%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
G+ A+K + G+ + E+ ++ +H N+V FG L ++ + E+ SL
Sbjct: 34 GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93
Query: 72 -DVFLFDSTRS-VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
D++ S Q+ + R ++ +GL YLH + +HRD+K +N+LL +
Sbjct: 94 QDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK---MHRDIKGANILLTDNGHV 145
Query: 130 KISDFGM-ARIFGGNQSEANTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEI 185
K++DFG+ A+I + A +GT +MAPE A +G ++ D+++ G+ +E+
Sbjct: 146 KLADFGVSAQI---TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 2e-11
Identities = 58/189 (30%), Positives = 93/189 (49%), Gaps = 28/189 (14%)
Query: 13 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
+ +A+K+LSR F+N+ AK ++ LV L C +N L+ + P KSL+
Sbjct: 43 RNVAIKKLSRP-------FQNQTH--AKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLE 92
Query: 73 VF--------LFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
F L D+ ++LD +R ++ + G+ +LH IIHRDLK SN
Sbjct: 93 EFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 149
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
+++ + KI DFG+AR G S T +V Y Y APE + + D++S G
Sbjct: 150 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 206
Query: 181 LLLEIISGK 189
++ E++ K
Sbjct: 207 IMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 43/114 (37%), Positives = 63/114 (55%), Gaps = 10/114 (8%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIV 153
IA GL +LH II+RDLK NV+L+ E + KI+DFGM + ++ G T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-TGFYLSELGQSLLSY 206
GT Y+APE + D ++FGVLL E+++G+ G EL QS++ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 52/184 (28%), Positives = 90/184 (48%), Gaps = 20/184 (10%)
Query: 14 EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
E+ +K L ++ + F +++++L HK+LV +G C+ +ES+++ EY+ SLD
Sbjct: 29 EVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDT 88
Query: 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-----N 128
+L + + + WK + + +A L +L + + H ++ A NVLL E N
Sbjct: 89 YLKKNKNLINISWK--LEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGN 143
Query: 129 P---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLE 184
P K+SD G++ E RI ++ PE S+ +D +SFG L E
Sbjct: 144 PPFIKLSDPGISITV--LPKEILLERI----PWVPPECIENPQNLSLAADKWSFGTTLWE 197
Query: 185 IISG 188
I SG
Sbjct: 198 IFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 53/184 (28%), Positives = 91/184 (49%), Gaps = 16/184 (8%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---EVTLIAKLQHKNLVRLFGCCLEENESLLIYE--YM 66
G+++A+K+LSR Q K E+ L+ + H+N++ L SL ++ Y+
Sbjct: 40 GRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDV-FTPASSLEDFQDVYL 97
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
+ L + + +L ++ I RGL Y+H IIHRDLK SN+ +N +
Sbjct: 98 VTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNED 154
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEI 185
KI DFG+AR ++ V T Y APE + + ++ D++S G ++ E+
Sbjct: 155 CELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
Query: 186 ISGK 189
++GK
Sbjct: 210 LTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 13 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
KEI RL ++S +++ + E L+AK++H N+V + ++ EY L
Sbjct: 31 KEI---RLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLM 86
Query: 73 VFLFDS-----TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
+ L W ++ + G+ ++HE +++HRD+K+ N+ L
Sbjct: 87 QKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNG 137
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
K+ DFG AR+ + A T VGT Y+ PE ++ KSD++S G +L E+ +
Sbjct: 138 KVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
Query: 188 GK 189
K
Sbjct: 196 LK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 53/184 (28%), Positives = 88/184 (47%), Gaps = 11/184 (5%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEY 65
GK+ K++ KR+ + G+ + NE ++ K+ + +V L E ++L L+
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTL 81
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
M L +++ D +R + I GL LH R +I++RDLK N+LL+
Sbjct: 82 MNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDD 137
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ +ISD G+A ++ VGT GYMAPE ++ D + G L+ E+
Sbjct: 138 YGHIRISDLGLAVEIPEGETIRGR---VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEM 194
Query: 186 ISGK 189
I GK
Sbjct: 195 IEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-11
Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 16/194 (8%)
Query: 5 LQGKLADGKEIA---VKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESL 60
L G+ G A VK L ++ Q F EV +L H N+++ G C+E L
Sbjct: 12 LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71
Query: 61 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--SIINGIARGLLYLHEDSRLKIIHRDLKA 118
L+ E+ P L +L + V ++ + + +A GLL+LH + IH DL
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLAL 128
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME---GLFSVK--- 172
N L +++ KI D+G+A + ++APE L
Sbjct: 129 RNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTK 188
Query: 173 -SDVFSFGVLLLEI 185
S+++S GV + E+
Sbjct: 189 KSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 57/188 (30%), Positives = 94/188 (50%), Gaps = 13/188 (6%)
Query: 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62
S L L KEI RL G + EV+L+ L+H N+V L E L+
Sbjct: 26 SKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDIIHTERCLTLV 81
Query: 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
+EY+ + L +L D+ ++ +I + + RGL Y H + KI+HRDLK N+L
Sbjct: 82 FEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KRKILHRDLKPQNLL 135
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVL 181
+N + K++DFG+AR ++ +N +V T Y P+ + +S D++ G +
Sbjct: 136 INEKGELKLADFGLARA-KSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMWGVGCI 193
Query: 182 LLEIISGK 189
L E+ +G+
Sbjct: 194 LYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 13/185 (7%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEY 65
GK+ K++ KR+ + G+ + NE ++ K+ + +V L E ++L L+
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL-AYAYETKDALCLVLTI 81
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
M L +++ D +R I + GL L R +I++RDLK N+LL+
Sbjct: 82 MNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDD 137
Query: 126 EMNPKISDFGMARIFGGNQSEANTNR-IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
+ +ISD G+A E T R VGT GYMAPE ++ D + G L+ E
Sbjct: 138 RGHIRISDLGLAV----QIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYE 193
Query: 185 IISGK 189
+I G+
Sbjct: 194 MIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 35/94 (37%), Positives = 58/94 (61%), Gaps = 8/94 (8%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I GL ++H +R +++RDLK +N+LL+ + +ISD G+A F + A+ VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
Query: 156 YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 188
+GYMAPE +G+ + +D FS G +L +++ G
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 12/149 (8%)
Query: 43 HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLY 102
H LV L C E+ + E++ L +F R +L + I+ L +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNF 111
Query: 103 LHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE 162
LHE II+RDLK NVLL+ E + K++D+GM + G + T+ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPE 166
Query: 163 Y--AMEGLFSVKSDVFSFGVLLLEIISGK 189
+ FSV D ++ GVL+ E+++G+
Sbjct: 167 ILRGEDYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 6e-11
Identities = 56/194 (28%), Positives = 93/194 (47%), Gaps = 23/194 (11%)
Query: 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62
S QGK + IA KR+ S +Q +NE+ + +L H+N++++ E +L
Sbjct: 184 STNQGKPKCERLIA-KRVKAGSRAAIQ-LENEILALGRLNHENILKI--------EEILR 233
Query: 63 YE---YMPNKSLDVFLFDSTRSVQLDWKRRI------SIINGIARGLLYLHEDSRLKIIH 113
E YM + D L+ DWK R +I+ + + Y+H+ K+IH
Sbjct: 234 SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIH 290
Query: 114 RDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKS 173
RD+K N+ LN + + DFG A F + EA VGT +PE + +
Sbjct: 291 RDIKLENIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEIT 349
Query: 174 DVFSFGVLLLEIIS 187
D++S G++LL+++S
Sbjct: 350 DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 53/199 (26%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFK-NEVTLIAKLQHKNLVRLFGCCLE--ENESLLI 62
+ K DGK+ L + G G+ E+ L+ +L+H N++ L L + + L+
Sbjct: 19 KAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 78
Query: 63 YEYMPNKSLDVFLFD-----STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
++Y + + F + + VQL S++ I G+ YLH + ++HRDLK
Sbjct: 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLK 135
Query: 118 ASNVLLNHEMNP-----KISDFGMARIFGGN-QSEANTNRIVGTYGYMAPEYAMEGLFSV 171
+N+L+ E P KI+D G AR+F + A+ + +V T+ Y APE +
Sbjct: 136 PANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 194
Query: 172 KS-DVFSFGVLLLEIISGK 189
K+ D+++ G + E+++ +
Sbjct: 195 KAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 33/91 (36%), Positives = 53/91 (58%)
Query: 100 LLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159
LL +H +IHRD+K++N+LL K+ DFG ++++ S+ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKK 190
APE +S K+D+FS GVLL E+++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 35/94 (37%), Positives = 57/94 (60%), Gaps = 8/94 (8%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I GL ++H +R +++RDLK +N+LL+ + +ISD G+A F + A+ VGT
Sbjct: 106 IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGT 158
Query: 156 YGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 188
+GYMAPE +G + +D FS G +L +++ G
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 3/95 (3%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
IA +L L +L II+RD+K N+LL+ E + ++DFG+++ F + E GT
Sbjct: 111 IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGT 169
Query: 156 YGYMAPEYAM--EGLFSVKSDVFSFGVLLLEIISG 188
YMAPE G D +S GVL E+++G
Sbjct: 170 IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 15/182 (8%)
Query: 11 DGKEI-AVKRLSRTSGQGLQEFK---NEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
D EI A+KR+ ++ L E + E ++ + + LV+L ++ L EY+
Sbjct: 24 DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
P L ++ + D R +A + L IHRDLK N L++
Sbjct: 84 PGGDFRTLL-NNLGVLSEDHARFY-----MAEMFEAVDALHELGYIHRDLKPENFLIDAS 137
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
+ K++DFG+++ G + AN+ +VG+ YMAPE + D +S G +L E +
Sbjct: 138 GHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL 192
Query: 187 SG 188
G
Sbjct: 193 CG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 40/103 (38%), Positives = 55/103 (53%), Gaps = 8/103 (7%)
Query: 91 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTN 150
S I I GL Y+H + ++HRDLK N+L+N + KI DFG+AR F N E N
Sbjct: 109 SFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-NAG 164
Query: 151 RI---VGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLEIISGK 189
+ V T Y APE + K+ DV+S G +L E++ K
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 8/144 (5%)
Query: 46 LVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 105
LV L C + L+ EY+ L +F R +L + I L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 106 DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM 165
II+RDLK NVLL+ + + K++D+GM + G T+ GT Y+APE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 166 EGLFSVKSDVFSFGVLLLEIISGK 189
+ D ++ GVL+ E+++G+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 19/199 (9%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFK-NEVTLIAKLQHKNLVRLFGCCLEENES--LLI 62
+ K DGK+ L + G G+ E+ L+ +L+H N++ L L ++ L+
Sbjct: 19 KAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLL 78
Query: 63 YEYMPNKSLDVFLFD-----STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
++Y + + F + + +QL S++ I G+ YLH + ++HRDLK
Sbjct: 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLK 135
Query: 118 ASNVLLNHEMNP-----KISDFGMARIFGGN-QSEANTNRIVGTYGYMAPEYAMEGLFSV 171
+N+L+ E P KI+D G AR+F + A+ + +V T+ Y APE +
Sbjct: 136 PANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYT 194
Query: 172 KS-DVFSFGVLLLEIISGK 189
K+ D+++ G + E+++ +
Sbjct: 195 KAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 17/163 (10%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEE-----NESLLIYEYMPNKSLDVFLFDSTRSVQ-LDWK 87
E+ L+ L H+N++ + N+ ++YE M D L RS Q L
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDD 108
Query: 88 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA 147
+ + RGL Y+H + ++HRDLK SN+LLN + KI DFG+AR ++
Sbjct: 109 HCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGD 163
Query: 148 NTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 189
V T Y APE + ++ DV+S G + E++ K
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 11/184 (5%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
GK+ K + KR+ + G+ + NE ++ K+ + +V L ++ L+ M
Sbjct: 25 GKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
L +++ + +R + I GL LH ++ ++RDLK N+LL+
Sbjct: 83 NGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDY 138
Query: 127 MNPKISDFGMA-RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ +ISD G+A +I G VGT GYMAPE +++ D + G L+ E+
Sbjct: 139 GHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEM 194
Query: 186 ISGK 189
I G+
Sbjct: 195 IEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 5e-10
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 20/164 (12%)
Query: 33 NEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI- 90
EV + KL H N+V+L E +E ++EYM +++ R + + I
Sbjct: 46 REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG---NLYQLMKDRKGKPFSESVIR 102
Query: 91 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTN 150
SII I +GL ++H + HRDLK N+L++ KI+DFG+AR E +
Sbjct: 103 SIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSR 152
Query: 151 R----IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK 189
V T Y APE + +S D+++ G ++ E+ + +
Sbjct: 153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-10
Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESL-----LIYE 64
DG AVK L S +E + E ++ L H N+V+ +G + ++ + L+ E
Sbjct: 46 DGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE 104
Query: 65 YMPNKSLDVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
S+ + Q LD I+ G GL +LH + +IIHRD+K +N+LL
Sbjct: 105 LCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILL 161
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEY-----AMEGLFSVKSDVFSF 178
E K+ DFG++ + NT+ VGT +MAPE + + + DV+S
Sbjct: 162 TTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219
Query: 179 GVLLLEIISG 188
G+ +E+ G
Sbjct: 220 GITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 51/194 (26%), Positives = 87/194 (44%), Gaps = 27/194 (13%)
Query: 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62
S L G+L KEI RL G + E +L+ L+H N+V L + L+
Sbjct: 26 SKLTGQLVALKEI---RLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDIIHTKKTLTLV 81
Query: 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIA-------RGLLYLHEDSRLKIIHRD 115
+EY+ D+ +D ++ + RGL Y H + +++HRD
Sbjct: 82 FEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRD 128
Query: 116 LKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSD 174
LK N+L++ K++DFG+AR S+ +N +V T Y P+ + +S D
Sbjct: 129 LKPQNLLISERGELKLADFGLARA-KSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLD 186
Query: 175 VFSFGVLLLEIISG 188
++ G + E+ +G
Sbjct: 187 MWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 50/163 (30%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 31 FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 90
F +L++++ H +L + G C+ +E++++ E++ + LDV L V + WK I
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--I 120
Query: 91 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-----MNP--KISDFGMARIFGGN 143
++ +A L YL ED L +H ++ A N+LL +P K+SD G++ F
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 144 QSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEI 185
E RI ++APE G S +D +SFG LLEI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 57/244 (23%), Positives = 110/244 (45%), Gaps = 33/244 (13%)
Query: 12 GKEIAVKRLSRTSGQGLQE---FKNEVTLIAKLQHKNLVRLFGCCLEENES-----LLIY 63
G E+A+K L + + + F+ E L A+L H N+V L L+ E+ ++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFAVF 58
Query: 64 EYMPNKSL-DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
EY+P ++L +V D + + +++ +A H I+HRDLK N++
Sbjct: 59 EYVPGRTLREVLAADGALPAGETGRLMLQVLDALACA----H---NQGIVHRDLKPQNIM 111
Query: 123 LNH---EMNPKISDFGMARIFGGNQSEA-----NTNRIVGTYGYMAPEYAMEGLFSVKSD 174
++ + K+ DFG+ + G + T ++GT Y APE + SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 175 VFSFGVLLLEIISGKKN-TGFYLSELGQSLLS---YTWKLWCEGEAL-ELMEPVLKQSCV 229
++++G++ LE ++G++ G ++E+ LS + W G L +++ L +
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPR 231
Query: 230 AAEL 233
Sbjct: 232 QRAA 235
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
IA L YLH L II+RDLK N+LL+ + + ++DFG+ + G + T+ GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGT 159
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
Y+APE + + D + G +L E++ G
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 32 KNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS 91
++E+ +A H +V+ F +++ LLI EY L+ + ++ K +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLN-------KQIKQRLKEHLP 165
Query: 92 IINGIARGLLY-----LHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146
L Y L E K++HRDLK++N+ L K+ DFG ++ + + S
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225
Query: 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+ GT Y+APE +S K+D++S GV+L E+++
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIV 153
I+ L +LH + II+RDLK N+LL+ + + K++DFG+ + I G T+
Sbjct: 109 ISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFC 161
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
GT YMAPE M D +S G L+ ++++G
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 21/223 (9%)
Query: 14 EIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
++ VK L ++ Q +F E LQH NL++ G C E LL+ E+ P L
Sbjct: 24 QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLK 83
Query: 73 VFLFDSTRSVQL---DWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
+L S R +L D + IA GLL+LH+++ IH DL N LL ++
Sbjct: 84 GYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTV 139
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME---GLFSV----KSDVFSFGVLL 182
KI D+G++ +++ ++APE E L V +S+V+S GV +
Sbjct: 140 KIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199
Query: 183 LEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225
E+ +LS+ + +L+YT + + L+L +P LK
Sbjct: 200 WELFELGSQPYRHLSD--EQVLTYTVR----EQQLKLPKPRLK 236
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 44/169 (26%), Positives = 78/169 (46%), Gaps = 20/169 (11%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E+ ++ +++H+N++ L +E + L+ + M + V R ++L + I+
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVV----DRKIRLTESQVKCIL 125
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFG------------ 141
I GL LH+ +HRDL +N+ +N + KI+DFG+AR +G
Sbjct: 126 LQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 142 GNQSEANTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 189
Q V T Y APE M + D++S G + E+++GK
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
+A G+ +L + +HRDL A NVL+ KI DFG+AR + + +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+MAPE L++ SDV+SFG+LL EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 8/87 (9%)
Query: 102 YLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAP 161
YLH II+RDLK N+LL+++ + K++DFG A+ + T + GT Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184
Query: 162 EYAMEGLFSVKSDVFSFGVLLLEIISG 188
E D ++ GVLL E I+G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-09
Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 13/179 (7%)
Query: 15 IAVKRLSRTSGQGLQEFKN----EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
+A+K+ + +E K E+ ++ L+ +N+V L + L++EY+
Sbjct: 29 VAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86
Query: 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
L+ L + + K R S I + + + + H++ I+HRD+K N+L++H K
Sbjct: 87 LE--LLEEMPNGVPPEKVR-SYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLK 140
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+ DFG AR S AN V T Y +PE + + D++S G +L E+ G+
Sbjct: 141 LCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 8e-09
Identities = 30/94 (31%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN-TNRIVG 154
A L L + +I+RDLK N+LL+++ + + DFG+ ++ N + + TN G
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNTFCG 155
Query: 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
T Y+APE + ++ D ++ GVLL E+++G
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 13/185 (7%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
K++ VK + G + E+ ++ + H+ ++ L ++ ++ MP
Sbjct: 117 EQRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKY 168
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
D+F + RS L ++ I+I + L YLH IIHRD+K N+ L+ N
Sbjct: 169 KCDLFTY-VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENA 224
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+ DFG A + GT +PE + K+D++S G++L E +S K
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSVK 283
Query: 190 KNTGF 194
T F
Sbjct: 284 NVTLF 288
|
Length = 392 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 99 GLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158
GL +LH + K IHRD+K +N+LL E K+ DFG++ + NT+ VGT +
Sbjct: 136 GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 190
Query: 159 MAPEY-----AMEGLFSVKSDVFSFGVLLLEIISG 188
MAPE ++ + + DV+S G+ +E+ G
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 49/178 (27%)
Query: 46 LVRLFGCCLEENESL-LIYEYMPNKSL-------DVFLFDSTRSVQLDWKRRISIINGIA 97
+V+L+ ++ E L L+ EYMP L DVF ++ R IA
Sbjct: 63 IVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-------------IA 108
Query: 98 RGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA-------------------- 137
+L L +L IHRD+K N+L++ + + K++DFG+
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 138 -------RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
R Q N VGT Y+APE + ++ D +S GV+L E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 35/97 (36%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 98 RGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI-FGGNQSEANTNRIVGTY 156
R L Y+H + + HRDLK N+L N + KI DFG+AR+ F + V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 157 GYMAPEYAMEGLFSVKS----DVFSFGVLLLEIISGK 189
Y APE G F K D++S G + E+++GK
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 49/183 (26%), Positives = 92/183 (50%), Gaps = 14/183 (7%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFK--NEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMP 67
+G+ +A+K +S + +G+ F E +L+ L+H N+V L + E+L ++EYM
Sbjct: 29 NGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI-IHTKETLTFVFEYM- 85
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
D+ + L + + RGL Y+H I+HRDLK N+L+++
Sbjct: 86 --HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLG 140
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEII 186
K++DFG+AR S+ ++ +V T Y P+ + +S D++ G + +E++
Sbjct: 141 ELKLADFGLARA-KSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
Query: 187 SGK 189
G+
Sbjct: 199 QGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 16/174 (9%)
Query: 31 FKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRR 89
F E ++A +V+LF C ++++ L ++ EYMP L + S V W +
Sbjct: 90 FWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKF 146
Query: 90 ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149
+ A +L L + +IHRD+K N+LL+ + K++DFG
Sbjct: 147 YT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRC 200
Query: 150 NRIVGTYGYMAPEY----AMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSEL 199
+ VGT Y++PE +G + + D +S GV L E++ G +T FY L
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG--DTPFYADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 12/181 (6%)
Query: 11 DGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+GK +A+K RL G + E +L+ L+H N+V L + L++EY+
Sbjct: 29 NGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTLVFEYV-- 85
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
D+ + L + + + RGL Y+H+ I+HRDLK N+L++
Sbjct: 86 -HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGE 141
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIIS 187
K++DFG+AR S +N +V T Y P+ + +S D++ G + +E+I
Sbjct: 142 LKLADFGLARA-KSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199
Query: 188 G 188
G
Sbjct: 200 G 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 36/206 (17%)
Query: 12 GKEIAVKRLSRT-SGQGL--QEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+ +A+K++ S L + F E + A L H +V ++ C ++ +Y MP
Sbjct: 27 SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC---SDGDPVYYTMPY 83
Query: 69 ------KSL--DVFLFDSTRS---VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
KSL V+ +S + +SI + I + Y+H S+ ++HRDLK
Sbjct: 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--SK-GVLHRDLK 140
Query: 118 ASNVLLNHEMNPKISDFGMARIFGGNQSE----------------ANTNRIVGTYGYMAP 161
N+LL I D+G A + + +IVGT YMAP
Sbjct: 141 PDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200
Query: 162 EYAMEGLFSVKSDVFSFGVLLLEIIS 187
E + S +D+++ GV+L ++++
Sbjct: 201 ERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 7/106 (6%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
+A + YLH L II+RDLK N+LL+ + + ++DFG+ + G + E T+ GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQ 201
Y+APE + + D + G +L E++ G FY ++ Q
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP--FYSRDVSQ 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 9/156 (5%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E+ ++ +L+H NLV L + + L++EY + L+ L + R V ++I I
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKI--I 106
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
+ + + H + IHRD+K N+L+ + K+ DFG ARI G + V
Sbjct: 107 WQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYTDYV 161
Query: 154 GTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 188
T Y APE + + DV++ G + E+++G
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-08
Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I L +LH +L I++RD+K N+LL+ E + ++DFG+++ F + E T GT
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGT 169
Query: 156 YGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISG 188
YMAPE +G D +S G+L+ E+++G
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I L +LH +L II+RD+K N+LL+ + ++DFG+++ F ++ E GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGT 169
Query: 156 YGYMAPEYAM--EGLFSVKSDVFSFGVLLLEIISG 188
YMAP+ +G D +S GVL+ E+++G
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 45/180 (25%), Positives = 84/180 (46%), Gaps = 20/180 (11%)
Query: 15 IAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
+A+KR ++ + + +E ++ + H V L+G +E+ L+ E++
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 72 DVFLFDSTR---SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
FL + R V + +I +I YL L I++RDLK N+LL+ +
Sbjct: 119 FTFLRRNKRFPNDVGCFYAAQIVLI------FEYLQS---LNIVYRDLKPENLLLDKDGF 169
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
K++DFG A++ + T + GT Y+APE + +D ++ G+ + EI+ G
Sbjct: 170 IKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-08
Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I L YLH KI++RDLK N++L+ + + KI+DFG+ + G A GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
Y+APE + + D + GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 48/173 (27%), Positives = 77/173 (44%), Gaps = 14/173 (8%)
Query: 31 FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 90
F E ++A +V+LF ++ ++ EYMP L + S V W R
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY 147
Query: 91 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTN 150
+ A +L L + IHRD+K N+LL+ + K++DFG + +
Sbjct: 148 T-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCD 201
Query: 151 RIVGTYGYMAPEY----AMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSEL 199
VGT Y++PE +G + + D +S GV L E++ G +T FY L
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYADSL 252
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 52/185 (28%), Positives = 90/185 (48%), Gaps = 21/185 (11%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKN--EVTLIAKLQ-HKNLVRLFGCCLEE-NESL-LIYEY 65
GK A+K + + + L++ N E+ + +L H N++RL + L L++E
Sbjct: 23 TGKYYAIKCMKKHF-KSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81
Query: 66 MPNKSLDVFLFDSTRSVQ--LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
M D+ L++ + + L KR S + + + L ++H R I HRD+K N+L+
Sbjct: 82 M-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILI 133
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLL 182
+ K++DFG R G T I T Y APE + +G + K D+++ G +
Sbjct: 134 KDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVF 189
Query: 183 LEIIS 187
EI+S
Sbjct: 190 FEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I L YLH +++RD+K N++L+ + + KI+DFG+ + G A GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
Y+APE + + D + GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
IA +L L + I++RDLK N+LL+ + + DFG+++ TN GT
Sbjct: 102 IAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGT 159
Query: 156 YGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISG 188
Y+APE + E ++ D +S GVL+ E+ G
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I L YLH S +++RDLK N++L+ + + KI+DFG+ + G + A GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
Y+APE + + D + GV++ E++ G+
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-07
Identities = 19/48 (39%), Positives = 27/48 (56%), Gaps = 2/48 (4%)
Query: 263 SDTVTLPQPTEPAFSVGRNVARPGQFSSG--AEVCSVNEVTLSNVTPR 308
S+T +PQP +P F VGR+ SS E +VN+VT+S + R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I L YLH +++RDLK N++L+ + + KI+DFG+ + G A GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
Y+APE + + D + GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 19/163 (11%)
Query: 31 FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI 90
F +++ ++ HK++V L+G C+ + E++++ E++ LD+F+ + + WK ++
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV 110
Query: 91 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL-----NHEMNP--KISDFGMARIFGGN 143
+ +A L YL ED L +H ++ N+LL + E P K+SD G+
Sbjct: 111 A--KQLASALSYL-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165
Query: 144 QSEANTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEI 185
Q RI ++APE + S+ +D +SFG L EI
Sbjct: 166 QE--CVERI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 36/123 (29%), Positives = 57/123 (46%), Gaps = 11/123 (8%)
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLL----YLHEDSRLKIIHRDLKASNV 121
+P D++ + R L + + +AR LL Y+H + IIHRD+K NV
Sbjct: 239 LPKYRSDLYTYLGARLRPLGLAQ----VTAVARQLLSAIDYIHGEG---IIHRDIKTENV 291
Query: 122 LLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
L+N + + DFG A G+ S I GT APE ++ D++S G++
Sbjct: 292 LVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLV 351
Query: 182 LLE 184
+ E
Sbjct: 352 IFE 354
|
Length = 461 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
IA L YLH + I++RDLK N+LL+ + + ++DFG+ + G QS+ T GT
Sbjct: 105 IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTT-FCGT 159
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
Y+APE + + D + G +L E++ G
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 36/109 (33%), Positives = 58/109 (53%), Gaps = 8/109 (7%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
IA +L +H +L +HRD+K NVLL+ + +++DFG + ++ VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGT 166
Query: 156 YGYMAPEY--AME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSEL 199
Y++PE AME G + + D +S GV + E++ G+ T FY L
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
IA L YLH L I++RDLK N+LL+ + + ++DFG+ + + T+ GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
Y+APE + + D + G +L E++ G
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 10/110 (9%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA-RIFGGNQSEANTNRIVG 154
+A +L + +L +HRD+K NVLL+ + +++DFG R+ ++N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165
Query: 155 TYGYMAPEY--AME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSEL 199
T Y++PE AME G + + D +S GV + E++ G+ T FY L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESL 213
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-07
Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 23/173 (13%)
Query: 41 LQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS-------II 93
LQH N+++ G C+E LL++EY L +L Q W RR S +
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMA 105
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
IA G+ ++H + +H DL N L ++ K+ D+G+ +
Sbjct: 106 CEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC 162
Query: 154 GTYGYMAPEYAME---GLFSVK----SDVFSFGVLLLEIISGKKNTGFYLSEL 199
++APE E GL + + S+V++ GV L E+ +LS+
Sbjct: 163 VPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 58/201 (28%)
Query: 32 KNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMPNKSL-------DVFLFDSTRSVQ 83
+ E ++A+ + +V+L+ ++ L LI EY+P + D F + TR
Sbjct: 49 RAERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY- 106
Query: 84 LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGM------- 136
IA +L + +L IHRD+K N+LL+ + + K+SDFG+
Sbjct: 107 ------------IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154
Query: 137 -----ARIFGGNQSEANT------------------NRI------VGTYGYMAPEYAMEG 167
RI NR VGT Y+APE ++
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214
Query: 168 LFSVKSDVFSFGVLLLEIISG 188
++ + D +S GV++ E++ G
Sbjct: 215 GYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 41/189 (21%), Positives = 86/189 (45%), Gaps = 21/189 (11%)
Query: 11 DGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL----LIY 63
+ KE+ ++ + + +NE+ + ++ N+++++G ++ + L LI
Sbjct: 42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
EY L L D + L +K ++ + +GL L+ +++L + + L+
Sbjct: 102 EYCTRGYLREVL-DKEK--DLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNLTSVSFLV 156
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFS---VKSDVFSFGV 180
KI G+ +I + N N +V Y + + + +FS +K D++S GV
Sbjct: 157 TENYKLKIICHGLEKILS-SPPFKNVNFMV----YFSYKM-LNDIFSEYTIKDDIYSLGV 210
Query: 181 LLLEIISGK 189
+L EI +GK
Sbjct: 211 VLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 34 EVTLIAKLQHKN-LVRLFGCCLEENES-------LLIYEYMPNKSLDVFLFDSTR---SV 82
E++L+ L +VRL +E E L++EY+ + L F+ DS
Sbjct: 50 EISLLQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGR 105
Query: 83 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP-KISDFGMARIFG 141
L K S + + +G+ + H + ++HRDLK N+L++ + KI+D G+ R F
Sbjct: 106 PLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF- 161
Query: 142 GNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISG 188
++ T+ IV T Y APE + +S D++S G + E+
Sbjct: 162 SIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 55/236 (23%), Positives = 89/236 (37%), Gaps = 68/236 (28%)
Query: 8 KLADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
K GK A+K L ++ L K E ++A+ +V L+ + LI E
Sbjct: 22 KKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81
Query: 65 YMPNKSL-------DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
++P L D F D TR +A +L + +L IHRD+K
Sbjct: 82 FLPGGDLMTMLIKYDTFSEDVTRFY-------------MAECVLAIEAVHKLGFIHRDIK 128
Query: 118 ASNVLLNHEMNPKISDFGMARIFGGN----------QSEANTNRI--------------- 152
N+L++ + K+SDFG++ F Q ++N NRI
Sbjct: 129 PDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTM 188
Query: 153 --------------------VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
VGT Y+APE ++ + + D +S G ++ E + G
Sbjct: 189 SSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (116), Expect = 2e-06
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 46/203 (22%)
Query: 24 SGQGLQEFKN-----EVTLIAKLQHKNLVRLFGCCLEE-NESLLIYEYMPNKSLDVFLFD 77
S +GL+E + EV ++ +L+HKN+VR L + N+ L I + D
Sbjct: 47 SYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAG------D 100
Query: 78 STRSVQLDWKRRISI----INGIARGLL----YLHE----DSRLKIIHRDLKASNVLLN- 124
+R++Q +K I I I R LL Y H + +++HRDLK N+ L+
Sbjct: 101 LSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST 160
Query: 125 ------------HEMN----PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL 168
+ +N KI DFG+++ G E+ + VGT Y +PE +
Sbjct: 161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG---IESMAHSCVGTPYYWSPELLLHET 217
Query: 169 FSV--KSDVFSFGVLLLEIISGK 189
S KSD+++ G ++ E+ SGK
Sbjct: 218 KSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 16/170 (9%)
Query: 31 FKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRR 89
F E ++A + +V+L ++++ L ++ EYMP L V L S + W R
Sbjct: 90 FWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDL-VNLM-SNYDIPEKWARF 146
Query: 90 ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149
A +L L + IHRD+K N+LL+ + K++DFG N
Sbjct: 147 Y-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRC 200
Query: 150 NRIVGTYGYMAPEYAM----EGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195
+ VGT Y++PE +G + + D +S GV L E++ G +T FY
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 43/150 (28%), Positives = 71/150 (47%), Gaps = 29/150 (19%)
Query: 55 EENESL-LIYEYMP--------NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 105
++ ++L L+ EY P N+ D F D + +A +L +H
Sbjct: 71 QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-------------LAELVLAIHS 117
Query: 106 DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEY-- 163
++ +HRD+K NVL++ + K++DFG A N+ N+ VGT Y+APE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPEVLT 176
Query: 164 AMEG----LFSVKSDVFSFGVLLLEIISGK 189
M G + V+ D +S GV+ E+I G+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 25/154 (16%)
Query: 43 HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IINGI 96
+ N ++L+ +LI +Y+ D LFD + + ++S II +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKK-----EGKLSEAEVKKIIRQL 118
Query: 97 ARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP-KISDFGMARIFGGNQSEANTNRIVGT 155
L LH + IIH D+K NVL + + + D+G+ +I G S + GT
Sbjct: 119 VEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII-GTPSCYD-----GT 169
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
Y +PE + V D ++ GVL E+++GK
Sbjct: 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 41/193 (21%), Positives = 76/193 (39%), Gaps = 27/193 (13%)
Query: 12 GKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
+AVK+ L S + L+ + E+ +LQH N++ + ++E ++ M
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN----- 124
S + L + L I+ + L Y+H IHR +KAS++LL+
Sbjct: 85 SCED-LLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKV 140
Query: 125 -----HEMNPKIS-DFGMARIFG-GNQSEANTNRIVGTYGYMAPEYAMEGL--FSVKSDV 175
I + S N +++PE + L ++ KSD+
Sbjct: 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-------WLSPEVLQQNLQGYNEKSDI 193
Query: 176 FSFGVLLLEIISG 188
+S G+ E+ +G
Sbjct: 194 YSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 16/99 (16%)
Query: 46 LVRLFGCCLEENESLLIYEYMPNKSLDVFL-----FDSTRSVQLDWKRRISIINGIARGL 100
+V L+ N L+ EY+ + L FD +V+ I+ +A L
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--------ISEVALAL 117
Query: 101 LYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139
YLH R IIHRDLK N+L+++E + K++DFG++++
Sbjct: 118 DYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 16/102 (15%)
Query: 100 LLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI----FGGNQSEANTNR---- 151
L YLH I+HRDLK N+L+ + K++DFG+++I N E + +
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 152 -----IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
+ GT Y+APE + + D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 45/184 (24%)
Query: 30 EFKNEVTLIAK-LQHKNLVRL----FGCCLEENESLL----IYEYMP------------- 67
++KN LI K L H N++ L + C ++NE + + E++P
Sbjct: 104 QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN 163
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
N +L +FL S QL R L Y+H I HRDLK N+L++
Sbjct: 164 NHALPLFLV-KLYSYQL------------CRALAYIHSKF---ICHRDLKPQNLLIDPNT 207
Query: 128 NP-KISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGVLLLE 184
+ K+ DFG A+ + G +S + I + Y APE + ++ D++S G ++ E
Sbjct: 208 HTLKLCDFGSAKNLLAGQRS---VSYICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAE 263
Query: 185 IISG 188
+I G
Sbjct: 264 MILG 267
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 32/119 (26%), Positives = 49/119 (41%), Gaps = 34/119 (28%)
Query: 99 GLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF---------GMARIFGGNQSE--- 146
L YLH L I++RDLK N+LL+ + +SDF +
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 147 ---------------ANTNRIVGTYGYMAPEY-AMEG-LFSVKSDVFSFGVLLLEIISG 188
+N VGT Y+APE + +G +V D ++ G+LL E++ G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 108 RLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEY--AM 165
+L +HRD+K N+L++ + +++DFG + + ++ VGT Y++PE AM
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAM 178
Query: 166 E---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQS 202
E G + + D +S GV + E++ G+ T FY L ++
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVET 216
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 33/126 (26%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR-IFGGNQSE-------- 146
IA +L + +L IHRD+K N+LL+ + + K+SDFG+ + +++E
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 147 ---------ANTNR---------------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
N+ R VGT Y+APE M+ ++ D +S GV++
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 183 LEIISG 188
E++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 39/176 (22%)
Query: 46 LVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 105
+V++F ++ LI E++P + L + + I+ +L +
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA------ETVLAIDA 116
Query: 106 DSRLKIIHRDLKASNVLLNHEMNPKISDFGMA------------RIFGGN---------- 143
+L IHRD+K N+LL+ + + K+SDFG+ R N
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 144 --QSEANT---NR------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
+ +A T NR VGT Y+APE M+ ++ D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 24/55 (43%), Positives = 33/55 (60%), Gaps = 7/55 (12%)
Query: 87 KRRISIINGIAR----GLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137
KR I++I G+ R GL LH R+ I+HRD+K N+L+ + KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 27/127 (21%), Positives = 48/127 (37%), Gaps = 34/127 (26%)
Query: 19 RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCC------LEENESLLIYEYMPNKSLD 72
R RT + E ++AK R G ++ + L++ EY+ + L
Sbjct: 42 RRERT--------RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLK 87
Query: 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
L + R ++ + R + LH+ I+H DL SN++L+
Sbjct: 88 DAL----------EEARPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFI 133
Query: 133 DFGMARI 139
DFG+
Sbjct: 134 DFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 29/108 (26%), Positives = 60/108 (55%), Gaps = 14/108 (12%)
Query: 91 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIF----GGNQSE 146
+I+ G RGL YLH++ IHR++KAS++L++ + +S G++ ++ G +++
Sbjct: 105 NILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAK 159
Query: 147 AN---TNRIVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGK 189
+++PE + L ++VKSD++S G+ E+ +G+
Sbjct: 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 47/242 (19%), Positives = 92/242 (38%), Gaps = 66/242 (27%)
Query: 2 ESCLQGKLADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE 58
E CL K+ A+K L + + K E ++A+ ++ +VRL+ +++
Sbjct: 16 EVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 75
Query: 59 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIING------IARGLLYLHEDSRLKII 112
+ +Y+P + L R+ I IA + ++ I
Sbjct: 76 LYFVMDYIPGGDMMSLLI------------RMGIFPEDLARFYIAELTCAVESVHKMGFI 123
Query: 113 HRDLKASNVLLNHEMNPKISDFGMARIF----------GGNQSEANT------------- 149
HRD+K N+L++ + + K++DFG+ F G+ ++
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 150 ----------------------NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+ +VGT Y+APE + ++ D +S GV+L E++
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 243
Query: 188 GK 189
G+
Sbjct: 244 GQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 45/236 (19%), Positives = 96/236 (40%), Gaps = 54/236 (22%)
Query: 2 ESCLQGKLADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE 58
E CL K+ A+K L + + + K E ++A+ ++ +V+L+ +++
Sbjct: 16 EVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN 75
Query: 59 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
+ +Y+P + L ++++ + IA L + ++ IHRD+K
Sbjct: 76 LYFVMDYIPGGDMMSLL------IRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKP 129
Query: 119 SNVLLNHEMNPKISDFGMARIF----------GGNQSEANT------------------- 149
N+L++ + + K++DFG+ F G+ ++
Sbjct: 130 DNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRL 189
Query: 150 ----------------NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+ +VGT Y+APE + ++ D +S GV+L E++ G+
Sbjct: 190 KTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.002
Identities = 25/131 (19%), Positives = 51/131 (38%), Gaps = 14/131 (10%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV--RLFGCCLEENESLLIYEYMPN 68
++ +K + + EV ++ L K L ++ + S L+ E++
Sbjct: 20 KDEDYVLKINPSREKG--ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
++LD ++ + + I +A L LH+ L + H DL N+L++
Sbjct: 78 ETLD----------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI 127
Query: 129 PKISDFGMARI 139
I D+ A
Sbjct: 128 LGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 28/123 (22%), Positives = 53/123 (43%), Gaps = 41/123 (33%)
Query: 108 RLKIIHRDLKASNVLLNHEMNPKISDFGM---------ARIFGGNQ-------------S 145
++ IHRD+K N+L++ + + K++DFG+ ++ + S
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 146 EANTNR-------------------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
E + R +VGT Y+APE + ++ D +S GV+L E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 187 SGK 189
G+
Sbjct: 239 VGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 308 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.17 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.86 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.84 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.69 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.56 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.47 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.37 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.25 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.23 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.06 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.04 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.98 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.89 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.79 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.75 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.72 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.58 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.51 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.5 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.47 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.39 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.37 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.34 | |
| PLN02236 | 344 | choline kinase | 97.29 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.27 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.02 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.0 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.93 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.91 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.85 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.81 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.76 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.71 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.61 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.5 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.47 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.43 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.27 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.13 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.88 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.88 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.87 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.87 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.77 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=320.81 Aligned_cols=239 Identities=28% Similarity=0.372 Sum_probs=194.3
Q ss_pred CccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe-EEEEEEecCCCChhhHhhcC
Q 021771 2 ESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE-SLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 2 g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~ 78 (308)
|+||++++ .+++-+|+|.+... .+....++.+|+++++..+||+||.+|+.|.++.. .+++||||++|+|++++...
T Consensus 93 G~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~ 172 (364)
T KOG0581|consen 93 GTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV 172 (364)
T ss_pred cEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc
Confidence 89999997 48999999999544 45667899999999999999999999999999995 99999999999999998543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
+.+++..+..++.++++||.|||. . +|+||||||.||||+..|.|||||||.+..+... ..+.+.||..
T Consensus 173 ---g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~ 242 (364)
T KOG0581|consen 173 ---GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSA 242 (364)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hccccccccc
Confidence 459999999999999999999996 5 4999999999999999999999999999876433 3455789999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|||||.+.+..|+.++||||||++++|++.|+.|+...... .....+.-.. ...+.-+.+.+ . ....++.
T Consensus 243 YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll~~-Iv~~ppP~lP~-----~---~fS~ef~ 312 (364)
T KOG0581|consen 243 YMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELLCA-IVDEPPPRLPE-----G---EFSPEFR 312 (364)
T ss_pred ccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHHHH-HhcCCCCCCCc-----c---cCCHHHH
Confidence 99999999999999999999999999999999998654111 0111111100 11111111111 1 1344588
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.++..||++||.+|||+.|+++.
T Consensus 313 ~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 313 SFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHhcCCcccCCCHHHHhcC
Confidence 88889999999999999999853
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=327.96 Aligned_cols=262 Identities=45% Similarity=0.742 Sum_probs=224.8
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-eEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-ESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+|.+.+|+.||||++.........+|.+|+.+|.+++|||+++++++|.+.+ ..+||+||+++|+|.+.++...
T Consensus 88 fg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~ 167 (361)
T KOG1187|consen 88 FGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKK 167 (361)
T ss_pred CeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCC
Confidence 899999999999999999886654431344999999999999999999999999998 4999999999999999997754
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee-ecccCc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI-VGTYGY 158 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~-~~~~~y 158 (308)
.. .++|..+.+|+.++|+||+|||......|+|||||+.|||+|++.+.||+|||++...... ....... .|+..|
T Consensus 168 ~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY 244 (361)
T KOG1187|consen 168 GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGY 244 (361)
T ss_pred CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCcc
Confidence 43 7999999999999999999999987667999999999999999999999999999654321 1111111 689999
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccc-ccchH-HHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK-QSCVA-AELLKF 236 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l 236 (308)
+|||+...+..+.++||||+|+++.+|++|+.+.+.........+..+....+....+.+++|+.+. ..... .....+
T Consensus 245 ~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~ 324 (361)
T KOG1187|consen 245 LAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKL 324 (361)
T ss_pred CChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHH
Confidence 9999998899999999999999999999999888766544555578888888888899999999987 44443 688889
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
..+..+|++.+|++||++.+|++.|+...
T Consensus 325 ~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 325 AELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999999999999999999996543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=335.48 Aligned_cols=235 Identities=25% Similarity=0.363 Sum_probs=198.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
|+.||.++. .+|+.||+|++.+. .+..++.+.+|+++-+.|+|||||+++++|++.++.|||.|.|..++|..+++
T Consensus 31 FA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K 110 (592)
T KOG0575|consen 31 FARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK 110 (592)
T ss_pred ceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH
Confidence 789999996 89999999999764 46677899999999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.+..+++.+++.+++||+.||.|||+++ |+|||||..|+|++++-+|||+|||+|..+.... ......+||+
T Consensus 111 ---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTP 182 (592)
T KOG0575|consen 111 ---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTP 182 (592)
T ss_pred ---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCC
Confidence 4456999999999999999999999997 9999999999999999999999999999875332 2344578999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
-|+|||++.....+..+||||+|||+|-|+.|++||+........ ....... . ..+.......
T Consensus 183 NYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety------~~Ik~~~----Y-------~~P~~ls~~A 245 (592)
T KOG0575|consen 183 NYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY------NKIKLNE----Y-------SMPSHLSAEA 245 (592)
T ss_pred cccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH------HHHHhcC----c-------ccccccCHHH
Confidence 999999999989999999999999999999999999754332211 1111110 0 1122233457
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+||.++|+.||.+|||+++|+.-
T Consensus 246 ~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 246 KDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcC
Confidence 889999999999999999999953
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=315.45 Aligned_cols=186 Identities=29% Similarity=0.514 Sum_probs=167.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+|++ ++|..||||.+... .....+.+..|+.+|+.++|||||.+++++.+++.++||||||+||+|..+++.
T Consensus 23 favVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~ 102 (429)
T KOG0595|consen 23 FAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR 102 (429)
T ss_pred eEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH
Confidence 899999996 58999999999766 677788899999999999999999999999999999999999999999999965
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC------CCeeeecccceeeeCCCCCccccce
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE------MNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~------~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.. .+++.++..++.|++.|+++||+++ |+||||||+|||++.. -.+||+|||+++.+.... -...
T Consensus 103 ~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~---~a~t 173 (429)
T KOG0595|consen 103 RG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS---MAET 173 (429)
T ss_pred cC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh---HHHH
Confidence 43 5999999999999999999999997 9999999999999865 348999999999986332 2334
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcc
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 195 (308)
.+|++.|||||++....|+.|+|+||+|+++|++++|..||...
T Consensus 174 lcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 174 LCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 58999999999999999999999999999999999999999643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=312.65 Aligned_cols=246 Identities=25% Similarity=0.370 Sum_probs=199.5
Q ss_pred CCccEEee-eCCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceee-eEEeCCe-EEEEEEecCCCChhhHh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFG-CCLEENE-SLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~l 75 (308)
||+||++. ..+|+.+|.|.++-. +...++....|+.+|++|+|||||++++ .|.+++. +++|||+|.+|+|...+
T Consensus 32 Fg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmI 111 (375)
T KOG0591|consen 32 FGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMI 111 (375)
T ss_pred chheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHH
Confidence 89999999 579999999988644 5667788999999999999999999999 5666555 89999999999999998
Q ss_pred hcC-CCccccChHHHHHHHHHHHHHHHhchhCC-CCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 76 FDS-TRSVQLDWKRRISIINGIARGLLYLHEDS-RLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 76 ~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g-~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
... .++..+++.++|+++.|++.||..+|++- +..+.||||||.||+++.+|.+||+|||+++.+..... .....+
T Consensus 112 k~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~V 189 (375)
T KOG0591|consen 112 KHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLV 189 (375)
T ss_pred HHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH--HHHhhc
Confidence 764 45677999999999999999999999941 12499999999999999999999999999998754433 234478
Q ss_pred cccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
||+.||+||.+....|+.+||||||||++|+|+..++||... +......+ ...++.+.+.+ .-..
T Consensus 190 GTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~K-I~qgd~~~~p~--------~~YS 254 (375)
T KOG0591|consen 190 GTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKK-IEQGDYPPLPD--------EHYS 254 (375)
T ss_pred CCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHH-HHcCCCCCCcH--------HHhh
Confidence 999999999999999999999999999999999999999543 22222222 22222221111 3345
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
.++.+||..|+..||+.||+.-.+++.+..
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred hHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 578889999999999999996666666554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=325.30 Aligned_cols=249 Identities=30% Similarity=0.482 Sum_probs=200.5
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-eEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-ESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+|.+++...||+|++.... ....+.+..|+.+|.+++|||||++++++.+.. .+++||||+++|+|..+++.
T Consensus 54 ~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~ 133 (362)
T KOG0192|consen 54 FGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHK 133 (362)
T ss_pred ceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhh
Confidence 799999999655559999997553 223568999999999999999999999999988 79999999999999999976
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCccccceeeccc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ....++...++.++.+|+.|+.|||+++ .|+|+|||++|||++.++ .+||+|||+++...... .......||.
T Consensus 134 ~-~~~~l~~~~~l~~aldiArGm~YLH~~~--~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~ 208 (362)
T KOG0192|consen 134 K-RKRKLPLKVRLRIALDIARGMEYLHSEG--PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTY 208 (362)
T ss_pred c-ccCCCCHHHHHHHHHHHHHHHHHHhcCC--CeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCc
Confidence 4 3456999999999999999999999985 399999999999999997 99999999998765332 2222257899
Q ss_pred CccCchhhc--cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 157 GYMAPEYAM--EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 157 ~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
.|||||++. +..++.++||||+|+++|+|++|+.||...... .............. .+.....
T Consensus 209 ~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~v~~~~~Rp~---------~p~~~~~ 273 (362)
T KOG0192|consen 209 RWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASAVVVGGLRPP---------IPKECPP 273 (362)
T ss_pred cccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCCCCC---------CCccCCH
Confidence 999999999 568999999999999999999999999755431 11111111111111 1222344
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLP 269 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~ 269 (308)
.+..|+..||..||+.||++.+|+..|+.......
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 58888889999999999999999999987655443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=324.02 Aligned_cols=237 Identities=22% Similarity=0.311 Sum_probs=188.7
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcc-------cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQ-------GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.|-+|. .++|+.||||++++.... ....+.+|+++|++|+|||||+++++|......||||||+.||.|.
T Consensus 185 fg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLf 264 (475)
T KOG0615|consen 185 FGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELF 264 (475)
T ss_pred eeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHH
Confidence 78899998 579999999999765211 1233579999999999999999999999999999999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC---CCeeeecccceeeeCCCCCcccc
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE---MNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~---~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
+.+..+ +.+.+..-..+++||+.|+.|||++| |+||||||+|||++.+ ..+||+|||+|+..+ .....
T Consensus 265 d~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm 335 (475)
T KOG0615|consen 265 DKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFM 335 (475)
T ss_pred HHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhccc---cceeh
Confidence 998554 34788888999999999999999999 9999999999999876 569999999999865 23334
Q ss_pred ceeecccCccCchhhccCc---ccccccchhhhHHHHHHHhCCcCCCcccccc-ccchhHHHHHhhhccccccccccccc
Q 021771 150 NRIVGTYGYMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNTGFYLSEL-GQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
...+||+.|.|||++.+.. +..+.|+|||||++|-+++|.+||......+ ....+....-.+.+.
T Consensus 336 ~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~----------- 404 (475)
T KOG0615|consen 336 KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL----------- 404 (475)
T ss_pred hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh-----------
Confidence 4578999999999998654 3357899999999999999999997665553 111111100001000
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.-....++.++||.+||..||++|||+.|+|+
T Consensus 405 --~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 405 --QWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred --hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11223456888999999999999999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=296.40 Aligned_cols=251 Identities=18% Similarity=0.267 Sum_probs=197.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+.+. .+|+-||||++... ++.-.+-..+|+.+|++++|+|+|.++++|.....++||+|||+..-|+++-..
T Consensus 15 YGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~ 94 (396)
T KOG0593|consen 15 YGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERY 94 (396)
T ss_pred ceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhc
Confidence 799999996 57999999999655 344456677999999999999999999999999999999999988777776543
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
..+ ++.+.+.++++|++.|+.|+|+++ ++||||||+||||+.+|.+||||||+|+.+.. .....+..+.|.+
T Consensus 95 p~G---~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRW 166 (396)
T KOG0593|consen 95 PNG---VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRW 166 (396)
T ss_pred cCC---CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC--Ccchhhhhhhhhh
Confidence 332 889999999999999999999996 99999999999999999999999999998753 2333455688999
Q ss_pred ccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhH--------HHHHhhhcccc------cccccc
Q 021771 158 YMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLS--------YTWKLWCEGEA------LELMEP 222 (308)
Q Consensus 158 y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~------~~~~~~ 222 (308)
|+|||++.+ ..|....|||++||++.+|++|.+.|...........+. .-...+..... ++.-+.
T Consensus 167 YRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~ 246 (396)
T KOG0593|consen 167 YRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHP 246 (396)
T ss_pred ccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCc
Confidence 999999988 689999999999999999999999997765553322221 11222222221 111111
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..-....+....-+++|+..||+.||.+|++-++++.
T Consensus 247 epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 247 EPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111122223346889999999999999999999983
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=309.60 Aligned_cols=252 Identities=22% Similarity=0.235 Sum_probs=194.2
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcc-cHHHHHHHHHHHhcCC-CcCccceeeeEEeCC-eEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEEN-ESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+|+ ..+|+.||||+++++--. +...-.+|+..|++++ ||||+++.+++.++. .+++|||||+. +|.++++
T Consensus 23 fGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK 101 (538)
T KOG0661|consen 23 FGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMK 101 (538)
T ss_pred ceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHh
Confidence 89999999 578999999999766322 2223458999999998 999999999999888 89999999954 8989887
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ...+++..+..|++||++||+|+|.+| +.|||+||+||||..+..+||+|||+|+...... ..+..+.|.
T Consensus 102 ~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp---PYTeYVSTR 173 (538)
T KOG0661|consen 102 DR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKP---PYTEYVSTR 173 (538)
T ss_pred hc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCC---Ccchhhhcc
Confidence 65 557999999999999999999999999 9999999999999998899999999999875432 344567899
Q ss_pred CccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccc------ccc---c----
Q 021771 157 GYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALE------LME---P---- 222 (308)
Q Consensus 157 ~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~---~---- 222 (308)
+|+|||++.. +.|+.+.|||++|||++|+.+.++.|......+.-..+-.+........+.+ .+. +
T Consensus 174 WYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~ 253 (538)
T KOG0661|consen 174 WYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKP 253 (538)
T ss_pred cccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCC
Confidence 9999997764 6899999999999999999999999865544321111111100000011111 000 0
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L 261 (308)
.--....+....+.++|+..|++|||++||||.+.|+.-
T Consensus 254 ~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 254 SPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred CChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 000111223556788999999999999999999999764
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=302.18 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=191.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC--eEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN--ESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||++.. ++|...|||.+...+....+.+.+|+.+|.+++|||||++++...... .++++|||+++|+|.+++..
T Consensus 30 ~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~ 109 (313)
T KOG0198|consen 30 FGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKR 109 (313)
T ss_pred ceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHH
Confidence 799999996 469999999886654333677999999999999999999999744444 68999999999999999966
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-CCCeeeecccceeeeCC-CCCccccceeecc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMNPKISDFGMARIFGG-NQSEANTNRIVGT 155 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~~ 155 (308)
... .+++..+..++.||+++|+|||++| |+|+||||+|||++. ++.+||+|||.+..... ...........|+
T Consensus 110 ~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gt 184 (313)
T KOG0198|consen 110 YGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGT 184 (313)
T ss_pred cCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCC
Confidence 432 5999999999999999999999998 999999999999999 79999999999987654 1222223346789
Q ss_pred cCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
+.|||||++.++ ....++|||||||++.+|++|.+||... ................+. .+.....
T Consensus 185 p~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~---------ip~~ls~ 250 (313)
T KOG0198|consen 185 PNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPE---------IPDSLSD 250 (313)
T ss_pred ccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCC---------CCcccCH
Confidence 999999999853 3445999999999999999999998753 111111222222222221 1222333
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
+..+++..|++.||++||||+++|+-.-
T Consensus 251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 251 EAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 5778888999999999999999997653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=300.41 Aligned_cols=234 Identities=24% Similarity=0.270 Sum_probs=191.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.|+..+. .+++.||+|++++. ...+.+....|..+|..++||+||+++..|++..++|||+||+.||.|...+.
T Consensus 38 fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~ 117 (357)
T KOG0598|consen 38 FGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQ 117 (357)
T ss_pred CceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHH
Confidence 899999995 67999999999766 23456788999999999999999999999999999999999999999999984
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. .+.+++.++..++..|+.||.|||++| |+|||+||+|||++.+|.++|+|||+++..... ...+...+||+
T Consensus 118 ~---eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~~t~tfcGT~ 189 (357)
T KOG0598|consen 118 R---EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GDATRTFCGTP 189 (357)
T ss_pred h---cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC--CCccccccCCc
Confidence 3 445999999999999999999999998 999999999999999999999999999864322 22233478999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|||||++.+..++..+|.||||+++|+|++|.+||....... ........ +. ...+.-.....
T Consensus 190 eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~~-k~---------~~~p~~ls~~a 253 (357)
T KOG0598|consen 190 EYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILKG-KL---------PLPPGYLSEEA 253 (357)
T ss_pred cccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhcC-cC---------CCCCccCCHHH
Confidence 9999999999999999999999999999999999996443221 11111111 10 01111123457
Q ss_pred HHHHhhcccCCCCCCC----CHHHHH
Q 021771 237 IHIGLLCVQADSADRP----TMSSVV 258 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP----s~~eil 258 (308)
.+++..+|+.||++|. ++.+|-
T Consensus 254 rdll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 254 RDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred HHHHHHHhccCHHHhcCCCCChHHhh
Confidence 8888899999999995 455544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=308.18 Aligned_cols=238 Identities=25% Similarity=0.330 Sum_probs=194.2
Q ss_pred CCccEEee-eCCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
|++|++|+ ..+++.||||++.+. ...-.+.+..|-+.|.+| .||.|+++|..|.|+..+|+|+||+++|+|.++|
T Consensus 86 YStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i 165 (604)
T KOG0592|consen 86 YSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLI 165 (604)
T ss_pred ceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHH
Confidence 78999999 578999999998765 233446678899999999 6999999999999999999999999999999999
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc---------
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--------- 146 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--------- 146 (308)
+.. +.+++.-++.++.+|+.||+|||++| |+||||||+|||++.+++++|+|||.+..++.....
T Consensus 166 ~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~ 239 (604)
T KOG0592|consen 166 KKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQ 239 (604)
T ss_pred HHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCccc
Confidence 654 45999999999999999999999999 999999999999999999999999999987643222
Q ss_pred cc--cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccc
Q 021771 147 AN--TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVL 224 (308)
Q Consensus 147 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
.. ...++||..|.+||++.....+..+|+|+|||++|+|+.|.+||.....- ..-++.. ++ +-
T Consensus 240 a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------liFqkI~------~l-~y-- 304 (604)
T KOG0592|consen 240 ASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------LIFQKIQ------AL-DY-- 304 (604)
T ss_pred ccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------HHHHHHH------Hh-cc--
Confidence 11 24579999999999999999999999999999999999999999643111 1111110 00 11
Q ss_pred cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 021771 225 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 225 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L 261 (308)
.++........+|+.+.|..||++|+|+.+|.+-.
T Consensus 305 --~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 305 --EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred --cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11111124577888899999999999999998653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=282.95 Aligned_cols=256 Identities=21% Similarity=0.266 Sum_probs=201.6
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQ--GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+|+ .++|+.||||+++...-. .--...+|++.|+.++|+||+.++++|.....+.||+||++. +|...+++
T Consensus 15 ~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd 93 (318)
T KOG0659|consen 15 YGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKD 93 (318)
T ss_pred eEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcc
Confidence 79999999 589999999999755322 123567899999999999999999999999999999999954 89999876
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ...++...+..++.+++++++|||++. |.||||||.|+|++.+|.+||+|||+++.+.......... +-|.+
T Consensus 94 ~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~--V~TRW 166 (318)
T KOG0659|consen 94 K--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ--VVTRW 166 (318)
T ss_pred c--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc--eeeee
Confidence 4 346899999999999999999999997 9999999999999999999999999999987654443332 56899
Q ss_pred ccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccc---cc--------ccc
Q 021771 158 YMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELM---EP--------VLK 225 (308)
Q Consensus 158 y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--------~~~ 225 (308)
|+|||++.| ..|+...||||.||++.||+-+.+.|...........+-.........+++++. +- ...
T Consensus 167 YRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~ 246 (318)
T KOG0659|consen 167 YRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPL 246 (318)
T ss_pred ccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcc
Confidence 999999887 479999999999999999999998887665554433333222222222222211 10 001
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.........+.++|+..||..||.+|+|++|.++.=--.
T Consensus 247 ~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 247 NNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred ccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 113334456689999999999999999999999764443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=309.47 Aligned_cols=236 Identities=24% Similarity=0.378 Sum_probs=195.9
Q ss_pred CccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 2 ESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 2 g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
|.||.++ ..+++.||||++....-...+.+.+|+.+|+..+|+|||.+++.|...+.+++||||++||+|.+.+ .
T Consensus 287 G~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvV----t 362 (550)
T KOG0578|consen 287 GGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVV----T 362 (550)
T ss_pred cceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhh----h
Confidence 7899998 5789999999997665555678899999999999999999999999999999999999999999988 3
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..+..+.++++.||+|||.+| |+|+|||.+|||+..+|.+||+|||++..+..... .....+||+.|||
T Consensus 363 ~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMA 437 (550)
T KOG0578|consen 363 KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMA 437 (550)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccc
Confidence 345999999999999999999999998 99999999999999999999999999988764443 3344689999999
Q ss_pred chhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG 240 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (308)
||++....|..+.||||||+|+.||+.|++||=+... +...+....++.. + ..........|.+|+
T Consensus 438 PEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng~P-~-------lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 438 PEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGTP-K-------LKNPEKLSPELKDFL 503 (550)
T ss_pred hhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcCCC-C-------cCCccccCHHHHHHH
Confidence 9999999999999999999999999999999844221 1222222222111 1 111222334588888
Q ss_pred hhcccCCCCCCCCHHHHHHH
Q 021771 241 LLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 241 ~~cl~~~p~~RPs~~eil~~ 260 (308)
.+||+.|+++|||+.|||+-
T Consensus 504 ~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHhhcchhcCCCHHHHhcC
Confidence 99999999999999999964
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=301.86 Aligned_cols=253 Identities=22% Similarity=0.305 Sum_probs=195.9
Q ss_pred CCccEEee-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|+ ..+|+.||+|++.... +.......+|+.+|++|.||||+++.+...+. ..+|||+|||+. +|.-++
T Consensus 130 yg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl 208 (560)
T KOG0600|consen 130 YGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLL 208 (560)
T ss_pred hhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhh
Confidence 89999999 5899999999986553 55566778999999999999999999999876 579999999965 787777
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. .+..+++..+.+++.|++.||+|||++| +.|||||..|||||.+|.+||+|||+|+++....... .+..+-|
T Consensus 209 ~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvT 282 (560)
T KOG0600|consen 209 SS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVT 282 (560)
T ss_pred cC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEE
Confidence 43 3456999999999999999999999998 9999999999999999999999999999887554443 3334568
Q ss_pred cCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH-----Hhhhccccc--cccccccc--
Q 021771 156 YGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW-----KLWCEGEAL--ELMEPVLK-- 225 (308)
Q Consensus 156 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~--~~~~~~~~-- 225 (308)
.+|+|||++.|. .|+.+.|+||+|||+.||+.|++.|...........+.... ..|...+++ ..+.+...
T Consensus 283 LWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~ 362 (560)
T KOG0600|consen 283 LWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYK 362 (560)
T ss_pred eeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCccc
Confidence 999999999885 79999999999999999999999986654443222222111 112211111 11111111
Q ss_pred ---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 226 ---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 226 ---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
...........++|+..||..||++|.||.+.|+-
T Consensus 363 r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 363 RRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred chHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00112223457888999999999999999999854
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=309.73 Aligned_cols=242 Identities=32% Similarity=0.468 Sum_probs=200.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||.|.++....||+|.++... ...+.+.+|+.+|+.|+|++||++++++..+..++|||||++.|+|.+++.. ..
T Consensus 219 FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~-~~ 296 (468)
T KOG0197|consen 219 FGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT-RE 296 (468)
T ss_pred cceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh-cC
Confidence 899999999888899999996653 3446788999999999999999999999998899999999999999999976 34
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
+..+.....+.++.|||+|++||++++ +|||||.+.||||+++..+||+|||+++......+.... ...-...|.|
T Consensus 297 ~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~-~~kfPIkWtA 372 (468)
T KOG0197|consen 297 GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE-GGKFPIKWTA 372 (468)
T ss_pred CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC-CCCCCceecC
Confidence 556889999999999999999999996 999999999999999999999999999965544433322 2233678999
Q ss_pred chhhccCcccccccchhhhHHHHHHHhC-CcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIISG-KKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+..+.++.+|||||+|++|||+++. +.|+...... ++.+.++.-.+-..+..++..+.++
T Consensus 373 PEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~----------------ev~~~le~GyRlp~P~~CP~~vY~l 436 (468)
T KOG0197|consen 373 PEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE----------------EVLELLERGYRLPRPEGCPDEVYEL 436 (468)
T ss_pred HHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH----------------HHHHHHhccCcCCCCCCCCHHHHHH
Confidence 9999999999999999999999999984 4565443322 2233333333444455556668888
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+..||..+|++|||++.+...|+..
T Consensus 437 M~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 437 MKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred HHHHhhCCcccCCCHHHHHHHHHHh
Confidence 8999999999999999999988865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.18 Aligned_cols=233 Identities=22% Similarity=0.315 Sum_probs=190.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC----Cc-ccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT----SG-QGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+|+.|.. .+|..||+|+++.. .. ...+.+.+|+.+++.++ ||||+++++++....++++|||||.+|.|.+
T Consensus 30 fgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~ 109 (370)
T KOG0583|consen 30 FGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFD 109 (370)
T ss_pred CeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHH
Confidence 799999984 68999999987654 22 23457778999999999 9999999999999999999999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC-CCeeeecccceeeeCCCCCcccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
++.. ...+.+..+..++.|++.|++|||++| |+||||||+||+++.+ +++||+|||++.... .........
T Consensus 110 ~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~ 181 (370)
T KOG0583|consen 110 YIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTF 181 (370)
T ss_pred HHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCC
Confidence 9965 345899999999999999999999998 9999999999999999 999999999998863 112223446
Q ss_pred ecccCccCchhhccCc-cc-ccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc-ccccccccccccccch
Q 021771 153 VGTYGYMAPEYAMEGL-FS-VKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE-GEALELMEPVLKQSCV 229 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~-~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (308)
.|++.|+|||++.+.. |+ .++||||+|+++|.|++|..||+..... ....+.... -.++..+.
T Consensus 182 cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~ki~~~~~~~p~~~~-------- 247 (370)
T KOG0583|consen 182 CGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRKIRKGEFKIPSYLL-------- 247 (370)
T ss_pred CCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHHHhcCCccCCCCcC--------
Confidence 8999999999999866 75 7899999999999999999999862211 111111110 11111110
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVV 258 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil 258 (308)
..++..|+.+||..||.+|+|+.+|+
T Consensus 248 ---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 248 ---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 34588899999999999999999999
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=295.30 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=195.2
Q ss_pred CccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 2 ESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 2 g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
++||+|+. ..++.||||+++-.. ..+.+.+.+|+..|..++||||++++..|..++.+++||.||.+|++.++++..-
T Consensus 40 a~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~ 119 (516)
T KOG0582|consen 40 AVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY 119 (516)
T ss_pred eEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHc
Confidence 47999994 678999999997543 3346889999999999999999999999999999999999999999999997754
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc-c-ceeecccC
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN-T-NRIVGTYG 157 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~-~-~~~~~~~~ 157 (308)
.. .+++..+..+++++++||.|||.+| .+|||||+.||||+.+|.|||+|||.+..+........ . +.+.|+++
T Consensus 120 ~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~ 195 (516)
T KOG0582|consen 120 PD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPC 195 (516)
T ss_pred cc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCccc
Confidence 33 2999999999999999999999999 99999999999999999999999999877654332221 2 45689999
Q ss_pred ccCchhhcc--CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 158 YMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 158 y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
|+|||++.. ..|+.|+||||+|+++.||.+|..||..+..-.- +-... .+..+.+.-..+..+........
T Consensus 196 wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv---Ll~tL----qn~pp~~~t~~~~~d~~k~~~ks 268 (516)
T KOG0582|consen 196 WMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV---LLLTL----QNDPPTLLTSGLDKDEDKKFSKS 268 (516)
T ss_pred ccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH---HHHHh----cCCCCCcccccCChHHhhhhcHH
Confidence 999998654 4799999999999999999999999976543210 00000 01111111111111222223336
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+.+++..||+.||++|||+++++.-
T Consensus 269 f~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 269 FREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHHHHHHhhcCcccCCCHHHHhcc
Confidence 8888999999999999999999853
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=300.63 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=188.1
Q ss_pred CCccEEeee------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCC-eEEEEEEecCCCCh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEEN-ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L 71 (308)
||.||++.. .+++.||+|++.... ......+.+|+.+|..+ +||||+++++++...+ .++++|||+++|+|
T Consensus 20 fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L 99 (338)
T cd05102 20 FGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL 99 (338)
T ss_pred cceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcH
Confidence 799999963 346789999986543 33446788999999999 8999999999887644 58899999999999
Q ss_pred hhHhhcCCC-----------------------------------------------------------ccccChHHHHHH
Q 021771 72 DVFLFDSTR-----------------------------------------------------------SVQLDWKRRISI 92 (308)
Q Consensus 72 ~~~l~~~~~-----------------------------------------------------------~~~~~~~~~~~~ 92 (308)
.+++..... ...+++..+..+
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 179 (338)
T cd05102 100 SNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICY 179 (338)
T ss_pred HHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHH
Confidence 998864321 124778888999
Q ss_pred HHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccCccccc
Q 021771 93 INGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVK 172 (308)
Q Consensus 93 ~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 172 (308)
+.||+.||+|||++| |+|+||||+||+++.++.+||+|||++................++..|+|||++.+..++.+
T Consensus 180 ~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 256 (338)
T cd05102 180 SFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQ 256 (338)
T ss_pred HHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcc
Confidence 999999999999998 99999999999999999999999999976532222122222344578999999988889999
Q ss_pred ccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCC
Q 021771 173 SDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADR 251 (308)
Q Consensus 173 ~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 251 (308)
+|||||||++|+|++ |..||....... .............. +......+.+++.+||+.||++|
T Consensus 257 sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 257 SDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMRA---------PENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred cCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCCC---------CCCCCHHHHHHHHHHccCChhhC
Confidence 999999999999997 899986533211 01111111111110 11123458889999999999999
Q ss_pred CCHHHHHHHhhcC
Q 021771 252 PTMSSVVVMLASD 264 (308)
Q Consensus 252 Ps~~eil~~L~~~ 264 (308)
||+.+|++.|+..
T Consensus 322 Ps~~el~~~l~~~ 334 (338)
T cd05102 322 PTFSALVEILGDL 334 (338)
T ss_pred cCHHHHHHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=291.99 Aligned_cols=237 Identities=19% Similarity=0.304 Sum_probs=187.5
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCccc---HHHHHHHHHHHhcCCCcCccceeeeEEe----CCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNLVRLFGCCLE----ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~ 73 (308)
+|.||+|+. +|+.||||++....... .+.+.+|+.+|++++||||+++++++.+ ....++||||+++|+|.+
T Consensus 33 ~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~ 111 (283)
T PHA02988 33 QNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111 (283)
T ss_pred ceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHH
Confidence 578999988 78999999987553333 4677899999999999999999999877 346899999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhC-CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
++... ..+++.....++.+++.++.|||+. + ++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 112 ~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~ 180 (283)
T PHA02988 112 VLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKN 180 (283)
T ss_pred HHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccc
Confidence 98543 3588899999999999999999985 5 8899999999999999999999999987653221 123
Q ss_pred ecccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 153 VGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 153 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
.++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ............ ..+.
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~---------~~~~ 245 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IYDLIINKNNSL---------KLPL 245 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhcCCCC---------CCCC
Confidence 46788999999876 678999999999999999999999997542211 111110010000 0111
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.....+.+++.+||+.||++|||++||++.|+..
T Consensus 246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 246 DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 2234588899999999999999999999999864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=299.94 Aligned_cols=234 Identities=24% Similarity=0.358 Sum_probs=195.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+|+. .+++.||+|.+.+.. ..+...+.+|+++++.++||||+.++++|+...++++|.|||.| +|..++.+
T Consensus 15 fg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~ 93 (808)
T KOG0597|consen 15 FGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQ 93 (808)
T ss_pred cceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHh
Confidence 799999995 589999999997653 44566788999999999999999999999999999999999966 99999954
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.+.++++.+..++.+++.||.|||+++ |.|+|+||.||+++.+|.+|++|||+++.+..+. .......||+.
T Consensus 94 ---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vltsikGtPl 165 (808)
T KOG0597|consen 94 ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVLTSIKGTPL 165 (808)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc--eeeeeccCccc
Confidence 445999999999999999999999997 9999999999999999999999999999876543 33445689999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|||||++.+..|+..+|+|||||++|+++.|++||- ...+......+.+.+. ..+......+.
T Consensus 166 YmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------a~si~~Lv~~I~~d~v-----------~~p~~~S~~f~ 228 (808)
T KOG0597|consen 166 YMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------ARSITQLVKSILKDPV-----------KPPSTASSSFV 228 (808)
T ss_pred ccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------HHHHHHHHHHHhcCCC-----------CCcccccHHHH
Confidence 999999999999999999999999999999999982 2222222222222211 12224445688
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.++...|.+||..|.|..+++.-
T Consensus 229 nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 229 NFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHhhcChhhcccHHHHhcC
Confidence 88889999999999999999853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=305.63 Aligned_cols=233 Identities=25% Similarity=0.326 Sum_probs=190.6
Q ss_pred CccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 2 ESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 2 g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
|.|-.|++ .+|+.+|||++.+. .....+.+..|+.+|+.+.||||+++|+++.++.++|+|.||+++|.|.+++.
T Consensus 26 g~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv- 104 (786)
T KOG0588|consen 26 GCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLV- 104 (786)
T ss_pred ceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHH-
Confidence 67788885 68999999999655 33445678899999999999999999999999999999999999999999994
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.++.+++.++.+++.||+.|+.|+|..+ |||||+||+|+|++..+++||+|||.|..-..+ .--...+|+++
T Consensus 105 --~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g---klLeTSCGSPH 176 (786)
T KOG0588|consen 105 --RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG---KLLETSCGSPH 176 (786)
T ss_pred --hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC---ccccccCCCcc
Confidence 4556999999999999999999999996 999999999999999999999999999763222 22233579999
Q ss_pred ccCchhhccCccc-ccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 158 YMAPEYAMEGLFS-VKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 158 y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
|++||++.|..|+ .++||||+|+|+|.|++|+.||+.. ....++..+++. ..++ +.....+.
T Consensus 177 YA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV~~G-----~f~M---------Ps~Is~ea 239 (786)
T KOG0588|consen 177 YAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKVQRG-----VFEM---------PSNISSEA 239 (786)
T ss_pred cCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHHHcC-----cccC---------CCcCCHHH
Confidence 9999999998764 7899999999999999999999722 222222211111 1111 22233458
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+||.+|+..||++|.|.+||++-
T Consensus 240 QdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 240 QDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHHHHHhccCccccccHHHHhhC
Confidence 888999999999999999999964
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=302.09 Aligned_cols=246 Identities=27% Similarity=0.431 Sum_probs=197.6
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+|++. | .||||+++... ++..+.|++|+..|++.+|-||+-+.+++..... .+|+.||.|.+|..+++..
T Consensus 405 FGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~ 481 (678)
T KOG0193|consen 405 FGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQ 481 (678)
T ss_pred ccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccch
Confidence 8999999974 3 79999998764 4567789999999999999999999999998876 9999999999999999764
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
. ..+++.+.+.|+.||++|+.|||.++ |+|+|||.+||++.++++|||+|||++..-.............|...|
T Consensus 482 e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilw 556 (678)
T KOG0193|consen 482 E--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLW 556 (678)
T ss_pred h--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhh
Confidence 4 45999999999999999999999996 999999999999999999999999999875433333334445678899
Q ss_pred cCchhhcc---CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 159 MAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 159 ~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
||||++.- .+|+..+||||+|+|+|||++|..||.....+..-..+... .-..+. ..........
T Consensus 557 mAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG---------~l~pd~---s~~~s~~pk~ 624 (678)
T KOG0193|consen 557 MAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG---------YLMPDL---SKIRSNCPKA 624 (678)
T ss_pred hcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc---------ccCccc---hhhhccCHHH
Confidence 99998863 47899999999999999999999999744333221111110 000011 0112234456
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhcCCC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLASDTV 266 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~~~~ 266 (308)
+.+|+..||.+++++||.+.+|+..|+....
T Consensus 625 mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 625 MKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 8888889999999999999999998887643
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=297.68 Aligned_cols=238 Identities=24% Similarity=0.317 Sum_probs=200.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe-EEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE-SLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~ 76 (308)
||.+++.++ .+++.+|+|.+... ....+.....|+.++++++|||||.+++.|..++. +++||+||+||++.+.+.
T Consensus 17 fG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~ 96 (426)
T KOG0589|consen 17 FGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIK 96 (426)
T ss_pred cchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHH
Confidence 788998885 58999999988644 34455577899999999999999999999999888 999999999999999997
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... +..++++.+..|+.|++.|+.|||++. |+|||||+.|||++.++.|+|+|||+++.++.... ......||+
T Consensus 97 ~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp 170 (426)
T KOG0589|consen 97 EQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTP 170 (426)
T ss_pred HHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCC
Confidence 654 677999999999999999999999885 99999999999999999999999999999865542 233468999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+.||++.+.+|..|+|||||||++|+|++.+++|...+.... ..+.. . ..-...+..+..++
T Consensus 171 ~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L------i~ki~---------~-~~~~Plp~~ys~el 234 (426)
T KOG0589|consen 171 YYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL------ILKIN---------R-GLYSPLPSMYSSEL 234 (426)
T ss_pred cccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH------HHHHh---------h-ccCCCCCccccHHH
Confidence 99999999999999999999999999999999999976544421 11110 0 01123345566679
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..|+..|++.+|+.||++.++|..
T Consensus 235 ~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 235 RSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999999999999999999965
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=311.32 Aligned_cols=243 Identities=24% Similarity=0.276 Sum_probs=196.3
Q ss_pred CCccEEeeeCCC-CEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeee-EE---eCC---eEEEEEEecCCCCh
Q 021771 1 MESCLQGKLADG-KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGC-CL---EEN---ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~~~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~---~~~---~~~lv~e~~~~~~L 71 (308)
|+.||++....+ +.||+|++-..+......+.+|+++|+.|+ |+|||.+++. .. .++ .++|+||||.++.|
T Consensus 50 Fa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~L 129 (738)
T KOG1989|consen 50 FAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSL 129 (738)
T ss_pred cEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcH
Confidence 889999996554 999999987777788889999999999997 9999999993 22 112 36889999999999
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc---
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN--- 148 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~--- 148 (308)
-++++...+.. |++.++++|++++++|+++||.. ..+|+|||||-+|||++.+|.+||||||.+...........
T Consensus 130 vd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~ 207 (738)
T KOG1989|consen 130 VDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVN 207 (738)
T ss_pred HHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHH
Confidence 99998765443 99999999999999999999998 47899999999999999999999999999875432221110
Q ss_pred ----cceeecccCccCchhhc---cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccc
Q 021771 149 ----TNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELME 221 (308)
Q Consensus 149 ----~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
.-....|+.|+|||++. +...++|+|||+|||+||-|+....||+..- -..++.
T Consensus 208 ~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------------------~laIln 268 (738)
T KOG1989|consen 208 YVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------------------KLAILN 268 (738)
T ss_pred HHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------------------ceeEEe
Confidence 01125688999999875 5678999999999999999999999996431 112233
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.-.....+...|.+||+.||+.||++||++.+++..+...
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 3333333456778899999999999999999999999876443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=294.53 Aligned_cols=235 Identities=23% Similarity=0.350 Sum_probs=196.1
Q ss_pred CCccEEee-eCCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+|. .+.++.||+|++... ...+.+.++.|+.+|.+++++||.++|+.+..+..++++||||.||++.+.+.
T Consensus 26 fG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~-- 103 (467)
T KOG0201|consen 26 FGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLK-- 103 (467)
T ss_pred cceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhc--
Confidence 89999999 578999999999755 45567889999999999999999999999999999999999999999999984
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
.+..+++..+..++++++.|+.|||..+ .+|+|||+.||++..+|.+||+|||.+..+....... ..++||+.|
T Consensus 104 -~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfw 177 (467)
T KOG0201|consen 104 -SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTFVGTPFW 177 (467)
T ss_pred -cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc--ccccccccc
Confidence 3334588889999999999999999997 9999999999999999999999999998876544333 557899999
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
||||++.+..|+.++||||||+++++|++|.+|+....+-....+ +++-.-+.+.. .....+.+
T Consensus 178 MAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~----~~S~~~kE 241 (467)
T KOG0201|consen 178 MAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDG----DFSPPFKE 241 (467)
T ss_pred cchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCcccc----ccCHHHHH
Confidence 999999988999999999999999999999999865443211110 11111111212 23334888
Q ss_pred HHhhcccCCCCCCCCHHHHHH
Q 021771 239 IGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~ 259 (308)
|+..||..||+.||||.++|+
T Consensus 242 FV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 242 FVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred HHHHHhhcCcccCcCHHHHhh
Confidence 888999999999999999984
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=287.88 Aligned_cols=251 Identities=26% Similarity=0.404 Sum_probs=188.1
Q ss_pred CCccEEeeeCC-----------------CCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEE
Q 021771 1 MESCLQGKLAD-----------------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62 (308)
Q Consensus 1 ~g~v~~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 62 (308)
||.||++..++ +..||+|.+.... ......+.+|+.+|..++||||+++++++.+.+..++|
T Consensus 18 fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 97 (304)
T cd05096 18 FGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMI 97 (304)
T ss_pred CeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEE
Confidence 79999987532 3479999886543 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhcCC----------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC
Q 021771 63 YEYMPNKSLDVFLFDST----------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126 (308)
Q Consensus 63 ~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~ 126 (308)
|||+.+++|.+++.... ....+++..++.++.||+.||+|||+.| ++|+||||+||+++.+
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~ 174 (304)
T cd05096 98 TEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGEN 174 (304)
T ss_pred EecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcchhheEEcCC
Confidence 99999999999885431 1124677889999999999999999998 9999999999999999
Q ss_pred CCeeeecccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhC--CcCCCccccccccchh
Q 021771 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG--KKNTGFYLSELGQSLL 204 (308)
Q Consensus 127 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~--~~p~~~~~~~~~~~~~ 204 (308)
+.+||+|||++................++..|+|||++.+..++.++||||||+++|+|+++ ..||...... ...
T Consensus 175 ~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~ 251 (304)
T cd05096 175 LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE---QVI 251 (304)
T ss_pred ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHH---HHH
Confidence 99999999999865433222222233456789999998888899999999999999999874 4566543221 111
Q ss_pred HHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 205 SYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
........... .... ...+......+.+|+.+||+.+|++|||+.+|.+.|++
T Consensus 252 ~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 252 ENAGEFFRDQG-RQVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred HHHHHHhhhcc-cccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 11111111100 0000 00111223458899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=274.87 Aligned_cols=223 Identities=26% Similarity=0.309 Sum_probs=186.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+|.+.+. .+|..+|+|++++. .-...+...+|..+|+.+.||+++++++.|.+.+.++|||||.+||.|..+++
T Consensus 57 FGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lr 136 (355)
T KOG0616|consen 57 FGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLR 136 (355)
T ss_pred cceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHH
Confidence 899999995 57999999999765 23455677899999999999999999999999999999999999999999995
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ..++++..++.++.||+.||+|||+.+ |++||+||+|||+|.+|.+||+|||++...... +-..+||+
T Consensus 137 k---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTP 205 (355)
T KOG0616|consen 137 K---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTP 205 (355)
T ss_pred h---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCc
Confidence 4 345999999999999999999999997 999999999999999999999999999986432 34468999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++....+..++|.|+||+++|+|+.|.+||...... ....++. .++ -.++......+
T Consensus 206 eYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~------~iY~KI~-~~~----------v~fP~~fs~~~ 268 (355)
T KOG0616|consen 206 EYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI------QIYEKIL-EGK----------VKFPSYFSSDA 268 (355)
T ss_pred cccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH------HHHHHHH-hCc----------ccCCcccCHHH
Confidence 999999999999999999999999999999999998644331 1111111 111 12233333457
Q ss_pred HHHHhhcccCCCCCC
Q 021771 237 IHIGLLCVQADSADR 251 (308)
Q Consensus 237 ~~li~~cl~~~p~~R 251 (308)
.+|+...|+.|-.+|
T Consensus 269 kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 269 KDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHHHHhhhhHhh
Confidence 788888999998888
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=293.35 Aligned_cols=234 Identities=20% Similarity=0.195 Sum_probs=187.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .......+..|+.+++.++||||+++++++..++..++||||+++++|.+++.
T Consensus 8 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 87 (323)
T cd05571 8 FGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 87 (323)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 799999985 68999999998654 23344567789999999999999999999999999999999999999998885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||++....... .......|+.
T Consensus 88 ~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~ 159 (323)
T cd05571 88 RE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTP 159 (323)
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCc
Confidence 43 35899999999999999999999998 9999999999999999999999999987532111 1122356899
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||........ ..... .... ..+......+
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~~~-~~~~----------~~p~~~~~~~ 222 (323)
T cd05571 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELIL-MEEI----------RFPRTLSPEA 222 (323)
T ss_pred cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH------HHHHH-cCCC----------CCCCCCCHHH
Confidence 99999999888899999999999999999999999854322110 00110 0000 0111223458
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHH
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~ 259 (308)
.+|+.+||+.||++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 8899999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=290.73 Aligned_cols=234 Identities=20% Similarity=0.212 Sum_probs=186.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .......+..|+.+++.++||||+++++++..+...++||||+++++|..++.
T Consensus 8 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~ 87 (323)
T cd05595 8 FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 87 (323)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHH
Confidence 799999985 58999999998654 23344567789999999999999999999999999999999999999988875
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++....... .......|+.
T Consensus 88 ~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~ 159 (323)
T cd05595 88 RE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTP 159 (323)
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCCc
Confidence 43 35899999999999999999999998 9999999999999999999999999987532211 1122346789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||....... ...... .... . . +......+
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~-~~~~-~-----~----p~~~~~~~ 222 (323)
T cd05595 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELIL-MEEI-R-----F----PRTLSPEA 222 (323)
T ss_pred CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCCC-C-----C----CCCCCHHH
Confidence 9999999988889999999999999999999999986432221 111111 0000 0 0 11122357
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHH
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~ 259 (308)
.+++.+||+.||++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 8888999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=296.35 Aligned_cols=246 Identities=28% Similarity=0.402 Sum_probs=189.3
Q ss_pred CCccEEeee------CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .++..||+|+++.. .....+.+.+|+.+|+.+ +||||+++++++.+....++|||||++|+|.
T Consensus 48 fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~ 127 (375)
T cd05104 48 FGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLL 127 (375)
T ss_pred cceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHH
Confidence 799999863 34678999998644 334456788999999999 7999999999999999999999999999999
Q ss_pred hHhhcCCC------------------------------------------------------------------------
Q 021771 73 VFLFDSTR------------------------------------------------------------------------ 80 (308)
Q Consensus 73 ~~l~~~~~------------------------------------------------------------------------ 80 (308)
+++.....
T Consensus 128 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (375)
T cd05104 128 NFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEED 207 (375)
T ss_pred HHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhcc
Confidence 88854221
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..+..++.||+.||+|||++| ++|+||||+||+++.++.++|+|||++................++..|+|
T Consensus 208 ~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 284 (375)
T cd05104 208 ELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMA 284 (375)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeC
Confidence 124778889999999999999999998 99999999999999999999999999987643322211222234567999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++||||||+++|+|++ |..||....... ...+......... .+.....++.+|
T Consensus 285 PE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~l~~l 349 (375)
T cd05104 285 PESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGYRML---------SPECAPSEMYDI 349 (375)
T ss_pred hhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCccCC---------CCCCCCHHHHHH
Confidence 999988889999999999999999997 788875432211 0111111111000 001112358889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+||+.||++|||+.+|++.|+..
T Consensus 350 i~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 350 MKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHccCChhHCcCHHHHHHHHHhh
Confidence 9999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=279.12 Aligned_cols=241 Identities=28% Similarity=0.382 Sum_probs=188.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.+++|.+.... ......+.+|+++++.++|+||+++++++......++||||+++++|.+++...
T Consensus 8 ~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 87 (252)
T cd05084 8 FGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE 87 (252)
T ss_pred CccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhC
Confidence 799999996 589999999876443 334567889999999999999999999999999999999999999999988543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+++..++.++.|++.+|+|||++| ++|+||+|+||+++.++.++|+|||++.................+..|
T Consensus 88 --~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 162 (252)
T cd05084 88 --GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162 (252)
T ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceee
Confidence 235889999999999999999999998 999999999999999999999999998764322111111111224569
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
+|||.+.+..++.++||||||+++|+|++ |..||........ ....... .. ...+......+.
T Consensus 163 ~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~~-~~--------~~~~~~~~~~~~ 226 (252)
T cd05084 163 TAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQG-VR--------LPCPELCPDAVY 226 (252)
T ss_pred cCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHcC-CC--------CCCcccCCHHHH
Confidence 99999988889999999999999999997 8888754322110 0000000 00 011112234588
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 238 HIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
+++.+||+.+|++|||+.++++.|.
T Consensus 227 ~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 227 RLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHh
Confidence 8999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=282.66 Aligned_cols=239 Identities=22% Similarity=0.282 Sum_probs=187.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++.. .+|+.||+|.+.... ......+.+|+.+++.++|++|+++++++.+++..++||||+++++|..++.
T Consensus 13 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~ 92 (285)
T cd05631 13 FGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY 92 (285)
T ss_pred CEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHH
Confidence 799999995 689999999886442 2233467789999999999999999999999999999999999999988775
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ....+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++........ .....|+.
T Consensus 93 ~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~ 165 (285)
T cd05631 93 NM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTV 165 (285)
T ss_pred hh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCC
Confidence 42 2235889999999999999999999998 99999999999999999999999999987532211 12346789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||........... ........ . ..........+
T Consensus 166 ~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~~~~~~-~---------~~~~~~~s~~~ 232 (285)
T cd05631 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---VDRRVKED-Q---------EEYSEKFSEDA 232 (285)
T ss_pred CccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH---HHHHhhcc-c---------ccCCccCCHHH
Confidence 99999999988999999999999999999999999975432211100 00000000 0 01111123457
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHH
Q 021771 237 IHIGLLCVQADSADRPT-----MSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs-----~~eil~ 259 (308)
.+|+.+||+.||++||+ ++++++
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 88999999999999997 788885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=287.34 Aligned_cols=237 Identities=19% Similarity=0.201 Sum_probs=186.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.||+|++... .......+..|+.+++.++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 6 ~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 85 (312)
T cd05585 6 FGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ 85 (312)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHH
Confidence 799999996 57899999998643 23345667889999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++....... .......|+.
T Consensus 86 ~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~ 157 (312)
T cd05585 86 RE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTP 157 (312)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCc
Confidence 43 34899999999999999999999998 9999999999999999999999999987532221 1122346889
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||...... ........ ... ..+......+
T Consensus 158 ~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~-~~~----------~~~~~~~~~~ 220 (312)
T cd05585 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ-EPL----------RFPDGFDRDA 220 (312)
T ss_pred ccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc-CCC----------CCCCcCCHHH
Confidence 999999999888999999999999999999999998643221 11111111 000 0111123457
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
.+++.+||+.||++||++..+.+.|.
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 88899999999999986544444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=284.79 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=184.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||++.. .+++.||+|++.... ......+.+|+.+++.++|+||+++++++.+.+..++||||+++ +|.+++...
T Consensus 18 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~ 96 (288)
T cd07871 18 YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC 96 (288)
T ss_pred CEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhc
Confidence 789999985 579999999986443 23345678999999999999999999999999999999999975 888877543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
. ..+++..+..++.||+.||+|||++| |+|+||||+||+++.++.+||+|||++......... .....++..|
T Consensus 97 ~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~--~~~~~~~~~y 169 (288)
T cd07871 97 G--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVVTLWY 169 (288)
T ss_pred C--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc--ccCceecccc
Confidence 2 34788899999999999999999998 999999999999999999999999998765322211 1223568899
Q ss_pred cCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHH-----HHhhhc----cccccccccccccc-
Q 021771 159 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYT-----WKLWCE----GEALELMEPVLKQS- 227 (308)
Q Consensus 159 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~-----~~~~~~----~~~~~~~~~~~~~~- 227 (308)
+|||++.+ ..++.++|||||||++|+|++|..||............... ...+.. ........+.....
T Consensus 170 ~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
T cd07871 170 RPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQP 249 (288)
T ss_pred cChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCc
Confidence 99998865 46789999999999999999999999654322111000000 000000 00000000000000
Q ss_pred ---chHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 228 ---CVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 228 ---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.......++.+|+.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 250 LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00112245789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=288.12 Aligned_cols=235 Identities=20% Similarity=0.203 Sum_probs=187.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .......+.+|+.+++.++||||+++++++.+++..++||||+++++|..++.
T Consensus 8 ~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~ 87 (328)
T cd05593 8 FGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLS 87 (328)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHH
Confidence 799999985 57999999998654 23345677889999999999999999999999999999999999999988875
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.||+.||+|||++| |+|+||||+||+++.++.+||+|||++....... .......|+.
T Consensus 88 ~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~ 159 (328)
T cd05593 88 RE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTP 159 (328)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCc
Confidence 43 35899999999999999999999998 9999999999999999999999999987532211 1122346889
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||....... ...... .... ..+......+
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~~~~-~~~~----------~~p~~~~~~~ 222 (328)
T cd05593 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELIL-MEDI----------KFPRTLSADA 222 (328)
T ss_pred CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHHHhc-cCCc----------cCCCCCCHHH
Confidence 9999999988889999999999999999999999986432211 011110 0000 0011123357
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHHH
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~~ 260 (308)
.+++.+||+.||++|| ++.++++.
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 8889999999999997 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=286.61 Aligned_cols=239 Identities=20% Similarity=0.250 Sum_probs=188.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.+|+|++++.. ....+.+..|-++|...++++||++|..|++..++||||||++||++..+|.
T Consensus 154 fGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~ 233 (550)
T KOG0605|consen 154 FGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLM 233 (550)
T ss_pred ceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHH
Confidence 899999995 589999999997763 4456678889999999999999999999999999999999999999999995
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC--------------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG-------------- 142 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~-------------- 142 (308)
. ...+++..+..++.+++.|+..+|+.| ++||||||+|+|||..|.+||+|||++.-+..
T Consensus 234 ~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~ 307 (550)
T KOG0605|consen 234 R---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQ 307 (550)
T ss_pred h---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhh
Confidence 4 345999999999999999999999998 99999999999999999999999999843311
Q ss_pred --------CCCcc----c-------------------cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcC
Q 021771 143 --------NQSEA----N-------------------TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN 191 (308)
Q Consensus 143 --------~~~~~----~-------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 191 (308)
..... . ....+||+.|+|||++.+..|+..+|.||||||+|||+.|-+|
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPP 387 (550)
T KOG0605|consen 308 INLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPP 387 (550)
T ss_pred hhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCC
Confidence 00000 0 0124799999999999999999999999999999999999999
Q ss_pred CCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 021771 192 TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT---MSSVVV 259 (308)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~eil~ 259 (308)
|........ ..+...........+. .....+..+||.+|+. ||+.|.. ++||.+
T Consensus 388 F~s~tp~~T------~rkI~nwr~~l~fP~~-------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 388 FCSETPQET------YRKIVNWRETLKFPEE-------VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred CCCCCHHHH------HHHHHHHhhhccCCCc-------CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 965544432 2222111111111010 0111457888889999 9999975 666664
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=281.87 Aligned_cols=244 Identities=29% Similarity=0.470 Sum_probs=191.4
Q ss_pred CCccEEeeeCC-C-----CEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLAD-G-----KEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+|.... + +.+++|.+.... ......+.+|+.+++.++||||+++++++.+....+++|||+++++|.+
T Consensus 18 ~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~ 97 (283)
T cd05048 18 FGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHE 97 (283)
T ss_pred CCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHH
Confidence 78999998532 2 579999886443 3345678899999999999999999999999889999999999999999
Q ss_pred HhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeee
Q 021771 74 FLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIF 140 (308)
Q Consensus 74 ~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~ 140 (308)
++..... ...+++..++.++.|++.||+|||++| ++|+||||+||++++++.++|+|||++...
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~ 174 (283)
T cd05048 98 FLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDI 174 (283)
T ss_pred HHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeec
Confidence 9865321 145788899999999999999999998 999999999999999999999999999765
Q ss_pred CCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccc
Q 021771 141 GGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALEL 219 (308)
Q Consensus 141 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (308)
.............++..|+|||.+.+..++.++|||||||++|+|++ |..||....... . ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~----~~~i~~~~~~-- 245 (283)
T cd05048 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---V----IEMIRSRQLL-- 245 (283)
T ss_pred cccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcCCcC--
Confidence 43322222233345778999999888889999999999999999997 888875432211 1 1111111111
Q ss_pred ccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 220 MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
..+......+.+|+.+||+.||++||++.+|++.|+.
T Consensus 246 -------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 246 -------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1122334568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=303.40 Aligned_cols=240 Identities=20% Similarity=0.243 Sum_probs=190.7
Q ss_pred CCccEEeee-CC-CCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-AD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||++.. .+ ++.||+|.+..........+..|+.+|+.++||||+++++++..++..++||||+++++|.+++...
T Consensus 80 ~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~ 159 (478)
T PTZ00267 80 TTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR 159 (478)
T ss_pred CcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHH
Confidence 689999984 34 6788999775555555567788999999999999999999999999999999999999999887543
Q ss_pred -CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 -TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 -~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.....+++..+..++.|++.||.|||+.| |+||||||+||+++.++.+||+|||++..+.............|+..
T Consensus 160 ~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~ 236 (478)
T PTZ00267 160 LKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236 (478)
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCcc
Confidence 23446889999999999999999999998 99999999999999999999999999987654332222334568999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||++.+..++.++|||||||++|+|++|..||...... ........ .... + .+......+.
T Consensus 237 y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~~-~~~~----~-----~~~~~s~~~~ 300 (478)
T PTZ00267 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVLY-GKYD----P-----FPCPVSSGMK 300 (478)
T ss_pred ccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCCC----C-----CCccCCHHHH
Confidence 99999998888999999999999999999999998643221 11111111 1100 0 0111224588
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+++.+||+.+|++|||++++++
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHh
Confidence 8999999999999999999874
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=283.23 Aligned_cols=241 Identities=33% Similarity=0.514 Sum_probs=184.4
Q ss_pred CCccEEeeeC-----CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLA-----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||.|.++ .+..|+||.++.. .....+.+.+|++.++.++||||+++++++......++|+||+++++|.++
T Consensus 12 fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~ 91 (259)
T PF07714_consen 12 FGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDY 91 (259)
T ss_dssp SEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHH
T ss_pred CcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccccccccccc
Confidence 7999999976 4788999999654 334478899999999999999999999999988889999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+... ....+++..+..++.||+.||+|||+++ ++|++|+++||+++.++.+||+|||++.................
T Consensus 92 L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~ 167 (259)
T PF07714_consen 92 LKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQL 167 (259)
T ss_dssp HHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSES
T ss_pred cccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccc
Confidence 9765 2345899999999999999999999997 99999999999999999999999999987633322222333456
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
...|+|||.+.+..++.++||||||+++|++++ |..||....... ..... ....... .+....
T Consensus 168 ~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~~~~~-~~~~~~~---------~~~~~~ 231 (259)
T PF07714_consen 168 PLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------IIEKL-KQGQRLP---------IPDNCP 231 (259)
T ss_dssp GGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------HHHHH-HTTEETT---------SBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc------ccccc-cccccce---------eccchh
Confidence 778999999998889999999999999999999 678875442221 11111 1111111 111123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L 261 (308)
..+.+++..||..+|++|||+.+|++.|
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 3478889999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=295.75 Aligned_cols=246 Identities=28% Similarity=0.415 Sum_probs=188.5
Q ss_pred CCccEEeee------CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+++.||+|++... .......+.+|+.+++.+ +|+||+++++++......++|||||++++|.
T Consensus 51 fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~ 130 (374)
T cd05106 51 FGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLL 130 (374)
T ss_pred cccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHH
Confidence 799998873 23468999998654 333456788999999999 7999999999999999999999999999999
Q ss_pred hHhhcCCC-------------------------------------------------------------------ccccC
Q 021771 73 VFLFDSTR-------------------------------------------------------------------SVQLD 85 (308)
Q Consensus 73 ~~l~~~~~-------------------------------------------------------------------~~~~~ 85 (308)
+++..... ...++
T Consensus 131 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 210 (374)
T cd05106 131 NFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLD 210 (374)
T ss_pred HHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcC
Confidence 98854211 12477
Q ss_pred hHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhc
Q 021771 86 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM 165 (308)
Q Consensus 86 ~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 165 (308)
+..++.++.||+.||+|||++| ++||||||+||++++++.++|+|||++................++..|+|||++.
T Consensus 211 ~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 287 (374)
T cd05106 211 LDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 287 (374)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhc
Confidence 8889999999999999999998 9999999999999999999999999997654322211122223456799999998
Q ss_pred cCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcc
Q 021771 166 EGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCV 244 (308)
Q Consensus 166 ~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 244 (308)
+..++.++|||||||++|+|++ |..||....... . ......... . . ..+......+.+++.+||
T Consensus 288 ~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~--~---~----~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 288 DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGY--Q---M----SRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHccc--C---c----cCCCCCCHHHHHHHHHHc
Confidence 8889999999999999999997 999986432211 0 001111100 0 0 000111245888899999
Q ss_pred cCCCCCCCCHHHHHHHhhcC
Q 021771 245 QADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 245 ~~~p~~RPs~~eil~~L~~~ 264 (308)
+.||++|||+.+|++.|+..
T Consensus 353 ~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 353 NLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=279.22 Aligned_cols=241 Identities=30% Similarity=0.442 Sum_probs=194.9
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+|..++++.+++|.+..........+..|+.+++.++|+||+++++++.+....++||||+++++|.+++....
T Consensus 19 ~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~- 97 (261)
T cd05148 19 FGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE- 97 (261)
T ss_pred CccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCC-
Confidence 7899999988899999999977666567789999999999999999999999999999999999999999999986542
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++.......... ....++..|+|
T Consensus 98 ~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~ 172 (261)
T cd05148 98 GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS--SDKKIPYKWTA 172 (261)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccccc--cCCCCceEecC
Confidence 345899999999999999999999998 9999999999999999999999999997754322211 12234567999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||...+..++.++||||||+++|+|++ |..||....... . ..... .... ...+......+.++
T Consensus 173 PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~---~~~~~-~~~~---------~~~~~~~~~~~~~~ 236 (261)
T cd05148 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---V---YDQIT-AGYR---------MPCPAKCPQEIYKI 236 (261)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---H---HHHHH-hCCc---------CCCCCCCCHHHHHH
Confidence 999888888999999999999999998 788885432111 1 11111 0000 01112223458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||+.+|++|||+.+|++.|+.
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 237 MLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHcCCCchhCcCHHHHHHHHhc
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=281.35 Aligned_cols=243 Identities=28% Similarity=0.431 Sum_probs=191.2
Q ss_pred CCccEEeeeCC------CCEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLAD------GKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~~------g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+|+..+ ++.+++|.+...... ..+.+.+|+++|+.++|+||+++++++..+...++||||+++++|.+
T Consensus 18 ~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 97 (280)
T cd05049 18 FGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNK 97 (280)
T ss_pred CceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHH
Confidence 78999998633 578999998655433 45688999999999999999999999999999999999999999999
Q ss_pred HhhcCC-----------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 74 FLFDST-----------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 74 ~l~~~~-----------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
++.... ....+++..+..++.|++.++++||++| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 98 ~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~ 174 (280)
T cd05049 98 FLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174 (280)
T ss_pred HHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceeccc
Confidence 986532 1245788899999999999999999998 99999999999999999999999999876533
Q ss_pred CCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELME 221 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
...........++..|+|||++.+..++.++||||||+++|+|++ |..||....... .. .. ........
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~---~~-~~~~~~~~--- 244 (280)
T cd05049 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI---EC-ITQGRLLQ--- 244 (280)
T ss_pred CcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH---HH-HHcCCcCC---
Confidence 222111222344678999999998899999999999999999998 999975432221 11 11 11111110
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
.+......+.+++.+||+.||++|||+.||++.|+
T Consensus 245 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 245 ------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 01112345888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=270.73 Aligned_cols=273 Identities=21% Similarity=0.246 Sum_probs=197.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCccc--HHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQG--LQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|+. ++++.||+|+++.....+ .-...+|+.+|.+++|||||.+..+.... +.+|+|||||+. +|..++
T Consensus 89 yGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~ 167 (419)
T KOG0663|consen 89 YGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLM 167 (419)
T ss_pred ceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHH
Confidence 899999994 789999999997543222 23456899999999999999999998754 469999999955 899988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... .++...++..+..|+++|++|||.+. |+|||+|++|+|+++.|.+|++|||+|+.++..... .+..+-|
T Consensus 168 d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~--~T~lVVT 240 (419)
T KOG0663|consen 168 ETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP--YTPLVVT 240 (419)
T ss_pred Hhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCccc--CcceEEE
Confidence 6543 46999999999999999999999998 999999999999999999999999999998765333 2334568
Q ss_pred cCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHH-----HHhhhccccc---------ccc
Q 021771 156 YGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYT-----WKLWCEGEAL---------ELM 220 (308)
Q Consensus 156 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~---------~~~ 220 (308)
.+|+|||++.+. .|+...||||+|||+.+|+++++.|...........+-.. ...|..-... +..
T Consensus 241 LWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~p 320 (419)
T KOG0663|consen 241 LWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHP 320 (419)
T ss_pred eeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCC
Confidence 999999998874 6999999999999999999999998654333221111110 0111111000 000
Q ss_pred cccccccchHH-HHHHHHHHHhhcccCCCCCCCCHHHHHHH--hhcCCCCCCCCCCCCcccCcc
Q 021771 221 EPVLKQSCVAA-ELLKFIHIGLLCVQADSADRPTMSSVVVM--LASDTVTLPQPTEPAFSVGRN 281 (308)
Q Consensus 221 ~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~eil~~--L~~~~~~~~~~~~p~~~~~~~ 281 (308)
-..+...+... ....-.+|+..+|.+||.+|.||+|.|+- ....-.+..|...|++.....
T Consensus 321 yn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P~k~~ 384 (419)
T KOG0663|consen 321 YNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWPAKSE 384 (419)
T ss_pred chhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCccccc
Confidence 01111111111 22445678888999999999999999853 333333334444444444333
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=287.46 Aligned_cols=186 Identities=26% Similarity=0.361 Sum_probs=161.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|..+|+|.+... .+.....+.+|+.+|+.++|+||+++++++.+++..++||||+++++|.+++...
T Consensus 18 ~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 97 (331)
T cd06649 18 GGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA 97 (331)
T ss_pred CEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc
Confidence 789999996 47999999988654 3344567899999999999999999999999999999999999999999998543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
..+++..+..++.|++.+|.|||+.+ .++|+||||+||+++.++.++|+|||++....... .....++..|
T Consensus 98 ---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y 168 (331)
T cd06649 98 ---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSY 168 (331)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCc
Confidence 34889999999999999999999863 49999999999999999999999999987653221 2234578899
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCcc
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 195 (308)
+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 169 ~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred CCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999998888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=289.97 Aligned_cols=240 Identities=20% Similarity=0.221 Sum_probs=189.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++.... ......+..|+.+++.++||||+++++++.+....++||||+++++|.+++.
T Consensus 14 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 93 (333)
T cd05600 14 YGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN 93 (333)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHH
Confidence 799999996 469999999986442 2344567889999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.||+.||.|||++| ++|+||||+||+++.++.+||+|||++..... ......|+.
T Consensus 94 ~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~ 162 (333)
T cd05600 94 NL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSP 162 (333)
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCc
Confidence 43 34889999999999999999999998 99999999999999999999999999876532 222346789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||.......... ........ +...............+
T Consensus 163 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~~~~---~~~~~~~~~~~~~s~~~ 233 (333)
T cd05600 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE------NLKYWKET---LQRPVYDDPRFNLSDEA 233 (333)
T ss_pred cccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHH------HHHhcccc---ccCCCCCccccccCHHH
Confidence 9999999998899999999999999999999999996543221110 00000000 00000000001223457
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+|+.+||+.+|++|||++++++.
T Consensus 234 ~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 234 WDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHhhChhhhcCCHHHHHhC
Confidence 888999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=307.10 Aligned_cols=250 Identities=30% Similarity=0.447 Sum_probs=204.2
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+|+.. +.+.||||.++..... .+++|++|+++|..++|||||+++++|.+++..++|+|||..|+|.+
T Consensus 499 FGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~e 578 (774)
T KOG1026|consen 499 FGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHE 578 (774)
T ss_pred hhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHH
Confidence 8999999843 3568899999877555 78899999999999999999999999999999999999999999999
Q ss_pred HhhcCCC-------cc----ccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 74 FLFDSTR-------SV----QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 74 ~l~~~~~-------~~----~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
++..... +. +++..+.+.++.||+.|+.||-++. +|||||-..|+||.++..|||+|||+++..-.
T Consensus 579 FLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYs 655 (774)
T KOG1026|consen 579 FLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYS 655 (774)
T ss_pred HHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhh
Confidence 9975421 22 3888999999999999999999986 99999999999999999999999999987554
Q ss_pred CCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELME 221 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
.++........-.++|||||.+..+.++.+|||||+||++||+++ |+.|+.....+ ++.+.+.
T Consensus 656 sDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~----------------EVIe~i~ 719 (774)
T KOG1026|consen 656 SDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ----------------EVIECIR 719 (774)
T ss_pred hhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH----------------HHHHHHH
Confidence 444444434455789999999999999999999999999999997 55776433222 1112222
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLP 269 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~ 269 (308)
....-.++...+.++++|+..||+.+|++|||++||-..|+......+
T Consensus 720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 720 AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 211134455556679999999999999999999999999988754443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=286.21 Aligned_cols=232 Identities=22% Similarity=0.233 Sum_probs=186.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.
T Consensus 14 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 93 (291)
T cd05612 14 FGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR 93 (291)
T ss_pred CeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHH
Confidence 799999996 479999999986432 2334568899999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++...... .....|+.
T Consensus 94 ~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~ 162 (291)
T cd05612 94 NS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTP 162 (291)
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCCh
Confidence 43 35889999999999999999999998 999999999999999999999999998765322 12245788
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||....... ...... .... ..+......+
T Consensus 163 ~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~-~~~~----------~~~~~~~~~~ 225 (291)
T cd05612 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKIL-AGKL----------EFPRHLDLYA 225 (291)
T ss_pred hhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCc----------CCCccCCHHH
Confidence 9999999988888999999999999999999999986432211 111111 1100 0011112357
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHHH
Q 021771 237 IHIGLLCVQADSADRPT-----MSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs-----~~eil~~ 260 (308)
.+|+.+||+.||.+||+ ++++++.
T Consensus 226 ~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 226 KDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 88999999999999995 8888854
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=283.15 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=195.5
Q ss_pred CCccEEeee------CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||.++. .++..+++|.+..........+.+|+.+++.++|+||+++++++..+...++||||+++++|.++
T Consensus 18 ~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 97 (291)
T cd05094 18 FGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97 (291)
T ss_pred CCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHH
Confidence 689999874 24567899988766555567789999999999999999999999999999999999999999999
Q ss_pred hhcCC-------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeC
Q 021771 75 LFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFG 141 (308)
Q Consensus 75 l~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~ 141 (308)
+.... ....+++..++.++.||+.+++|||++| ++|+||||+||+++.++.++|+|||++....
T Consensus 98 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~ 174 (291)
T cd05094 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVY 174 (291)
T ss_pred HHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccC
Confidence 86532 1234888999999999999999999998 9999999999999999999999999987654
Q ss_pred CCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccc
Q 021771 142 GNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELM 220 (308)
Q Consensus 142 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (308)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .............
T Consensus 175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~- 246 (291)
T cd05094 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIECITQGRVLER- 246 (291)
T ss_pred CCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHhCCCCCCC-
Confidence 3322222223345678999999988889999999999999999998 899875432211 1111111111111
Q ss_pred cccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCC
Q 021771 221 EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVT 267 (308)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~ 267 (308)
.......+.+++.+||+.+|++|||+.+|++.|+....+
T Consensus 247 --------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 247 --------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred --------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111234588999999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=289.53 Aligned_cols=232 Identities=22% Similarity=0.237 Sum_probs=186.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++||||+.+++|.+++.
T Consensus 31 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 110 (329)
T PTZ00263 31 FGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110 (329)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHH
Confidence 799999996 57999999998643 22344678899999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++....... ....|+.
T Consensus 111 ~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~ 179 (329)
T PTZ00263 111 KA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTP 179 (329)
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCCh
Confidence 43 34888999999999999999999998 9999999999999999999999999998754321 2246788
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||...... ....... .... . .+......+
T Consensus 180 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~-~~~~-~---------~p~~~~~~~ 242 (329)
T PTZ00263 180 EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKIL-AGRL-K---------FPNWFDGRA 242 (329)
T ss_pred hhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHh-cCCc-C---------CCCCCCHHH
Confidence 999999999888899999999999999999999998543221 1111111 1100 0 001112347
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHHH
Q 021771 237 IHIGLLCVQADSADRPT-----MSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs-----~~eil~~ 260 (308)
.+|+.+||+.||++||+ ++++++.
T Consensus 243 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 243 RDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 88999999999999997 6777743
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=283.58 Aligned_cols=252 Identities=19% Similarity=0.256 Sum_probs=187.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+++.+|+|++... .....+.+.+|+.+++.++|+||+++++++..++..++||||++++.+..+...
T Consensus 14 ~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~ 93 (287)
T cd07848 14 YGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM 93 (287)
T ss_pred CEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc
Confidence 789999996 47899999998654 233456788999999999999999999999999999999999998877665422
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..+..++.|++.||.|||+.| ++|+||||+||+++.++.+||+|||++......... ......++..
T Consensus 94 ---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~ 166 (287)
T cd07848 94 ---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRW 166 (287)
T ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccc
Confidence 235889999999999999999999998 999999999999999999999999999875432211 1223457889
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHH--------HHHhhhccc-cccccccccc---
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY--------TWKLWCEGE-ALELMEPVLK--- 225 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~~--- 225 (308)
|+|||++.+..++.++|||||||++|+|++|..||.............. ....+.... ......+...
T Consensus 167 y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T cd07848 167 YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQ 246 (287)
T ss_pred cCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcc
Confidence 9999999888899999999999999999999999965432211000000 000000000 0000000000
Q ss_pred ---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 226 ---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 226 ---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..........+.+|+.+||+.||++|||++++++
T Consensus 247 ~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 247 SLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001112345889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=275.14 Aligned_cols=241 Identities=30% Similarity=0.443 Sum_probs=191.2
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||++...+++.|++|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+++++|.+++....
T Consensus 19 ~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~- 96 (261)
T cd05068 19 FGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA- 96 (261)
T ss_pred CccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC-
Confidence 689999998788899999986443 345678899999999999999999999999999999999999999999986533
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..+..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||++.......... ......+..|+|
T Consensus 97 ~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~a 172 (261)
T cd05068 97 GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA-REGAKFPIKWTA 172 (261)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc-cCCCcCceeccC
Confidence 345899999999999999999999998 9999999999999999999999999998765322111 111122457999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||...+..++.++||||||+++|+|++ |..||....... .. ........ ...+......+.++
T Consensus 173 PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~---------~~~~~~~~~~~~~l 236 (261)
T cd05068 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VL----QQVDQGYR---------MPCPPGCPKELYDI 236 (261)
T ss_pred ccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCCC---------CCCCCcCCHHHHHH
Confidence 999888888999999999999999998 888885432111 00 01001000 00111223468889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||+.+|++||++.+|++.|+.
T Consensus 237 i~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 237 MLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHhhcCcccCCCHHHHHHHHhc
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=282.09 Aligned_cols=234 Identities=24% Similarity=0.284 Sum_probs=181.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+++.||+|++... .....+....|..++..+ +||||+++++++..+...++||||+++++|..++
T Consensus 8 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~ 87 (316)
T cd05592 8 FGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHI 87 (316)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHH
Confidence 799999996 57889999998643 223344556666776654 7999999999999999999999999999999888
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||++....... .......|+
T Consensus 88 ~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt 159 (316)
T cd05592 88 QSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGT 159 (316)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCC
Confidence 543 34899999999999999999999998 9999999999999999999999999997643222 122334688
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||....... ........ . +.. +......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~--~-----~~~----~~~~~~~ 222 (316)
T cd05592 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDSILND--R-----PHF----PRWISKE 222 (316)
T ss_pred ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcC--C-----CCC----CCCCCHH
Confidence 99999999988889999999999999999999999996443211 11111000 0 000 1112234
Q ss_pred HHHHHhhcccCCCCCCCCHH-HHHH
Q 021771 236 FIHIGLLCVQADSADRPTMS-SVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~-eil~ 259 (308)
+.+++.+||+.+|++||++. ++++
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHHc
Confidence 77888999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=275.10 Aligned_cols=239 Identities=26% Similarity=0.397 Sum_probs=188.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+++++++..+++|.+... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++....
T Consensus 17 ~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~- 94 (256)
T cd05114 17 FGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ- 94 (256)
T ss_pred CceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc-
Confidence 78999999888889999988543 2334678899999999999999999999999999999999999999999886432
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
..+++..+..++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||.+.......... .....++..|+|
T Consensus 95 -~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~a 169 (256)
T cd05114 95 -GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSP 169 (256)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec-cCCCCCchhhCC
Confidence 24888999999999999999999998 9999999999999999999999999987653222111 112234567999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++||||+|+++|+|++ |..||....... ..... ...... ..+ ......+.++
T Consensus 170 PE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~------~~~~i-~~~~~~--~~~-------~~~~~~~~~l 233 (256)
T cd05114 170 PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE------VVEMI-SRGFRL--YRP-------KLASMTVYEV 233 (256)
T ss_pred hhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHH-HCCCCC--CCC-------CCCCHHHHHH
Confidence 999888888999999999999999999 888885432211 11111 111100 000 1112357899
Q ss_pred HhhcccCCCCCCCCHHHHHHHhh
Q 021771 240 GLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~ 262 (308)
+.+||+.+|++|||+.++++.|.
T Consensus 234 i~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 234 MYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHccCCcccCcCHHHHHHhhC
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=275.64 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=190.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. +.++.+++|.+... ......+.+|+.+++.++|+||+++++++..+...+++|||+++++|.+++....
T Consensus 19 ~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 97 (263)
T cd05052 19 YGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 97 (263)
T ss_pred cceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCC
Confidence 689999985 56999999988643 3345678899999999999999999999999999999999999999999885532
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
...+++..++.++.|++.+|+|||++| ++|+||+|+||++++++.++|+|||++.......... ......+..|+
T Consensus 98 -~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~ 172 (263)
T cd05052 98 -RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWT 172 (263)
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec-cCCCCCccccC
Confidence 345888999999999999999999998 9999999999999999999999999987764332211 11122356799
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
|||.+.+..++.++||||||+++|+|++ |..||........ ........ . ...+......+.+
T Consensus 173 aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~-----~----~~~~~~~~~~~~~ 236 (263)
T cd05052 173 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKGY-----R----MERPEGCPPKVYE 236 (263)
T ss_pred CHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCC-----C----CCCCCCCCHHHHH
Confidence 9999888889999999999999999998 8888754322211 11111100 0 0111112345888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
++.+||+.+|++|||+.++++.|+..
T Consensus 237 li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHHccCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=287.72 Aligned_cols=235 Identities=26% Similarity=0.344 Sum_probs=180.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.||||++.... ......+.+|+.+++.++|+||+++++++.+++.+++||||+++++|....
T Consensus 87 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~--- 163 (353)
T PLN00034 87 GGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH--- 163 (353)
T ss_pred CeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc---
Confidence 799999995 579999999986543 334567889999999999999999999999999999999999999886532
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++..+..... ......|+..|
T Consensus 164 ----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y 234 (353)
T PLN00034 164 ----IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAY 234 (353)
T ss_pred ----cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccc
Confidence 2456778899999999999999998 99999999999999999999999999987643221 12234678999
Q ss_pred cCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 159 MAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 159 ~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+|||++.. ...+.++|||||||++|+|++|+.||............ .... .... ........
T Consensus 235 ~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~-~~~~---------~~~~~~~~ 301 (353)
T PLN00034 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM---CAIC-MSQP---------PEAPATAS 301 (353)
T ss_pred cCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH---HHHh-ccCC---------CCCCCccC
Confidence 99998743 23456899999999999999999999732221110000 0000 0000 01111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+.+|+.+||+.||++|||+.|+++.
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 458899999999999999999999964
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=277.99 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=192.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe-----CCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-----ENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~ 72 (308)
||.|..+.. .+|+.||||++... +....++..+|+.+|++++|+||+.+++++.. -+.+|+|+|+| +.+|.
T Consensus 35 yGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~ 113 (359)
T KOG0660|consen 35 YGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLH 113 (359)
T ss_pred eeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHH
Confidence 688999984 68999999999733 45566788899999999999999999999875 34689999999 66999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
..++. +..++...+..+++|++.||.|+|+.+ ++|||+||.|++++.+..+|++|||+|+..........-+..
T Consensus 114 ~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeY 187 (359)
T KOG0660|consen 114 QIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEY 187 (359)
T ss_pred HHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcc
Confidence 99844 334999999999999999999999997 999999999999999999999999999987644222233556
Q ss_pred ecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHH--------HHhhhccccccccccc
Q 021771 153 VGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYT--------WKLWCEGEALELMEPV 223 (308)
Q Consensus 153 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 223 (308)
+.|.+|+|||++.. ..|+.+.||||+||++.+|++|++.|.+.+......++... ............+...
T Consensus 188 VaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~sl 267 (359)
T KOG0660|consen 188 VATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSL 267 (359)
T ss_pred eeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhC
Confidence 78999999997765 57999999999999999999999999765544222221110 0111111111111111
Q ss_pred cc---c---cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 224 LK---Q---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 224 ~~---~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.. . ..........++|+.+||..||.+|+|++|.|+-
T Consensus 268 p~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 268 PQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 0 0011222357889999999999999999999953
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=276.79 Aligned_cols=242 Identities=26% Similarity=0.341 Sum_probs=187.9
Q ss_pred CCccEEeeeC----CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|.++ .+..+++|.++... ......+.+|+..++.++||||+++++++..+...++||||+++++|.+++
T Consensus 18 fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 97 (266)
T cd05064 18 FGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL 97 (266)
T ss_pred CCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHH
Confidence 7999999753 46789999987553 333457889999999999999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... ..+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.++++|||.+......... ......++
T Consensus 98 ~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~ 171 (266)
T cd05064 98 RKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSP 171 (266)
T ss_pred HhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCc
Confidence 6532 35889999999999999999999998 999999999999999999999999987653221111 11112335
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||.+.+..++.++||||+||++|++++ |..||....... .. ......... ..+.....
T Consensus 172 ~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~----~~~~~~~~~---------~~~~~~~~ 235 (266)
T cd05064 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VI----KAVEDGFRL---------PAPRNCPN 235 (266)
T ss_pred eeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HH----HHHHCCCCC---------CCCCCCCH
Confidence 67999999988889999999999999999775 999986442221 00 011111000 01112234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+.+++.+||+.+|++|||+++|++.|+..
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 588888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=282.72 Aligned_cols=241 Identities=22% Similarity=0.288 Sum_probs=186.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+++.||+|+++.. .......+..|..+++.+ +||||+++++++.+.+..++||||+++++|..++
T Consensus 8 ~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~ 87 (329)
T cd05588 8 YAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM 87 (329)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHH
Confidence 799999995 57999999999754 233445678899999998 6999999999999999999999999999998887
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.|++.||+|||++| ++||||||+||+++.++.+||+|||++...... ........|+
T Consensus 88 ~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt 159 (329)
T cd05588 88 QRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGT 159 (329)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CCccccccCC
Confidence 543 35899999999999999999999998 999999999999999999999999998642211 1112234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcccccc--ccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSEL--GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
..|+|||++.+..++.++|+|||||++|+|++|..||....... .........+....... . .+....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~---------~p~~~~ 229 (329)
T cd05588 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R---------IPRSLS 229 (329)
T ss_pred ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C---------CCCCCC
Confidence 99999999998889999999999999999999999996432221 11111111111111110 0 011122
Q ss_pred HHHHHHHhhcccCCCCCCCC------HHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPT------MSSVVV 259 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs------~~eil~ 259 (308)
..+.+++.+||+.||++|+| ++++++
T Consensus 230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 35788999999999999998 567663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=274.70 Aligned_cols=243 Identities=29% Similarity=0.434 Sum_probs=190.3
Q ss_pred CCccEEeeeC----CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+|+++ +...+++|.+.... ......+..|+.+++.++|+||+++++++..++..+++|||+++++|.+++
T Consensus 17 ~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~ 96 (266)
T cd05033 17 FGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL 96 (266)
T ss_pred cceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHH
Confidence 7999999874 24689999886543 334567888999999999999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... ..+++..++.++.|++.+++|||+++ ++|+||+|+||++++++.++|+|||++..+.............++
T Consensus 97 ~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 171 (266)
T cd05033 97 REND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171 (266)
T ss_pred Hhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCC
Confidence 6533 25889999999999999999999997 999999999999999999999999999876522222112222345
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||.+.+..++.++||||||+++|+|++ |..||........ .......... ..+.....
T Consensus 172 ~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~---------~~~~~~~~ 235 (266)
T cd05033 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-------IKAVEDGYRL---------PPPMDCPS 235 (266)
T ss_pred ccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-------HHHHHcCCCC---------CCCCCCCH
Confidence 68999999988889999999999999999997 8888854322210 0111000000 00112234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+.+++.+||+.+|++||++++|++.|+..
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 588999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=273.38 Aligned_cols=239 Identities=27% Similarity=0.417 Sum_probs=188.5
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||.++..++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+....+++|||+.+++|.+++.....
T Consensus 17 ~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~ 95 (256)
T cd05113 17 FGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK 95 (256)
T ss_pred cceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC
Confidence 689999998777789999886443 3346788999999999999999999999998889999999999999998865322
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
.+++..++.++.||+.||+|||+.| ++|+||+|+||+++.++.+||+|||.+.......... .....++..|+|
T Consensus 96 --~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~~ 169 (256)
T cd05113 96 --RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSP 169 (256)
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee-cCCCccChhhCC
Confidence 5899999999999999999999998 9999999999999999999999999987654322111 111234567999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||...+..++.++||||||+++|+|++ |..||....... ..... ....... ........+.++
T Consensus 170 pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~-~~~~~~~---------~~~~~~~~~~~l 233 (256)
T cd05113 170 PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------TVEKV-SQGLRLY---------RPHLASEKVYAI 233 (256)
T ss_pred HHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHH-hcCCCCC---------CCCCCCHHHHHH
Confidence 999988888999999999999999998 888885433211 00011 1110000 001123468889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhh
Q 021771 240 GLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~ 262 (308)
+.+||+.+|++|||+.+|++.|+
T Consensus 234 i~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 234 MYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHHHhhC
Confidence 99999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.08 Aligned_cols=235 Identities=20% Similarity=0.196 Sum_probs=185.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .......+..|+.+++.++||||+++++++.++...++||||+++++|..++.
T Consensus 8 ~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~ 87 (325)
T cd05594 8 FGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 87 (325)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 799999985 68999999998654 22344567789999999999999999999999999999999999999988874
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. ..+++..+..++.||+.||+|||+ .| ++|+||||+||+++.++.+||+|||++........ ......|+
T Consensus 88 ~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt 159 (325)
T cd05594 88 RE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGT 159 (325)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCC
Confidence 43 358999999999999999999997 66 99999999999999999999999999875422211 12224588
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||........ ..... .... . . +......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i~-~~~~-~-----~----p~~~~~~ 222 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELIL-MEEI-R-----F----PRTLSPE 222 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHHh-cCCC-C-----C----CCCCCHH
Confidence 999999999888899999999999999999999999864332210 01100 0000 0 0 1112235
Q ss_pred HHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021771 236 FIHIGLLCVQADSADRP-----TMSSVVVM 260 (308)
Q Consensus 236 l~~li~~cl~~~p~~RP-----s~~eil~~ 260 (308)
+.+++.+||+.||++|+ ++.++++.
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 78889999999999996 89999853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=273.19 Aligned_cols=241 Identities=30% Similarity=0.431 Sum_probs=191.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+|...+++.|++|.+.... ...+.+.+|+.+++.++|+||+++++.+.+.+..+++|||+++++|.+++... .
T Consensus 19 ~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~ 96 (261)
T cd05072 19 FGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD-E 96 (261)
T ss_pred CceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh-c
Confidence 689999998888999999875432 34578899999999999999999999999999999999999999999988653 2
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++.......... .....++..|+|
T Consensus 97 ~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~a 172 (261)
T cd05072 97 GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA-REGAKFPIKWTA 172 (261)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec-cCCCccceecCC
Confidence 345888899999999999999999997 9999999999999999999999999998764322211 112234567999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||...+..++.++||||||+++|+|++ |..||....... ............ ........+.++
T Consensus 173 PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~~~~~~~l 236 (261)
T cd05072 173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGYRMP---------RMENCPDELYDI 236 (261)
T ss_pred HHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCCCHHHHHH
Confidence 999888888999999999999999998 888985432211 011111110000 001122458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||..+|++|||++++++.|+.
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=282.42 Aligned_cols=234 Identities=24% Similarity=0.299 Sum_probs=181.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHH---hcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLI---AKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||++.. .+|+.||+|+++... ....+.+..|..++ +.++||||+++++++.+.+..++||||+++++|..
T Consensus 12 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~ 91 (324)
T cd05589 12 FGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMM 91 (324)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHH
Confidence 789999985 579999999986442 23345666676655 45679999999999999999999999999999988
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
.+.. ..+++..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++....... .......
T Consensus 92 ~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~ 162 (324)
T cd05589 92 HIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFC 162 (324)
T ss_pred Hhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--Ccccccc
Confidence 7732 35899999999999999999999998 9999999999999999999999999986532211 1122346
Q ss_pred cccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
|+..|+|||++.+..++.++|||||||++|+|++|..||....... ...... .... . .+....
T Consensus 163 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~i~-~~~~------~----~p~~~~ 225 (324)
T cd05589 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIV-NDEV------R----YPRFLS 225 (324)
T ss_pred cCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCC------C----CCCCCC
Confidence 7899999999988889999999999999999999999986443221 011111 1000 0 011123
Q ss_pred HHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRP-----TMSSVVVM 260 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RP-----s~~eil~~ 260 (308)
..+.+++.+||+.||++|| ++.++++.
T Consensus 226 ~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 226 REAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 3578899999999999999 57777653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=279.64 Aligned_cols=234 Identities=20% Similarity=0.368 Sum_probs=192.3
Q ss_pred CCccEEee-eCCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.|-++. +..|+.||||.+.+. +..+.-.+.+|+++|..|+||||+.+|++|++.+...+||||..+|.|.+++.
T Consensus 66 YGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiS 145 (668)
T KOG0611|consen 66 YGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYIS 145 (668)
T ss_pred ccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHH
Confidence 78888888 589999999998765 34455567899999999999999999999999999999999999999999995
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. +..+++.++..+++||..|+.|+|.++ ++|||+|.+|||+|.++++||+|||++..+..... -..++|++
T Consensus 146 e---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf---LqTFCGSP 216 (668)
T KOG0611|consen 146 E---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF---LQTFCGSP 216 (668)
T ss_pred H---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccH---HHHhcCCc
Confidence 4 455999999999999999999999997 99999999999999999999999999987653322 23468999
Q ss_pred CccCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 157 GYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 157 ~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
.|.+||++++.+| .+..|-||||+++|-|+.|.-||+..+-.. + ..++ .++...+ + +...+
T Consensus 217 LYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---l---vrQI-s~GaYrE---P--------~~PSd 278 (668)
T KOG0611|consen 217 LYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---L---VRQI-SRGAYRE---P--------ETPSD 278 (668)
T ss_pred ccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---H---HHHh-hcccccC---C--------CCCch
Confidence 9999999999876 578999999999999999999997553321 1 1111 1111111 1 11123
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHh
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L 261 (308)
..-||+|||..||+.|.|+++|..-.
T Consensus 279 A~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 279 ASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHHHHHHhcCcccchhHHHHhhhh
Confidence 56688899999999999999998653
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=287.99 Aligned_cols=241 Identities=18% Similarity=0.261 Sum_probs=182.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+++.||+|++.... ......+..|+.+++.++|+||+++++++.+...+++||||+++++|.+++.
T Consensus 14 ~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~ 93 (381)
T cd05626 14 FGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI 93 (381)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH
Confidence 799999985 689999999986542 2344578899999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc----------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE---------- 146 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~---------- 146 (308)
.. ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.++|+|||++..+......
T Consensus 94 ~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~ 167 (381)
T cd05626 94 RM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIR 167 (381)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccccccccc
Confidence 43 34889999999999999999999998 999999999999999999999999987543110000
Q ss_pred -----------------------------------cccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcC
Q 021771 147 -----------------------------------ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN 191 (308)
Q Consensus 147 -----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 191 (308)
.......|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~P 247 (381)
T cd05626 168 QDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247 (381)
T ss_pred ccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCC
Confidence 001124688999999999888899999999999999999999999
Q ss_pred CCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhh--cccCCCCCCCCHHHHHHH
Q 021771 192 TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL--CVQADSADRPTMSSVVVM 260 (308)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPs~~eil~~ 260 (308)
|........ ............... . .....++.+|+.+ |+..++..||++.++++.
T Consensus 248 f~~~~~~~~------~~~i~~~~~~~~~~~----~---~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 248 FLAPTPTET------QLKVINWENTLHIPP----Q---VKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CcCCCHHHH------HHHHHccccccCCCC----C---CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 965432211 011100000000000 0 0112346666666 455566679999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=283.58 Aligned_cols=230 Identities=24% Similarity=0.255 Sum_probs=178.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHH-HHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVT-LIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+++. .+|+.||+|++.... ......+..|.. +++.++||||+++++.+.+.+..++||||+++++|..++
T Consensus 8 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l 87 (323)
T cd05575 8 FGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHL 87 (323)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHH
Confidence 799999996 589999999986432 222334444444 567899999999999999999999999999999999888
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.||+.||+|||++| ++||||||+||+++.++.+||+|||++...... ........|+
T Consensus 88 ~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt 159 (323)
T cd05575 88 QRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGT 159 (323)
T ss_pred Hhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccccCC
Confidence 542 35889999999999999999999998 999999999999999999999999998653211 1122234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||....... ....... .. .. . .......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~-~~-~~-----~----~~~~~~~ 222 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILN-KP-LR-----L----KPNISVS 222 (323)
T ss_pred hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHc-CC-CC-----C----CCCCCHH
Confidence 99999999988889999999999999999999999986432211 1111111 00 00 0 0111345
Q ss_pred HHHHHhhcccCCCCCCCCHH
Q 021771 236 FIHIGLLCVQADSADRPTMS 255 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~ 255 (308)
+.+++.+||+.||++||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCC
Confidence 78899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=279.76 Aligned_cols=249 Identities=21% Similarity=0.267 Sum_probs=182.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.++...++||||+. ++|.+++...
T Consensus 18 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~ 96 (303)
T cd07869 18 YATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKH 96 (303)
T ss_pred CEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhC
Confidence 789999996 479999999986543 2233467789999999999999999999999999999999996 5676666443
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+++..+..++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++........ ......++..|
T Consensus 97 --~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y 169 (303)
T cd07869 97 --PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWY 169 (303)
T ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCC
Confidence 234888999999999999999999998 99999999999999999999999999876432211 11224568899
Q ss_pred cCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh---cccccc-----cccc-cc---c
Q 021771 159 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC---EGEALE-----LMEP-VL---K 225 (308)
Q Consensus 159 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~-----~~~~-~~---~ 225 (308)
+|||++.+ ..++.++|||||||++|+|++|..||........ .......... ...+.. ...+ .. .
T Consensus 170 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (303)
T cd07869 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYS 247 (303)
T ss_pred CChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhccccccccccccC
Confidence 99998765 4578899999999999999999999975422110 0000000000 000000 0000 00 0
Q ss_pred ccchH------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 226 QSCVA------AELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 226 ~~~~~------~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..... .....+.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 248 PKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 01235778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=278.75 Aligned_cols=246 Identities=27% Similarity=0.433 Sum_probs=192.3
Q ss_pred CCccEEeee------CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||++.. .++..+++|.+..........+.+|+.+++.++|+||+++++++..+...++||||+++++|.++
T Consensus 18 ~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 97 (288)
T cd05093 18 FGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97 (288)
T ss_pred CeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHH
Confidence 789999874 23567899988766555667889999999999999999999999999999999999999999999
Q ss_pred hhcCC----------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCC
Q 021771 75 LFDST----------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQ 144 (308)
Q Consensus 75 l~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~ 144 (308)
+.... ....+++..++.++.|++.+|+|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 98 i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 174 (288)
T cd05093 98 LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 174 (288)
T ss_pred HHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCc
Confidence 86432 1234899999999999999999999998 9999999999999999999999999987653322
Q ss_pred CccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccc
Q 021771 145 SEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 145 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... . ............
T Consensus 175 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~----~~~i~~~~~~~~---- 243 (288)
T cd05093 175 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V----IECITQGRVLQR---- 243 (288)
T ss_pred eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCcCCC----
Confidence 2222222334678999999988889999999999999999998 888875433211 0 011111111111
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
... ....+.+|+.+||+.+|.+|||+.++++.|+...
T Consensus 244 -~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 244 -PRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred -CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 011 1235889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=272.29 Aligned_cols=243 Identities=34% Similarity=0.470 Sum_probs=193.9
Q ss_pred CCccEEeeeC-C---CCEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-D---GKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~---g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||.++.. + +..+++|.+...... ....+.+|+..++.++|+||+++++++.+....++||||+++++|.+++
T Consensus 8 ~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 87 (262)
T cd00192 8 FGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYL 87 (262)
T ss_pred ceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHH
Confidence 7899999964 3 899999998765433 3678899999999999999999999999988999999999999999998
Q ss_pred hcCCC------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc
Q 021771 76 FDSTR------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 76 ~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
..... ...+++..++.++.|++.||++||++| ++|+||+|+||+++.++.++|+|||.+............
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 164 (262)
T cd00192 88 RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK 164 (262)
T ss_pred hhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccc
Confidence 66421 256999999999999999999999998 999999999999999999999999999876543322222
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ......... ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~-~~~~~~~~~---------~~ 228 (262)
T cd00192 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VL-EYLRKGYRL---------PK 228 (262)
T ss_pred cCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HH-HHHHcCCCC---------CC
Confidence 33456778999999888889999999999999999998 588886542211 11 111111110 11
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112346888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=276.71 Aligned_cols=244 Identities=28% Similarity=0.444 Sum_probs=188.3
Q ss_pred CCccEEeee-----CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-----ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|+. .+++.+++|.+.... ......+.+|+.+++.++|+||+++++++......++||||+++++|.++
T Consensus 18 ~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 97 (283)
T cd05090 18 FGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEF 97 (283)
T ss_pred CcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHH
Confidence 799999984 356889999986433 33346788999999999999999999999999999999999999999998
Q ss_pred hhcCCC--------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeee
Q 021771 75 LFDSTR--------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIF 140 (308)
Q Consensus 75 l~~~~~--------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~ 140 (308)
+..... ...+++..+..++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++...
T Consensus 98 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (283)
T cd05090 98 LIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREI 174 (283)
T ss_pred HHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccc
Confidence 853211 234788889999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccc
Q 021771 141 GGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALEL 219 (308)
Q Consensus 141 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (308)
.............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~- 246 (283)
T cd05090 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VI----EMVRKRQLLP- 246 (283)
T ss_pred cCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCCcCC-
Confidence 43322222222334567999999988888999999999999999998 888875322110 00 1111111110
Q ss_pred ccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 220 MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
.+......+.+++.+||+.+|++||++.+|++.|..
T Consensus 247 --------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 247 --------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 011122357888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=283.22 Aligned_cols=186 Identities=26% Similarity=0.358 Sum_probs=160.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.+++|.+... .......+.+|+.+++.++|+||+++++++.+++..++||||+++++|.+++...
T Consensus 18 ~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 97 (333)
T cd06650 18 GGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 97 (333)
T ss_pred CEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHc
Confidence 789999996 47899999988654 3334567889999999999999999999999999999999999999999998543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
..+++..+..++.|++.+|.|||+.+ +++|+||||+||+++.++.+||+|||++....... .....++..|
T Consensus 98 ---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y 168 (333)
T cd06650 98 ---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSY 168 (333)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccc
Confidence 34888999999999999999999752 39999999999999999999999999987543221 1224578899
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCcc
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 195 (308)
+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 169 ~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999998888999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=289.59 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=190.3
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+|+.. .+..||||++.... ....+.+.+|+.+|+++. ||||+++++++.+....++|||||++++|.
T Consensus 50 fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~ 129 (400)
T cd05105 50 FGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLV 129 (400)
T ss_pred CceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHH
Confidence 7999999742 24579999986443 334567889999999996 999999999999999999999999999999
Q ss_pred hHhhcCCC------------------------------------------------------------------------
Q 021771 73 VFLFDSTR------------------------------------------------------------------------ 80 (308)
Q Consensus 73 ~~l~~~~~------------------------------------------------------------------------ 80 (308)
+++.....
T Consensus 130 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (400)
T cd05105 130 NYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYD 209 (400)
T ss_pred HHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCccc
Confidence 88764311
Q ss_pred ---------------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 81 ---------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 81 ---------------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
...+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 210 ~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~ 286 (400)
T cd05105 210 RPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARD 286 (400)
T ss_pred ccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCccee
Confidence 123777888999999999999999997 99999999999999999999999999987
Q ss_pred eCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccc
Q 021771 140 FGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALE 218 (308)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (308)
..............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ............
T Consensus 287 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~~~~~~~~~~~~- 359 (400)
T cd05105 287 IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------TFYNKIKSGYRM- 359 (400)
T ss_pred ccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------HHHHHHhcCCCC-
Confidence 543322222223345678999999988889999999999999999997 888885432111 001111111000
Q ss_pred cccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 219 LMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
.........+.+++.+||+.+|++|||+.+|.+.|+...
T Consensus 360 --------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 360 --------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 011122345888999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=275.76 Aligned_cols=241 Identities=23% Similarity=0.285 Sum_probs=187.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||++.. .+|+.+|+|.+.... ....+.+..|+.+++.++|+||+++.+++..+...++||||+++++|...+.
T Consensus 6 ~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~ 85 (280)
T cd05608 6 FGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIY 85 (280)
T ss_pred ceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHH
Confidence 799999985 589999999986432 2233566789999999999999999999999999999999999999988775
Q ss_pred cC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. .....+++..++.++.||+.||+|||++| ++|+||+|+||+++.++.++|+|||++..+...... .....++
T Consensus 86 ~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~ 160 (280)
T cd05608 86 NVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGT 160 (280)
T ss_pred hccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCC
Confidence 43 23346899999999999999999999998 999999999999999999999999999775433221 2234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||.+.+..++.++||||+|+++|+|++|..||......... ........ ... ...+......
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~-~~~----------~~~~~~~~~~ 227 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRIL-NDS----------VTYPDKFSPA 227 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhc-ccC----------CCCcccCCHH
Confidence 8999999999888999999999999999999999998643222110 00000000 000 0111122345
Q ss_pred HHHHHhhcccCCCCCCC-----CHHHHHH
Q 021771 236 FIHIGLLCVQADSADRP-----TMSSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RP-----s~~eil~ 259 (308)
+.+++.+||+.||++|| |++++++
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 78888999999999999 6777875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=274.66 Aligned_cols=240 Identities=23% Similarity=0.274 Sum_probs=185.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.+|+|.+.... .........|+++++.++||||+++++++.++...++||||+++++|.+++.
T Consensus 6 ~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~ 85 (277)
T cd05607 6 FGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIY 85 (277)
T ss_pred ceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHH
Confidence 799999985 579999999986432 1223345669999999999999999999999999999999999999988875
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ....+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++....... ......++.
T Consensus 86 ~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~ 158 (277)
T cd05607 86 NV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTN 158 (277)
T ss_pred hc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCC
Confidence 43 2334888999999999999999999998 9999999999999999999999999988764322 122345788
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||........ ......... ..... . . ......++
T Consensus 159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~~~-~----~----~~~~~~~~ 226 (277)
T cd05607 159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL-EDEVK-F----E----HQNFTEES 226 (277)
T ss_pred CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh-ccccc-c----c----cccCCHHH
Confidence 99999999888899999999999999999999999864322111 001111111 00000 0 0 01123357
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+|+.+||+.||++||+++|+++
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchh
Confidence 88999999999999999977664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=269.80 Aligned_cols=254 Identities=22% Similarity=0.255 Sum_probs=191.0
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCcC-ccceeeeEEeCC------eEEEEEEecCCCC
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKN-LVRLFGCCLEEN------ESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~ 70 (308)
||+||+|+ ..+|+.||+|++.-... .......+|+.+|++++|+| |+.+++++.+.+ .+++|+||+ ..+
T Consensus 24 yg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~D 102 (323)
T KOG0594|consen 24 YGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRD 102 (323)
T ss_pred ceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-ccc
Confidence 79999999 47899999999865433 23345679999999999999 999999999877 789999999 459
Q ss_pred hhhHhhcCCCc-cccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc
Q 021771 71 LDVFLFDSTRS-VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 71 L~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
|..++...... ..++...+..+++||+.||+|||+++ |+||||||.||+|+++|.+||+|||+++.+.-.... .
T Consensus 103 L~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--y 177 (323)
T KOG0594|consen 103 LKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--Y 177 (323)
T ss_pred HHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCccc--c
Confidence 99998765422 34777889999999999999999998 999999999999999999999999999865422222 2
Q ss_pred ceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccc-----ccc
Q 021771 150 NRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELM-----EPV 223 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~ 223 (308)
..-+.|.+|+|||++.+. .|+...||||+||++++|+++++.|...........+...........++... +..
T Consensus 178 t~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~ 257 (323)
T KOG0594|consen 178 TPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAP 257 (323)
T ss_pred cccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccccccc
Confidence 334668899999999886 79999999999999999999999987665532211111111111111111111 100
Q ss_pred ccc-----cch---HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 224 LKQ-----SCV---AAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 224 ~~~-----~~~---~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
... ... ........+++.+||+.+|.+|.|++..++.
T Consensus 258 f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 258 FPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 000 0111357889999999999999999999975
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=283.81 Aligned_cols=229 Identities=25% Similarity=0.326 Sum_probs=181.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+++. .+++.||+|++... .......+..|..++..+ +||||+++++++.+.+..++||||+++++|..++
T Consensus 8 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i 87 (320)
T cd05590 8 FGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI 87 (320)
T ss_pred CeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHH
Confidence 799999996 57899999998643 233455667888888877 6999999999999999999999999999999888
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.|++.||+|||++| ++||||||+||+++.++.++|+|||++....... .......|+
T Consensus 88 ~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt 159 (320)
T cd05590 88 QKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGT 159 (320)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccC
Confidence 543 34899999999999999999999998 9999999999999999999999999987542221 112234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||....... ...... ..... .+......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~-~~~~~----------~~~~~~~~ 222 (320)
T cd05590 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAIL-NDEVV----------YPTWLSQD 222 (320)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHh-cCCCC----------CCCCCCHH
Confidence 99999999988889999999999999999999999996443221 111111 11000 01112335
Q ss_pred HHHHHhhcccCCCCCCCCH
Q 021771 236 FIHIGLLCVQADSADRPTM 254 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~ 254 (308)
+.+++.+||+.||++||++
T Consensus 223 ~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHcccCHHHCCCC
Confidence 7889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=282.42 Aligned_cols=236 Identities=21% Similarity=0.223 Sum_probs=180.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHH-HHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEV-TLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||+|++.... ......+..|. .+++.++|+||+++++++.+.+..++||||+++++|...+
T Consensus 8 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 87 (321)
T cd05603 8 FGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHL 87 (321)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHH
Confidence 799999996 578999999986432 22233444454 4678899999999999999999999999999999998877
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. ...+++..+..++.||+.||.|||++| ++||||||+||+++.++.+||+|||++....... .......|+
T Consensus 88 ~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt 159 (321)
T cd05603 88 QR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGT 159 (321)
T ss_pred HH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--CccccccCC
Confidence 43 235888999999999999999999998 9999999999999999999999999987532111 112234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||.+.+..++.++|||||||++|+|++|..||....... ...... .... ..+......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~-~~~~----------~~~~~~~~~ 222 (321)
T cd05603 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNIL-HKPL----------QLPGGKTVA 222 (321)
T ss_pred cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHh-cCCC----------CCCCCCCHH
Confidence 99999999988889999999999999999999999986432211 111111 1000 011112335
Q ss_pred HHHHHhhcccCCCCCCCCHH-HHHHHh
Q 021771 236 FIHIGLLCVQADSADRPTMS-SVVVML 261 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~-eil~~L 261 (308)
+.+++.+||+.+|++||++. ++++.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~~~ 249 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAKADFLEIK 249 (321)
T ss_pred HHHHHHHHccCCHhhcCCCCCCHHHHh
Confidence 78899999999999999864 333433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=289.23 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=208.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.|+++.. .+++.+|||++++. ..++.+..+.|..++.... ||.++.++.+|+...++|+||||+.||++..+.
T Consensus 381 FGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~ 460 (694)
T KOG0694|consen 381 FGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI 460 (694)
T ss_pred CceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEE
Confidence 899999996 57999999999876 4677888999999998885 999999999999999999999999999955443
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
....+++.++..++..|+.||.|||++| |++||||.+|||+|.+|.+||+|||+++..-. ....+..+.||
T Consensus 461 ----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~~TsTfCGT 531 (694)
T KOG0694|consen 461 ----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGDRTSTFCGT 531 (694)
T ss_pred ----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC--CCCccccccCC
Confidence 3345999999999999999999999998 99999999999999999999999999987422 23345668999
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccccc--chHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS--CVAAEL 233 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 233 (308)
+.|+|||++.+..|+.+.|.|+|||++|+|+.|+.||...+.+ ++.+.++..+ ++.-..
T Consensus 532 pey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------e~FdsI~~d~~~yP~~ls 592 (694)
T KOG0694|consen 532 PEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------EVFDSIVNDEVRYPRFLS 592 (694)
T ss_pred hhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------HHHHHHhcCCCCCCCccc
Confidence 9999999999999999999999999999999999999754433 2222222221 233344
Q ss_pred HHHHHHHhhcccCCCCCCCCH-----HHHHHH----------hhcCCCCCCCCCCCCcccCccCCCC
Q 021771 234 LKFIHIGLLCVQADSADRPTM-----SSVVVM----------LASDTVTLPQPTEPAFSVGRNVARP 285 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~-----~eil~~----------L~~~~~~~~~~~~p~~~~~~~~~~~ 285 (308)
.+.+++++++|..+|++|..+ .+|.+- |+ ....+||-.|.+..+++.++-
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~--~r~i~PPf~P~i~~~~D~snF 657 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLL--NRRIKPPFVPTIKGPEDVSNF 657 (694)
T ss_pred HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHh--hccCCCCCCcccCChhhhccc
Confidence 568888889999999999865 444421 22 256788888888877766554
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=271.77 Aligned_cols=260 Identities=20% Similarity=0.216 Sum_probs=203.7
Q ss_pred CccEEeeeC-CCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 2 ESCLQGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 2 g~v~~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
|+||+++.+ ++..+|+|++.+.. .....+.+.|-+||+.++||.++.+|..|+.++..|++||||+||+|..+++.
T Consensus 91 G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk 170 (459)
T KOG0610|consen 91 GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK 170 (459)
T ss_pred eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh
Confidence 899999975 56899999997663 33345677899999999999999999999999999999999999999998866
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCC--------------
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGN-------------- 143 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~-------------- 143 (308)
+ .+..+++..++.++..++-||+|||-.| ||.|||||+||||-++|.+-|+||.++......
T Consensus 171 Q-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~ 246 (459)
T KOG0610|consen 171 Q-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGS 246 (459)
T ss_pred C-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCC
Confidence 4 4456999999999999999999999999 999999999999999999999999986443110
Q ss_pred ------------------C-C---------------------ccccceeecccCccCchhhccCcccccccchhhhHHHH
Q 021771 144 ------------------Q-S---------------------EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183 (308)
Q Consensus 144 ------------------~-~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 183 (308)
. . ......++||..|.|||++.+...+.+.|.|+||+.+|
T Consensus 247 ~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflY 326 (459)
T KOG0610|consen 247 QPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLY 326 (459)
T ss_pred CcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHH
Confidence 0 0 01123357899999999999999999999999999999
Q ss_pred HHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCC----HHHHHH
Q 021771 184 EIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT----MSSVVV 259 (308)
Q Consensus 184 ~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs----~~eil~ 259 (308)
||+.|..||.......... .++.+.+.-.........+.+||+..|.+||++|.. |.||.+
T Consensus 327 EmLyG~TPFKG~~~~~Tl~---------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 327 EMLYGTTPFKGSNNKETLR---------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHhCCCCcCCCCchhhHH---------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 9999999997665543211 111111111111234456889999999999999998 888885
Q ss_pred H--hhcCCCCC----CCCCCCCcccCc
Q 021771 260 M--LASDTVTL----PQPTEPAFSVGR 280 (308)
Q Consensus 260 ~--L~~~~~~~----~~~~~p~~~~~~ 280 (308)
- .++..+.+ .||..|......
T Consensus 392 HpFF~gVnWaLir~~~PP~iP~~~d~~ 418 (459)
T KOG0610|consen 392 HPFFEGVNWALIRCARPPEIPKPVDGG 418 (459)
T ss_pred CccccCCChhheeccCCCcCCCccccC
Confidence 3 45554444 566666655443
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=275.02 Aligned_cols=249 Identities=20% Similarity=0.244 Sum_probs=184.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-----eEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-----ESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~ 74 (308)
||+||.|+. .+++.||||+...+.. .-..|+.+|+.++|||||++..+|.... ...+||||++. +|..+
T Consensus 37 Fg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~ 111 (364)
T KOG0658|consen 37 FGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRV 111 (364)
T ss_pred cceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHH
Confidence 899999996 5789999998754432 2247999999999999999998887532 34689999976 78887
Q ss_pred hhcC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC-CCeeeecccceeeeCCCCCcccccee
Q 021771 75 LFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 75 l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
++.. ..+..++...+.-+.+||++||+|||+.| ||||||||.|+|+|.+ |.+||+|||.|+.+-.+... ...
T Consensus 112 ~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSY 185 (364)
T KOG0658|consen 112 IRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISY 185 (364)
T ss_pred HHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeE
Confidence 7643 23456888899999999999999999997 9999999999999976 88999999999987543322 234
Q ss_pred ecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHh--------hhcc----ccccc
Q 021771 153 VGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKL--------WCEG----EALEL 219 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~--------~~~~----~~~~~ 219 (308)
..+..|+|||++.+. .|+.+.||||.|||+.||+-|++.|...........+-..... .+.. +.+++
T Consensus 186 icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~i 265 (364)
T KOG0658|consen 186 ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQI 265 (364)
T ss_pred EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCccc
Confidence 558899999998874 7999999999999999999999999775444221111110000 0000 00111
Q ss_pred ccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 220 MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
-......-.......+.++|+.++|+++|.+|.++.|++..
T Consensus 266 k~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 266 KAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11000011222334568899999999999999999999954
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=283.02 Aligned_cols=234 Identities=22% Similarity=0.251 Sum_probs=185.2
Q ss_pred CCccEEeee----CCCCEEEEEEeccC----CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL----ADGKEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~----~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||.++. .+|+.||+|++... .......+..|+.+|+.++||||+++++++..++..++||||+++++|.
T Consensus 9 ~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 88 (323)
T cd05584 9 YGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF 88 (323)
T ss_pred CeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHH
Confidence 799999874 36889999998643 2233456778999999999999999999999999999999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+++... ..+.+..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++....... ......
T Consensus 89 ~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 160 (323)
T cd05584 89 MHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTF 160 (323)
T ss_pred HHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--Cccccc
Confidence 988543 34788899999999999999999998 9999999999999999999999999987543221 112234
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.|+..|+|||++.+..++.++||||||+++|+|++|..||....... ...... .... . .+...
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~-~~~~-~---------~~~~~ 223 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKIL-KGKL-N---------LPPYL 223 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHH-cCCC-C---------CCCCC
Confidence 67899999999988888999999999999999999999986433211 111111 1100 0 01111
Q ss_pred HHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRP-----TMSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RP-----s~~eil~ 259 (308)
...+.+++.+||+.+|++|| ++.++++
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 23578899999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.75 Aligned_cols=231 Identities=22% Similarity=0.233 Sum_probs=182.7
Q ss_pred CCccEEeee----CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL----ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~----~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+++. .+|+.+|+|++.... ......+..|+.+|++++||||+++++++.+++..++||||+.+++|.++
T Consensus 9 ~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 88 (318)
T cd05582 9 FGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR 88 (318)
T ss_pred CEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHH
Confidence 789998874 368999999986542 22345677899999999999999999999999999999999999999998
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+... ..+++..+..++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++....... .......|
T Consensus 89 l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g 160 (318)
T cd05582 89 LSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCG 160 (318)
T ss_pred HHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccC
Confidence 8542 35899999999999999999999998 9999999999999999999999999987643221 11223467
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
+..|+|||.+.+..++.++|||||||++|+|++|..||....... ...... .... . .+.....
T Consensus 161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~------~~~~i~-~~~~-~---------~p~~~~~ 223 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE------TMTMIL-KAKL-G---------MPQFLSP 223 (318)
T ss_pred ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH------HHHHHH-cCCC-C---------CCCCCCH
Confidence 889999999988888999999999999999999999986432211 111111 0000 0 0111223
Q ss_pred HHHHHHhhcccCCCCCCCCHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSS 256 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~e 256 (308)
.+.+|+.+||+.||++|||+.+
T Consensus 224 ~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 224 EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHhhcCHhHcCCCCC
Confidence 5788889999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=286.03 Aligned_cols=253 Identities=21% Similarity=0.259 Sum_probs=182.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeC-----CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE-----NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+|+.||+|++... .......+.+|+.+++.++||||+++++++... ...++|||||. ++|.
T Consensus 13 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 91 (338)
T cd07859 13 YGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLH 91 (338)
T ss_pred CeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHH
Confidence 789999995 58999999998643 223445688999999999999999999988643 24799999995 5888
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC-ccccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS-EANTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 151 (308)
+++... ..+++..+..++.||+.||.|||++| ++|+||||+||+++.++.+||+|||++........ ......
T Consensus 92 ~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~ 165 (338)
T cd07859 92 QVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165 (338)
T ss_pred HHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccC
Confidence 887433 34899999999999999999999998 99999999999999999999999999876432211 111223
Q ss_pred eecccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCCCccccccccchhH--------HHHHhhhccccccccc
Q 021771 152 IVGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLS--------YTWKLWCEGEALELME 221 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 221 (308)
..++..|+|||++.+ ..++.++|||||||++|+|++|+.||............. ..............+.
T Consensus 166 ~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 245 (338)
T cd07859 166 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLS 245 (338)
T ss_pred CCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHH
Confidence 467899999998865 578899999999999999999999986543211000000 0000000000000000
Q ss_pred ---cccccc---chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 222 ---PVLKQS---CVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 222 ---~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
...... ........+.+++.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 246 SMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 000112357889999999999999999999953
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.40 Aligned_cols=245 Identities=19% Similarity=0.217 Sum_probs=180.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .+++.||+|... ...+.+|+.+|+.++||||+++++++..+...++|+|++. ++|..++...
T Consensus 105 ~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~- 176 (391)
T PHA03212 105 EGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAK- 176 (391)
T ss_pred CeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhc-
Confidence 789999985 689999999653 2346789999999999999999999999999999999995 5787777442
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..++.++.||+.||+|||++| |+||||||+||+++.++.++|+|||++....... ........|+..|+
T Consensus 177 --~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~ 250 (391)
T PHA03212 177 --RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATN 250 (391)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCC
Confidence 34889999999999999999999998 9999999999999999999999999986532211 11122346899999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCcccccccc----chhHHHHHhhh--ccc--------ccccc-----
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQ----SLLSYTWKLWC--EGE--------ALELM----- 220 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~----~~~~~~~~~~~--~~~--------~~~~~----- 220 (308)
|||++.+..++.++|||||||++|+|++|..||-........ ..+........ ... .....
T Consensus 251 aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~ 330 (391)
T PHA03212 251 APELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAK 330 (391)
T ss_pred ChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHh
Confidence 999998888999999999999999999999775332211100 00000000000 000 00000
Q ss_pred ----ccccc--ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 221 ----EPVLK--QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 221 ----~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+... .........++.+|+.+||+.||++|||++|+++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 331 KSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred ccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 0011123456889999999999999999999995
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=280.14 Aligned_cols=236 Identities=24% Similarity=0.309 Sum_probs=182.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+++.+|+|++... .......+..|+.++..+ +||||+++++++.+.+..++||||+++++|..++
T Consensus 8 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~ 87 (329)
T cd05618 8 YAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 87 (329)
T ss_pred CeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHH
Confidence 799999995 57899999998754 233445677888888777 7999999999999999999999999999998887
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.||+.||+|||++| ++||||||+||+++.++.+||+|||++....... .......|+
T Consensus 88 ~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt 159 (329)
T cd05618 88 QRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGT 159 (329)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccCC
Confidence 443 35899999999999999999999998 9999999999999999999999999987532111 112234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccc--cchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELG--QSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
..|+|||++.+..++.++|||||||++|+|++|..||........ ................ . .+....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~---------~p~~~~ 229 (329)
T cd05618 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R---------IPRSLS 229 (329)
T ss_pred ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C---------CCCCCC
Confidence 999999999988899999999999999999999999964222111 1111111111111110 0 111223
Q ss_pred HHHHHHHhhcccCCCCCCCCH
Q 021771 234 LKFIHIGLLCVQADSADRPTM 254 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~ 254 (308)
..+.+++.+||+.||++|||+
T Consensus 230 ~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 230 VKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHHhcCCHHHcCCC
Confidence 357889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=276.39 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=188.6
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+|+.. +++.+|+|++..... .....+.+|..++..++||||+++++++.+....++++||+.+++|.+
T Consensus 18 ~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~ 97 (283)
T cd05091 18 FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE 97 (283)
T ss_pred CCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHH
Confidence 7899999853 357899999875432 234678899999999999999999999999999999999999999999
Q ss_pred HhhcCC-------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeee
Q 021771 74 FLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIF 140 (308)
Q Consensus 74 ~l~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~ 140 (308)
++.... ....+++..+..++.|++.||+|||+.| ++|+||||+||++++++.+||+|||++...
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (283)
T cd05091 98 FLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREV 174 (283)
T ss_pred HHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEeccccccccc
Confidence 885321 1234788889999999999999999998 999999999999999999999999998765
Q ss_pred CCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccc
Q 021771 141 GGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALEL 219 (308)
Q Consensus 141 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (308)
.............++..|+|||...+..++.++|||||||++|+|++ |..||...... .. ..........
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~-~~~i~~~~~~-- 245 (283)
T cd05091 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV-IEMIRNRQVL-- 245 (283)
T ss_pred ccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHHcCCcC--
Confidence 43322222223345678999999888888999999999999999998 77777543221 11 1111111111
Q ss_pred ccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 220 MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
..+......+.+++.+||+.+|++||++++|++.|+.
T Consensus 246 -------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 246 -------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111223458889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=282.82 Aligned_cols=235 Identities=22% Similarity=0.273 Sum_probs=185.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||+|++... .......+..|..++..+ +||||+++++++.+.+..++||||+++++|..++
T Consensus 8 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l 87 (321)
T cd05591 8 FGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQI 87 (321)
T ss_pred CeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHH
Confidence 799999996 46899999998653 233445677888888876 7999999999999999999999999999999888
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.||+.||.|||++| ++||||||+||+++.++.++|+|||++........ ......|+
T Consensus 88 ~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt 159 (321)
T cd05591 88 QRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGT 159 (321)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccC
Confidence 543 34889999999999999999999998 99999999999999999999999999876432211 12234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||....... ...... ..... .+......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~i~-~~~~~----------~p~~~~~~ 222 (321)
T cd05591 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFESIL-HDDVL----------YPVWLSKE 222 (321)
T ss_pred ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHHHH-cCCCC----------CCCCCCHH
Confidence 99999999988889999999999999999999999996543221 111111 11100 01112235
Q ss_pred HHHHHhhcccCCCCCCC-------CHHHHHHH
Q 021771 236 FIHIGLLCVQADSADRP-------TMSSVVVM 260 (308)
Q Consensus 236 l~~li~~cl~~~p~~RP-------s~~eil~~ 260 (308)
+.+++..||+.||++|| ++.++++.
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 78889999999999999 78888744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=269.76 Aligned_cols=241 Identities=27% Similarity=0.383 Sum_probs=189.9
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++...+++.+++|.+...... ....+..|+++++.++|+||+++++++.+....++||||+++++|.+++....
T Consensus 8 ~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~ 87 (251)
T cd05041 8 FGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK 87 (251)
T ss_pred CceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC
Confidence 68999999766999999988765433 55678999999999999999999999999999999999999999999885532
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.+++.+|+|||+++ ++|+||+|+||+++.++.++|+|||++.................+..|+
T Consensus 88 --~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~ 162 (251)
T cd05041 88 --NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT 162 (251)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccC
Confidence 24788899999999999999999998 9999999999999999999999999987654222221111122345699
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
|||.+.+..++.++|+||||+++|+|++ |..||......... ....... ....+......+.+
T Consensus 163 ~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~~~~~ 226 (251)
T cd05041 163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-------ERIESGY---------RMPAPQLCPEEIYR 226 (251)
T ss_pred ChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-------HHHhcCC---------CCCCCccCCHHHHH
Confidence 9999888889999999999999999998 77887544321100 0010000 00111122346888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhh
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
++.+||+.+|++|||+.||++.|.
T Consensus 227 li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 227 LMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=287.74 Aligned_cols=240 Identities=22% Similarity=0.274 Sum_probs=189.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||+|++... .......+..|+.++..++|+||+++++++.+++..++||||+++++|.+++.
T Consensus 14 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 93 (350)
T cd05573 14 FGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLI 93 (350)
T ss_pred cEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHH
Confidence 799999996 48999999998643 22445678899999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCC------------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQ------------ 144 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~------------ 144 (308)
.. ..+++..+..++.||+.||+|||+.| ++|+||||+||+++.++.++|+|||++.......
T Consensus 94 ~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~ 167 (350)
T cd05573 94 RK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167 (350)
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccc
Confidence 54 45899999999999999999999998 9999999999999999999999999987654332
Q ss_pred ---------------CccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH
Q 021771 145 ---------------SEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK 209 (308)
Q Consensus 145 ---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~ 209 (308)
.........|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~------~~~~ 241 (350)
T cd05573 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE------TYNK 241 (350)
T ss_pred cccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH------HHHH
Confidence 0011223468899999999999899999999999999999999999986543211 1111
Q ss_pred hhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCC-HHHHHHH
Q 021771 210 LWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT-MSSVVVM 260 (308)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs-~~eil~~ 260 (308)
........... . .......+.+|+.+||+ +|++||+ ++++++.
T Consensus 242 i~~~~~~~~~p-----~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 242 IINWKESLRFP-----P--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HhccCCcccCC-----C--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11000000000 0 00023457888889997 9999999 9999974
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.40 Aligned_cols=246 Identities=21% Similarity=0.311 Sum_probs=192.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++++||+++++|.+++.
T Consensus 15 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 94 (267)
T cd08228 15 FSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIK 94 (267)
T ss_pred CeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHH
Confidence 789999995 58999999987543 23344567889999999999999999999999999999999999999998885
Q ss_pred cCC-CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ....+++..+..++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++..+...... .....++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~ 169 (267)
T cd08228 95 YFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGT 169 (267)
T ss_pred HhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhHH--HhcCCCC
Confidence 432 2345888999999999999999999998 999999999999999999999999998876433211 1223567
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||.+.+..++.++|+||+|+++|+|++|..||....... ...... ....... ..........
T Consensus 170 ~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~-~~~~~~~--------~~~~~~~~~~ 236 (267)
T cd08228 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQK-IEQCDYP--------PLPTEHYSEK 236 (267)
T ss_pred ccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHH-HhcCCCC--------CCChhhcCHH
Confidence 88999999888888999999999999999999999975332111 111111 0000000 0011223356
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+++.+||+.+|++|||+.++++.|++.
T Consensus 237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 237 LRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 88899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=275.96 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=186.5
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||.|... +++.+|+|++.... ......+.+|+.+++.++|+||+++++++.++...++||||+++++|.+
T Consensus 19 ~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 98 (277)
T cd05062 19 FGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 98 (277)
T ss_pred CCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHH
Confidence 6899988742 35789999885432 2344568899999999999999999999999999999999999999999
Q ss_pred HhhcCCC-------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 74 FLFDSTR-------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 74 ~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
++..... ...+++..+..++.|++.+|+|||+.| ++|+||||+||++++++.++|+|||++.........
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 175 (277)
T cd05062 99 YLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175 (277)
T ss_pred HHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCccee
Confidence 9865321 223577888999999999999999998 999999999999999999999999998765432222
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .............
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~~------ 242 (277)
T cd05062 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRFVMEGGLLDK------ 242 (277)
T ss_pred ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCcCCC------
Confidence 11112234678999999988889999999999999999998 678875432211 1111111111111
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+......+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 243 ---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 243 ---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11122358889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=277.62 Aligned_cols=245 Identities=29% Similarity=0.406 Sum_probs=189.9
Q ss_pred CCccEEeeeC------CCCEEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||++... +...+++|.+... .......+.+|+.+++.+ +|+||+++++++..+...+++|||+++++|.
T Consensus 25 ~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~ 104 (293)
T cd05053 25 FGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLR 104 (293)
T ss_pred cccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHH
Confidence 6899999853 2368899988654 233445688899999999 7999999999999999999999999999999
Q ss_pred hHhhcC-------------CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 73 VFLFDS-------------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 73 ~~l~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.++... .....+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.++|+|||++..
T Consensus 105 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~ 181 (293)
T cd05053 105 DFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARD 181 (293)
T ss_pred HHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccc
Confidence 998642 12346889999999999999999999997 99999999999999999999999999986
Q ss_pred eCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccc
Q 021771 140 FGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALE 218 (308)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (308)
+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ..+........
T Consensus 182 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~- 253 (293)
T cd05053 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LFKLLKEGYRM- 253 (293)
T ss_pred cccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCcC-
Confidence 543322211222234567999999888889999999999999999997 888875432211 11111111110
Q ss_pred cccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 219 LMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+......+.+|+.+||+.+|++|||+.++++.|+..
T Consensus 254 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 254 --------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11112234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=283.50 Aligned_cols=239 Identities=21% Similarity=0.256 Sum_probs=186.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||+|+++... ......+.+|+.+++.++|+||+++++++.+.+..++||||+++++|.+++.
T Consensus 14 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 93 (330)
T cd05601 14 FGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN 93 (330)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHH
Confidence 789999985 589999999986542 2345668899999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... ..+++..+..++.|++.||.|||+.| ++||||||+||+++.++.+||+|||++..+...... ......++.
T Consensus 94 ~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~ 167 (330)
T cd05601 94 RYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTP 167 (330)
T ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCc
Confidence 542 35899999999999999999999998 999999999999999999999999999876433221 122346788
Q ss_pred CccCchhhc------cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 157 GYMAPEYAM------EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 157 ~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
.|+|||++. +..++.++|||||||++|+|++|..||....... ...............+ ..
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~~~-------~~ 234 (330)
T cd05601 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFLKFPE-------DP 234 (330)
T ss_pred cccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCccCCCC-------CC
Confidence 999999886 3457789999999999999999999986432211 1111111111111000 01
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.....+.+|+..||+ +|++|||+.++++
T Consensus 235 ~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 235 KVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 123347788889998 9999999999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=274.47 Aligned_cols=244 Identities=29% Similarity=0.418 Sum_probs=190.4
Q ss_pred CCccEEeee------CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||++.. .++..+++|.+..........+.+|+++++.++|+||+++++++.+....+++|||+++++|.++
T Consensus 18 ~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 97 (280)
T cd05092 18 FGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97 (280)
T ss_pred CCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHH
Confidence 789999863 24678999988766666677899999999999999999999999999999999999999999999
Q ss_pred hhcCCC------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 75 LFDSTR------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 75 l~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
+..... ...+++..++.++.|++.|++|||+.| ++|+||+|+||++++++.++|+|||++.....
T Consensus 98 i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~ 174 (280)
T cd05092 98 LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174 (280)
T ss_pred HHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCC
Confidence 865321 134788999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELME 221 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
...........++..|+|||.+.+..++.++|||||||++|+|++ |.+||....... .. .... ......
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~---~~~~-~~~~~~--- 244 (280)
T cd05092 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AI---ECIT-QGRELE--- 244 (280)
T ss_pred CceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HH---HHHH-cCccCC---
Confidence 222121222334678999999988889999999999999999998 888874322111 00 0000 000000
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
.+......+.+++.+||+.||++||++.+|++.|+.
T Consensus 245 ------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 245 ------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 011122347888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=271.68 Aligned_cols=238 Identities=27% Similarity=0.399 Sum_probs=187.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+++.+++..+++|++.... .....+.+|+.+++.++|+||+++++++......++||||+++++|.+++.....
T Consensus 17 ~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 95 (256)
T cd05059 17 FGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG 95 (256)
T ss_pred CceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc
Confidence 689999998888899999886433 2345678899999999999999999999999999999999999999998865332
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
.+++..++.++.|++.+++|||+.| ++|+||+|+||+++.++.++|+|||++.......... .....++..|+|
T Consensus 96 --~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~ 169 (256)
T cd05059 96 --KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAP 169 (256)
T ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc-cCCCCCCccccC
Confidence 5889999999999999999999998 9999999999999999999999999987654221111 111123457999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++||||||+++|+|++ |..||....... .... ..... .. ..+......+.++
T Consensus 170 Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~-~~~~~-----~~----~~~~~~~~~~~~l 233 (256)
T cd05059 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------VVES-VSAGY-----RL----YRPKLAPTEVYTI 233 (256)
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------HHHH-HHcCC-----cC----CCCCCCCHHHHHH
Confidence 999988889999999999999999998 788886432221 0111 10100 00 0011123458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHh
Q 021771 240 GLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L 261 (308)
+.+||..+|++|||+.++++.|
T Consensus 234 i~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 234 MYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHhcCChhhCcCHHHHHHHh
Confidence 9999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=272.01 Aligned_cols=240 Identities=28% Similarity=0.407 Sum_probs=186.4
Q ss_pred CCccEEeee---CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL---ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~---~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|.+ .+++.+|+|+++... ....+.+..|+.+++.+.|+||+++++++.. ...++||||+++++|.+++
T Consensus 8 ~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l 86 (257)
T cd05116 8 FGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFL 86 (257)
T ss_pred CcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHH
Confidence 799999964 368899999986443 3345678899999999999999999998764 4678999999999999988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc-cceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN-TNRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~ 154 (308)
... ..+++..+..++.|++.||++||++| ++|+||||.||+++.++.++|+|||++........... .....+
T Consensus 87 ~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 87 QKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred Hhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 543 35889999999999999999999998 99999999999999999999999999877643322111 111233
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... .. .......... .+....
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~i~~~~~~~---------~~~~~~ 224 (257)
T cd05116 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VT----QMIESGERME---------CPQRCP 224 (257)
T ss_pred CccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHCCCCCC---------CCCCCC
Confidence 568999999888888899999999999999997 899986432221 11 1111111111 111123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
.++.+++.+||+.||++||++.+|.+.|+.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 458889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=269.66 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=194.0
Q ss_pred CCccEEeeeC-CCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++... +|+.+++|.++.. .....+.+.+|+.++++++|+||+++++.+.+++..++||||+++++|..++.
T Consensus 15 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 94 (267)
T cd08224 15 FSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK 94 (267)
T ss_pred ceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHH
Confidence 6899999965 8999999988532 23345678899999999999999999999999999999999999999999886
Q ss_pred cC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. .....+++..++.++.+++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++..+...... .....++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~ 169 (267)
T cd08224 95 HFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGT 169 (267)
T ss_pred HhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCC
Confidence 53 23445899999999999999999999998 999999999999999999999999998775433221 1223567
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...... .......... ........
T Consensus 170 ~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~~~~--------~~~~~~~~ 236 (267)
T cd08224 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEKCDYPPL--------PADHYSEE 236 (267)
T ss_pred ccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh-hhhcCCCCCC--------ChhhcCHH
Confidence 8899999988888899999999999999999999998543211 000000 0001101000 01123346
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+++.+||..+|++|||+.+|++.|+..
T Consensus 237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 237 LRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 88899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=286.81 Aligned_cols=231 Identities=26% Similarity=0.381 Sum_probs=190.0
Q ss_pred CccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCc
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRS 81 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 81 (308)
|.||.|++ .++.||||+++. .-..+++-|++|+|+||+.+.++|....-+|||||||..|.|..+++. +
T Consensus 138 GAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka---~ 206 (904)
T KOG4721|consen 138 GAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA---G 206 (904)
T ss_pred cceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc---c
Confidence 78999998 567899998742 223578889999999999999999999999999999999999999954 4
Q ss_pred cccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCc
Q 021771 82 VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAP 161 (308)
Q Consensus 82 ~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 161 (308)
..+.......|..+|+.++.|||.+- |+|||||.-||||+.+..|||+|||.++..... ...-.+.||..||||
T Consensus 207 ~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAP 280 (904)
T KOG4721|consen 207 RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAP 280 (904)
T ss_pred CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCH
Confidence 45888999999999999999999995 999999999999999999999999998876433 222336789999999
Q ss_pred hhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHh
Q 021771 162 EYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGL 241 (308)
Q Consensus 162 E~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (308)
|++.+.+.+.|.||||+|||||+|++|..||...+.... +...=...+.-..+..+...|.-|++
T Consensus 281 EvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------------IwGVGsNsL~LpvPstcP~GfklL~K 345 (904)
T KOG4721|consen 281 EVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------------IWGVGSNSLHLPVPSTCPDGFKLLLK 345 (904)
T ss_pred HHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---------------EEeccCCcccccCcccCchHHHHHHH
Confidence 999999999999999999999999999999865443321 00111122222334455556888888
Q ss_pred hcccCCCCCCCCHHHHHHHhhcC
Q 021771 242 LCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 242 ~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+||+..|.+|||+++|+.-|.--
T Consensus 346 qcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 346 QCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred HHHhcCCCCCccHHHHHHHHhhc
Confidence 99999999999999999988643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=283.49 Aligned_cols=250 Identities=20% Similarity=0.259 Sum_probs=193.3
Q ss_pred CCccEEeeeC-C-CCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-D-GKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~-g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++.. + +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+++
T Consensus 43 ~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i 122 (340)
T PTZ00426 43 FGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL 122 (340)
T ss_pred CeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 7999999853 3 468999988543 2334567889999999999999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.|++.||.|||++| ++||||||+||+++.++.++|+|||++...... .....|+
T Consensus 123 ~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt 191 (340)
T PTZ00426 123 RRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGT 191 (340)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCC
Confidence 543 34889999999999999999999998 999999999999999999999999999875422 1234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||....... ..... ..... . +. . .....
T Consensus 192 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i-~~~~~-~-~p----~----~~~~~ 254 (340)
T PTZ00426 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKI-LEGII-Y-FP----K----FLDNN 254 (340)
T ss_pred hhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHH-hcCCC-C-CC----C----CCCHH
Confidence 99999999988888999999999999999999999996432211 11111 11110 0 00 1 11234
Q ss_pred HHHHHhhcccCCCCCCC-----CHHHHHHH--hhcC------CCCCCCCCCCCccc
Q 021771 236 FIHIGLLCVQADSADRP-----TMSSVVVM--LASD------TVTLPQPTEPAFSV 278 (308)
Q Consensus 236 l~~li~~cl~~~p~~RP-----s~~eil~~--L~~~------~~~~~~~~~p~~~~ 278 (308)
+.+++.+||+.+|++|+ |++++++. +... ...++.|..|....
T Consensus 255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred HHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 67888999999999995 89998864 2211 23445566665543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=278.00 Aligned_cols=240 Identities=21% Similarity=0.256 Sum_probs=184.1
Q ss_pred CCccEEeee----CCCCEEEEEEeccC----CcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL----ADGKEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~----~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
||.||+++. .+|+.||+|++... .....+.+..|+.+++.++ |++|+++++++..++..++||||+++++|
T Consensus 13 ~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 92 (332)
T cd05614 13 YGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEM 92 (332)
T ss_pred CEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcH
Confidence 789999874 36899999998643 2233456788999999995 99999999999999999999999999999
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++... ..+++..+..++.||+.||+|||++| ++||||||+|||++.++.+||+|||++..+...... ....
T Consensus 93 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~ 165 (332)
T cd05614 93 FTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYS 165 (332)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-cccc
Confidence 9988543 34899999999999999999999998 999999999999999999999999998765332221 1223
Q ss_pred eecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 152 IVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
..|+..|+|||++.+. .++.++|||||||++|+|++|..||.......... ......... +... +.
T Consensus 166 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~~-------~~~~----~~ 232 (332)
T cd05614 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILKC-------DPPF----PS 232 (332)
T ss_pred ccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhcC-------CCCC----CC
Confidence 4688999999988764 47889999999999999999999986432221111 111111100 0001 11
Q ss_pred HHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021771 231 AELLKFIHIGLLCVQADSADRP-----TMSSVVVM 260 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RP-----s~~eil~~ 260 (308)
.....+.+++.+||+.||++|| +++++++.
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1223477888999999999999 67777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.48 Aligned_cols=246 Identities=28% Similarity=0.402 Sum_probs=187.3
Q ss_pred CCccEEeee------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeC-CeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEE-NESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L 71 (308)
||.||.|.. .+++.||+|++.... ......+..|+.+++++ +|+||+++++++... ..++++|||+++++|
T Consensus 20 fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L 99 (337)
T cd05054 20 FGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNL 99 (337)
T ss_pred CceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCH
Confidence 799999863 235789999986442 23345677899999999 799999999988654 568899999999999
Q ss_pred hhHhhcCCC----------------------------------------------------------ccccChHHHHHHH
Q 021771 72 DVFLFDSTR----------------------------------------------------------SVQLDWKRRISII 93 (308)
Q Consensus 72 ~~~l~~~~~----------------------------------------------------------~~~~~~~~~~~~~ 93 (308)
.+++..... ...+++..+..++
T Consensus 100 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 179 (337)
T cd05054 100 SNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYS 179 (337)
T ss_pred HHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHH
Confidence 998854221 1257889999999
Q ss_pred HHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccCcccccc
Q 021771 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKS 173 (308)
Q Consensus 94 ~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 173 (308)
.||+.||+|||++| |+|+||||+||+++.++.++|+|||++..+.............++..|+|||++.+..++.++
T Consensus 180 ~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 256 (337)
T cd05054 180 FQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQS 256 (337)
T ss_pred HHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccc
Confidence 99999999999998 999999999999999999999999999875433222222233456789999999999999999
Q ss_pred cchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCC
Q 021771 174 DVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRP 252 (308)
Q Consensus 174 Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 252 (308)
|||||||++|+|++ |..||....... ............. .+.....++.+++.+||+.+|++||
T Consensus 257 Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 257 DVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRMR---------APEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred cHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCCC---------CCccCCHHHHHHHHHHccCChhhCc
Confidence 99999999999998 888885432211 0011111111100 0111234588899999999999999
Q ss_pred CHHHHHHHhhcC
Q 021771 253 TMSSVVVMLASD 264 (308)
Q Consensus 253 s~~eil~~L~~~ 264 (308)
++.||++.|+..
T Consensus 322 s~~ell~~l~~~ 333 (337)
T cd05054 322 TFSELVEILGDL 333 (337)
T ss_pred CHHHHHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=278.02 Aligned_cols=236 Identities=22% Similarity=0.301 Sum_probs=184.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+++.+|+|++... .....+.+..|..++..+ +|++|+.+++++.+.+..++||||+++++|..++
T Consensus 8 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 87 (327)
T cd05617 8 YAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM 87 (327)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 799999995 57899999999754 223445678899999888 5999999999999999999999999999998887
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++....... .......|+
T Consensus 88 ~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt 159 (327)
T cd05617 88 QRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGT 159 (327)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCC
Confidence 443 34899999999999999999999998 9999999999999999999999999987532111 112234688
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||......................... .+......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~p~~~~~~ 229 (327)
T cd05617 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------IPRFLSVK 229 (327)
T ss_pred cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------CCCCCCHH
Confidence 99999999988889999999999999999999999996543332222222222221111100 01112234
Q ss_pred HHHHHhhcccCCCCCCCCH
Q 021771 236 FIHIGLLCVQADSADRPTM 254 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~ 254 (308)
+.+++.+||+.||++|+++
T Consensus 230 ~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhccCHHHcCCC
Confidence 7788899999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=287.07 Aligned_cols=240 Identities=19% Similarity=0.259 Sum_probs=182.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++.... ......+.+|+.+|+.++|+||+++++.+.+++.+++|||||++++|.+++.
T Consensus 14 ~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~ 93 (376)
T cd05598 14 FGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI 93 (376)
T ss_pred CeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 799999995 579999999986432 2344668899999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC-----------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS----------- 145 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~----------- 145 (308)
.. ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.++|+|||++..+.....
T Consensus 94 ~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~ 167 (376)
T cd05598 94 RL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167 (376)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccc
Confidence 43 34888999999999999999999998 99999999999999999999999999753310000
Q ss_pred ------------------------------ccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcc
Q 021771 146 ------------------------------EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195 (308)
Q Consensus 146 ------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 195 (308)
........|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred cccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCC
Confidence 00011236889999999998888999999999999999999999999654
Q ss_pred ccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCC---CHHHHHHH
Q 021771 196 LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRP---TMSSVVVM 260 (308)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---s~~eil~~ 260 (308)
..... ............. .........+.+++.+|+ .+|++|+ |+.++++-
T Consensus 248 ~~~~~------~~~i~~~~~~~~~-------~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 248 TPAET------QLKVINWETTLHI-------PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CHHHH------HHHHhccCccccC-------CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 32211 0111000000000 000111224666777765 4999999 88888854
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.51 Aligned_cols=242 Identities=25% Similarity=0.412 Sum_probs=186.8
Q ss_pred CCccEEeee-CCCC----EEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGK----EIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|++ .+|+ .||+|+++... ......+.+|+.+++.++|+||+++++++... ..+++++|+++++|.++
T Consensus 20 ~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~ 98 (316)
T cd05108 20 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDY 98 (316)
T ss_pred CceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHH
Confidence 799999985 3444 38999986543 34456788999999999999999999998875 56899999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+.... ..++...++.++.||+.||+|||+.| ++|+||||+||+++.++.+||+|||++..+..............
T Consensus 99 l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 173 (316)
T cd05108 99 VREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173 (316)
T ss_pred HHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCcc
Confidence 86543 34788899999999999999999998 99999999999999999999999999987653322221222233
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||.+.+..++.++||||||+++|+|++ |..||+....... ........... .+....
T Consensus 174 ~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~ 237 (316)
T cd05108 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGERLP---------QPPICT 237 (316)
T ss_pred ceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCCCCC---------CCCCCC
Confidence 567999999988889999999999999999997 8999864322211 01111110000 001112
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+++.+||+.+|++|||+.+++..|...
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3578888999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=269.85 Aligned_cols=242 Identities=24% Similarity=0.369 Sum_probs=186.3
Q ss_pred CCccEEeeeC---CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+|++. .+..+|+|++.... ....+.+.+|+.++++++|+||+++++++.. ...++||||+++++|.+++.
T Consensus 8 ~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~ 86 (257)
T cd05115 8 FGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLS 86 (257)
T ss_pred cccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHH
Confidence 7999999753 45679999886553 3334678899999999999999999998864 46899999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc-cceeecc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN-TNRIVGT 155 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~ 155 (308)
.. ...+++..++.++.|++.+|.|||++| ++|+||||+||+++.++.++|+|||++........... .....++
T Consensus 87 ~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05115 87 GK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP 161 (257)
T ss_pred hC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCC
Confidence 43 235899999999999999999999998 99999999999999999999999999876543222111 1112234
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||.+.+..++.++||||||+++|++++ |..||....... . ......... ...+.....
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~---------~~~~~~~~~ 225 (257)
T cd05115 162 LKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---V----MSFIEQGKR---------LDCPAECPP 225 (257)
T ss_pred cccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---H----HHHHHCCCC---------CCCCCCCCH
Confidence 67999999888888999999999999999996 899986432211 0 011111110 111122234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 688899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=276.41 Aligned_cols=233 Identities=24% Similarity=0.276 Sum_probs=182.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||+|+++... .........|..++... +|+||+++++++.+.+..++||||+.+++|..++
T Consensus 8 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i 87 (316)
T cd05620 8 FGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI 87 (316)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHH
Confidence 799999996 479999999986531 23445667788887765 7999999999999999999999999999999888
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.|++.||+|||++| ++||||||+||+++.++.++|+|||++....... .......|+
T Consensus 88 ~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt 159 (316)
T cd05620 88 QDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGT 159 (316)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCC
Confidence 543 34889999999999999999999998 9999999999999999999999999987532111 112234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||....... . ..... .. ... . +.....+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~---~~~~~-~~-~~~-----~----~~~~~~~ 222 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---L---FESIR-VD-TPH-----Y----PRWITKE 222 (316)
T ss_pred cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHH-hC-CCC-----C----CCCCCHH
Confidence 99999999998889999999999999999999999996433211 1 11110 00 000 0 0112235
Q ss_pred HHHHHhhcccCCCCCCCCHH-HHH
Q 021771 236 FIHIGLLCVQADSADRPTMS-SVV 258 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~-eil 258 (308)
+.+|+.+||+.||++||++. +++
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 78889999999999999985 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=278.81 Aligned_cols=243 Identities=21% Similarity=0.288 Sum_probs=196.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
|..|-++++ =+|++||||++.+. +.-....+..|+..|+.++|||||++|++...+..+|||+|.=++|+|.+|+..
T Consensus 31 FAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK 110 (864)
T KOG4717|consen 31 FAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK 110 (864)
T ss_pred eehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHh
Confidence 556666763 58999999999765 334456789999999999999999999999999999999999999999999988
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC-CCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
..++ +++..+.++++||+.|+.|+|+.. +||||+||+|+.+- .-|-+||+|||++..+.... .-...+|+.
T Consensus 111 He~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~---kL~TsCGSL 182 (864)
T KOG4717|consen 111 HEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK---KLTTSCGSL 182 (864)
T ss_pred hhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc---hhhcccchh
Confidence 7665 999999999999999999999997 99999999999765 56889999999998775332 233457899
Q ss_pred CccCchhhccCccc-ccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 157 GYMAPEYAMEGLFS-VKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 157 ~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
.|.|||++.+..|+ ++.||||||+|+|+|++|++||+....... ..-+++- +-..+.-...+
T Consensus 183 AYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDC--KYtvPshvS~e 245 (864)
T KOG4717|consen 183 AYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDC--KYTVPSHVSKE 245 (864)
T ss_pred hccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcc--cccCchhhhHH
Confidence 99999999998776 678999999999999999999975443322 1112222 12234455667
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH--HhhcCCCCC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVV--MLASDTVTL 268 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~--~L~~~~~~~ 268 (308)
..+||..||..||++|.|.+||.. .|+.....+
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 888999999999999999999984 344443333
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=274.43 Aligned_cols=250 Identities=23% Similarity=0.306 Sum_probs=180.1
Q ss_pred CCccEEeee-C-CCCEEEEEEeccCC--cccHHHHHHHHHHHhcC---CCcCccceeeeEEe-----CCeEEEEEEecCC
Q 021771 1 MESCLQGKL-A-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL---QHKNLVRLFGCCLE-----ENESLLIYEYMPN 68 (308)
Q Consensus 1 ~g~v~~~~~-~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~ 68 (308)
||.||+++. . +|+.+|+|++.... ......+.+|+.+++.+ +||||+++++++.. ....++||||++
T Consensus 14 ~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~- 92 (290)
T cd07862 14 YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD- 92 (290)
T ss_pred CeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-
Confidence 799999985 3 57889999886442 22234556677777766 69999999998852 346899999996
Q ss_pred CChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc
Q 021771 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 69 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
++|.+++.... ...+++..+..++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++...... ..
T Consensus 93 ~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~ 165 (290)
T cd07862 93 QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MA 165 (290)
T ss_pred CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cc
Confidence 58888875432 335889999999999999999999998 999999999999999999999999999875432 12
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcccccccc-chhHHHHHhhhcccccc-------cc
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQ-SLLSYTWKLWCEGEALE-------LM 220 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~-------~~ 220 (308)
.....++..|+|||.+.+..++.++|||||||++|+|++|.+||......... .+.... .......+.. ..
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~ 244 (290)
T cd07862 166 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GLPGEEDWPRDVALPRQAF 244 (290)
T ss_pred cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCCChhhchhhhcccchhc
Confidence 22346788999999998888999999999999999999999998754322110 000000 0000000000 00
Q ss_pred cccc---cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 221 EPVL---KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 221 ~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.... ...........+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 00001112345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=267.71 Aligned_cols=240 Identities=27% Similarity=0.366 Sum_probs=189.0
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++...++..+++|.+..... .....+.+|+.+++.++|+||+++++++......++||||+++++|.+++....
T Consensus 8 ~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 87 (250)
T cd05085 8 FGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK 87 (250)
T ss_pred CceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC
Confidence 7899999988899999999865533 334568899999999999999999999999999999999999999999885432
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.+|.|+|++| ++|+||+|+||+++.++.++|+|||++.......... .....++..|+
T Consensus 88 --~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~ 161 (250)
T cd05085 88 --DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQIPIKWT 161 (250)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCCCCccccc
Confidence 34789999999999999999999998 9999999999999999999999999987643322111 11123356799
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
|||++.+..++.++||||||+++|++++ |..||........ . ......... ..+......+.+
T Consensus 162 aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~------~-~~~~~~~~~---------~~~~~~~~~~~~ 225 (250)
T cd05085 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA------R-EQVEKGYRM---------SCPQKCPDDVYK 225 (250)
T ss_pred CHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH------H-HHHHcCCCC---------CCCCCCCHHHHH
Confidence 9999988888999999999999999998 8888854322110 0 111111000 001112346888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhh
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
++.+||+.+|++|||+.++++.|.
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=279.80 Aligned_cols=234 Identities=25% Similarity=0.275 Sum_probs=185.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+++.||+|++... .......+..|..+++.+ +||||+++++++.+.+..++||||+++++|..++
T Consensus 8 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 87 (318)
T cd05570 8 FGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHI 87 (318)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHH
Confidence 799999996 46899999998654 233455677888888888 6999999999999999999999999999999888
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++....... .......++
T Consensus 88 ~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~ 159 (318)
T cd05570 88 QRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGT 159 (318)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--CcccceecC
Confidence 543 35899999999999999999999998 9999999999999999999999999987532111 112234578
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||....... ..... ..... . .+......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~~~i-~~~~~------~----~~~~~~~~ 222 (318)
T cd05570 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LFQSI-LEDEV------R----YPRWLSKE 222 (318)
T ss_pred ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HHHHH-HcCCC------C----CCCcCCHH
Confidence 89999999998889999999999999999999999996443211 01111 11100 0 01112345
Q ss_pred HHHHHhhcccCCCCCCCCH-----HHHHH
Q 021771 236 FIHIGLLCVQADSADRPTM-----SSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~-----~eil~ 259 (308)
+.+|+.+||+.||++|||+ .++++
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 7889999999999999999 88875
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=269.95 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=187.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+|+. .+|+.+++|++..........+.+|+.+++.++|+||+++++++..+...++||||+++++|.+++...
T Consensus 22 ~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~- 100 (267)
T cd06646 22 YGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT- 100 (267)
T ss_pred CeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-
Confidence 789999995 689999999987655455567889999999999999999999999999999999999999999988543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.++.|||+.| ++|+||+|+||+++.++.++|+|||++..+...... .....++..|+
T Consensus 101 --~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~ 173 (267)
T cd06646 101 --GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWM 173 (267)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccc--cCccccCcccc
Confidence 34889999999999999999999997 999999999999999999999999999876432211 12235678899
Q ss_pred Cchhhc---cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 160 APEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 160 aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
|||.+. ...++.++|+||+||++|+|++|..||........... ..... ...+.. .........+
T Consensus 174 ~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~---~~~~~~--~~~~~~~~~~ 241 (267)
T cd06646 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSN---FQPPKL--KDKTKWSSTF 241 (267)
T ss_pred CHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCC---CCCCCC--ccccccCHHH
Confidence 999874 34577899999999999999999999743321110000 00000 000000 0011223468
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHh
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~L 261 (308)
.+++.+||+.+|++|||+++|++.|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCC
Confidence 8899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=286.12 Aligned_cols=239 Identities=20% Similarity=0.256 Sum_probs=184.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||||++.... ......+..|+.+|+.++|+||+++++++.++...++||||+.+++|.+++.
T Consensus 14 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~ 93 (364)
T cd05599 14 FGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM 93 (364)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHH
Confidence 799999996 579999999996432 2344567889999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc---------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA--------- 147 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~--------- 147 (308)
.. ..+++..+..++.|++.||+|||++| ++||||||+||+++.++.++|+|||++..+.......
T Consensus 94 ~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 167 (364)
T cd05599 94 KK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167 (364)
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccc
Confidence 43 34899999999999999999999998 9999999999999999999999999987653211100
Q ss_pred ---------------------------ccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccc
Q 021771 148 ---------------------------NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELG 200 (308)
Q Consensus 148 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~ 200 (308)
......|++.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~- 246 (364)
T cd05599 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE- 246 (364)
T ss_pred cccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHH-
Confidence 0011358899999999988889999999999999999999999996443221
Q ss_pred cchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 021771 201 QSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT---MSSVVV 259 (308)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~eil~ 259 (308)
................ . ......+.+|+.+|+. +|.+|++ +.++++
T Consensus 247 -----~~~~i~~~~~~~~~~~-----~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 247 -----TYRKIINWKETLQFPD-----E--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred -----HHHHHHcCCCccCCCC-----C--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 1111111000000000 0 0112346778888886 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=280.78 Aligned_cols=231 Identities=23% Similarity=0.251 Sum_probs=179.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHH-HHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVT-LIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.+|+|++... .......+..|.. +++.++||||+++++++...+..++||||+++++|..++
T Consensus 8 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 87 (325)
T cd05604 8 FGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHL 87 (325)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHH
Confidence 799999985 58999999998644 1223334445544 577789999999999999999999999999999998887
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. ...+++..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++....... .......|+
T Consensus 88 ~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt 159 (325)
T cd05604 88 QR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGT 159 (325)
T ss_pred HH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcccccCC
Confidence 43 335899999999999999999999998 9999999999999999999999999987532111 122334688
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||...... ........ ... .... .....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~-~~~------~~~~----~~~~~ 222 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILH-KPL------VLRP----GASLT 222 (325)
T ss_pred hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHc-CCc------cCCC----CCCHH
Confidence 9999999999888999999999999999999999998643221 11111111 100 0001 12234
Q ss_pred HHHHHhhcccCCCCCCCCHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSS 256 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~e 256 (308)
+.+++.+||+.+|.+||++.+
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCC
Confidence 778889999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=280.05 Aligned_cols=237 Identities=23% Similarity=0.262 Sum_probs=196.5
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCc---ccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||.++.+ +|+.+|+|.+.+... ...+.+.+|+.+|+++. ||||+.+++.|++...+++|||+|.||.|.+.+
T Consensus 48 Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i 127 (382)
T KOG0032|consen 48 FGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRI 127 (382)
T ss_pred ceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHH
Confidence 8999999964 699999999976633 34578999999999998 999999999999999999999999999999999
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC----CCeeeecccceeeeCCCCCccccce
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE----MNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~----~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
... .+++..+..++.|++.+++|||+.| ++|+|+||+|+|+... +.++++|||++..... ......
T Consensus 128 ~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~ 197 (382)
T KOG0032|consen 128 VKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHT 197 (382)
T ss_pred HHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEee
Confidence 665 3999999999999999999999998 9999999999999643 4799999999998764 334556
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.+|++.|+|||++....++..+||||+|+++|.|++|.+||...........+. ..+. ......-..
T Consensus 198 ~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-------~~~~------~f~~~~w~~ 264 (382)
T KOG0032|consen 198 IVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-------RGDF------DFTSEPWDD 264 (382)
T ss_pred ecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH-------cCCC------CCCCCCccc
Confidence 789999999999998999999999999999999999999996554332211111 1111 111122223
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
....+.+++..|+..||.+|+|+.++|+-
T Consensus 265 is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 265 ISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 34568889999999999999999999983
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=274.19 Aligned_cols=256 Identities=28% Similarity=0.384 Sum_probs=187.5
Q ss_pred CCccEEee-----eCCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChh
Q 021771 1 MESCLQGK-----LADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~-----~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~ 72 (308)
||+||+++ ..++..+|+|.+.... ......+.+|+.+|+.++||||+++++++... ...+++|||+++++|.
T Consensus 17 ~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~ 96 (283)
T cd05080 17 FGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR 96 (283)
T ss_pred CcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHH
Confidence 68887754 2468899999986543 23456788999999999999999999987653 3578999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc-cce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN-TNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~-~~~ 151 (308)
+++.. ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++........... ...
T Consensus 97 ~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 169 (283)
T cd05080 97 DYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 169 (283)
T ss_pred HHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCC
Confidence 98843 24899999999999999999999998 99999999999999999999999999886543221111 111
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..++..|+|||...+..++.++||||||+++|+|++|..|+........ ................+..+.......+..
T Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (283)
T cd05080 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGMRLPCPKN 248 (283)
T ss_pred CCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCCCCCCCCC
Confidence 2345569999998888889999999999999999999999754322110 000000000000001111111111111122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
....+.+++.+||+.+|++|||+++|++.|+..
T Consensus 249 ~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 249 CPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 234688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=274.72 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=187.2
Q ss_pred CCccEEeee-----CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe--CCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 73 (308)
||.||.+.. .+++.|++|.+..........+.+|+.+++.++|+||+++++++.. ....++||||+++++|.+
T Consensus 17 ~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 96 (284)
T cd05081 17 FGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD 96 (284)
T ss_pred CceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHH
Confidence 789999874 3688999999876665556788999999999999999999998754 346899999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-cccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-NTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~ 152 (308)
++... ...+++..++.++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++.......... .....
T Consensus 97 ~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 171 (284)
T cd05081 97 YLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG 171 (284)
T ss_pred HHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCC
Confidence 98543 234889999999999999999999998 9999999999999999999999999998754322111 11111
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.++..|+|||.+.+..++.++||||||+++|+|++|..++.........................+.+............
T Consensus 172 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (284)
T cd05081 172 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGC 251 (284)
T ss_pred CCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCC
Confidence 23446999999988889999999999999999999877654322110000000000000000000000000000001112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
...+.+|+.+||+.+|++|||+.+|++.|+..
T Consensus 252 ~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 252 PAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 34588899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=294.84 Aligned_cols=241 Identities=23% Similarity=0.289 Sum_probs=189.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC--------eEEEEEEecCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN--------ESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~ 69 (308)
||+||+++. .+|+.||||++... .......+.+|+.++..++|+||+++++.+.... .+++||||++++
T Consensus 45 fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~g 124 (496)
T PTZ00283 45 TGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAG 124 (496)
T ss_pred CEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCC
Confidence 799999984 68999999998654 3344567889999999999999999988775432 368999999999
Q ss_pred ChhhHhhcCC-CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc
Q 021771 70 SLDVFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 70 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
+|.+++.... ....+++..+..++.|++.+|.|||+.| |+||||||+||+++.++.+||+|||+++.+........
T Consensus 125 sL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~ 201 (496)
T PTZ00283 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201 (496)
T ss_pred cHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccc
Confidence 9999886532 2346899999999999999999999998 99999999999999999999999999987653322222
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||...... ....... .... .+ .
T Consensus 202 ~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~-~~~~----~~-----~ 265 (496)
T PTZ00283 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTL-AGRY----DP-----L 265 (496)
T ss_pred cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHh-cCCC----CC-----C
Confidence 33456889999999999888999999999999999999999999643221 1111111 0100 00 1
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+......+.+++.+||+.+|++|||+.++++.
T Consensus 266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11123458889999999999999999999853
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=272.88 Aligned_cols=240 Identities=23% Similarity=0.273 Sum_probs=187.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++.. .+++.||+|++.... ......+.+|+.+++.++|+||+++++.+.+++..++||||+.+++|.+++.
T Consensus 13 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 92 (285)
T cd05605 13 FGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 92 (285)
T ss_pred CeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHH
Confidence 799999995 579999999986542 2223456789999999999999999999999999999999999999998875
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ....+++..+..++.|++.||.|||++| ++|+||+|+||++++++.++|+|||++........ .....++.
T Consensus 93 ~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~ 165 (285)
T cd05605 93 NM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTV 165 (285)
T ss_pred hc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCC
Confidence 43 2345899999999999999999999998 99999999999999999999999999887532211 12235788
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++||||+|+++|+|++|..||........ ........... ...........+
T Consensus 166 ~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~----------~~~~~~~~~~~~ 232 (285)
T cd05605 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKED----------QEEYSEKFSEAA 232 (285)
T ss_pred CccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhc----------ccccCcccCHHH
Confidence 99999999888899999999999999999999999975332211 00000000000 001112233457
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHHH
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~~ 260 (308)
.+|+.+||+.||++|| +++++++.
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 8899999999999999 88898753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=279.10 Aligned_cols=232 Identities=22% Similarity=0.215 Sum_probs=178.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHH-HHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNE-VTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e-~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+++. .+++.+|+|++.... ......+..| ..+++.++|+||+++++++.+.+..++||||+++++|..++
T Consensus 8 fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 87 (325)
T cd05602 8 FGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL 87 (325)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHH
Confidence 799999996 478899999986432 1222233334 44577889999999999999999999999999999999988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.||+.||+|||++| ++||||||+||+++.++.++|+|||++....... .......|+
T Consensus 88 ~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt 159 (325)
T cd05602 88 QRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGT 159 (325)
T ss_pred Hhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccccCC
Confidence 542 34788899999999999999999998 9999999999999999999999999987532211 112234688
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||....... ....... ... . + .......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~-~~~-~-~--------~~~~~~~ 222 (325)
T cd05602 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILN-KPL-Q-L--------KPNITNS 222 (325)
T ss_pred ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------HHHHHHh-CCc-C-C--------CCCCCHH
Confidence 99999999998889999999999999999999999986432211 1111110 000 0 0 0112235
Q ss_pred HHHHHhhcccCCCCCCCCHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSV 257 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~ei 257 (308)
+.+++.+||+.+|++||++.+.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCC
Confidence 7888899999999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=257.67 Aligned_cols=250 Identities=22% Similarity=0.236 Sum_probs=196.5
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe-----EEEEEEecCCCChhhH
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE-----SLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~ 74 (308)
|+-||+++ ..+++.||+|++.....++.+...+|++.-++++|||+++++++...+.. .|++++|...|+|.+.
T Consensus 34 fsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~ 113 (302)
T KOG2345|consen 34 FSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDE 113 (302)
T ss_pred ceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHH
Confidence 56788888 67899999999987777788889999999999999999999998765443 8999999999999998
Q ss_pred hhcC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc-----
Q 021771 75 LFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN----- 148 (308)
Q Consensus 75 l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~----- 148 (308)
+... .++..+++.+++.|+.++++||.+||+.. .++.|+||||.||++++.+.++|.|||.+....-......
T Consensus 114 i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~l 192 (302)
T KOG2345|consen 114 IERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRL 192 (302)
T ss_pred HHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHH
Confidence 8764 34557999999999999999999999984 4699999999999999999999999999876432111110
Q ss_pred --cceeecccCccCchhhcc---CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccc
Q 021771 149 --TNRIVGTYGYMAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 149 --~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
...-..+..|+|||++.- ...+.++|||||||++|.|+.|..||+.....-+...+. .....
T Consensus 193 Qe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA-------------v~n~q 259 (302)
T KOG2345|consen 193 QEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA-------------VQNAQ 259 (302)
T ss_pred HHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe-------------eeccc
Confidence 111245789999998863 457899999999999999999999997654432111111 11111
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.-.......+.+.+++.+||+.||.+||++.+++..+...
T Consensus 260 ~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 260 ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111223566799999999999999999999999988754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=267.86 Aligned_cols=238 Identities=26% Similarity=0.354 Sum_probs=191.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.+++|.+... .......+.+|+.+++.++|+||+++++++.+++..++||||+++++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 92 (256)
T cd08529 13 FGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKM 92 (256)
T ss_pred CeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHH
Confidence 688999996 57999999998643 344567788999999999999999999999999999999999999999999865
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ....+++..++.++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||++..+...... .....++..
T Consensus 93 ~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~ 166 (256)
T cd08529 93 Q-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPY 166 (256)
T ss_pred h-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCcc
Confidence 4 2346889999999999999999999998 999999999999999999999999998876533221 122356788
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||+..+..++.++|+||||+++|+|++|..||....... ..... ....... ........+.
T Consensus 167 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~~---------~~~~~~~~~~ 230 (256)
T cd08529 167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA------LILKI-IRGVFPP---------VSQMYSQQLA 230 (256)
T ss_pred ccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HcCCCCC---------CccccCHHHH
Confidence 999999988888999999999999999999999986443211 01111 1111110 1112334588
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+++.+||+.+|++||++.++++.
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 231 QLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHccCCcccCcCHHHHhhC
Confidence 89999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=275.07 Aligned_cols=239 Identities=24% Similarity=0.322 Sum_probs=184.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--------------cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEE
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--------------GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIY 63 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 63 (308)
||.|-+|+. .+++.||||++.+.. ....+....|+.+|+++.|+|||+++++..+. +++|||+
T Consensus 110 yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVl 189 (576)
T KOG0585|consen 110 YGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVL 189 (576)
T ss_pred cceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEE
Confidence 789999984 689999999986531 11236788999999999999999999998864 5799999
Q ss_pred EecCCCChhhHhhcCCCccc-cChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 64 EYMPNKSLDVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 64 e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
|||..|.+...- .... +++.++++++++++.||+|||.+| |+||||||.|+|++++|.+||+|||.+..+..
T Consensus 190 ey~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~ 262 (576)
T KOG0585|consen 190 EYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQ 262 (576)
T ss_pred EeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeeccceeeeccc
Confidence 999988875432 2233 999999999999999999999998 99999999999999999999999999987743
Q ss_pred CCCc---cccceeecccCccCchhhccCc----ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccc
Q 021771 143 NQSE---ANTNRIVGTYGYMAPEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGE 215 (308)
Q Consensus 143 ~~~~---~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 215 (308)
.... ..-....||+.|+|||+..++. .+.+.||||+|++||.|+.|+.||-..... ..-.++
T Consensus 263 ~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~------~l~~KI----- 331 (576)
T KOG0585|consen 263 GSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL------ELFDKI----- 331 (576)
T ss_pred CCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH------HHHHHH-----
Confidence 3221 1122368999999999877632 356789999999999999999998432111 111111
Q ss_pred ccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 021771 216 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L 261 (308)
+...+.-....+....+.+||.+||++||+.|.+..+|..-.
T Consensus 332 ----vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 332 ----VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ----hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111111122224456788999999999999999999987544
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=277.88 Aligned_cols=234 Identities=23% Similarity=0.294 Sum_probs=182.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+++.||+|++.... .........|..++..+ +||||+++++++.+....++||||+++++|..++
T Consensus 8 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l 87 (316)
T cd05619 8 FGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI 87 (316)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 799999996 468899999986541 23345566777777764 8999999999999999999999999999999988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.|++.||.|||++| ++|+||||+||+++.++.++|+|||++....... .......|+
T Consensus 88 ~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt 159 (316)
T cd05619 88 QSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGT 159 (316)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCC
Confidence 543 34888999999999999999999998 9999999999999999999999999987532211 112234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++||||+||++|+|++|..||....... . .... .... ... +......
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~---~~~i-~~~~------~~~----~~~~~~~ 222 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---L---FQSI-RMDN------PCY----PRWLTRE 222 (316)
T ss_pred ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---H---HHHH-HhCC------CCC----CccCCHH
Confidence 99999999988889999999999999999999999986443211 0 1110 0000 000 1112235
Q ss_pred HHHHHhhcccCCCCCCCCHH-HHHH
Q 021771 236 FIHIGLLCVQADSADRPTMS-SVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~-eil~ 259 (308)
+.+++.+||+.||++||++. ++++
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHHc
Confidence 78889999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=274.24 Aligned_cols=245 Identities=29% Similarity=0.411 Sum_probs=188.8
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+|+.. .+..+++|.+.... ......+..|+.+++.++||||+++++.+..++..++++||+.+++|.+
T Consensus 13 ~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (290)
T cd05045 13 FGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92 (290)
T ss_pred CcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHH
Confidence 7999999852 23578888876443 2345678899999999999999999999999999999999999999999
Q ss_pred HhhcCC---------------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeee
Q 021771 74 FLFDST---------------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132 (308)
Q Consensus 74 ~l~~~~---------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~ 132 (308)
++.... ....+++..++.++.|++.+|.|||+.| ++|+||+|+||++++++.++|+
T Consensus 93 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~ 169 (290)
T cd05045 93 FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKIS 169 (290)
T ss_pred HHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEec
Confidence 875421 1234788899999999999999999998 9999999999999999999999
Q ss_pred cccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhh
Q 021771 133 DFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLW 211 (308)
Q Consensus 133 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~ 211 (308)
|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .....
T Consensus 170 dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~ 242 (290)
T cd05045 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-------LFNLL 242 (290)
T ss_pred cccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHH
Confidence 9999876532222111222334568999999888889999999999999999998 888885432211 11111
Q ss_pred hcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 212 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..... ...+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 243 ~~~~~---------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 243 KTGYR---------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred hCCCC---------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11100 011112234588899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=262.54 Aligned_cols=237 Identities=22% Similarity=0.250 Sum_probs=187.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
|+.|+...+ .+|+.+++|+++.. +..+.+.+.+|+.+-+.|+||||+++.+...+.+..++|+|++.|+.|..-+
T Consensus 24 FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eI-- 101 (355)
T KOG0033|consen 24 FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-- 101 (355)
T ss_pred hHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHH--
Confidence 566666654 57999999988644 4457788999999999999999999999999999999999999999996655
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC---CeeeecccceeeeCCCCCccccceeec
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM---NPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
..+..+++..+...+.||+++|+|+|.++ |+|||+||+|+++.... -+||+|||++...+.. ..-....|
T Consensus 102 -V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g---~~~~G~~G 174 (355)
T KOG0033|consen 102 -VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG---EAWHGFAG 174 (355)
T ss_pred -HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCCc---cccccccC
Confidence 34467899999999999999999999998 99999999999996443 4999999999988622 22334589
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
++.|+|||++...+++..+|||+.|+++|-|+.|.+||....... +.+...+.. -+... ..-+....
T Consensus 175 tP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---lye~I~~g~--yd~~~--------~~w~~is~ 241 (355)
T KOG0033|consen 175 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYEQIKAGA--YDYPS--------PEWDTVTP 241 (355)
T ss_pred CCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---HHHHHhccc--cCCCC--------cccCcCCH
Confidence 999999999999999999999999999999999999986532221 111111100 00000 01112233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+..+|+++||..||.+|.|+.|.|+
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhC
Confidence 5778899999999999999999874
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=272.13 Aligned_cols=243 Identities=29% Similarity=0.420 Sum_probs=186.5
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||++... .+..|++|.+.... ......+..|+.+++.++|+||+++++++.+....++||||+++++|.+
T Consensus 19 ~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~ 98 (277)
T cd05036 19 FGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98 (277)
T ss_pred CCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHH
Confidence 6899999864 46788999886443 3334568889999999999999999999999889999999999999999
Q ss_pred HhhcCCC----ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC---CeeeecccceeeeCCCCCc
Q 021771 74 FLFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM---NPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 74 ~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~---~~kl~dfg~~~~~~~~~~~ 146 (308)
++..... ...+++..+..++.||+.+|+|||+++ ++|+||+|+||+++.++ .+||+|||++.........
T Consensus 99 ~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~ 175 (277)
T cd05036 99 FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175 (277)
T ss_pred HHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCccccccCCccce
Confidence 9865421 235888999999999999999999998 99999999999998765 4899999998865322221
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
........+..|+|||.+.+..++.++|||||||++|+|++ |..||....... .. .........
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~----~~~~~~~~~-------- 240 (277)
T cd05036 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM----EFVTGGGRL-------- 240 (277)
T ss_pred ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcCCcC--------
Confidence 11112233467999999988889999999999999999996 888886432221 11 111111000
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
..+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 241 -~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 -DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 011112345888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.02 Aligned_cols=239 Identities=19% Similarity=0.213 Sum_probs=185.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.
T Consensus 56 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~ 135 (370)
T cd05596 56 FGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMS 135 (370)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHH
Confidence 789999995 57999999998643 22334567789999999999999999999999999999999999999999884
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++......... ......|++
T Consensus 136 ~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~ 207 (370)
T cd05596 136 N----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTP 207 (370)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCc
Confidence 3 24788899999999999999999998 999999999999999999999999999875432211 122346899
Q ss_pred CccCchhhccC----cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 157 GYMAPEYAMEG----LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 157 ~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.|+|||++.+. .++.++|||||||++|+|++|..||...... ................+ ....
T Consensus 208 ~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~~~~-------~~~~ 274 (370)
T cd05596 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSLTFPD-------DIEI 274 (370)
T ss_pred CeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcCCCCC-------cCCC
Confidence 99999988653 4788999999999999999999998643321 11111111110000000 0112
Q ss_pred HHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSAD--RPTMSSVVVM 260 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~--RPs~~eil~~ 260 (308)
...+.+|+.+||+.+|++ |+|+.++++-
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 345788899999999987 9999999854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=272.63 Aligned_cols=244 Identities=26% Similarity=0.398 Sum_probs=189.4
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||++..+ .++.+++|.+.... ......+.+|+.+++.++|+||+++++++.+....++||||+++++|.+
T Consensus 19 ~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 98 (277)
T cd05032 19 FGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS 98 (277)
T ss_pred CceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHH
Confidence 7899998853 24789999886442 3344578899999999999999999999999999999999999999999
Q ss_pred HhhcCCC-------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 74 FLFDSTR-------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 74 ~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
++..... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 99 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~ 175 (277)
T cd05032 99 YLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYY 175 (277)
T ss_pred HHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCccc
Confidence 9865321 224678889999999999999999997 999999999999999999999999998765433222
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.......++..|+|||.+.+..++.++||||||+++|++++ |..||....... ..+..........
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~------ 242 (277)
T cd05032 176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVIDGGHLDL------ 242 (277)
T ss_pred ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHHhcCCCCCC------
Confidence 22222345678999999888889999999999999999998 888885432221 0111111111111
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 243 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 243 ---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11113468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.19 Aligned_cols=240 Identities=20% Similarity=0.223 Sum_probs=182.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.
T Consensus 14 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 93 (377)
T cd05629 14 FGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI 93 (377)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHH
Confidence 799999985 68999999988543 22344678889999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc----------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE---------- 146 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~---------- 146 (308)
.. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||+++.+......
T Consensus 94 ~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~ 167 (377)
T cd05629 94 KY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167 (377)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccc
Confidence 43 34889999999999999999999998 999999999999999999999999998643211000
Q ss_pred -c----------------------------------ccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcC
Q 021771 147 -A----------------------------------NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN 191 (308)
Q Consensus 147 -~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 191 (308)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~P 247 (377)
T cd05629 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPP 247 (377)
T ss_pred ccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCC
Confidence 0 00013588899999999888899999999999999999999999
Q ss_pred CCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCC---CCHHHHHHH
Q 021771 192 TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADR---PTMSSVVVM 260 (308)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Ps~~eil~~ 260 (308)
|....... ...............+ .......+.+|+.+||+ +|.+| +|+.++++.
T Consensus 248 f~~~~~~~------~~~~i~~~~~~~~~p~-------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 248 FCSENSHE------TYRKIINWRETLYFPD-------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHH------HHHHHHccCCccCCCC-------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 96433211 1111110000000000 00112357788889997 77765 599998864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=269.49 Aligned_cols=245 Identities=26% Similarity=0.420 Sum_probs=188.0
Q ss_pred CCccEEeeeC-C---CCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe------EEEEEEecCC
Q 021771 1 MESCLQGKLA-D---GKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE------SLLIYEYMPN 68 (308)
Q Consensus 1 ~g~v~~~~~~-~---g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~ 68 (308)
||.||.|+.. + +..+|+|+++... ......+..|+..++.++|+||+++++++..... .+++|||+++
T Consensus 12 ~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~ 91 (273)
T cd05035 12 FGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKH 91 (273)
T ss_pred CceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCC
Confidence 7999999864 2 4789999986542 2334678899999999999999999998866543 7999999999
Q ss_pred CChhhHhhcCC---CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC
Q 021771 69 KSLDVFLFDST---RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS 145 (308)
Q Consensus 69 ~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~ 145 (308)
++|..++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 92 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 168 (273)
T cd05035 92 GDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168 (273)
T ss_pred CCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccceeecccccc
Confidence 99998885432 2245888999999999999999999997 99999999999999999999999999987643322
Q ss_pred ccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccc
Q 021771 146 EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVL 224 (308)
Q Consensus 146 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
.........+..|+|||.+.+..++.++|||||||++|+|++ |..||....... .. ..........
T Consensus 169 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~~------ 235 (273)
T cd05035 169 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IY----DYLRHGNRLK------ 235 (273)
T ss_pred ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCCC------
Confidence 221222234567999999888889999999999999999998 788875432111 11 1111111111
Q ss_pred cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 225 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 225 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus 236 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 236 ---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1112234688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=281.64 Aligned_cols=235 Identities=20% Similarity=0.217 Sum_probs=178.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcC---CCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL---QHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+++. .+|+.||+|++.... .........|..++... .||||+++++.+.+....++||||+.+++|..
T Consensus 6 ~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~ 85 (330)
T cd05586 6 FGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFW 85 (330)
T ss_pred ceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHH
Confidence 799999995 579999999986432 12233444566666655 69999999999999999999999999999988
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
++.. ...+++..+..++.||+.||+|||++| |+|+||||+||+++.++.++|+|||++....... .......
T Consensus 86 ~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~ 157 (330)
T cd05586 86 HLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFC 157 (330)
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCcc
Confidence 8854 335899999999999999999999998 9999999999999999999999999987532211 1122346
Q ss_pred cccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 154 GTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 154 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
|+..|+|||.+.+. .++.++|||||||++|+|++|..||....... ..... ..... .... . ..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i-~~~~~-~~~~-----~---~~ 221 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNI-AFGKV-RFPK-----N---VL 221 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHH-HcCCC-CCCC-----c---cC
Confidence 88999999988754 47899999999999999999999985432211 11111 11100 0000 0 11
Q ss_pred HHHHHHHHhhcccCCCCCCC----CHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRP----TMSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RP----s~~eil~ 259 (308)
...+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 23577888999999999998 5666664
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=268.30 Aligned_cols=241 Identities=30% Similarity=0.457 Sum_probs=190.5
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||++..++++.+++|.+.... ...+.+.+|+.+++.++|+||+++++++.+....++||||+++++|.+++....
T Consensus 19 ~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~- 96 (261)
T cd05034 19 FGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE- 96 (261)
T ss_pred ceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccc-
Confidence 689999998888999999986443 345678999999999999999999999999889999999999999999986532
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..+..++.|++.|++|||++| ++|+||+|+||+++.++.++|+|||++..+....... ......+..|+|
T Consensus 97 ~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~ 172 (261)
T cd05034 97 GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA-REGAKFPIKWTA 172 (261)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhh-hhccCCCccccC
Confidence 345899999999999999999999998 9999999999999999999999999988764321111 111223467999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++||||||+++|+|++ |..||....... .. .... .. ... ..+......+.++
T Consensus 173 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---~~~~-~~-----~~~----~~~~~~~~~~~~~ 236 (261)
T cd05034 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VL---EQVE-RG-----YRM----PRPPNCPEELYDL 236 (261)
T ss_pred HHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHH-cC-----CCC----CCCCCCCHHHHHH
Confidence 999988889999999999999999998 888885332110 11 1110 00 000 0011113458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||+.+|++||+++++++.|+.
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHcccCcccCCCHHHHHHHHhc
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=272.54 Aligned_cols=246 Identities=25% Similarity=0.348 Sum_probs=190.4
Q ss_pred CCccEEeeeCC-----CCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEe-CCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLAD-----GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+|...+ +..|++|.+... .......+.+|+.+++.++|+||+++++++.. +...+++++|+++++|.+
T Consensus 19 ~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~ 98 (280)
T cd05043 19 FGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKL 98 (280)
T ss_pred CceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHH
Confidence 79999999765 788999988644 33445678899999999999999999998766 456899999999999999
Q ss_pred HhhcCCCc-----cccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc
Q 021771 74 FLFDSTRS-----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 74 ~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
++...... ..+++..++.++.|++.||+|||+++ ++|+||+|+||+++.++.+||+|||+++.+........
T Consensus 99 ~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~ 175 (280)
T cd05043 99 FLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL 175 (280)
T ss_pred HHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEe
Confidence 98654322 46899999999999999999999997 99999999999999999999999999976543222211
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccccccc
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS 227 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
.....++..|+|||.+.+..++.++||||||+++|++++ |..||....... .. ..........
T Consensus 176 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~-~~~~~~~~~~--------- 239 (280)
T cd05043 176 GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------MA-AYLKDGYRLA--------- 239 (280)
T ss_pred CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH------HH-HHHHcCCCCC---------
Confidence 122234667999999988889999999999999999998 999986432211 11 1111110000
Q ss_pred chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 228 CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 228 ~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
........+.+++.+||+.+|++|||+.++++.|+...
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 01112235788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=268.92 Aligned_cols=238 Identities=24% Similarity=0.348 Sum_probs=185.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+++.+|+|.+... .......+.+|+.++++++||||+++++.+...+..++||||+++++|..+.
T Consensus 14 ~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~--- 90 (279)
T cd06619 14 GGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR--- 90 (279)
T ss_pred CeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh---
Confidence 689999985 68999999998654 3334457889999999999999999999999999999999999999986542
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
.+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++....... .....++..|
T Consensus 91 ----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y 159 (279)
T cd06619 91 ----KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAY 159 (279)
T ss_pred ----cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhh
Confidence 3678889999999999999999998 9999999999999999999999999997653221 2224678899
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
+|||.+.+..++.++|+||||+++|+|++|..||.......................... .. .......+.+
T Consensus 160 ~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~---~~~~~~~~~~ 231 (279)
T cd06619 160 MAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----LP---VGQFSEKFVH 231 (279)
T ss_pred cCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----CC---CCcCCHHHHH
Confidence 999999888899999999999999999999999865332221111111111110000000 00 0112235788
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021771 239 IGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~ 260 (308)
++.+||+.+|++||+++|+++.
T Consensus 232 li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 232 FITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHHhhCChhhCCCHHHHhcC
Confidence 8999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=268.37 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=192.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++.. .+|+.+++|.+... .......+.+|+.+++.++|+||+++++++..++..+++|||+++++|.+++.
T Consensus 15 ~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 94 (267)
T cd08229 15 FSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 94 (267)
T ss_pred CeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHH
Confidence 689999995 68999999987543 22344678899999999999999999999999999999999999999999886
Q ss_pred cC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. .....+++..++.++.|++.+|+|||++| ++|+||+|+||+++.++.++|+|||++..+...... .....++
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~ 169 (267)
T cd08229 95 HFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGT 169 (267)
T ss_pred HhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCC
Confidence 42 22345899999999999999999999998 999999999999999999999999998765433221 1223567
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||.+.+..++.++|+||||+++|+|++|..||....... ..... ... ....+.. ........
T Consensus 170 ~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~-~~~-----~~~~~~~---~~~~~~~~ 236 (267)
T cd08229 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCK-KIE-----QCDYPPL---PSDHYSEE 236 (267)
T ss_pred cCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhh-hhh-----cCCCCCC---CcccccHH
Confidence 88999999988888999999999999999999999985332210 00000 000 0000000 11123346
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+++.+||+.+|++|||+.+|++.++..
T Consensus 237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 237 LRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred HHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 88889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=271.64 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=189.3
Q ss_pred CCccEEeeeC-----------------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEE
Q 021771 1 MESCLQGKLA-----------------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62 (308)
Q Consensus 1 ~g~v~~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 62 (308)
||.||+++.. .+..+++|.+.... ....+.+..|+.+++.++|+||+++++++..+...+++
T Consensus 18 ~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (296)
T cd05051 18 FGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMI 97 (296)
T ss_pred CccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEE
Confidence 7899988753 23568999886543 34566788999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhcCCC--------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecc
Q 021771 63 YEYMPNKSLDVFLFDSTR--------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134 (308)
Q Consensus 63 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~df 134 (308)
||++.+++|..++..... ...+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.++|+||
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~~~~~l~df 174 (296)
T cd05051 98 MEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADF 174 (296)
T ss_pred EecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCCCceEEccc
Confidence 999999999999865431 125899999999999999999999998 999999999999999999999999
Q ss_pred cceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh--CCcCCCccccccccchhHHHHHhhh
Q 021771 135 GMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNTGFYLSELGQSLLSYTWKLWC 212 (308)
Q Consensus 135 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--~~~p~~~~~~~~~~~~~~~~~~~~~ 212 (308)
|++................++..|+|||.+.+..++.++||||||+++|+|++ +..||...... .........+.
T Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~ 251 (296)
T cd05051 175 GMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QVIENAGHFFR 251 (296)
T ss_pred cceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HHHHHHHhccc
Confidence 99876543322222233345678999999888889999999999999999998 56676433211 11111111111
Q ss_pred cccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 213 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
........ ..+.....++.+++.+||+.+|++|||+.+|++.|+
T Consensus 252 ~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 252 DDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred cccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11100000 011112346899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=274.97 Aligned_cols=245 Identities=28% Similarity=0.388 Sum_probs=189.3
Q ss_pred CCccEEeee--------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKL--------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||.||+++. .++..+++|.+.... ......+..|+.+++.+ +|+||+++++++......+++|||+++++
T Consensus 28 ~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 107 (304)
T cd05101 28 FGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 107 (304)
T ss_pred CceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCc
Confidence 789999873 234579999886442 34456788999999999 79999999999999999999999999999
Q ss_pred hhhHhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 71 LDVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 71 L~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
|.+++..... ...+++..+..++.||+.||.|||++| ++|+||||+||+++.++.++|+|||++
T Consensus 108 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~ 184 (304)
T cd05101 108 LREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA 184 (304)
T ss_pred HHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccc
Confidence 9999865321 234778889999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~~~ 257 (304)
T cd05101 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------ELFKL-LKEGHR 257 (304)
T ss_pred eecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HHHHH-HHcCCc
Confidence 87643322222222234567999999988889999999999999999998 67777433211 11111 111111
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
. ..+......+.+|+.+||+.+|++|||+.++++.|+..
T Consensus 258 ~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 258 M---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred C---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 0 01112234588899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=267.80 Aligned_cols=242 Identities=30% Similarity=0.403 Sum_probs=189.5
Q ss_pred CCccEEeeeC--CCC--EEEEEEeccCCc-ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA--DGK--EIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~--~g~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||++.+. +++ .+|+|.+..... ...+.+..|+.++++++|+||+++++.+.+ ...++||||+++++|.+++
T Consensus 8 ~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l 86 (257)
T cd05040 8 FGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRL 86 (257)
T ss_pred cccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHH
Confidence 6899999864 333 689999876654 556788999999999999999999999988 8899999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-ccceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-NTNRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~ 154 (308)
..... ..+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.+||+|||++..+....... ......+
T Consensus 87 ~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 162 (257)
T cd05040 87 RKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162 (257)
T ss_pred Hhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCC
Confidence 66432 45899999999999999999999998 9999999999999999999999999998765322211 1112345
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||...+..++.++|||||||++|+|++ |..||....... ............. .+....
T Consensus 163 ~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~ 227 (257)
T cd05040 163 PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGERLE---------RPEACP 227 (257)
T ss_pred CceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCcCC---------CCccCC
Confidence 678999999888889999999999999999998 999985332211 1111110000000 011123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
..+.+++.+||+.+|++|||+.++++.|.
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 45888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=270.48 Aligned_cols=244 Identities=26% Similarity=0.420 Sum_probs=185.5
Q ss_pred CCccEEeeeCC-CC--EEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeC------CeEEEEEEecCCC
Q 021771 1 MESCLQGKLAD-GK--EIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE------NESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~~~-g~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~ 69 (308)
||.||+|+..+ +. .+|+|.++.. .....+.+..|+.+++.++|+||+++++++... ...+++|||+.++
T Consensus 12 ~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~ 91 (272)
T cd05075 12 FGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHG 91 (272)
T ss_pred CceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCC
Confidence 79999999643 33 6899988654 234456788999999999999999999976432 2468999999999
Q ss_pred ChhhHhhcC---CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 70 SLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 70 ~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
+|..++... .....+++..+..++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++..+......
T Consensus 92 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 168 (272)
T cd05075 92 DLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY 168 (272)
T ss_pred cHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccce
Confidence 998887432 12345889999999999999999999997 999999999999999999999999999876433221
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.......++..|++||...+..++.++||||||+++|+|++ |..||....... .............
T Consensus 169 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------ 235 (272)
T cd05075 169 RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGNRLKQ------ 235 (272)
T ss_pred ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCCCCCC------
Confidence 11222344668999999988889999999999999999998 788885432211 1111111111110
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
.......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus 236 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 236 ---PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 11123357889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=267.24 Aligned_cols=240 Identities=29% Similarity=0.449 Sum_probs=189.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||++..++++.+++|.+.... .....+.+|+.+++.++|+||+++++++.+ ...+++|||+.+++|.+++... .
T Consensus 19 ~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-~ 95 (260)
T cd05067 19 FGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-E 95 (260)
T ss_pred cceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEEEEcCCCCCHHHHHHhc-C
Confidence 799999998899999999986443 345678899999999999999999998754 5689999999999999988553 3
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
+..+++..+..++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++.......... .....++..|+|
T Consensus 96 ~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~ 171 (260)
T cd05067 96 GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA-REGAKFPIKWTA 171 (260)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCccc-ccCCcccccccC
Confidence 346888999999999999999999998 9999999999999999999999999997764222111 112234678999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++||||||+++|++++ |..||....... .. ......... .........+.++
T Consensus 172 pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~---------~~~~~~~~~~~~l 235 (260)
T cd05067 172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VI----QNLERGYRM---------PRPDNCPEELYEL 235 (260)
T ss_pred HHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HH----HHHHcCCCC---------CCCCCCCHHHHHH
Confidence 999988888999999999999999998 999986432211 00 011111000 0111123458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||..+|++|||++++++.|+.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHccCChhhCCCHHHHHHHhhc
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=268.99 Aligned_cols=239 Identities=22% Similarity=0.325 Sum_probs=186.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc-----ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG-----QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||.+.. .+|+.+++|.+..... .....+.+|+.+++.++||||+++++++.++...++|+||+++++|.++
T Consensus 15 ~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~ 94 (263)
T cd06625 15 FGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQ 94 (263)
T ss_pred ceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHH
Confidence 688999985 5799999998864421 1235678899999999999999999999999999999999999999998
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc-cceee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN-TNRIV 153 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~ 153 (308)
+... ..+++..+..++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||++........... .....
T Consensus 95 ~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 168 (263)
T cd06625 95 LKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168 (263)
T ss_pred HHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCC
Confidence 8543 34888999999999999999999998 99999999999999999999999999876542211111 12235
Q ss_pred cccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
++..|+|||.+.+..++.++||||||+++|+|++|..||...... ............. ..+....
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~---------~~~~~~~ 233 (263)
T cd06625 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTNP---------QLPSHVS 233 (263)
T ss_pred cCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCCC---------CCCccCC
Confidence 677899999998888999999999999999999999998543211 1011111000000 1111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+.+++.+||..+|++|||+.++++.
T Consensus 234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 234 PDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 357889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=266.74 Aligned_cols=240 Identities=28% Similarity=0.453 Sum_probs=188.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||++..+++..+++|.+..... ..+.+.+|+.+++.++|+||+++++++.. ...+++|||+++++|.+++....
T Consensus 19 ~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~- 95 (260)
T cd05070 19 FGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGE- 95 (260)
T ss_pred CceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcC-
Confidence 6899999988888999998865432 34678999999999999999999998854 56789999999999999986532
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.|++.||+|||++| ++|+||+|+||++++++.++|+|||++..+....... .....++..|+|
T Consensus 96 ~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~a 171 (260)
T cd05070 96 GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTA 171 (260)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc-ccCCCCCccccC
Confidence 335889999999999999999999998 9999999999999999999999999998764332111 111234567999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||...+..++.++||||||+++|+|++ |..||...... ...... ..... ...+......+.++
T Consensus 172 PE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~-~~~~~---------~~~~~~~~~~~~~l 235 (260)
T cd05070 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQV-ERGYR---------MPCPQDCPISLHEL 235 (260)
T ss_pred hHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHH-HcCCC---------CCCCCcCCHHHHHH
Confidence 999888888999999999999999999 88888543211 111111 11000 01111223458899
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||+.+|++|||+.++++.|+.
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=272.19 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=186.5
Q ss_pred CCccEEeeeCC---------------CCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEE
Q 021771 1 MESCLQGKLAD---------------GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64 (308)
Q Consensus 1 ~g~v~~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 64 (308)
||.||.++..+ ...||+|.+... .......+.+|+++++.++|+||+++++++......++|||
T Consensus 18 ~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 97 (295)
T cd05097 18 FGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITE 97 (295)
T ss_pred CceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEe
Confidence 78899887532 235899988654 33345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhcCCC---------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeeccc
Q 021771 65 YMPNKSLDVFLFDSTR---------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFG 135 (308)
Q Consensus 65 ~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg 135 (308)
|+++++|.+++..... ...+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||
T Consensus 98 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg 174 (295)
T cd05097 98 YMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFG 174 (295)
T ss_pred cCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCCCcEEecccc
Confidence 9999999998854321 123678889999999999999999998 9999999999999999999999999
Q ss_pred ceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh--CCcCCCccccccccchhHHHHHhhhc
Q 021771 136 MARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNTGFYLSELGQSLLSYTWKLWCE 213 (308)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--~~~p~~~~~~~~~~~~~~~~~~~~~~ 213 (308)
++................++..|+|||...+..++.++||||||+++|+|++ +..||....... ......+.+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~~ 251 (295)
T cd05097 175 MSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VIENTGEFFRN 251 (295)
T ss_pred cccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HHHHHHHhhhh
Confidence 9876533222222222344678999999888889999999999999999998 455664332211 11111111111
Q ss_pred ccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 214 GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
....... .........+.+|+.+||+.+|++|||+.+|++.|..
T Consensus 252 ~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 252 QGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 0000000 0011122468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=268.39 Aligned_cols=241 Identities=26% Similarity=0.409 Sum_probs=187.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHH--HHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQ--EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+++.+|+|++......... ....|+.+++.++|+||+++++++.+....++|||++++++|.+++.
T Consensus 12 ~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~- 90 (260)
T PF00069_consen 12 FGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ- 90 (260)
T ss_dssp SEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-
T ss_pred CEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccccccccc-
Confidence 799999996 56779999999776544322 33569999999999999999999999999999999999999999986
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
....+++..++.++.||+++|.+||+.| ++|+||+|+||+++.++.++|+|||.+.... ..........++..
T Consensus 91 --~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~~~~~~~ 163 (260)
T PF00069_consen 91 --KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNPFVGTPE 163 (260)
T ss_dssp --HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSSSSSSGG
T ss_pred --cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cccccccccccccc
Confidence 3345899999999999999999999998 9999999999999999999999999988641 11222333467889
Q ss_pred ccCchhhc-cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 158 YMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 158 y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
|+|||++. +...+.++||||||+++|+|++|..||.................. ...... .........+
T Consensus 164 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~---~~~~~~~~~l 233 (260)
T PF00069_consen 164 YMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR-------PLPSSS---QQSREKSEEL 233 (260)
T ss_dssp GSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT-------HHHHHT---TSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc-------cccccc---cccchhHHHH
Confidence 99999988 778999999999999999999999998755111111111000000 000000 0000011568
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.||++|||+.++++
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 99999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=266.52 Aligned_cols=241 Identities=27% Similarity=0.433 Sum_probs=188.3
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+|+..++..+++|++.... ...+.+..|+.+++.++|+||+++++.+.+ ...++||||+++++|.+++... .
T Consensus 19 ~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~-~ 95 (262)
T cd05071 19 FGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-M 95 (262)
T ss_pred CCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhc-c
Confidence 689999998777789999986433 234678899999999999999999998754 4679999999999999998643 2
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..+..++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||.+..+....... .....++..|+|
T Consensus 96 ~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~ 171 (262)
T cd05071 96 GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTA 171 (262)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc-ccCCcccceecC
Confidence 335788999999999999999999998 9999999999999999999999999998764332211 112345667999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||...+..++.++||||||+++|+|++ |..||....... .. .... ... ...........+.++
T Consensus 172 PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~---~~~~-~~~---------~~~~~~~~~~~l~~l 235 (262)
T cd05071 172 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL---DQVE-RGY---------RMPCPPECPESLHDL 235 (262)
T ss_pred HhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH---HHHh-cCC---------CCCCccccCHHHHHH
Confidence 999888889999999999999999999 777875432211 00 0000 000 001112234568899
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+||+.+|++|||+.++++.|+.-
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHHccCCcccCCCHHHHHHHHHHh
Confidence 9999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=272.95 Aligned_cols=236 Identities=22% Similarity=0.331 Sum_probs=188.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+++++|.+++..
T Consensus 33 ~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-- 110 (296)
T cd06654 33 SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-- 110 (296)
T ss_pred CeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--
Confidence 689999984 58999999998766555567888999999999999999999999999999999999999999998843
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++......... .....++..|+
T Consensus 111 --~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~ 183 (296)
T cd06654 111 --TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWM 183 (296)
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCcccc
Confidence 24788899999999999999999998 999999999999999999999999998764322111 12235678899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||.+.+..++.++||||+||++|+|++|..||....... ........ ..... ..+......+.++
T Consensus 184 aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~-~~~~~-------~~~~~~~~~l~~l 249 (296)
T cd06654 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATN-GTPEL-------QNPEKLSAIFRDF 249 (296)
T ss_pred CHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcC-CCCCC-------CCccccCHHHHHH
Confidence 9999888888999999999999999999999985432211 00000000 00000 0111233458889
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
+.+||..+|++|||+.+|++
T Consensus 250 i~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 250 LNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHHCcCCcccCcCHHHHhh
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=272.24 Aligned_cols=244 Identities=27% Similarity=0.450 Sum_probs=188.1
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++.. +++.+++|++.... ......+.+|+.+++.++|+||+++++++.++...+++|||+++++|.+
T Consensus 18 ~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 97 (288)
T cd05050 18 FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 97 (288)
T ss_pred cccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHH
Confidence 7899999853 57899999886543 3345678899999999999999999999999989999999999999999
Q ss_pred HhhcCC-------------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecc
Q 021771 74 FLFDST-------------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134 (308)
Q Consensus 74 ~l~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~df 134 (308)
++.... ....+++..++.++.|++.+|+|||++| ++|+||+|+||+++.++.++|+||
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 174 (288)
T cd05050 98 FLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADF 174 (288)
T ss_pred HHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECcc
Confidence 986421 1134778889999999999999999998 999999999999999999999999
Q ss_pred cceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhc
Q 021771 135 GMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCE 213 (308)
Q Consensus 135 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~ 213 (308)
|++.................+..|+|||...+..++.++|||||||++|+|++ |..||...... ... .....
T Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~------~~~-~~~~~ 247 (288)
T cd05050 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE------EVI-YYVRD 247 (288)
T ss_pred ccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHH-HHHhc
Confidence 99876543322111222234567999999888889999999999999999997 77776432111 111 11111
Q ss_pred ccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 214 GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
..... .+......+.+|+.+||+.+|++|||+.|+++.|+.
T Consensus 248 ~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 248 GNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111 011123458889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=284.75 Aligned_cols=239 Identities=19% Similarity=0.250 Sum_probs=181.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.+|+|++.... ......+.+|+.+++.++|+||+++++.+.++...++|||||++++|.+++.
T Consensus 14 ~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 93 (382)
T cd05625 14 FGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI 93 (382)
T ss_pred CEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence 799999995 679999999986542 2334578899999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC-----------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS----------- 145 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~----------- 145 (308)
.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..+.....
T Consensus 94 ~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~ 167 (382)
T cd05625 94 RM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVR 167 (382)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccc
Confidence 43 34888999999999999999999998 99999999999999999999999999753210000
Q ss_pred ----------------------------------ccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcC
Q 021771 146 ----------------------------------EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN 191 (308)
Q Consensus 146 ----------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 191 (308)
........|+..|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~P 247 (382)
T cd05625 168 QDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 247 (382)
T ss_pred cccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCC
Confidence 0001123588999999999888899999999999999999999999
Q ss_pred CCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCC---HHHHHH
Q 021771 192 TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT---MSSVVV 259 (308)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs---~~eil~ 259 (308)
|....... ............... ........+.+++.+|+ .+|++|++ +.++++
T Consensus 248 f~~~~~~~------~~~~i~~~~~~~~~p-------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 248 FLAQTPLE------TQMKVINWQTSLHIP-------PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred CCCCCHHH------HHHHHHccCCCcCCC-------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 96543211 111111100000000 00111234666666665 49999997 777774
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=273.96 Aligned_cols=190 Identities=25% Similarity=0.415 Sum_probs=152.9
Q ss_pred CCccEEeeeC---CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe--CCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+++.+ +++.+|+|.+.... ....+.+|+.+|+.++||||+++++++.+ +...+++|||+.+ +|..++
T Consensus 14 ~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 90 (317)
T cd07868 14 YGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII 90 (317)
T ss_pred CeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHH
Confidence 7999999854 57899999886442 22457789999999999999999999864 4468999999954 777766
Q ss_pred hcCC------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe----CCCCCeeeecccceeeeCCCCC
Q 021771 76 FDST------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL----NHEMNPKISDFGMARIFGGNQS 145 (308)
Q Consensus 76 ~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv----~~~~~~kl~dfg~~~~~~~~~~ 145 (308)
.... ....+++..+..++.||+.||+|||++| ++|+||||+||++ +.++.+||+|||++..+.....
T Consensus 91 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~ 167 (317)
T cd07868 91 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167 (317)
T ss_pred HhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCc
Confidence 4321 1235889999999999999999999998 9999999999999 4567899999999987653322
Q ss_pred c-cccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccc
Q 021771 146 E-ANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYL 196 (308)
Q Consensus 146 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 196 (308)
. .......++..|+|||++.+ ..++.++||||+||++|+|++|.+||....
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 1 12233467889999998876 458899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=273.82 Aligned_cols=244 Identities=29% Similarity=0.404 Sum_probs=188.2
Q ss_pred CCccEEeee------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. ..+..+|+|.+.... ....+.+.+|+.+++++ +|+||+++++++...+..+++|||+++++|.
T Consensus 48 ~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 127 (302)
T cd05055 48 FGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127 (302)
T ss_pred CeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHH
Confidence 688998863 245689999886543 34456788999999999 7999999999999999999999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+++.... ...+++..+..++.|++.+|+|||+++ ++|+||+|+||+++.++.++|+|||++..+............
T Consensus 128 ~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 203 (302)
T cd05055 128 NFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203 (302)
T ss_pred HHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCC
Confidence 9986432 233899999999999999999999998 999999999999999999999999998765433221112223
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.++..|+|||.+.+..++.++||||+|+++|+|++ |..||....... ............. ....
T Consensus 204 ~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~---------~~~~ 268 (302)
T cd05055 204 RLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYRMA---------QPEH 268 (302)
T ss_pred CcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCcCC---------CCCC
Confidence 44678999999988889999999999999999998 888875332111 0011111110000 0011
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
....+.+++.+||..+|++|||+.++++.|+.
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 12358889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=267.39 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=182.4
Q ss_pred CCccEEeeeC---CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+|+.. ++..+++|.+.... ......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.
T Consensus 8 ~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 87 (269)
T cd05087 8 FGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLR 87 (269)
T ss_pred CceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHH
Confidence 7999999864 34678999886543 2334578889999999999999999999999888999999999999999986
Q ss_pred cCCC--ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 77 DSTR--SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 77 ~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
.... ....++..+..++.|++.|++|||+.| ++|+||||+||+++.++.++|+|||++................+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 164 (269)
T cd05087 88 SCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV 164 (269)
T ss_pred HhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCC
Confidence 5322 234567778899999999999999998 99999999999999999999999999865432222122223345
Q ss_pred ccCccCchhhccC-------cccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccc
Q 021771 155 TYGYMAPEYAMEG-------LFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226 (308)
Q Consensus 155 ~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
+..|+|||++.+. .++.++||||||+++|+|++ |..||........ .. .. . .........+....
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~--~~-~-~~~~~~~~~~~~~~ 237 (269)
T cd05087 165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LT--YT-V-REQQLKLPKPRLKL 237 (269)
T ss_pred cccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HH--HH-h-hcccCCCCCCccCC
Confidence 6789999987642 35789999999999999996 9999864322210 00 00 0 01111111111111
Q ss_pred cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 227 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
.....+.+++..|| .+|++|||++||+..|+
T Consensus 238 ----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 ----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11224667778898 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=269.71 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=186.9
Q ss_pred CCccEEeeeC-----------------CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEE
Q 021771 1 MESCLQGKLA-----------------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62 (308)
Q Consensus 1 ~g~v~~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 62 (308)
||.||++... ++..+|+|++... .......+..|+.+++.++|+||+++++++..+...++|
T Consensus 18 ~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv 97 (296)
T cd05095 18 FGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMI 97 (296)
T ss_pred CCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 7889987532 3557899988654 333456789999999999999999999999999999999
Q ss_pred EEecCCCChhhHhhcCCC--------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecc
Q 021771 63 YEYMPNKSLDVFLFDSTR--------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134 (308)
Q Consensus 63 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~df 134 (308)
|||+++++|.+++..... ...+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++|+||
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~~~~~l~df 174 (296)
T cd05095 98 TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADF 174 (296)
T ss_pred EEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCCCCEEeccC
Confidence 999999999999865321 124777889999999999999999998 999999999999999999999999
Q ss_pred cceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh--CCcCCCccccccccchhHHHHHhhh
Q 021771 135 GMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNTGFYLSELGQSLLSYTWKLWC 212 (308)
Q Consensus 135 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--~~~p~~~~~~~~~~~~~~~~~~~~~ 212 (308)
|++..+..............+..|++||...+..++.++|||||||++|+|++ |..||....... ........+.
T Consensus 175 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---~~~~~~~~~~ 251 (296)
T cd05095 175 GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---VIENTGEFFR 251 (296)
T ss_pred cccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---HHHHHHHHHh
Confidence 99876543222111222234567999998888889999999999999999998 667775432211 1111111111
Q ss_pred cccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 213 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
.... ....+ .+......+.+|+.+||+.||++|||+.+|++.|+
T Consensus 252 ~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 252 DQGR-QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred hccc-cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1100 00000 01112245888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=265.96 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=179.5
Q ss_pred CCccEEeeeCC---CCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLAD---GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+|+..+ ...+++|.+.... ......+.+|+..++.++|+||+++++.+.+....++||||+++++|.+++.
T Consensus 8 fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 87 (269)
T cd05042 8 FGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLR 87 (269)
T ss_pred CceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHH
Confidence 79999997543 4567888775433 2334567889999999999999999999999999999999999999999986
Q ss_pred cCCC--ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 77 DSTR--SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 77 ~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
.... ....++..+..++.||+.||+|||+++ ++|+||||+||+++.++.+||+|||++................+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 164 (269)
T cd05042 88 SNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV 164 (269)
T ss_pred hccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCC
Confidence 6432 233567788899999999999999998 99999999999999999999999999865432211111222344
Q ss_pred ccCccCchhhcc-------CcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccc
Q 021771 155 TYGYMAPEYAME-------GLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226 (308)
Q Consensus 155 ~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
+..|+|||+... ..++.++|||||||++|+|++ |..||....... ....... ........+....
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~ 237 (269)
T cd05042 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVR-EQDIKLPKPQLDL 237 (269)
T ss_pred cccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhh-ccCccCCCCcccc
Confidence 667999998643 346789999999999999998 677775432211 0111111 1111111111111
Q ss_pred cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 227 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
.....+.+++..|| .||++|||+++|++.|.
T Consensus 238 ----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 238 ----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 12233566677788 59999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=275.06 Aligned_cols=234 Identities=23% Similarity=0.262 Sum_probs=182.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCC-cCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQH-KNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+++.||+|++... .....+.+..|..++..+.| ++|+.+++++.+.+..++||||+++++|..++
T Consensus 13 ~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~ 92 (324)
T cd05587 13 FGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 92 (324)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHH
Confidence 799999995 46889999998643 23345667789999999975 56888999999999999999999999999888
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.||+.||+|||++| ++|+||||+||+++.++.++|+|||++....... .......|+
T Consensus 93 ~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt 164 (324)
T cd05587 93 QQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGT 164 (324)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCC
Confidence 543 34888999999999999999999998 9999999999999999999999999987532211 112234688
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++||||+||++|+|++|..||....... ...... ... . ..+......
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~-~~~-~---------~~~~~~~~~ 227 (324)
T cd05587 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQSIM-EHN-V---------SYPKSLSKE 227 (324)
T ss_pred ccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHH-cCC-C---------CCCCCCCHH
Confidence 99999999998889999999999999999999999996443221 011110 000 0 001112235
Q ss_pred HHHHHhhcccCCCCCCCCH-----HHHHH
Q 021771 236 FIHIGLLCVQADSADRPTM-----SSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~-----~eil~ 259 (308)
+.+++.+||..||++|++. .++++
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 228 AVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 7888999999999999986 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=266.66 Aligned_cols=239 Identities=21% Similarity=0.321 Sum_probs=186.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+++.+++|.++.........+.+|+.+++.++||||+++++.+.+....++||||+++++|.+++...
T Consensus 22 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~- 100 (267)
T cd06645 22 YGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT- 100 (267)
T ss_pred CeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc-
Confidence 689999985 579999999987665555567889999999999999999999999999999999999999999988543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..++.++.|++.++.|||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 101 --~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 173 (267)
T cd06645 101 --GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWM 173 (267)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccccCccccc
Confidence 35899999999999999999999998 99999999999999999999999999877643221 122346788999
Q ss_pred Cchhhc---cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 160 APEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 160 aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
|||.+. +..++.++|+|||||++|+|++|..||........ . ............ ... .......+
T Consensus 174 aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~~~~~~~~~~~----~~~--~~~~~~~~ 241 (267)
T cd06645 174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLMTKSNFQPPK----LKD--KMKWSNSF 241 (267)
T ss_pred ChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----HhhhccCCCCCc----ccc--cCCCCHHH
Confidence 999874 44578899999999999999999999753321110 0 000000000000 000 00122357
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.+|++|||+++|++
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhc
Confidence 88999999999999999999885
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=266.07 Aligned_cols=238 Identities=21% Similarity=0.301 Sum_probs=189.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+++.+++|.+... .....+.+..|+.+++.++|+||+++++.+.++...+++|||+++++|.+++...
T Consensus 13 ~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~ 92 (255)
T cd08219 13 FGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ 92 (255)
T ss_pred CeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhc
Confidence 688999985 57999999988543 3445677889999999999999999999999999999999999999998887543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
....+++..++.++.|++.||.+||++| ++|+||+|+||+++.++.++|+|||.+........ ......++..|
T Consensus 93 -~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~ 166 (255)
T cd08219 93 -RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYY 166 (255)
T ss_pred -cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccc
Confidence 2345788999999999999999999998 99999999999999999999999999876643221 12224577889
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
+|||++.+..++.++|+||+|+++|+|++|..||....... ..... ....... .+......+.+
T Consensus 167 ~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~~---------~~~~~~~~~~~ 230 (255)
T cd08219 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKV-CQGSYKP---------LPSHYSYELRS 230 (255)
T ss_pred cCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHH-hcCCCCC---------CCcccCHHHHH
Confidence 99999988889999999999999999999999986432111 11111 1111110 01112335788
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021771 239 IGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~ 260 (308)
++.+||+.||++|||+.+|+..
T Consensus 231 li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 231 LIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHhCCcccCCCHHHHhhc
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=281.44 Aligned_cols=189 Identities=22% Similarity=0.314 Sum_probs=161.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||+|++.... ......+..|+.++..++|+||+++++.+.+....++|||||++++|.+++.
T Consensus 14 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 93 (363)
T cd05628 14 FGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM 93 (363)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHH
Confidence 799999985 579999999986432 2334567889999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc----------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE---------- 146 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~---------- 146 (308)
.. ..+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||++..+......
T Consensus 94 ~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 167 (363)
T cd05628 94 KK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167 (363)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccc
Confidence 43 35899999999999999999999998 999999999999999999999999998754321100
Q ss_pred -----------------------cccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcc
Q 021771 147 -----------------------ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195 (308)
Q Consensus 147 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 195 (308)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0011246899999999998888999999999999999999999999643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=274.55 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=183.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++..++..++||||+++ +|.+++...
T Consensus 19 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~ 97 (309)
T cd07872 19 YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDC 97 (309)
T ss_pred CEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhc
Confidence 789999985 478899999986443 23334677899999999999999999999999999999999975 777776543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+++..+..++.||+.||+|||++| ++||||||+||+++.++.++|+|||++......... .....++..|
T Consensus 98 --~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y 170 (309)
T cd07872 98 --GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWY 170 (309)
T ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccc
Confidence 234788899999999999999999998 999999999999999999999999998765332211 1223567899
Q ss_pred cCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHH--------HHHhhhc------cccccccccc
Q 021771 159 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY--------TWKLWCE------GEALELMEPV 223 (308)
Q Consensus 159 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------~~~~~~~------~~~~~~~~~~ 223 (308)
+|||.+.+ ..++.++||||||+++|+|++|..||.............. .+..... ..........
T Consensus 171 ~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (309)
T cd07872 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQP 250 (309)
T ss_pred cCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCc
Confidence 99998765 4578899999999999999999999965433211110000 0000000 0000000000
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. ........++.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 251 LI-NHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hh-hhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 000112345788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=269.27 Aligned_cols=243 Identities=26% Similarity=0.364 Sum_probs=185.1
Q ss_pred CCccEEeee-CCCC----EEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGK----EIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|+. .+|+ .+++|.+.... ......+..|+..++.++||||+++++++.. ...++++||+++++|.++
T Consensus 20 ~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~ 98 (279)
T cd05111 20 FGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDH 98 (279)
T ss_pred CcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHH
Confidence 799999986 4555 47778775432 2234567778889999999999999998764 457889999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+.... ..+++..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++................+
T Consensus 99 l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 173 (279)
T cd05111 99 VRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173 (279)
T ss_pred HHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCC
Confidence 86532 35899999999999999999999998 99999999999999999999999999987643322222223345
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||.+.+..++.++||||||+++|++++ |..||........ ............ ... ..
T Consensus 174 ~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~~-----~~~----~~ 237 (279)
T cd05111 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERLAQ-----PQI----CT 237 (279)
T ss_pred cccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcCCC-----CCC----CC
Confidence 678999999988889999999999999999998 8888854322211 111111111110 011 12
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
..+.+++.+||..+|++|||+.|+++.|....
T Consensus 238 ~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 238 IDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 34677888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=266.01 Aligned_cols=236 Identities=31% Similarity=0.427 Sum_probs=188.5
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||.+.. .|+.+++|.+..... ..+.+.+|+.+++.++|+||+++++++.+....++||||+++++|.+++....
T Consensus 19 ~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~- 95 (256)
T cd05039 19 FGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG- 95 (256)
T ss_pred CceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcC-
Confidence 689999986 478999999865543 56788899999999999999999999998889999999999999999986543
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..+..++.|++.+|.|||++| ++|+||+|+||+++.++.++|+|||.+........ ....+..|+|
T Consensus 96 ~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~a 167 (256)
T cd05039 96 RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTA 167 (256)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccC
Confidence 235899999999999999999999998 99999999999999999999999999877532211 1233567999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+....++.++||||||+++|++++ |..||....... + ........... .+......+.++
T Consensus 168 pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~~~---------~~~~~~~~~~~l 231 (256)
T cd05039 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPHVEKGYRME---------APEGCPPEVYKV 231 (256)
T ss_pred chhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhcCCCCC---------CccCCCHHHHHH
Confidence 999888888999999999999999997 888875432211 0 01111110000 011123458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||..+|++|||++++++.|+.
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHhccChhhCcCHHHHHHHHhc
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=269.04 Aligned_cols=242 Identities=27% Similarity=0.379 Sum_probs=186.7
Q ss_pred CCccEEeee-CCCC----EEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGK----EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|++ .+|+ .||+|++... .......+.+|+.+++.+.|+||+++++++... ..+++++|+++++|.++
T Consensus 20 ~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~ 98 (279)
T cd05109 20 FGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDY 98 (279)
T ss_pred CceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHH
Confidence 799999985 4555 4799988654 334456788999999999999999999998764 57899999999999998
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+.... ..+++..++.++.|++.||+|||+++ ++|+||||+||++++++.+||+|||++................+
T Consensus 99 l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~ 173 (279)
T cd05109 99 VRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173 (279)
T ss_pred Hhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCcc
Confidence 86532 35889999999999999999999998 99999999999999999999999999987643322211212234
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||...+..++.++|||||||++|+|++ |..||........ ........... ......
T Consensus 174 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~ 237 (279)
T cd05109 174 PIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-------PDLLEKGERLP---------QPPICT 237 (279)
T ss_pred chhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcCC---------CCccCC
Confidence 567999999988889999999999999999998 8888864322110 01111111100 011123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+++.+||+.||++||++.++++.|+..
T Consensus 238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 3578899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=269.41 Aligned_cols=253 Identities=24% Similarity=0.281 Sum_probs=185.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+|+. .+|+.|++|++.... ......+.+|+.+++.++|+||+++++++.++...++||||+. ++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~ 91 (285)
T cd07861 13 YGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDS 91 (285)
T ss_pred ceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhc
Confidence 689999996 579999999886432 2334678899999999999999999999999999999999997 578887755
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
......+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++........ ......++..
T Consensus 92 ~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~ 166 (285)
T cd07861 92 LPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLW 166 (285)
T ss_pred CCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCccccc
Confidence 444456899999999999999999999998 99999999999999999999999999976543221 1122345788
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHH-----HHHhhhcc----ccccccccccc--
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY-----TWKLWCEG----EALELMEPVLK-- 225 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~-----~~~~~~~~----~~~~~~~~~~~-- 225 (308)
|+|||.+.+. .++.++||||||+++|+|++|+.||.............. ....|... ...........
T Consensus 167 y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (285)
T cd07861 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGS 246 (285)
T ss_pred ccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcch
Confidence 9999987654 568899999999999999999999864322110000000 00000000 00000000000
Q ss_pred -ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 226 -QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 226 -~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.........++.+++.+||+.||++|||+.+|++
T Consensus 247 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 247 LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0001112345778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=274.08 Aligned_cols=245 Identities=29% Similarity=0.407 Sum_probs=187.8
Q ss_pred CCccEEeeeC--------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||.||.++.. ++..+|+|.+.... ......+..|+.+++.+ +|+||+++++++..+...++||||+++++
T Consensus 31 ~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (307)
T cd05098 31 FGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110 (307)
T ss_pred CeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCc
Confidence 7899998742 23579999986542 33456788899999999 79999999999999999999999999999
Q ss_pred hhhHhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 71 LDVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 71 L~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
|.+++..... ...+++.+++.++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++
T Consensus 111 L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a 187 (307)
T cd05098 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLA 187 (307)
T ss_pred HHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCccc
Confidence 9999965321 134888899999999999999999998 999999999999999999999999998
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..........
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~ 260 (307)
T cd05098 188 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLLKEGHR 260 (307)
T ss_pred ccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HHHHHHcCCC
Confidence 76532211111111223467999999988889999999999999999998 778875432211 1111111111
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.. .+......+.+|+.+||..+|++|||+.++++.|...
T Consensus 261 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 261 MD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred CC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11 1112234688889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=267.73 Aligned_cols=243 Identities=26% Similarity=0.438 Sum_probs=187.5
Q ss_pred CCccEEeeeC-CCC---EEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGK---EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|+.+ +|+ .|++|.+... .......+..|+.+++.++||||+++++++.++...++||||+++++|.+++
T Consensus 17 ~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 96 (269)
T cd05065 17 FGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFL 96 (269)
T ss_pred CCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHH
Confidence 7999999964 443 6999998654 3445568899999999999999999999999999999999999999999988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce-e--
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR-I-- 152 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~-~-- 152 (308)
.... ..+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++.............. .
T Consensus 97 ~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 171 (269)
T cd05065 97 RQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171 (269)
T ss_pred hhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCC
Confidence 6532 35889999999999999999999998 99999999999999999999999999876543222111111 1
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..+..|+|||.+.+..++.++||||+|+++|++++ |..||....... ... .. ... . . ...+..
T Consensus 172 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~---~i-~~~-~----~----~~~~~~ 235 (269)
T cd05065 172 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIN---AI-EQD-Y----R----LPPPMD 235 (269)
T ss_pred CcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHH---HH-HcC-C----c----CCCccc
Confidence 11347999999988889999999999999999886 888885432211 111 00 000 0 0 000112
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
....+.+++.+||+.+|++||++.+|+..|+..
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 236 CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 234578889999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=264.15 Aligned_cols=240 Identities=28% Similarity=0.437 Sum_probs=187.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||++...++..+++|.+.... ...+.+.+|+.+++.++|+|++++++++.. ...+++|||+.+++|.+++... .
T Consensus 19 ~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-~ 95 (260)
T cd05069 19 FGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEG-D 95 (260)
T ss_pred CCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhC-C
Confidence 689999998777789999875432 334678899999999999999999998764 4678999999999999998653 2
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..+..++.|++.||+|||+.| ++|+||+|+||++++++.++|+|||++.......... .....++..|+|
T Consensus 96 ~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~ 171 (260)
T cd05069 96 GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTA 171 (260)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc-cCCCccchhhCC
Confidence 334788999999999999999999998 9999999999999999999999999998764332211 112234567999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||...+..++.++||||||+++|+|++ |..||....... .... ....... ..+......+.++
T Consensus 172 Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~-~~~~~~~---------~~~~~~~~~~~~l 235 (260)
T cd05069 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLEQ-VERGYRM---------PCPQGCPESLHEL 235 (260)
T ss_pred HHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HHcCCCC---------CCCcccCHHHHHH
Confidence 999888889999999999999999999 888885432211 0011 1010000 0111223468889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||..+|++||++++|++.|+.
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHccCCcccCcCHHHHHHHHhc
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=268.54 Aligned_cols=244 Identities=30% Similarity=0.433 Sum_probs=188.5
Q ss_pred CCccEEeeeCC-------CCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLAD-------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||.++..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++..+...++||||+++++|.
T Consensus 8 ~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (269)
T cd05044 8 FGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLL 87 (269)
T ss_pred ceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHH
Confidence 68999998642 2578999875443 344567889999999999999999999999988999999999999999
Q ss_pred hHhhcCC----CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-----CeeeecccceeeeCCC
Q 021771 73 VFLFDST----RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-----NPKISDFGMARIFGGN 143 (308)
Q Consensus 73 ~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-----~~kl~dfg~~~~~~~~ 143 (308)
+++.... ....+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++ .++|+|||++......
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~ 164 (269)
T cd05044 88 SYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS 164 (269)
T ss_pred HHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccc
Confidence 9986532 1234788999999999999999999997 99999999999999887 7999999998765433
Q ss_pred CCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccc
Q 021771 144 QSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEP 222 (308)
Q Consensus 144 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (308)
..........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ........
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------~~~-~~~~~~~~----- 232 (269)
T cd05044 165 DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------VLQ-HVTAGGRL----- 232 (269)
T ss_pred cccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------HHH-HHhcCCcc-----
Confidence 22222222344678999999988889999999999999999998 888885332211 000 00011000
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
.........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 ----QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0111223467889999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.58 Aligned_cols=240 Identities=22% Similarity=0.338 Sum_probs=190.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .+++.+++|.+........+.+..|+.+++.++|+||+++++++.+.+..+++|||+++++|.+++....
T Consensus 16 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~ 95 (262)
T cd06613 16 YGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR 95 (262)
T ss_pred ceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc
Confidence 689999985 5788999999976666667889999999999999999999999999999999999999999999885532
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.+|.|||++| ++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 96 --~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~ 168 (262)
T cd06613 96 --GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWM 168 (262)
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCcccc
Confidence 35889999999999999999999997 99999999999999999999999999876542211 112235677899
Q ss_pred CchhhccC---cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 160 APEYAMEG---LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 160 aPE~~~~~---~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
|||.+.+. .++.++|+||||+++|+|++|..||........ ..... .... .... ..........+
T Consensus 169 ~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~~~-~~~~---~~~~--~~~~~~~~~~~ 236 (262)
T cd06613 169 APEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFLIS-KSNF---PPPK--LKDKEKWSPVF 236 (262)
T ss_pred CchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-hccC---CCcc--ccchhhhhHHH
Confidence 99998766 788999999999999999999999854322110 00000 0000 0000 01122334568
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.+|.+|||+.+|+.
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhc
Confidence 89999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=273.22 Aligned_cols=246 Identities=29% Similarity=0.417 Sum_probs=188.3
Q ss_pred CCccEEeeeC--------CCCEEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKLA--------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||.||+++.. .+..+++|.+... .......+..|+.+++.+ +|+||+++++++.++...+++|||+++++
T Consensus 25 ~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 104 (314)
T cd05099 25 FGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGN 104 (314)
T ss_pred cccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCc
Confidence 6899998742 3557899988644 233456788999999999 59999999999999889999999999999
Q ss_pred hhhHhhcCC-------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 71 LDVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 71 L~~~l~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
|.+++.... ....+++..+..++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++
T Consensus 105 L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~ 181 (314)
T cd05099 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLA 181 (314)
T ss_pred HHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEcccccc
Confidence 999986532 1235888899999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~ 254 (314)
T cd05099 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-------LFKLLREGHR 254 (314)
T ss_pred ccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 76543222111111223457999999988889999999999999999998 778875432211 1111111111
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
.. .+......+.+++.+||+.+|++|||+.++++.|....
T Consensus 255 ~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 255 MD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 11 11122335888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=286.37 Aligned_cols=246 Identities=19% Similarity=0.222 Sum_probs=176.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeC--------CeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--------NESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L 71 (308)
||.||+|.. .+++.||||++.... ....+|+.+|+.++|+||+++++++... ..+++||||+++ ++
T Consensus 79 fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l 153 (440)
T PTZ00036 79 FGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TV 153 (440)
T ss_pred CEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cH
Confidence 799999996 578999999885432 2345799999999999999999887432 246789999975 66
Q ss_pred hhHhhcC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCcccc
Q 021771 72 DVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 72 ~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
.+++... .....+++..++.++.||+.||+|||+.| |+||||||+||+++.++ .+||+|||++..+..... .
T Consensus 154 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~ 227 (440)
T PTZ00036 154 HKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---S 227 (440)
T ss_pred HHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---c
Confidence 6665432 23456899999999999999999999998 99999999999999665 699999999986543221 1
Q ss_pred ceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH-------hh-------hcc
Q 021771 150 NRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK-------LW-------CEG 214 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~-------~~-------~~~ 214 (308)
....++..|+|||++.+. .++.++|||||||++|+|++|.+||........ +...... .+ ...
T Consensus 228 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p~~~~~~~~~~~~~~~ 305 (440)
T PTZ00036 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPTEDQLKEMNPNYADI 305 (440)
T ss_pred ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhchhhhcc
Confidence 224568899999987664 689999999999999999999999965432211 0000000 00 000
Q ss_pred cccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 215 EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.........+....+.....++.+|+.+||+.||++|||+.|+++
T Consensus 306 ~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred cCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000000001111122346889999999999999999999984
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=280.47 Aligned_cols=248 Identities=19% Similarity=0.234 Sum_probs=184.2
Q ss_pred CCccEEeeeC---CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||++... .++.|++|.+... ....+|+.+|+.++|+||+++++++......+++||++. ++|.+++.
T Consensus 105 ~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~- 177 (392)
T PHA03207 105 EGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD- 177 (392)
T ss_pred CeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH-
Confidence 7899998743 4678999987533 235689999999999999999999999999999999995 57777773
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
....+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++................|+..
T Consensus 178 --~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~ 252 (392)
T PHA03207 178 --RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252 (392)
T ss_pred --hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccC
Confidence 2345899999999999999999999998 99999999999999999999999999977654333333334568999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccc--cc-----cc------ccccc
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGE--AL-----EL------MEPVL 224 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~------~~~~~ 224 (308)
|+|||++.+..++.++|||||||++|+|++|+.||...........+....+...... .. .+ +....
T Consensus 253 y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (392)
T PHA03207 253 TNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVL 332 (392)
T ss_pred ccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccc
Confidence 9999999888899999999999999999999999855433221111111111000000 00 00 00000
Q ss_pred cccch-------HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 225 KQSCV-------AAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 225 ~~~~~-------~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..... .....++.++|.+||+.||++|||+.|++..
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 333 RPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0112357788999999999999999999975
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=258.96 Aligned_cols=228 Identities=28% Similarity=0.381 Sum_probs=179.1
Q ss_pred CCCCEEEEEEeccC----CcccH----HHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 10 ADGKEIAVKRLSRT----SGQGL----QEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 10 ~~g~~vavK~~~~~----~~~~~----~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
++|+.+|+|++... .+... +.-..|+.+|+++. ||+|+++.++++.+...++|+|.|+.|.|.+++ .+
T Consensus 40 ~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL---ts 116 (411)
T KOG0599|consen 40 ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL---TS 116 (411)
T ss_pred ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh---hh
Confidence 57999999988543 22222 33457999999996 999999999999999999999999999999999 45
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++++...++.|++++++|||.+. |||||+||+|||++++-+++|+|||++..+... ..-...+||+.|.|
T Consensus 117 ~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~G---ekLrelCGTPgYLA 190 (411)
T KOG0599|consen 117 KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPG---EKLRELCGTPGYLA 190 (411)
T ss_pred heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccCCc---hhHHHhcCCCcccC
Confidence 566999999999999999999999995 999999999999999999999999999986533 22334689999999
Q ss_pred chhhc------cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 161 PEYAM------EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 161 PE~~~------~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
||.+. ...|+...|+|++|+++|-|+.|.+||-...+-.-...+...+-.+.+.++ .+...
T Consensus 191 PEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW-------------adis~ 257 (411)
T KOG0599|consen 191 PETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW-------------ADISA 257 (411)
T ss_pred hhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch-------------hhccc
Confidence 99875 246888999999999999999999998543222111111111111111111 12233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...+||.+||+.||.+|.|++|+|+
T Consensus 258 ~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 258 TVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred cHHHHHHHHHeeCchhcccHHHHhc
Confidence 5788999999999999999999984
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=280.00 Aligned_cols=239 Identities=20% Similarity=0.221 Sum_probs=182.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.+|+|++... .......+.+|+.+++.++||||+++++++.++...++||||+++++|.+++.
T Consensus 56 fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~ 135 (370)
T cd05621 56 FGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS 135 (370)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 799999996 57899999998542 22334567889999999999999999999999999999999999999999884
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++........ .......|+.
T Consensus 136 ~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~ 207 (370)
T cd05621 136 NY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTP 207 (370)
T ss_pred hc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCc
Confidence 32 4788999999999999999999998 99999999999999999999999999987643221 1123346899
Q ss_pred CccCchhhccC----cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 157 GYMAPEYAMEG----LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 157 ~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.|+|||++.+. .++.++|||||||++|+|++|..||...... ................. ....
T Consensus 208 ~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~p~-------~~~~ 274 (370)
T cd05621 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLNFPE-------DVEI 274 (370)
T ss_pred ccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccCCCC-------cccC
Confidence 99999988653 3778999999999999999999999643221 11111111111011000 0112
Q ss_pred HHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSAD--RPTMSSVVVM 260 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~--RPs~~eil~~ 260 (308)
...+.+++..|++.++.. |+|+.|+++.
T Consensus 275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 334677788888755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=270.32 Aligned_cols=250 Identities=28% Similarity=0.426 Sum_probs=191.0
Q ss_pred CCccEEeeeC-----CCCEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEe--CCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLA-----DGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~ 72 (308)
||.||++++. +++.+|+|++...... ....+.+|+.+++.++|+||+++++++.. ....+++|||+++++|.
T Consensus 17 ~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~ 96 (284)
T cd05038 17 FGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLR 96 (284)
T ss_pred CeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHH
Confidence 7899999853 4789999998755443 45688999999999999999999999887 55789999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-ccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-NTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-~~~~ 151 (308)
+++..... .+++..+..++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||.+.......... ....
T Consensus 97 ~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 171 (284)
T cd05038 97 DYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEP 171 (284)
T ss_pred HHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCC
Confidence 99865332 4889999999999999999999998 9999999999999999999999999998765221111 1111
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcccccccc--------chhHHHHHhhhccccccccccc
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQ--------SLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
..++..|++||...+..++.++||||||+++|+|++|..|+......... ..............
T Consensus 172 ~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 243 (284)
T cd05038 172 GESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE-------- 243 (284)
T ss_pred CCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC--------
Confidence 23455799999988888899999999999999999999887543222111 00111111111110
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
....+......+.+++.+||+.+|++|||+.||++.|+..
T Consensus 244 -~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 244 -RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0111112235688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=270.37 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=188.0
Q ss_pred CCccEEeee-----CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-----ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+++.|++|.+.... ......+.+|+.+++.++|+||+++++++.+. ...++||||+++++|.
T Consensus 17 ~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~ 96 (284)
T cd05079 17 FGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 96 (284)
T ss_pred ceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHH
Confidence 789999873 468899999986543 33456788999999999999999999998875 5689999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 151 (308)
+++.... ..+++..+..++.|++.+|+|||++| ++|+||+|+||+++.++.++|+|||++..+...... .....
T Consensus 97 ~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 171 (284)
T cd05079 97 EYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 171 (284)
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCC
Confidence 9985432 24889999999999999999999998 999999999999999999999999998876433221 11122
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcccccc--------ccchhHHHHHhhhccccccccccc
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSEL--------GQSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
..++..|+|||.+.+..++.++||||||+++|+|+++..|........ ..................
T Consensus 172 ~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 245 (284)
T cd05079 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL------ 245 (284)
T ss_pred CCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccC------
Confidence 345667999999888888999999999999999999876542211100 000000000001111000
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.........+.+|+.+||+.+|++|||+.++++.|+..
T Consensus 246 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 246 ---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 01111234688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.38 Aligned_cols=233 Identities=22% Similarity=0.362 Sum_probs=180.1
Q ss_pred CCccEEeeeCC-------------CCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecC
Q 021771 1 MESCLQGKLAD-------------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67 (308)
Q Consensus 1 ~g~v~~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 67 (308)
||.||+|++.+ ...+++|.+..........+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 8 ~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 87 (262)
T cd05077 8 RTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVE 87 (262)
T ss_pred cceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEeccc
Confidence 78999998532 33589998866555556678899999999999999999999999888999999999
Q ss_pred CCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC-------eeeecccceeee
Q 021771 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN-------PKISDFGMARIF 140 (308)
Q Consensus 68 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~-------~kl~dfg~~~~~ 140 (308)
+++|..++... ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++. ++++|||++...
T Consensus 88 ~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~ 162 (262)
T cd05077 88 FGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV 162 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccc
Confidence 99999887543 235889999999999999999999998 999999999999987664 899999988654
Q ss_pred CCCCCccccceeecccCccCchhhc-cCcccccccchhhhHHHHHHH-hCCcCCCccccccccchhHHHHHhhhcccccc
Q 021771 141 GGNQSEANTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEII-SGKKNTGFYLSELGQSLLSYTWKLWCEGEALE 218 (308)
Q Consensus 141 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (308)
... ....++..|+|||.+. +..++.++|||||||++|+|+ .|..|+....... ..... .... .
T Consensus 163 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~-~~~~-~ 227 (262)
T cd05077 163 LSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFY-EGQC-M 227 (262)
T ss_pred cCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHH-hcCc-c
Confidence 321 1234577899999876 456889999999999999998 5777765322111 00111 1100 0
Q ss_pred cccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 219 LMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
. ......++.+|+.+||+.||++||++.+|++.++
T Consensus 228 ~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 228 L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0112345788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=267.25 Aligned_cols=239 Identities=24% Similarity=0.301 Sum_probs=186.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++.. .+++.+|+|.+.... ......+..|+.+++.++|++|+.+++.+.+++..++||||+.+++|.+++.
T Consensus 13 ~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 92 (285)
T cd05630 13 FGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 92 (285)
T ss_pred CeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHH
Confidence 799999985 579999999886542 2223456789999999999999999999999999999999999999998885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ....+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++........ .....++.
T Consensus 93 ~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~ 165 (285)
T cd05630 93 HM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTV 165 (285)
T ss_pred Hh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCc
Confidence 43 2235889999999999999999999998 99999999999999999999999999876532211 12235788
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++||||+|+++|+|++|..||........... ...... .... .........+
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~--~~~~--------~~~~~~~~~~ 232 (285)
T cd05630 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVK--EVQE--------EYSEKFSPDA 232 (285)
T ss_pred cccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhh--hhhh--------hcCccCCHHH
Confidence 99999999888899999999999999999999999965332211000 000000 0000 0011122357
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHH
Q 021771 237 IHIGLLCVQADSADRPT-----MSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs-----~~eil~ 259 (308)
.+|+.+||+.||++||| ++|+++
T Consensus 233 ~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 233 RSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred HHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 88899999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=263.12 Aligned_cols=236 Identities=24% Similarity=0.372 Sum_probs=188.4
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++.+ +++.+++|.+..... .+.+.+|+.+++.++|+||+++++++.++...++++||+++++|.+++...
T Consensus 16 ~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~- 92 (256)
T cd06612 16 YGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT- 92 (256)
T ss_pred CeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhC-
Confidence 6889999975 589999999864432 678999999999999999999999999999999999999999999988543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
...+++..+..++.|++.++.|||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 93 -~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 166 (256)
T cd06612 93 -NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWM 166 (256)
T ss_pred -ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCcccc
Confidence 235899999999999999999999998 99999999999999999999999999887543321 122344678899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||.+.+..++.++||||+|+++|+|++|..||.......... .. ..... .. ...+......+.++
T Consensus 167 ~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~------~~--~~~~~----~~--~~~~~~~~~~~~~~ 232 (256)
T cd06612 167 APEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF------MI--PNKPP----PT--LSDPEKWSPEFNDF 232 (256)
T ss_pred CHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh------hh--ccCCC----CC--CCchhhcCHHHHHH
Confidence 9999988888999999999999999999999986432221100 00 00000 00 00111223458889
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
+.+||+.+|++|||++++++
T Consensus 233 i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 233 VKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHhcChhhCcCHHHHhc
Confidence 99999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=263.34 Aligned_cols=241 Identities=32% Similarity=0.453 Sum_probs=186.6
Q ss_pred CCccEEeeeC-C---CCEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-D---GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|+.. . +..+++|.+..... ...+.+.+|+.+++.+.|+||+++++++.. ...++||||+++++|.+++
T Consensus 8 ~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l 86 (257)
T cd05060 8 FGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYL 86 (257)
T ss_pred ceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHH
Confidence 7899999742 2 27899999865533 345678899999999999999999998764 4679999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc-cceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN-TNRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~ 154 (308)
.... .+++..+..++.|++.+++|||..+ ++|+||+|+||+++.++.++|+|||++........... .....+
T Consensus 87 ~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05060 87 KKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW 160 (257)
T ss_pred HhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccc
Confidence 5433 5899999999999999999999997 99999999999999999999999999887643322211 111123
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||...+..++.++||||||+++|++++ |..||....... ... ........ ..+....
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~----~~~~~~~~---------~~~~~~~ 224 (257)
T cd05060 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIA----MLESGERL---------PRPEECP 224 (257)
T ss_pred cccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHH----HHHcCCcC---------CCCCCCC
Confidence 457999999988889999999999999999997 899986442211 111 11111000 0111122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+++.+||+.+|++|||+.+|++.|+..
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 4588899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.89 Aligned_cols=236 Identities=23% Similarity=0.353 Sum_probs=188.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||++.. .+|+.+++|.+........+.+.+|+.+++.++|+||+++++++..+...++|+||+++++|..++..
T Consensus 32 ~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-- 109 (296)
T cd06655 32 SGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-- 109 (296)
T ss_pred CeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--
Confidence 689999984 68999999998766555567888999999999999999999999999999999999999999998843
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.++++||+.| ++|+||+|+||+++.++.++|+|||++......... .....++..|+
T Consensus 110 --~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~ 182 (296)
T cd06655 110 --TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWM 182 (296)
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCcccc
Confidence 24889999999999999999999998 999999999999999999999999998765432221 12235678899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||.+.+..++.++|+|||||++|+|++|..||......... ...... ..... ..+......+.++
T Consensus 183 aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~-~~~~~-------~~~~~~~~~~~~l 248 (296)
T cd06655 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATN-GTPEL-------QNPEKLSPIFRDF 248 (296)
T ss_pred CcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhc-CCccc-------CCcccCCHHHHHH
Confidence 999988888899999999999999999999998654322110 000000 00000 0011122357788
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
+.+||+.+|++|||+.+|++
T Consensus 249 i~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHhhcChhhCCCHHHHhh
Confidence 99999999999999999994
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=282.97 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=197.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||.|+. .+...+|||-+...+....+-+.+|+.+=++|+|.|||++++.+..++.+-++||..+||+|.+++...-
T Consensus 588 YG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW 667 (1226)
T KOG4279|consen 588 YGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW 667 (1226)
T ss_pred eeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc
Confidence 799999995 5778889999998888888899999999999999999999999999999999999999999999997654
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC-CCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
+-..-.+.++-.+..||+++|.|||.+. |||||||-+|++|+ -.|.+||.|||.++++..-. .-+..+.||..|
T Consensus 668 GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TETFTGTLQY 742 (1226)
T KOG4279|consen 668 GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQY 742 (1226)
T ss_pred CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--ccccccccchhh
Confidence 3322388889999999999999999996 99999999999997 56789999999998864322 223446789999
Q ss_pred cCchhhccC--cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 159 MAPEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 159 ~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
||||++.++ .|..++|||||||++.+|.+|++||-..-.... ..+.-+ .-......+.+..++.
T Consensus 743 MAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------AMFkVG------myKvHP~iPeelsaea 808 (1226)
T KOG4279|consen 743 MAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------AMFKVG------MYKVHPPIPEELSAEA 808 (1226)
T ss_pred hChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------hhhhhc------ceecCCCCcHHHHHHH
Confidence 999999865 588999999999999999999999843211100 001100 0111234566777889
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+|.+|+..+|.+||+++++|+-
T Consensus 809 k~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 809 KNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHcCCCcccCccHHHhccC
Confidence 999999999999999999999964
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=269.16 Aligned_cols=236 Identities=22% Similarity=0.334 Sum_probs=188.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.|++|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+++++|.+++..
T Consensus 32 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-- 109 (297)
T cd06656 32 SGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-- 109 (297)
T ss_pred CeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--
Confidence 689999985 68999999999766555567788999999999999999999999999999999999999999998843
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||++......... .....++..|+
T Consensus 110 --~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~ 182 (297)
T cd06656 110 --TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWM 182 (297)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCcccc
Confidence 24788899999999999999999998 999999999999999999999999998765433211 12235678899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||.+.+..++.++|+||+|+++|++++|..||........... ..... ... ...+......+.++
T Consensus 183 aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~-~~~-------~~~~~~~~~~~~~l 248 (297)
T cd06656 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-TPE-------LQNPERLSAVFRDF 248 (297)
T ss_pred CHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC-CCC-------CCCccccCHHHHHH
Confidence 99999888889999999999999999999999854322111000 00000 000 00111223457788
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
+.+||+.+|++|||++++++
T Consensus 249 i~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 249 LNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred HHHHccCChhhCcCHHHHhc
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=282.86 Aligned_cols=249 Identities=30% Similarity=0.416 Sum_probs=195.0
Q ss_pred CCccEEeeeC--CC--CE-EEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLA--DG--KE-IAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~--~g--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+|+++ ++ .. ||+|..... .......+.+|+.+|+.++||||+++||+......+++|||+|+||+|.
T Consensus 170 FGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~ 249 (474)
T KOG0194|consen 170 FGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLD 249 (474)
T ss_pred ccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHH
Confidence 8999999964 33 23 799988642 3556778899999999999999999999999999999999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+++....+ .++..+...++.+.+.||+|||+++ ++||||-..|+|++.++.+|++|||++.... .........
T Consensus 250 ~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--~~~~~~~~~ 322 (474)
T KOG0194|consen 250 DYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS--QYVMKKFLK 322 (474)
T ss_pred HHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc--ceeeccccc
Confidence 99976543 5889999999999999999999996 9999999999999999999999999987632 111111111
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.-...|+|||.+..+.++.++||||+|+++||+++ |..||....... ...+....+ .+...+..
T Consensus 323 klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------v~~kI~~~~---------~r~~~~~~ 387 (474)
T KOG0194|consen 323 KLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------VKAKIVKNG---------YRMPIPSK 387 (474)
T ss_pred cCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH------HHHHHHhcC---------ccCCCCCC
Confidence 24578999999999999999999999999999998 677875443321 111110111 11111223
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCCCC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQP 271 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~ 271 (308)
....+..++.+||..+|++|||+.++.+.|+........+
T Consensus 388 ~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 388 TPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred CHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 3345666777999999999999999999999886666544
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=266.34 Aligned_cols=242 Identities=28% Similarity=0.401 Sum_probs=185.3
Q ss_pred CCccEEeeeC-CCC--EEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGK--EIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++.. +|. .+++|.+... .....+.+..|+.++.++ +||||+++++++...+..++||||+++++|.+++
T Consensus 8 ~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i 87 (270)
T cd05047 8 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 87 (270)
T ss_pred CceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHH
Confidence 7999999964 454 4688887643 234456788999999999 7999999999999999999999999999999998
Q ss_pred hcCC-------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 76 FDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 76 ~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
.... ....+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~ 164 (270)
T cd05047 88 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV 164 (270)
T ss_pred HhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccch
Confidence 6532 1234788999999999999999999998 99999999999999999999999998753211
Q ss_pred CCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELME 221 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
. ........+..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. .........+
T Consensus 165 ~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~-~~~~~~~~~~--- 231 (270)
T cd05047 165 Y---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY-EKLPQGYRLE--- 231 (270)
T ss_pred h---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HH-HHHhCCCCCC---
Confidence 1 01111123457999999888888999999999999999996 889985432111 00 1111110001
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
........+.+++.+||+.+|.+|||+.++++.|+..
T Consensus 232 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 232 ------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0111223578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=300.30 Aligned_cols=249 Identities=31% Similarity=0.455 Sum_probs=200.5
Q ss_pred CCccEEeeeC--CCC----EEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA--DGK----EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~--~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||.|... +|. .||+|.+.+. +......|.+|..+|+.++||||+++++++.+....++++|||.+|+|..
T Consensus 705 FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~s 784 (1025)
T KOG1095|consen 705 FGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLS 784 (1025)
T ss_pred ccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHH
Confidence 8999999964 343 3899988765 45567789999999999999999999999999889999999999999999
Q ss_pred HhhcCC----CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc
Q 021771 74 FLFDST----RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 74 ~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
+++... +...++....+.++.+|++++.||++++ +|||||...|+|++....+|++|||+|+-+....+....
T Consensus 785 flr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~ 861 (1025)
T KOG1095|consen 785 FLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKH 861 (1025)
T ss_pred HHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheecc
Confidence 997652 2346899999999999999999999996 999999999999999999999999999844333333333
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
....-...|||||.+..+.++.|+||||+|+++||+++ |..||........... +..+- +-+.
T Consensus 862 ~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~-------~~~gg---------RL~~ 925 (1025)
T KOG1095|consen 862 GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD-------VLEGG---------RLDP 925 (1025)
T ss_pred CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-------HHhCC---------ccCC
Confidence 33344568999999999999999999999999999998 5577765443321110 00111 2233
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
+..+..++++++.+||+.+|++||++..|++.+.......
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 5556667889999999999999999999999887764433
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=267.31 Aligned_cols=239 Identities=23% Similarity=0.336 Sum_probs=186.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .++..+++|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+++++|..++...
T Consensus 18 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~- 96 (282)
T cd06643 18 FGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL- 96 (282)
T ss_pred CeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhc-
Confidence 689999996 468889999987666556677889999999999999999999999999999999999999998887542
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
...+++..+..++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 97 -~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~ 170 (282)
T cd06643 97 -ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWM 170 (282)
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--cccccccccccc
Confidence 235899999999999999999999998 99999999999999999999999999876532211 122235778899
Q ss_pred Cchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 160 APEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 160 aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
|||++. +..++.++||||+||++|+|++|.+||...... ......... ...... .+.....
T Consensus 171 aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~-~~~~~~-------~~~~~~~ 236 (282)
T cd06643 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKS-EPPTLA-------QPSRWSS 236 (282)
T ss_pred CHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhc-CCCCCC-------CccccCH
Confidence 999874 345778999999999999999999998643211 001111000 000000 0111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 58889999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=262.79 Aligned_cols=240 Identities=33% Similarity=0.476 Sum_probs=188.0
Q ss_pred CCccEEeeeCC-----CCEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLAD-----GKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||.++..+ +..+++|.+...... ....+..|+..++.++|+||+++++++.+.+..+++|||+++++|.++
T Consensus 12 ~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~ 91 (258)
T smart00219 12 FGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDY 91 (258)
T ss_pred CcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHH
Confidence 79999999643 488999998655433 567889999999999999999999999999999999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+..... ..+++..+..++.|++.+|++||+.| ++|+||+|+||+++.++.++|+|||++............ ...+
T Consensus 92 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~ 166 (258)
T smart00219 92 LRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKL 166 (258)
T ss_pred HHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCC
Confidence 855322 12899999999999999999999998 999999999999999999999999999876543221111 1235
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||...+..++.++||||||+++|+|++ |.+||....... ... ......... ......
T Consensus 167 ~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~~-~~~~~~~~~---------~~~~~~ 230 (258)
T smart00219 167 PIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VLE-YLKKGYRLP---------KPENCP 230 (258)
T ss_pred cccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH-HHhcCCCCC---------CCCcCC
Confidence 678999999888889999999999999999998 677775421111 000 111111111 011133
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L 261 (308)
..+.+++.+||+.+|++|||+.++++.|
T Consensus 231 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 231 PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 4588899999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=262.78 Aligned_cols=239 Identities=27% Similarity=0.434 Sum_probs=187.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||++...++..+++|.+.... .....+..|+++++.++|+||+++++++......++||||+.+++|.+++....
T Consensus 17 ~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~- 94 (256)
T cd05112 17 FGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR- 94 (256)
T ss_pred cceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc-
Confidence 689999998778899999885432 334678899999999999999999999999999999999999999999885432
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
..+++..++.++.|++.++++||+.| ++|+||+|+||+++.++.++|+|||.+.......... .....++..|+|
T Consensus 95 -~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~~~a 169 (256)
T cd05112 95 -GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSS 169 (256)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc-cCCCccchhhcC
Confidence 34788999999999999999999998 9999999999999999999999999987654322211 111234568999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++||||||+++|+|++ |..||....... ..... ... .....+ . .....+.+|
T Consensus 170 Pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~--~~~~~~---~----~~~~~~~~l 233 (256)
T cd05112 170 PEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETI-NAG--FRLYKP---R----LASQSVYEL 233 (256)
T ss_pred HhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHH-hCC--CCCCCC---C----CCCHHHHHH
Confidence 999888888999999999999999998 888886433221 01110 000 000011 0 112458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhh
Q 021771 240 GLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~ 262 (308)
+.+||+.+|++|||+.++++.|.
T Consensus 234 ~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 234 MQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHcccChhhCCCHHHHHHhhC
Confidence 99999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=279.70 Aligned_cols=180 Identities=22% Similarity=0.284 Sum_probs=152.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. ..++.|+||.... ..+.+|+.+|++++|+||+++++++..+...++|||++. ++|..++....
T Consensus 182 ~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 254 (461)
T PHA03211 182 EGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARL 254 (461)
T ss_pred CeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcC
Confidence 789999996 5688999996421 335689999999999999999999999999999999995 57777774422
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..++.++.|++.+|.|||++| |+|+||||+|||++.++.++|+|||++................|+..|+
T Consensus 255 --~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~ 329 (461)
T PHA03211 255 --RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329 (461)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCc
Confidence 35899999999999999999999998 9999999999999999999999999998764332222222346899999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCC
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNT 192 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~ 192 (308)
|||++.+..++.++|||||||++|+|++|..++
T Consensus 330 APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 330 APEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred CHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 999999888999999999999999999987653
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=269.35 Aligned_cols=245 Identities=27% Similarity=0.402 Sum_probs=187.0
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++||||+++++|.+
T Consensus 19 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~ 98 (288)
T cd05061 19 FGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKS 98 (288)
T ss_pred CcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHH
Confidence 7899998743 35689999876443 2334467789999999999999999999999999999999999999999
Q ss_pred HhhcCCC-------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 74 FLFDSTR-------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 74 ~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
++..... ....+...+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++.........
T Consensus 99 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~ 175 (288)
T cd05061 99 YLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 175 (288)
T ss_pred HHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccc
Confidence 9965321 233566778899999999999999998 999999999999999999999999998765332222
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .............
T Consensus 176 ~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~~~------ 242 (288)
T cd05061 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLKFVMDGGYLDQ------ 242 (288)
T ss_pred cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC------
Confidence 21222234567999999888888999999999999999998 677875432211 1111111111110
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+......+.+++.+||+.+|++|||+.++++.|...
T Consensus 243 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 243 ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred ---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 011124688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=264.37 Aligned_cols=240 Identities=25% Similarity=0.362 Sum_probs=185.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+|+. .++..+++|.+........+.+.+|+.+++.++|+||+++++++..++..++|+||+++++|.+++....
T Consensus 21 ~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 100 (268)
T cd06624 21 YGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW 100 (268)
T ss_pred ceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc
Confidence 789999995 5788999999876666666788999999999999999999999999999999999999999999986532
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-CCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
.....++..+..++.|++.||+|||+.| ++|+||+|+||+++. ++.++|+|||++........ ......++..|
T Consensus 101 ~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~ 175 (268)
T cd06624 101 GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQY 175 (268)
T ss_pred ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccc
Confidence 2212377888899999999999999998 999999999999976 67899999999876542221 11223467889
Q ss_pred cCchhhccC--cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 159 MAPEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 159 ~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
+|||.+.+. .++.++|+||+|+++|+|++|..||......... ........ . . ...+......+
T Consensus 176 ~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~---~----~----~~~~~~~~~~~ 241 (268)
T cd06624 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK---I----H----PEIPESLSAEA 241 (268)
T ss_pred cChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc---c----C----CCCCcccCHHH
Confidence 999987653 3788999999999999999999998543221100 00000000 0 0 01112223458
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.+|++|||+.++++
T Consensus 242 ~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 242 KNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HHHHHHHcCCCchhCCCHHHHHh
Confidence 88899999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=280.89 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=188.7
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||++++. .++.||+|+++... ....+.+..|+.+|..+. |+||+++++++......++|||||++++|.
T Consensus 50 fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~ 129 (401)
T cd05107 50 FGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLV 129 (401)
T ss_pred ceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHH
Confidence 7999999853 35689999997543 333457889999999997 999999999999999999999999999999
Q ss_pred hHhhcCCC------------------------------------------------------------------------
Q 021771 73 VFLFDSTR------------------------------------------------------------------------ 80 (308)
Q Consensus 73 ~~l~~~~~------------------------------------------------------------------------ 80 (308)
++++....
T Consensus 130 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (401)
T cd05107 130 DYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNY 209 (401)
T ss_pred HHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCc
Confidence 99865321
Q ss_pred -----------------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 81 -----------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 81 -----------------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
...+++..+..++.||+.||+|||+.+ ++|+||||.||++++++.++|+|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla 286 (401)
T cd05107 210 ESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLA 286 (401)
T ss_pred CCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcc
Confidence 123566778899999999999999997 999999999999999999999999999
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ........+..
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~~~~~~~~~~~ 360 (401)
T cd05107 287 RDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------QFYNAIKRGYR 360 (401)
T ss_pred eecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------HHHHHHHcCCC
Confidence 86543222111222345678999999988888999999999999999998 888875432111 00111111100
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.. .+......+.+|+.+||..+|++||++++|++.|+..
T Consensus 361 ~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 361 MA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00 0111234688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=278.64 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=183.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-----eEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-----ESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~ 72 (308)
||.||++.. .+|+.||+|++... .......+.+|+.+++.++|+||+++++++.... ..++||||+. ++|.
T Consensus 13 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 91 (372)
T cd07853 13 FGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLH 91 (372)
T ss_pred CEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHH
Confidence 799999995 68999999998643 2234457889999999999999999999998776 7899999996 5777
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
..+.. ...+++..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 92 ~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~ 164 (372)
T cd07853 92 KIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK-HMTQE 164 (372)
T ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCccc-cCCCC
Confidence 76643 335899999999999999999999998 999999999999999999999999999865432211 11223
Q ss_pred ecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHH----------------HHHhhhcc-
Q 021771 153 VGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY----------------TWKLWCEG- 214 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----------------~~~~~~~~- 214 (308)
.++..|+|||.+.+. .++.++||||+||++|+|++|+.||...........+.. ........
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 244 (372)
T cd07853 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP 244 (372)
T ss_pred CcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCC
Confidence 567889999988764 478899999999999999999999965432211000000 00000000
Q ss_pred cccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 215 EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.......... .........+.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 245 HKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred CCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 0011123468889999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=272.41 Aligned_cols=247 Identities=29% Similarity=0.410 Sum_probs=188.9
Q ss_pred CCccEEeeeC--------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKLA--------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||.||.+... .+..+++|.+.... ......+..|+.+++++ +|+||+++++++..+...+++|||+++++
T Consensus 25 ~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 104 (334)
T cd05100 25 FGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104 (334)
T ss_pred CCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCc
Confidence 7899998742 22368999886442 33456788999999999 79999999999999989999999999999
Q ss_pred hhhHhhcCC-------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 71 LDVFLFDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 71 L~~~l~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
|.+++.... ....+++..+..++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++
T Consensus 105 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~ 181 (334)
T cd05100 105 LREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLA 181 (334)
T ss_pred HHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccc
Confidence 999986532 1234778889999999999999999998 999999999999999999999999998
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~ 254 (334)
T cd05100 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-------LFKLLKEGHR 254 (334)
T ss_pred eecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 87543222211222233457999999988889999999999999999998 778875432211 1111111111
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCC
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTV 266 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~ 266 (308)
.. .+......+.+++.+||+.+|++|||+.++++.|.....
T Consensus 255 ~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 255 MD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 111223358889999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=265.35 Aligned_cols=237 Identities=27% Similarity=0.420 Sum_probs=186.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc---------cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ---------GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||.||.|.. .+++.+++|.+...... ..+.+..|+.+++.++|+||+++++++.+....++||||+++++
T Consensus 13 ~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (267)
T cd06628 13 FGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGS 92 (267)
T ss_pred CeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCC
Confidence 689999985 57899999988654322 12567889999999999999999999999999999999999999
Q ss_pred hhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc---
Q 021771 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA--- 147 (308)
Q Consensus 71 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~--- 147 (308)
|.+++... ..+++..+..++.|++.+|+|||++| ++|+||+|+||+++.++.++|+|||++..........
T Consensus 93 L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06628 93 VAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTN 166 (267)
T ss_pred HHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCcc
Confidence 99998543 34888899999999999999999998 9999999999999999999999999988764321111
Q ss_pred -ccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccc
Q 021771 148 -NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226 (308)
Q Consensus 148 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...... ....+
T Consensus 167 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~------~~~~~---- 230 (267)
T cd06628 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ------AIFKIG------ENASP---- 230 (267)
T ss_pred ccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH------HHHHHh------ccCCC----
Confidence 1112346788999999988888999999999999999999999986432110 000000 00011
Q ss_pred cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 227 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..+......+.+++.+||+.+|++||++.+|++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111122345888899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=268.90 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=186.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.+++|.+... .......+.+|++++++++||||+++++++.+++..++||||+++++|.+++...
T Consensus 14 ~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~ 93 (308)
T cd06615 14 GGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 93 (308)
T ss_pred CeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc
Confidence 789999985 57889999988644 2334566889999999999999999999999999999999999999999998543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
..+++..+..++.|++++|.|||+ .+ ++|+||+|+||+++.++.++|+|||++....... .....++..
T Consensus 94 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~ 163 (308)
T cd06615 94 ---GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRS 163 (308)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcC
Confidence 348899999999999999999997 45 9999999999999999999999999986543221 122456789
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccc-----------------ccccc
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGE-----------------ALELM 220 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~ 220 (308)
|+|||.+.+..++.++|+||||+++|+|++|..||....................... ..+..
T Consensus 164 ~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (308)
T cd06615 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELL 243 (308)
T ss_pred ccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHH
Confidence 9999998888889999999999999999999999854332211110000000000000 00000
Q ss_pred ccccc---cc-chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 221 EPVLK---QS-CVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 221 ~~~~~---~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+.... .. ........+.+++.+||+.+|++|||+.+|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 244 DYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred HHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00 000123458899999999999999999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=262.06 Aligned_cols=235 Identities=28% Similarity=0.384 Sum_probs=183.2
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEE-eCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCL-EENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .|+.+++|.+... ...+.+.+|+.+++.++|+|++++++++. .++..+++|||+++++|.+++...
T Consensus 19 ~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~- 94 (256)
T cd05082 19 FGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR- 94 (256)
T ss_pred CCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc-
Confidence 689999976 4788999988543 23467889999999999999999999764 456789999999999999988653
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
....+++..++.++.|++.+|+|||++| ++|+||+|+||++++++.+||+|||++........ ....+..|+
T Consensus 95 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~ 166 (256)
T cd05082 95 GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWT 166 (256)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC-----CCccceeec
Confidence 2334888999999999999999999998 99999999999999999999999999876432211 122345799
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
|||+..+..++.++|||||||++|+|++ |..||....... ... ........ .........+.+
T Consensus 167 aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~----~~~~~~~~---------~~~~~~~~~~~~ 230 (256)
T cd05082 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP----RVEKGYKM---------DAPDGCPPVVYD 230 (256)
T ss_pred CHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhcCCCC---------CCCCCCCHHHHH
Confidence 9999988889999999999999999997 888875332111 111 01111000 011112335788
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
++.+||+.+|++|||+.++++.|+.
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHHHhc
Confidence 8999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=270.97 Aligned_cols=243 Identities=27% Similarity=0.393 Sum_probs=184.9
Q ss_pred CCccEEeee-CCCCE--EEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKE--IAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~--vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||++.. .+|.. +++|.+.... ......+.+|+.++.++ +|+||+++++++.+++..++||||+++++|.+++
T Consensus 20 ~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 99 (303)
T cd05088 20 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 99 (303)
T ss_pred CceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHH
Confidence 799999996 45654 5777765432 33445788899999999 7999999999999999999999999999999998
Q ss_pred hcCC-------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 76 FDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 76 ~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
.... ....+++..++.++.|++.|++|||++| ++|+||||+||+++.++.++|+|||++.....
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 176 (303)
T cd05088 100 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV 176 (303)
T ss_pred HhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccch
Confidence 6432 1235789999999999999999999998 99999999999999999999999999853211
Q ss_pred CCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELME 221 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
. ........+..|+|||...+..++.++||||||+++|+|++ |..||....... .. ..........
T Consensus 177 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~-~~~~~~~~~~--- 243 (303)
T cd05088 177 Y---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY-EKLPQGYRLE--- 243 (303)
T ss_pred h---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HH-HHHhcCCcCC---
Confidence 1 11111223567999999888888999999999999999998 899985332211 00 0110000000
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
.+......+.+|+.+||+.+|++|||+.++++.|+...
T Consensus 244 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 244 ------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112235788999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=264.71 Aligned_cols=238 Identities=24% Similarity=0.358 Sum_probs=186.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.+++|.+..........+..|+.+++.++|+||+++++.+..++..++||||+++++|..++....
T Consensus 25 ~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 104 (292)
T cd06644 25 FGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD 104 (292)
T ss_pred CeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc
Confidence 789999996 4699999999977666667788899999999999999999999999999999999999999988775432
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.++.|||+.| ++|+||+|+||+++.++.++|+|||++....... .......++..|+
T Consensus 105 --~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~ 177 (292)
T cd06644 105 --RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWM 177 (292)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCcccc
Confidence 34889999999999999999999997 9999999999999999999999999887543221 1122345678899
Q ss_pred Cchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 160 APEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 160 aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
|||++. ...++.++|||||||++|+|++|..||...... ....... ....... ..+.....
T Consensus 178 aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~-~~~~~~~-------~~~~~~~~ 243 (292)
T cd06644 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSEPPTL-------SQPSKWSM 243 (292)
T ss_pred CceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHh-cCCCccC-------CCCcccCH
Confidence 999874 344678999999999999999999998543211 0011110 0000000 00112233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
++.+++.+||+.+|++||+++++++
T Consensus 244 ~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 244 EFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 5788899999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=268.42 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=179.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcC---CCcCccceeeeEEeC-----CeEEEEEEecCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL---QHKNLVRLFGCCLEE-----NESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~ 69 (308)
||+||+++. .+|+.+|+|.+.... ........+|+.+++.+ +||||+++++++.+. ...+++|||+++
T Consensus 13 ~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~- 91 (288)
T cd07863 13 YGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ- 91 (288)
T ss_pred CeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-
Confidence 799999995 579999999886542 22233456677777665 699999999988652 357999999975
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
+|.+++.... ...+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++........ .
T Consensus 92 ~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~ 164 (288)
T cd07863 92 DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---L 164 (288)
T ss_pred CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCccc---C
Confidence 7877775432 234899999999999999999999998 99999999999999999999999999876542211 1
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhh---hccccccc-------
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLW---CEGEALEL------- 219 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~------- 219 (308)
....++..|+|||++.+..++.++|||||||++|+|++|.+||......... ....... ....+...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07863 165 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLPPEDDWPRDVTLPRGA 241 (288)
T ss_pred CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH---HHHHHHhCCCChhhCcccccccccc
Confidence 2235688899999998888999999999999999999999998543222110 0000000 00000000
Q ss_pred ccccc---cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 220 MEPVL---KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 220 ~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..+.. ...........+.+++.+||+.||++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 00111122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=264.29 Aligned_cols=243 Identities=28% Similarity=0.444 Sum_probs=188.2
Q ss_pred CCccEEeeeC-CCC---EEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGK---EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++.. +++ .+++|.+... .....+.+..|+.+++.++|+||+++++++.+....++||||+++++|.+++
T Consensus 18 ~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 97 (268)
T cd05063 18 FGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL 97 (268)
T ss_pred CccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHH
Confidence 6899999864 443 7899988654 2344567889999999999999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc-ceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT-NRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~ 154 (308)
.... ..+++..+..++.|++.|++|||+.| ++|+||+|+||+++.++.++|+|||++............ .....
T Consensus 98 ~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 172 (268)
T cd05063 98 RDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172 (268)
T ss_pred HhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCc
Confidence 6532 35888999999999999999999998 999999999999999999999999998766432221111 11122
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ...... ........
T Consensus 173 ~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~-i~~~~~---------~~~~~~~~ 236 (268)
T cd05063 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKA-INDGFR---------LPAPMDCP 236 (268)
T ss_pred CceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHH-HhcCCC---------CCCCCCCC
Confidence 457999999888888999999999999999997 99998543221 11111 111000 00011123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 4578999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=272.43 Aligned_cols=190 Identities=17% Similarity=0.264 Sum_probs=156.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+|+.||+|++.... ......+++|+.+++.++||||+++++++..++..++||||+++++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~ 92 (327)
T cd08227 13 LMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT 92 (327)
T ss_pred eEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHh
Confidence 578999985 689999999986542 23345678899999999999999999999999999999999999999998854
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-----ccccee
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-----ANTNRI 152 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~ 152 (308)
.. ...+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+++.||+........... ......
T Consensus 93 ~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (327)
T cd08227 93 HF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYS 168 (327)
T ss_pred hc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccc
Confidence 32 234889999999999999999999998 999999999999999999999999865433211110 001122
Q ss_pred ecccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCCCc
Q 021771 153 VGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNTGF 194 (308)
Q Consensus 153 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~ 194 (308)
.++..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 169 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 45667999998875 3588999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=267.15 Aligned_cols=242 Identities=19% Similarity=0.206 Sum_probs=181.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.||+|++... .......+.+|..+++.++|+||+++++++.+++..++||||+++++|.+++.
T Consensus 14 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 93 (331)
T cd05597 14 FGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLS 93 (331)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHH
Confidence 799999995 57999999998642 23344568889999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ...+++..+..++.||+.||+|||++| ++|+||||+||+++.++.++|+|||++..+...... ......|+.
T Consensus 94 ~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~ 167 (331)
T cd05597 94 KF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTP 167 (331)
T ss_pred Hh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccc
Confidence 43 234889999999999999999999998 999999999999999999999999998765432221 122246889
Q ss_pred CccCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 157 GYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 157 ~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.|+|||++.. ..++.++||||+||++|+|++|..||...... .................. ...
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~~~------~~~ 235 (331)
T cd05597 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQFPPD------VTD 235 (331)
T ss_pred cccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCcccCCCc------cCC
Confidence 9999998863 34678999999999999999999998643221 111111111111111000 011
Q ss_pred HHHHHHHHHhhcccC--CCCCCCCHHHHHHH
Q 021771 232 ELLKFIHIGLLCVQA--DSADRPTMSSVVVM 260 (308)
Q Consensus 232 ~~~~l~~li~~cl~~--~p~~RPs~~eil~~ 260 (308)
....+.+++.+|+.. ++..|++++++++.
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 233466777777654 33447899988865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=269.82 Aligned_cols=237 Identities=22% Similarity=0.334 Sum_probs=188.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .+++.+++|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++|.+++..
T Consensus 35 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-- 112 (292)
T cd06658 35 TGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-- 112 (292)
T ss_pred CeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--
Confidence 689999985 57999999998766555667788999999999999999999999999999999999999999998732
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.||+.+|+|||++| ++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 113 --~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~ 185 (292)
T cd06658 113 --TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWM 185 (292)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCcccc
Confidence 24888999999999999999999997 99999999999999999999999999876432221 122345788999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||...+..++.++||||+|+++|+|++|..||....... ....... .+...... .......+.++
T Consensus 186 aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~~~---------~~~~~~~~--~~~~~~~~~~l 251 (292)
T cd06658 186 APEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMRRIRD---------NLPPRVKD--SHKVSSVLRGF 251 (292)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---------cCCCcccc--ccccCHHHHHH
Confidence 9999988888999999999999999999999986432211 0000000 00111100 01122357788
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~ 260 (308)
+.+||+.+|++|||++++++.
T Consensus 252 i~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 252 LDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHccCChhHCcCHHHHhhC
Confidence 889999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=269.24 Aligned_cols=190 Identities=26% Similarity=0.414 Sum_probs=152.2
Q ss_pred CCccEEeeeC---CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe--CCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++.+ +++.||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||+.+ +|.+++
T Consensus 14 ~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 90 (317)
T cd07867 14 YGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHII 90 (317)
T ss_pred CeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHH
Confidence 7999999864 45789999886443 22457789999999999999999999854 4568999999965 666665
Q ss_pred hcC------CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe----CCCCCeeeecccceeeeCCCCC
Q 021771 76 FDS------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL----NHEMNPKISDFGMARIFGGNQS 145 (308)
Q Consensus 76 ~~~------~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv----~~~~~~kl~dfg~~~~~~~~~~ 145 (308)
... .....+++..+..++.||+.||.|||+.| ++|+||||+||++ +.++.+||+|||++........
T Consensus 91 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~ 167 (317)
T cd07867 91 KFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167 (317)
T ss_pred HhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcc
Confidence 421 12235888899999999999999999998 9999999999999 4667899999999987653322
Q ss_pred c-cccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccc
Q 021771 146 E-ANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYL 196 (308)
Q Consensus 146 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 196 (308)
. .......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||....
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 1 12233467889999998876 457899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=265.03 Aligned_cols=238 Identities=26% Similarity=0.369 Sum_probs=186.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC------cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS------GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|...+|+.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+....+++|||+++++|.++
T Consensus 13 ~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (265)
T cd06631 13 YGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSI 92 (265)
T ss_pred CeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHH
Confidence 789999998899999999886432 11235688899999999999999999999999999999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCC----Cccccc
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQ----SEANTN 150 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~----~~~~~~ 150 (308)
+... ..+++..+..++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 93 l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 166 (265)
T cd06631 93 LNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166 (265)
T ss_pred HHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcccccccccccc
Confidence 8543 34788999999999999999999998 9999999999999999999999999987643211 111112
Q ss_pred eeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc-ccccccccccccccch
Q 021771 151 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE-GEALELMEPVLKQSCV 229 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 229 (308)
...++..|+|||.+.+..++.++||||||+++|+|++|..||........ ....... ..... ..
T Consensus 167 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~---------~~ 231 (265)
T cd06631 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------MFYIGAHRGLMPR---------LP 231 (265)
T ss_pred ccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------HHHhhhccCCCCC---------CC
Confidence 23577889999999888889999999999999999999999864321110 0000000 00001 11
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
......+.+++.+||+.+|++|||+.++++
T Consensus 232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122345788999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=262.10 Aligned_cols=240 Identities=26% Similarity=0.404 Sum_probs=188.6
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||++...++..+++|.+... ....+.+.+|+.+++.++|+||+++++++.+ ...+++|||+++++|.+++... .
T Consensus 19 ~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~-~ 95 (260)
T cd05073 19 FGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-E 95 (260)
T ss_pred ceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC-C
Confidence 78999999888889999988543 3345678899999999999999999999888 6789999999999999998653 2
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..+..++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||.+..+....... .....++..|+|
T Consensus 96 ~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~y~~ 171 (260)
T cd05073 96 GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTA 171 (260)
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCccc-ccCCcccccccC
Confidence 345788899999999999999999998 9999999999999999999999999998764322211 112234567999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++|+||||+++|++++ |..||....... . ........... ........+.++
T Consensus 172 PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~----~~~~~~~~~~~---------~~~~~~~~~~~~ 235 (260)
T cd05073 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V----IRALERGYRMP---------RPENCPEELYNI 235 (260)
T ss_pred HhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---H----HHHHhCCCCCC---------CcccCCHHHHHH
Confidence 999988888999999999999999998 888886432211 0 01111110000 011223458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||+.+|++||++.++++.|+.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHHcccCcccCcCHHHHHHHHhc
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=269.54 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=183.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+++.||+|.+... .......+.+|+.+++.++|+||+++++++.+.+..++||||++ ++|..++...
T Consensus 19 ~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~ 97 (301)
T cd07873 19 YATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC 97 (301)
T ss_pred CEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhc
Confidence 689999986 47899999998644 23334567789999999999999999999999999999999996 4787777543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++......... .....++..|
T Consensus 98 --~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y 170 (301)
T cd07873 98 --GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWY 170 (301)
T ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecc
Confidence 234788999999999999999999998 999999999999999999999999998764322211 1123457889
Q ss_pred cCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhH--------HHHHh-hhcccccccccccccccc
Q 021771 159 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLS--------YTWKL-WCEGEALELMEPVLKQSC 228 (308)
Q Consensus 159 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~--------~~~~~-~~~~~~~~~~~~~~~~~~ 228 (308)
+|||.+.+ ..++.++||||||+++|+|++|.+||............. ..+.. ...........+.....+
T Consensus 171 ~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (301)
T cd07873 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADC 250 (301)
T ss_pred cCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCcccccc
Confidence 99998765 357889999999999999999999996543321100000 00000 000000000000000000
Q ss_pred ----hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 229 ----VAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 229 ----~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.......+.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 251 LHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0112335788999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.99 Aligned_cols=233 Identities=22% Similarity=0.254 Sum_probs=181.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+++.+|+|++.... .........|..++..+ .|++|+++++++.+.+..++||||+++++|..++
T Consensus 13 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~ 92 (323)
T cd05616 13 FGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI 92 (323)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHH
Confidence 799999986 478899999986542 22334566778888777 4899999999999999999999999999999888
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.||+.||+|||++| ++||||||+||+++.++.+||+|||++........ ......|+
T Consensus 93 ~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt 164 (323)
T cd05616 93 QQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164 (323)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCC
Confidence 543 34889999999999999999999998 99999999999999999999999999875432111 12234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||........ ..... .... ..+.....+
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~------~~~i~-~~~~----------~~p~~~s~~ 227 (323)
T cd05616 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIM-EHNV----------AYPKSMSKE 227 (323)
T ss_pred hhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH------HHHHH-hCCC----------CCCCcCCHH
Confidence 999999999988899999999999999999999999965432211 11111 1100 011112345
Q ss_pred HHHHHhhcccCCCCCCCCH-----HHHH
Q 021771 236 FIHIGLLCVQADSADRPTM-----SSVV 258 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~-----~eil 258 (308)
+.+++.+||+.+|++|++. .+++
T Consensus 228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~ 255 (323)
T cd05616 228 AVAICKGLMTKHPGKRLGCGPEGERDIK 255 (323)
T ss_pred HHHHHHHHcccCHHhcCCCCCCCHHHHh
Confidence 7889999999999999985 5665
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=265.81 Aligned_cols=235 Identities=26% Similarity=0.389 Sum_probs=186.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+|.. .+|+.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++||||+++++|.+++..
T Consensus 17 ~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~- 95 (277)
T cd06642 17 FGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP- 95 (277)
T ss_pred CeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-
Confidence 689999985 578899999886442 33456788999999999999999999999999999999999999999988742
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
..+++..+..++.|++.++.|||++| ++|+||+|+||+++.++.++|+|||++..+..... ......++..|
T Consensus 96 ---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y 167 (277)
T cd06642 96 ---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFW 167 (277)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccc
Confidence 35888999999999999999999998 99999999999999999999999999876543211 12223567889
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
+|||.+.+..++.++|+||||+++|+|++|..|+........ .. ...... .+.. .......+.+
T Consensus 168 ~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~~~~~~-----~~~~----~~~~~~~~~~ 231 (277)
T cd06642 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF-LIPKNS-----PPTL----EGQYSKPFKE 231 (277)
T ss_pred cCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh-hhhcCC-----CCCC----CcccCHHHHH
Confidence 999999888889999999999999999999999854322110 00 000000 0111 1122345888
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021771 239 IGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~ 260 (308)
++.+||+.+|++|||+.++++.
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 232 FVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHccCCcccCcCHHHHHHh
Confidence 9999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=262.18 Aligned_cols=231 Identities=23% Similarity=0.409 Sum_probs=180.0
Q ss_pred CCccEEeeeCCCC-----------EEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCC
Q 021771 1 MESCLQGKLADGK-----------EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 69 (308)
||.||+|...+.. .+++|.+...... ...+.+|+.+++.++|+||+++++++.. ...++||||++++
T Consensus 8 ~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 85 (259)
T cd05037 8 FTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFG 85 (259)
T ss_pred cceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCC
Confidence 7899999975432 5788877544333 5788899999999999999999999988 6789999999999
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-------CeeeecccceeeeCC
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-------NPKISDFGMARIFGG 142 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-------~~kl~dfg~~~~~~~ 142 (308)
+|.+++..... .+++..+..++.||+.||+|||++| ++|+||||+||+++.++ .++|+|||++.....
T Consensus 86 ~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~ 160 (259)
T cd05037 86 PLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS 160 (259)
T ss_pred cHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCccccccc
Confidence 99999865332 5888999999999999999999997 99999999999999887 799999999876532
Q ss_pred CCCccccceeecccCccCchhhccC--cccccccchhhhHHHHHHHhC-CcCCCccccccccchhHHHHHhhhccccccc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEG--LFSVKSDVFSFGVLLLEIISG-KKNTGFYLSELGQSLLSYTWKLWCEGEALEL 219 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (308)
.....+...|+|||++.+. .++.++||||||+++|+|++| ..||........ ...+......
T Consensus 161 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-------~~~~~~~~~~-- 225 (259)
T cd05037 161 ------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-------ERFYQDQHRL-- 225 (259)
T ss_pred ------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-------HHHHhcCCCC--
Confidence 1123456679999998776 788999999999999999994 666654321110 0011100000
Q ss_pred ccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 220 MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
+......+.+++.+||..+|++|||+.++++.|+
T Consensus 226 ---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 226 ---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0001156888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=263.53 Aligned_cols=242 Identities=27% Similarity=0.442 Sum_probs=187.3
Q ss_pred CCccEEeeeC-C---CCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-D---GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|+.. + +..+++|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+++++|.+++
T Consensus 17 ~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 96 (267)
T cd05066 17 FGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL 96 (267)
T ss_pred CCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHH
Confidence 7999999853 3 3378999886543 334567889999999999999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc-cceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN-TNRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~ 154 (308)
.... ..+++.++..++.|++.++++||++| ++|+||+|+||+++.++.++|+|||++..+........ .....+
T Consensus 97 ~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 171 (267)
T cd05066 97 RKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171 (267)
T ss_pred HhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCcc
Confidence 6533 35788999999999999999999998 99999999999999999999999999887643221111 111122
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||.+.+..++.++|+||||+++|++++ |..||....... ... .. .... . ........
T Consensus 172 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~---~~-~~~~--~-------~~~~~~~~ 235 (267)
T cd05066 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIK---AI-EEGY--R-------LPAPMDCP 235 (267)
T ss_pred ceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHH---HH-hCCC--c-------CCCCCCCC
Confidence 457999999988889999999999999999886 998985432221 000 00 0000 0 00011123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
..+.+++.+||+.+|++|||+.++++.|..
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=264.90 Aligned_cols=239 Identities=25% Similarity=0.307 Sum_probs=185.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||++.. .+|+.+|+|.+.... ......+.+|+.+++.++|+||+.+++.+..++..+++|||+++++|.+++.
T Consensus 13 ~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 92 (285)
T cd05632 13 FGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY 92 (285)
T ss_pred CeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHH
Confidence 799999995 589999999986442 2233457789999999999999999999999999999999999999998875
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ....+++..+..++.|++.+|.|||+.| |+|+||+|+||+++.++.++|+|||++........ .....++.
T Consensus 93 ~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~ 165 (285)
T cd05632 93 NM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTV 165 (285)
T ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCc
Confidence 43 2235899999999999999999999998 99999999999999999999999999876532211 12235789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||.+.+..++.++|+||+|+++|+|++|..||......... ...... +... .... .......+
T Consensus 166 ~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~~------~~~~-~~~~----~~~~~~~~ 232 (285)
T cd05632 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDRR------VLET-EEVY----SAKFSEEA 232 (285)
T ss_pred CccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHh------hhcc-cccc----CccCCHHH
Confidence 999999998888999999999999999999999999643221110 000000 0000 0000 11112347
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHH
Q 021771 237 IHIGLLCVQADSADRPT-----MSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs-----~~eil~ 259 (308)
.+|+..||+.||++||+ +.++++
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 78888999999999999 677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=261.02 Aligned_cols=239 Identities=23% Similarity=0.355 Sum_probs=190.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||.++. .+++.+++|.+... .......+.+|+.++++++|+||+++++++.+....+++|||+++++|.+++..
T Consensus 13 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~ 92 (256)
T cd08221 13 FGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR 92 (256)
T ss_pred CceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHh
Confidence 688888884 67999999988654 344456788999999999999999999999999999999999999999998865
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.. ...+++..+..++.|++.++.|||+.| ++|+||+|+||+++.++.+||+|||++........ ......++..
T Consensus 93 ~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~ 166 (256)
T cd08221 93 QK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPY 166 (256)
T ss_pred cc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCcc
Confidence 32 345899999999999999999999998 99999999999999999999999999987643332 1223457889
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||...+..++.++|+||||+++|+|++|..||...... ....... ....... .......+.
T Consensus 167 y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~~~---------~~~~~~~~~ 230 (256)
T cd08221 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIV-QGNYTPV---------VSVYSSELI 230 (256)
T ss_pred ccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-cCCCCCC---------ccccCHHHH
Confidence 99999988878889999999999999999999998543211 1111111 1111110 112234588
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHh
Q 021771 238 HIGLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~L 261 (308)
+++.+||+.+|++|||++++++.+
T Consensus 231 ~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 231 SLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHHHcccCcccCCCHHHHhhCc
Confidence 889999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=277.05 Aligned_cols=240 Identities=20% Similarity=0.216 Sum_probs=182.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.+|+|++... .......+.+|..+++.++||||+++++.+.++...++||||+++++|.+++.
T Consensus 56 fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~ 135 (371)
T cd05622 56 FGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 135 (371)
T ss_pred CeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 799999996 57899999998542 22334567789999999999999999999999999999999999999999884
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||++........ .......|++
T Consensus 136 ~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~ 207 (371)
T cd05622 136 N----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTP 207 (371)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCc
Confidence 3 24788899999999999999999998 99999999999999999999999999987643221 1122346899
Q ss_pred CccCchhhccC----cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 157 GYMAPEYAMEG----LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 157 ~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.|+|||++.+. .++.++|||||||++|+|++|..||...... ................+ ....
T Consensus 208 ~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~~~-------~~~~ 274 (371)
T cd05622 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLTFPD-------DNDI 274 (371)
T ss_pred cccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCcccCCC-------cCCC
Confidence 99999988653 3788999999999999999999999643221 11111111111111100 1122
Q ss_pred HHHHHHHHhhcccCCCCC--CCCHHHHHHHh
Q 021771 233 LLKFIHIGLLCVQADSAD--RPTMSSVVVML 261 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~--RPs~~eil~~L 261 (308)
...+.+++..||+.++.+ |+++++|++..
T Consensus 275 s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 275 SKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 335777888899843332 77999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=262.81 Aligned_cols=235 Identities=23% Similarity=0.360 Sum_probs=188.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||.|.. .+++.+|+|.+.... ......+.+|+.+++.+.|+||+++++++.+++..++||||+++++|.+++..
T Consensus 17 ~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~- 95 (277)
T cd06640 17 FGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA- 95 (277)
T ss_pred CeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-
Confidence 689999996 468999999886543 34456788999999999999999999999999999999999999999998843
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
..+++..+..++.|++.++++||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|
T Consensus 96 ---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y 167 (277)
T cd06640 96 ---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFW 167 (277)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccc
Confidence 24788899999999999999999997 99999999999999999999999999977643221 12223567789
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
+|||.+.+..++.++|+||||+++|+|++|..||......... .. +...............+.+
T Consensus 168 ~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~----------~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06640 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FL----------IPKNNPPTLTGEFSKPFKE 231 (277)
T ss_pred cCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hh----------hhcCCCCCCchhhhHHHHH
Confidence 9999988888899999999999999999999998643221100 00 0000011122234456888
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021771 239 IGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~ 260 (308)
++.+||+.+|++||++.++++.
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 232 FIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHcccCcccCcCHHHHHhC
Confidence 9999999999999999999854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=274.04 Aligned_cols=248 Identities=22% Similarity=0.222 Sum_probs=180.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------eEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L 71 (308)
||.||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++.... ..++||||+++ ++
T Consensus 34 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 112 (359)
T cd07876 34 QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NL 112 (359)
T ss_pred CEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CH
Confidence 789999985 57999999998643 2334466788999999999999999999987543 47999999966 55
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
...+. ..+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||++....... ....
T Consensus 113 ~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~ 181 (359)
T cd07876 113 CQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTP 181 (359)
T ss_pred HHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCC
Confidence 55442 13788899999999999999999998 9999999999999999999999999987543221 1222
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccch---------hH-------HHHHhhhcc-
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSL---------LS-------YTWKLWCEG- 214 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~---------~~-------~~~~~~~~~- 214 (308)
..++..|+|||++.+..++.++|||||||++|+|++|..||........... .. .........
T Consensus 182 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (359)
T cd07876 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRP 261 (359)
T ss_pred CcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCC
Confidence 4578899999999888899999999999999999999999975432210000 00 000000000
Q ss_pred -----cccccccccccc---cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 215 -----EALELMEPVLKQ---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 215 -----~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
...+........ .........+.+|+.+||+.||++|||+.|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 262 QYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000000000 0001113457889999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=262.08 Aligned_cols=241 Identities=25% Similarity=0.420 Sum_probs=188.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc------ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||.++. .+|+.+++|++..... .....+..|+.+++.++|+||+++++++.+.+..++||||+++++|.+
T Consensus 13 ~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~ 92 (268)
T cd06630 13 FSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSH 92 (268)
T ss_pred ceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHH
Confidence 689999984 7899999999864321 134678899999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCc--cccc
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSE--ANTN 150 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~--~~~~ 150 (308)
++... ..+++..+..++.|++.||++||++| ++|+||+|+||+++.++ .++|+|||.+......... ....
T Consensus 93 ~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 166 (268)
T cd06630 93 LLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG 166 (268)
T ss_pred HHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccc
Confidence 98543 35888999999999999999999998 99999999999998776 5999999998776533111 1122
Q ss_pred eeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 151 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .......... ......+.
T Consensus 167 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~---------~~~~~~~~ 234 (268)
T cd06630 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASA---------TTAPSIPE 234 (268)
T ss_pred ccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhcc---------CCCCCCch
Confidence 34567899999998888889999999999999999999999864332211 1111111000 00111222
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.....+.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 235 HLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 33456888999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=249.94 Aligned_cols=235 Identities=23% Similarity=0.302 Sum_probs=193.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||.|+. +++.-||+|++-+. ......++.+|+++-..|+||||+++|++|-+....||++||.+.|.+...+.
T Consensus 35 FG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~ 114 (281)
T KOG0580|consen 35 FGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQ 114 (281)
T ss_pred cccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHH
Confidence 899999994 68999999998544 23344678899999999999999999999999999999999999999988886
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ....+++.....++.|++.|+.|+|... ++||||||+|+|++..|.+|++|||-+-.-+ .......+||.
T Consensus 115 ~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~ 186 (281)
T KOG0580|consen 115 EG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTL 186 (281)
T ss_pred hc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC----CCCceeeeccc
Confidence 43 3446999999999999999999999996 9999999999999999999999999987643 22344468999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|.+||+..+...+...|+|++|+..|+++.|.+||+....... .+.....+ -..+.......
T Consensus 187 dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-------YkrI~k~~----------~~~p~~is~~a 249 (281)
T KOG0580|consen 187 DYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-------YKRIRKVD----------LKFPSTISGGA 249 (281)
T ss_pred ccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-------HHHHHHcc----------ccCCcccChhH
Confidence 99999999999999999999999999999999999975542211 11111100 01122233458
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+||.+|+..+|.+|.+..|+++-
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhh
Confidence 888999999999999999998763
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=265.70 Aligned_cols=239 Identities=23% Similarity=0.352 Sum_probs=188.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+++.+++|.+........+.+..|+.+++.++|+||+++++.+..+...++||||+++++|.+++....
T Consensus 18 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 97 (280)
T cd06611 18 FGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE 97 (280)
T ss_pred CceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc
Confidence 689999996 5799999999876665666788899999999999999999999999999999999999999999885432
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..++.++.|++.+|.|||++| ++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 98 --~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~ 170 (280)
T cd06611 98 --RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWM 170 (280)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhc
Confidence 35899999999999999999999998 99999999999999999999999998765432211 122345788899
Q ss_pred Cchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 160 APEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 160 aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
|||.+.. ..++.++|+||||+++|+|++|..||....... ...... ....... ..+.....
T Consensus 171 ~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~-------~~~~~~~~ 236 (280)
T cd06611 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKIL-KSEPPTL-------DQPSKWSS 236 (280)
T ss_pred CHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHh-cCCCCCc-------CCcccCCH
Confidence 9998752 346789999999999999999999986542211 000110 0000000 00111223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+.+++..||+.+|++|||+.++++.
T Consensus 237 ~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 237 SFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhcC
Confidence 57888999999999999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=266.08 Aligned_cols=237 Identities=20% Similarity=0.323 Sum_probs=188.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++..++..+++|||+++++|..++..
T Consensus 34 ~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-- 111 (297)
T cd06659 34 TGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-- 111 (297)
T ss_pred ceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--
Confidence 789999985 57999999998765545567788999999999999999999999999999999999999999987733
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..++.++.|++.+|++||++| ++|+||+|+||+++.++.++|+|||++..+..... ......++..|+
T Consensus 112 --~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~ 184 (297)
T cd06659 112 --TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWM 184 (297)
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCcccc
Confidence 34889999999999999999999997 99999999999999999999999999865432221 122345788999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||.+.+..++.++||||+|+++|+|++|..||........ ... ...... .... ........+.++
T Consensus 185 aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~~-~~~~------~~~~~~~~l~~~ 250 (297)
T cd06659 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------MKR-LRDSPP-PKLK------NAHKISPVLRDF 250 (297)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HhccCC-CCcc------ccCCCCHHHHHH
Confidence 99999888889999999999999999999999864322111 000 000000 0000 001112347788
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~ 260 (308)
+.+||+.+|++||+++++++.
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 251 LERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhC
Confidence 899999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=263.36 Aligned_cols=235 Identities=24% Similarity=0.387 Sum_probs=188.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.+++|.+.... ......+..|+.+++.++|+||+++++++.++...++|+||+++++|.+++...
T Consensus 14 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~ 93 (274)
T cd06609 14 FGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG 93 (274)
T ss_pred CeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc
Confidence 689999995 579999999986543 344567889999999999999999999999999999999999999999988542
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
.+++..++.++.|++.++.|||+++ ++|+||+|+||++++++.++|+|||++........ ......++..|
T Consensus 94 ----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y 164 (274)
T cd06609 94 ----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFW 164 (274)
T ss_pred ----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccc
Confidence 6899999999999999999999998 99999999999999999999999999988753321 12234567789
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
+|||.+.+..++.++||||||+++|+|++|..||....... ...... .... +.+... .....+.+
T Consensus 165 ~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~-~~~~-----~~~~~~---~~~~~~~~ 229 (274)
T cd06609 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIP-KNNP-----PSLEGN---KFSKPFKD 229 (274)
T ss_pred cChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhh-hcCC-----CCCccc---ccCHHHHH
Confidence 99999988889999999999999999999999986433111 000000 0000 011011 02335888
Q ss_pred HHhhcccCCCCCCCCHHHHHH
Q 021771 239 IGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~ 259 (308)
++.+||..+|++|||++++++
T Consensus 230 ~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 230 FVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHhhCChhhCcCHHHHhh
Confidence 899999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=268.86 Aligned_cols=246 Identities=27% Similarity=0.374 Sum_probs=186.3
Q ss_pred CCccEEeeeC-CCC--EEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGK--EIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||++..+ +|. .+++|.++.. .....+.+..|+.++.++ +||||+++++++.+....+++|||+++++|.+++
T Consensus 15 ~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 94 (297)
T cd05089 15 FGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL 94 (297)
T ss_pred cceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHH
Confidence 7999999864 443 4688887643 333456788999999999 6999999999999998999999999999999998
Q ss_pred hcCC-------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 76 FDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 76 ~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
.... ....+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 171 (297)
T cd05089 95 RKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEV 171 (297)
T ss_pred HhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCccccc
Confidence 6432 1134888899999999999999999998 99999999999999999999999999754211
Q ss_pred CCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELME 221 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
. ........+..|+|||...+..++.++|||||||++|+|++ |..||....... . . .........
T Consensus 172 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~---~-~~~~~~~~~---- 237 (297)
T cd05089 172 Y---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L---Y-EKLPQGYRM---- 237 (297)
T ss_pred e---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---H-HHHhcCCCC----
Confidence 1 01111122456999999888888999999999999999997 889985432211 0 0 111111000
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
..+......+.+|+.+||+.+|.+|||++++++.|+......
T Consensus 238 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 238 -----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 001112245888999999999999999999999987765433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=268.09 Aligned_cols=240 Identities=21% Similarity=0.213 Sum_probs=187.8
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQ---GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||.+... +++.+++|.+...... ....+..|+++++.++|+||+++++.+.++...++||||+.+++|.+++.
T Consensus 14 ~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 93 (316)
T cd05574 14 VGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ 93 (316)
T ss_pred cEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHH
Confidence 6899999964 6999999998755322 44568899999999999999999999999999999999999999999886
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc---------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA--------- 147 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~--------- 147 (308)
.. ....+++..+..++.|++.+|+|||+.| ++|+||||+||+++.++.++|+|||++..........
T Consensus 94 ~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 169 (316)
T cd05574 94 RQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169 (316)
T ss_pred hC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccc
Confidence 43 2346899999999999999999999998 9999999999999999999999999987543221100
Q ss_pred ------------------ccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH
Q 021771 148 ------------------NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK 209 (308)
Q Consensus 148 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~ 209 (308)
......|+..|+|||++.+..++.++||||||+++|+|++|..||........ ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~------~~~ 243 (316)
T cd05574 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET------FSN 243 (316)
T ss_pred cccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH------HHH
Confidence 11123567889999999888889999999999999999999999864432211 001
Q ss_pred hhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCC----HHHHHH
Q 021771 210 LWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT----MSSVVV 259 (308)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs----~~eil~ 259 (308)
..... . ...........+.+++.+||+.+|++||| ++++++
T Consensus 244 ~~~~~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 244 ILKKE-V--------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HhcCC-c--------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11000 0 00001113456889999999999999999 888776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=278.61 Aligned_cols=189 Identities=22% Similarity=0.321 Sum_probs=161.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .......+..|..++..++|++|+++++.+.+...+++||||+++++|.+++.
T Consensus 14 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~ 93 (360)
T cd05627 14 FGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM 93 (360)
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHH
Confidence 799999985 57999999998643 23345677889999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc----------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE---------- 146 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~---------- 146 (308)
.. ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++..+......
T Consensus 94 ~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~ 167 (360)
T cd05627 94 KK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167 (360)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCC
Confidence 43 35899999999999999999999998 999999999999999999999999998654211000
Q ss_pred -----------------------cccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcc
Q 021771 147 -----------------------ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195 (308)
Q Consensus 147 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 195 (308)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 0011246889999999999888999999999999999999999999644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=260.25 Aligned_cols=237 Identities=23% Similarity=0.319 Sum_probs=186.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEe-CCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-ENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||.++. .+++.+++|.+.... ....+.+.+|+.+++.++|+|++++++.+.. +...+++|||+++++|.+++.
T Consensus 13 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~ 92 (257)
T cd08223 13 YGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLK 92 (257)
T ss_pred CeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHH
Confidence 688999985 578999999986542 3345678899999999999999999998864 446799999999999999886
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ....+++..+..++.+++.++++||+.| ++|+||+|+||+++.++.++|+|||++........ ......++.
T Consensus 93 ~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~ 166 (257)
T cd08223 93 EQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTP 166 (257)
T ss_pred Hh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCc
Confidence 53 2345899999999999999999999998 99999999999999999999999999987643222 122345678
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|+||||+++++|++|..||...... ...... ....... ........+
T Consensus 167 ~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~-~~~~~~~---------~~~~~~~~~ 230 (257)
T cd08223 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRI-IEGKLPP---------MPKDYSPEL 230 (257)
T ss_pred CccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-HhcCCCC---------CccccCHHH
Confidence 899999998888899999999999999999999998643221 111111 1111111 112233468
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.+|++|||+.++++
T Consensus 231 ~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 231 GELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred HHHHHHHhccCcccCCCHHHHhc
Confidence 88999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=273.12 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=185.2
Q ss_pred CCccEEeee------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeC-CeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEE-NESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L 71 (308)
||.||++.. .+++.||||++.... ......+..|+.+|.++ +|+||+++++++... ...+++||||++++|
T Consensus 20 fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L 99 (343)
T cd05103 20 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 99 (343)
T ss_pred cceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcH
Confidence 799999962 467899999996543 23345688899999999 589999999988654 457899999999999
Q ss_pred hhHhhcCCC----------------------------------------------------------------ccccChH
Q 021771 72 DVFLFDSTR----------------------------------------------------------------SVQLDWK 87 (308)
Q Consensus 72 ~~~l~~~~~----------------------------------------------------------------~~~~~~~ 87 (308)
.+++..... ...+++.
T Consensus 100 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (343)
T cd05103 100 SNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLE 179 (343)
T ss_pred HHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHH
Confidence 998864321 1236777
Q ss_pred HHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccC
Q 021771 88 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG 167 (308)
Q Consensus 88 ~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 167 (308)
.+..++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus 180 ~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 256 (343)
T cd05103 180 DLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 256 (343)
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCC
Confidence 88899999999999999998 999999999999999999999999998765332221122222345679999998888
Q ss_pred cccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccC
Q 021771 168 LFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQA 246 (308)
Q Consensus 168 ~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 246 (308)
.++.++||||||+++|+|++ |..||....... . ............. +......+.+++..||+.
T Consensus 257 ~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~-~~~~~~~~~~~~~---------~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 257 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----E-FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----H-HHHHHhccCCCCC---------CCCCCHHHHHHHHHHccC
Confidence 89999999999999999997 888875432210 0 0111111111110 001123578888999999
Q ss_pred CCCCCCCHHHHHHHhhcC
Q 021771 247 DSADRPTMSSVVVMLASD 264 (308)
Q Consensus 247 ~p~~RPs~~eil~~L~~~ 264 (308)
+|++|||+.+|++.|+..
T Consensus 322 ~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 322 EPSQRPTFSELVEHLGNL 339 (343)
T ss_pred ChhhCcCHHHHHHHHHHH
Confidence 999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=262.33 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=186.6
Q ss_pred CCccEEeeeCC----CCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLAD----GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|...+ ...+++|...... ....+.+.+|+.+++.++|+||+++++++.++ ..++||||+++++|.+++
T Consensus 19 ~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l 97 (270)
T cd05056 19 FGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYL 97 (270)
T ss_pred ceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHH
Confidence 68999998543 3478999886554 44566889999999999999999999988764 578999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... ..+++..++.++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++.......... .....++
T Consensus 98 ~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~ 171 (270)
T cd05056 98 QVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLP 171 (270)
T ss_pred HhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCcc
Confidence 5532 24899999999999999999999997 9999999999999999999999999988754332111 1122334
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||.+.+..++.++||||||+++|++++ |..||........ ... ........ .+.....
T Consensus 172 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~-~~~~~~~~---------~~~~~~~ 235 (270)
T cd05056 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGR-IENGERLP---------MPPNCPP 235 (270)
T ss_pred ccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHH-HHcCCcCC---------CCCCCCH
Confidence 67999999888888999999999999999986 9999854432210 001 11111110 0111233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+.+++.+||..+|++|||+.++++.|+..
T Consensus 236 ~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 588889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=264.51 Aligned_cols=221 Identities=21% Similarity=0.330 Sum_probs=170.1
Q ss_pred CEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHH
Q 021771 13 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 92 (308)
Q Consensus 13 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 92 (308)
..+++|++..........+.+|+.+++.++|+||+++++++.++...++||||+++++|..++... ...+++..+..+
T Consensus 45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i 122 (274)
T cd05076 45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITV 122 (274)
T ss_pred eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHH
Confidence 458899886554444567888999999999999999999999999999999999999999988543 235888999999
Q ss_pred HHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-------CeeeecccceeeeCCCCCccccceeecccCccCchhhc
Q 021771 93 INGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-------NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM 165 (308)
Q Consensus 93 ~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 165 (308)
+.||+.||+|||++| ++|+||||+||+++..+ .++++|||++...... ....++..|+|||.+.
T Consensus 123 ~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 123 AQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVP 193 (274)
T ss_pred HHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhc
Confidence 999999999999998 99999999999997654 3799999987543211 1124567899999876
Q ss_pred c-CcccccccchhhhHHHHHHH-hCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhc
Q 021771 166 E-GLFSVKSDVFSFGVLLLEII-SGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLC 243 (308)
Q Consensus 166 ~-~~~~~~~Di~slG~~l~~l~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 243 (308)
+ ..++.++||||||+++|+++ +|..||........ .. ..... ... .. .....+.+++.+|
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~--~~~-----~~----~~~~~~~~li~~c 255 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK---ER----FYEKK--HRL-----PE----PSCKELATLISQC 255 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH---HH----HHHhc--cCC-----CC----CCChHHHHHHHHH
Confidence 5 56789999999999999985 68888754322111 00 00000 000 00 1123588899999
Q ss_pred ccCCCCCCCCHHHHHHHhh
Q 021771 244 VQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 244 l~~~p~~RPs~~eil~~L~ 262 (308)
|+.+|++|||+.+|++.|+
T Consensus 256 l~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 256 LTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred cccChhhCcCHHHHHHhhC
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=263.52 Aligned_cols=239 Identities=23% Similarity=0.339 Sum_probs=185.8
Q ss_pred CCccEEeeeC-CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||++... +|+.+|+|.+... .......+.+|+.++++++|+||+++++.+..++..++||||+++++|..++...
T Consensus 14 ~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~ 93 (286)
T cd06622 14 YGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGG 93 (286)
T ss_pred CeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhc
Confidence 7899999964 8999999988644 3344567889999999999999999999999999999999999999999988654
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhC-CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~-g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.....+++..+..++.|++.+|.|||+. + ++|+||+|+||+++.++.++|+|||++..+.... .....++..
T Consensus 94 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~ 166 (286)
T cd06622 94 VATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQS 166 (286)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccC
Confidence 3234689999999999999999999974 5 9999999999999999999999999987653221 112346778
Q ss_pred ccCchhhccC------cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 158 YMAPEYAMEG------LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 158 y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
|+|||.+.+. .++.++|+|||||++|+|++|..||....... ......... .... ...+..
T Consensus 167 y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-~~~~---------~~~~~~ 233 (286)
T cd06622 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIV-DGDP---------PTLPSG 233 (286)
T ss_pred ccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHh-hcCC---------CCCCcc
Confidence 9999987543 34789999999999999999999985432111 111000000 0000 111222
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
....+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 3456888999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=272.00 Aligned_cols=177 Identities=22% Similarity=0.310 Sum_probs=148.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+++.||+|+.... ....|+.+++.++|+||+++++++......++|||++. ++|.+++...
T Consensus 79 ~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~- 150 (357)
T PHA03209 79 EGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKR- 150 (357)
T ss_pred CeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhc-
Confidence 799999996 46789999975322 23468999999999999999999999999999999995 5777777543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
...+++..+..++.||+.||.|||++| |+||||||+||+++.++.++|+|||++...... .......|+..|+
T Consensus 151 -~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~ 223 (357)
T PHA03209 151 -SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETN 223 (357)
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC---ccccccccccccc
Confidence 335899999999999999999999998 999999999999999999999999998753211 1122345788999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCC
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNT 192 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~ 192 (308)
|||++.+..++.++|||||||++|+|+++..++
T Consensus 224 aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 224 APEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999998888999999999999999999865543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=270.60 Aligned_cols=229 Identities=21% Similarity=0.263 Sum_probs=179.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||+|++... .....+.+..|..++..+. |++|+++++++.+.+..++||||+++++|..++
T Consensus 13 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i 92 (323)
T cd05615 13 FGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI 92 (323)
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHH
Confidence 799999985 57999999998643 2234456778888888886 577889999999999999999999999999988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++........ ......|+
T Consensus 93 ~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt 164 (323)
T cd05615 93 QQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGT 164 (323)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCC
Confidence 543 34899999999999999999999998 99999999999999999999999999875422211 12234578
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++||||+||++|+|++|..||....... ....... ... ..+......
T Consensus 165 ~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~------~~~~i~~-~~~----------~~p~~~~~~ 227 (323)
T cd05615 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE------LFQSIME-HNV----------SYPKSLSKE 227 (323)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCC----------CCCccCCHH
Confidence 99999999988889999999999999999999999986543211 1111110 000 001112235
Q ss_pred HHHHHhhcccCCCCCCCCH
Q 021771 236 FIHIGLLCVQADSADRPTM 254 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~ 254 (308)
+.+++.+||+.+|++|++.
T Consensus 228 ~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 228 AVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHcccCHhhCCCC
Confidence 7888999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=273.33 Aligned_cols=184 Identities=24% Similarity=0.331 Sum_probs=158.7
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-C-----cCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-H-----KNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||-|.++. .++++.||||+++.. ..-..+-..|+.+|..|+ | -|+|+++++|...+++|||+|.+ ..+|.+
T Consensus 199 FGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYe 276 (586)
T KOG0667|consen 199 FGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYE 276 (586)
T ss_pred cceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHH
Confidence 78999998 578999999999644 444566778999999996 4 48999999999999999999999 669999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC--CeeeecccceeeeCCCCCccccce
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM--NPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~--~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
+++.+. -..++...++.++.||+.+|.+||+.| |+|+||||+|||+.+.+ .|||+|||.+.+...... .
T Consensus 277 llK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----t 347 (586)
T KOG0667|consen 277 LLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----T 347 (586)
T ss_pred HHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccccCCcce-----e
Confidence 997753 345999999999999999999999998 99999999999997554 599999999988543322 3
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcc
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 195 (308)
...+..|+|||++.|.+|+.+.||||||||+.||++|.+.|...
T Consensus 348 YiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 348 YIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred eeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 46688899999999999999999999999999999998888553
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=263.58 Aligned_cols=251 Identities=20% Similarity=0.290 Sum_probs=185.7
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++.+ +|+.+++|++.... ....+.+.+|+.+++.++|+||+++++++......++||||+++++|..++..
T Consensus 14 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~ 93 (286)
T cd07847 14 YGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN 93 (286)
T ss_pred CeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC
Confidence 6899999964 79999999886442 23345678999999999999999999999999999999999999888887643
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..+..++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..
T Consensus 94 ---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~ 165 (286)
T cd07847 94 ---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRW 165 (286)
T ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccc
Confidence 234899999999999999999999998 99999999999999999999999999987643321 1222346778
Q ss_pred ccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhH--------HHHHhhhcccccc---ccccccc
Q 021771 158 YMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLS--------YTWKLWCEGEALE---LMEPVLK 225 (308)
Q Consensus 158 y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~~ 225 (308)
|+|||.+.+ ..++.++||||+|+++|+|++|..||............. .....+....... ...+...
T Consensus 166 ~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd07847 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETR 245 (286)
T ss_pred cCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccc
Confidence 999998766 457889999999999999999999986543221100000 0000000000000 0000000
Q ss_pred c---cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 226 Q---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 226 ~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
. .........+.+|+.+||+.+|++|||+.|++.
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 246 EPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 000112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=262.39 Aligned_cols=243 Identities=28% Similarity=0.377 Sum_probs=181.6
Q ss_pred CCccEEeeeC----CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEE-eCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCL-EENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|+.. ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+.+++|.++
T Consensus 8 ~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 87 (262)
T cd05058 8 FGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNF 87 (262)
T ss_pred CceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHH
Confidence 7999999853 3457999988543 3344567889999999999999999999765 45567899999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc--ccccee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--ANTNRI 152 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~ 152 (308)
+.... ...++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......... ......
T Consensus 88 ~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 162 (262)
T cd05058 88 IRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162 (262)
T ss_pred HHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccC
Confidence 86432 23567778899999999999999997 999999999999999999999999998754322111 111122
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCC-cCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK-KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.++..|+|||.+.+..++.++||||||+++|+|++|+ +||...... ....... ...... ... .
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~~~~~~~-~~~~~~-----~~~----~ 226 (262)
T cd05058 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------DITVYLL-QGRRLL-----QPE----Y 226 (262)
T ss_pred cCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHh-cCCCCC-----CCC----c
Confidence 3456899999988888899999999999999999964 555432111 1111111 100000 001 1
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
....+.+++.+||+.+|++||++.+|++.|+..
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 123588899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=258.92 Aligned_cols=247 Identities=20% Similarity=0.307 Sum_probs=178.6
Q ss_pred CCccEEeeeCCC---CEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADG---KEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++++|.+++.
T Consensus 8 ~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 87 (268)
T cd05086 8 FGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLS 87 (268)
T ss_pred CceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHH
Confidence 799999985443 345677665432 3345678899999999999999999999999989999999999999999986
Q ss_pred cCCC-ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DSTR-SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... ....+...+..++.||+.||+|||+.+ ++|+||||+||+++.++.++|+|||++................++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 164 (268)
T cd05086 88 QEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164 (268)
T ss_pred hhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCc
Confidence 5322 234667778899999999999999997 999999999999999999999999987542211111112234567
Q ss_pred cCccCchhhcc-------CcccccccchhhhHHHHHHHhC-CcCCCccccccccchhHHHHHhhhccccccccccccccc
Q 021771 156 YGYMAPEYAME-------GLFSVKSDVFSFGVLLLEIISG-KKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS 227 (308)
Q Consensus 156 ~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
..|+|||++.. ..++.++||||||+++|+|+++ ..||...... ....... ........++.....
T Consensus 165 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~ 237 (268)
T cd05086 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVI-KDQQVKLFKPQLELP 237 (268)
T ss_pred ccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-hhcccccCCCccCCC
Confidence 88999998743 2357789999999999999975 5676432211 1111111 111122222222222
Q ss_pred chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 228 CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 228 ~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
....+.+++..|| .+|++|||+++|++.|.
T Consensus 238 ----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 238 ----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2234677778899 68999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=263.51 Aligned_cols=233 Identities=23% Similarity=0.373 Sum_probs=179.9
Q ss_pred CCccEEeeeC-C-------CCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLA-D-------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~-~-------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+|..+ . ...+++|.+........+.+.+|..+++.++||||+++++++..+...++||||+++++|.
T Consensus 8 ~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 87 (258)
T cd05078 8 FTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLD 87 (258)
T ss_pred chhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHH
Confidence 7999999853 2 3348888876555555567889999999999999999999999988999999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC--------eeeecccceeeeCCCC
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN--------PKISDFGMARIFGGNQ 144 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~--------~kl~dfg~~~~~~~~~ 144 (308)
.++.... ..+++..+..++.||+.||+|||++| ++|+||||+||+++.++. ++++|||++......
T Consensus 88 ~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~- 161 (258)
T cd05078 88 TYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK- 161 (258)
T ss_pred HHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccccCCc-
Confidence 9986533 25788899999999999999999998 999999999999987765 689999987654321
Q ss_pred CccccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCC-cCCCccccccccchhHHHHHhhhcccccccccc
Q 021771 145 SEANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGK-KNTGFYLSELGQSLLSYTWKLWCEGEALELMEP 222 (308)
Q Consensus 145 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (308)
....++..|+|||.+.+ ..++.++||||||+++|+|++|. .|+........ .... .. ...
T Consensus 162 -----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-------~~~~-~~-~~~---- 223 (258)
T cd05078 162 -----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-------LQFY-ED-RHQ---- 223 (258)
T ss_pred -----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-------HHHH-Hc-ccc----
Confidence 12346778999998876 45788999999999999999985 55433221110 0000 00 000
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
.+.....++.+++.+||+.+|++|||+++|++.|+
T Consensus 224 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 224 -----LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11112245888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=262.24 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=187.1
Q ss_pred CCccEEeeeC-CCC----EEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLA-DGK----EIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|..+ +|+ .+++|.+.... ......+.+|+.+++.++|+||+++++++.. ...++||||+++++|.++
T Consensus 20 ~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~ 98 (279)
T cd05057 20 FGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDY 98 (279)
T ss_pred CccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHH
Confidence 7999999853 443 58999876553 3345678899999999999999999999887 678999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+.... ..+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++................+
T Consensus 99 l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 173 (279)
T cd05057 99 VRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173 (279)
T ss_pred HHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcc
Confidence 86532 24899999999999999999999997 99999999999999999999999999987643322111111223
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||......++.++|+||||+++|++++ |..||....... ..... ...... ..+....
T Consensus 174 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~~~~---------~~~~~~~ 237 (279)
T cd05057 174 PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPDLL-EKGERL---------PQPPICT 237 (279)
T ss_pred cccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHH-hCCCCC---------CCCCCCC
Confidence 467999999888888999999999999999998 999986543221 11111 111000 0001112
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+++.+||..+|++|||+.++++.|+..
T Consensus 238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 238 IDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 3477888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=262.03 Aligned_cols=243 Identities=26% Similarity=0.347 Sum_probs=189.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||++.. .+|+.+++|++.... ......+.+|+.+++.++|+||+++++++......++||||+++++|.+++...
T Consensus 18 ~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 97 (284)
T cd06620 18 GGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG 97 (284)
T ss_pred CeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc
Confidence 789999995 579999999876543 344578889999999999999999999999999999999999999999988542
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
..+++..+..++.+++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|||++....... .....++..
T Consensus 98 ---~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~ 167 (284)
T cd06620 98 ---GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTST 167 (284)
T ss_pred ---cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcc
Confidence 358899999999999999999997 45 9999999999999999999999999886542211 123457889
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccc-----cchhHHHHHhhhcccccccccccccccchHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELG-----QSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
|+|||.+.+..++.++|+||+||++|+|++|..||........ ............. .. + .......
T Consensus 168 ~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----~---~~~~~~~ 238 (284)
T cd06620 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PP-----P---RLPSSDF 238 (284)
T ss_pred cCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cC-----C---CCCchhc
Confidence 9999998888889999999999999999999999875433211 1111111111100 00 0 0001113
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
...+.+|+.+||+.||++|||+.|+++..-
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 346888999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=262.64 Aligned_cols=243 Identities=28% Similarity=0.384 Sum_probs=187.2
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++.+ +.+.+++|.+...... ..+.+..|+.++++++|+||+++++++.+....++||||+++++|.+
T Consensus 18 ~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 97 (275)
T cd05046 18 FGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQ 97 (275)
T ss_pred eeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHH
Confidence 7899999853 3567999988654433 45678999999999999999999999999889999999999999999
Q ss_pred HhhcCCCc------cccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc
Q 021771 74 FLFDSTRS------VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA 147 (308)
Q Consensus 74 ~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~ 147 (308)
++...... ..+++..+..++.|++.+|+|||++| ++|+||+|+||+++.++.++++|||++.........
T Consensus 98 ~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~- 173 (275)
T cd05046 98 FLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY- 173 (275)
T ss_pred HHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccccccCccccc-
Confidence 98654322 25899999999999999999999998 999999999999999999999999998654322111
Q ss_pred ccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccc
Q 021771 148 NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .......... .
T Consensus 174 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~----~~~~~~~~~~----~-- 240 (275)
T cd05046 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN----RLQAGKLELP----V-- 240 (275)
T ss_pred ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH----HHHcCCcCCC----C--
Confidence 1222345667999999888888899999999999999998 677874322111 110 1111111000 0
Q ss_pred cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 227 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
.......+.+++.+||+.+|++|||+.++++.|.
T Consensus 241 --~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 241 --PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1112235888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=259.56 Aligned_cols=245 Identities=25% Similarity=0.397 Sum_probs=190.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||++.. .++..+++|++.... ......+.+|+..++.++|+||+++++.+...+..++|||++++++|.+++...
T Consensus 14 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~ 93 (267)
T cd06610 14 TAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSS 93 (267)
T ss_pred CeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHh
Confidence 689999995 578999999986543 335678899999999999999999999999999999999999999999998654
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc--ccceeeccc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA--NTNRIVGTY 156 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~ 156 (308)
.....+++..+..++.|++.+|++||+.| ++|+||+|+||++++++.++|+|||++..+....... ......++.
T Consensus 94 ~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~ 170 (267)
T cd06610 94 YPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170 (267)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCCh
Confidence 33346899999999999999999999998 9999999999999999999999999987654332221 122345778
Q ss_pred CccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 157 GYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 157 ~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
.|+|||.+... .++.++|+||||+++|+|++|..||....... ... ..... .. ..+.. ..........
T Consensus 171 ~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~----~~~~~-~~-~~~~~---~~~~~~~~~~ 239 (267)
T cd06610 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLM----LTLQN-DP-PSLET---GADYKKYSKS 239 (267)
T ss_pred hhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHH----HHhcC-CC-CCcCC---ccccccccHH
Confidence 89999988766 78899999999999999999999986442221 000 00000 00 00000 0001122345
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+.+++.+||+.||++|||+++|++
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhh
Confidence 788999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=290.86 Aligned_cols=247 Identities=21% Similarity=0.262 Sum_probs=187.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+|+. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++.
T Consensus 15 fG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~ 94 (932)
T PRK13184 15 MGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLK 94 (932)
T ss_pred CEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHH
Confidence 799999995 579999999986542 2234578899999999999999999999999999999999999999999886
Q ss_pred cCCC--------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC---
Q 021771 77 DSTR--------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS--- 145 (308)
Q Consensus 77 ~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~--- 145 (308)
.... ....+...++.++.||+.||+|||++| ++||||||+||+++.++.++|+|||++........
T Consensus 95 s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~ 171 (932)
T PRK13184 95 SVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171 (932)
T ss_pred HhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceeccccccccc
Confidence 4211 123556778899999999999999998 99999999999999999999999999987621110
Q ss_pred -------------ccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh
Q 021771 146 -------------EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC 212 (308)
Q Consensus 146 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 212 (308)
........|+..|+|||.+.+..++.++|||||||++|+|++|..||........ . ..
T Consensus 172 ~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki---~---~~--- 242 (932)
T PRK13184 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI---S---YR--- 242 (932)
T ss_pred ccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh---h---hh---
Confidence 0011224689999999999988899999999999999999999999864322110 0 00
Q ss_pred cccccccccccccccchHHHHHHHHHHHhhcccCCCCCCC-CHHHHHHHhhcC
Q 021771 213 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRP-TMSSVVVMLASD 264 (308)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-s~~eil~~L~~~ 264 (308)
......... .........+.+++.+||+.||++|| +++++++.|+..
T Consensus 243 -~~i~~P~~~----~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 243 -DVILSPIEV----APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred -hhccChhhc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000000000 00011223477888999999999996 667777777654
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=256.58 Aligned_cols=235 Identities=27% Similarity=0.362 Sum_probs=186.5
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCC-----cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTS-----GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|... +++.|++|.+.... .+....+..|+.+++.++|+||+++++++.++...++++||+++++|.++
T Consensus 13 ~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 92 (258)
T cd06632 13 FGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKL 92 (258)
T ss_pred CceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHH
Confidence 6899999965 89999999886442 22445788999999999999999999999999999999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+... ..+++..+..++.|++.++++||+.| ++|+||+|+||+++.++.+||+|||++....... ......+
T Consensus 93 ~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~ 163 (258)
T cd06632 93 LKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKG 163 (258)
T ss_pred HHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCC
Confidence 8543 34888999999999999999999998 9999999999999999999999999987754332 1223457
Q ss_pred ccCccCchhhccCc-ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|++||.+.... ++.++|+||||+++|+|++|..||...... .............. .+....
T Consensus 164 ~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~---------~~~~~~ 228 (258)
T cd06632 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------AAVFKIGRSKELPP---------IPDHLS 228 (258)
T ss_pred CcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------HHHHHHHhcccCCC---------cCCCcC
Confidence 78899999887665 889999999999999999999998654311 11111100000100 111123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..+.+++.+||+.+|++|||+.+++.
T Consensus 229 ~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 229 DEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 45788899999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=261.03 Aligned_cols=237 Identities=24% Similarity=0.395 Sum_probs=182.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeC------CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEE------NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~ 72 (308)
||.||+|.. .+++.+|+|++.... .....+..|+.+++.+ +|+||+++++++... ...+++|||+++++|.
T Consensus 19 ~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (272)
T cd06637 19 YGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 97 (272)
T ss_pred CeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHH
Confidence 789999985 579999999986543 4446788999999998 699999999998753 4579999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+++... ....+++..+..++.|++.+++|||+++ ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 98 ~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~ 171 (272)
T cd06637 98 DLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTF 171 (272)
T ss_pred HHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcc
Confidence 988653 2345889999999999999999999998 99999999999999999999999999876532211 12234
Q ss_pred ecccCccCchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccccc
Q 021771 153 VGTYGYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS 227 (308)
Q Consensus 153 ~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
.++..|+|||++. +..++.++||||+||++|+|++|..||........ ..... ......... .
T Consensus 172 ~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~------~~~~~-~~~~~~~~~----~- 239 (272)
T cd06637 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIP-RNPAPRLKS----K- 239 (272)
T ss_pred cccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH------HHHHh-cCCCCCCCC----C-
Confidence 5788899999875 23578899999999999999999999854322110 00000 111111100 1
Q ss_pred chHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 228 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 228 ~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.....+.+|+.+||..+|.+|||+.+++.
T Consensus 240 ---~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 240 ---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11235788999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=273.56 Aligned_cols=247 Identities=25% Similarity=0.283 Sum_probs=179.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeC------CeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE------NESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L 71 (308)
||+||++.. .+++.||+|++.... ......+.+|+.+|+.++|+||+++++++... ...+++++++ +++|
T Consensus 28 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l 106 (343)
T cd07878 28 YGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADL 106 (343)
T ss_pred CeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCH
Confidence 799999985 688999999986542 22345677899999999999999999988643 3468999988 7788
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
..++. ...+++..+..++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++...... ...
T Consensus 107 ~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~ 174 (343)
T cd07878 107 NNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTG 174 (343)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCC
Confidence 88763 235899999999999999999999998 999999999999999999999999999875422 222
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchh-HH-------HHHhhhcccccccccc
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL-SY-------TWKLWCEGEALELMEP 222 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~ 222 (308)
..++..|+|||++.+ ..++.++|||||||++|+|++|..||............ .. .............+..
T Consensus 175 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07878 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQS 254 (343)
T ss_pred ccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhc
Confidence 457889999998876 46889999999999999999999998643221100000 00 0000000000000000
Q ss_pred c--cccc----chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 223 V--LKQS----CVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 223 ~--~~~~----~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
. .... ........+.+|+.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 255 LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 000011246789999999999999999999953
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=261.67 Aligned_cols=240 Identities=26% Similarity=0.368 Sum_probs=188.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||++.. .+++.+++|.+.... ......+.+|+++++.++|+||+++++.+..+...++++||+++++|.+++...
T Consensus 14 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 93 (265)
T cd06605 14 SGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV 93 (265)
T ss_pred CeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc
Confidence 689999996 479999999987653 344567889999999999999999999999999999999999999999998653
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ..+++..+..++.|++.+++|||+ .| ++|+||+|+||+++.++.++|+|||.+......... ...++..
T Consensus 94 ~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~ 164 (265)
T cd06605 94 Q--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSS 164 (265)
T ss_pred c--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----cccCChh
Confidence 2 458899999999999999999999 87 999999999999999999999999998665322111 1456788
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||.+.+..++.++||||||+++|+|++|..||........ .......... .... +.+.. ......+.
T Consensus 165 y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~-----~~~~~---~~~~~~~~ 234 (265)
T cd06605 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV-NEPP-----PRLPS---GKFSPDFQ 234 (265)
T ss_pred ccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHh-cCCC-----CCCCh---hhcCHHHH
Confidence 9999999888899999999999999999999999865432111 1111111111 0000 00000 11344588
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
++|.+||..+|++|||+.+++.
T Consensus 235 ~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 235 DFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHcCCCchhCcCHHHHhh
Confidence 8999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=257.95 Aligned_cols=234 Identities=29% Similarity=0.400 Sum_probs=183.6
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||.+.. +++.+++|.+.... ..+.+.+|+.+++.++|+||+++++++..+ ..+++|||+.+++|.+++....
T Consensus 19 ~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~- 93 (254)
T cd05083 19 FGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRG- 93 (254)
T ss_pred CCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcC-
Confidence 789999875 78889999885432 346788999999999999999999998765 4799999999999999986532
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++....... .....+..|+|
T Consensus 94 ~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~ 165 (254)
T cd05083 94 RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTA 165 (254)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecC
Confidence 335788999999999999999999998 9999999999999999999999999987643211 11223467999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++|+||||+++|+|++ |..||....... . ........... ........+.++
T Consensus 166 pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~~~~---------~~~~~~~~~~~l 229 (254)
T cd05083 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------V-KECVEKGYRME---------PPEGCPADVYVL 229 (254)
T ss_pred HHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------H-HHHHhCCCCCC---------CCCcCCHHHHHH
Confidence 999888889999999999999999997 888885432211 0 11111111110 011123457889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||+.+|++||++.+|++.|+.
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHcCCChhhCcCHHHHHHHHcc
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=263.13 Aligned_cols=249 Identities=22% Similarity=0.262 Sum_probs=185.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc-----cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ-----GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|.. .+|+.|++|.+...... ....+..|+.+++.++|+||+++++++.+++..++||||+ +++|.++
T Consensus 13 ~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 91 (298)
T cd07841 13 YAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKV 91 (298)
T ss_pred ccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHH
Confidence 689999995 57999999998654322 2345678999999999999999999999999999999999 8899998
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+.... ..+++..++.++.||++||+|||++| ++|+||+|+||+++.++.++|+|||++......... .....+
T Consensus 92 i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~ 164 (298)
T cd07841 92 IKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVV 164 (298)
T ss_pred HhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--cccccc
Confidence 85433 35899999999999999999999998 999999999999999999999999999876433211 112244
Q ss_pred ccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhh--------hc-ccccccccccc
Q 021771 155 TYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLW--------CE-GEALELMEPVL 224 (308)
Q Consensus 155 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~ 224 (308)
+..|+|||.+.+ ..++.++|||||||++|+|++|.++|....... ......... .. ...........
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T cd07841 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGKIFEALGTPTEENWPGVTSLPDYVEFKP 241 (298)
T ss_pred ceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHHHHHHcCCCchhhhhhcccccccccccc
Confidence 678999998765 457889999999999999999987775433211 000000000 00 00000000000
Q ss_pred ccc-----chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 225 KQS-----CVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 225 ~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
... ........+.+++.+||+.+|++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 242 FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 112224568899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=272.93 Aligned_cols=248 Identities=22% Similarity=0.238 Sum_probs=180.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeC------CeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE------NESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L 71 (308)
||.||.+.. ..++.+|||++... .......+.+|+.+++.++|+||+++++++... ...++||||+++ ++
T Consensus 37 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 115 (364)
T cd07875 37 QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NL 115 (364)
T ss_pred CeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CH
Confidence 789999985 57999999998643 233446678899999999999999999987643 357999999965 66
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
...+.. .+++..+..++.|++.||+|||++| |+||||||+||+++.++.+||+|||++....... ....
T Consensus 116 ~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~ 184 (364)
T cd07875 116 CQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTP 184 (364)
T ss_pred HHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccC
Confidence 665521 3788899999999999999999998 9999999999999999999999999997653221 1122
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchh-H--------H-------HHHhhhc-c
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL-S--------Y-------TWKLWCE-G 214 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~-~--------~-------~~~~~~~-~ 214 (308)
..++..|+|||++.+..++.++|||||||++|+|++|+.||............ . . ....... .
T Consensus 185 ~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (364)
T cd07875 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP 264 (364)
T ss_pred CcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCC
Confidence 45788999999999888999999999999999999999999654322110000 0 0 0000000 0
Q ss_pred cc-----ccccccccc---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 215 EA-----LELMEPVLK---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 215 ~~-----~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.. .+....... ..........+.+|+.+||+.||++|||+.++++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 000000000 00001122457899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=264.38 Aligned_cols=249 Identities=21% Similarity=0.271 Sum_probs=181.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.+++|++.... ......+.+|+.+++.++|+||+++++++.+....++++||+++ +|.+++..
T Consensus 13 ~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 91 (284)
T cd07839 13 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDS 91 (284)
T ss_pred CeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHh
Confidence 689999996 579999999986432 22335677899999999999999999999999999999999965 67776644
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ...+++..++.++.||++||.|||+.| ++|+||+|+||+++.++.++|+|||++..+...... .....++..
T Consensus 92 ~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~ 164 (284)
T cd07839 92 C--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLW 164 (284)
T ss_pred c--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccC
Confidence 2 235899999999999999999999998 999999999999999999999999998765432211 122345788
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc---------ccccc--ccccc--
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE---------GEALE--LMEPV-- 223 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~~--~~~~~-- 223 (308)
|+|||.+.+. .++.++|||||||++|+|++|+.|+....... ............ ..... .....
T Consensus 165 y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd07839 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPA 242 (284)
T ss_pred CcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCC
Confidence 9999988764 46889999999999999999998853222110 000000000000 00000 00000
Q ss_pred -cc-ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 224 -LK-QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 224 -~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. ..........+.+++.+||+.||++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 243 TTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 0001112346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=274.08 Aligned_cols=248 Identities=21% Similarity=0.229 Sum_probs=180.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------eEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L 71 (308)
||.||.+.. ..++.+|+|++... .......+.+|+.+++.++|+||+++++++.... ..++||||+++ ++
T Consensus 30 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 108 (355)
T cd07874 30 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NL 108 (355)
T ss_pred CEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cH
Confidence 789999985 57999999998643 2334466778999999999999999999886543 47999999966 55
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
...+.. .+++..+..++.|++.||+|||++| ++||||||+||+++.++.+||+|||++....... ....
T Consensus 109 ~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~ 177 (355)
T cd07874 109 CQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTP 177 (355)
T ss_pred HHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCC
Confidence 555521 3788899999999999999999998 9999999999999999999999999997653221 1222
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccc-hhH---------------HHHHhhhcc-
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQS-LLS---------------YTWKLWCEG- 214 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~-~~~---------------~~~~~~~~~- 214 (308)
..++..|+|||++.+..++.++|||||||++|+|++|..||.......... ... .........
T Consensus 178 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (355)
T cd07874 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257 (355)
T ss_pred ccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCC
Confidence 467889999999988889999999999999999999999996543211000 000 000000000
Q ss_pred cc-----ccccccc-cc--ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 215 EA-----LELMEPV-LK--QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 215 ~~-----~~~~~~~-~~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.. ....... .. ..........+.+|+.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred ccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 0000000 00 00111123467899999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=289.42 Aligned_cols=245 Identities=20% Similarity=0.272 Sum_probs=184.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe--CCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+++. .+++.+++|++... .......+..|+.+|+.++||||++++++|.+ ...++|||||+++++|.+++
T Consensus 26 FGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL 105 (1021)
T PTZ00266 26 FGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI 105 (1021)
T ss_pred CeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHH
Confidence 799999995 57889999988644 23345678899999999999999999999865 35689999999999999988
Q ss_pred hcCC-CccccChHHHHHHHHHHHHHHHhchhCCC----CceeecCCCCCceEeCCC-----------------CCeeeec
Q 021771 76 FDST-RSVQLDWKRRISIINGIARGLLYLHEDSR----LKIIHRDLKASNVLLNHE-----------------MNPKISD 133 (308)
Q Consensus 76 ~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g~----~~i~H~di~p~nilv~~~-----------------~~~kl~d 133 (308)
.... ....+++..++.|+.||+.||.|||+.+. .+|+|+||||+|||++.. +.+||+|
T Consensus 106 ~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsD 185 (1021)
T PTZ00266 106 QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185 (1021)
T ss_pred HHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEcc
Confidence 6532 23469999999999999999999998431 239999999999999642 3489999
Q ss_pred ccceeeeCCCCCccccceeecccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhh
Q 021771 134 FGMARIFGGNQSEANTNRIVGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLW 211 (308)
Q Consensus 134 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~ 211 (308)
||++..+..... .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||....... .. ....
T Consensus 186 FGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~-----ql-i~~l 256 (1021)
T PTZ00266 186 FGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS-----QL-ISEL 256 (1021)
T ss_pred CCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH-----HH-HHHH
Confidence 999976543221 223467899999998864 457899999999999999999999996432211 10 1111
Q ss_pred hcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHH--HHhhcC
Q 021771 212 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV--VMLASD 264 (308)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil--~~L~~~ 264 (308)
... ..+ .. ......+.+||..||+.+|++|||+.++| ..+...
T Consensus 257 k~~--p~l-----pi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 257 KRG--PDL-----PI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred hcC--CCC-----Cc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 110 000 00 01124588899999999999999999999 445433
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=256.58 Aligned_cols=237 Identities=20% Similarity=0.253 Sum_probs=188.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.+++|++.... ....+.+.+|+.+++.++|+||+++++.+.++...+++|||+++++|.+++.
T Consensus 6 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 85 (262)
T cd05572 6 FGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILR 85 (262)
T ss_pred ceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHh
Confidence 689999996 469999999986542 2344678899999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.|++.+|+|||++| ++|+||+|+||+++.++.++|+|||++....... ......++.
T Consensus 86 ~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~ 156 (262)
T cd05572 86 DR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTP 156 (262)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCc
Confidence 43 34888999999999999999999998 9999999999999999999999999998764332 122235678
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|++||.+.+..++.++|+||+|+++|+|++|..||....... ............. ...+......+
T Consensus 157 ~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~---------~~~~~~~~~~~ 223 (262)
T cd05572 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNGK---------LEFPNYIDKAA 223 (262)
T ss_pred CccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCCC---------CCCCcccCHHH
Confidence 8999999888888999999999999999999999987554211 1111111100000 01111114468
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHH
Q 021771 237 IHIGLLCVQADSADRPT-----MSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs-----~~eil~ 259 (308)
.+++.+||+.+|++||+ ++|+++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 89999999999999999 888876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.02 Aligned_cols=242 Identities=28% Similarity=0.436 Sum_probs=185.0
Q ss_pred CCccEEeee-CCCC----EEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGK----EIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+++. .+|. .+++|.+.... ......+.+|+.+++.++|+||+++++++... ..++++||+++++|.++
T Consensus 20 ~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~ 98 (303)
T cd05110 20 FGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDY 98 (303)
T ss_pred CccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHH
Confidence 799999985 4554 47888876543 23344678999999999999999999998764 46789999999999998
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+... ...+++..+..++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++..+.............+
T Consensus 99 ~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~ 173 (303)
T cd05110 99 VHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173 (303)
T ss_pred HHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcccccccCCCcc
Confidence 8543 234788899999999999999999998 99999999999999999999999999987643322222222344
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||.+.+..++.++||||||+++|+|++ |+.||........ ............ .....
T Consensus 174 ~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~~---------~~~~~ 237 (303)
T cd05110 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-------PDLLEKGERLPQ---------PPICT 237 (303)
T ss_pred ccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHCCCCCCC---------CCCCC
Confidence 668999999988889999999999999999997 8888854321111 111111111000 01112
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+++..||..+|++||+++++++.|+..
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 3578888999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=257.91 Aligned_cols=237 Identities=22% Similarity=0.345 Sum_probs=188.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.+|+++. .+|+.+++|.+... .......+.+|+.+++.++|+||+++++++.+.+..++||||+.+++|.+++..
T Consensus 13 ~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~ 92 (256)
T cd08218 13 FGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINA 92 (256)
T ss_pred ceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHh
Confidence 688999984 68999999998643 233456788999999999999999999999999999999999999999988854
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ....+++..+..++.|++.++.|||++| ++|+||+|+||+++.++.++|+|||++......... .....++..
T Consensus 93 ~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~ 166 (256)
T cd08218 93 Q-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPY 166 (256)
T ss_pred c-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCcc
Confidence 2 2234788899999999999999999998 999999999999999999999999999875432211 122346778
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||...+..++.++|+||+|+++++|++|..||...... ....... .+.... .+.....++.
T Consensus 167 ~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~-~~~~~~---------~~~~~~~~~~ 230 (256)
T cd08218 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKII-RGSYPP---------VSSHYSYDLR 230 (256)
T ss_pred ccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHh-cCCCCC---------CcccCCHHHH
Confidence 99999988888899999999999999999999998643211 1111111 111100 1112234588
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+++.+||+.+|++||++.+|++
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhh
Confidence 8999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=259.16 Aligned_cols=231 Identities=25% Similarity=0.304 Sum_probs=185.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||.+.. .+++.+++|++.... ....+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++.
T Consensus 14 ~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~ 93 (290)
T cd05580 14 FGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR 93 (290)
T ss_pred CeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHH
Confidence 689999985 579999999986432 2345678899999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.|++.+|.|||+.| ++|+||+|.||+++.++.++|+|||++...... .....++.
T Consensus 94 ~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~ 162 (290)
T cd05580 94 KS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTP 162 (290)
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCc
Confidence 43 45899999999999999999999998 999999999999999999999999998875433 22235678
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||.+.+...+.++||||||+++|+|++|..||....... ...... .... . .+......+
T Consensus 163 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~-~---------~~~~~~~~l 225 (290)
T cd05580 163 EYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEKIL-EGKV-R---------FPSFFSPDA 225 (290)
T ss_pred cccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCCc-c---------CCccCCHHH
Confidence 8999999888888899999999999999999999986443110 011110 1100 0 011113457
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHH
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~ 259 (308)
.+++.+||+.||.+|+ +++|+++
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 226 KDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 8899999999999999 7788874
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.23 Aligned_cols=250 Identities=21% Similarity=0.298 Sum_probs=187.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.+++|++.... ......+.+|+.+++.++|+||+++++++.++...++||||+ +++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~ 91 (286)
T cd07832 13 HGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD 91 (286)
T ss_pred CcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHh
Confidence 689999995 579999999987553 334567889999999999999999999999999999999999 9999998865
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.. ..+++..++.++.||+.+|+|||+.| ++|+||+|+||+++.++.++|+|||++........ .......++..
T Consensus 92 ~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~ 165 (286)
T cd07832 92 EE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRW 165 (286)
T ss_pred cC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCccc
Confidence 33 45899999999999999999999998 99999999999999999999999999887643321 11223457888
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHh--------hhc----ccccccccccc
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKL--------WCE----GEALELMEPVL 224 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~--------~~~----~~~~~~~~~~~ 224 (308)
|+|||.+.+. .++.++||||+|+++|+|++|.++|........ ....... +.. ...........
T Consensus 166 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd07832 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLPDYNKITFPES 242 (286)
T ss_pred ccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcchhhcccCCCC
Confidence 9999987654 468899999999999999999887754322110 0000000 000 00000000000
Q ss_pred ----cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 225 ----KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 225 ----~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
...........+.+++.+||+.+|++|||++++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 243 KPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000011223678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=258.40 Aligned_cols=237 Identities=22% Similarity=0.342 Sum_probs=179.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-----cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-----GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~ 72 (308)
||.||++.. .+|..+++|++.... ......+.+|+.+++.++|+||+++++++.+. ...++++||+++++|.
T Consensus 15 ~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~ 94 (266)
T cd06651 15 FGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK 94 (266)
T ss_pred CEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHH
Confidence 689999985 579999999875432 12335678899999999999999999998763 5678999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC-ccccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS-EANTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 151 (308)
+++... ..+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 95 ~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (266)
T cd06651 95 DQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168 (266)
T ss_pred HHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCcccc
Confidence 988543 24788999999999999999999997 99999999999999999999999999876532111 111122
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..++..|+|||.+.+..++.++||||+||++|+|++|..||....... .......... . ...+..
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~~~~~-----~----~~~~~~ 233 (266)
T cd06651 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIATQPT-----N----PQLPSH 233 (266)
T ss_pred CCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHhcCCC-----C----CCCchh
Confidence 346788999999988888999999999999999999999986432110 0111100000 0 111111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
....+.+++ +||..+|++|||++||++
T Consensus 234 ~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 234 ISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred cCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 223355555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=259.69 Aligned_cols=239 Identities=26% Similarity=0.324 Sum_probs=185.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||++.. .+|+.+++|.+.... ......+..|+.+++.++||||+++++.+...+..++||||+++++|.+++.
T Consensus 6 ~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 85 (277)
T cd05577 6 FGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIY 85 (277)
T ss_pred ceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHH
Confidence 799999985 579999999986432 2234456789999999999999999999999999999999999999999886
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... ...+++..+..++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 86 ~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~ 158 (277)
T cd05577 86 NVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTP 158 (277)
T ss_pred HcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCC
Confidence 543 235899999999999999999999998 9999999999999999999999999887653211 112234677
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||...+..++.++||||||+++|+|++|..||............ ... .... . ...+......+
T Consensus 159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~------~~~~-~----~~~~~~~~~~~ 225 (277)
T cd05577 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL--KRR------TLEM-A----VEYPDKFSPEA 225 (277)
T ss_pred CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH--Hhc------cccc-c----ccCCccCCHHH
Confidence 899999988888899999999999999999999998654332111100 000 0000 0 00111123457
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHH
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~ 259 (308)
.+++.+||+.+|++|| ++.++++
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHh
Confidence 8899999999999999 6776764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=278.65 Aligned_cols=232 Identities=29% Similarity=0.425 Sum_probs=186.3
Q ss_pred CCccEEee-eCCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||.++ .++.+.||||++.... ..-.+.+..|+..|+.++|||++.+.++|..+...+||||||-| +-.+++.
T Consensus 39 FGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-SAsDlle 117 (948)
T KOG0577|consen 39 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLE 117 (948)
T ss_pred cceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-cHHHHHH
Confidence 89999999 5799999999987553 33456788999999999999999999999999999999999954 7777663
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
- .++++.+.++..|..+.+.||+|||+.+ .+|||||..|||+++.|.|||+|||.+.... ..+.++||+
T Consensus 118 V--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTP 186 (948)
T KOG0577|consen 118 V--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTP 186 (948)
T ss_pred H--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC------chhcccCCc
Confidence 3 3456999999999999999999999997 9999999999999999999999999987643 234578999
Q ss_pred CccCchhhcc---CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 157 GYMAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 157 ~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.|||||++.. +.|+-++||||||++-.+|...++|.-+...- ...+.+. ..+. +.+. .....
T Consensus 187 ywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM------SALYHIA-QNes-----PtLq---s~eWS 251 (948)
T KOG0577|consen 187 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIA-QNES-----PTLQ---SNEWS 251 (948)
T ss_pred cccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH------HHHHHHH-hcCC-----CCCC---CchhH
Confidence 9999998763 68999999999999999999999995322111 1111110 0000 1111 23445
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..+..++..||++-|.+|||.++++.
T Consensus 252 ~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 252 DYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred HHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 56888888999999999999999874
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=252.66 Aligned_cols=239 Identities=26% Similarity=0.392 Sum_probs=192.1
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 75 (308)
||.||.|... +|+.+++|++..... ...+.+.+|+..+++++|+||+++++.+.+. ...++++||+++++|.+++
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 92 (260)
T cd06606 13 FGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL 92 (260)
T ss_pred ceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHH
Confidence 6899999964 799999999865542 4567889999999999999999999999988 8899999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... .+++..++.++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||.+................++
T Consensus 93 ~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 166 (260)
T cd06606 93 KKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166 (260)
T ss_pred HHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCC
Confidence 6533 6899999999999999999999998 999999999999999999999999999887544321112234567
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||...+...+.++||||||+++|+|++|..||...... .............. ..+......
T Consensus 167 ~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~---------~~~~~~~~~ 232 (260)
T cd06606 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSSGEPP---------EIPEHLSEE 232 (260)
T ss_pred ccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccccCCCc---------CCCcccCHH
Confidence 8899999988888899999999999999999999998755411 11111111001111 111222456
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+.+++.+||+.+|++||++.++++
T Consensus 233 l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 233 AKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHHHHhCcCChhhCCCHHHHhh
Confidence 889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=259.27 Aligned_cols=249 Identities=20% Similarity=0.281 Sum_probs=181.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.|++|.+.... ......+.+|+.+++.++|+||+++++++.++...++||||+.+ +|.+++...
T Consensus 18 ~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~ 96 (291)
T cd07844 18 YATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDC 96 (291)
T ss_pred CeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhC
Confidence 689999996 478999999986442 22334567899999999999999999999999999999999975 888887543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
.. .+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++......... .....++..|
T Consensus 97 ~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~ 169 (291)
T cd07844 97 GG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWY 169 (291)
T ss_pred CC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCcc--cccccccccc
Confidence 32 5889999999999999999999997 999999999999999999999999998754322111 1112356789
Q ss_pred cCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh---cccc---------ccccccccc
Q 021771 159 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC---EGEA---------LELMEPVLK 225 (308)
Q Consensus 159 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~---------~~~~~~~~~ 225 (308)
+|||.+.+ ..++.++||||+|+++|+|++|..||........ .......... ...+ .........
T Consensus 170 ~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T cd07844 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYP 247 (291)
T ss_pred CCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhccccccccccccC
Confidence 99998765 4578899999999999999999999864431100 0000000000 0000 000000000
Q ss_pred cc------chHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 226 QS------CVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 226 ~~------~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. ........+.+++.+||+.+|++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 248 PRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 00011246788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.29 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=184.8
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||++... +|+.+|+|++..... ...+.+.+|+++++.++|+||+++++++.++...++||||++++++..+...
T Consensus 14 ~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~ 93 (286)
T cd07846 14 YGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY 93 (286)
T ss_pred CeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc
Confidence 6899999964 699999998865422 2345678999999999999999999999999999999999999988887643
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ..+++..+..++.|++.+|+|||+.| ++|+||+|+||++++++.++|+|||++........ ......++..
T Consensus 94 ~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~ 165 (286)
T cd07846 94 P---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRW 165 (286)
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceee
Confidence 2 23889999999999999999999998 99999999999999999999999999887543321 1222356788
Q ss_pred ccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccc-hh-------HHHHHhhhccc------ccccccc
Q 021771 158 YMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQS-LL-------SYTWKLWCEGE------ALELMEP 222 (308)
Q Consensus 158 y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~-~~-------~~~~~~~~~~~------~~~~~~~ 222 (308)
|+|||.+.+ ..++.++||||+|+++|+|++|.+||.......... .. ......+.... ..+....
T Consensus 166 y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd07846 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245 (286)
T ss_pred ccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCc
Confidence 999998875 346788999999999999999999885432211000 00 00000000000 0000000
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.............+.+|+.+||+.+|++||++.++++
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 246 EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000001122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=257.88 Aligned_cols=239 Identities=22% Similarity=0.336 Sum_probs=188.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe--CCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||++.. .+|+.+++|.+... .....+.+..|+.+++.++|+||+++++++.. +...+++|||+++++|.+++
T Consensus 13 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l 92 (265)
T cd08217 13 FGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI 92 (265)
T ss_pred CeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHH
Confidence 689999985 68899999988644 23345678899999999999999999998764 34679999999999999998
Q ss_pred hcC-CCccccChHHHHHHHHHHHHHHHhch-----hCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc
Q 021771 76 FDS-TRSVQLDWKRRISIINGIARGLLYLH-----EDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 76 ~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH-----~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
... .....+++..++.++.|++.+|++|| +.+ ++|+||+|+||+++.++.++|+|||++......... .
T Consensus 93 ~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~ 167 (265)
T cd08217 93 QKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--A 167 (265)
T ss_pred HHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCccc--c
Confidence 653 22456899999999999999999999 766 999999999999999999999999999876533221 1
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||....... .. +....... ...+
T Consensus 168 ~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~---------~~~~ 231 (265)
T cd08217 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ------LA-SKIKEGKF---------RRIP 231 (265)
T ss_pred cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH------HH-HHHhcCCC---------CCCc
Confidence 22357889999999988888999999999999999999999987543111 11 11111111 1111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
......+.+++.+||+.+|++|||+.+|++.
T Consensus 232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 2233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=258.55 Aligned_cols=242 Identities=23% Similarity=0.329 Sum_probs=184.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc----------ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG----------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 69 (308)
||.||+|.. .+|+.+++|.+..... ...+.+..|+.+++.++|+||+++++++...+..++||||++++
T Consensus 14 ~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 93 (272)
T cd06629 14 YGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGG 93 (272)
T ss_pred ceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCC
Confidence 689999985 5799999998753210 01245778999999999999999999999999999999999999
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
+|.+++... ..+++..+..++.|++.+|.+||+++ ++|+||+|+||+++.++.++|+|||++............
T Consensus 94 ~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 167 (272)
T cd06629 94 SIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN 167 (272)
T ss_pred cHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccccccccccccc
Confidence 999998553 35888999999999999999999997 999999999999999999999999998765322222222
Q ss_pred ceeecccCccCchhhccCc--ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccccc
Q 021771 150 NRIVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS 227 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
....++..|+|||.+.... ++.++|+||||+++|++++|..||...... ............... . ..
T Consensus 168 ~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~-~----~~ 236 (272)
T cd06629 168 MSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKRSAPPI-P----PD 236 (272)
T ss_pred ccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccccCCcC-C----cc
Confidence 2345678899999887644 788999999999999999999998532211 001111101000011 0 11
Q ss_pred chHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 228 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 228 ~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
........+.+++.+||..+|++|||+.+|++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 237 VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11122356888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=257.78 Aligned_cols=241 Identities=22% Similarity=0.348 Sum_probs=186.4
Q ss_pred CCccEEeeeC--CCCEEEEEEeccCC----------cccHHHHHHHHHHHhc-CCCcCccceeeeEEeCCeEEEEEEecC
Q 021771 1 MESCLQGKLA--DGKEIAVKRLSRTS----------GQGLQEFKNEVTLIAK-LQHKNLVRLFGCCLEENESLLIYEYMP 67 (308)
Q Consensus 1 ~g~v~~~~~~--~g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~ 67 (308)
||.||++... +++.+++|.+.... ......+..|+.++.. ++|+||+++++++.+++..+++|||++
T Consensus 13 ~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (269)
T cd08528 13 FGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIE 92 (269)
T ss_pred CceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCC
Confidence 7899999965 47899999875321 2233456678887765 689999999999999999999999999
Q ss_pred CCChhhHhhcC-CCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC
Q 021771 68 NKSLDVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS 145 (308)
Q Consensus 68 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~ 145 (308)
+++|.+++... .....+++..++.++.|++.+|.+||+ .| ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 93 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 168 (269)
T cd08528 93 GAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES- 168 (269)
T ss_pred CCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccceeeccccc-
Confidence 99999887542 234468999999999999999999996 55 9999999999999999999999999998764332
Q ss_pred ccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 146 EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 146 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
......++..|++||.+.+..++.++|+||||+++|+|++|..||....... . . ........... .
T Consensus 169 --~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~---~-~~~~~~~~~~~----~- 234 (269)
T cd08528 169 --KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---L---A-TKIVEAVYEPL----P- 234 (269)
T ss_pred --ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---H---H-HHHhhccCCcC----C-
Confidence 2223457888999999988888999999999999999999999985432211 0 0 01111111100 0
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
. ......+.+++.+||+.||++||++.|+.++++
T Consensus 235 ~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 235 E---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred c---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 012245888999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=254.90 Aligned_cols=239 Identities=26% Similarity=0.349 Sum_probs=191.7
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++.. +|+.+++|++..... .....+.+|+..+..++|+||+++++++......++||||+++++|.+++...
T Consensus 14 ~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 93 (264)
T cd06623 14 SGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV 93 (264)
T ss_pred CeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc
Confidence 6889999965 699999999876543 44577899999999999999999999999999999999999999999998543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
..+++..++.++.|++++++|||+ .| ++|+||+|+||+++.++.++|+|||++......... .....++..
T Consensus 94 ---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~ 165 (264)
T cd06623 94 ---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CNTFVGTVT 165 (264)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc--ccceeeccc
Confidence 458999999999999999999999 87 999999999999999999999999998876433222 123456788
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH-HHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA-ELLKF 236 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l 236 (308)
|+|||...+..++.++|+||||+++|+|++|..||........ ........ ...... .... ....+
T Consensus 166 y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~-~~~~~~---------~~~~~~~~~l 232 (264)
T cd06623 166 YMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FELMQAIC-DGPPPS---------LPAEEFSPEF 232 (264)
T ss_pred ccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HHHHHHHh-cCCCCC---------CCcccCCHHH
Confidence 9999998888889999999999999999999999865532111 11111111 111100 1111 33568
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+++.+||..+|++|||+.++++.
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhC
Confidence 899999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=258.18 Aligned_cols=235 Identities=24% Similarity=0.406 Sum_probs=186.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCC---CcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQ---HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|.. .+|+.+++|.+... .....+.+.+|+.+++.++ |+|++++++++.++...++||||+++++|.+++
T Consensus 14 ~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 93 (277)
T cd06917 14 YGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM 93 (277)
T ss_pred CceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHH
Confidence 789999995 68999999998654 3445567889999999996 999999999999999999999999999999987
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. ..+++..++.++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||++......... .....++
T Consensus 94 ~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~ 164 (277)
T cd06917 94 KA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGT 164 (277)
T ss_pred Hc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCC
Confidence 43 25889999999999999999999998 999999999999999999999999999876543321 2223577
Q ss_pred cCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... ...... .+.+... ....
T Consensus 165 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~~~~~~-----~~~~~~~---~~~~ 229 (277)
T cd06917 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------LIPKSK-----PPRLEDN---GYSK 229 (277)
T ss_pred cceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------ccccCC-----CCCCCcc---cCCH
Confidence 88999998765 456889999999999999999999986432211000 000000 0001111 1234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+.+++.+||+.||++||++.+++.
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhh
Confidence 5888999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=260.80 Aligned_cols=237 Identities=23% Similarity=0.339 Sum_probs=188.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .+++.+++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+++++|.+++..
T Consensus 32 ~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-- 109 (293)
T cd06647 32 SGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-- 109 (293)
T ss_pred CeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh--
Confidence 689999985 57899999998655555567788999999999999999999999999999999999999999998843
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.+++|||++| ++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 110 --~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~ 182 (293)
T cd06647 110 --TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWM 182 (293)
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhc
Confidence 24788899999999999999999998 99999999999999999999999998876543222 122235678899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
+||.+.+..++.++|+||+|+++|++++|..||............ ..... .. ..........+.++
T Consensus 183 ~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~-~~-------~~~~~~~~~~l~~l 248 (293)
T cd06647 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT-PE-------LQNPEKLSAIFRDF 248 (293)
T ss_pred CchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCC-CC-------CCCccccCHHHHHH
Confidence 999988888899999999999999999999999654322110000 00000 00 00111223458889
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~ 260 (308)
+.+||+.+|++||++.+++..
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=257.88 Aligned_cols=236 Identities=21% Similarity=0.337 Sum_probs=187.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .+++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||+++++|.+++..
T Consensus 32 ~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-- 109 (285)
T cd06648 32 TGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-- 109 (285)
T ss_pred CeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--
Confidence 688999985 58999999998655545556788999999999999999999999999999999999999999998854
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.++++||++| ++|+||+|+||+++.++.++|+|||++......... .....++..|+
T Consensus 110 --~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~ 182 (285)
T cd06648 110 --TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWM 182 (285)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--cccccCCcccc
Confidence 34888999999999999999999998 999999999999999999999999987654322211 12245788899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||...+..++.++||||+|+++|+|++|..||...... ....... ...... ... .......+.++
T Consensus 183 aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~-~~~~~~-----~~~--~~~~~~~l~~l 248 (285)
T cd06648 183 APEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIR-DNLPPK-----LKN--LHKVSPRLRSF 248 (285)
T ss_pred CHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHH-hcCCCC-----Ccc--cccCCHHHHHH
Confidence 999988888899999999999999999999998542211 1111111 000000 000 11122458889
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
+.+||+.+|++|||+.++++
T Consensus 249 i~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 249 LDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHcccChhhCcCHHHHcc
Confidence 99999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=264.94 Aligned_cols=242 Identities=18% Similarity=0.193 Sum_probs=182.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.||+|++... .......+.+|..++..++|++|+++++++.+++..++||||+++++|.+++.
T Consensus 14 fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~ 93 (331)
T cd05624 14 FGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLS 93 (331)
T ss_pred CeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 799999996 57899999998642 22334567889999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... ..+++..+..++.|++.||+|||++| |+|+||||+||+++.++.+||+|||++......... ......|+.
T Consensus 94 ~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~ 167 (331)
T cd05624 94 KFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTP 167 (331)
T ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCc
Confidence 532 35888999999999999999999998 999999999999999999999999999876433221 122346889
Q ss_pred CccCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 157 GYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 157 ~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.|+|||++.+ ..++.++||||+|+++|+|++|..||...... ............... . .....
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-p-----~~~~~ 235 (331)
T cd05624 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQF-P-----SHITD 235 (331)
T ss_pred ccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcccC-C-----Ccccc
Confidence 9999998865 45788999999999999999999998643221 111111111100000 0 00111
Q ss_pred HHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSAD--RPTMSSVVVM 260 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~--RPs~~eil~~ 260 (308)
....+.+++.+|+..++++ |++++++++.
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 2345777888888865543 4578888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=258.94 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=185.3
Q ss_pred CCccEEeeeC----CCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------eEEEEEEecCC
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ESLLIYEYMPN 68 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~ 68 (308)
||.||+|... +|+.+|+|++... .....+.+.+|+.+++.++||||+++++++.... ..+++++|+.+
T Consensus 12 ~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (273)
T cd05074 12 FGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKH 91 (273)
T ss_pred CCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCC
Confidence 7899999853 4789999988654 3344567889999999999999999999886532 23688899999
Q ss_pred CChhhHhhcCC---CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC
Q 021771 69 KSLDVFLFDST---RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS 145 (308)
Q Consensus 69 ~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~ 145 (308)
++|..++.... ....++...+..++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++........
T Consensus 92 ~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~ 168 (273)
T cd05074 92 GDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168 (273)
T ss_pred CcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcc
Confidence 99988774321 1234788899999999999999999998 99999999999999999999999999886543222
Q ss_pred ccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccc
Q 021771 146 EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVL 224 (308)
Q Consensus 146 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
........++..|++||...+..++.++||||||+++|+|++ |.+||....... . ...........
T Consensus 169 ~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~~------ 235 (273)
T cd05074 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---I----YNYLIKGNRLK------ 235 (273)
T ss_pred eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---H----HHHHHcCCcCC------
Confidence 111122234567999999888888999999999999999998 778875432211 1 11111111000
Q ss_pred cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 225 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 225 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
........+.+++.+||+.+|++|||+.++++.|+..
T Consensus 236 ---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 236 ---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011234688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=262.21 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=187.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||++.. .+++.|++|++... .....+.+.+|+.+++.++|+||+++++++.+++..+++|||++++.+..+...
T Consensus 14 ~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~ 93 (288)
T cd07833 14 YGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS 93 (288)
T ss_pred CeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc
Confidence 688999986 47899999988644 233457889999999999999999999999999999999999998777766533
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..++.++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++........ .......++..
T Consensus 94 ---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~ 166 (288)
T cd07833 94 ---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRW 166 (288)
T ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccC
Confidence 234889999999999999999999998 99999999999999999999999999887653322 11223456788
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHH--------HHHhhhccc------ccccccc
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY--------TWKLWCEGE------ALELMEP 222 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------~~~~~~~~~------~~~~~~~ 222 (308)
|+|||++.+. .++.++||||||+++|+|++|..||.............. ....+.... .......
T Consensus 167 ~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
T cd07833 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQP 246 (288)
T ss_pred CcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCc
Confidence 9999998877 788999999999999999999999864322110000000 000000000 0000000
Q ss_pred c-ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 223 V-LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 223 ~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
. ............+.+++.+||..+|++|||++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 247 ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 000011112466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=263.10 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=184.4
Q ss_pred CCccEEeeeC---CCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~ 72 (308)
||.||+|+.. +|+.||+|.+.... ......+..|+.+++.++||||+++++++.+. ...++||||+++ ++.
T Consensus 13 ~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 91 (316)
T cd07842 13 YGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLW 91 (316)
T ss_pred cEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHH
Confidence 6899999964 58999999987632 34446778899999999999999999999988 789999999965 566
Q ss_pred hHhhcCC--CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC----CCCeeeecccceeeeCCCCC-
Q 021771 73 VFLFDST--RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH----EMNPKISDFGMARIFGGNQS- 145 (308)
Q Consensus 73 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~----~~~~kl~dfg~~~~~~~~~~- 145 (308)
+++.... ....+++..++.++.|++.+|+|||+.+ ++|+||+|+||+++. ++.+||+|||++........
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 168 (316)
T cd07842 92 QIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168 (316)
T ss_pred HHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCccc
Confidence 6554322 2236899999999999999999999998 999999999999999 89999999999887543322
Q ss_pred ccccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccch------hHHHHHhhh------
Q 021771 146 EANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSL------LSYTWKLWC------ 212 (308)
Q Consensus 146 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~------~~~~~~~~~------ 212 (308)
........++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... .........
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 248 (316)
T cd07842 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKD 248 (316)
T ss_pred ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhH
Confidence 111223456788999998766 4578899999999999999999999975544321000 000000000
Q ss_pred ------cccccc---ccc-ccccccchH-------HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 213 ------EGEALE---LME-PVLKQSCVA-------AELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 213 ------~~~~~~---~~~-~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...... ... ......... .....+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 249 WPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000 000000000 22345889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=254.81 Aligned_cols=236 Identities=24% Similarity=0.371 Sum_probs=186.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||++.. .+++.+++|.+... .......+.+|+.+++.++|+||+++++.+......++||||+++++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 92 (256)
T cd08220 13 FGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQK 92 (256)
T ss_pred ceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHH
Confidence 688999885 58999999998654 233456788999999999999999999999999999999999999999999865
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCccccceeeccc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ....+++..+..++.+++.++.|||++| ++|+||+|+||+++.++ .++|+|||.+........ .....++.
T Consensus 93 ~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~ 165 (256)
T cd08220 93 R-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTP 165 (256)
T ss_pred h-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCC
Confidence 3 2335889999999999999999999998 99999999999998655 579999999987643321 12235678
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||.+.+..++.++||||+|+++|+|++|..||....... ...... ....... .......+
T Consensus 166 ~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~-~~~~~~~---------~~~~~~~l 229 (256)
T cd08220 166 CYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIM-SGTFAPI---------SDRYSPDL 229 (256)
T ss_pred cccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHH-hcCCCCC---------CCCcCHHH
Confidence 8999999988888999999999999999999999986543221 111111 0000011 11123358
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.+|++|||+.++++
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhh
Confidence 88999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=258.50 Aligned_cols=235 Identities=25% Similarity=0.393 Sum_probs=186.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||++.. .+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.++...++||||+++++|..++..
T Consensus 17 ~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~- 95 (277)
T cd06641 17 FGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP- 95 (277)
T ss_pred CeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-
Confidence 789999985 578999999876442 33446788999999999999999999999999999999999999999998843
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
..+++..+..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||++......... .....++..|
T Consensus 96 ---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y 167 (277)
T cd06641 96 ---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFW 167 (277)
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh--hccccCCccc
Confidence 34889999999999999999999998 999999999999999999999999998765432211 1223567789
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
+|||.+.+..++.++|+||+||++|+|++|..||....... ..... ..... +.+ .......+.+
T Consensus 168 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~~-----~~~----~~~~~~~~~~ 231 (277)
T cd06641 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLI-PKNNP-----PTL----EGNYSKPLKE 231 (277)
T ss_pred cChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHH-hcCCC-----CCC----CcccCHHHHH
Confidence 99999888888899999999999999999999985432110 00000 00000 001 1122345788
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021771 239 IGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~ 260 (308)
++.+||+.+|++||++.++++.
T Consensus 232 ~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 232 FVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHccCChhhCcCHHHHHhC
Confidence 8899999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=260.85 Aligned_cols=253 Identities=20% Similarity=0.242 Sum_probs=185.9
Q ss_pred CccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 2 ESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 2 g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
|.||+++. .+|+.||+|++... .......+..|+.+++.++|+||+++++++.+++..+++|||+++++|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~ 93 (314)
T cd08216 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH 93 (314)
T ss_pred ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh
Confidence 56777774 47999999998654 3445678999999999999999999999999999999999999999999998653
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-----cccceee
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-----ANTNRIV 153 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~ 153 (308)
. ...+++..+..++.|++.||+|||+++ |+|+||+|+||+++.++.++|+||+.+......... .......
T Consensus 94 ~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 94 F-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred c-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccc
Confidence 2 234888999999999999999999998 999999999999999999999999988765322111 0112234
Q ss_pred cccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH----hhhcc-------cccc--
Q 021771 154 GTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK----LWCEG-------EALE-- 218 (308)
Q Consensus 154 ~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~-------~~~~-- 218 (308)
++..|+|||++.+ ..++.++||||+|+++|+|++|..||....... ........ ..... ....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCccc
Confidence 5678999998865 357889999999999999999999986432211 00000000 00000 0000
Q ss_pred --cccc----cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 219 --LMEP----VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 219 --~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.... .............+.+++.+||+.||++|||++++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00011112233568889999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=257.09 Aligned_cols=235 Identities=24% Similarity=0.265 Sum_probs=188.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.+++|.+.... ....+.+.+|+.++++++||||+++++++.++...++|+||+.+++|..++.
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 92 (258)
T cd05578 13 FGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLS 92 (258)
T ss_pred CceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHH
Confidence 789999996 479999999986542 2345788899999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.|++++|.|||++| ++|+||+|+||++++++.++|+|||++....... ......++.
T Consensus 93 ~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 163 (258)
T cd05578 93 QK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTP 163 (258)
T ss_pred hc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCCh
Confidence 43 45899999999999999999999998 9999999999999999999999999987754332 122345677
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||.+.+..++.++|+||||+++|+|++|..||........... . ..... .. ...+......+
T Consensus 164 ~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~-~~~~~-~~---------~~~~~~~~~~~ 229 (258)
T cd05578 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI---R-AKQET-AD---------VLYPATWSTEA 229 (258)
T ss_pred hhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH---H-HHhcc-cc---------ccCcccCcHHH
Confidence 89999998888889999999999999999999999875543211110 0 00000 00 11111223568
Q ss_pred HHHHhhcccCCCCCCCCH--HHHH
Q 021771 237 IHIGLLCVQADSADRPTM--SSVV 258 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~--~eil 258 (308)
.+++.+||+.||++||++ +|++
T Consensus 230 ~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 230 IDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHHHccCChhHcCCccHHHHh
Confidence 889999999999999999 6655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=260.59 Aligned_cols=237 Identities=24% Similarity=0.377 Sum_probs=181.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEe------CCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLE------ENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+++.+++|++.... .....+..|+.+++++ +|+||+++++++.. ....+++|||+++++|.
T Consensus 29 ~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~ 107 (282)
T cd06636 29 YGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT 107 (282)
T ss_pred CeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHH
Confidence 789999995 679999999885443 3446688899999998 69999999999853 45689999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+++... ....+++..+..++.|++.|++|||+.| ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 108 ~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 181 (282)
T cd06636 108 DLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTF 181 (282)
T ss_pred HHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcc
Confidence 988653 2345788889999999999999999998 99999999999999999999999999876432211 12234
Q ss_pred ecccCccCchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccccc
Q 021771 153 VGTYGYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS 227 (308)
Q Consensus 153 ~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
.++..|+|||.+. +..++.++|+||||+++|+|++|..||......... .... ...... .
T Consensus 182 ~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~~~~-~~~~~~-----~--- 246 (282)
T cd06636 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------FLIP-RNPPPK-----L--- 246 (282)
T ss_pred cccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------hhHh-hCCCCC-----C---
Confidence 5788899999875 345778999999999999999999998543211100 0000 000000 0
Q ss_pred chHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 228 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 228 ~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
........+.+++.+||+.||++|||+.||++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 01112346889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=260.55 Aligned_cols=251 Identities=22% Similarity=0.255 Sum_probs=183.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|+. .+++.+++|.++... ......+.+|+.+++.++||||+++++++... ...++||||+++ +|.+++
T Consensus 18 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~ 96 (293)
T cd07843 18 YGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLM 96 (293)
T ss_pred CeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHH
Confidence 689999996 479999999986443 22234567899999999999999999999877 789999999975 888877
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... ..+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++..+..... ......++
T Consensus 97 ~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~ 169 (293)
T cd07843 97 ETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVT 169 (293)
T ss_pred Hhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc--cccccccc
Confidence 5433 25899999999999999999999998 99999999999999999999999999987654321 12223567
Q ss_pred cCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHH--------HHHhhhc------ccccccc
Q 021771 156 YGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY--------TWKLWCE------GEALELM 220 (308)
Q Consensus 156 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------~~~~~~~------~~~~~~~ 220 (308)
..|+|||.+.+. .++.++|+||||+++|+|++|..||.............. .+..+.. .......
T Consensus 170 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (293)
T cd07843 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYP 249 (293)
T ss_pred ccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhccccccccc
Confidence 889999987654 468899999999999999999999865432211000000 0000000 0000000
Q ss_pred cccccccchHH-HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 221 EPVLKQSCVAA-ELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 221 ~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...+....... ....+.+++.+||+.+|++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 250 YNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00011111111 2445788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.51 Aligned_cols=247 Identities=25% Similarity=0.289 Sum_probs=187.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||.+.. .+++.+++|.+.... ......+.+|+++++.++|+||+++++++.+. ...++||||+++++|.+++.
T Consensus 14 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 93 (287)
T cd06621 14 GGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYK 93 (287)
T ss_pred ceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHH
Confidence 689999996 578999999886543 23456788999999999999999999998654 36899999999999988765
Q ss_pred cC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. .....+++..+..++.||+.+|+|||+.| ++|+||+|+||+++.++.++|+|||++........ ....++
T Consensus 94 ~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~ 166 (287)
T cd06621 94 KVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGT 166 (287)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCC
Confidence 42 22345888999999999999999999998 99999999999999999999999999865432211 123467
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||.+.+..++.++||||||+++|+|++|..||......... ....... ........+... .. ........
T Consensus 167 ~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~-~~--~~~~~~~~ 241 (287)
T cd06621 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELLSY-IVNMPNPELKDE-PG--NGIKWSEE 241 (287)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHHHH-HhcCCchhhccC-CC--CCCchHHH
Confidence 7899999998888999999999999999999999998755331111 1111111 111111111110 00 00112346
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+.+++.+||+.+|++|||+.|+++
T Consensus 242 ~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 242 FKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHh
Confidence 889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.59 Aligned_cols=242 Identities=24% Similarity=0.306 Sum_probs=189.6
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++.. +|+.+++|++..... ...+.+.+|+.+++.++|+||+++++.+..+...+++|||+++++|.+++.
T Consensus 6 ~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 85 (265)
T cd05579 6 YGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE 85 (265)
T ss_pred ceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHH
Confidence 6899999975 599999999865432 345678899999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC------ccccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS------EANTN 150 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~------~~~~~ 150 (308)
... .+++..+..++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 86 ~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 86 NVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 432 5899999999999999999999998 99999999999999999999999999876432211 11222
Q ss_pred eeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 151 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
...++..|++||...+...+.++||||||+++|+|++|..||........ .... ..... ... . ..
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~-~~~~~-~~~-----~--~~ 224 (265)
T cd05579 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQNI-LNGKI-EWP-----E--DV 224 (265)
T ss_pred CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-hcCCc-CCC-----c--cc
Confidence 34567789999998888888999999999999999999999864432210 0000 00000 000 0 00
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
.....+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 013458889999999999999999777766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=253.06 Aligned_cols=237 Identities=26% Similarity=0.425 Sum_probs=190.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .+|+.+++|++..........+.+|+..++.++|++|+++++++..+...++++||+++++|.+++....
T Consensus 13 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~ 92 (253)
T cd05122 13 FGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN 92 (253)
T ss_pred ceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC
Confidence 688999996 4799999999976655566789999999999999999999999999999999999999999999885532
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||.+........ .....++..|+
T Consensus 93 --~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~ 164 (253)
T cd05122 93 --QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWM 164 (253)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCccc
Confidence 35899999999999999999999997 99999999999999999999999999877643321 23346788899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||.+.+..++.++|+||||+++|+|++|..||........ ... ........... .......+.++
T Consensus 165 ~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~~~~~~~~-------~~~~~~~~~~~ 230 (253)
T cd05122 165 APEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFK-IATNGPPGLRN-------PEKWSDEFKDF 230 (253)
T ss_pred CHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HHH-HHhcCCCCcCc-------ccccCHHHHHH
Confidence 99999888889999999999999999999999864321110 000 00011111111 01113458889
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
+.+||+.||++|||+.++++
T Consensus 231 i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 231 LKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHccCChhhCCCHHHHhc
Confidence 99999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=258.63 Aligned_cols=240 Identities=24% Similarity=0.318 Sum_probs=181.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEE-----eCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCL-----EENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.+++|++.... .....+..|+.+++.+ +|+||+++++++. .+...++||||+++++|.+
T Consensus 31 ~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 109 (286)
T cd06638 31 YGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD 109 (286)
T ss_pred CcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHH
Confidence 689999985 578999999875432 2235678899999999 6999999999874 3456899999999999998
Q ss_pred HhhcC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 74 FLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 74 ~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
++... .....+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 110 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~ 184 (286)
T cd06638 110 LVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTS 184 (286)
T ss_pred HHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCCCc--cccc
Confidence 87542 23345888999999999999999999998 999999999999999999999999998876432211 2223
Q ss_pred ecccCccCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccccc
Q 021771 153 VGTYGYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS 227 (308)
Q Consensus 153 ~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
.++..|+|||.+.. ..++.++||||+||++|+|++|..||........ .... ..........
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------~~~~-~~~~~~~~~~------ 251 (286)
T cd06638 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------LFKI-PRNPPPTLHQ------ 251 (286)
T ss_pred cCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------Hhhc-cccCCCcccC------
Confidence 57889999998753 3478899999999999999999999854322110 0000 0000000000
Q ss_pred chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 228 CVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 228 ~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+......+.+++.+||+.+|++|||+.||++.
T Consensus 252 -~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 252 -PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 01112358889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=279.54 Aligned_cols=246 Identities=18% Similarity=0.200 Sum_probs=174.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCC------cCccceeeeEEeC-CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH------KNLVRLFGCCLEE-NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~ 72 (308)
||+||++.. .+++.||||+++... ........|+.+++.++| .+++++++++..+ .++++||+++ +++|.
T Consensus 142 fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~ 219 (467)
T PTZ00284 142 FGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLL 219 (467)
T ss_pred CEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHH
Confidence 799999985 578899999985432 223345667777777654 4588888888765 4689999988 66788
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCC----------------Ceeeeccc
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEM----------------NPKISDFG 135 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~----------------~~kl~dfg 135 (308)
+++... ..+++..+..++.||+.||+|||+ .| |+||||||+|||++.++ .+||+|||
T Consensus 220 ~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG 293 (467)
T PTZ00284 220 DWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293 (467)
T ss_pred HHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCC
Confidence 777543 358999999999999999999997 47 99999999999998765 49999999
Q ss_pred ceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH----Hhh
Q 021771 136 MARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW----KLW 211 (308)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~----~~~ 211 (308)
.+.... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ..+
T Consensus 294 ~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~ 368 (467)
T PTZ00284 294 GCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEW 368 (467)
T ss_pred ccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHH
Confidence 875421 11223568899999999999899999999999999999999999997544321111110000 000
Q ss_pred hc----ccccccc------cccc---------cccch--HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 212 CE----GEALELM------EPVL---------KQSCV--AAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 212 ~~----~~~~~~~------~~~~---------~~~~~--~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. ....++. .+.. ..... ......+.+||.+||++||++|||++|+++
T Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 369 AGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 00 0000000 0000 00000 011245779999999999999999999996
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=263.61 Aligned_cols=255 Identities=21% Similarity=0.252 Sum_probs=184.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||.++. .+|+.||+|++... .....+.+.+|+.+++.++||||++++++|..+...++||||+.++++.+++..
T Consensus 13 ~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~ 92 (328)
T cd08226 13 LTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKT 92 (328)
T ss_pred ceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHh
Confidence 578999996 58999999998643 233456788999999999999999999999999999999999999999998865
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-----cccee
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-----NTNRI 152 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~ 152 (308)
.. ...+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.++++||+.+.......... .....
T Consensus 93 ~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (328)
T cd08226 93 YF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS 168 (328)
T ss_pred hc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccc
Confidence 32 234888999999999999999999998 9999999999999999999999997653321111100 00111
Q ss_pred ecccCccCchhhccC--cccccccchhhhHHHHHHHhCCcCCCccccccccchh-H-------------HHHHhhhc---
Q 021771 153 VGTYGYMAPEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL-S-------------YTWKLWCE--- 213 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~-~-------------~~~~~~~~--- 213 (308)
.++..|+|||++.+. .++.++||||+||++|+|++|..||............ . .....+..
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (328)
T cd08226 169 TSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQS 248 (328)
T ss_pred cCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchh
Confidence 235579999988763 4788999999999999999999998654322100000 0 00000000
Q ss_pred --------cc-----ccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 214 --------GE-----ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 214 --------~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. ....................+.+|+++||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 249 GVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 00000111111122334567899999999999999999999984
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=258.25 Aligned_cols=238 Identities=24% Similarity=0.371 Sum_probs=188.7
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||.+... +++.+++|++..... ..+.+.+|+..++.++|+||+++++.+......++++||+++++|.+++....
T Consensus 32 ~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 110 (286)
T cd06614 32 SGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF 110 (286)
T ss_pred CeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc
Confidence 6889999975 799999999975544 45678899999999999999999999999999999999999999999986533
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.+|++||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 111 --~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~ 183 (286)
T cd06614 111 --VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWM 183 (286)
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccC
Confidence 35899999999999999999999998 99999999999999999999999998765432211 112234677899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
+||.+.+..++.++|+||||+++|+|++|..||........ .... ........ .........+.++
T Consensus 184 ~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~~~-------~~~~~~~~~l~~l 249 (286)
T cd06614 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLI-TTKGIPPL-------KNPEKWSPEFKDF 249 (286)
T ss_pred CHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-HhcCCCCC-------cchhhCCHHHHHH
Confidence 99998888889999999999999999999999864322210 0000 00000000 0011123458889
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~ 260 (308)
+.+||+.+|.+|||+.++++.
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HHHHhccChhhCcCHHHHhhC
Confidence 999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=255.32 Aligned_cols=237 Identities=21% Similarity=0.295 Sum_probs=181.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-----cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-----GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~ 72 (308)
||.||.+.. .+|+.|++|.+.... ......+..|+.+++.++|+||+++++++.+. ..++++|||+++++|.
T Consensus 15 ~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~ 94 (265)
T cd06652 15 FGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIK 94 (265)
T ss_pred ceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHH
Confidence 789999985 569999999875321 12345778899999999999999999998764 4678999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 151 (308)
+++... ..+++..+..++.|++.+|++||+++ ++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 95 ~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 168 (265)
T cd06652 95 DQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS 168 (265)
T ss_pred HHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccccccccccccc
Confidence 988543 24788899999999999999999998 999999999999999999999999998765322111 11122
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..++..|+|||.+.+..++.++||||||+++|+|++|..||....... . ........ . ....+..
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~-----~----~~~~~~~ 233 (265)
T cd06652 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP-----T----NPVLPPH 233 (265)
T ss_pred CCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHhcCC-----C----CCCCchh
Confidence 346788999999888888999999999999999999999986331111 0 00110000 0 0111223
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
....+.+++.+|+. +|++||++++|++
T Consensus 234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 234 VSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 34457778888885 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=260.06 Aligned_cols=244 Identities=17% Similarity=0.191 Sum_probs=187.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++.. .+++.|++|.+.... ......+.+|+++++.++|+||+++++.+..++..++||||+++++|.+++.
T Consensus 14 ~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 93 (305)
T cd05609 14 YGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLK 93 (305)
T ss_pred CeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHH
Confidence 689999996 578999999886543 2334567889999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc----------
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE---------- 146 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~---------- 146 (308)
.. ..+++..+..++.|++.+++|||+.| ++|+||+|+||+++.++.++|+|||++.........
T Consensus 94 ~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 167 (305)
T cd05609 94 NI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167 (305)
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccc
Confidence 43 35889999999999999999999998 999999999999999999999999987642111000
Q ss_pred ---cccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccc
Q 021771 147 ---ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 147 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ....... ..... .+.
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~-~~~~~---~~~ 237 (305)
T cd05609 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVI-SDDIE---WPE 237 (305)
T ss_pred hhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hcccC---CCC
Confidence 0011234677899999988888899999999999999999999998533211 1111111 00000 000
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
. .......+.+++.+||+.+|++||+..++.+.|+..
T Consensus 238 ~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 238 G----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred c----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 0 001233578899999999999999988888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=265.06 Aligned_cols=242 Identities=17% Similarity=0.195 Sum_probs=181.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.+|+|++.+. .......+.+|..++..++|++|+++++++.+.+..++||||+++++|.+++.
T Consensus 14 fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~ 93 (332)
T cd05623 14 FGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLS 93 (332)
T ss_pred CeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHH
Confidence 799999996 46888999998542 22234457889999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... ..+++..+..++.||+.||.|||+.| ++||||||+||+++.++.++|+|||++........ .......|+.
T Consensus 94 ~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~ 167 (332)
T cd05623 94 KFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTP 167 (332)
T ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc-ceecccccCc
Confidence 532 34888999999999999999999998 99999999999999999999999999876532211 1122346899
Q ss_pred CccCchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 157 GYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 157 ~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.|+|||++. ...++.++|||||||++|+|++|..||...... ............... ......
T Consensus 168 ~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~~------p~~~~~ 235 (332)
T cd05623 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQF------PAQVTD 235 (332)
T ss_pred cccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCccccC------CCcccc
Confidence 999999886 245788999999999999999999998643221 111111111100000 000111
Q ss_pred HHHHHHHHHhhcccCCCC--CCCCHHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSA--DRPTMSSVVVM 260 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~--~RPs~~eil~~ 260 (308)
....+.+|+.+|+..+++ .|++++++++.
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 234577778888865444 36889998865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=257.06 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=186.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+|+. .+|+.+++|++.... ......+.+|+.+++.++|+||+++++++.+.+..++||||+++ +|.+++...
T Consensus 13 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~ 91 (284)
T cd07836 13 YATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTH 91 (284)
T ss_pred ceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhc
Confidence 689999996 479999999986553 23446677899999999999999999999999999999999975 788877654
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
.....+++..+..++.|++.+|+|||+.| ++|+||+|+||++++++.++|+|||++......... .....++..|
T Consensus 92 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y 166 (284)
T cd07836 92 GVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWY 166 (284)
T ss_pred CCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--cccccccccc
Confidence 44456899999999999999999999998 999999999999999999999999998765432211 1123457789
Q ss_pred cCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchh-HH-------HHHhhhc-ccc----cccccccc
Q 021771 159 MAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL-SY-------TWKLWCE-GEA----LELMEPVL 224 (308)
Q Consensus 159 ~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~-~~-------~~~~~~~-~~~----~~~~~~~~ 224 (308)
++||.+.+. .++.++||||||+++|+|++|..||............ .. ..+.... ... ....+...
T Consensus 167 ~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
T cd07836 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDL 246 (284)
T ss_pred cChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHH
Confidence 999987653 5688999999999999999999998754332110000 00 0000000 000 00000000
Q ss_pred cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 225 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 225 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..........+.+++.+||+.||++||++.++++
T Consensus 247 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 247 -QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred -HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011122346788999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=256.12 Aligned_cols=239 Identities=24% Similarity=0.379 Sum_probs=183.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCC------eEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEEN------ESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~ 72 (308)
||.||++.. .+++.+++|++.... ...+.+.+|+.+++++ .|+||+++++++.... ..++||||+++++|.
T Consensus 19 ~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 97 (275)
T cd06608 19 YGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT 97 (275)
T ss_pred CeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHH
Confidence 688999996 478899999886543 3446788999999999 6999999999997644 489999999999999
Q ss_pred hHhhcCC-CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 73 VFLFDST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 73 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
+++.... ....+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 172 (275)
T cd06608 98 DLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNT 172 (275)
T ss_pred HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcC
Confidence 9886532 2356899999999999999999999998 99999999999999999999999999876543221 1223
Q ss_pred eecccCccCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccc
Q 021771 152 IVGTYGYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
..++..|+|||.+.. ..++.++||||||+++|+|++|..||...... ....+.. .......
T Consensus 173 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~------- 238 (275)
T cd06608 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIP-RNPPPTL------- 238 (275)
T ss_pred ccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhh-ccCCCCC-------
Confidence 457888999998753 34678899999999999999999998532111 1111111 1000000
Q ss_pred cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 227 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.........+.+++.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111223446889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=253.98 Aligned_cols=240 Identities=25% Similarity=0.398 Sum_probs=187.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||.+.. .+++.+++|.+..... .....+..|+.+++.++|+||+++++++.+.+..++|+||+++++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 92 (264)
T cd06626 13 FGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH 92 (264)
T ss_pred CcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh
Confidence 689999985 5899999999876544 3667889999999999999999999999999999999999999999998854
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc--cceeecc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN--TNRIVGT 155 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~ 155 (308)
. ..+++..+..++.+++.++.|||+.| ++|+||+|+||+++.++.++|+|||++........... .....++
T Consensus 93 ~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T cd06626 93 G---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166 (264)
T ss_pred c---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCC
Confidence 2 34788899999999999999999998 99999999999999999999999999887653322211 1123567
Q ss_pred cCccCchhhccCc---ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 156 YGYMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 156 ~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
..|+|||.+.+.. .+.++||||+|+++|++++|..||....... ....... ....... .. ....
T Consensus 167 ~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~-~~~~~~~-----~~--~~~~ 233 (264)
T cd06626 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVG-AGHKPPI-----PD--SLQL 233 (264)
T ss_pred cCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHh-cCCCCCC-----Cc--cccc
Confidence 8999999887655 7899999999999999999999986432110 0000000 0000000 00 0111
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...+.+++.+||+.+|++|||+.+++.
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 234 SPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 334778999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=256.50 Aligned_cols=236 Identities=22% Similarity=0.218 Sum_probs=178.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHhc---CCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAK---LQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||++.. .+|+.+|+|.+..... .......+|..+++. ..|++|+.+++.+..++..++||||+++++|.+
T Consensus 7 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 86 (279)
T cd05633 7 FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHY 86 (279)
T ss_pred CeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHH
Confidence 799999995 5799999998864421 112233444444433 469999999999999999999999999999998
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
++... ..+++..+..++.|++.||+|||+.| ++|+||||+||++++++.++|+|||++....... .....
T Consensus 87 ~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~ 156 (279)
T cd05633 87 HLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (279)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcC
Confidence 88543 34899999999999999999999998 9999999999999999999999999987653221 12235
Q ss_pred cccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 154 GTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 154 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
++..|+|||...+ ..++.++||||+||++|+|++|..||.......... ....... .. ...+...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~----~~~~~~~ 222 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VN----VELPDSF 222 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CC----cCCcccc
Confidence 7889999998764 567899999999999999999999986443221110 0000000 00 0111222
Q ss_pred HHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRP-----TMSSVVVM 260 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RP-----s~~eil~~ 260 (308)
...+.+++.+||+.||++|| |++|+++.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 34688889999999999999 69999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=259.45 Aligned_cols=236 Identities=21% Similarity=0.323 Sum_probs=186.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .+|+.+++|++..........+.+|+.+++.++|+||+++++.+..++..++||||+++++|.+++..
T Consensus 33 ~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-- 110 (292)
T cd06657 33 TGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-- 110 (292)
T ss_pred CeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc--
Confidence 689999986 58999999998655555566788999999999999999999999999999999999999999987732
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.+++|||+.| ++|+||+|.||+++.++.++|+|||++........ ......++..|+
T Consensus 111 --~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 183 (292)
T cd06657 111 --TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWM 183 (292)
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCcccc
Confidence 24788999999999999999999998 99999999999999999999999999876543221 122245678899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||.+.+..++.++|+||+|+++|+|++|..||........ ...... ........ .......+.++
T Consensus 184 ~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~-----~~~~~~~~------~~~~~~~l~~l 249 (292)
T cd06657 184 APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRD-----NLPPKLKN------LHKVSPSLKGF 249 (292)
T ss_pred CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh-----hCCcccCC------cccCCHHHHHH
Confidence 99988877889999999999999999999999864322111 000000 00000000 01112347788
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
+.+||+.+|.+||++.++++
T Consensus 250 i~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHhCCcccCcCHHHHhc
Confidence 88999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=258.28 Aligned_cols=238 Identities=24% Similarity=0.345 Sum_probs=178.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHH-HhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTL-IAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.||+|+++... ......+..|+.. ++.++|+||+++++++..++..+++|||++ ++|.+++..
T Consensus 14 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~ 92 (283)
T cd06617 14 YGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKK 92 (283)
T ss_pred CeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHH
Confidence 799999996 579999999986542 2233445556554 666789999999999999999999999996 578777654
Q ss_pred C-CCccccChHHHHHHHHHHHHHHHhchhC-CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 78 S-TRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 78 ~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~-g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
. .....+++..++.++.|++.+|+|||++ + ++|+||+|+||+++.++.+||+|||++..+.... ......++
T Consensus 93 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~ 166 (283)
T cd06617 93 VYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGC 166 (283)
T ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCC
Confidence 2 2335689999999999999999999987 6 9999999999999999999999999987653221 11223567
Q ss_pred cCccCchhhcc----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 156 YGYMAPEYAME----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 156 ~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..|+|||.+.+ ..++.++|+|||||++|+|++|..||....... ........ ....... ...
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~-~~~~~~~--------~~~ 232 (283)
T cd06617 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQLKQVVE-EPSPQLP--------AEK 232 (283)
T ss_pred ccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHHHHHHh-cCCCCCC--------ccc
Confidence 88999998764 346789999999999999999999985432110 00111110 0000000 011
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
....+.+++.+||..+|++|||+.++++
T Consensus 233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 233 FSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2345888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=259.56 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=181.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 75 (308)
||.||++.. .+|+.||+|++..... .....+.+|+.+++.++|+||+++++++.+. +..++||||+.+ +|.+++
T Consensus 20 ~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l 98 (309)
T cd07845 20 YGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLL 98 (309)
T ss_pred CEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHH
Confidence 689999996 5799999999864422 2233566899999999999999999998765 468999999965 787777
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... ..+++..+..++.||+.+|+|||+.| ++|+||+|+||+++.++.++|+|||++......... .....++
T Consensus 99 ~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~ 171 (309)
T cd07845 99 DNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVT 171 (309)
T ss_pred Hhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCccccc
Confidence 5432 45899999999999999999999998 999999999999999999999999999876533211 1122346
Q ss_pred cCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH-----Hhhh---ccc---cccccccc
Q 021771 156 YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW-----KLWC---EGE---ALELMEPV 223 (308)
Q Consensus 156 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~-----~~~~---~~~---~~~~~~~~ 223 (308)
..|+|||.+.+ ..++.++||||||+++|+|++|.+||................ ..+. ... ....-...
T Consensus 172 ~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (309)
T cd07845 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQP 251 (309)
T ss_pred ccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCC
Confidence 78999998765 457899999999999999999999986443221100000000 0000 000 00000000
Q ss_pred ccc--cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 224 LKQ--SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 224 ~~~--~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
... .........+.+++.+||+.||++|||++++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 252 YNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0001124457789999999999999999999953
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=258.14 Aligned_cols=239 Identities=26% Similarity=0.328 Sum_probs=182.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeC-----CeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEE-----NESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~ 73 (308)
||.||++.. .+|+.+++|++.... .....+.+|+.+++++ +|+|++++++++... ...++||||+++++|.+
T Consensus 35 ~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~ 113 (291)
T cd06639 35 YGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE 113 (291)
T ss_pred CeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHH
Confidence 689999985 679999999885432 2345678899999999 799999999998753 35899999999999999
Q ss_pred HhhcC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 74 FLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 74 ~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
++... .....+++..++.++.|++.+|++||+.| ++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~ 188 (291)
T cd06639 114 LVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTS 188 (291)
T ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCc
Confidence 87542 23346899999999999999999999998 999999999999999999999999998765422211 1223
Q ss_pred ecccCccCchhhccC-----cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccccc
Q 021771 153 VGTYGYMAPEYAMEG-----LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS 227 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
.++..|+|||.+... .++.++|||||||++|+|++|..||........ .... ..........
T Consensus 189 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~------~~~~-~~~~~~~~~~------ 255 (291)
T cd06639 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT------LFKI-PRNPPPTLLH------ 255 (291)
T ss_pred cCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH------HHHH-hcCCCCCCCc------
Confidence 567889999987543 367899999999999999999999864322110 0111 0111111100
Q ss_pred chHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 228 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 228 ~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.......+.+++.+||+.+|++||++.++++
T Consensus 256 -~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 256 -PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1122345888999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=257.54 Aligned_cols=248 Identities=21% Similarity=0.263 Sum_probs=186.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||++.. .+|+.+++|.+..... .....+..|+.+++.++|+||+++++++.++...++|+||+++ ++..++..
T Consensus 12 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~ 90 (283)
T cd05118 12 YGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKD 90 (283)
T ss_pred CceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHh
Confidence 688999986 5899999999865532 2456788899999999999999999999999999999999975 77777654
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.. ..+++..++.++.|++.+|.|||+++ ++|+||+|+||+++.++.++|+|||.+........ ......++..
T Consensus 91 ~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~ 163 (283)
T cd05118 91 RQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRW 163 (283)
T ss_pred hc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCccc
Confidence 32 46899999999999999999999998 99999999999999999999999999987654331 1122346778
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh---ccccccccc-----------c
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC---EGEALELME-----------P 222 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-----------~ 222 (308)
|+|||.+.+. .++.++|+||||+++|+|++|+.||......... ........ ...+....+ .
T Consensus 164 ~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05118 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240 (283)
T ss_pred ccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence 9999988776 7889999999999999999999998644322110 00000000 000000000 0
Q ss_pred --cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 223 --VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 223 --~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
............++.+++.+||+.||++||++++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=254.17 Aligned_cols=237 Identities=23% Similarity=0.348 Sum_probs=195.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.+ .+|..+|+|.+... .+.+.+.+|+.++++.+.+++|++|+.+..+..+++|||||..|++.+.++..
T Consensus 46 YGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R- 122 (502)
T KOG0574|consen 46 YGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRAR- 122 (502)
T ss_pred chHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHh-
Confidence 799999986 58999999988654 45678899999999999999999999999999999999999999999999764
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
++++++.++..++...+++|+|||... -+|||||..|||++.+|..||+|||.+..+.... ...+...||+.||
T Consensus 123 -~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGTPFWM 196 (502)
T KOG0574|consen 123 -RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGTPFWM 196 (502)
T ss_pred -cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccCcccc
Confidence 346999999999999999999999874 8999999999999999999999999998765332 2234467999999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||++..-.|+.++||||||++..+|..|++||..-..--.-..+ .-.+...-..+.....++.++
T Consensus 197 APEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------------PT~PPPTF~KPE~WS~~F~DF 262 (502)
T KOG0574|consen 197 APEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------------PTKPPPTFKKPEEWSSEFNDF 262 (502)
T ss_pred cHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------------cCCCCCCCCChHhhhhHHHHH
Confidence 999999889999999999999999999999998532211000000 000111112244556679999
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~ 260 (308)
+++||-.+|++|.|+.++++-
T Consensus 263 i~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 263 IRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHhcCCHHHHHHHHHHhhh
Confidence 999999999999999998864
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=257.44 Aligned_cols=248 Identities=21% Similarity=0.282 Sum_probs=182.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.|+||++.... ......+.+|+.++++++|+||+++++++.++...++||||+. ++|..++..
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~ 91 (284)
T cd07860 13 YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDA 91 (284)
T ss_pred ceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHh
Confidence 689999985 579999999886442 2334578899999999999999999999999999999999996 578887754
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.. ...+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++......... .....++..
T Consensus 92 ~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~ 165 (284)
T cd07860 92 SP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLW 165 (284)
T ss_pred CC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc--ccccccccc
Confidence 32 345889999999999999999999998 999999999999999999999999998765432211 122245778
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc----------------ccccccc
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE----------------GEALELM 220 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~ 220 (308)
|+|||.+.+. .++.++||||||+++|+|++|+.||........ ..... ..... .......
T Consensus 166 y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd07860 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIF-RTLGTPDEVVWPGVTSLPDYKPSFPKWA 242 (284)
T ss_pred ccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCCCChhhhhhhhHHHHHHhhccccc
Confidence 9999987654 468889999999999999999999864322110 00000 00000 0000000
Q ss_pred cccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 221 EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.... ..........+.+++.+||+.||++|||++++++
T Consensus 243 ~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 243 RQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred ccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 0000112245778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=248.31 Aligned_cols=239 Identities=21% Similarity=0.330 Sum_probs=191.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||++.. .+++.+++|++..... .....+..|+++++.++|+|++++++.+..+...++|+||+++++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 92 (258)
T cd08215 13 FGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKK 92 (258)
T ss_pred CeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHH
Confidence 689999996 4799999999875533 4567788999999999999999999999999999999999999999998865
Q ss_pred CC-CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 78 ST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 78 ~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ....+++..+..++.+++.+|.+||++| ++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 93 ~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 167 (258)
T cd08215 93 QKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTP 167 (258)
T ss_pred hhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeee
Confidence 32 2356899999999999999999999998 9999999999999999999999999998765432 1222346788
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||...+..++.++|+||+|+++++|++|..||....... .... ........+ +......+
T Consensus 168 ~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~---------~~~~~~~~ 231 (258)
T cd08215 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALK-ILKGQYPPI---------PSQYSSEL 231 (258)
T ss_pred cccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHH-HhcCCCCCC---------CCCCCHHH
Confidence 8999999888888999999999999999999999986543211 1111 111111111 11223458
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+++.+||..+|++|||+.++++.
T Consensus 232 ~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 232 RNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHHHcCCChhhCcCHHHHhcC
Confidence 888999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=273.34 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=203.1
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||.|.|+ -.-.||||.++. +....+.|..|..+|+.+.|||+|+++++|..+..+|||+|||..|+|.+|++.+.
T Consensus 280 YGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecn 358 (1157)
T KOG4278|consen 280 YGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECN 358 (1157)
T ss_pred ccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhc
Confidence 7999999985 466789998854 45677899999999999999999999999999999999999999999999998764
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
. ..++...++.++.||..|++||..+. ++||||...|+||.++..+|++|||+++.+....+....+- .-.+-|.
T Consensus 359 r-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGA-KFPIKWT 433 (1157)
T KOG4278|consen 359 R-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGA-KFPIKWT 433 (1157)
T ss_pred h-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCc-cCccccc
Confidence 3 34777888999999999999999985 99999999999999999999999999999877666554322 2357899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
|||-+....++.++|||++|+++|++.+ |.-||...+. .++..+++...+.+.+..+..++++
T Consensus 434 APEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------------SqVY~LLEkgyRM~~PeGCPpkVYe 497 (1157)
T KOG4278|consen 434 APESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYGLLEKGYRMDGPEGCPPKVYE 497 (1157)
T ss_pred CcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------------HHHHHHHhccccccCCCCCCHHHHH
Confidence 9999888899999999999999999998 4466543322 2344555555555556666677999
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
|++.||+|+|++||++.|+-+.++..
T Consensus 498 LMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 498 LMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HHHHHhcCCcccCccHHHHHHHHHHH
Confidence 99999999999999999999888654
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=253.91 Aligned_cols=238 Identities=19% Similarity=0.204 Sum_probs=180.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc---cHHHHHHHHHH-HhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ---GLQEFKNEVTL-IAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.+|+|.+...... ....+..|..+ ....+|+|++++++++..++..++|+||+++++|.+++
T Consensus 9 ~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 88 (260)
T cd05611 9 FGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI 88 (260)
T ss_pred CeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHH
Confidence 689999985 57999999998654321 12233444444 44558999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..... .....++
T Consensus 89 ~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~ 156 (260)
T cd05611 89 KTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGT 156 (260)
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCC
Confidence 543 34889999999999999999999997 99999999999999999999999999876432 2223567
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||.+.+..++.++||||+|+++|+|++|..||....... .. ......... .. ..........
T Consensus 157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~--~~----~~~~~~~~~~ 223 (260)
T cd05611 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------VF-DNILSRRIN--WP----EEVKEFCSPE 223 (260)
T ss_pred cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------HH-HHHHhcccC--CC----CcccccCCHH
Confidence 88999999888778999999999999999999999986432211 00 000000000 00 0001112345
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 8899999999999999988777776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=263.64 Aligned_cols=248 Identities=23% Similarity=0.247 Sum_probs=181.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeC------CeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE------NESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L 71 (308)
||.||+++. .+|+.+|+|.+... .......+.+|+.+++.++|+||+++++++... ...++||||+.+ +|
T Consensus 29 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 107 (353)
T cd07850 29 QGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NL 107 (353)
T ss_pred CEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CH
Confidence 689999995 58999999998643 233445677899999999999999999988644 347999999965 77
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+.+.. .++...+..++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++........ ...
T Consensus 108 ~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~ 176 (353)
T cd07850 108 CQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTP 176 (353)
T ss_pred HHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCC
Confidence 776632 2788899999999999999999998 99999999999999999999999999987543221 122
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchh------------HH----HHHhhhccc
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL------------SY----TWKLWCEGE 215 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~------------~~----~~~~~~~~~ 215 (308)
..++..|+|||.+.+..++.++|||||||++|+|++|..||............ .. .........
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (353)
T cd07850 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRP 256 (353)
T ss_pred CcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCC
Confidence 35678899999998888999999999999999999999998654321100000 00 000000000
Q ss_pred ------cccccccc----ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 216 ------ALELMEPV----LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 216 ------~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+..... ............+.+++.+||+.||++|||+.|+|+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 257 KYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred CCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000011234567899999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=252.91 Aligned_cols=237 Identities=24% Similarity=0.296 Sum_probs=189.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.+++|.+.... ......+.+|+.+++.++|+||+++++++.+....++||||+++++|..++..
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 92 (256)
T cd08530 13 YGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISK 92 (256)
T ss_pred ceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHH
Confidence 688999984 588999999986542 33455677899999999999999999999999999999999999999998855
Q ss_pred C-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 78 S-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 78 ~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. .....+++..++.++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||++....... .....++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~ 165 (256)
T cd08530 93 RKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTP 165 (256)
T ss_pred HHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCc
Confidence 3 22345889999999999999999999998 9999999999999999999999999987764331 11234678
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||.+.+..++.++|+||||+++|+|++|..||....... .. ......... ........++
T Consensus 166 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~-~~~~~~~~~---------~~~~~~~~~~ 229 (256)
T cd08530 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------LR-YKVQRGKYP---------PIPPIYSQDL 229 (256)
T ss_pred cccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhcCCCC---------CCchhhCHHH
Confidence 8999999988888999999999999999999999986543221 00 011111111 1112334568
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+++.+||+.+|++|||+.++++.
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 230 QNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHHHcCCCcccCCCHHHHhcC
Confidence 899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=256.75 Aligned_cols=242 Identities=26% Similarity=0.378 Sum_probs=181.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.+|+|.+.... ......+.+|+.++.++. |+||+++++++......+++|||+.. ++.++...
T Consensus 17 ~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~ 95 (288)
T cd06616 17 FGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKY 95 (288)
T ss_pred ceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHH
Confidence 789999985 579999999986542 344567889999999996 99999999999998899999999854 55543321
Q ss_pred --CCCccccChHHHHHHHHHHHHHHHhchhC-CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 78 --STRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 78 --~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
......+++..+..++.|++.||+|||+. + ++|+||+|+||+++.++.++|+|||++........ .....+
T Consensus 96 ~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~ 169 (288)
T cd06616 96 VYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA---KTRDAG 169 (288)
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc---cccccC
Confidence 11234689999999999999999999975 5 99999999999999999999999999876432211 122246
Q ss_pred ccCccCchhhccC---cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 155 TYGYMAPEYAMEG---LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 155 ~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
+..|+|||.+.+. .++.++||||+|+++|+|++|+.||..... ......... .... +.+.......
T Consensus 170 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~-~~~~-----~~~~~~~~~~ 238 (288)
T cd06616 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVV-KGDP-----PILSNSEERE 238 (288)
T ss_pred ccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhc-CCCC-----CcCCCcCCCc
Confidence 7889999988765 688999999999999999999999865431 111111110 0000 1111111122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
....+.+|+.+||+.+|++|||+.+|+..
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 34468899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=266.43 Aligned_cols=240 Identities=23% Similarity=0.394 Sum_probs=194.3
Q ss_pred CCccEEeeeC---CCC--EEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLA---DGK--EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~---~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||.|... .|+ .||||.-+.+ .++..+.|..|..+|+.++||||+++++++.++ ..++|||.++-|.|..+
T Consensus 402 FGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~y 480 (974)
T KOG4257|consen 402 FGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREY 480 (974)
T ss_pred ccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHH
Confidence 8999999853 344 4677877653 567788999999999999999999999999985 67999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+..+.. .++..+...+.+||+.||+|||+.. +|||||...||||....-+||+|||+++.+.....-..+ ...-
T Consensus 481 Lq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kL 554 (974)
T KOG4257|consen 481 LQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKL 554 (974)
T ss_pred HHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-cccc
Confidence 976543 4888899999999999999999995 999999999999999999999999999987655433222 2234
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.+-|||||-++-..++.++|||.+|+++|++++ |..||...... ++.-.+++.-+...+..++
T Consensus 555 PIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~iEnGeRlP~P~nCP 618 (974)
T KOG4257|consen 555 PIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHIENGERLPCPPNCP 618 (974)
T ss_pred ceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEecCCCCCCCCCCCC
Confidence 678999999999999999999999999999876 66787543322 2333333333334455555
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
..|..|..+||.++|.+||++.+|...|+.
T Consensus 619 p~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 668889999999999999999999877743
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=258.84 Aligned_cols=233 Identities=27% Similarity=0.382 Sum_probs=180.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.|++|.+.... ......+.+|+.+++.++||||+++++++.+++..++||||+.+ ++.+++.
T Consensus 28 ~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~ 106 (307)
T cd06607 28 FGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILE 106 (307)
T ss_pred CeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCC-CHHHHHH
Confidence 689999996 479999999886432 22335688999999999999999999999999999999999965 6666654
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ...+++..+..++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||++...... ....++.
T Consensus 107 ~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~ 175 (307)
T cd06607 107 VH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTP 175 (307)
T ss_pred Hc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCc
Confidence 32 235899999999999999999999998 999999999999999999999999998764322 1234677
Q ss_pred CccCchhhc---cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 157 GYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 157 ~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.|+|||.+. ...++.++||||+|+++|+|++|..||........ ..... ...... .......
T Consensus 176 ~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~-~~~~~~--------~~~~~~~ 240 (307)
T cd06607 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNDSPT--------LSSNDWS 240 (307)
T ss_pred cccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHh-cCCCCC--------CCchhhC
Confidence 899999874 35678899999999999999999999854322110 00000 000000 0011233
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+.+++.+||+.+|++||++.+|+..
T Consensus 241 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 241 DYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 468899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=252.76 Aligned_cols=237 Identities=24% Similarity=0.345 Sum_probs=186.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||++.. .+|..+++|.+... .....+.+.+|+.+++.++|+||+++++.+.++...++|+||+++++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 92 (257)
T cd08225 13 FGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINR 92 (257)
T ss_pred cceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHh
Confidence 689999996 57899999998654 233456788999999999999999999999999999999999999999998865
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC-eeeecccceeeeCCCCCccccceeeccc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN-PKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++. ++|+|||.+........ ......++.
T Consensus 93 ~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~ 166 (257)
T cd08225 93 Q-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTP 166 (257)
T ss_pred c-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCc
Confidence 3 2335789999999999999999999998 999999999999998865 69999999876543221 112235778
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||...+..++.++|+||+|+++|+|++|..||...... ....... ...... ........+
T Consensus 167 ~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~---------~~~~~~~~~ 230 (257)
T cd08225 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKIC-QGYFAP---------ISPNFSRDL 230 (257)
T ss_pred cccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-cccCCC---------CCCCCCHHH
Confidence 899999988888899999999999999999999998543211 1111111 111110 011123458
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.+|++|||+.++++
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhh
Confidence 88999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=265.16 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=201.6
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.|.+.....+..||+|.++... ...+..|..|+++|.+++||||+.++++|..++.+|+++||+++|+|..++....
T Consensus 551 FGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahe 630 (807)
T KOG1094|consen 551 FGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHE 630 (807)
T ss_pred cceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhcc
Confidence 899999999888999999997664 4456899999999999999999999999999999999999999999999997653
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
.. .+..+....++.||+.+++||.+. ++||||+.+.|+|++.++++|++|||.++.+-...+....+..+-.++||
T Consensus 631 ap-t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwm 706 (807)
T KOG1094|consen 631 LP-TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWM 706 (807)
T ss_pred Cc-ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeeh
Confidence 32 245566678999999999999988 59999999999999999999999999999776666666666677789999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh--CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS--GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|||.+..++++.++|+|++|+++||+++ ...||+....+. +.+.....+..... ......+.-+..+++
T Consensus 707 awEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~------~~~l~~P~~cp~~ly 777 (807)
T KOG1094|consen 707 AWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGR------QVVLSRPPACPQGLY 777 (807)
T ss_pred hHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCc------ceeccCCCcCcHHHH
Confidence 9999999999999999999999999865 457775443332 11111111111111 011122334455688
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 238 HIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+|+..||..+-++|||+++|...|.+.
T Consensus 778 elml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 778 ELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 999999999999999999999887654
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=265.25 Aligned_cols=236 Identities=22% Similarity=0.328 Sum_probs=185.3
Q ss_pred CccEEeeeCCCCEEEEEEecc--CCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 2 ESCLQGKLADGKEIAVKRLSR--TSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
+.||++...+...||+|++.. .+....+-+.+|+..|.+|+ |.+|+++|++=..++.+||||||= ..+|..+++..
T Consensus 375 SkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~ 453 (677)
T KOG0596|consen 375 SKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKK 453 (677)
T ss_pred ceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhc
Confidence 468888877778888887643 35667788999999999996 999999999999999999999974 67999998664
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
.. ......++.+..||+.|+.++|..| |||.||||.|+++-. |.+||+|||+|..+............+||..|
T Consensus 454 ~~--~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NY 527 (677)
T KOG0596|consen 454 KS--IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNY 527 (677)
T ss_pred cC--CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccc
Confidence 33 2443488899999999999999998 999999999999876 57999999999988777666667778999999
Q ss_pred cCchhhccC-----------cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccc--
Q 021771 159 MAPEYAMEG-----------LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK-- 225 (308)
Q Consensus 159 ~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 225 (308)
|+||.+... ..+.++|||||||++|+|+.|++||+...... . ++..+.++...
T Consensus 528 MsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~--------a------Kl~aI~~P~~~Ie 593 (677)
T KOG0596|consen 528 MSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI--------A------KLHAITDPNHEIE 593 (677)
T ss_pred cCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH--------H------HHHhhcCCCcccc
Confidence 999988632 25678999999999999999999997443221 0 11111111110
Q ss_pred -ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 226 -QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 226 -~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
...+.. ..+++++..||+.||++|||..+||+.
T Consensus 594 fp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 594 FPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 011111 128888899999999999999999974
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.02 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=183.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||++.. .+|+.|++|++.... ......+.+|+.+++.++|+|++++++++.++...+++|||++ ++|.+++..
T Consensus 12 ~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~ 90 (283)
T cd07835 12 YGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDS 90 (283)
T ss_pred CeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhh
Confidence 688999985 589999999986543 2233567889999999999999999999999999999999995 588888754
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.. ...+++..++.++.|++.+|+|||+++ ++|+||+|+||+++.++.++|+|||++......... .....++..
T Consensus 91 ~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~ 164 (283)
T cd07835 91 SP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLW 164 (283)
T ss_pred CC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccC
Confidence 33 235899999999999999999999997 999999999999999999999999998765322211 111245778
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH-------hhhc-cccccccccc-----
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK-------LWCE-GEALELMEPV----- 223 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~~~~----- 223 (308)
|+|||.+.+. .++.++||||||+++|+|++|..||........ ....... .+.. ....+.....
T Consensus 165 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd07835 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWAR 242 (283)
T ss_pred CCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhhhhhcccccc
Confidence 9999977654 568899999999999999999999864432110 0000000 0000 0000000000
Q ss_pred -ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 224 -LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 224 -~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
............+.+++.+||+.+|++|||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 243 QDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred cchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000011112246888999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=265.84 Aligned_cols=231 Identities=25% Similarity=0.347 Sum_probs=190.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
|+.|.++++ .+|..||||.+++. +....+.+.+|+++|+.++||||++++.+......+++||||+.++.+.+++..
T Consensus 69 f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~ 148 (596)
T KOG0586|consen 69 FAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVK 148 (596)
T ss_pred eEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHh
Confidence 678889985 58999999999776 344456688999999999999999999999999999999999999999999965
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.. ...+..+..++.|+..|++|||+++ |+|||||++|++++.+-++||+|||++.++... .....++|++.
T Consensus 149 ~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgspp 219 (596)
T KOG0586|consen 149 HG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPP 219 (596)
T ss_pred cc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc---ccccccCCCCC
Confidence 43 3677899999999999999999997 999999999999999999999999999998633 22334689999
Q ss_pred ccCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccc--cchHHHHH
Q 021771 158 YMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ--SCVAAELL 234 (308)
Q Consensus 158 y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 234 (308)
|+|||++.+..+ .+++|+||||+++|.|++|..||+...... +-+..+.. ..+.....
T Consensus 220 yAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~rvl~gk~rIp~~ms~ 280 (596)
T KOG0586|consen 220 YAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPRVLRGKYRIPFYMSC 280 (596)
T ss_pred ccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccchheeeeecccceeec
Confidence 999999988654 588999999999999999999997432221 11111111 12222334
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+..+||+++|-.+|.+|++..++..
T Consensus 281 dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 281 DCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred hhHHHHHHhhccCccccCCHHHhhh
Confidence 5777888999999999999999874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=254.66 Aligned_cols=252 Identities=21% Similarity=0.259 Sum_probs=185.0
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++.. +|+.+++|++.... ......+..|+.+++.++|+|++++++++.+. ...++||||+++ +|..++
T Consensus 12 ~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 90 (287)
T cd07840 12 YGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL 90 (287)
T ss_pred CeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHH
Confidence 6899999964 68999999997653 33445678899999999999999999999988 789999999975 788777
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... ..+++..++.++.|+++||++||+.| ++|+||+|+||++++++.++|+|||++.......... .....++
T Consensus 91 ~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~ 164 (287)
T cd07840 91 DSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD-YTNRVIT 164 (287)
T ss_pred hccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc-ccccccc
Confidence 5432 35899999999999999999999998 9999999999999999999999999998765432211 1223456
Q ss_pred cCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccc--------------c
Q 021771 156 YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALEL--------------M 220 (308)
Q Consensus 156 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~ 220 (308)
..|+|||.+.+ ..++.++||||||+++|+|++|..||.......................+... .
T Consensus 165 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T cd07840 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPY 244 (287)
T ss_pred cccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccc
Confidence 78999997765 45789999999999999999999998644322110000000000000000000 0
Q ss_pred cccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 221 EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...+...........+.+++.+||+.+|++||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 245 KRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000012456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=255.46 Aligned_cols=251 Identities=21% Similarity=0.219 Sum_probs=180.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCe-----EEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENE-----SLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L 71 (308)
||.||++.. .+|+.||+|++.... ......+.+|+.+++.++ |+||+++++++..... .++||||+++ +|
T Consensus 14 ~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 92 (295)
T cd07837 14 YGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DL 92 (295)
T ss_pred CeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CH
Confidence 789999995 579999999876442 223456788999999995 6999999999987665 8999999976 78
Q ss_pred hhHhhcCCC--ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-CCCeeeecccceeeeCCCCCccc
Q 021771 72 DVFLFDSTR--SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 72 ~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-~~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
.+++..... ...+++..++.++.||+.||.|||++| ++|+||+|+||+++. ++.++|+|||++..+......
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~-- 167 (295)
T cd07837 93 KKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS-- 167 (295)
T ss_pred HHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--
Confidence 777754322 346899999999999999999999998 999999999999998 889999999998865432211
Q ss_pred cceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc-c-cccc---c---
Q 021771 149 TNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE-G-EALE---L--- 219 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~-~~~~---~--- 219 (308)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ........... . .+.. .
T Consensus 168 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T cd07837 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLHIFKLLGTPTEQVWPGVSKLRDW 245 (295)
T ss_pred cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHhCCCChhhCcchhhccch
Confidence 111245778999998765 4578999999999999999999999864322110 00000000000 0 0000 0
Q ss_pred --ccc---cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 220 --MEP---VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 220 --~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
... .............+.++|.+||+.||++|||+.|++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 246 HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 0000001123445888999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=290.74 Aligned_cols=247 Identities=25% Similarity=0.473 Sum_probs=189.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+|+. .+|+.||+|++...... ...|+..+++++||||+++++++.+....++||||+++++|.+++.
T Consensus 703 ~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--- 775 (968)
T PLN00113 703 KGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--- 775 (968)
T ss_pred CeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---
Confidence 799999996 68999999988644322 2346889999999999999999999999999999999999999984
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
.+++..+..++.|++.|++|||..+..+++||||||+||+++.++..++. ++....... .....++..|+
T Consensus 776 ---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~ 845 (968)
T PLN00113 776 ---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYV 845 (968)
T ss_pred ---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCcccccccc
Confidence 27889999999999999999995433349999999999999998887765 444432211 11125678999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccc--cchHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ--SCVAAELLKFI 237 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~ 237 (308)
|||++.+..++.++||||+||++|+|++|+.||...... ......+.............+++.+.. .....+...+.
T Consensus 846 aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 924 (968)
T PLN00113 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM 924 (968)
T ss_pred CcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHH
Confidence 999998888999999999999999999999998533222 223333333322222233333443322 22345666788
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 238 HIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
+++.+||+.+|++|||++|+++.|+...
T Consensus 925 ~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 925 NLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred HHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 9999999999999999999999998763
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=252.23 Aligned_cols=249 Identities=20% Similarity=0.252 Sum_probs=179.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCC-CcCccceeeeEEeC--CeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+++.+|+|++.... .........|+..+.++. |+||+++++++.++ +..++||||+++ ++.+.+
T Consensus 12 ~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l 90 (282)
T cd07831 12 FSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI 90 (282)
T ss_pred cceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHH
Confidence 689999985 579999999986542 222234457888898885 99999999999987 789999999975 676666
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... ..+++..++.++.|++.||+|||+.| ++|+||+|+||+++. +.++|+|||++......... ....++
T Consensus 91 ~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~ 161 (282)
T cd07831 91 KGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYIST 161 (282)
T ss_pred Hhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCC
Confidence 4422 35899999999999999999999998 999999999999999 99999999999765432211 123467
Q ss_pred cCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchh--------HHHHHhhhccccccccccccc-
Q 021771 156 YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL--------SYTWKLWCEGEALELMEPVLK- 225 (308)
Q Consensus 156 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~- 225 (308)
..|+|||.+.. ..++.++|||||||++|+|++|..||............ .................+...
T Consensus 162 ~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (282)
T cd07831 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKG 241 (282)
T ss_pred cccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCccccc
Confidence 88999997644 55788999999999999999999998654321100000 000000000000000000000
Q ss_pred ---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 226 ---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 226 ---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..........+.+++.+||+.+|++|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 242 TGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0001123567999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=254.57 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=179.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||++.. .+|+.+++|++.... ......+.+|+.+++.++|+||+++++++.++...++||||+. +++.+++...
T Consensus 18 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~ 96 (291)
T cd07870 18 YATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQH 96 (291)
T ss_pred CEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhC
Confidence 689999985 579999999986543 2333467789999999999999999999999999999999996 5666655432
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
. ..+.+..+..++.|++.||.|||+.| ++|+||||+||+++.++.++|+|||++......... .....++..|
T Consensus 97 ~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y 169 (291)
T cd07870 97 P--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWY 169 (291)
T ss_pred C--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccc
Confidence 2 24778888999999999999999998 999999999999999999999999998754322111 1223457889
Q ss_pred cCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh--c-------cccccccccccccc-
Q 021771 159 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC--E-------GEALELMEPVLKQS- 227 (308)
Q Consensus 159 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~- 227 (308)
+|||.+.+ ..++.++||||||+++|+|++|..||....... ..+.. ....+. . ..............
T Consensus 170 ~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T cd07870 170 RPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEK-IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCK 247 (291)
T ss_pred cCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHH-HHHHcCCCChhhhhhhhhcccccchhccccC
Confidence 99998765 357889999999999999999999986543211 00000 000000 0 00000000000000
Q ss_pred --c------hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 228 --C------VAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 228 --~------~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
. .......+.+++.+|++.||++|||+.+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 248 PQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred CcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 0011245778889999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=270.44 Aligned_cols=239 Identities=21% Similarity=0.334 Sum_probs=193.0
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++.+ .+-..|.|+|..+.....+.+.-|+++|....||+|+++++.|...+.++++.|||.||.++..+-.-
T Consensus 45 FGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL- 123 (1187)
T KOG0579|consen 45 FGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLEL- 123 (1187)
T ss_pred chhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHh-
Confidence 8999999965 45556889998888888999999999999999999999999999999999999999999999888543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
+..+.+..+.-+.+|++.||.|||++. |+|||||..|||++-+|.++|+|||.+.... ........+.||+.||
T Consensus 124 -~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkRDsFIGTPYWM 197 (1187)
T KOG0579|consen 124 -GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKRDSFIGTPYWM 197 (1187)
T ss_pred -ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch--hHHhhhccccCCcccc
Confidence 346999999999999999999999995 9999999999999999999999999986532 1223345578999999
Q ss_pred Cchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 160 APEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 160 aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
|||++. ..+|+.++||||||+++.+|..+.+|-... +......+.-.. .-+.++ .++....
T Consensus 198 APEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllKiaKS-ePPTLl-------qPS~Ws~ 263 (1187)
T KOG0579|consen 198 APEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKS-EPPTLL-------QPSHWSR 263 (1187)
T ss_pred cchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHHHhhc-CCCccc-------Ccchhhh
Confidence 999875 357999999999999999999999985321 111111111111 111111 1344555
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+.+++..||..||+.||++.+|++-
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 68889999999999999999999853
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=256.10 Aligned_cols=236 Identities=27% Similarity=0.369 Sum_probs=181.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.+++|++.... ......+..|+.+++.++|+|++++++++.++...++||||+.+ ++.+.+.
T Consensus 38 ~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~ 116 (317)
T cd06635 38 FGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLE 116 (317)
T ss_pred CeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHH
Confidence 689999995 579999999986432 23345688899999999999999999999999999999999975 6666664
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ...+++..+..++.|++.++.|||++| ++|+||+|+||+++.++.++|+|||++...... ....++.
T Consensus 117 ~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~ 185 (317)
T cd06635 117 VH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTP 185 (317)
T ss_pred Hh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCc
Confidence 32 234889999999999999999999998 999999999999999999999999988654321 1235677
Q ss_pred CccCchhhc---cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 157 GYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 157 ~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.|+|||.+. ...++.++||||+|+++|+|++|..||....... ......... .. ........
T Consensus 186 ~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~-~~--------~~~~~~~~ 250 (317)
T cd06635 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE-SP--------TLQSNEWS 250 (317)
T ss_pred cccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhcc-CC--------CCCCcccc
Confidence 899999874 3567889999999999999999999975432111 011111000 00 00011223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
..+.+++.+||+.+|++||++.++++.+-.
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 357889999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=247.78 Aligned_cols=235 Identities=25% Similarity=0.365 Sum_probs=188.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.+++..+++|||+++++|.+++..
T Consensus 13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 92 (254)
T cd06627 13 FGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK 92 (254)
T ss_pred CeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh
Confidence 688999985 4789999999876543 4567889999999999999999999999999999999999999999998854
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ..+++..+..++.|++.++.+||+.| ++|+||+|+||+++.++.++|+|||++......... .....++..
T Consensus 93 ~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~ 164 (254)
T cd06627 93 F---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPY 164 (254)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchh
Confidence 3 45899999999999999999999998 999999999999999999999999999876543221 222456788
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||...+..++.++|||++|+++|+|++|..||...... ....... ..... ..+......+.
T Consensus 165 y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~---------~~~~~~~~~~~ 228 (254)
T cd06627 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------AALFRIV-QDDHP---------PLPEGISPELK 228 (254)
T ss_pred hcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHh-ccCCC---------CCCCCCCHHHH
Confidence 99999988777889999999999999999999998643211 0001100 00000 01111234578
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+++.+||..+|++|||+.+++.
T Consensus 229 ~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 229 DFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHHhCChhhCcCHHHHhc
Confidence 8899999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=256.13 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=178.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC--------eEEEEEEecCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN--------ESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~ 69 (308)
||.||+++. .+|+.||+|.+.... ......+.+|+.+++.++||||+++++++.... ..++||||+.+
T Consensus 25 ~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~- 103 (310)
T cd07865 25 FGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH- 103 (310)
T ss_pred CEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-
Confidence 689999996 579999999885442 222345668999999999999999999987643 35999999965
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc--c
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--A 147 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--~ 147 (308)
++.+.+... ...+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++..+...... .
T Consensus 104 ~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 178 (310)
T cd07865 104 DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178 (310)
T ss_pred CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCC
Confidence 777766432 235899999999999999999999998 999999999999999999999999999876432221 1
Q ss_pred ccceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccc-----cccc
Q 021771 148 NTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEAL-----ELME 221 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 221 (308)
......++..|+|||.+.+. .++.++||||+|+++|+|++|..||......................... ...+
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (310)
T cd07865 179 RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFK 258 (310)
T ss_pred CccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhh
Confidence 11223467789999987664 46889999999999999999999986543221111100000000000000 0000
Q ss_pred cc-ccccc---------hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 222 PV-LKQSC---------VAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 222 ~~-~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. ..... ..-....+.+++.+||+.||++|||++++++
T Consensus 259 ~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 259 KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 00000 0001234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=260.87 Aligned_cols=253 Identities=19% Similarity=0.269 Sum_probs=183.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEe----CCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE----ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~ 73 (308)
||.||++.. .+|+.|++|++.... ......+.+|+.+|+.++|+||+++++++.. ....++||||+. ++|..
T Consensus 18 ~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~ 96 (334)
T cd07855 18 YGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHH 96 (334)
T ss_pred CeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHH
Confidence 688999985 579999999986542 2345667889999999999999999998763 346899999995 58888
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc--ccce
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA--NTNR 151 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~--~~~~ 151 (308)
++.. ...+++..+..++.||+.||+|||++| ++|+||+|+||+++.++.++|+|||++.......... ....
T Consensus 97 ~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 170 (334)
T cd07855 97 IIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170 (334)
T ss_pred Hhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCccccc
Confidence 8743 234899999999999999999999998 9999999999999999999999999998764332211 1123
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHH--------HHHhhhcccccccccc
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY--------TWKLWCEGEALELMEP 222 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~ 222 (308)
..++..|+|||.+.+ ..++.++||||||+++|+|++|..||.............. .........+....+.
T Consensus 171 ~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 250 (334)
T cd07855 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN 250 (334)
T ss_pred ccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhh
Confidence 467888999998765 4578999999999999999999999854322110000000 0000000000000000
Q ss_pred cc-c-----ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 223 VL-K-----QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 223 ~~-~-----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.. . ..........+.+++.+||+.+|++|||++++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 251 LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 0 00011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=266.69 Aligned_cols=235 Identities=23% Similarity=0.366 Sum_probs=181.7
Q ss_pred CccEEeee-CCCCEEEEEEec----cCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe--EEEEEEecCCCChhhH
Q 021771 2 ESCLQGKL-ADGKEIAVKRLS----RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE--SLLIYEYMPNKSLDVF 74 (308)
Q Consensus 2 g~v~~~~~-~~g~~vavK~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~~L~~~ 74 (308)
=+||+|-. .+|..||.-.++ .+++...+++..|+.+|+.|+|+||+++|++|.+... ..+|+|.+..|+|..|
T Consensus 54 KtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y 133 (632)
T KOG0584|consen 54 KTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREY 133 (632)
T ss_pred eeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHH
Confidence 36777763 467777654332 1255667899999999999999999999999998765 7889999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC-CCeeeecccceeeeCCCCCccccceee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
++... ..+...+..|++||+++|.|||++ ..+|+|||||.+||||+.+ |.|||+|+|+|+..... ......
T Consensus 134 ~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s----~aksvI 205 (632)
T KOG0584|consen 134 RKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS----HAKSVI 205 (632)
T ss_pred HHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc----ccceec
Confidence 96543 488899999999999999999999 5899999999999999865 78999999999886422 233368
Q ss_pred cccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
||+.|||||++. ..|+...||||+|+++.+|+++..||. .+.+.....++. ..+.-+..+.. .. .
T Consensus 206 GTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKKV-~SGiKP~sl~k-----V~---d 270 (632)
T KOG0584|consen 206 GTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKKV-TSGIKPAALSK-----VK---D 270 (632)
T ss_pred cCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHHH-HcCCCHHHhhc-----cC---C
Confidence 999999999876 789999999999999999999999974 222222222211 11111111111 11 1
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+.++|.+|+.. .++|||+.|+|+-
T Consensus 271 Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2477888899999 8999999999953
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=247.52 Aligned_cols=229 Identities=21% Similarity=0.241 Sum_probs=175.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|..+++|.+........ |......+ +|+||+++++.+..++..++||||+++++|.+++...
T Consensus 29 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~ 103 (267)
T PHA03390 29 FGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE 103 (267)
T ss_pred ceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc
Confidence 789999985 5789999999865432211 22222223 6999999999999999999999999999999998553
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. .+++..+..++.|+++||.+||+.| ++|+||+|+||+++.++ .++|+|||++....... ...++..
T Consensus 104 ~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~ 171 (267)
T PHA03390 104 G---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYDGTLD 171 (267)
T ss_pred C---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCCCCCc
Confidence 2 6899999999999999999999998 99999999999999998 99999999987654221 2346788
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||++.+..++.++||||+|+++|+|++|..||........ ......... .... .........+.
T Consensus 172 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~---~~~~---------~~~~~~~~~~~ 238 (267)
T PHA03390 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ---QKKL---------PFIKNVSKNAN 238 (267)
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh---cccC---------CcccccCHHHH
Confidence 9999999888889999999999999999999999974332211 000000000 0000 00112334588
Q ss_pred HHHhhcccCCCCCCCC-HHHHHH
Q 021771 238 HIGLLCVQADSADRPT-MSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs-~~eil~ 259 (308)
+++.+||+.+|++||+ ++++++
T Consensus 239 ~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 239 DFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHhccChhhCCchHHHHhc
Confidence 8899999999999996 598874
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=250.67 Aligned_cols=236 Identities=22% Similarity=0.232 Sum_probs=178.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc---cHHHHHHHHH---HHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ---GLQEFKNEVT---LIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~---~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||++.. .+|+.||+|.+...... .......|.. .++...|++|+.+++.+.+....++||||+.+++|..
T Consensus 7 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~ 86 (278)
T cd05606 7 FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY 86 (278)
T ss_pred CeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHH
Confidence 789999985 57999999988654211 1122333433 3444579999999999999999999999999999998
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
++.. ...+++..+..++.|++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.... .....
T Consensus 87 ~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~ 156 (278)
T cd05606 87 HLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 156 (278)
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcC
Confidence 8853 235899999999999999999999998 9999999999999999999999999987553221 12235
Q ss_pred cccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 154 GTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 154 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
++..|+|||.+.++ .++.++||||+|+++|+|++|..||........... ..... . ..... +...
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~-~------~~~~~----~~~~ 222 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTL-T------MAVEL----PDSF 222 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHHhh-c------cCCCC----CCcC
Confidence 78899999988754 688999999999999999999999865422211110 00000 0 00001 1112
Q ss_pred HHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRP-----TMSSVVVM 260 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RP-----s~~eil~~ 260 (308)
...+.+++.+||..+|++|| ++.++++.
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 34588888999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=260.08 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=181.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-----eEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-----ESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~ 72 (308)
||+||.++. .+|+.||+|.+... .......+..|+.+++.++|+||+++++++.... ..++|+||+. ++|.
T Consensus 18 ~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 96 (337)
T cd07858 18 YGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLH 96 (337)
T ss_pred CeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHH
Confidence 689999985 57999999988643 2334456778999999999999999999887542 4799999995 5788
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 97 ~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~ 168 (337)
T cd07858 97 QIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEY 168 (337)
T ss_pred HHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--cccccc
Confidence 877432 35899999999999999999999998 9999999999999999999999999987654321 112223
Q ss_pred ecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHH--------HHHhhhccccccccccc
Q 021771 153 VGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY--------TWKLWCEGEALELMEPV 223 (308)
Q Consensus 153 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 223 (308)
.++..|+|||.+.+ ..++.++||||||+++|+|++|..||.............. .............+...
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (337)
T cd07858 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248 (337)
T ss_pred ccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhc
Confidence 56788999998765 4688999999999999999999999865422110000000 00000000000000000
Q ss_pred c---c---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 224 L---K---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 224 ~---~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
. . ..........+.+++.+||+.+|++|||++++++-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0 0 00011234568899999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.36 Aligned_cols=235 Identities=29% Similarity=0.390 Sum_probs=181.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||.|+. .+++.+++|.+... .......+.+|+.+++.++|+|++++++++.+....++||||+. +++.+.+.
T Consensus 28 ~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~ 106 (308)
T cd06634 28 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE 106 (308)
T ss_pred CEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHH
Confidence 689999995 57899999988543 22334567789999999999999999999999999999999996 47766664
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... ..+++..+..++.|++.++.|||+.| ++|+||+|+||+++.++.++|+|||++...... ....++.
T Consensus 107 ~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~ 175 (308)
T cd06634 107 VHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTP 175 (308)
T ss_pred HcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCc
Confidence 322 34888999999999999999999998 999999999999999999999999998765322 1234677
Q ss_pred CccCchhhc---cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 157 GYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 157 ~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.|+|||.+. ...++.++|||||||++|+|++|..||........ .. .......... ......
T Consensus 176 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~-~~~~~~~~~~--------~~~~~~ 240 (308)
T cd06634 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY-HIAQNESPAL--------QSGHWS 240 (308)
T ss_pred cccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HH-HHhhcCCCCc--------Cccccc
Confidence 899999874 34578899999999999999999999754321110 00 0001111000 011233
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
..+.+++.+||+.+|++||++.++++..-
T Consensus 241 ~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 45788999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=248.27 Aligned_cols=237 Identities=22% Similarity=0.310 Sum_probs=181.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-----CcccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-----SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~ 72 (308)
||.||++.. .+|+.+++|.+... .......+.+|+.+++.++|+||+++++++.+. ..+++++||+++++|.
T Consensus 15 ~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~ 94 (264)
T cd06653 15 FGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK 94 (264)
T ss_pred CeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHH
Confidence 689999985 57999999987432 223445788999999999999999999998764 4578999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC-ccccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS-EANTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 151 (308)
+++... ..+++..+..++.|++.+|.|||++| ++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 95 ~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 168 (264)
T cd06653 95 DQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS 168 (264)
T ss_pred HHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccc
Confidence 988542 24788899999999999999999998 99999999999999999999999999986532111 111122
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ............ ...+..
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---------~~~p~~ 233 (264)
T cd06653 169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------AAIFKIATQPTK---------PMLPDG 233 (264)
T ss_pred cCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------HHHHHHHcCCCC---------CCCCcc
Confidence 45778899999998888899999999999999999999998643111 111111111000 111222
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
....+.+++.+||+ +|..||++.+++.
T Consensus 234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 234 VSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred cCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 33458888889999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=259.76 Aligned_cols=253 Identities=21% Similarity=0.273 Sum_probs=181.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-----eEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-----ESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.||+|.+.... ......+..|+.+++.++|+||+++++++.... ..++++||+.+ ++..
T Consensus 18 ~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 96 (336)
T cd07849 18 YGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYK 96 (336)
T ss_pred CeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHH
Confidence 689999985 689999999986432 233456788999999999999999999876543 57999999965 7776
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-cccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-NTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~ 152 (308)
.+. ...+++..+..++.|++.||++||+.| ++|+||||+||+++.++.++|+|||++.......... .....
T Consensus 97 ~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 169 (336)
T cd07849 97 LIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169 (336)
T ss_pred HHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCc
Confidence 663 235899999999999999999999998 9999999999999999999999999988754322111 11224
Q ss_pred ecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc---cccc--------ccc
Q 021771 153 VGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE---GEAL--------ELM 220 (308)
Q Consensus 153 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~--------~~~ 220 (308)
.++..|+|||.+.+ ..++.++||||+|+++|+|++|..||........ .......... .... ...
T Consensus 170 ~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (336)
T cd07849 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDLNCIISLRARNYI 246 (336)
T ss_pred CcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHHHhhchhhhhHH
Confidence 56888999997654 5678999999999999999999999854322110 0000000000 0000 000
Q ss_pred c---cccc---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hhcC
Q 021771 221 E---PVLK---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM--LASD 264 (308)
Q Consensus 221 ~---~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~--L~~~ 264 (308)
. .... ..........+.+++.+||+.+|++|||+.++++. ++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 247 KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0 0000 00011124458899999999999999999999975 4443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=271.87 Aligned_cols=226 Identities=22% Similarity=0.329 Sum_probs=160.9
Q ss_pred cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC--ccccChHHHHHHHHHHHHHHHhch
Q 021771 27 GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR--SVQLDWKRRISIINGIARGLLYLH 104 (308)
Q Consensus 27 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH 104 (308)
....+.+|+.+|+.++|+||+++++++.+.+..++|++++.+ ++..++..... ........+..++.||+.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999854 66665543211 122345677889999999999999
Q ss_pred hCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHH
Q 021771 105 EDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184 (308)
Q Consensus 105 ~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 184 (308)
++| |+||||||+|||++.++.+||+|||++..+...... ......|+..|+|||++.+..++.++|||||||++|+
T Consensus 285 ~~g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 360 (501)
T PHA03210 285 DKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360 (501)
T ss_pred hCC---eecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHH
Confidence 998 999999999999999999999999999876433221 1223468999999999998889999999999999999
Q ss_pred HHhCCcC-CCccccccccchhHHHHHh-hhccccc-------cc------------ccccccccchHHHHHHHHHHHhhc
Q 021771 185 IISGKKN-TGFYLSELGQSLLSYTWKL-WCEGEAL-------EL------------MEPVLKQSCVAAELLKFIHIGLLC 243 (308)
Q Consensus 185 l~~~~~p-~~~~~~~~~~~~~~~~~~~-~~~~~~~-------~~------------~~~~~~~~~~~~~~~~l~~li~~c 243 (308)
|++|..+ +..........+....... ....... +. +...+... ....++.+++.+|
T Consensus 361 ll~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~km 437 (501)
T PHA03210 361 MLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL---GLPADFEYPLVKM 437 (501)
T ss_pred HHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc---CCChHHHHHHHHH
Confidence 9998754 4322211111111110000 0000000 00 00000000 0123467788899
Q ss_pred ccCCCCCCCCHHHHHHH
Q 021771 244 VQADSADRPTMSSVVVM 260 (308)
Q Consensus 244 l~~~p~~RPs~~eil~~ 260 (308)
|+.||++|||+.|+++.
T Consensus 438 L~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 438 LTFDWHLRPGAAELLAL 454 (501)
T ss_pred hccCcccCcCHHHHhhC
Confidence 99999999999999863
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=259.41 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=187.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-----eEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-----ESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+|+.+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+++|||++ ++|.
T Consensus 13 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 91 (330)
T cd07834 13 YGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLH 91 (330)
T ss_pred CeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHH
Confidence 689999996 469999999986543 445567889999999999999999999998775 7899999997 4788
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 151 (308)
+++... ..+++..++.++.|++.+|++||+.| ++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 92 ~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~ 165 (330)
T cd07834 92 KVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165 (330)
T ss_pred HHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccc
Confidence 877432 26899999999999999999999998 999999999999999999999999999886543210 11222
Q ss_pred eecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHH--------HHhhhcccccccccc
Q 021771 152 IVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYT--------WKLWCEGEALELMEP 222 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 222 (308)
..++..|+|||.+.+. .++.++|+||||+++|+|++|..||............... ............+..
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (330)
T cd07834 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKS 245 (330)
T ss_pred cccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhh
Confidence 3567889999998877 7899999999999999999999998654432110000000 000000000000000
Q ss_pred ccc------ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 223 VLK------QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 223 ~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
... ..........+.+++.+||+.+|++|||++++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 246 LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 00011134568889999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=248.51 Aligned_cols=249 Identities=20% Similarity=0.276 Sum_probs=181.9
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcc--cHHHHHHHHHHHhcC---CCcCccceeeeEEeCCe-----EEEEEEecCCC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQ--GLQEFKNEVTLIAKL---QHKNLVRLFGCCLEENE-----SLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~ 69 (308)
||.||+++.+ +|+.+++|++...... ....+..|+.+++++ +|+||+++++++.+... .+++|||+++
T Consensus 12 ~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~- 90 (287)
T cd07838 12 YGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ- 90 (287)
T ss_pred ceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-
Confidence 6899999975 5999999998644222 234556787777666 59999999999998776 8999999975
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
+|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+......
T Consensus 91 ~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~--- 163 (287)
T cd07838 91 DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL--- 163 (287)
T ss_pred CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCccc---
Confidence 7888775432 235899999999999999999999997 999999999999999999999999999876433211
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH-------hhhcccc--cccc
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK-------LWCEGEA--LELM 220 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~--~~~~ 220 (308)
....++..|+|||.+.+..++.++|+||+||++|+|++|.+||......... ...... .+..... ....
T Consensus 164 ~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (287)
T cd07838 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPSEEEWPRNVSLPRSSF 241 (287)
T ss_pred ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCChHhcCCCcccchhhc
Confidence 1224678899999998888999999999999999999999988643322100 000000 0000000 0000
Q ss_pred cccc---cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 221 EPVL---KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 221 ~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.... ...........+.+++.+||+.||++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 242 PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 01111233456788999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=253.82 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=179.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC----------eEEEEEEecC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN----------ESLLIYEYMP 67 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~ 67 (308)
||.||+|.. .+|+.|++|++.... ......+.+|+.+++.++||||+++++++.+.. ..++|+||++
T Consensus 20 ~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T cd07864 20 YGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD 99 (302)
T ss_pred CEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccC
Confidence 689999996 469999999986442 233456778999999999999999999987654 7899999997
Q ss_pred CCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc
Q 021771 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA 147 (308)
Q Consensus 68 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~ 147 (308)
+ ++...+... ...+++..++.++.|++.||+|||+.| ++|+||+|+||++++++.+||+|||++.........
T Consensus 100 ~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~- 172 (302)
T cd07864 100 H-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR- 172 (302)
T ss_pred c-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCccc-
Confidence 6 666655432 335899999999999999999999998 999999999999999999999999998865433211
Q ss_pred ccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh---cccccccc---
Q 021771 148 NTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC---EGEALELM--- 220 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--- 220 (308)
......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||........ ......... ...+....
T Consensus 173 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T cd07864 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRLCGSPCPAVWPDVIKLP 249 (302)
T ss_pred ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhhcccccccc
Confidence 1111234678999998765 3568899999999999999999999864322110 000011000 00000000
Q ss_pred -----cc------cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 221 -----EP------VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 221 -----~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+. .... ........+.+++.+||+.+|++|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 250 YFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 0000 00012345889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=256.42 Aligned_cols=250 Identities=20% Similarity=0.243 Sum_probs=182.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCccc--------------HHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEe
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQG--------------LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 65 (308)
||+||++.. .+|+.||+|.+....... ...+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 22 ~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 101 (335)
T PTZ00024 22 YGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDI 101 (335)
T ss_pred ceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEec
Confidence 789999995 589999999885432111 12467899999999999999999999999999999999
Q ss_pred cCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC
Q 021771 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS 145 (308)
Q Consensus 66 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~ 145 (308)
+. ++|.+++.. ...+++..+..++.|++.||++||+.| ++|+||+|+||+++.++.++|+|||.+........
T Consensus 102 ~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~ 174 (335)
T PTZ00024 102 MA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174 (335)
T ss_pred cc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccceeecccccc
Confidence 96 588888743 334899999999999999999999998 99999999999999999999999999987642111
Q ss_pred ------------ccccceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh
Q 021771 146 ------------EANTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC 212 (308)
Q Consensus 146 ------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 212 (308)
........++..|+|||.+.+. .++.++|+|||||++|+|++|..||........ .........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---~~~i~~~~~ 251 (335)
T PTZ00024 175 SDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ---LGRIFELLG 251 (335)
T ss_pred cccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC
Confidence 0111122356789999988764 468899999999999999999999865433211 110000000
Q ss_pred c---cccccc--------ccccccc---cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 213 E---GEALEL--------MEPVLKQ---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 213 ~---~~~~~~--------~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
. ..+... ....... .........+.+++.+||+.+|++|||+++++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 0 000000 0000000 0011123568889999999999999999999963
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=253.23 Aligned_cols=233 Identities=27% Similarity=0.389 Sum_probs=179.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+|+. .+|+.+++|++..... .....+.+|+.+++.++|+|++++++++.++...++||||+.+ ++.+++.
T Consensus 34 ~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~ 112 (313)
T cd06633 34 FGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLE 112 (313)
T ss_pred CeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC-CHHHHHH
Confidence 689999985 5799999999864422 2335678899999999999999999999999999999999965 6666654
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ...+++..+..++.|++.++.|||++| ++|+||+|+||+++.++.++|+|||++..... .....++.
T Consensus 113 ~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~ 181 (313)
T cd06633 113 VH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTP 181 (313)
T ss_pred hc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccc
Confidence 32 235889999999999999999999998 99999999999999999999999998754221 12245678
Q ss_pred CccCchhhc---cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 157 GYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 157 ~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.|+|||.+. +..++.++||||||+++|+|++|..||........ ..... ......... ....
T Consensus 182 ~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~-~~~~~~~~~--------~~~~ 246 (313)
T cd06633 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QNDSPTLQS--------NEWT 246 (313)
T ss_pred cccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHH-hcCCCCCCc--------cccC
Confidence 899999874 35678899999999999999999999754322110 00000 011111100 1112
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+.+++.+||+.+|.+||++.+++..
T Consensus 247 ~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 247 DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 347888999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=251.62 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=180.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+|+.|++|.+.... ......+.+|+.+++.++|+||+++++++.++...++||||+++ ++.+++..
T Consensus 15 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 93 (294)
T PLN00009 15 YGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDS 93 (294)
T ss_pred CEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHh
Confidence 689999996 479999999886442 23345678899999999999999999999999999999999964 77776643
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-CCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ....+++..+..++.||+.||+|||+++ ++|+||+|+||+++. ++.+||+|||++......... .....++.
T Consensus 94 ~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~ 167 (294)
T PLN00009 94 S-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTL 167 (294)
T ss_pred C-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccCceee
Confidence 2 2334678888999999999999999998 999999999999985 456999999999765432111 12234578
Q ss_pred CccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcc---------cccccccc--cc
Q 021771 157 GYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEG---------EALELMEP--VL 224 (308)
Q Consensus 157 ~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~--~~ 224 (308)
.|+|||.+.+ ..++.++||||+|+++|+|++|..||........ ........... ........ ..
T Consensus 168 ~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (294)
T PLN00009 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTPNEETWPGVTSLPDYKSAFPKW 244 (294)
T ss_pred cccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhccccccchhhhhhcccC
Confidence 8999998765 4578899999999999999999999865332110 00000000000 00000000 00
Q ss_pred c----ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 225 K----QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 225 ~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
. ..........+.+++.+||+.+|++||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 245 PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0001112345788999999999999999999986
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=272.70 Aligned_cols=244 Identities=27% Similarity=0.434 Sum_probs=202.9
Q ss_pred CCccEEeeeC----CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.|+.|+++ .-..||||.++.. ....+..|..|+.+|-+++||||+++.++........+|.|||++|+|+.++
T Consensus 642 FGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFL 721 (996)
T KOG0196|consen 642 FGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFL 721 (996)
T ss_pred ccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHH
Confidence 8999999974 2467899999765 3456678999999999999999999999999999999999999999999999
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~ 154 (308)
+.+.. .+...++.-+++.|+.++.||-..+ +|||||...||||+.+...|++|||+++.+.+.... ........
T Consensus 722 R~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKI 796 (996)
T KOG0196|consen 722 RQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKI 796 (996)
T ss_pred hhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCcc
Confidence 87653 4888999999999999999999987 999999999999999999999999999987544321 11111233
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
..+|.|||.+....++.++||||+|+++||.++ |..|+..+... ++.+.++.-++-..+.+++
T Consensus 797 PiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----------------dVIkaIe~gyRLPpPmDCP 860 (996)
T KOG0196|consen 797 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----------------DVIKAIEQGYRLPPPMDCP 860 (996)
T ss_pred ceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----------------HHHHHHHhccCCCCCCCCc
Confidence 579999999999999999999999999999765 77886544332 3344444444455566667
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
..|.+|+..||++|-..||.+.+|+..|....
T Consensus 861 ~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 861 AALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 77999999999999999999999999987653
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=251.37 Aligned_cols=236 Identities=26% Similarity=0.347 Sum_probs=187.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.+++|++... .......+.+|+.+++.++ |+||+++++++.+++..++|||++.+++|.+++
T Consensus 14 ~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 93 (280)
T cd05581 14 FSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI 93 (280)
T ss_pred ceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHH
Confidence 689999996 58999999998653 2233467888999999998 999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc---------
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--------- 146 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--------- 146 (308)
.... .+++..++.++.|++.+|.+||+.| ++|+||+|+||+++.++.++|+|||++.........
T Consensus 94 ~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 167 (280)
T cd05581 94 RKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167 (280)
T ss_pred HHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcc
Confidence 5532 5899999999999999999999998 999999999999999999999999998876533221
Q ss_pred ---------cccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccc
Q 021771 147 ---------ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEAL 217 (308)
Q Consensus 147 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (308)
.......++..|+|||......++.++|+||||++++++++|..||....... ...... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~--- 237 (280)
T cd05581 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------TFQKIL-KL--- 237 (280)
T ss_pred ccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHH-hc---
Confidence 11223456788999998888888999999999999999999999987543110 000000 00
Q ss_pred ccccccccccchHHHHHHHHHHHhhcccCCCCCCCCH----HHHHH
Q 021771 218 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTM----SSVVV 259 (308)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~----~eil~ 259 (308)
....+......+.+++.+||+.+|++|||+ +++++
T Consensus 238 -------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 238 -------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 001111113458889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=245.40 Aligned_cols=217 Identities=18% Similarity=0.157 Sum_probs=169.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.+|+|++.... ....|...+....||||+++++++.+....+++|||+++++|.+++...
T Consensus 6 ~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 79 (237)
T cd05576 6 IDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF- 79 (237)
T ss_pred cceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-
Confidence 688999985 689999999986542 2233444555567999999999999999999999999999999988543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.+|.|||+.| ++|+||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 80 --~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~ 149 (237)
T cd05576 80 --LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC 149 (237)
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence 34889999999999999999999998 9999999999999999999999999876653221 1123456799
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||...+..++.++|+||+|+++|+|++|..|+........ ..... ..+......+.++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~~~~---------~~~~~~~~~~~~l 208 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------THTTL---------NIPEWVSEEARSL 208 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------ccccc---------CCcccCCHHHHHH
Confidence 99988877889999999999999999999987643211100 00000 0111122357889
Q ss_pred HhhcccCCCCCCCCH
Q 021771 240 GLLCVQADSADRPTM 254 (308)
Q Consensus 240 i~~cl~~~p~~RPs~ 254 (308)
+.+||+.||++||++
T Consensus 209 i~~~l~~dp~~R~~~ 223 (237)
T cd05576 209 LQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHccCCHHHhcCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=248.59 Aligned_cols=251 Identities=24% Similarity=0.284 Sum_probs=186.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||.++. .+++.+++|.+.... ....+.+..|+.+++.++|+||+++++++.+....++||||++ ++|.+++..
T Consensus 12 ~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~ 90 (282)
T cd07829 12 YGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDK 90 (282)
T ss_pred cceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHh
Confidence 689999996 469999999987653 3344667889999999999999999999999999999999997 589998865
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.. ..+++..+..++.|++.+|++||++| ++|+||+|+||++++++.++|+|||++......... .....++..
T Consensus 91 ~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~ 163 (282)
T cd07829 91 RP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLW 163 (282)
T ss_pred hc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcC
Confidence 32 35899999999999999999999998 999999999999999999999999998775432211 112234678
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchh--------HHHHHhhhccc-cccccccc---c
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL--------SYTWKLWCEGE-ALELMEPV---L 224 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~~~---~ 224 (308)
|+|||.+.+. .++.++||||||+++|++++|..||............ ...+....... ........ .
T Consensus 164 ~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (282)
T cd07829 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKD 243 (282)
T ss_pred cCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccc
Confidence 9999988765 7889999999999999999999998654322110000 00000000000 00000000 0
Q ss_pred cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 225 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 225 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...........+.+++.+||+.+|++||++++++.
T Consensus 244 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 244 LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00011112456899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=242.89 Aligned_cols=231 Identities=25% Similarity=0.287 Sum_probs=184.2
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||.++.. +++.+++|.+..... .....+..|+.+++.++|+||+++++.+..+...+++|||+++++|.+++.
T Consensus 6 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~ 85 (250)
T cd05123 6 FGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLS 85 (250)
T ss_pred ceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHH
Confidence 6899999964 699999999865432 245678899999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.|++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++.
T Consensus 86 ~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 157 (250)
T cd05123 86 KE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTP 157 (250)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCc
Confidence 43 24899999999999999999999997 9999999999999999999999999988754322 1122345677
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|++||...+...+.++|+||||+++|++++|..||....... ...... ... ...+......+
T Consensus 158 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-~~~----------~~~~~~~~~~l 220 (250)
T cd05123 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE------IYEKIL-KDP----------LRFPEFLSPEA 220 (250)
T ss_pred cccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHh-cCC----------CCCCCCCCHHH
Confidence 8999999888888899999999999999999999986543211 011110 000 00111113458
Q ss_pred HHHHhhcccCCCCCCCCHHH
Q 021771 237 IHIGLLCVQADSADRPTMSS 256 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~e 256 (308)
.+++.+||..||++|||+.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 88999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=289.15 Aligned_cols=238 Identities=25% Similarity=0.326 Sum_probs=190.3
Q ss_pred CCccEEee-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||-+. ..+|+-.|+|-+.-+. ......+.+|..+|..++|||+|++|++=...+..+|+||||.+|+|.+++.
T Consensus 1248 fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~- 1326 (1509)
T KOG4645|consen 1248 FGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLE- 1326 (1509)
T ss_pred eeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHH-
Confidence 89999999 5789999999876543 3345678899999999999999999999999889999999999999999883
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC--ccccceeecc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS--EANTNRIVGT 155 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~ 155 (308)
.+...++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|.....+.. ...-....||
T Consensus 1327 --~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT 1401 (1509)
T KOG4645|consen 1327 --HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGT 1401 (1509)
T ss_pred --hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCC
Confidence 3344677777889999999999999999 99999999999999999999999999988765421 1222346899
Q ss_pred cCccCchhhccC---cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc--ccccccccccccccchH
Q 021771 156 YGYMAPEYAMEG---LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE--GEALELMEPVLKQSCVA 230 (308)
Q Consensus 156 ~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (308)
+.|||||++.+. .-..++||||||||+.+|++|+.||...+.+= .-.++- +..++ .+.
T Consensus 1402 ~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~--------aIMy~V~~gh~Pq---------~P~ 1464 (1509)
T KOG4645|consen 1402 PMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW--------AIMYHVAAGHKPQ---------IPE 1464 (1509)
T ss_pred chhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh--------HHHhHHhccCCCC---------Cch
Confidence 999999999763 35578999999999999999999997665541 011111 11111 122
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~~L 261 (308)
.....=.++|.+||+.||++|.++.||++.=
T Consensus 1465 ~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1465 RLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred hhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 2333456777899999999999999888754
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=249.06 Aligned_cols=251 Identities=23% Similarity=0.240 Sum_probs=183.1
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+|+.. +++.+++|++..... .......+|+..+++++ |+||+++++++.++...++||||+ +++|.+++..
T Consensus 12 ~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~ 90 (283)
T cd07830 12 FGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKD 90 (283)
T ss_pred ceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHh
Confidence 6899999964 688999999865432 23334567999999999 999999999999999999999999 7788887755
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.. ...+++..+..++.|++.+|.|||++| ++|+||+|+||+++.++.++|+|||++........ .....++..
T Consensus 91 ~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~ 163 (283)
T cd07830 91 RK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRW 163 (283)
T ss_pred cc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCccc
Confidence 33 245899999999999999999999998 99999999999999999999999999987543221 122356778
Q ss_pred ccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccch-hH---------HHHHhhhccccccccccccc-
Q 021771 158 YMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSL-LS---------YTWKLWCEGEALELMEPVLK- 225 (308)
Q Consensus 158 y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~~~~- 225 (308)
|+|||.+.+ ..++.++|+||+|+++|+|++|.+||........... .. +.............+.....
T Consensus 164 ~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (283)
T cd07830 164 YRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPT 243 (283)
T ss_pred ccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccc
Confidence 999997754 5678999999999999999999999854432211000 00 00000000000000000000
Q ss_pred --ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 226 --QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 226 --~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..........+.+++++||+.+|++|||++|++.
T Consensus 244 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 244 SLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0001111356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=256.95 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=181.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeC--CeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|.. .+|+.+++|++... .......+..|+.+++.+ +|+||+++++++... ...++||||++ ++|..+
T Consensus 20 ~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~ 98 (337)
T cd07852 20 YGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAV 98 (337)
T ss_pred CeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHH
Confidence 689999996 47899999988543 233445677899999999 999999999998654 35899999996 488887
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc---cccce
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE---ANTNR 151 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~---~~~~~ 151 (308)
+... .+++..+..++.||+.+|+|||+.| ++|+||+|+||+++.++.++|+|||++......... .....
T Consensus 99 ~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~ 171 (337)
T cd07852 99 IRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171 (337)
T ss_pred HhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhc
Confidence 7432 5788889999999999999999998 999999999999999999999999998866433221 12223
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHH--------HHhhhcccccccccc
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYT--------WKLWCEGEALELMEP 222 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 222 (308)
..++..|+|||.+.+ ..++.++||||||+++|+|++|..||............... ............++.
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (337)
T cd07852 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDS 251 (337)
T ss_pred ccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhh
Confidence 457888999997754 45788999999999999999999998643322110000000 000000000000000
Q ss_pred ccc------ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 223 VLK------QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 223 ~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
... ..........+.+++.+||+.+|++|||+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 252 LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred cccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 00001124568899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=259.01 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=179.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeC--------------CeEEEEEEe
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--------------NESLLIYEY 65 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~ 65 (308)
||.||++.. .+|+.|++|.+..........+.+|+.+++.++|+||+++++++... ...++||||
T Consensus 18 ~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 97 (342)
T cd07854 18 NGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEY 97 (342)
T ss_pred CEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeec
Confidence 689999985 57999999998766666667888999999999999999999876654 357899999
Q ss_pred cCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-CCCeeeecccceeeeCCCC
Q 021771 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMNPKISDFGMARIFGGNQ 144 (308)
Q Consensus 66 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-~~~~kl~dfg~~~~~~~~~ 144 (308)
++ ++|.+++.. ..+++..++.++.||++||.|||+.| ++|+||+|+||+++. ++.++|+|||.+.......
T Consensus 98 ~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~ 169 (342)
T cd07854 98 ME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169 (342)
T ss_pred cc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCcc
Confidence 96 588777632 34889999999999999999999998 999999999999984 4568999999997654321
Q ss_pred Ccc-ccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHH--------HHHhhhcc
Q 021771 145 SEA-NTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY--------TWKLWCEG 214 (308)
Q Consensus 145 ~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------~~~~~~~~ 214 (308)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.............. ...... .
T Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 248 (342)
T cd07854 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL-N 248 (342)
T ss_pred ccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh-h
Confidence 111 1122346778999997654 4678899999999999999999999954322110000000 000000 0
Q ss_pred ccccccc-ccccc-----cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 215 EALELME-PVLKQ-----SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 215 ~~~~~~~-~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
....... ..... ........++.+|+.+||+.||++|||+.+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 249 VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 00000 001112346888999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=240.86 Aligned_cols=237 Identities=26% Similarity=0.317 Sum_probs=189.2
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCccc-HHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++.. +|+.+++|++....... .+.+..|+..++.++|+||+++++++......++++|++++++|..++...
T Consensus 2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~ 81 (244)
T smart00220 2 FGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR 81 (244)
T ss_pred ceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc
Confidence 7999999975 59999999997665444 678999999999999999999999999989999999999999999988543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
.. ++...++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 82 ~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 82 GR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred cC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 32 888999999999999999999997 9999999999999999999999999998765332 22234567789
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
++||...+..++.++|||++|++++++++|..||...... .. ............ .. ........+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~----~~~~~~~~~~~~-~~------~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LE----LFKKIGKPKPPF-PP------PEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH----HHHHHhccCCCC-cc------ccccCCHHHHH
Confidence 9999988888899999999999999999999998653111 00 011111000000 00 00002346888
Q ss_pred HHhhcccCCCCCCCCHHHHHH
Q 021771 239 IGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~ 259 (308)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=247.47 Aligned_cols=244 Identities=21% Similarity=0.249 Sum_probs=185.7
Q ss_pred CCccEEeee----CCCCEEEEEEeccCC----cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
||.||+++. .+++.+++|.+.... ......+.+|+.++..+ +|+||+++++.+..+...++||||+++++|
T Consensus 13 ~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (288)
T cd05583 13 YGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGEL 92 (288)
T ss_pred CceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcH
Confidence 688999874 367899999886432 22345678899999999 599999999999999999999999999999
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++... ..+++..+..++.|++++|.|||+.| ++|+||+|+||+++.++.++|+|||++..+...... ....
T Consensus 93 ~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~ 165 (288)
T cd05583 93 FTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYS 165 (288)
T ss_pred HHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccccccc-cccc
Confidence 9888542 34888999999999999999999998 999999999999999999999999998765432211 1222
Q ss_pred eecccCccCchhhccCc--ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 152 IVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
..++..|+|||.+.+.. .+.++|+||||+++|+|++|..||........ ........... ... .+
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~-------~~~----~~ 232 (288)
T cd05583 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS-------KPP----FP 232 (288)
T ss_pred ccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc-------CCC----CC
Confidence 35678999999887654 78899999999999999999999864321111 11111111100 000 11
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 233 KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 11223578889999999999999999888887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=252.43 Aligned_cols=252 Identities=21% Similarity=0.279 Sum_probs=178.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCcCccceeeeEEeCC--------eEEEEEEecCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ--GLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN--------ESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~ 69 (308)
||.||+++. .+|+.+++|++...... ....+.+|+++++.++|+||+++++++.+.. .+++||||+.+
T Consensus 21 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~- 99 (311)
T cd07866 21 FGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH- 99 (311)
T ss_pred CEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-
Confidence 689999995 57999999988644322 2345678999999999999999999876433 46999999965
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc-
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN- 148 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~- 148 (308)
++...+... ...+++..+..++.|++++|+|||++| ++|+||+|+||++++++.++|+|||++...........
T Consensus 100 ~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 174 (311)
T cd07866 100 DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174 (311)
T ss_pred CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCccccc
Confidence 566655432 345999999999999999999999998 99999999999999999999999999876543221111
Q ss_pred --------cceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc------
Q 021771 149 --------TNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE------ 213 (308)
Q Consensus 149 --------~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~------ 213 (308)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|.+||.....................
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T cd07866 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGW 254 (311)
T ss_pred CCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 1123457789999987654 5788999999999999999999998643332111000000000000
Q ss_pred ccccccc--------cccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 214 GEALELM--------EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 214 ~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
....... ...+.. ........+.+++.+||+.+|++|||+.+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 255 RSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 000000 01112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=262.00 Aligned_cols=192 Identities=28% Similarity=0.434 Sum_probs=167.2
Q ss_pred CCccEEee-eCCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------eEEEEEEecCCCChh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~ 72 (308)
||.||.|+ ..+|+.||||.++.. ....++..-.|+++|++++|+|||+++++=.+.. ...+|||||.+|+|.
T Consensus 26 ~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~ 105 (732)
T KOG4250|consen 26 FGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLR 105 (732)
T ss_pred cceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHH
Confidence 79999999 478999999998754 4667788999999999999999999998866543 358999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC--CCCC--eeeecccceeeeCCCCCccc
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN--HEMN--PKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~--~~~~--~kl~dfg~~~~~~~~~~~~~ 148 (308)
..+........+++.+++.++..++.|+.|||++| |+||||||.||++- ++|+ .||+|||.|+.+..+. .
T Consensus 106 ~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~ 179 (732)
T KOG4250|consen 106 KVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---L 179 (732)
T ss_pred HHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---e
Confidence 99988777788999999999999999999999998 99999999999984 3344 7999999999875443 3
Q ss_pred cceeecccCccCchhhc-cCcccccccchhhhHHHHHHHhCCcCCCccccc
Q 021771 149 TNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSE 198 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~ 198 (308)
....+||..|.+||++. ++.++...|.||+||++|+.++|..||......
T Consensus 180 ~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 180 FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 45578999999999998 588999999999999999999999998654433
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=248.36 Aligned_cols=238 Identities=24% Similarity=0.379 Sum_probs=177.0
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++.+ +|+.+|||.++... ......+..|+.++.... |+||+++++++.+....+++|||+. +++.+++..
T Consensus 28 ~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~ 106 (296)
T cd06618 28 CGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR 106 (296)
T ss_pred CeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH
Confidence 6899999975 49999999986543 233445666777666664 9999999999999999999999985 467776644
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.|++.+++|||+ .| ++|+||+|+||++++++.++|+|||++..+..... .....++.
T Consensus 107 ~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~ 178 (296)
T cd06618 107 IQ--GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCA 178 (296)
T ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCc
Confidence 22 258889999999999999999997 46 99999999999999999999999999876532221 12234677
Q ss_pred CccCchhhccC----cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 157 GYMAPEYAMEG----LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 157 ~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.|+|||.+.+. .++.++||||||+++|+|++|..||...... .......... ..... . .. ...
T Consensus 179 ~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~-~~~~~-~----~~--~~~ 245 (296)
T cd06618 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQE-EPPSL-P----PN--EGF 245 (296)
T ss_pred cccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcC-CCCCC-C----CC--CCC
Confidence 89999988654 3788999999999999999999998643211 0001111111 00000 0 00 012
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
...+.+|+.+||..+|++|||+.++++.
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3458889999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=238.82 Aligned_cols=239 Identities=24% Similarity=0.384 Sum_probs=184.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
.|.|++.++ .+|+..|||.+... +.++.+++..+++++..-. +|+||+++++|..+...++.||.| ..+++.++..
T Consensus 105 cG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr 183 (391)
T KOG0983|consen 105 CGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR 183 (391)
T ss_pred ccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH
Confidence 388999996 56999999998765 4556677888888776664 999999999999999999999998 5577777754
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ..++++.-+-++...+++||.||..+. .|+|||+||+|||+|+.|++||||||++.++-.... .....|-+.
T Consensus 184 i--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---htrsAGC~~ 256 (391)
T KOG0983|consen 184 I--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HTRSAGCAA 256 (391)
T ss_pred h--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---cccccCCcc
Confidence 3 345888889999999999999999876 699999999999999999999999999988753332 223457788
Q ss_pred ccCchhhcc---CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 158 YMAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 158 y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
|||||.+.- ..|+.++||||||+.+++|.+|+.||..-..+- ..+. +..+ +.+ +.+.... ....
T Consensus 257 YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~lt---kvln--~eP----P~L~~~~--gFSp 323 (391)
T KOG0983|consen 257 YMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLT---KVLN--EEP----PLLPGHM--GFSP 323 (391)
T ss_pred ccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHH---HHHh--cCC----CCCCccc--CcCH
Confidence 999998763 468899999999999999999999987533321 1111 1111 111 1111111 0233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+.+++..||+.|+.+||.+.++++-
T Consensus 324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 324 DFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HHHHHHHHHhhcCcccCcchHHHhcC
Confidence 57777888999999999999999853
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=242.02 Aligned_cols=243 Identities=24% Similarity=0.313 Sum_probs=187.2
Q ss_pred CccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 2 ESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 2 g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
+.|--.+ +.+|+.||||++.++....+.++.+|++++.+.+ |+||++++++|+++..+|||||-|.||+|-..|..
T Consensus 92 asVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~-- 169 (463)
T KOG0607|consen 92 ASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK-- 169 (463)
T ss_pred eeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHH--
Confidence 4444444 5789999999999988888999999999999996 99999999999999999999999999999888854
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC---eeeecccceeeeCC--CCCc---cccce
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN---PKISDFGMARIFGG--NQSE---ANTNR 151 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~---~kl~dfg~~~~~~~--~~~~---~~~~~ 151 (308)
+..+++.++..+..+|+.||.+||.+| |.|||+||+|||+.+... +||+||.+..-... .-.. ..-..
T Consensus 170 -~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~t 245 (463)
T KOG0607|consen 170 -RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLT 245 (463)
T ss_pred -hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccC
Confidence 445999999999999999999999999 999999999999986654 89999988654321 1111 11223
Q ss_pred eecccCccCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccc-----cccc
Q 021771 152 IVGTYGYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEAL-----ELME 221 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~ 221 (308)
.+|+..|||||++.- ..|+.+.|.||||+|+|-|++|-+||...-..... |.+++.- .+++
T Consensus 246 PvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG---------WdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 246 PVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG---------WDRGEVCRVCQNKLFE 316 (463)
T ss_pred cccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---------ccCCCccHHHHHHHHH
Confidence 578889999997752 35889999999999999999999999665444321 1111111 1111
Q ss_pred cccccc--chHHH----HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 222 PVLKQS--CVAAE----LLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 222 ~~~~~~--~~~~~----~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...... ++..+ .....+|+...+..++.+|.++.++++
T Consensus 317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111 22222 234566778888999999999999986
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=240.27 Aligned_cols=253 Identities=20% Similarity=0.201 Sum_probs=197.3
Q ss_pred CCccEEee-eCCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.|.+.+ ..+|+.||+|++++.- .++.+.-..|-.+|+..+||.+..+...|+.+..+|+||||.+||.|.-.+.
T Consensus 181 FGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs 260 (516)
T KOG0690|consen 181 FGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS 260 (516)
T ss_pred cceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehh
Confidence 78999988 5689999999997653 3445555678899999999999999999999999999999999999988874
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ...+++.+.+.+...|+.||.|||+++ ||.||+|.+|.|++.+|.+||+|||+++.-. ........++|++
T Consensus 261 r---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t~kTFCGTP 332 (516)
T KOG0690|consen 261 R---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDTTKTFCGTP 332 (516)
T ss_pred h---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc--cccceeccccCCh
Confidence 3 345999999999999999999999986 9999999999999999999999999987632 2233445578999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|.|||++....|....|.|.+|+++|+|++|+.||-..+.+....++.... -.++.....+.
T Consensus 333 EYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-----------------~kFPr~ls~eA 395 (516)
T KOG0690|consen 333 EYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-----------------LKFPRTLSPEA 395 (516)
T ss_pred hhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-----------------ccCCccCCHHH
Confidence 9999999999999999999999999999999999986555443222211110 01122222346
Q ss_pred HHHHhhcccCCCCCCC--CHHHHHHHhhcC-----------CCCCCCCCCCCccc
Q 021771 237 IHIGLLCVQADSADRP--TMSSVVVMLASD-----------TVTLPQPTEPAFSV 278 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP--s~~eil~~L~~~-----------~~~~~~~~~p~~~~ 278 (308)
..|+.-.|..||.+|. ...+..+..+.. .+.++||-.|+...
T Consensus 396 ktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtS 450 (516)
T KOG0690|consen 396 KTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTS 450 (516)
T ss_pred HHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCccc
Confidence 6677788999999995 344444443222 25567777776643
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=244.27 Aligned_cols=240 Identities=21% Similarity=0.248 Sum_probs=181.9
Q ss_pred CCccEEeee----CCCCEEEEEEeccCC----cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
||.||.++. .+|+.||+|++.... ....+.+..|+.+++.+ +|+||+.+++++..+...++||||+++++|
T Consensus 13 ~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 92 (290)
T cd05613 13 YGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGEL 92 (290)
T ss_pred cceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcH
Confidence 689999885 378999999986432 22345678899999999 599999999999999999999999999999
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++... ..+++..+..++.|++.+|.|||+.| ++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 93 ~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 165 (290)
T cd05613 93 FTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYS 165 (290)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccccccc-cccc
Confidence 9988543 34888999999999999999999998 999999999999999999999999998775432211 1122
Q ss_pred eecccCccCchhhccC--cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 152 IVGTYGYMAPEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
..++..|+|||.+.+. .++.++||||||+++|+|++|..||....... ............. .. .+
T Consensus 166 ~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~-------~~----~~ 232 (290)
T cd05613 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE-------PP----YP 232 (290)
T ss_pred ccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC-------CC----CC
Confidence 4577889999987653 46788999999999999999999986422111 1111111111100 00 01
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRP-----TMSSVVVM 260 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~~ 260 (308)
......+.+++.+||+.+|++|| ++++++..
T Consensus 233 ~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 233 QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11223577888999999999997 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=271.56 Aligned_cols=263 Identities=21% Similarity=0.239 Sum_probs=205.3
Q ss_pred CCccEEeee-CCCCEEEEEEecc---CCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.|.+.++ .+++.||+|++++ ....+.+.|.+|-++|..-+.+.|+.++-.|.++.++|+||||++||+|-.++.
T Consensus 88 FGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlS 167 (1317)
T KOG0612|consen 88 FGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLS 167 (1317)
T ss_pred cceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHh
Confidence 899999996 5799999999875 234456789999999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... .+++..+..++..|.-||.-||+.| +|||||||+|||++..|.+||+|||.+-.+..... ..+...+||+
T Consensus 168 k~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~-V~s~~aVGTP 240 (1317)
T KOG0612|consen 168 KFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT-VRSSVAVGTP 240 (1317)
T ss_pred hcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc-EEeccccCCC
Confidence 544 5999999999999999999999999 99999999999999999999999999988764432 3345578999
Q ss_pred CccCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 157 GYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 157 ~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.|++||++.. +.|+..+|.||+|+++|+|+.|..||- ...+.....++.+..+...+.+. ..
T Consensus 241 DYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~KIm~hk~~l~FP~~-------~~ 307 (1317)
T KOG0612|consen 241 DYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGKIMNHKESLSFPDE-------TD 307 (1317)
T ss_pred CccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHHHhchhhhcCCCcc-------cc
Confidence 9999998862 568899999999999999999999983 22333333333333222222211 11
Q ss_pred HHHHHHHHHhhcccCCCCCCCC---HHHHHHHh--hcCC----CCCCCCCCCCcccCccCCC
Q 021771 232 ELLKFIHIGLLCVQADSADRPT---MSSVVVML--ASDT----VTLPQPTEPAFSVGRNVAR 284 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs---~~eil~~L--~~~~----~~~~~~~~p~~~~~~~~~~ 284 (308)
......+||+..+. +|+.|.. ++++-.-. +++. ....||-.|..+.+.+.++
T Consensus 308 VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsn 368 (1317)
T KOG0612|consen 308 VSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSN 368 (1317)
T ss_pred cCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCcccc
Confidence 33446666666555 8889988 88887542 2222 3457788888776654443
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=242.84 Aligned_cols=246 Identities=15% Similarity=0.153 Sum_probs=168.9
Q ss_pred CCccEEeeeCC----CCEEEEEEeccCCccc-HH----------HHHHHHHHHhcCCCcCccceeeeEEeCC----eEEE
Q 021771 1 MESCLQGKLAD----GKEIAVKRLSRTSGQG-LQ----------EFKNEVTLIAKLQHKNLVRLFGCCLEEN----ESLL 61 (308)
Q Consensus 1 ~g~v~~~~~~~----g~~vavK~~~~~~~~~-~~----------~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~l 61 (308)
||+||+|+..+ +..+++|+........ .+ ....++..+..+.|++|++++++..... ..++
T Consensus 25 fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 104 (294)
T PHA02882 25 FGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI 104 (294)
T ss_pred CceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEE
Confidence 89999999644 4566777543222111 01 1122344556678999999998765543 3467
Q ss_pred EEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeC
Q 021771 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFG 141 (308)
Q Consensus 62 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~ 141 (308)
+++++.. ++.+.+... ...++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..+.
T Consensus 105 ~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l~DFGla~~~~ 177 (294)
T PHA02882 105 LLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177 (294)
T ss_pred EEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEEEEcCCceeec
Confidence 7887743 565555322 23567788999999999999999997 9999999999999999999999999998764
Q ss_pred CCCCc-----cccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccc
Q 021771 142 GNQSE-----ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 142 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
..... .......|+..|+|||+..+..++.++|||||||++|+|++|..||........ ........+.
T Consensus 178 ~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~--~~~~~~~~~~---- 251 (294)
T PHA02882 178 IHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN--LIHAAKCDFI---- 251 (294)
T ss_pred cCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH--HHHHhHHHHH----
Confidence 32211 112234689999999999988899999999999999999999999975522211 1110000000
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
..+...... .......+.+++..||+.+|++||++.+|++.+.
T Consensus 252 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 252 KRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 000000000 0111345788888999999999999999998763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=247.97 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=179.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe-CCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-ENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++.. .+|+.+++|++... .......+..|+.+++.++||||+++++++.. ....++++||+ +++|..++.
T Consensus 23 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~ 101 (328)
T cd07856 23 FGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT 101 (328)
T ss_pred CeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh
Confidence 789999984 58999999987543 23345678899999999999999999999876 45789999999 558888774
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ..+++..+..++.|+++||+|||+.| ++|+||+|+||+++.++.++|+|||.+....... ....++.
T Consensus 102 ~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~ 169 (328)
T cd07856 102 S----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYVSTR 169 (328)
T ss_pred c----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCc-----CCCcccc
Confidence 2 24788888999999999999999998 9999999999999999999999999987543211 1234577
Q ss_pred CccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhH--------HHHHhhhccccccccccccc-c
Q 021771 157 GYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLS--------YTWKLWCEGEALELMEPVLK-Q 226 (308)
Q Consensus 157 ~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~-~ 226 (308)
.|+|||.+.+ ..++.++||||||+++|+|++|..||............. ............+.+..... .
T Consensus 170 ~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (328)
T cd07856 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE 249 (328)
T ss_pred cccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccC
Confidence 8999998765 568899999999999999999999986543211100000 00000000000000000000 0
Q ss_pred cch-----HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 227 SCV-----AAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 227 ~~~-----~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+ ......+.+++.+||+.+|++|||+.+++..
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 250 PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 1123568899999999999999999999755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=252.47 Aligned_cols=247 Identities=25% Similarity=0.285 Sum_probs=177.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeC------CeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE------NESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L 71 (308)
||.||++.. .+|+.||+|++.... ....+.+.+|+.+++.++|+||+++++++... ...+++++++ +++|
T Consensus 30 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L 108 (345)
T cd07877 30 YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 108 (345)
T ss_pred CeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCH
Confidence 789999984 689999999986532 22345677899999999999999999988643 3467888887 7788
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++.. ..+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 109 ~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~ 176 (345)
T cd07877 109 NNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 176 (345)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccc
Confidence 887732 24889999999999999999999998 999999999999999999999999998764321 222
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchh-H-------HHHHhhhcccc---ccc
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL-S-------YTWKLWCEGEA---LEL 219 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~-~-------~~~~~~~~~~~---~~~ 219 (308)
..++..|+|||.+.+ ..++.++||||+||++|+|++|..||............ . ........... ...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (345)
T cd07877 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 256 (345)
T ss_pred cccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHH
Confidence 356788999998766 46788999999999999999999998543221100000 0 00000000000 000
Q ss_pred ccccccc---cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 220 MEPVLKQ---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 220 ~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+...... .........+.+++.+||+.+|++|||+.++++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 257 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 0000123457899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=247.64 Aligned_cols=246 Identities=21% Similarity=0.286 Sum_probs=178.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------eEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L 71 (308)
||.||++.. .+|+.||+|++.... ......+.+|+.+++.++|+||+++++++..+. ..++||||+ +++|
T Consensus 28 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l 106 (343)
T cd07880 28 YGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDL 106 (343)
T ss_pred CeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCH
Confidence 689999984 689999999885432 223456789999999999999999999987654 358999999 6788
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
..++.. ..+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 107 ~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~ 174 (343)
T cd07880 107 GKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTG 174 (343)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccc
Confidence 887742 35889999999999999999999998 999999999999999999999999998764322 122
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccc-hhHH-------HHHhhhcccccccccc
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQS-LLSY-------TWKLWCEGEALELMEP 222 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~-~~~~-------~~~~~~~~~~~~~~~~ 222 (308)
..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......... .... ................
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (343)
T cd07880 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKK 254 (343)
T ss_pred cccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHh
Confidence 345788999998876 457889999999999999999999986443211000 0000 0000000000000000
Q ss_pred c--cc----ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 223 V--LK----QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 223 ~--~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
. .. ..........+.+++.+|++.||++|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 255 LPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred ccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00 0000112335789999999999999999999993
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=240.74 Aligned_cols=237 Identities=25% Similarity=0.320 Sum_probs=180.4
Q ss_pred CCccEEeeeC-CCCEEEEEEeccC-----CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRT-----SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+++.. .+..+++|+++.. .......+..|+.+++.++||||+++++++.+....++||||+++++|.++
T Consensus 13 ~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 92 (260)
T cd08222 13 FGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCK 92 (260)
T ss_pred CceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHH
Confidence 7899999853 4555666655432 222334566789999999999999999999999999999999999999988
Q ss_pred hhcC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 75 LFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 75 l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
+... .....+++..++.++.|++.+|.|||+.| ++|+||+|+||+++. +.++|+|||++........ ......
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~ 166 (260)
T cd08222 93 LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFT 166 (260)
T ss_pred HHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCC
Confidence 8642 23456899999999999999999999998 999999999999975 5699999999877543221 122234
Q ss_pred cccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
++..|+|||...+..++.++|+||+|+++|+|++|..||..... ....... ...... ..+....
T Consensus 167 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~-~~~~~~---------~~~~~~~ 230 (260)
T cd08222 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRI-VEGPTP---------SLPETYS 230 (260)
T ss_pred CCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHH-HcCCCC---------CCcchhc
Confidence 67789999998877888999999999999999999999853211 1111111 011111 1122334
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 231 RQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 46888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=254.09 Aligned_cols=243 Identities=24% Similarity=0.311 Sum_probs=179.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe------EEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE------SLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L 71 (308)
||.||+++. .+++.|++|++... .......+.+|+.+++.++|+||+++++++..... .++|+||+ +++|
T Consensus 28 ~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L 106 (343)
T cd07851 28 YGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL 106 (343)
T ss_pred ceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCH
Confidence 689999996 57899999988643 22334567789999999999999999998876554 89999999 6689
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++.. ..+++..++.++.|++.+|+|||+.| ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 107 ~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~ 174 (343)
T cd07851 107 NNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTG 174 (343)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccC
Confidence 888743 35899999999999999999999998 999999999999999999999999998765322 122
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHh-----------hhccccccc
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKL-----------WCEGEALEL 219 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~ 219 (308)
..++..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ....... +........
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07851 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMNLVGTPDEELLQKISSESARNY 251 (343)
T ss_pred CcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCHHHHhhccchhHHHH
Confidence 346778999998765 3678899999999999999999999864432210 0000000 000000000
Q ss_pred ccccc---cc---cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 220 MEPVL---KQ---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 220 ~~~~~---~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+.... .. .........+.+++.+||+.+|++|||+.+|++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 252 IQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 00 000112456889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=249.98 Aligned_cols=252 Identities=24% Similarity=0.258 Sum_probs=177.9
Q ss_pred CCccEEeee-CC--CCEEEEEEeccCC--cccHHHHHHHHHHHhcC-CCcCccceeeeEEeC----CeEEEEEEecCCCC
Q 021771 1 MESCLQGKL-AD--GKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEE----NESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~-~~--g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~ 70 (308)
||.||+++. .+ ++.+|+|++.... ......+..|+.+++++ .|+||+++++.+... ...+++++++. ++
T Consensus 13 ~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~ 91 (332)
T cd07857 13 YGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-AD 91 (332)
T ss_pred CeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CC
Confidence 789999995 35 8899999886432 22345678899999999 499999999875432 45788899985 58
Q ss_pred hhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc--cc
Q 021771 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--AN 148 (308)
Q Consensus 71 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--~~ 148 (308)
|.+++.. ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++.++|+|||++..+...... ..
T Consensus 92 L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (332)
T cd07857 92 LHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165 (332)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceeccccccccccc
Confidence 8887743 335899999999999999999999998 999999999999999999999999999876432211 11
Q ss_pred cceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccch-h-------HHHHHhhhccccccc
Q 021771 149 TNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSL-L-------SYTWKLWCEGEALEL 219 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~ 219 (308)
.....++..|+|||...+ ..++.++||||+|+++|+|++|.+||........... . ...............
T Consensus 166 ~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (332)
T cd07857 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNY 245 (332)
T ss_pred ccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHH
Confidence 223467889999997765 4678999999999999999999999865432110000 0 000000000000000
Q ss_pred cc---cccc---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 220 ME---PVLK---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 220 ~~---~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. .... ..........+.+++.+||+.||++|||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 246 IRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 0000 0000011346888999999999999999999973
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=253.78 Aligned_cols=235 Identities=24% Similarity=0.324 Sum_probs=186.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||-|++ ++|+.||||++.+. ......++.+|+.+|+.+.||.||.+...|+..+..++|||.+.|.-|.-.+ .
T Consensus 577 FG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMIL-S 655 (888)
T KOG4236|consen 577 FGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMIL-S 655 (888)
T ss_pred ceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHH-H
Confidence 899999996 69999999999765 2444578999999999999999999999999999999999999665454444 3
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC---CCeeeecccceeeeCCCCCccccceeec
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE---MNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
. +...+++.....++.||+.||+|||-++ |+|+|+||+|||+... ..+||||||+++.++.... ....+|
T Consensus 656 s-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---RrsVVG 728 (888)
T KOG4236|consen 656 S-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---RRSVVG 728 (888)
T ss_pred h-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh---hhhhcC
Confidence 2 3446999889999999999999999996 9999999999999755 4599999999999864433 334589
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
|+.|.|||++.+..|...-|+||.|+++|--++|..||+.......+ +....-.+....| .+...
T Consensus 729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNAaFMyPp~PW-------------~eis~ 793 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNAAFMYPPNPW-------------SEISP 793 (888)
T ss_pred CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhccccccCCCch-------------hhcCH
Confidence 99999999999999999999999999999999999999754333211 1111111111111 12233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVV 258 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil 258 (308)
..++||...|+..-++|-|...-+
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhc
Confidence 577888889999999999887765
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=237.82 Aligned_cols=238 Identities=20% Similarity=0.191 Sum_probs=170.9
Q ss_pred CccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeC----CeEEEEEEecCCCChhhHh
Q 021771 2 ESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEE----NESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 2 g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l 75 (308)
|.|..... .+|+++|+|++. +. ....+|+++=-.. .|+|||.+++++.+. ..+.+|||.++||.|...+
T Consensus 76 GkV~~C~~k~T~ekfALKvL~-Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsri 150 (400)
T KOG0604|consen 76 GKVVQCVHKRTQEKFALKVLL-DS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRI 150 (400)
T ss_pred CceEEEEeccchhhhHHHHHh-cC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHH
Confidence 44444443 578888888773 22 3345666653334 599999999998753 2467899999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC---CCeeeecccceeeeCCCCCcccccee
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE---MNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
.+. ....+.+.++..|+.||+.|++|||+.. |.||||||+|+|+... ..+||+|||+++.-.. ...-...
T Consensus 151 q~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TP 223 (400)
T KOG0604|consen 151 QDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTP 223 (400)
T ss_pred HHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCC---CccccCC
Confidence 664 3456999999999999999999999984 9999999999999754 4599999999987432 1222234
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
..|+.|.|||++-...|+...|+||||+++|-|++|-+||=.........- -+.....+ -.+. ...-=+..
T Consensus 224 c~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg---Mk~rI~~g-qy~F-----P~pEWs~V 294 (400)
T KOG0604|consen 224 CFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKRRIRTG-QYEF-----PEPEWSCV 294 (400)
T ss_pred cccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh---HHhHhhcc-CccC-----CChhHhHH
Confidence 568999999999888899999999999999999999999832221110000 00000000 0000 00111234
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+...++|+.+|+.+|.+|.|++++++.
T Consensus 295 Se~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 295 SEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred HHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 5567888999999999999999999853
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=248.75 Aligned_cols=242 Identities=24% Similarity=0.299 Sum_probs=175.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------eEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L 71 (308)
||.||+|+. .+|+.||+|++.... ......+.+|+.+++.++|+||+++++++.... ..++|+||+.. +|
T Consensus 28 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 106 (342)
T cd07879 28 YGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DL 106 (342)
T ss_pred CeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CH
Confidence 689999995 579999999986432 223456789999999999999999999987543 46899999854 66
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
..+. ...+++..+..++.|++.||+|||+.| ++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 107 ~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~ 173 (342)
T cd07879 107 QKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTG 173 (342)
T ss_pred HHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCC
Confidence 6654 124888999999999999999999998 999999999999999999999999998754221 122
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHh-----------hhccccccc
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKL-----------WCEGEALEL 219 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~ 219 (308)
..++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........ .........
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (342)
T cd07879 174 YVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGPEFVQKLEDKAAKSY 250 (342)
T ss_pred ceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence 356778999998766 457889999999999999999999996533211 00000000 000000000
Q ss_pred ---cccccccc---chHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 220 ---MEPVLKQS---CVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 220 ---~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
........ ........+.+|+.+||+.||++|||+.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000 00112345789999999999999999999984
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=253.68 Aligned_cols=274 Identities=20% Similarity=0.241 Sum_probs=216.4
Q ss_pred CCccEEeeeCCCC-EEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGK-EIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.|=+.+.++.. .+|+|++++. +....+.+..|-++|...++|.||++|..|.++.+.|++||-|-||.+...+.
T Consensus 433 FGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLr 512 (732)
T KOG0614|consen 433 FGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILR 512 (732)
T ss_pred cceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhh
Confidence 7888888865443 3888988665 44556778899999999999999999999999999999999999999999995
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
+ +..+++.++..++..+++|++|||++| |+.||+||+|.+++.+|.+||.|||+++.+.... .+-.++||+
T Consensus 513 d---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTp 583 (732)
T KOG0614|consen 513 D---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTP 583 (732)
T ss_pred h---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC---ceeeecCCc
Confidence 4 445999999999999999999999998 9999999999999999999999999999876443 334468999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|.|||++.+...+.++|.|+||+.+|+|++|.+||...++-...+++...... .+ .+.......
T Consensus 584 EYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~------i~---------~Pr~I~k~a 648 (732)
T KOG0614|consen 584 EYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK------IE---------FPRRITKTA 648 (732)
T ss_pred ccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh------hh---------cccccchhH
Confidence 999999999999999999999999999999999999877666544433222111 11 111222236
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHHH--hhcC------CCCCCCCCCCCcccCccCCCCCCCCCCCcccccC
Q 021771 237 IHIGLLCVQADSADRPT-----MSSVVVM--LASD------TVTLPQPTEPAFSVGRNVARPGQFSSGAEVCSVN 298 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs-----~~eil~~--L~~~------~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 298 (308)
.+|+++..+.+|.+|.. +.+|..- +++- ...+++|..|....+++.++=+.++-.+.-.+..
T Consensus 649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p~dnd~pppd 723 (732)
T KOG0614|consen 649 TDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFPPDNDEPPPD 723 (732)
T ss_pred HHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCCcccCCCCch
Confidence 67777788899999976 4555422 1111 3567999999998888888777766655554433
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=241.38 Aligned_cols=254 Identities=27% Similarity=0.364 Sum_probs=191.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcC--CCcCccceeeeEEeCC----eEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL--QHKNLVRLFGCCLEEN----ESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|++ +++.||||++... ..+.+++|.++.... +|+||+++++.-.... .+.||++|.+.|+|.++
T Consensus 223 fg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dy 298 (534)
T KOG3653|consen 223 FGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDY 298 (534)
T ss_pred cceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHH
Confidence 899999998 5589999999643 456788888887765 7999999998866554 68999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCC------CCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDS------RLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g------~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
+..+ .+++....+++..|++||+|||+.- +..|+|||||.+||||-.+++..|+|||++..+........
T Consensus 299 L~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d 374 (534)
T KOG3653|consen 299 LKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGD 374 (534)
T ss_pred HHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcc
Confidence 9554 4899999999999999999999741 35799999999999999999999999999999876665555
Q ss_pred cceeecccCccCchhhccCc-cc-----ccccchhhhHHHHHHHhCCcCCCccccccccchhH----------HHHHh-h
Q 021771 149 TNRIVGTYGYMAPEYAMEGL-FS-----VKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLS----------YTWKL-W 211 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~-~~-----~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~----------~~~~~-~ 211 (308)
....+||.+|||||++.+.. +. .+.||||+|.|+||+++....+........+...+ .-+.. .
T Consensus 375 ~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV 454 (534)
T KOG3653|consen 375 THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVV 454 (534)
T ss_pred hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHH
Confidence 55578999999999998742 22 46899999999999999765543211111111111 00111 1
Q ss_pred hcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCC
Q 021771 212 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTV 266 (308)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~ 266 (308)
.....+.+.+.+... .....+.+.+..||..||+.|.|+.=+-+++.+...
T Consensus 455 ~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 455 RKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred hhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 111222222222222 344568888889999999999999999988877643
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=257.62 Aligned_cols=239 Identities=28% Similarity=0.361 Sum_probs=191.2
Q ss_pred CCccEEeeeC--CCC--EEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA--DGK--EIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.|+.|.|. +|+ .||||.+...... ....|..|+..|.+|+|+|++++|+++.+ ....||||.++.|+|.+.+
T Consensus 123 FgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrL 201 (1039)
T KOG0199|consen 123 FGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRL 201 (1039)
T ss_pred eeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHH
Confidence 8999999974 455 4599988655433 67889999999999999999999999998 6789999999999999999
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc-ceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT-NRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~ 154 (308)
+. .....+-...+..++.||+.|+.||.+++ +||||+-..|+++.....|||+|||+.+-++.+...... ....-
T Consensus 202 rk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkv 277 (1039)
T KOG0199|consen 202 RK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKV 277 (1039)
T ss_pred hh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcC
Confidence 87 45556888899999999999999999997 999999999999999999999999999987644322211 11123
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhC-CcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG-KKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.+.|+|||.+....++.++|||++|+++|||+++ +.||-..... .+.+.+|..-.-..+..+.
T Consensus 278 PfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~~erLpRPk~cs 341 (1039)
T KOG0199|consen 278 PFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDAGERLPRPKYCS 341 (1039)
T ss_pred cccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhccccccCCCCCCCh
Confidence 4679999999999999999999999999999985 4666322111 1222233222223345566
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+++++++..||..+|.+|||+..|.+.
T Consensus 342 edIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHh
Confidence 789999999999999999999999743
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=246.41 Aligned_cols=234 Identities=24% Similarity=0.289 Sum_probs=186.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.|+..+. .+|+.||+|.+.++. ........+|..+|..++.+.||.+-..|...+.+|+|+..|+||+|.-.|.
T Consensus 198 FGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiy 277 (591)
T KOG0986|consen 198 FGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIY 277 (591)
T ss_pred ccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEee
Confidence 899999985 689999999886552 2233556789999999999999999999999999999999999999998886
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
+.. ...+++.+++.++.+|+-+|++||+.+ ||.||+||+|||+|+.|+++|+|+|+|..+....... ..+||.
T Consensus 278 n~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~---~rvGT~ 350 (591)
T KOG0986|consen 278 NHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR---GRVGTV 350 (591)
T ss_pred ccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCccc---cccCcc
Confidence 643 356999999999999999999999997 9999999999999999999999999999876443322 237999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|||||++.+..|+...|.|||||++|+|+.|+.||..........-+ .... +-+ ...++.....+.
T Consensus 351 GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv-------drr~---~~~---~~ey~~kFS~ea 417 (591)
T KOG0986|consen 351 GYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV-------DRRT---LED---PEEYSDKFSEEA 417 (591)
T ss_pred cccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH-------HHHH---hcc---hhhcccccCHHH
Confidence 999999999999999999999999999999999998644322211000 0000 000 011223333456
Q ss_pred HHHHhhcccCCCCCCCCH
Q 021771 237 IHIGLLCVQADSADRPTM 254 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~ 254 (308)
.+|++..|+.||++|..-
T Consensus 418 kslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHHHHccCHHHhccC
Confidence 677778899999999643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=255.17 Aligned_cols=225 Identities=20% Similarity=0.252 Sum_probs=175.5
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.|-... ..+++..++|++..... .-.+|+.++... +|+||+++.+.+.++.+.++|||.+.++.+.+.+...
T Consensus 335 ~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~ 410 (612)
T KOG0603|consen 335 FSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK 410 (612)
T ss_pred ccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhc
Confidence 45666666 35788999999865522 234566565555 6999999999999999999999999999887777543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe-CCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL-NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.. .+ ..+..|+++|+.|+.|||++| ++|||+||+|||+ +..++++|+|||.+...... .....-|..
T Consensus 411 ~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~ 478 (612)
T KOG0603|consen 411 PE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQ 478 (612)
T ss_pred ch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhc
Confidence 32 33 778889999999999999999 9999999999999 58899999999999875433 112345788
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|.|||++....++.++|+||||+++|+|++|..||..-... .++..................
T Consensus 479 y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------------------~ei~~~i~~~~~s~~vS~~AK 540 (612)
T KOG0603|consen 479 YVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------------------IEIHTRIQMPKFSECVSDEAK 540 (612)
T ss_pred ccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------------------HHHHHhhcCCccccccCHHHH
Confidence 99999999999999999999999999999999998654333 011111111222233344577
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+|+.+||+.||.+||++.+++.
T Consensus 541 dLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 541 DLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHHhccCChhhCcChhhhcc
Confidence 8888999999999999999984
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=234.31 Aligned_cols=265 Identities=20% Similarity=0.260 Sum_probs=190.4
Q ss_pred CCccEEeeeC---C--CCEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCcCccceeeeEEe-CCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLA---D--GKEIAVKRLSRTSG--QGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-ENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~---~--g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++-+ + .+.+|+|.++.... ......-+|+.+++.++|+||+.+..+|.. +..+++++||.+. +|.
T Consensus 37 YG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~ 115 (438)
T KOG0666|consen 37 YGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLW 115 (438)
T ss_pred cceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHH
Confidence 7999999632 2 34689999975521 222345689999999999999999999987 6789999999955 787
Q ss_pred hHhhcC--CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC----CCeeeecccceeeeCCCCCc
Q 021771 73 VFLFDS--TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE----MNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 73 ~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~----~~~kl~dfg~~~~~~~~~~~ 146 (308)
..++.. .....++...+..++.||+.++.|||++= +.|||+||.||||..+ |.|||+|+|+++.+......
T Consensus 116 ~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkp 192 (438)
T KOG0666|consen 116 HIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKP 192 (438)
T ss_pred HHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccc
Confidence 777653 23457899999999999999999999996 9999999999999877 89999999999988755333
Q ss_pred c-ccceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccc---hhHHHHHhhh------ccc
Q 021771 147 A-NTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQS---LLSYTWKLWC------EGE 215 (308)
Q Consensus 147 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~------~~~ 215 (308)
. .....+-|++|+|||++.+. .|+.+.|||++||++.||++.++.|.......... ......+++. ...
T Consensus 193 l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~ 272 (438)
T KOG0666|consen 193 LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKD 272 (438)
T ss_pred cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCcccc
Confidence 2 33445668999999999885 69999999999999999999998886644332111 1111111111 011
Q ss_pred cccc---------ccccccccch----HHH-------HHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 021771 216 ALEL---------MEPVLKQSCV----AAE-------LLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLP 269 (308)
Q Consensus 216 ~~~~---------~~~~~~~~~~----~~~-------~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~ 269 (308)
++.+ +...-..... ... ...-++|+.+||++||-+|.|+++.++-.-....++|
T Consensus 273 Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 273 WPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred chhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 1110 0000000000 000 0126678889999999999999999987655555444
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=267.79 Aligned_cols=239 Identities=26% Similarity=0.391 Sum_probs=175.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEe-----------------------
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE----------------------- 55 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------------- 55 (308)
||.||+++. -||..||||+|.... ......+.+|+..|.+|+|||||++|..|.+
T Consensus 492 FG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s 571 (1351)
T KOG1035|consen 492 FGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSAS 571 (1351)
T ss_pred CceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCC
Confidence 899999996 499999999997553 3344578899999999999999999863220
Q ss_pred --------------------------------------------------------------------------------
Q 021771 56 -------------------------------------------------------------------------------- 55 (308)
Q Consensus 56 -------------------------------------------------------------------------------- 55 (308)
T Consensus 572 ~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s 651 (1351)
T KOG1035|consen 572 KYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSES 651 (1351)
T ss_pred CcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhh
Confidence
Q ss_pred --------C--------CeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCC
Q 021771 56 --------E--------NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119 (308)
Q Consensus 56 --------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~ 119 (308)
. ..+|+=||||+..++.+++..+.-. -.....|.++++|++||+|+|++| ++||||||.
T Consensus 652 ~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~ 726 (1351)
T KOG1035|consen 652 IPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPR 726 (1351)
T ss_pred ccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcc
Confidence 0 1245668999888888877554321 146788999999999999999999 999999999
Q ss_pred ceEeCCCCCeeeecccceeeeC------C----------CCCccccceeecccCccCchhhccC---cccccccchhhhH
Q 021771 120 NVLLNHEMNPKISDFGMARIFG------G----------NQSEANTNRIVGTYGYMAPEYAMEG---LFSVKSDVFSFGV 180 (308)
Q Consensus 120 nilv~~~~~~kl~dfg~~~~~~------~----------~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~Di~slG~ 180 (308)
||++++++.|||+|||+++... . .......+...||.-|+|||++.+. .|+.|+||||||+
T Consensus 727 NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGI 806 (1351)
T KOG1035|consen 727 NIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGI 806 (1351)
T ss_pred eeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHH
Confidence 9999999999999999998721 0 0111123456899999999998764 4999999999999
Q ss_pred HHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 181 LLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 181 ~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
|+|||+.- |+...... .....+..+.++.. .++..+....=.++|++|++.||.+||||.|+|+
T Consensus 807 VlFEM~yP---F~TsMERa------~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 807 VLFEMLYP---FGTSMERA------SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcc---CCchHHHH------HHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 99999964 43221110 01111112222221 1222333334567888999999999999999985
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=249.78 Aligned_cols=239 Identities=23% Similarity=0.369 Sum_probs=193.0
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEe-----CCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLE-----ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++ .++|+..|+|+..... +..+.++.|+++|+... |||++.+|++|.- ++.++||||||.+|+..+
T Consensus 32 ygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTD 110 (953)
T KOG0587|consen 32 YGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTD 110 (953)
T ss_pred ceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHH
Confidence 68899999 5789999999875443 33467889999999995 9999999999873 457999999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
+++... +..+.+..+..|++.++.++.+||.+- ++|||||-.|||++.++.|||+|||.+..+..... ..+...
T Consensus 111 LVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g--rRnT~i 184 (953)
T KOG0587|consen 111 LVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG--RRNTFI 184 (953)
T ss_pred HHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecccc--cccCcC
Confidence 997654 778999999999999999999999995 99999999999999999999999999988754332 234468
Q ss_pred cccCccCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 154 GTYGYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 154 ~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
|++.|||||++.- ..|+..+|+||||++..+|.-|.+|+-....--. -.++ ...+......
T Consensus 185 GtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------LF~I--------pRNPPPkLkr 250 (953)
T KOG0587|consen 185 GTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLI--------PRNPPPKLKR 250 (953)
T ss_pred CCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------hccC--------CCCCCccccc
Confidence 9999999998863 3477889999999999999999999743322211 0000 0111222233
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+....+++.++|..||.+|.+.||+..++++.
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 56677889999999999999999999998853
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=235.79 Aligned_cols=248 Identities=19% Similarity=0.212 Sum_probs=183.2
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-C-c----CccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-H-K----NLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.|-..- .+.+..+|||+++.. ..-++..+-|+++|.++. + | .++++.++|.-.++.|+|+|.+ |.++.+
T Consensus 102 FGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~d 179 (415)
T KOG0671|consen 102 FGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFD 179 (415)
T ss_pred ccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHH
Confidence 56666655 345889999988543 344566678999999993 2 2 3788889999999999999998 668999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC--------------------CCCeeeec
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH--------------------EMNPKISD 133 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~--------------------~~~~kl~d 133 (308)
++..+ ...+++...+..+++|+++++++||+.+ ++|.|+||+||++.+ +..|+++|
T Consensus 180 Flk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vID 255 (415)
T KOG0671|consen 180 FLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVID 255 (415)
T ss_pred HhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEe
Confidence 98654 4457999999999999999999999997 999999999999832 23489999
Q ss_pred ccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccch----------
Q 021771 134 FGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSL---------- 203 (308)
Q Consensus 134 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~---------- 203 (308)
||.+++-.... ...+.|..|+|||++.+-.++..+||||+||||+||.+|...|..-+.....-.
T Consensus 256 FGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~ 330 (415)
T KOG0671|consen 256 FGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPS 330 (415)
T ss_pred cCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcH
Confidence 99998743222 345679999999999999999999999999999999999988865442211001
Q ss_pred --hHH--HHHhhhcccc--c------------ccccccc-cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 204 --LSY--TWKLWCEGEA--L------------ELMEPVL-KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 204 --~~~--~~~~~~~~~~--~------------~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+.. ..+.+..+.+ . +...++- .......+...|++|+..||.+||.+|+|+.|+|.
T Consensus 331 ~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 331 RMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 100 1122222210 0 0001100 01123455667999999999999999999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=255.07 Aligned_cols=132 Identities=27% Similarity=0.398 Sum_probs=117.7
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++... +++.||||++.... ......+..|+.+++.++|+||+++++++......++||||+.+++|.+++.
T Consensus 17 fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~ 96 (669)
T cd05610 17 FGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH 96 (669)
T ss_pred CeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHH
Confidence 7999999964 79999999986442 2334678899999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeeccccee
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR 138 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~ 138 (308)
.. ..+++..++.++.||+.||.|||+.| |+|+||||+|||++.++.++|+|||++.
T Consensus 97 ~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 97 IY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 43 34788899999999999999999997 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=209.61 Aligned_cols=252 Identities=21% Similarity=0.240 Sum_probs=184.9
Q ss_pred CCccEEee-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+|+ ..+++-||+|+..-.+ ..-.....+|+-+|+.++|.||++++++...+..+-+|+|||+. +|..+...
T Consensus 15 ygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfds 93 (292)
T KOG0662|consen 15 YGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS 93 (292)
T ss_pred ceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHh
Confidence 79999999 5689999999886543 23345678999999999999999999999999999999999955 78887755
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
.++ .++.+.+..++.|++++|.++|++. +.|||+||.|.+|+.+|.+||+|||+++-++-...... .-+-+.+
T Consensus 94 lng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcys--aevvtlw 166 (292)
T KOG0662|consen 94 LNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS--AEVVTLW 166 (292)
T ss_pred cCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEeee--ceeeeee
Confidence 443 4899999999999999999999995 99999999999999999999999999988764432221 1244789
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcC-CCccccccccchhHHHHHhhhcccccc---cccccccccc----
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKN-TGFYLSELGQSLLSYTWKLWCEGEALE---LMEPVLKQSC---- 228 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~---- 228 (308)
|++|.++.+. .|+...|+||.||++.++.....| |...+.......+.+......+++++. +.+-..-..+
T Consensus 167 yrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypatt 246 (292)
T KOG0662|consen 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATT 246 (292)
T ss_pred ccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccc
Confidence 9999988875 588999999999999999975544 654444332222221111122222222 1111110100
Q ss_pred -----hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 229 -----VAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 229 -----~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+.....=.+|+...+.-+|..|.++++.++.
T Consensus 247 swsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 247 SWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred hHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 01111123456667778899999999998864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-33 Score=228.07 Aligned_cols=244 Identities=25% Similarity=0.333 Sum_probs=185.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+|++-.+ .+|+..|||++.... ..+..++..|.+...+- ++||||++|+.+..++..++.||.| ..+++.+-..
T Consensus 77 fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~ 155 (361)
T KOG1006|consen 77 FGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKR 155 (361)
T ss_pred chhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHH
Confidence 799999885 589999999997654 35667788888865555 6999999999999999999999999 4577665432
Q ss_pred C--CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 78 S--TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 78 ~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
. .+...+++.-+-++....+.||.||...- +|+||||||+|||++..|.+||||||++..+-... ..+...|-
T Consensus 156 vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---AkT~daGC 230 (361)
T KOG1006|consen 156 VYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---AKTVDAGC 230 (361)
T ss_pred HHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH---HhhhccCC
Confidence 1 34456888888899999999999998865 89999999999999999999999999986653221 12233567
Q ss_pred cCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 156 YGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 156 ~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
..|+|||.+.. ..++.+|||||||+++||+.+|..|+..+... .+...... .++.+.+ ..........
T Consensus 231 rpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~Vv-~gdpp~l----~~~~~~~~~s 300 (361)
T KOG1006|consen 231 RPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQVV-IGDPPIL----LFDKECVHYS 300 (361)
T ss_pred ccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHHH-cCCCCee----cCcccccccC
Confidence 78999998864 35899999999999999999999998766542 11111111 1111111 1122223345
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+..++..|+.+|-++||.+.+++..
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcC
Confidence 568889999999999999999998853
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=231.69 Aligned_cols=243 Identities=26% Similarity=0.335 Sum_probs=183.0
Q ss_pred CCccEEee-eCCCCEEEEEEeccC--CcccH-----HHHHHHHHHHhcCCCcCccceeeeEE-eCCeEEEEEEecCCCCh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRT--SGQGL-----QEFKNEVTLIAKLQHKNLVRLFGCCL-EENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~--~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L 71 (308)
|+.||++- +...+.||+|+-... ..++. +..-+|+.+-+.|+||.||++|++|. +.+.+|-|+|||+|.+|
T Consensus 476 FSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDL 555 (775)
T KOG1151|consen 476 FSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDL 555 (775)
T ss_pred HHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCch
Confidence 67899987 567889999975422 11211 22347999999999999999999997 45568999999999999
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC---CCeeeecccceeeeCCCCCccc
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE---MNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~---~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
+.+++.. ..++++++..|+.||+.||.||.+. +.+|+|.||||.|||+... |.+||+|||++..+........
T Consensus 556 DFYLKQh---klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~v 631 (775)
T KOG1151|consen 556 DFYLKQH---KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSV 631 (775)
T ss_pred hHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcc
Confidence 9999654 4599999999999999999999988 5799999999999999643 6799999999998875544322
Q ss_pred -----cceeecccCccCchhhccC----cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccc
Q 021771 149 -----TNRIVGTYGYMAPEYAMEG----LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALEL 219 (308)
Q Consensus 149 -----~~~~~~~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (308)
+....||.+|++||.+.-+ ..+.+.||||+|+++|+.+.|+.||+.......-.... .+++...+.-.
T Consensus 632 dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN---TIlkAtEVqFP 708 (775)
T KOG1151|consen 632 DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN---TILKATEVQFP 708 (775)
T ss_pred cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh---chhcceeccCC
Confidence 2345789999999976532 47889999999999999999999998764442211111 11111111111
Q ss_pred ccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 021771 220 MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 258 (308)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 258 (308)
..+. .......+|++||++.-++|....++.
T Consensus 709 ~KPv--------VsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 709 PKPV--------VSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCCc--------cCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1111 122467788999999999999887775
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=251.39 Aligned_cols=246 Identities=29% Similarity=0.394 Sum_probs=190.8
Q ss_pred CCccEEeeeC--------CCCEEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKLA--------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||.|++|... ....||||.++.. +..+.+.+..|+++|+.+ .|+||+.+++++...+..++|+||+..|+
T Consensus 309 fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~ 388 (609)
T KOG0200|consen 309 FGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGD 388 (609)
T ss_pred ccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCc
Confidence 7999999843 1457899988654 345678899999999999 59999999999999889999999999999
Q ss_pred hhhHhhcCC-----Cc--------cccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 71 LDVFLFDST-----RS--------VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 71 L~~~l~~~~-----~~--------~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
|..+++... .. ..++....+.++.||+.+++||++.. ++|||+-..|||+..+..+|++|||++
T Consensus 389 L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGla 465 (609)
T KOG0200|consen 389 LLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLA 465 (609)
T ss_pred HHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccce
Confidence 999997654 01 13888999999999999999999996 999999999999999999999999999
Q ss_pred eeeCCCCCcc-ccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccc
Q 021771 138 RIFGGNQSEA-NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGE 215 (308)
Q Consensus 138 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 215 (308)
+......... ......-...|||||.+....++.++||||+|+++|++++ |..|+...... . .. .+....+.
T Consensus 466 r~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~---~l-~~~l~~G~ 539 (609)
T KOG0200|consen 466 RDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--E---EL-LEFLKEGN 539 (609)
T ss_pred eccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--H---HH-HHHHhcCC
Confidence 8644332222 1111013456999999999999999999999999999998 45777541100 0 00 11111221
Q ss_pred ccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 216 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+...+.....++.++++.||+.+|++||++.++.+.++..
T Consensus 540 ---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 540 ---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1222333345678888999999999999999999999873
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=226.63 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=186.5
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcC--CCcCccceeeeEEeCC----eEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL--QHKNLVRLFGCCLEEN----ESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~ 74 (308)
||.||.|++ -|+.||||++...+ ...+.+|.++.+.. +|+||+.+++.-..++ .++||++|-+.|+|.++
T Consensus 224 yGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~Dy 299 (513)
T KOG2052|consen 224 FGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDY 299 (513)
T ss_pred ccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHH
Confidence 899999999 68899999995443 24567788877764 8999999998876544 47999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchh-----CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC--cc
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHE-----DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS--EA 147 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-----~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~--~~ 147 (308)
+.. ..++.+..++++..++.+|++||. +|+..|.|||||.+||||..++...|+|+|+|-....... ..
T Consensus 300 L~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi 375 (513)
T KOG2052|consen 300 LNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDI 375 (513)
T ss_pred Hhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccC
Confidence 954 458899999999999999999995 4667899999999999999999999999999987654432 22
Q ss_pred ccceeecccCccCchhhccCc----c--cccccchhhhHHHHHHHhCC----------cCCCccccccccchhHHHHHhh
Q 021771 148 NTNRIVGTYGYMAPEYAMEGL----F--SVKSDVFSFGVLLLEIISGK----------KNTGFYLSELGQSLLSYTWKLW 211 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~~~----~--~~~~Di~slG~~l~~l~~~~----------~p~~~~~~~~~~~~~~~~~~~~ 211 (308)
..+..+||.+|||||++.... + -..+||||+|.|+||++-.. +||-..-+... ..+.-.+..
T Consensus 376 ~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP--s~eeMrkVV 453 (513)
T KOG2052|consen 376 PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP--SFEEMRKVV 453 (513)
T ss_pred CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC--CHHHHhcce
Confidence 244568999999999886431 1 24599999999999997532 34321111110 000011111
Q ss_pred hccccccccccccc-ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 212 CEGEALELMEPVLK-QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 212 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
+ .+.+.+.+. .=...+....+.+|++.||..||..|-|+--|...|....
T Consensus 454 C----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 454 C----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred e----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 1 111222221 2234566778899999999999999999999998887764
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=219.94 Aligned_cols=258 Identities=21% Similarity=0.334 Sum_probs=183.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEe--------CCeEEEEEEecCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--------ENESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~ 69 (308)
||.||+++. ++|+.|++|++--.+ ..-.....+|+++|..++|+|++.+++.|.. ...+++||++|+.
T Consensus 30 fgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh- 108 (376)
T KOG0669|consen 30 FGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH- 108 (376)
T ss_pred HHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-
Confidence 688999995 678889998653322 2223455689999999999999999887753 2347999999954
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc--c
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--A 147 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--~ 147 (308)
+|.-++.+. ...++..++.+++.++.++|.|+|.+. |+|||+|+.|++|+.+|.+||+|||+++.+...... .
T Consensus 109 DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kp 183 (376)
T KOG0669|consen 109 DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKP 183 (376)
T ss_pred hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCC
Confidence 788877543 345899999999999999999999985 999999999999999999999999999876533222 2
Q ss_pred ccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH-----hhhccccccccc
Q 021771 148 NTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK-----LWCEGEALELME 221 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 221 (308)
.....+-|.+|++||.+.+ ..++++.|||+.||++.+|+++.+.+...........+..... .|.+-+-..+..
T Consensus 184 rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~ 263 (376)
T KOG0669|consen 184 RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQ 263 (376)
T ss_pred CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHH
Confidence 2223345889999998887 4799999999999999999999988765444432222222211 122111111111
Q ss_pred cc----ccccc---hHHHH------HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 222 PV----LKQSC---VAAEL------LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 222 ~~----~~~~~---~~~~~------~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.. +.... ..+-. ....+|+..+|..||.+|+++.++++---..
T Consensus 264 sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 264 SIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred hccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 11 10100 01111 1466778889999999999999998664433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-32 Score=246.51 Aligned_cols=233 Identities=27% Similarity=0.371 Sum_probs=177.7
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC-CC
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS-TR 80 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 80 (308)
.||.|.. +|+.||||++-.. ..+...+|+..|+.-+ ||||+++|+.=.+.+..|+..|.| ..+|++++... ..
T Consensus 525 ~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d 599 (903)
T KOG1027|consen 525 VVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLD 599 (903)
T ss_pred EEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccc
Confidence 5888887 7889999987432 3346679999999985 999999999999999999999999 55999999653 11
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC---CC--CeeeecccceeeeCCCCCcc-ccceeec
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH---EM--NPKISDFGMARIFGGNQSEA-NTNRIVG 154 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~---~~--~~kl~dfg~~~~~~~~~~~~-~~~~~~~ 154 (308)
.........+..+.|+++||++||+.+ |+||||||.||||+. ++ +++|+|||+++.+....... ......|
T Consensus 600 ~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sG 676 (903)
T KOG1027|consen 600 VEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSG 676 (903)
T ss_pred hhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCC
Confidence 111222456789999999999999987 999999999999976 33 58999999999987554432 2344578
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhC-CcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG-KKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||++.....+.++|||||||++|+.++| .+||+........-+ ........+.+ ....
T Consensus 677 t~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--------~~~~~L~~L~~------~~d~- 741 (903)
T KOG1027|consen 677 TSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--------TGNYTLVHLEP------LPDC- 741 (903)
T ss_pred cccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh--------cCccceeeecc------CchH-
Confidence 9999999999988888899999999999998887 799986544422111 11111111111 1111
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...+||.+|+..+|..||+|.+|+.
T Consensus 742 -eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 742 -EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 5778899999999999999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=234.59 Aligned_cols=192 Identities=21% Similarity=0.336 Sum_probs=162.2
Q ss_pred CCccEEee-eCCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.|.++. +.+...||+|.+.+.+ ......++.|-+||...++..||++|..|.+...+|+||+|++||++-.++.
T Consensus 642 FGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLI 721 (1034)
T KOG0608|consen 642 FGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI 721 (1034)
T ss_pred cceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHH
Confidence 78888887 4567788999887664 3445667889999999999999999999999999999999999999998885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeC---------CCCCcc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFG---------GNQSEA 147 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~---------~~~~~~ 147 (308)
.. .-+.+..++.++..+..|++++|..| ++||||||+|||||.+|.+||+|||+++-+. ......
T Consensus 722 rm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~R 795 (1034)
T KOG0608|consen 722 RM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHR 795 (1034)
T ss_pred Hh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccc
Confidence 43 34888999999999999999999999 9999999999999999999999999985431 000000
Q ss_pred -------------------------------ccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccc
Q 021771 148 -------------------------------NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYL 196 (308)
Q Consensus 148 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 196 (308)
.....+||..|+|||++....++..+|.||.|+|||+|+.|+.||-...
T Consensus 796 qDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 796 QDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred cccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCC
Confidence 0112478999999999999999999999999999999999999996544
Q ss_pred cc
Q 021771 197 SE 198 (308)
Q Consensus 197 ~~ 198 (308)
..
T Consensus 876 p~ 877 (1034)
T KOG0608|consen 876 PG 877 (1034)
T ss_pred CC
Confidence 44
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=244.32 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=193.8
Q ss_pred CCccEEeee-CCCC----EEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGK----EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|.+ .+|+ +||+|++... .++.-..+.+|+-+|..++|||++++++++.... ..||++|++.|+|.++
T Consensus 709 fGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDy 787 (1177)
T KOG1025|consen 709 FGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDY 787 (1177)
T ss_pred ceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHH
Confidence 899999995 4555 4588877544 4555678999999999999999999999998765 7889999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
++.. +..+..+..+.|.+||++|+.|||.+. ++||||-..|+||..-..+|+.|||++..+.....+.......-
T Consensus 788 vr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~ 862 (1177)
T KOG1025|consen 788 VREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKV 862 (1177)
T ss_pred HHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccccccccccc
Confidence 9764 345888999999999999999999996 99999999999999999999999999998765544444433444
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.+.|+|-|.+....++.++||||+||++||++| |..|+.....+. +.++++.-.+-..+....
T Consensus 863 pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~geRLsqPpiCt 926 (1177)
T KOG1025|consen 863 PIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGERLSQPPICT 926 (1177)
T ss_pred CcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhccccCCCCCCcc
Confidence 567899998889999999999999999999986 667765443332 222222222233344455
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.++..++.+||..|++.||+++++...+...
T Consensus 927 iDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 927 IDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred HHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 5677778889999999999999999876443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=208.08 Aligned_cols=205 Identities=33% Similarity=0.550 Sum_probs=175.7
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++.. +|+.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++|++++++|.+++...
T Consensus 6 ~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~ 85 (215)
T cd00180 6 FGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN 85 (215)
T ss_pred ceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhc
Confidence 5889999974 4999999998755432 3567899999999999999999999999988999999999989999998543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-CCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ..++...+..++.+++.++.+||+.| ++|+||+|.||+++. ++.++|+||+.+........ ......+...
T Consensus 86 ~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~ 158 (215)
T cd00180 86 E--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPA 158 (215)
T ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCC
Confidence 2 35888999999999999999999998 999999999999999 89999999999987643321 1222346778
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
|++||..... ..+.++|+|++|++++++ ..+
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------~~~ 190 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------PEL 190 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------HHH
Confidence 9999988776 788999999999999999 348
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+++..|++.+|++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 888899999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=208.69 Aligned_cols=243 Identities=19% Similarity=0.305 Sum_probs=178.2
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCC--eEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEEN--ESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~ 76 (308)
|+.||.|. ..+.++++||+++.. ..+.+++|+.+|+.|. ||||++++++..+.. ...|++||+++.+...+-
T Consensus 51 YSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly- 126 (338)
T KOG0668|consen 51 YSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY- 126 (338)
T ss_pred HhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh-
Confidence 57788888 578999999998633 3367899999999997 999999999998754 468999999887776654
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
..++...+..++.++++||.|+|+.| |.|||+||.|+||+... .++|+|||+|.++.... ..+..+.+
T Consensus 127 -----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~---eYnVRVAS 195 (338)
T KOG0668|consen 127 -----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVAS 195 (338)
T ss_pred -----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCc---eeeeeeeh
Confidence 23788899999999999999999999 99999999999999654 59999999999876443 33344667
Q ss_pred cCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH--------Hhhh------cccccccc
Q 021771 156 YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW--------KLWC------EGEALELM 220 (308)
Q Consensus 156 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~--------~~~~------~~~~~~~~ 220 (308)
..|..||++.. ..++.+-|+|||||++..|++.+.||-.......+.+ .... .... ......++
T Consensus 196 RyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV-kIakVLGt~el~~Yl~KY~i~Ldp~~~~i~ 274 (338)
T KOG0668|consen 196 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV-KIAKVLGTDELYAYLNKYQIDLDPQFEDIL 274 (338)
T ss_pred hhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH-HHHHHhChHHHHHHHHHHccCCChhHhhHh
Confidence 88999998876 4688999999999999999999999744333322111 1100 0000 00000000
Q ss_pred cc--------cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 221 EP--------VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 221 ~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. .+..+...-...+.++|+...|..|.++|+|++|...
T Consensus 275 ~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 275 GRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00 0001100111235778888999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=239.90 Aligned_cols=249 Identities=16% Similarity=0.166 Sum_probs=152.9
Q ss_pred CCccEEeee-CC----CCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeee------EEeCCeEEEEEEecCCC
Q 021771 1 MESCLQGKL-AD----GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGC------CLEENESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~----g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~------~~~~~~~~lv~e~~~~~ 69 (308)
||.||+|+. .+ +..||+|++...... +....+ .+....+.++..++.. ...+...++||||+.++
T Consensus 145 FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~g 220 (566)
T PLN03225 145 FGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGES 220 (566)
T ss_pred CeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCC
Confidence 899999996 45 799999987543221 111111 1222222222222222 23455789999999999
Q ss_pred ChhhHhhcCCC-----------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-CCCeee
Q 021771 70 SLDVFLFDSTR-----------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMNPKI 131 (308)
Q Consensus 70 ~L~~~l~~~~~-----------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-~~~~kl 131 (308)
+|.+++..... ........+..++.||+.+|+|||+++ |+||||||+|||++. ++.+||
T Consensus 221 sL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~~~~~~KL 297 (566)
T PLN03225 221 TLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKI 297 (566)
T ss_pred cHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeCCCCcEEE
Confidence 99998864321 011123446689999999999999997 999999999999986 578999
Q ss_pred ecccceeeeCCCCCccccceeecccCccCchhhccC----------------------cccccccchhhhHHHHHHHhCC
Q 021771 132 SDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG----------------------LFSVKSDVFSFGVLLLEIISGK 189 (308)
Q Consensus 132 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Di~slG~~l~~l~~~~ 189 (308)
+|||++..+...... ......+++.|+|||.+... .++.++||||+||++|+|+++.
T Consensus 298 ~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~ 376 (566)
T PLN03225 298 IDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPN 376 (566)
T ss_pred EeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCc
Confidence 999999765322211 12234678899999965321 2344679999999999999877
Q ss_pred cCCCccccccccchhHHHHHhhhccccccccccccccc------chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 190 KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS------CVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 190 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+++.........+... ......+........... ..........+|+.+||+.||++|||++++++-
T Consensus 377 ~~~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 377 LRSDSNLIQFNRQLKRN---DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred CCCchHHHHHHHHHHhc---CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence 66432211100000000 000000000011100000 000111234579999999999999999999973
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=222.57 Aligned_cols=260 Identities=22% Similarity=0.257 Sum_probs=196.4
Q ss_pred CCccEEeeeC-CCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.|.++..+ +.+.||||++++. ..++.+.-..|..+|... +-|.+++++.+|+..+.+|+||||+.||+|--.+
T Consensus 362 FGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhi 441 (683)
T KOG0696|consen 362 FGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHI 441 (683)
T ss_pred cceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHH
Confidence 7899999854 6888999998765 344555566777777776 4788999999999999999999999999998887
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.+. ..+.+..+..++..|+-+|-+||++| |+.||||.+|||++.+|.+||+|||++..--. ....+..+.||
T Consensus 442 QQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~--~~~TTkTFCGT 513 (683)
T KOG0696|consen 442 QQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF--DGVTTKTFCGT 513 (683)
T ss_pred HHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc--CCcceeeecCC
Confidence 543 34888899999999999999999999 99999999999999999999999999875221 12334457899
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+.|+|||++...+|..++|.||+|+++|+|+.|++||+..+.+.... ..... +-.++.....+
T Consensus 514 PdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~-------aI~eh----------nvsyPKslSkE 576 (683)
T KOG0696|consen 514 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-------AIMEH----------NVSYPKSLSKE 576 (683)
T ss_pred CcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHHHc----------cCcCcccccHH
Confidence 99999999999999999999999999999999999998665442111 11111 11223334445
Q ss_pred HHHHHhhcccCCCCCCCCH----H-HHHH-----Hh---hcCCCCCCCCCCCCcccCccCCCC
Q 021771 236 FIHIGLLCVQADSADRPTM----S-SVVV-----ML---ASDTVTLPQPTEPAFSVGRNVARP 285 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~----~-eil~-----~L---~~~~~~~~~~~~p~~~~~~~~~~~ 285 (308)
..+++...|..+|.+|... + +|-+ .+ .-+...+.||-.|...-+++.++=
T Consensus 577 Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNF 639 (683)
T KOG0696|consen 577 AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENF 639 (683)
T ss_pred HHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhh
Confidence 7777778889999999532 2 2211 11 112245677777877655555443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=200.94 Aligned_cols=192 Identities=26% Similarity=0.360 Sum_probs=156.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.|-+-++ .+|+..|+|++... .....+++..|+++..+. .+|++|.+|+...+....++.||.| ..+|+.+-..
T Consensus 59 yG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~ 137 (282)
T KOG0984|consen 59 YGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRK 137 (282)
T ss_pred cchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHH
Confidence 455555554 68999999999755 455667788888876665 6999999999999999999999999 4588776544
Q ss_pred C-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 78 S-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 78 ~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. .++..+++..+-+++..++.||.|||++- +++|||+||+|||++..|++|+||||.+..+.+... .+...|-.
T Consensus 138 v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---kt~daGCk 212 (282)
T KOG0984|consen 138 VLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA---KTMDAGCK 212 (282)
T ss_pred HHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH---HHHhcCCC
Confidence 2 45677999999999999999999999985 899999999999999999999999999987643322 22234667
Q ss_pred CccCchhhcc----CcccccccchhhhHHHHHHHhCCcCCCccccc
Q 021771 157 GYMAPEYAME----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSE 198 (308)
Q Consensus 157 ~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~ 198 (308)
.|+|||.+.. ..|+-++||||||+.+.||.+++.|++.+..+
T Consensus 213 pYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 213 PYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred ccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCH
Confidence 8999998763 46899999999999999999999998765433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-31 Score=217.10 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=184.1
Q ss_pred CCccEEee-eCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-----eEEEEEEecCCCChh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-----ESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~ 72 (308)
||.||..+ -++|+.|++|++.... --..+.+.+|+++|.-++|.|++..+++..-.+ .+|+++|.+ ..+|+
T Consensus 66 FGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLH 144 (449)
T KOG0664|consen 66 FGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLH 144 (449)
T ss_pred eeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-Hhhhh
Confidence 79999988 4799999999986542 234578889999999999999999988776443 246777887 45888
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
..+ ..-..++...+.-+++||+++|.|||+.+ |.||||||.|.+++.|..+||||||+++......... .+.-
T Consensus 145 KII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-MTqE 217 (449)
T KOG0664|consen 145 KII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-MTHE 217 (449)
T ss_pred hee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhhhhh-hHHH
Confidence 877 34456888999999999999999999997 9999999999999999999999999998754332211 1122
Q ss_pred ecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHH--------HHHhhhcccccccccc-
Q 021771 153 VGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY--------TWKLWCEGEALELMEP- 222 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~- 222 (308)
+-|..|+|||++++. .|+.+.||||.||++.+|+..+..|..........++.- .-+..+++....++..
T Consensus 218 VVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~ 297 (449)
T KOG0664|consen 218 VVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAG 297 (449)
T ss_pred HHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccC
Confidence 347789999999984 699999999999999999999888765444322111110 0011111111111111
Q ss_pred --------cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 223 --------VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 223 --------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
+..-......-..-..+++.++..+|++|.+.++.+..+-
T Consensus 298 ~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 298 LRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred CCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111122233345666777899999999999999987663
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=225.14 Aligned_cols=188 Identities=25% Similarity=0.314 Sum_probs=156.7
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC------CcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ------HKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+|..|. .+-|..||||+|.... --.+.=..|+++|++|. --++++++..|...+++|||+|-+ ..+|.+
T Consensus 445 Fs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRe 522 (752)
T KOG0670|consen 445 FSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLRE 522 (752)
T ss_pred eeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHH
Confidence 78888888 4568899999996442 22233457999999995 247999999999999999999988 669999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC-eeeecccceeeeCCCCCcccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN-PKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
++........+....+..++.|+.-||..|...| ++|.||||+||||++..+ +||||||.|...+.+.. +.+
T Consensus 523 vLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPY 595 (752)
T KOG0670|consen 523 VLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENEI----TPY 595 (752)
T ss_pred HHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccccccccccc----cHH
Confidence 9988877777999999999999999999999997 999999999999997754 89999999987643321 112
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcccc
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLS 197 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~ 197 (308)
.-+..|.|||++.|-.|+...|+||.||+||+|.+|+..|.....
T Consensus 596 LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 596 LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 335679999999999999999999999999999999988865433
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=216.77 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=187.9
Q ss_pred CCccEEeee------CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-eEEEEEEecCCCChh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-ESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~ 72 (308)
||.||.|.+ .+.+.+.+|.++.. +.-....+..|--.|..+.|||+..+.++..++. ..++++.++..|+|.
T Consensus 297 FGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK 376 (563)
T KOG1024|consen 297 FGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLK 376 (563)
T ss_pred hhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHH
Confidence 899999944 45566677766433 4445677888999999999999999999987654 568888999999999
Q ss_pred hHhhcC-----CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc
Q 021771 73 VFLFDS-----TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA 147 (308)
Q Consensus 73 ~~l~~~-----~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~ 147 (308)
.++..+ .....++......++.|++.|++|||+.| ++|.||...|.+|++..++||+|=.+++-+-..++..
T Consensus 377 ~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhc 453 (563)
T KOG1024|consen 377 SFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHC 453 (563)
T ss_pred HHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccccCcccccc
Confidence 999733 23345777788999999999999999998 9999999999999999999999998887654444433
Q ss_pred ccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccc
Q 021771 148 NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
-...-.....||+||.+.+..++.++|+||||+++|||++ |+.|+..-++..-. ..+....+-
T Consensus 454 LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----------------~ylkdGyRl 517 (563)
T KOG1024|consen 454 LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----------------HYLKDGYRL 517 (563)
T ss_pred cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----------------HHHhcccee
Confidence 3333345678999999999999999999999999999997 66776543333211 111111112
Q ss_pred cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 227 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
..+.+++.+|..++.-||...|++||+++++..-|.+
T Consensus 518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 2344455568888889999999999999999988764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=223.62 Aligned_cols=246 Identities=17% Similarity=0.197 Sum_probs=161.0
Q ss_pred CCccEEeee-----------------CCCCEEEEEEeccCCcccHHHH--------------HHHHHHHhcCCCcCc---
Q 021771 1 MESCLQGKL-----------------ADGKEIAVKRLSRTSGQGLQEF--------------KNEVTLIAKLQHKNL--- 46 (308)
Q Consensus 1 ~g~v~~~~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~e~~~l~~l~h~~i--- 46 (308)
||+||+|.. .+++.||||++........+.+ ..|+..+.+++|.++
T Consensus 158 FG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~ 237 (507)
T PLN03224 158 FGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAA 237 (507)
T ss_pred CeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhh
Confidence 899999863 3467899999864432222222 336666677765543
Q ss_pred --cceeeeEEe--------CCeEEEEEEecCCCChhhHhhcCCC---------------------ccccChHHHHHHHHH
Q 021771 47 --VRLFGCCLE--------ENESLLIYEYMPNKSLDVFLFDSTR---------------------SVQLDWKRRISIING 95 (308)
Q Consensus 47 --~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~~~~~q 95 (308)
++++++|.. ....+|||||+++++|.++++.... ...+++..+..++.|
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q 317 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ 317 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence 566666653 3457999999999999998864211 112456778899999
Q ss_pred HHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccCc-------
Q 021771 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL------- 168 (308)
Q Consensus 96 i~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------- 168 (308)
++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++......... ......+++.|+|||.+....
T Consensus 318 l~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~~~~~~~~~~~ 393 (507)
T PLN03224 318 VLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELVMPQSCPRAPA 393 (507)
T ss_pred HHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhhcCCCCCCccch
Confidence 999999999997 999999999999999999999999998765322111 111123468899999875321
Q ss_pred ---------------ccccccchhhhHHHHHHHhCCc-CCCccccccc-----cchhHHHHHhhhccccccccccccccc
Q 021771 169 ---------------FSVKSDVFSFGVLLLEIISGKK-NTGFYLSELG-----QSLLSYTWKLWCEGEALELMEPVLKQS 227 (308)
Q Consensus 169 ---------------~~~~~Di~slG~~l~~l~~~~~-p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
...+.||||+||++++|+++.. |+........ ..... .++....... +- .
T Consensus 394 ~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~-~~r~~~~~~~----~~----~ 464 (507)
T PLN03224 394 PAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN-RWRMYKGQKY----DF----S 464 (507)
T ss_pred hhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH-HHHhhcccCC----Cc----c
Confidence 1234799999999999999875 5532111100 00000 0011111000 00 0
Q ss_pred chHHHHHHHHHHHhhcccCCC---CCCCCHHHHHH
Q 021771 228 CVAAELLKFIHIGLLCVQADS---ADRPTMSSVVV 259 (308)
Q Consensus 228 ~~~~~~~~l~~li~~cl~~~p---~~RPs~~eil~ 259 (308)
..........+|+.+||..+| .+|+|++|+|+
T Consensus 465 ~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 465 LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111223457788888998765 78999999985
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=206.88 Aligned_cols=260 Identities=22% Similarity=0.292 Sum_probs=192.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
|..|..+++ ++.+-||+|++++. +.++.+-++.|..+..+. +||.+|-++.+|..+..+++|.||.+||+|--.+
T Consensus 263 yakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhm 342 (593)
T KOG0695|consen 263 YAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 342 (593)
T ss_pred hhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeeh
Confidence 345666664 57888999998754 345556677888888877 5999999999999999999999999999997766
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..++++.+..+...|+-||.|||+.| |+.||+|.+|++++..|.+||+|+|..+.-. .....+..+.||
T Consensus 343 qrq---rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l--~~gd~tstfcgt 414 (593)
T KOG0695|consen 343 QRQ---RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--GPGDTTSTFCGT 414 (593)
T ss_pred hhh---hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC--CCCcccccccCC
Confidence 433 34999999999999999999999999 9999999999999999999999999987632 222334557899
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcccccc-ccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSEL-GQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
+.|+|||++.+..|....|.|+||+++|+|+.|+.||+..-... ..+...+..+..-+.++.- +.....
T Consensus 415 pnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri----------prslsv 484 (593)
T KOG0695|consen 415 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI----------PRSLSV 484 (593)
T ss_pred CcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc----------cceeeh
Confidence 99999999999999999999999999999999999998754442 2222223333222222111 111111
Q ss_pred HHHHHHhhcccCCCCCCCC------HHHHH----------HHhhcCCCCCCCCCCCCcccCc
Q 021771 235 KFIHIGLLCVQADSADRPT------MSSVV----------VMLASDTVTLPQPTEPAFSVGR 280 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs------~~eil----------~~L~~~~~~~~~~~~p~~~~~~ 280 (308)
+...++...|.+||.+|.. ++++. ++|++ +...||-.|++....
T Consensus 485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq--k~v~ppf~p~i~~d~ 544 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ--KQVLPPFQPQITDDY 544 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh--cccCCCCCCcccccc
Confidence 2334455678899998853 33333 22332 445667777775444
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=210.60 Aligned_cols=118 Identities=23% Similarity=0.318 Sum_probs=96.2
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-----C---cCccceeeeEEe----CCeEEEEEEecC
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-----H---KNLVRLFGCCLE----ENESLLIYEYMP 67 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~i~~~~~~~~~----~~~~~lv~e~~~ 67 (308)
|+|||++- ..+.+.||+|+.+... .-.+....|+.+|++++ | ..||++++.|.. +.++|||+|++
T Consensus 91 FSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL- 168 (590)
T KOG1290|consen 91 FSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL- 168 (590)
T ss_pred cceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-
Confidence 89999998 4678899999885432 23355678999999984 2 359999999974 56899999999
Q ss_pred CCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe
Q 021771 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123 (308)
Q Consensus 68 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv 123 (308)
|.+|-.+|.... ...++...+..|++||+.||.|||..+ .|+|.||||+|||+
T Consensus 169 GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 169 GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 667777775542 234888999999999999999999987 79999999999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=207.46 Aligned_cols=238 Identities=25% Similarity=0.271 Sum_probs=173.3
Q ss_pred CCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------eEEEEEEecCCCChhhHhhcCCCcc
Q 021771 11 DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ESLLIYEYMPNKSLDVFLFDSTRSV 82 (308)
Q Consensus 11 ~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~ 82 (308)
.+.+|++|+.... +.........|+.++..+.|+||++++.+|.-.. ..++|||++.. +|...+. .
T Consensus 40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~-----~ 113 (369)
T KOG0665|consen 40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL-----M 113 (369)
T ss_pred ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH-----H
Confidence 5778888876432 2223356678999999999999999999988543 46999999954 7877774 2
Q ss_pred ccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCch
Q 021771 83 QLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE 162 (308)
Q Consensus 83 ~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 162 (308)
.++-+++..+++|++.|++|||+.| |+||||||+||++..+..+|+.|||++..-+.. ...+..+.+..|.|||
T Consensus 114 elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrape 187 (369)
T KOG0665|consen 114 ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPE 187 (369)
T ss_pred hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCch
Confidence 3777899999999999999999998 999999999999999999999999999875433 2233456688899999
Q ss_pred hhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhH---------------HHHHhhhc-------ccccccc
Q 021771 163 YAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLS---------------YTWKLWCE-------GEALELM 220 (308)
Q Consensus 163 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~---------------~~~~~~~~-------~~~~~~~ 220 (308)
++.+-.+...+||||+||++.+|+.|...|...+....-...- .....+.. -...+.+
T Consensus 188 vil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~f 267 (369)
T KOG0665|consen 188 VILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELF 267 (369)
T ss_pred heeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhC
Confidence 9998889999999999999999999998876443332111100 00000000 0000000
Q ss_pred cccc-c--ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 221 EPVL-K--QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 221 ~~~~-~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.... . .....-....+.+|+.+||..||++|.|++++|+-
T Consensus 268 pD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 268 PDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 0 01112334557788899999999999999999964
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-30 Score=227.98 Aligned_cols=238 Identities=22% Similarity=0.313 Sum_probs=187.9
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++ ..+|+..|+|+++-.-.++..-++.|+-+++..+|+||+.+++.+.....++++||||.+|+|.+.-+
T Consensus 28 ygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~--- 104 (829)
T KOG0576|consen 28 YGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH--- 104 (829)
T ss_pred ccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee---
Confidence 79999999 57999999999987777778888999999999999999999999999999999999999999998653
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
....+++.++....+..+++++|||++| =+|||||-.||++++.|.+||.|||.+..++... .....+.|++.||
T Consensus 105 ~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati--~KrksfiGtpywm 179 (829)
T KOG0576|consen 105 VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIGTPYWM 179 (829)
T ss_pred ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh--hhhhcccCCcccc
Confidence 3456999999999999999999999998 7999999999999999999999999987765332 2344578999999
Q ss_pred Cchhhc---cCcccccccchhhhHHHHHHHhCCcC-CCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 160 APEYAM---EGLFSVKSDVFSFGVLLLEIISGKKN-TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 160 aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
|||+.. .+.|..++|||++|+..-++-..++| |+--.+.... -.. .... ++. ..+.......-
T Consensus 180 apEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-------LmT--kS~~---qpp-~lkDk~kws~~ 246 (829)
T KOG0576|consen 180 APEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-------LMT--KSGF---QPP-TLKDKTKWSEF 246 (829)
T ss_pred chhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-------Hhh--ccCC---CCC-cccCCccchHH
Confidence 999764 46789999999999999999888777 3211111100 000 0000 000 00112223334
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
|-+|++.|+..+|++|||++.+|+
T Consensus 247 fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhhee
Confidence 667778899999999999998775
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=196.08 Aligned_cols=188 Identities=29% Similarity=0.427 Sum_probs=160.7
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||++... +++.+++|.+...... ..+.+.+|+..++.++|+|++++++++......++++|++++++|.+++...
T Consensus 12 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~ 91 (225)
T smart00221 12 FGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKK 91 (225)
T ss_pred CeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhc
Confidence 6889999975 4899999999766554 6678899999999999999999999999988999999999999999988543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
.. .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+......... ......+...|
T Consensus 92 ~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~ 165 (225)
T smart00221 92 GG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFY 165 (225)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCc
Confidence 22 1788899999999999999999998 999999999999999999999999999876543211 22234567789
Q ss_pred cCchhh-ccCcccccccchhhhHHHHHHHhCCcCCCc
Q 021771 159 MAPEYA-MEGLFSVKSDVFSFGVLLLEIISGKKNTGF 194 (308)
Q Consensus 159 ~aPE~~-~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 194 (308)
++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus 166 ~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 166 LAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999988 566777899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=238.67 Aligned_cols=197 Identities=17% Similarity=0.196 Sum_probs=136.6
Q ss_pred hcCCC-cCccceeeeEE-------eCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCc
Q 021771 39 AKLQH-KNLVRLFGCCL-------EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 110 (308)
Q Consensus 39 ~~l~h-~~i~~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~ 110 (308)
+.++| .||..++++|. ....+++++|++ +++|.+++... ...+++..++.++.||++||+|||++|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 44556 57888888772 233567778987 66999998543 345899999999999999999999998
Q ss_pred eeecCCCCCceEeCCCC-------------------CeeeecccceeeeCCCCC--------------ccccceeecccC
Q 021771 111 IIHRDLKASNVLLNHEM-------------------NPKISDFGMARIFGGNQS--------------EANTNRIVGTYG 157 (308)
Q Consensus 111 i~H~di~p~nilv~~~~-------------------~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~ 157 (308)
|+||||||+|||++..+ .+|++|||+++....... ........+++.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 455666666543211000 000111346788
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||++.+..++.++|||||||++|+|+++.+|+...... . ...... .+.+ ..........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-----~----~~~~~~----~~~~-----~~~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-----M----SSLRHR----VLPP-----QILLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-----H----HHHHHh----hcCh-----hhhhcCHHHH
Confidence 99999999888999999999999999999988775421100 0 000000 0000 0011123356
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+++.+||+.+|.+|||+.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7788999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=191.61 Aligned_cols=263 Identities=17% Similarity=0.253 Sum_probs=179.7
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeee-EEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGC-CLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.+-+++++ +.+.+|+|.+.... .....|.+|+.-=-.|. |.||+..|++ |+..+.+++++||++.|+|...+-.
T Consensus 37 FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~ 115 (378)
T KOG1345|consen 37 FGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA 115 (378)
T ss_pred eeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc
Confidence 7888888864 78889999885443 23467888888777775 8999998876 6777788899999999999887633
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC--CCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN--HEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
..+.+.....++.|+++|+.|+|++. +||||||.+||||- +..++||||||.....+.... .....
T Consensus 116 ----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~-----~~~~~ 183 (378)
T KOG1345|consen 116 ----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK-----YLEYV 183 (378)
T ss_pred ----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCceeh-----hhhhh
Confidence 34778888999999999999999995 99999999999995 345799999999876442221 12235
Q ss_pred cCccCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 156 YGYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 156 ~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
..|.+||...- ....+.+|+|.+|+++|..++|++||......+. .- +.+..|.....+...+. ..
T Consensus 184 ~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y--~~~~~w~~rk~~~~P~~------F~ 254 (378)
T KOG1345|consen 184 NNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PY--WEWEQWLKRKNPALPKK------FN 254 (378)
T ss_pred cccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hH--HHHHHHhcccCccCchh------hc
Confidence 56889996542 2356789999999999999999999973332222 11 12222333322222111 22
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh--cCCCCCCCCCCCCcccCccCCCC
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVVMLA--SDTVTLPQPTEPAFSVGRNVARP 285 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~--~~~~~~~~~~~p~~~~~~~~~~~ 285 (308)
.....++.+.++-|..++++|=-..+...+.. .....+.+...|.....++...+
T Consensus 255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~tn~d~~ 311 (378)
T KOG1345|consen 255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYTNIDTA 311 (378)
T ss_pred ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhccccccCCc
Confidence 22334777778889999999944444443321 11234455555554444444443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-28 Score=212.02 Aligned_cols=182 Identities=23% Similarity=0.347 Sum_probs=153.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--------cccHHHHHHHHHHHhcCC---CcCccceeeeEEeCCeEEEEEEec-C
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--------GQGLQEFKNEVTLIAKLQ---HKNLVRLFGCCLEENESLLIYEYM-P 67 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~-~ 67 (308)
||.|+.+.+ ++...|+||.+.+.. ....-.+-.|+.+|..++ |+||++++++|+++++++|+||.- +
T Consensus 574 yGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~ 653 (772)
T KOG1152|consen 574 YGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGE 653 (772)
T ss_pred cceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCC
Confidence 799999996 468888999875431 111123457999999997 999999999999999999999974 5
Q ss_pred CCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc
Q 021771 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA 147 (308)
Q Consensus 68 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~ 147 (308)
+.+|.+++. -...+++.++..++.|++-++++||++| |+|||||-+|+.++.+|-+||+|||.+....+.+
T Consensus 654 gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsaa~~ksgp--- 724 (772)
T KOG1152|consen 654 GIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP--- 724 (772)
T ss_pred Ccchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccchhhhcCCC---
Confidence 678889883 4456999999999999999999999998 9999999999999999999999999987654333
Q ss_pred ccceeecccCccCchhhccCcc-cccccchhhhHHHHHHHhCCcCC
Q 021771 148 NTNRIVGTYGYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNT 192 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~ 192 (308)
...+.||..|.|||++.+..| ...-|||+||+++|-++...+||
T Consensus 725 -fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 725 -FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred -cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 334689999999999988765 46689999999999999988886
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=183.72 Aligned_cols=166 Identities=19% Similarity=0.150 Sum_probs=121.8
Q ss_pred CChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc
Q 021771 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 69 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
|+|.+++... +..+++..++.++.|++.||+|||+++ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 5788888543 335999999999999999999999873 999999999999999 99988754321
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
..++..|+|||++.+..++.++||||+||++|+|++|..||....... ............. ... ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~------~~~-~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD------DPR-DRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC------Ccc-cccc
Confidence 146889999999999899999999999999999999999985432211 0111110000000 000 0001
Q ss_pred hHHHH--HHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 229 VAAEL--LKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 229 ~~~~~--~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
..... ..+.+++.+||+.+|++|||+.++++.+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 11112 258999999999999999999999988754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=194.62 Aligned_cols=249 Identities=22% Similarity=0.338 Sum_probs=180.2
Q ss_pred CCccEEeee-C---CCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-A---DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
|++||++.. . ..+.||+|.+.... ....+.+|+++|..+. +.||+++.+++..++..++|+||++.....++.
T Consensus 49 Fssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~ 126 (418)
T KOG1167|consen 49 FSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLY 126 (418)
T ss_pred hhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHH
Confidence 789999984 3 58899999886553 3356899999999996 899999999999999999999999998888877
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-CCCeeeecccceeeeCCC-------C---
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMNPKISDFGMARIFGGN-------Q--- 144 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-~~~~kl~dfg~~~~~~~~-------~--- 144 (308)
.. ++...+..+++.++.||+++|.+| |+||||||+||+.+. .++-.|+|||++...... .
T Consensus 127 ~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~ 197 (418)
T KOG1167|consen 127 RS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSG 197 (418)
T ss_pred hc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhc
Confidence 32 667899999999999999999999 999999999999985 456899999998621000 0
Q ss_pred ---Cc-----------------------------cccceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcC
Q 021771 145 ---SE-----------------------------ANTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKN 191 (308)
Q Consensus 145 ---~~-----------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p 191 (308)
.. .......||+.|+|||++... ..+.+.||||.|+++..++++..|
T Consensus 198 ~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~P 277 (418)
T KOG1167|consen 198 RHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYP 277 (418)
T ss_pred ccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccc
Confidence 00 001123689999999988764 568899999999999999999999
Q ss_pred CCccccccccchhHHH--------------HH--hhhcccccc----------c-cccccc-------c-cchHHHHHHH
Q 021771 192 TGFYLSELGQSLLSYT--------------WK--LWCEGEALE----------L-MEPVLK-------Q-SCVAAELLKF 236 (308)
Q Consensus 192 ~~~~~~~~~~~~~~~~--------------~~--~~~~~~~~~----------~-~~~~~~-------~-~~~~~~~~~l 236 (308)
|-....+......... .. .|....+.. + .....+ . .........+
T Consensus 278 Ff~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~ 357 (418)
T KOG1167|consen 278 FFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALL 357 (418)
T ss_pred cccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHH
Confidence 8554443211110000 00 000010000 0 000000 0 1111123368
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
++|+.+|+..||.+|.|+++.|.-
T Consensus 358 ~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 358 LDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred HHHHHHHccCChhhcccHHHHhcC
Confidence 899999999999999999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-23 Score=181.88 Aligned_cols=249 Identities=19% Similarity=0.189 Sum_probs=180.8
Q ss_pred CCccEEeeeCCC--CEEEEEEeccCCcccHHHHHHHHHHHhcCC----CcCccceeeeE-EeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLADG--KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ----HKNLVRLFGCC-LEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~~g--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||.+...+. +.+|+|............+..|..++..+. ..++..+++.. ......++||+.+ |.+|.+
T Consensus 31 fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~d 109 (322)
T KOG1164|consen 31 FGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLED 109 (322)
T ss_pred CceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHH
Confidence 899999996443 578888765543333237888999999886 36899999998 4777789999988 889999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC-----CCeeeeccccee--eeCCCCC-
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-----MNPKISDFGMAR--IFGGNQS- 145 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~-----~~~kl~dfg~~~--~~~~~~~- 145 (308)
+..... ...++..++..++.|++.+|+++|+.| ++||||||.|+++... ..+.|.|||+++ .+.....
T Consensus 110 l~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~ 185 (322)
T KOG1164|consen 110 LRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGG 185 (322)
T ss_pred HHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCc
Confidence 875544 456999999999999999999999999 9999999999999865 358999999998 4322211
Q ss_pred ----ccc-cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccc
Q 021771 146 ----EAN-TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELM 220 (308)
Q Consensus 146 ----~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (308)
... .....||.+|+++....+...+.+.|+||++.++.+++.|..||.................. ...
T Consensus 186 ~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~-------~~~ 258 (322)
T KOG1164|consen 186 NLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK-------LLT 258 (322)
T ss_pred ccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh-------hcc
Confidence 111 23356999999999999999999999999999999999999998554433221111100000 000
Q ss_pred cccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCC
Q 021771 221 EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTV 266 (308)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~ 266 (308)
.. ..........++. ..+-..+..++|.+..+...|.....
T Consensus 259 ~~--~~~~~~~~~~~~~---~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 259 DR--FGDLKPEEFAKIL---EYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred cc--ccCCChHHHHHHH---HHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 00 1122333333444 34445789999999999988765533
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=166.96 Aligned_cols=251 Identities=18% Similarity=0.208 Sum_probs=189.0
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.+|.|. ..+|+.||||+-..... ..++..|..+.+.|+ ...|..+..+..+..+-.+||+.+ |.+|+++.+-+
T Consensus 28 FGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC 104 (341)
T KOG1163|consen 28 FGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFC 104 (341)
T ss_pred hhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHH
Confidence 89999999 58999999997543322 246778999999997 578888888888888889999998 88999998776
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC---CCCeeeecccceeeeCCCCCc-----cccc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH---EMNPKISDFGMARIFGGNQSE-----ANTN 150 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~---~~~~kl~dfg~~~~~~~~~~~-----~~~~ 150 (308)
.. .++.++++.++-||+.-++|+|..+ ++||||||+|+|..- ...+.|+|||+++.+.+.... ....
T Consensus 105 ~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r 179 (341)
T KOG1163|consen 105 SR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDR 179 (341)
T ss_pred hh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCC
Confidence 55 4899999999999999999999998 999999999999964 346899999999887543221 1233
Q ss_pred eeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 151 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
...||.+|++-....+...+.+.|+-|+|.++.++--|..||............+ ...+.+..-.++.+... +
T Consensus 180 ~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE----kI~EkK~s~~ie~LC~G-~-- 252 (341)
T KOG1163|consen 180 NLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE----KISEKKMSTPIEVLCKG-F-- 252 (341)
T ss_pred ccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH----HHHHhhcCCCHHHHhCC-C--
Confidence 4578999999988888888899999999999999999999997654443222211 12222222222222221 2
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
+.++.-.+..|-...-++-|...-+.+........+
T Consensus 253 --P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 253 --PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred --cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 223555566788888889999988887765544443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-24 Score=200.18 Aligned_cols=214 Identities=22% Similarity=0.247 Sum_probs=163.3
Q ss_pred HHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCc
Q 021771 31 FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 110 (308)
Q Consensus 31 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~ 110 (308)
+..|+.+=..+.|+|++.....+.+.....-+||||++ +|..++... ..+...++..++.|++.+++|+|+.|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G--- 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG--- 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---
Confidence 44566666778899998888877776666566999999 999888432 35888999999999999999999999
Q ss_pred eeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc--cccceeecccCccCchhhccCcccc-cccchhhhHHHHHHHh
Q 021771 111 IIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--ANTNRIVGTYGYMAPEYAMEGLFSV-KSDVFSFGVLLLEIIS 187 (308)
Q Consensus 111 i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~ 187 (308)
+.|+|+|++|++++.+|.+|++|||.+..+...... .......|+..|+|||.+.+..|.+ ..||||.|+++..|.+
T Consensus 441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~ 520 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL 520 (601)
T ss_pred ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence 999999999999999999999999999887654443 3445578899999999999888765 4899999999999999
Q ss_pred CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 188 GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 188 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
|+.||........+... ....... . ...-..............++.+||+++|.+|.|+++|++
T Consensus 521 ~~~~Wk~a~~~~~~~~~-----~~~~~~~-~--~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 521 GRFPWKVAKKSDNSFKT-----NNYSDQR-N--IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred CCCccccccccccchhh-----hcccccc-c--cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 99999766555443200 0000000 0 000011122233445677888999999999999999985
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-24 Score=200.03 Aligned_cols=238 Identities=18% Similarity=0.215 Sum_probs=168.8
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcc-cHHHHHHHHHH--HhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQ-GLQEFKNEVTL--IAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
.|.+++..+|. |+||++-+.++. ....++++++- ...+++||.+.+..+...+...|||-+|.. .+|.+.+ .
T Consensus 38 Kv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRl---S 112 (1431)
T KOG1240|consen 38 KVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRL---S 112 (1431)
T ss_pred hhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhh---c
Confidence 45667777886 999998665432 33444443333 445589999999998888888899999984 4888888 3
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceee-eCCCCCccccceeecc---
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI-FGGNQSEANTNRIVGT--- 155 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~-~~~~~~~~~~~~~~~~--- 155 (308)
.+..+...+...|+.|++.||..+|..| |+|||||.+||||+.-..+.|+||...+. +-..+.......+..|
T Consensus 113 TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrR 189 (1431)
T KOG1240|consen 113 TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRR 189 (1431)
T ss_pred cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCc
Confidence 4556888889999999999999999998 99999999999999999999999987753 2223333334334333
Q ss_pred -cCccCchhhccC-----------cccccccchhhhHHHHHHHhC-CcCCCccccccccchhHHHHHhhhcccccccccc
Q 021771 156 -YGYMAPEYAMEG-----------LFSVKSDVFSFGVLLLEIISG-KKNTGFYLSELGQSLLSYTWKLWCEGEALELMEP 222 (308)
Q Consensus 156 -~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (308)
-.|+|||.+... ..+++-||||+||+++||++- .++|....--. ++.-........++.
T Consensus 190 RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a--------Yr~~~~~~~e~~Le~ 261 (1431)
T KOG1240|consen 190 RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA--------YRSGNADDPEQLLEK 261 (1431)
T ss_pred eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh--------HhccCccCHHHHHHh
Confidence 369999976531 156789999999999999875 66675321111 000000011111111
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.- ...+..|+..|++.||++|.|+++.|+.-.+.
T Consensus 262 Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 262 IE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred Cc--------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11 11478899999999999999999999986655
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=169.42 Aligned_cols=251 Identities=18% Similarity=0.213 Sum_probs=186.2
Q ss_pred CCccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.++.|+ +-+++.||||.-... +..-++..|+...+.|. .++|...|-+-..+.+-.||+|.+ |.+|+++..-+
T Consensus 41 FG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~C 117 (449)
T KOG1165|consen 41 FGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLC 117 (449)
T ss_pred ceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHh
Confidence 89999999 579999999965444 33467889999999995 799999998888888889999998 88999987554
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC-----eeeecccceeeeCCCCCcc-----c
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN-----PKISDFGMARIFGGNQSEA-----N 148 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~-----~kl~dfg~~~~~~~~~~~~-----~ 148 (308)
. ..++.+++..++.||+.-++++|++. ++.|||||+|+||...++ +.++|||+++.+.+..... .
T Consensus 118 g--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE 192 (449)
T KOG1165|consen 118 G--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYRE 192 (449)
T ss_pred c--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccc
Confidence 4 35999999999999999999999996 999999999999975443 8899999999876443322 2
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
.+...||.+||+-....+...+.+.|+-|||-|+++.+-|..||............+..........+.++.+ +
T Consensus 193 ~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~----g-- 266 (449)
T KOG1165|consen 193 HKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCE----G-- 266 (449)
T ss_pred ccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHh----c--
Confidence 3456799999999999999999999999999999999999999976554433222221111111111111111 1
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
.+.+ +..-++..-..+-.+-|.++-+...+......+
T Consensus 267 ~P~e---fa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 267 FPEE---FATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred CHHH---HHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 2233 333333444557778888887776665444333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-23 Score=168.44 Aligned_cols=235 Identities=22% Similarity=0.349 Sum_probs=172.8
Q ss_pred CccEEeeeCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
|..|+|++ .|..+++|++.... ......|.+|.-.|+.+.||||+.+++.|....++.++..||+.++|..+++...
T Consensus 204 gelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t 282 (448)
T KOG0195|consen 204 GELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQT 282 (448)
T ss_pred cccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCc
Confidence 67889988 56688889886542 3333568899999999999999999999999999999999999999999997753
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeee--cccceeeeCCCCCccccceeecccC
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS--DFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
....+..++.+++.+|+++++|||+.. .-|.---+...+++|+++.+.+|. |-.++.. .......+.
T Consensus 283 -~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pa 351 (448)
T KOG0195|consen 283 -SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPA 351 (448)
T ss_pred -cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee---------ccccccCcc
Confidence 345777889999999999999999985 223334588999999998776553 4332211 222234678
Q ss_pred ccCchhhccCc---ccccccchhhhHHHHHHHhCCcCCCccccc-cccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 158 YMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNTGFYLSE-LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 158 y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
|++||.+...+ .-.++|+||+++++|+|.+...||.....- .+..+. .+-+...+... .+.
T Consensus 352 wmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------leglrv~ippg-is~-- 416 (448)
T KOG0195|consen 352 WMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------LEGLRVHIPPG-ISR-- 416 (448)
T ss_pred cCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------------hccccccCCCC-ccH--
Confidence 99999887654 335799999999999999999999654332 221110 11111111111 122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+.+|+.-|+..||.+||.+..|+-+|+..
T Consensus 417 -hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 417 -HMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred -HHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 355555569999999999999999988753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=172.40 Aligned_cols=150 Identities=18% Similarity=0.212 Sum_probs=113.1
Q ss_pred CCccEEeeeC--CCCEEEEEEeccC-----CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA--DGKEIAVKRLSRT-----SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+|... +|+.+|||++... .......+.+|+.+|+.++|+|++..+.. ....++||||+++++|..
T Consensus 31 fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~ 107 (365)
T PRK09188 31 FSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHL 107 (365)
T ss_pred cEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHH
Confidence 8999999864 6888899986432 12235678999999999999999853322 245799999999999963
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCC-CCCceEeCCCCCeeeecccceeeeCCCCCccc----
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL-KASNVLLNHEMNPKISDFGMARIFGGNQSEAN---- 148 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di-~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~---- 148 (308)
.. . .. ...++.|++++|.|||++| |+|||| ||+||+++.++.++|+|||++..+........
T Consensus 108 ~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~ 174 (365)
T PRK09188 108 AR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAY 174 (365)
T ss_pred hC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhh
Confidence 21 1 11 1467889999999999998 999999 99999999999999999999997653321111
Q ss_pred --cceeecccCccCchhhcc
Q 021771 149 --TNRIVGTYGYMAPEYAME 166 (308)
Q Consensus 149 --~~~~~~~~~y~aPE~~~~ 166 (308)
-....++..|.|||.+..
T Consensus 175 ~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 175 EDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhccCccCCcccCCh
Confidence 123456778999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-20 Score=163.43 Aligned_cols=251 Identities=28% Similarity=0.355 Sum_probs=184.3
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCc-CccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQ---GLQEFKNEVTLIAKLQHK-NLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||.+... +.+++|.+...... ....+..|..++..+.|+ +|+++++.+......+++++++.++++.+++.
T Consensus 13 ~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 90 (384)
T COG0515 13 FGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK 90 (384)
T ss_pred CeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHH
Confidence 5778888865 78899988765322 367888999999999988 79999999977777899999999999996664
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCcc----ccce
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSEA----NTNR 151 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~~----~~~~ 151 (308)
.......+.......++.|++.++.++|+.| ++|+|+||+||+++..+ .++++|||.+..+....... ....
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 167 (384)
T COG0515 91 KIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167 (384)
T ss_pred hcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccc
Confidence 3221125888999999999999999999998 99999999999999998 69999999998655433221 2345
Q ss_pred eecccCccCchhhcc---CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 152 IVGTYGYMAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
..++..|++||.+.+ .......|+|++|+++++++.+..||...... ................ ..........
T Consensus 168 ~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~ 243 (384)
T COG0515 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-SLASPLSPSN 243 (384)
T ss_pred cccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-ccccccCccc
Confidence 678999999999887 57888999999999999999999996544431 0001111111111100 0000000000
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.......+.+++..|+..+|..|.+..+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 244 PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 02223457778888999999999999887764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=159.20 Aligned_cols=221 Identities=18% Similarity=0.211 Sum_probs=141.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCC----------CcCccceeeeEEe---------C-
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQ----------HKNLVRLFGCCLE---------E- 56 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~----------h~~i~~~~~~~~~---------~- 56 (308)
||.||.++. .+|+.+++|++... .....+.+++|.-....+. |-+++..++...- .
T Consensus 25 ~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~ 104 (288)
T PF14531_consen 25 FSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGP 104 (288)
T ss_dssp TEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECE
T ss_pred ceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCC
Confidence 578899985 67999999987433 2334567777765555542 2244444444331 1
Q ss_pred --C-----eEEEEEEecCCCChhhHhhc---C-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC
Q 021771 57 --N-----ESLLIYEYMPNKSLDVFLFD---S-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125 (308)
Q Consensus 57 --~-----~~~lv~e~~~~~~L~~~l~~---~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~ 125 (308)
. +.+++|+-+ .++|.+++.. . .....+.......+..|+++.+++||+.| ++|+||+|+|++++.
T Consensus 105 ~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~ 180 (288)
T PF14531_consen 105 GQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQ 180 (288)
T ss_dssp TTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-T
T ss_pred CCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcC
Confidence 1 236778877 5588777542 1 11223445556778899999999999999 999999999999999
Q ss_pred CCCeeeecccceeeeCCCCCccccceeecccCccCchhhcc--------CcccccccchhhhHHHHHHHhCCcCCCcccc
Q 021771 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME--------GLFSVKSDVFSFGVLLLEIISGKKNTGFYLS 197 (308)
Q Consensus 126 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~ 197 (308)
+|.++|+||+.....+..... ...+..|.|||.... -.++.+.|.|+||+++|.|+++..||+....
T Consensus 181 ~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~ 255 (288)
T PF14531_consen 181 DGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP 255 (288)
T ss_dssp TS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred CCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence 999999999988775422111 123467999997643 2468889999999999999999999976544
Q ss_pred ccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCC
Q 021771 198 ELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADR 251 (308)
Q Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 251 (308)
...... .-..+. +..+.+.+||..+|+.||.+|
T Consensus 256 ~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 256 EADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 432111 112344 666779999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=158.46 Aligned_cols=156 Identities=14% Similarity=0.195 Sum_probs=118.3
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHH---------HHHHHHHHhcCCCcCccceeeeEEeC--------CeEEEEE
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQE---------FKNEVTLIAKLQHKNLVRLFGCCLEE--------NESLLIY 63 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~ 63 (308)
||.||+... ++..+|+|++....+..... +..|+..+.++.|++|..+.+++... +..+++|
T Consensus 44 f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvm 122 (232)
T PRK10359 44 DTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLI 122 (232)
T ss_pred ceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEE
Confidence 788998766 57789999997554332222 67899999999999999999886643 3478999
Q ss_pred EecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCC
Q 021771 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGN 143 (308)
Q Consensus 64 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~ 143 (308)
||++|.+|.++.. +++ ..+.+++.++..+|..| ++|||+||+||+++.+| ++|+|||........
T Consensus 123 Eyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~ 187 (232)
T PRK10359 123 EYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQR 187 (232)
T ss_pred EEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccch
Confidence 9999999977631 222 24568999999999998 99999999999999988 999999987653211
Q ss_pred CCccccceeecccCccCchhhccCcccccccchhhhHHHHHHH
Q 021771 144 QSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186 (308)
Q Consensus 144 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 186 (308)
... ..++....+..++|+|+||+.+..+.
T Consensus 188 ~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 188 KAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred hhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 100 01334445567899999999877665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-21 Score=153.10 Aligned_cols=131 Identities=15% Similarity=0.150 Sum_probs=101.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcc--c------------------------HHHHHHHHHHHhcCCCcCccceeeeEE
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQ--G------------------------LQEFKNEVTLIAKLQHKNLVRLFGCCL 54 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 54 (308)
||.||.|...+|+.||||+++..... . ......|+.++..+.++++.....+..
T Consensus 10 ~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~ 89 (190)
T cd05147 10 EANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILL 89 (190)
T ss_pred ceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEe
Confidence 68999999779999999998654211 1 012245999999998877754443322
Q ss_pred eCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhc-hhCCCCceeecCCCCCceEeCCCCCeeeec
Q 021771 55 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYL-HEDSRLKIIHRDLKASNVLLNHEMNPKISD 133 (308)
Q Consensus 55 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~l-H~~g~~~i~H~di~p~nilv~~~~~~kl~d 133 (308)
. ..++||||++++++..... ....++...+..++.|++.+|.++ |+.| ++|+||||+||+++ ++.++|+|
T Consensus 90 ~--~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v~LiD 160 (190)
T cd05147 90 K--SHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKLYIID 160 (190)
T ss_pred c--CCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcEEEEE
Confidence 2 2389999998877655432 223588899999999999999999 6887 99999999999998 47899999
Q ss_pred ccceeee
Q 021771 134 FGMARIF 140 (308)
Q Consensus 134 fg~~~~~ 140 (308)
||++...
T Consensus 161 FG~a~~~ 167 (190)
T cd05147 161 VSQSVEH 167 (190)
T ss_pred ccccccC
Confidence 9998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=169.09 Aligned_cols=218 Identities=22% Similarity=0.346 Sum_probs=162.5
Q ss_pred HhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCC
Q 021771 38 IAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117 (308)
Q Consensus 38 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~ 117 (308)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+.. ....+++.-...++++++.+++|+|... -.+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 4678899999999999999999999999999999999966 3445888899999999999999999985 22999999
Q ss_pred CCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccC-------cccccccchhhhHHHHHHHhCCc
Q 021771 118 ASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG-------LFSVKSDVFSFGVLLLEIISGKK 190 (308)
Q Consensus 118 p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~l~~~~~ 190 (308)
..|.+++..-.+||+|||+.....................|.|||++.+. ..+.++||||+|++++++++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765321111111112234679999988763 14677999999999999999999
Q ss_pred CCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 191 NTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 191 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
||+........ .+....... .....+.+.+.... .....+..++..||..+|++||+++.|-..++...
T Consensus 157 ~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99765444332 222222211 11122222221111 22225888899999999999999999998887653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-20 Score=175.03 Aligned_cols=182 Identities=18% Similarity=0.155 Sum_probs=144.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCccc---HHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||.|+..+|+.+|+|+-+...+.+ ..+++..++ -.--+-|..+...+...+..+||+||.+.|+|.++++
T Consensus 711 y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N- 786 (974)
T KOG1166|consen 711 YGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN- 786 (974)
T ss_pred ceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc-
Confidence 799999998889999999876554442 233333332 1113456666666677778899999999999999996
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC-------CCCCeeeecccceeeeCCCCCccccc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-------HEMNPKISDFGMARIFGGNQSEANTN 150 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~-------~~~~~kl~dfg~~~~~~~~~~~~~~~ 150 (308)
....+++..++.+++||+..++.||..+ |+||||||+|+|+. +.-.++|+|||.+--+..-.......
T Consensus 787 --~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~ 861 (974)
T KOG1166|consen 787 --TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFK 861 (974)
T ss_pred --cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEe
Confidence 3445999999999999999999999998 99999999999994 22349999999987654333333444
Q ss_pred eeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcC
Q 021771 151 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN 191 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 191 (308)
..+++-.+-.+|+..|..+++++|.|.|+.+++-|++|+..
T Consensus 862 ~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 862 AVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 56788899999999999999999999999999999999744
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.5e-20 Score=147.76 Aligned_cols=132 Identities=17% Similarity=0.249 Sum_probs=103.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcc--c------------------------HHHHHHHHHHHhcCCCcCccceeeeEE
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQ--G------------------------LQEFKNEVTLIAKLQHKNLVRLFGCCL 54 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 54 (308)
||.||+|+..+|+.||||++...... . ......|+..+.++.++++.....+..
T Consensus 10 ~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 89 (190)
T cd05145 10 EANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILL 89 (190)
T ss_pred CcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEe
Confidence 68999999779999999998754211 0 122457899999999998755554443
Q ss_pred eCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeec
Q 021771 55 EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISD 133 (308)
Q Consensus 55 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~d 133 (308)
.. .+|||||++++++..... ....++...+..++.|++.++.++|+ .| ++|+||||+||+++ ++.++|+|
T Consensus 90 ~~--~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~~~liD 160 (190)
T cd05145 90 KK--NVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGKPYIID 160 (190)
T ss_pred cC--CEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCCEEEEE
Confidence 32 489999998875543321 12347788899999999999999999 88 99999999999999 78999999
Q ss_pred ccceeeeC
Q 021771 134 FGMARIFG 141 (308)
Q Consensus 134 fg~~~~~~ 141 (308)
||++....
T Consensus 161 FG~a~~~~ 168 (190)
T cd05145 161 VSQAVELD 168 (190)
T ss_pred cccceecC
Confidence 99998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=154.30 Aligned_cols=198 Identities=20% Similarity=0.246 Sum_probs=137.8
Q ss_pred CCcCccceeeeEEe---------------------------CCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHH
Q 021771 42 QHKNLVRLFGCCLE---------------------------ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIIN 94 (308)
Q Consensus 42 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 94 (308)
+||||+++..+|.+ +..+|+||..++. +|..++... ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 59999999988774 2457999988844 888888443 356677788999
Q ss_pred HHHHHHHhchhCCCCceeecCCCCCceEeCCCC----CeeeecccceeeeCC----CCCccccceeecccCccCchhhcc
Q 021771 95 GIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM----NPKISDFGMARIFGG----NQSEANTNRIVGTYGYMAPEYAME 166 (308)
Q Consensus 95 qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~----~~kl~dfg~~~~~~~----~~~~~~~~~~~~~~~y~aPE~~~~ 166 (308)
|+++++.|||++| +.|||+|.+||++.-+. .+.++|||++---.. -++........|+-..||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999995332 378999998754322 122333334567788999998764
Q ss_pred Cc------ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHH
Q 021771 167 GL------FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG 240 (308)
Q Consensus 167 ~~------~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (308)
.+ .-.++|.|+.|.+.||+++...||=. ..+...... .+.+.+.+.+ +......+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGem~L~~r-----~Yqe~qLPal---------p~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGEMLLDTR-----TYQESQLPAL---------PSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cchheechh-----hhhhhhCCCC---------cccCChHHHHHH
Confidence 22 22589999999999999999999732 111111100 0111122111 122223477788
Q ss_pred hhcccCCCCCCCCHHHHHHHhh
Q 021771 241 LLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 241 ~~cl~~~p~~RPs~~eil~~L~ 262 (308)
...|+.||++|+++.-..+.|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 8899999999999876666654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=140.47 Aligned_cols=174 Identities=16% Similarity=0.124 Sum_probs=126.3
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCc----ccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSG----QGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||.+.- .+.+++.+.+..... -....+.+|+++|+++. +++|++++++ +..+++|||+.|.+|....
T Consensus 15 f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~ 89 (218)
T PRK12274 15 FGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRP 89 (218)
T ss_pred cceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhh
Confidence 899996655 788888887754422 11235789999999996 5889999886 3469999999998886543
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCC-CCCceEeCCCCCeeeecccceeeeCCCCCc----c---
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL-KASNVLLNHEMNPKISDFGMARIFGGNQSE----A--- 147 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di-~p~nilv~~~~~~kl~dfg~~~~~~~~~~~----~--- 147 (308)
. . ....++.|++.+|.++|++| |+|+|| ||.||+++.++.++|+|||++......... .
T Consensus 90 ~---~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rD 156 (218)
T PRK12274 90 P---R-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARED 156 (218)
T ss_pred h---h-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHH
Confidence 1 1 11347789999999999998 999999 799999999999999999999865433210 0
Q ss_pred c----cceeecccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCC
Q 021771 148 N----TNRIVGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNT 192 (308)
Q Consensus 148 ~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~ 192 (308)
. ......++.+++|+-..- ..--...+.++.|+.+|.++|++.++
T Consensus 157 l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 157 LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 0 001123556666663221 12225678899999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-19 Score=162.57 Aligned_cols=227 Identities=22% Similarity=0.215 Sum_probs=172.0
Q ss_pred CCccEEee----eCCCCEEEEEEeccCCcc--cHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGK----LADGKEIAVKRLSRTSGQ--GLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~----~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.|++.+ ...|+.+++|+..+.... .......|-.++...+ ||.++++...++.+...++++++..++.+..
T Consensus 7 ~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft 86 (612)
T KOG0603|consen 7 YGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFT 86 (612)
T ss_pred CcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhh
Confidence 45555443 235888899988655311 2225556788888887 9999999999999999999999999999988
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
.+. +...+.+.....+...++-+++++|+.| ++++|+|++||+++.+|.+++.|||+++..-... ..+
T Consensus 87 ~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~c 154 (612)
T KOG0603|consen 87 RLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IAC 154 (612)
T ss_pred ccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh------hcc
Confidence 774 3344777888889999999999999998 9999999999999999999999999987642111 117
Q ss_pred cccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
|+..|||||++. .....+|.||+|+++|+|++|..||... ....+. . ..-..+....
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----------~~~~Il---------~--~~~~~p~~l~ 211 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----------TMKRIL---------K--AELEMPRELS 211 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----------HHHHHh---------h--hccCCchhhh
Confidence 899999999987 4567899999999999999999998640 000110 0 0112234445
Q ss_pred HHHHHHHhhcccCCCCCCCCH--HHHHHHhh
Q 021771 234 LKFIHIGLLCVQADSADRPTM--SSVVVMLA 262 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~--~eil~~L~ 262 (308)
....+++..++..+|.+|.-. ..+.+.++
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 567778888999999999755 45555543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-19 Score=158.04 Aligned_cols=124 Identities=27% Similarity=0.446 Sum_probs=108.4
Q ss_pred eEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 58 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 58 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
++++.|++|...+|.+++.........+......++.|++.++.| +| .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468899999999999999766556668888899999999999999 66 999999999999999999999999999
Q ss_pred eeeCCCC----CccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh
Q 021771 138 RIFGGNQ----SEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187 (308)
Q Consensus 138 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 187 (308)
....... .........|+..||+||.+.+..|+.++|||+||+++++|+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8765333 2223445689999999999999999999999999999999997
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=136.29 Aligned_cols=126 Identities=19% Similarity=0.326 Sum_probs=96.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-----CCcCccceeeeEEeCC---e-EEEEEEe--cCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-----QHKNLVRLFGCCLEEN---E-SLLIYEY--MPNK 69 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~---~-~~lv~e~--~~~~ 69 (308)
||.||. ...++.. +||++..........+.+|+.+++.+ .||||+++++++.++. . +.+|+|| +.++
T Consensus 15 ~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~ 92 (210)
T PRK10345 15 HRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSI 92 (210)
T ss_pred ceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcch
Confidence 678885 3335555 69988655444567789999999999 5799999999999874 3 2378999 5579
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHH-HhchhCCCCceeecCCCCCceEeCCC----CCeeeecccce
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGL-LYLHEDSRLKIIHRDLKASNVLLNHE----MNPKISDFGMA 137 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l-~~lH~~g~~~i~H~di~p~nilv~~~----~~~kl~dfg~~ 137 (308)
+|.+++... .+++. ..++.|++.++ +|||+++ |+|+||||+||+++.. +.++|+|++.+
T Consensus 93 tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 93 TLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred hHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999999442 25544 35678888777 9999998 9999999999999743 37999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.7e-17 Score=136.04 Aligned_cols=130 Identities=16% Similarity=0.198 Sum_probs=98.8
Q ss_pred CCccEEee--eCCCCEEEEEEeccCCcc------------------------cHHHHHHHHHHHhcCCCcC--ccceeee
Q 021771 1 MESCLQGK--LADGKEIAVKRLSRTSGQ------------------------GLQEFKNEVTLIAKLQHKN--LVRLFGC 52 (308)
Q Consensus 1 ~g~v~~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~--i~~~~~~ 52 (308)
||.||.|. ..+|+.||+|++...... ....+..|+.+++++.+.. ++++++
T Consensus 41 ~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~- 119 (237)
T smart00090 41 EANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIA- 119 (237)
T ss_pred ceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeE-
Confidence 68999998 578999999988643210 0123568999999997532 334443
Q ss_pred EEeCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeee
Q 021771 53 CLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132 (308)
Q Consensus 53 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~ 132 (308)
.. ..++||||+++.++...... ...+....+..++.|++.++.+||+.| .++|+||||+||+++ ++.++|+
T Consensus 120 --~~-~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIli~-~~~i~Li 190 (237)
T smart00090 120 --WR-RNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNILVH-DGKVVII 190 (237)
T ss_pred --ec-CceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEEEE-CCCEEEE
Confidence 22 34899999999887665422 223566677899999999999999985 599999999999999 7889999
Q ss_pred cccceeee
Q 021771 133 DFGMARIF 140 (308)
Q Consensus 133 dfg~~~~~ 140 (308)
|||.+...
T Consensus 191 DFg~a~~~ 198 (237)
T smart00090 191 DVSQSVEL 198 (237)
T ss_pred EChhhhcc
Confidence 99998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.9e-17 Score=132.88 Aligned_cols=127 Identities=18% Similarity=0.278 Sum_probs=105.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcc--------cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQ--------GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||.|.. .|..+++|+....... ....+..|+.++..+.|++|.....++.+....+++|||++|++|.
T Consensus 9 ~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~ 87 (211)
T PRK14879 9 EAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLK 87 (211)
T ss_pred eEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHH
Confidence 588999987 7778999976543211 1235678999999999999888777777777889999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
+++... .. ....++.+++.+|.++|+.| ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 88 ~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 88 DLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred HHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 987432 11 77889999999999999998 99999999999999 78899999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=130.64 Aligned_cols=124 Identities=19% Similarity=0.322 Sum_probs=99.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC---cc-----cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS---GQ-----GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~---~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||++.+ +|..+++|+..... .. ....+..|+.++..++++++....-++......++||||++|++|.
T Consensus 7 ~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~ 85 (199)
T TIGR03724 7 EAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLK 85 (199)
T ss_pred eEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHH
Confidence 689999985 67899999864331 11 1245678999999999887666555566666779999999999998
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
+++.... . .++.+++.+|.+||+.| ++|+|++|+||+++ ++.++++|||++..
T Consensus 86 ~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 86 DVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred HHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 8773311 0 78899999999999998 99999999999999 78999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=6e-16 Score=126.36 Aligned_cols=125 Identities=16% Similarity=0.164 Sum_probs=97.0
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcc----------------------cHHHHHHHHHHHhcCCCcC--ccceeeeEEeC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQ----------------------GLQEFKNEVTLIAKLQHKN--LVRLFGCCLEE 56 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~ 56 (308)
||.||++...+|+.++||++...... .......|+.++..+.+++ ++..++ .
T Consensus 28 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~ 103 (198)
T cd05144 28 ESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----W 103 (198)
T ss_pred ceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----c
Confidence 68899999889999999987543211 1123567888898887764 444443 2
Q ss_pred CeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccc
Q 021771 57 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGM 136 (308)
Q Consensus 57 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~ 136 (308)
...++||||+++++|...... .....++.+++.++.++|+.| ++|+||+|+||+++.++.++|+|||.
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg~ 171 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWPQ 171 (198)
T ss_pred CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECCc
Confidence 345899999999988765310 235678899999999999998 99999999999999999999999999
Q ss_pred eeeeC
Q 021771 137 ARIFG 141 (308)
Q Consensus 137 ~~~~~ 141 (308)
+....
T Consensus 172 ~~~~~ 176 (198)
T cd05144 172 MVSTD 176 (198)
T ss_pred cccCC
Confidence 86643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=142.58 Aligned_cols=123 Identities=17% Similarity=0.289 Sum_probs=99.1
Q ss_pred CCccEEeeeCCCCEEEEEEe-ccC-Cc------ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLADGKEIAVKRL-SRT-SG------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~-~~~-~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||+||++.+.+. .+++|+. ... .. ...+.+.+|+.+++.++|++++..+.++.+....++||||+++++|.
T Consensus 346 ~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~ 424 (535)
T PRK09605 346 EADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLK 424 (535)
T ss_pred cEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHH
Confidence 689999987444 4444432 221 11 12356789999999999999988877777777789999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
+++. ....++.+++.+|.+||+.| ++||||||+||++ .++.++|+|||++..
T Consensus 425 ~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 425 DVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8873 34678999999999999998 9999999999999 677899999999865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-16 Score=149.01 Aligned_cols=139 Identities=23% Similarity=0.206 Sum_probs=102.1
Q ss_pred HHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC-------------ccccceeecccCccCchh
Q 021771 97 ARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS-------------EANTNRIVGTYGYMAPEY 163 (308)
Q Consensus 97 ~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~ 163 (308)
+.+++|||+.| |+|+|+||+|.+|+.-|.+|++|||++........ +...+..+|++.|+|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78999999998 99999999999999999999999999865432211 111234589999999999
Q ss_pred hccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhc
Q 021771 164 AMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLC 243 (308)
Q Consensus 164 ~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 243 (308)
+....|....|+|++|+++|+.+-|+.||.....+.....+-.... .+++- ......+..++|.+.
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i-----~wpE~---------dea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-----EWPEE---------DEALPPEAQDLIEQL 295 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-----ccccc---------CcCCCHHHHHHHHHH
Confidence 9988899999999999999999999999866543322111111111 11111 111223477777889
Q ss_pred ccCCCCCCC
Q 021771 244 VQADSADRP 252 (308)
Q Consensus 244 l~~~p~~RP 252 (308)
|+.+|.+|-
T Consensus 296 L~qnp~~Rl 304 (1205)
T KOG0606|consen 296 LRQNPLCRL 304 (1205)
T ss_pred HHhChHhhc
Confidence 999999995
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.2e-15 Score=123.49 Aligned_cols=126 Identities=19% Similarity=0.254 Sum_probs=96.4
Q ss_pred CccEEeeeCCCCEEEEEEeccCC-------------cccHHHHHHHHHHHhcCCCcCc--cceeeeEEeCCe----EEEE
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTS-------------GQGLQEFKNEVTLIAKLQHKNL--VRLFGCCLEENE----SLLI 62 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~----~~lv 62 (308)
|++|.... ++..++||.+.... ......+.+|+.++..++|++| +..+++...... .++|
T Consensus 46 gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV 124 (239)
T PRK01723 46 GTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADIL 124 (239)
T ss_pred ccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEE
Confidence 67888776 47789999885321 1233567889999999998775 667766443222 3599
Q ss_pred EEecCC-CChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 63 YEYMPN-KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 63 ~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
||++++ .+|.+++.. ..++.. .+.+++.++.+||+.| |+|+||||.|||++.++.++|+|||.+..
T Consensus 125 ~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 125 IERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred EEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999987 688888743 124443 3578999999999998 99999999999999989999999998866
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1e-14 Score=132.74 Aligned_cols=168 Identities=20% Similarity=0.284 Sum_probs=131.9
Q ss_pred eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCccccChHH
Q 021771 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKR 88 (308)
Q Consensus 9 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 88 (308)
..+|.++.|+.++.......+...+-++.|+.++||||+++++.+......|+|+|.+ ..|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 5689999999987766544566788899999999999999999999999999999987 357777743 33567
Q ss_pred HHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccCc
Q 021771 89 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL 168 (308)
Q Consensus 89 ~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 168 (308)
+...+.||+.||.|||..+ +++|++|.-..|+|+..|..||++|.++........ ..........|..|+......
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 7888999999999999877 799999999999999999999999998866432222 111122233566676432211
Q ss_pred ccccccchhhhHHHHHHHhCCc
Q 021771 169 FSVKSDVFSFGVLLLEIISGKK 190 (308)
Q Consensus 169 ~~~~~Di~slG~~l~~l~~~~~ 190 (308)
...|.|.|||++++++.|..
T Consensus 182 --~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred --cchhhhhHHHHHHHHhCccc
Confidence 34799999999999999943
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.4e-15 Score=118.42 Aligned_cols=128 Identities=18% Similarity=0.200 Sum_probs=90.9
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcc--cHHH----------------------HHHHHHHHhcCCCcC--ccceeeeEE
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQ--GLQE----------------------FKNEVTLIAKLQHKN--LVRLFGCCL 54 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~~--i~~~~~~~~ 54 (308)
||+||.+...+|+.||||++...... .... ...|...+..+.+.. +.+++++
T Consensus 10 ~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-- 87 (187)
T cd05119 10 EADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL-- 87 (187)
T ss_pred ceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec--
Confidence 78999999878999999988643211 1111 135666666665433 4444443
Q ss_pred eCCeEEEEEEecCCCChhhH-hhcCCCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeee
Q 021771 55 EENESLLIYEYMPNKSLDVF-LFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKIS 132 (308)
Q Consensus 55 ~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~ 132 (308)
...++||||++++.+... +.... .. ..+..++.+++.++.++|. .| ++|+||+|+||+++ ++.++|+
T Consensus 88 --~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~li 156 (187)
T cd05119 88 --NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYII 156 (187)
T ss_pred --CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEE
Confidence 235899999998543211 11100 11 5678899999999999999 87 99999999999999 8899999
Q ss_pred cccceeeeC
Q 021771 133 DFGMARIFG 141 (308)
Q Consensus 133 dfg~~~~~~ 141 (308)
|||.+....
T Consensus 157 Dfg~a~~~~ 165 (187)
T cd05119 157 DVPQAVEID 165 (187)
T ss_pred ECccccccc
Confidence 999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.2e-14 Score=111.33 Aligned_cols=126 Identities=19% Similarity=0.218 Sum_probs=103.0
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCC--cCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH--KNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
++.||+++..+ ..+++|....... ...+..|+..++.+++ .++++++.+....+..+++|||+++..+..+
T Consensus 11 ~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---- 83 (155)
T cd05120 11 TNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---- 83 (155)
T ss_pred ccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----
Confidence 47889988744 7899998855433 4678899999999976 5899999888887889999999988776543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
+......++.+++.+++.+|......++|+|++|+||+++..+.++++||+.+..
T Consensus 84 ------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 84 ------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 4456677889999999999985222399999999999999988999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.8e-16 Score=146.13 Aligned_cols=230 Identities=23% Similarity=0.289 Sum_probs=168.9
Q ss_pred CEEEEEEeccCC--cccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCccccChHHH
Q 021771 13 KEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR 89 (308)
Q Consensus 13 ~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 89 (308)
..+++|.+.... .........|..+-+.+. |.|++.+++...+.+..++++++..++++.+.+.. ......+...+
T Consensus 47 ~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~-~~~~~~~~~~~ 125 (601)
T KOG0590|consen 47 SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH-PDSTGTSSSSA 125 (601)
T ss_pred ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccccccccccc-CCccCCCCcch
Confidence 344555554332 233345556777777776 99999999999999999999999999999887731 11214666778
Q ss_pred HHHHHHHHHHHHhch-hCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCC-CCCccccceeec-ccCccCchhhc
Q 021771 90 ISIINGIARGLLYLH-EDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGG-NQSEANTNRIVG-TYGYMAPEYAM 165 (308)
Q Consensus 90 ~~~~~qi~~~l~~lH-~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~-~~~~~~~~~~~~-~~~y~aPE~~~ 165 (308)
-.++.|+..++.|+| ..+ +.|+||+|+|.+++..+ .+++.|||++..+.. ...........| +..|+|||...
T Consensus 126 ~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~ 202 (601)
T KOG0590|consen 126 SRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLS 202 (601)
T ss_pred hhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCccccc
Confidence 889999999999999 887 99999999999999999 999999999998765 444444455567 99999999888
Q ss_pred cC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcc
Q 021771 166 EG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCV 244 (308)
Q Consensus 166 ~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 244 (308)
+. ...+..|+||+|+++..++.|..|+........... .|...... ........ ......+++.+++
T Consensus 203 ~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~------~~~~~~~~--~~~~~~~~----~~~~~~~~l~k~l 270 (601)
T KOG0590|consen 203 GKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS------SWKSNKGR--FTQLPWNS----ISDQAHDLLHKIL 270 (601)
T ss_pred chhhcCCCcccccccccccccccCCCCccccccccccce------eecccccc--cccCcccc----CChhhhhcccccc
Confidence 74 556789999999999999999999877665542111 01111100 00000111 1123666777899
Q ss_pred cCCCCCCCCHHHHH
Q 021771 245 QADSADRPTMSSVV 258 (308)
Q Consensus 245 ~~~p~~RPs~~eil 258 (308)
..+|+.|.+.+++-
T Consensus 271 ~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 271 KENPSNRLSIEELK 284 (601)
T ss_pred cCCchhcccccccc
Confidence 89999999999876
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.7e-14 Score=120.87 Aligned_cols=205 Identities=22% Similarity=0.236 Sum_probs=139.2
Q ss_pred HHHHHHhcCCCcCccceeeeEEeCCe-----EEEEEEecCCCChhhHhhcCC-CccccChHHHHHHHHHHHHHHHhchhC
Q 021771 33 NEVTLIAKLQHKNLVRLFGCCLEENE-----SLLIYEYMPNKSLDVFLFDST-RSVQLDWKRRISIINGIARGLLYLHED 106 (308)
Q Consensus 33 ~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~ 106 (308)
.-+..|.++.|.||++++.++.+... ..++.||+..|++..+++... ....+..+.-.+|+.||+.||.|||+.
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 34556667789999999999887543 678899999999999997642 234577788889999999999999998
Q ss_pred CCCceeecCCCCCceEeCCCCCeeeecccceeeeCC---CCCccccceeecccCccCchhhccCcccccccchhhhHHHH
Q 021771 107 SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG---NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183 (308)
Q Consensus 107 g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 183 (308)
...|+|+++..+.|++..+|-+|++--... .... ...........+.+.|.+||.-.-...+..+|||++|++..
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 578999999999999999998887532111 1110 01111122234567889999755556677899999999999
Q ss_pred HHHhCCcCCCccccc-cccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 184 EIISGKKNTGFYLSE-LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 184 ~l~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+|.-+..--...... .... ....+...++..+. ..++..|++-.|..||++++++.
T Consensus 274 emailEiq~tnseS~~~~ee---------~ia~~i~~len~lq-----------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEE---------NIANVIIGLENGLQ-----------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHHheeccCCCcceeehhh---------hhhhheeeccCccc-----------cCcCcccccCCCCCCcchhhhhc
Confidence 998876431111111 0000 00111111111111 22445699999999999999873
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.7e-13 Score=123.22 Aligned_cols=131 Identities=21% Similarity=0.317 Sum_probs=88.6
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHH----------------------------------------HHHHHHHHHhc
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQ----------------------------------------EFKNEVTLIAK 40 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~----------------------------------------~~~~e~~~l~~ 40 (308)
+|.||+|++++|+.||||+.......... .+..|...+.+
T Consensus 130 igQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~ 209 (437)
T TIGR01982 130 IAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASE 209 (437)
T ss_pred hhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHH
Confidence 58899999999999999987543111000 12234444444
Q ss_pred CC-----CcC--ccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHH-HHHhchhCCCCcee
Q 021771 41 LQ-----HKN--LVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIAR-GLLYLHEDSRLKII 112 (308)
Q Consensus 41 l~-----h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~-~l~~lH~~g~~~i~ 112 (308)
+. +++ |.+++. ...+..+|||||++|.+|.++......+ . ....++.+++. .+..+|..| ++
T Consensus 210 ~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~g---~~ 279 (437)
T TIGR01982 210 LGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRDG---FF 279 (437)
T ss_pred HHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhCC---ce
Confidence 42 233 223332 2233468999999999998876432111 1 23445666665 468889998 99
Q ss_pred ecCCCCCceEeCCCCCeeeecccceeeeC
Q 021771 113 HRDLKASNVLLNHEMNPKISDFGMARIFG 141 (308)
Q Consensus 113 H~di~p~nilv~~~~~~kl~dfg~~~~~~ 141 (308)
|+|+||.||+++.+++++++|||++..+.
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.4e-13 Score=124.04 Aligned_cols=237 Identities=20% Similarity=0.205 Sum_probs=168.6
Q ss_pred CCccEEeee---CCCCEEEEEEec--cCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL---ADGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~---~~g~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
+|.+|.+.. .++..+++|+-+ ...+.....-.+|+..-..+. |.+.++.+..+...+..++-+|.|. .++..+
T Consensus 129 ~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~ 207 (524)
T KOG0601|consen 129 KGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSY 207 (524)
T ss_pred CceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHh
Confidence 467777775 478899999743 233444455566777777775 9999999999999999999999994 677776
Q ss_pred hhcCCCccccChHHHHHHHHHHHH----HHHhchhCCCCceeecCCCCCceEeCCC-CCeeeecccceeeeCCCCCcccc
Q 021771 75 LFDSTRSVQLDWKRRISIINGIAR----GLLYLHEDSRLKIIHRDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~----~l~~lH~~g~~~i~H~di~p~nilv~~~-~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
... ....++...++..+.+... |+.++|+.. ++|.|++|.||+...+ ...+++|||+...+.........
T Consensus 208 ~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~ 282 (524)
T KOG0601|consen 208 CHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVF 282 (524)
T ss_pred hhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcceeEEccCCccccce
Confidence 643 2334788888999999999 999999996 9999999999999999 78999999999988765433222
Q ss_pred ---ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccc
Q 021771 150 ---NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226 (308)
Q Consensus 150 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
....+...|++||.. ++.++..+|+|+||.++.+-..+.......... .+.++-.-.+..
T Consensus 283 ~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----------------~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 283 KVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS----------------SWSQLRQGYIPL 345 (524)
T ss_pred eeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC----------------CccccccccCch
Confidence 233677889999954 556788999999999988888776553221111 011111101111
Q ss_pred cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 227 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
++.......+...+.+|++.+|-.|++.+.+...
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1111122234446778999999999998887743
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.2e-12 Score=120.67 Aligned_cols=74 Identities=15% Similarity=0.205 Sum_probs=53.5
Q ss_pred eEEEEEEecCCCChhhHhhcCCCc---cccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC----Cee
Q 021771 58 ESLLIYEYMPNKSLDVFLFDSTRS---VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM----NPK 130 (308)
Q Consensus 58 ~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~----~~k 130 (308)
..+|||||++|+.+.++..-...+ ..+....+..++.|++ ..| ++|+|+||+||+++.++ +++
T Consensus 235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~G---ffHaDpHPGNIlv~~~g~~~~~i~ 304 (537)
T PRK04750 235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDG---FFHADMHPGNIFVSYDPPENPRYI 304 (537)
T ss_pred CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCC---eeeCCCChHHeEEecCCCCCCeEE
Confidence 457999999999997743211111 1244444444555553 466 99999999999999888 899
Q ss_pred eecccceeeeC
Q 021771 131 ISDFGMARIFG 141 (308)
Q Consensus 131 l~dfg~~~~~~ 141 (308)
++|||++..++
T Consensus 305 llDFGivg~l~ 315 (537)
T PRK04750 305 ALDFGIVGSLN 315 (537)
T ss_pred EEecceEEECC
Confidence 99999998874
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.8e-12 Score=101.08 Aligned_cols=123 Identities=20% Similarity=0.172 Sum_probs=88.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCc-cceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL-VRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
++.||..+. +|..+++|....... ....+..|+.+++.+.+.++ ++++.+.. ...++||||+++.++....
T Consensus 11 ~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~---- 82 (170)
T cd05151 11 TNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED---- 82 (170)
T ss_pred cCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc----
Confidence 367888876 477899998754322 22356789999999865444 45554433 3357999999998875420
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCC--CCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDS--RLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g--~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
. .....+.+++++++.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 83 ----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 83 ----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 1 11345678999999999986 11259999999999999 66899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.1e-11 Score=106.51 Aligned_cols=166 Identities=22% Similarity=0.371 Sum_probs=125.1
Q ss_pred ccEEee-eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe----CCeEEEEEEecCC-CChhhHhh
Q 021771 3 SCLQGK-LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE----ENESLLIYEYMPN-KSLDVFLF 76 (308)
Q Consensus 3 ~v~~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~l~ 76 (308)
+.|++. ..+|..|++|+++............-++.++++.|.|||++.++|.. +..+++|++|.++ ++|.++-.
T Consensus 291 Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F 370 (655)
T KOG3741|consen 291 TTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYF 370 (655)
T ss_pred eeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHc
Confidence 567777 46999999999954433322334456789999999999999999873 3468999999875 45544432
Q ss_pred cCC------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCC
Q 021771 77 DST------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQ 144 (308)
Q Consensus 77 ~~~------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~ 144 (308)
... ++..+++..+|.++.|+..||.++|+.| +..+-+.+.+|+++.+-+++|...|.........
T Consensus 371 ~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 371 ANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred cCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 221 2345788999999999999999999998 8889999999999999999999888877654332
Q ss_pred CccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCc
Q 021771 145 SEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 190 (308)
Q Consensus 145 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 190 (308)
. +| +.. ..+.|.=.||.+++.|.+|..
T Consensus 448 ~--------------~~--le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 448 T--------------EP--LES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred C--------------cc--hhH---HhhhhHHHHHHHHHHHhhccc
Confidence 0 11 111 246788899999999999853
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.8e-11 Score=95.55 Aligned_cols=127 Identities=14% Similarity=0.125 Sum_probs=89.7
Q ss_pred CccEEeeeC-------CCCEEEEEEeccC-------------C---------cccHHHHH----HHHHHHhcCC--CcCc
Q 021771 2 ESCLQGKLA-------DGKEIAVKRLSRT-------------S---------GQGLQEFK----NEVTLIAKLQ--HKNL 46 (308)
Q Consensus 2 g~v~~~~~~-------~g~~vavK~~~~~-------------~---------~~~~~~~~----~e~~~l~~l~--h~~i 46 (308)
+.||.|.-. ++..+|||++... + ......+. +|+..|+++. .-++
T Consensus 11 a~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl~~~Gv~v 90 (197)
T cd05146 11 SVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRMQKAGIPC 90 (197)
T ss_pred eEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 467888643 2579999976432 0 01123344 7999999996 3566
Q ss_pred cceeeeEEeCCeEEEEEEecCCCChhh-HhhcCCCccccChHHHHHHHHHHHHHHHhc-hhCCCCceeecCCCCCceEeC
Q 021771 47 VRLFGCCLEENESLLIYEYMPNKSLDV-FLFDSTRSVQLDWKRRISIINGIARGLLYL-HEDSRLKIIHRDLKASNVLLN 124 (308)
Q Consensus 47 ~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~qi~~~l~~l-H~~g~~~i~H~di~p~nilv~ 124 (308)
++++++ ..-++||||+.+..+.. .+. ...++......++.+++.++..+ |..| ++|||+++.||++.
T Consensus 91 P~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~ 159 (197)
T cd05146 91 PEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH 159 (197)
T ss_pred CeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE
Confidence 777764 34589999997653321 221 12245556778889999999998 8887 99999999999997
Q ss_pred CCCCeeeecccceeee
Q 021771 125 HEMNPKISDFGMARIF 140 (308)
Q Consensus 125 ~~~~~kl~dfg~~~~~ 140 (308)
++.++|+|||-+-..
T Consensus 160 -~~~v~iIDF~qav~~ 174 (197)
T cd05146 160 -DGKVWFIDVSQSVEP 174 (197)
T ss_pred -CCcEEEEECCCceeC
Confidence 467999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-10 Score=90.86 Aligned_cols=122 Identities=20% Similarity=0.329 Sum_probs=90.7
Q ss_pred ccEEeeeCCCCEEEEEE-eccC--Ccc-----cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 3 SCLQGKLADGKEIAVKR-LSRT--SGQ-----GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~-~~~~--~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
.+|.+.+. |..+++|. +++. .+. ....-.+|+.++..++--.|.-.+=++.+.....++|||++|..|.+.
T Consensus 11 ~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~ 89 (204)
T COG3642 11 IIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDA 89 (204)
T ss_pred eEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHH
Confidence 34555443 33466663 3322 222 123456799999999766766666666777778899999999999988
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
+... ...++..+-.-+.-||..| |+|||++++||++...+ +.++|||++..
T Consensus 90 l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 90 LEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred HHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 8443 2556778888999999998 99999999999998875 99999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.1e-10 Score=99.81 Aligned_cols=204 Identities=13% Similarity=0.127 Sum_probs=129.5
Q ss_pred EEEEEEecCCC-ChhhHhhcC---CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecc
Q 021771 59 SLLIYEYMPNK-SLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134 (308)
Q Consensus 59 ~~lv~e~~~~~-~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~df 134 (308)
..++|..+.+. .+..+.+.. .......+.-++..++.++.+.+.||..| .+-||++++|+||++++.+.|.|=
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 67788877653 223322221 22344778889999999999999999999 899999999999999999999986
Q ss_pred cceeeeCCCCCccccceeecccCccCchhhc-----cCcccccccchhhhHHHHHHHhC-CcCCCccccc-cccchhHHH
Q 021771 135 GMARIFGGNQSEANTNRIVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISG-KKNTGFYLSE-LGQSLLSYT 207 (308)
Q Consensus 135 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~-~~~~~~~~~ 207 (308)
...... ......-..+|...|.+||... +...+...|.|.||+++|++++| .+||...... ......+..
T Consensus 162 Dsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 655442 2223344467889999999765 23457889999999999999987 7898654332 111111110
Q ss_pred HH--hh-hcccccccccccccccchHHHHHHHHHHHhhcccC--CCCCCCCHHHHHHHhhcCCCCC
Q 021771 208 WK--LW-CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQA--DSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 208 ~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~p~~RPs~~eil~~L~~~~~~~ 268 (308)
.. .+ ...+...-+.+............++..|..+|+.. ++.-|||++.++..|......+
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00 00 00000001111111111112223456666678875 3678999999998876554444
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.4e-10 Score=90.08 Aligned_cols=125 Identities=22% Similarity=0.271 Sum_probs=82.4
Q ss_pred ccEEeeeCCCCEEEEEEeccCCc---------------------c-----cHHHHHHHHHHHhcCCCc--CccceeeeEE
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSG---------------------Q-----GLQEFKNEVTLIAKLQHK--NLVRLFGCCL 54 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~---------------------~-----~~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 54 (308)
.||.|.-.+|..+|||+...... . .....++|+..|.++..- ++++++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999888999999997743200 0 113456899999999755 567776542
Q ss_pred eCCeEEEEEEecC--CCChhhHhhcCCCccccChHHHHHHHHHHHHHHHh-chhCCCCceeecCCCCCceEeCCCCCeee
Q 021771 55 EENESLLIYEYMP--NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLY-LHEDSRLKIIHRDLKASNVLLNHEMNPKI 131 (308)
Q Consensus 55 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~-lH~~g~~~i~H~di~p~nilv~~~~~~kl 131 (308)
.-++||||++ |..+..+... . ++......++.+++..+.. +|..| ++|||+++.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-D----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-G----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-c----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 2379999998 6555543321 1 2244566777888885544 57887 9999999999999988 8999
Q ss_pred ecccceeee
Q 021771 132 SDFGMARIF 140 (308)
Q Consensus 132 ~dfg~~~~~ 140 (308)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.8e-10 Score=88.61 Aligned_cols=132 Identities=21% Similarity=0.355 Sum_probs=97.2
Q ss_pred ccEEeeeCCCCEEEEEE-eccC--Ccc-----cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCC-CChhh
Q 021771 3 SCLQGKLADGKEIAVKR-LSRT--SGQ-----GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN-KSLDV 73 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~-~~~~--~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~ 73 (308)
.|+.+.+ +|+.++||. +.+. .|. ...+.+.|...|.++.--.|.-..-+|.+...-++.|||++| .++.+
T Consensus 22 rv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~ 100 (229)
T KOG3087|consen 22 RVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKD 100 (229)
T ss_pred eEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHH
Confidence 3455555 688888883 3222 222 345567899999998766776666678787788999999977 47777
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC---eeeecccceee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN---PKISDFGMARI 139 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~---~kl~dfg~~~~ 139 (308)
++...... .........++.+|-+.+.-||.++ ++|||++.+||++..++. +.++|||++..
T Consensus 101 ~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 101 FILSTMED-ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHHccC-cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 77654332 2333344788999999999999997 999999999999976654 48999999754
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.9e-10 Score=95.68 Aligned_cols=131 Identities=21% Similarity=0.204 Sum_probs=94.5
Q ss_pred cEEeeeCCCCEEEEEEeccCCcc-----------cHHHHHHHHHHHhcCCCcCc--cceeeeEEe-----CCeEEEEEEe
Q 021771 4 CLQGKLADGKEIAVKRLSRTSGQ-----------GLQEFKNEVTLIAKLQHKNL--VRLFGCCLE-----ENESLLIYEY 65 (308)
Q Consensus 4 v~~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~e~ 65 (308)
|+.+.+ +|+.+.||........ .......|+..+..+...+| +.++.+... ....++|+|+
T Consensus 38 vvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~ 116 (268)
T PRK15123 38 TLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITED 116 (268)
T ss_pred EEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEee
Confidence 444444 6789999977433211 11246789999988854443 444555543 2346899999
Q ss_pred cCCC-ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-------CCCeeeecccce
Q 021771 66 MPNK-SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-------EMNPKISDFGMA 137 (308)
Q Consensus 66 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-------~~~~kl~dfg~~ 137 (308)
+++. +|.+++.... ....+......++.+++..+..||..| ++|+|++++|||++. +..+.|+||+.+
T Consensus 117 l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 117 LAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred CCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 9886 7888875322 223556677899999999999999998 999999999999975 457899999987
Q ss_pred ee
Q 021771 138 RI 139 (308)
Q Consensus 138 ~~ 139 (308)
..
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 53
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.3e-10 Score=93.16 Aligned_cols=134 Identities=16% Similarity=0.267 Sum_probs=97.9
Q ss_pred CccEEeeeCCCCEEEEEEeccCCc-ccHHHHHHHHHHHhcCCC--cCccceeeeEEeCC---eEEEEEEecCCCChhhHh
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTSG-QGLQEFKNEVTLIAKLQH--KNLVRLFGCCLEEN---ESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l 75 (308)
+.+|+.+..+|+.+++|....... .....+..|+.+++.+.+ .++.+++.+..... ..++||||++|.++...+
T Consensus 12 n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~ 91 (223)
T cd05154 12 NLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRL 91 (223)
T ss_pred ceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCC
Confidence 578888877778999998754322 234578899999999975 34677777766532 568999999998887654
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCC------------------------------------------------
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDS------------------------------------------------ 107 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g------------------------------------------------ 107 (308)
.. ..++......++.+++++|..||+..
T Consensus 92 ~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (223)
T cd05154 92 LR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAH 167 (223)
T ss_pred CC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhh
Confidence 21 23566666677777777777777421
Q ss_pred -----CCceeecCCCCCceEeCC--CCCeeeecccceee
Q 021771 108 -----RLKIIHRDLKASNVLLNH--EMNPKISDFGMARI 139 (308)
Q Consensus 108 -----~~~i~H~di~p~nilv~~--~~~~kl~dfg~~~~ 139 (308)
...++|+|++++||+++. ++.+.|+||+.+..
T Consensus 168 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 168 LPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred CCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 56688999987754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.4e-11 Score=106.27 Aligned_cols=231 Identities=19% Similarity=0.155 Sum_probs=155.4
Q ss_pred CccEEeee--CCCCEEEEEEeccCCcccHHH--HHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 2 ESCLQGKL--ADGKEIAVKRLSRTSGQGLQE--FKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 2 g~v~~~~~--~~g~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
+.++.... .++..|++|...+.......+ -..|+.+...+ .|.+++.++..|....+.++=.|||.++++...+
T Consensus 279 ~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~- 357 (524)
T KOG0601|consen 279 SSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRS- 357 (524)
T ss_pred ccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhh-
Confidence 44444432 467788888765543222222 23466666666 4899999988888888888888999999887766
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC-CCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.-...+++...+.+..|++.++.++|+.. ++|+|++|+||++..+ +..+++||+.+..+...... ....+
T Consensus 358 --~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~----~~~~~ 428 (524)
T KOG0601|consen 358 --VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV----FHHID 428 (524)
T ss_pred --HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceeccc----ccccc
Confidence 23345888899999999999999999997 9999999999999987 67789999988653211111 11122
Q ss_pred cCc-cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGY-MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y-~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..| .++.+.....+..++|+++||..+.+.+++...-.. ...+..+....+.... ....
T Consensus 429 r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~------------------~~~~~~i~~~~~p~~~--~~~~ 488 (524)
T KOG0601|consen 429 RLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES------------------GVQSLTIRSGDTPNLP--GLKL 488 (524)
T ss_pred cccccchhhccccccccccccccccccccccccCcccCcc------------------cccceeeecccccCCC--chHH
Confidence 233 355566667888999999999999999988644211 0111111111111111 1113
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
.+..+..-|+..++..||++.++....+
T Consensus 489 ~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 489 QLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred hhhhhhhhhcCCccccchhhhhhcccch
Confidence 4555556688899999999998876544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.5e-08 Score=83.11 Aligned_cols=107 Identities=24% Similarity=0.287 Sum_probs=84.3
Q ss_pred HHHHHHHHHHHhcCCCc--CccceeeeEEeCC----eEEEEEEecCCC-ChhhHhhcCCCccccChHHHHHHHHHHHHHH
Q 021771 28 LQEFKNEVTLIAKLQHK--NLVRLFGCCLEEN----ESLLIYEYMPNK-SLDVFLFDSTRSVQLDWKRRISIINGIARGL 100 (308)
Q Consensus 28 ~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l 100 (308)
......|+..+..+... .+++.+.+..... ..++|+|++++. +|.+++..... .+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 45677899988888533 3456666665532 358999999874 78888854222 56667789999999999
Q ss_pred HhchhCCCCceeecCCCCCceEeCCCC---Ceeeecccceeee
Q 021771 101 LYLHEDSRLKIIHRDLKASNVLLNHEM---NPKISDFGMARIF 140 (308)
Q Consensus 101 ~~lH~~g~~~i~H~di~p~nilv~~~~---~~kl~dfg~~~~~ 140 (308)
+-||..| ++|+|+++.|||++.++ .+.|+||+.+...
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 7999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.9e-08 Score=83.42 Aligned_cols=121 Identities=19% Similarity=0.238 Sum_probs=87.4
Q ss_pred CccEEeeeCCCCEEEEEEeccCC------------------c----ccHHHHHHHHHHHhcCCCc--CccceeeeEEeCC
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTS------------------G----QGLQEFKNEVTLIAKLQHK--NLVRLFGCCLEEN 57 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~------------------~----~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~ 57 (308)
|.||.|...+|.+++||.-.... . -.+...++|++.|.+|... .|++.+++ +
T Consensus 105 sdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----n 180 (304)
T COG0478 105 SDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW----N 180 (304)
T ss_pred ceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc----c
Confidence 57899998899999999532110 0 0223456899999999754 67777653 3
Q ss_pred eEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 58 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 58 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
.-.+|||+++|..|...- ++.+..-.++..|+..+..+-..| ++|||+++-||+++++|.+.++||--+
T Consensus 181 RHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 181 RHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred cceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCccc
Confidence 457999999987665432 233444556666666666666777 999999999999999999999999543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.5e-10 Score=101.81 Aligned_cols=161 Identities=21% Similarity=0.262 Sum_probs=103.5
Q ss_pred HHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC-ccc------cceeecccCccC
Q 021771 88 RRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS-EAN------TNRIVGTYGYMA 160 (308)
Q Consensus 88 ~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~-~~~------~~~~~~~~~y~a 160 (308)
....=+.+++.|+.++|... .+||++|.|++|.++.++.+||+.|+++-....... ... .-.......|.|
T Consensus 100 ~~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a 177 (700)
T KOG2137|consen 100 DGFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA 177 (700)
T ss_pred HhhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence 33444556779999999876 799999999999999999999999998755432111 110 011123457999
Q ss_pred chhhccCcccccccchhhhHHHHHHHhCCcC-CCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||++.+...+.++|+||+|+.+|.+..++.+ +.......... ...................++.+=
T Consensus 178 pE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 178 PEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRES 244 (700)
T ss_pred chhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHH
Confidence 9999888888999999999999999955433 32211111000 000001111111222333345565
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+++..++.-||++.+++...-.
T Consensus 245 l~k~l~~~~~~rp~~~~l~~~~ff 268 (700)
T KOG2137|consen 245 LKKLLNGDSAVRPTLDLLLSIPFF 268 (700)
T ss_pred HHHHhcCCcccCcchhhhhccccc
Confidence 667889999999988777655433
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=9.1e-08 Score=77.39 Aligned_cols=133 Identities=17% Similarity=0.166 Sum_probs=96.3
Q ss_pred CccEEeeeCCCCEEEEEEeccC------CcccHHHHHHHHHHHhcCCC--cCccceeeeEEe----CCeEEEEEEecCC-
Q 021771 2 ESCLQGKLADGKEIAVKRLSRT------SGQGLQEFKNEVTLIAKLQH--KNLVRLFGCCLE----ENESLLIYEYMPN- 68 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~----~~~~~lv~e~~~~- 68 (308)
|.|+...+ +|+.+-+|+-..- .+-....+..|+..|..+.. -.++++...-.. ....+||+|-+++
T Consensus 32 SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~ 110 (216)
T PRK09902 32 SGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGF 110 (216)
T ss_pred ceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCC
Confidence 34666555 5557899976411 15566889999999999963 235555522211 1236899997753
Q ss_pred CChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC--eeeecccceee
Q 021771 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN--PKISDFGMARI 139 (308)
Q Consensus 69 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~--~kl~dfg~~~~ 139 (308)
.+|.+++.... ..+.+......++.+++.+++.||..| +.|+|+.+.||+++.++. ++++||..++.
T Consensus 111 ~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 111 ISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred ccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 58888774422 224677777899999999999999998 999999999999987777 99999976654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.9e-08 Score=90.38 Aligned_cols=79 Identities=18% Similarity=0.251 Sum_probs=55.3
Q ss_pred CeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccc
Q 021771 57 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGM 136 (308)
Q Consensus 57 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~ 136 (308)
+.-.|+|||++|..+.+...-... ..+.+.+...+.++. +..+-..| +.|+|.+|.||+++.+|++.+.|||.
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~ia~~~~~~f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi 311 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKSA--GIDRKELAELLVRAF--LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGI 311 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHhc--CCCHHHHHHHHHHHH--HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcc
Confidence 456899999999999887533222 244333333222221 23333355 99999999999999999999999999
Q ss_pred eeeeCC
Q 021771 137 ARIFGG 142 (308)
Q Consensus 137 ~~~~~~ 142 (308)
...+..
T Consensus 312 ~g~l~~ 317 (517)
T COG0661 312 VGRLDP 317 (517)
T ss_pred eecCCH
Confidence 987643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4e-09 Score=101.02 Aligned_cols=150 Identities=26% Similarity=0.290 Sum_probs=114.6
Q ss_pred CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceE
Q 021771 43 HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122 (308)
Q Consensus 43 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nil 122 (308)
+|.++...-.+.-....+|+++|+.+++|...++... ..+.+-....+..+..++++||+.- +.|+|++|.|.+
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l 936 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLL 936 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchh
Confidence 4555544444445567899999999999988875533 3666677778888999999999874 899999999999
Q ss_pred eCCCCCeeeecccceeeeCC------C-------------------CCc----cccceeecccCccCchhhccCcccccc
Q 021771 123 LNHEMNPKISDFGMARIFGG------N-------------------QSE----ANTNRIVGTYGYMAPEYAMEGLFSVKS 173 (308)
Q Consensus 123 v~~~~~~kl~dfg~~~~~~~------~-------------------~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~ 173 (308)
+..++..++.||+.....+. . ... .......++..|.+||...+......+
T Consensus 937 ~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~a 1016 (1205)
T KOG0606|consen 937 IAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAA 1016 (1205)
T ss_pred hcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcc
Confidence 99999999999974322110 0 000 012234678899999999998889999
Q ss_pred cchhhhHHHHHHHhCCcCCCccccc
Q 021771 174 DVFSFGVLLLEIISGKKNTGFYLSE 198 (308)
Q Consensus 174 Di~slG~~l~~l~~~~~p~~~~~~~ 198 (308)
|+|+.|+++++.++|.+||.....+
T Consensus 1017 d~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 1017 DWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred hhhhhhhhhhhhhcCCCCCCCcchh
Confidence 9999999999999999998755444
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.1e-07 Score=77.18 Aligned_cols=113 Identities=19% Similarity=0.246 Sum_probs=72.2
Q ss_pred CCCEEEEEEeccCCcccHHHH---------HHHHHHHhcCCC---cCccceeeeEE-----eCCeEEEEEEecCCCChhh
Q 021771 11 DGKEIAVKRLSRTSGQGLQEF---------KNEVTLIAKLQH---KNLVRLFGCCL-----EENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 11 ~g~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~h---~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~ 73 (308)
+|+.+++|............+ .+.+..+..++. .....++-+.. .....+++|||++|..|.+
T Consensus 53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d 132 (229)
T PF06176_consen 53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND 132 (229)
T ss_pred CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence 788999997754432222222 233444444432 22223222222 2234578999999988866
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeeccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR 138 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~ 138 (308)
... +++ .++..+.+++..+|+.| ++|||++|.|++++.++ ++++||+...
T Consensus 133 ~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 133 IED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred chh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECcccc
Confidence 531 222 24456778899999999 99999999999999665 9999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=6.6e-07 Score=73.58 Aligned_cols=128 Identities=16% Similarity=0.265 Sum_probs=88.5
Q ss_pred CccEEeeeCCCCEEEEEEeccCCcc-------------------cHHH-----HHHHHHHHhcCC--CcCccceeeeEEe
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTSGQ-------------------GLQE-----FKNEVTLIAKLQ--HKNLVRLFGCCLE 55 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~~~-------------------~~~~-----~~~e~~~l~~l~--h~~i~~~~~~~~~ 55 (308)
++||.|.-.++..+|+|++...... ...+ ..+|+..|+++. +-.+++.+.+...
T Consensus 62 A~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~n 141 (268)
T COG1718 62 ANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRNN 141 (268)
T ss_pred eEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecCC
Confidence 4688888778999999988543211 1111 136888888884 5566777776554
Q ss_pred CCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecc
Q 021771 56 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDF 134 (308)
Q Consensus 56 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~df 134 (308)
.|||||+..... -.-..+...+.......+..++++.+.-|-. .+ +||+||+.-|||+. ++.+.++||
T Consensus 142 ----VLvMEfIg~~g~---pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~ 210 (268)
T COG1718 142 ----VLVMEFIGDDGL---PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDV 210 (268)
T ss_pred ----eEEEEeccCCCC---CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEEC
Confidence 799999955311 1111122223444677788888888888877 54 99999999999999 778999999
Q ss_pred cceeee
Q 021771 135 GMARIF 140 (308)
Q Consensus 135 g~~~~~ 140 (308)
+-+...
T Consensus 211 ~QaV~~ 216 (268)
T COG1718 211 SQAVTI 216 (268)
T ss_pred cccccc
Confidence 877553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.9e-06 Score=70.50 Aligned_cols=129 Identities=12% Similarity=0.072 Sum_probs=75.8
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcC--ccceeeeEEeCCeEEEEEEecCCCC-hhhHh----
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLFGCCLEENESLLIYEYMPNKS-LDVFL---- 75 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l---- 75 (308)
.||+. .|..+++|...... ....+.+|+++++.+..-. +.+.+++..+.+...+|||+++|.. +...+
T Consensus 16 ~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~ 90 (226)
T TIGR02172 16 ESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNP 90 (226)
T ss_pred ceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCH
Confidence 46652 35577889875432 3356789999999986433 5778888888778889999998863 21111
Q ss_pred -----------------hcCC-CccccChH--HHH-----------HHHHHHHHHHHhchhCCCCceeecCCCCCceEeC
Q 021771 76 -----------------FDST-RSVQLDWK--RRI-----------SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124 (308)
Q Consensus 76 -----------------~~~~-~~~~~~~~--~~~-----------~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~ 124 (308)
+... ....+... ... .+...+...++- +.. ...++|+|++|.||+++
T Consensus 91 ~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~-~~~-~~~~~HgD~~~~Nii~~ 168 (226)
T TIGR02172 91 SRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE-VPD-TSTCLHGDFQIGNLITS 168 (226)
T ss_pred HHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh-CCC-CCceEecCCCCCcEEEc
Confidence 1100 00000000 000 000011111111 111 23579999999999999
Q ss_pred CCCCeeeecccceee
Q 021771 125 HEMNPKISDFGMARI 139 (308)
Q Consensus 125 ~~~~~kl~dfg~~~~ 139 (308)
+++ +.++||+.+..
T Consensus 169 ~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 169 GKG-TYWIDLGDFGY 182 (226)
T ss_pred CCC-cEEEechhcCc
Confidence 988 99999987753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.3e-06 Score=80.43 Aligned_cols=77 Identities=12% Similarity=0.169 Sum_probs=52.6
Q ss_pred eEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC----CCCeeeec
Q 021771 58 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH----EMNPKISD 133 (308)
Q Consensus 58 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~----~~~~kl~d 133 (308)
...|+||||+|..+.+.-.- ....++...+..-+.+...-. +=..| ++|+|-+|.||++.. ++.+.+.|
T Consensus 276 ~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~q--If~~G---ffHaDPHPGNilv~~~~~~~~~ivllD 348 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQ--IFKTG---FFHADPHPGNILVRPNPEGDEEIVLLD 348 (538)
T ss_pred ceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHH--HHhcC---CccCCCCCCcEEEecCCCCCccEEEEc
Confidence 56899999999877765322 122355555544444432222 22344 999999999999984 56799999
Q ss_pred ccceeeeC
Q 021771 134 FGMARIFG 141 (308)
Q Consensus 134 fg~~~~~~ 141 (308)
||+...+.
T Consensus 349 hGl~~~is 356 (538)
T KOG1235|consen 349 HGLYAVIS 356 (538)
T ss_pred cccccccc
Confidence 99987653
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.8e-06 Score=70.14 Aligned_cols=68 Identities=9% Similarity=0.092 Sum_probs=48.9
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
.||+... ++..+++|+..... ...+..|+.+++.+. +--+.+++++...++..++||++++|.++...
T Consensus 14 ~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 14 TVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred eEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 4676654 34688889775432 345678999988884 44567788877776678999999999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.25 E-value=5.6e-06 Score=66.63 Aligned_cols=104 Identities=22% Similarity=0.243 Sum_probs=81.2
Q ss_pred HHHHHHHhcCCC-cCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCc
Q 021771 32 KNEVTLIAKLQH-KNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 110 (308)
Q Consensus 32 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~ 110 (308)
..|.-+|+.+++ +++++++|+|.. +++.||...+++...-..-......++..+.+++.++++.+.+++......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999975 699999999954 678999976655321000012234788999999999999999999854335
Q ss_pred eeecCCCCCceEeCCCCCeeeecccceee
Q 021771 111 IIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 111 i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
+.-.|++++|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 89999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.9e-05 Score=65.74 Aligned_cols=69 Identities=16% Similarity=0.300 Sum_probs=47.5
Q ss_pred CccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCc--CccceeeeEEe---CCeEEEEEEecCCCChhh
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK--NLVRLFGCCLE---ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~---~~~~~lv~e~~~~~~L~~ 73 (308)
+.+|.....+ ..+++|..... .....+..|..+++.+... .+.+++..... ....+++|+++++..+..
T Consensus 11 n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 11 NRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp SEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred eeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 4578887766 59999986433 4456788899999888532 35666664433 334689999999987776
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.7e-05 Score=76.44 Aligned_cols=198 Identities=21% Similarity=0.203 Sum_probs=130.9
Q ss_pred HHHHHHHHHhcCCCcCccceeeeEEeCCeEE----EEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchh
Q 021771 30 EFKNEVTLIAKLQHKNLVRLFGCCLEENESL----LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE 105 (308)
Q Consensus 30 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 105 (308)
....|++.+..+.|+|++.++.+-....... +..++|...++...+. .....+....+.+..+..++++++|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3446777888889999999998876544333 3347787777777663 33458888999999999999999999
Q ss_pred CCCCceeecCCCCC---ceEeCCCCCeeee--cccceeeeCCCCCccccceeecccCccCchhhccCccc--ccccchhh
Q 021771 106 DSRLKIIHRDLKAS---NVLLNHEMNPKIS--DFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFS--VKSDVFSF 178 (308)
Q Consensus 106 ~g~~~i~H~di~p~---nilv~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~Di~sl 178 (308)
.. ..|.-+..+ +..++..+.+..+ ||+....+........ ......+.++|........ ...|+|++
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHH
Confidence 84 666555544 4445555666666 8887776543322211 1234456777766655444 44799999
Q ss_pred hHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 021771 179 GVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 258 (308)
Q Consensus 179 G~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 258 (308)
|.....+..|..+-...... ..+++ ..... .+.++...|+..++++|+++.+++
T Consensus 379 gll~~~~~~~~~i~~~~~~~------------------~~~l~----~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVP------------------VSLLD----VLSTS----ELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCcccccccch------------------hhhhc----cccch----hhhhhhhhhcchhhhhccchhhhh
Confidence 99999999887652211100 01111 11111 355666789999999999999999
Q ss_pred HHhh
Q 021771 259 VMLA 262 (308)
Q Consensus 259 ~~L~ 262 (308)
....
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 7654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.9e-05 Score=65.93 Aligned_cols=132 Identities=15% Similarity=0.095 Sum_probs=72.2
Q ss_pred CccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCc-cceeeeEEeCCeEEEEEEecCCCChhhH------
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL-VRLFGCCLEENESLLIYEYMPNKSLDVF------ 74 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~------ 74 (308)
+.+|+.. .+|+.+++|...............|..+++.+...++ .+++.... -++||||++|..+...
T Consensus 10 n~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~ 84 (256)
T TIGR02721 10 NRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALD 84 (256)
T ss_pred CCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCch
Confidence 3566665 4677889987543322211235789999999864333 44444332 2689999998765421
Q ss_pred -----------hhcCC-CccccChHH-HHHHHHHH---------HHHHHhchhC-----CCCceeecCCCCCceEeCCCC
Q 021771 75 -----------LFDST-RSVQLDWKR-RISIINGI---------ARGLLYLHED-----SRLKIIHRDLKASNVLLNHEM 127 (308)
Q Consensus 75 -----------l~~~~-~~~~~~~~~-~~~~~~qi---------~~~l~~lH~~-----g~~~i~H~di~p~nilv~~~~ 127 (308)
++... ....++... +..+..++ ...+..+-.. ....++|+|+.|.||++++++
T Consensus 85 ~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~ 164 (256)
T TIGR02721 85 LLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG 164 (256)
T ss_pred hHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC
Confidence 11110 011112111 11111111 1111111111 012489999999999999877
Q ss_pred Ceeeecccceee
Q 021771 128 NPKISDFGMARI 139 (308)
Q Consensus 128 ~~kl~dfg~~~~ 139 (308)
+.|+||+.+..
T Consensus 165 -~~lIDwE~a~~ 175 (256)
T TIGR02721 165 -LKLIDWEYASD 175 (256)
T ss_pred -CEEEeccccCc
Confidence 78999988754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00016 Score=58.61 Aligned_cols=114 Identities=17% Similarity=0.270 Sum_probs=76.2
Q ss_pred eCCCCEEEEEEeccCC----------------cccHHHHHHHHHHHhcCC------CcCccceeeeEEeCCeEEEEEEec
Q 021771 9 LADGKEIAVKRLSRTS----------------GQGLQEFKNEVTLIAKLQ------HKNLVRLFGCCLEENESLLIYEYM 66 (308)
Q Consensus 9 ~~~g~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~ 66 (308)
+.+.....||+..... .....+..+|+.-...+. +.+|.+++++..++....+|+|.+
T Consensus 20 HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I 99 (199)
T PF10707_consen 20 HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELI 99 (199)
T ss_pred CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEE
Confidence 5566677888876554 112345556666555554 788999999999999999999986
Q ss_pred CC------CChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC----Ceeeec
Q 021771 67 PN------KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM----NPKISD 133 (308)
Q Consensus 67 ~~------~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~----~~kl~d 133 (308)
.+ .+|.+++.. ..++. .....+.++ ..+|-.++ |+.+|++|+||++..+. .+.|+|
T Consensus 100 ~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 100 RDADGNISPTLEDYLKE----GGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ECCCCCcCccHHHHHHc----CCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEe
Confidence 32 367777732 22444 444444444 45555554 99999999999996433 366666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00017 Score=71.31 Aligned_cols=69 Identities=14% Similarity=0.367 Sum_probs=46.8
Q ss_pred ccEEeeeCCC---CEEEEEEeccCC-cccHHHHHHHHHHHhcCC-CcCc--cceeeeEEeC---CeEEEEEEecCCCCh
Q 021771 3 SCLQGKLADG---KEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQ-HKNL--VRLFGCCLEE---NESLLIYEYMPNKSL 71 (308)
Q Consensus 3 ~v~~~~~~~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~L 71 (308)
.+|.....++ ..+++|+..... ......+..|+.+|+.+. |.++ ++++.++.+. +..++||||++|..+
T Consensus 53 ~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 53 PTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred ceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 4566555443 467888764332 223357889999999995 6654 7777777664 357899999988653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=3.8e-06 Score=77.36 Aligned_cols=151 Identities=20% Similarity=0.201 Sum_probs=109.7
Q ss_pred HHHHHHHHHHhcCCCcC-ccceeeeEEeCCeEEEEEEecCCC-ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhC
Q 021771 29 QEFKNEVTLIAKLQHKN-LVRLFGCCLEENESLLIYEYMPNK-SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED 106 (308)
Q Consensus 29 ~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 106 (308)
....-++++|.+++||| .+..++-+..+....+.++++.++ +...... .....+.......+.+.-.++++++|+.
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~ 355 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSS 355 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhcccccccccc
Confidence 44556889999999999 777777777777889999999776 2222111 1122344445556667777889999986
Q ss_pred CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHH
Q 021771 107 SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186 (308)
Q Consensus 107 g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 186 (308)
. =+|+| ||+..+ +..+++||+....+.... ......++..++|||+.....+...-|.|++|.-.-++.
T Consensus 356 ~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~a 424 (829)
T KOG0576|consen 356 Y---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMA 424 (829)
T ss_pred c---ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcC
Confidence 3 37777 666665 568999999887765333 233456789999999998888999999999998877777
Q ss_pred hCCcCC
Q 021771 187 SGKKNT 192 (308)
Q Consensus 187 ~~~~p~ 192 (308)
-|.+|-
T Consensus 425 p~~pPr 430 (829)
T KOG0576|consen 425 PGLPPR 430 (829)
T ss_pred CCCCCC
Confidence 777664
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00015 Score=60.58 Aligned_cols=64 Identities=17% Similarity=0.317 Sum_probs=39.5
Q ss_pred ccEEeeeCC--CCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcC-ccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 3 SCLQGKLAD--GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN-LVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 3 ~v~~~~~~~--g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
.+|+....+ ++.+++|+...... .......|+.+++.+...+ .++++..+. + .++|||++|.++
T Consensus 13 ~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l 79 (235)
T cd05157 13 KLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL 79 (235)
T ss_pred eEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence 456665543 67899997654322 2223457888998885333 444444332 1 479999988765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.0002 Score=60.01 Aligned_cols=58 Identities=10% Similarity=0.173 Sum_probs=36.6
Q ss_pred CEEEEEEeccCCcccHHHHHHHHHHHhcCCCc---CccceeeeEEeCC---eEEEEEEecCCCChh
Q 021771 13 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK---NLVRLFGCCLEEN---ESLLIYEYMPNKSLD 72 (308)
Q Consensus 13 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~---~~~lv~e~~~~~~L~ 72 (308)
..+++|..... .....+..|..+|..+... .+.+++......+ ..+++|++++|.++.
T Consensus 19 ~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 19 DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT 82 (235)
T ss_pred CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence 45778865432 2345788999999888632 3455554433321 347899999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00073 Score=58.66 Aligned_cols=67 Identities=12% Similarity=0.071 Sum_probs=45.3
Q ss_pred CccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCC---cCccceeeeEEeC---CeEEEEEEecCCCCh
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH---KNLVRLFGCCLEE---NESLLIYEYMPNKSL 71 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~---~~~~lv~e~~~~~~L 71 (308)
+.||.....+| .+++|..+.. .....+..|...|+.+.. -.++++++++.+. +..++|||++++.++
T Consensus 28 ~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 28 AALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred eeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 34555444445 5677764321 123578899999999853 4688888877643 558999999988654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00039 Score=54.55 Aligned_cols=119 Identities=18% Similarity=0.261 Sum_probs=81.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCcc-ceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLV-RLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
+|.||.+.+.++ .+|+|+-.. ++.+..+..|+++|..+..-++. ++|.+-.+ ++.|||+.|..|.+.....
T Consensus 35 ~s~Vyl~~~~~~-~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~- 106 (201)
T COG2112 35 TSVVYLGEWRGG-EVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG- 106 (201)
T ss_pred ccEEEEeeccCc-eEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc-
Confidence 478999988544 888886533 34557899999999999866653 44444333 3559999998887765211
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCC-CCceEeCCCCCeeeecccceee
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK-ASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~-p~nilv~~~~~~kl~dfg~~~~ 139 (308)
+.+ -+..+++..--|...| |-|+.|+ |..+++..++.+.|+||..|+.
T Consensus 107 -----~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 107 -----DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred -----cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 222 2334556656667777 9999987 4555555555899999998874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00083 Score=60.35 Aligned_cols=66 Identities=11% Similarity=0.094 Sum_probs=45.1
Q ss_pred CccEEeeeCCC-CEEEEEEecc------C-CcccHHHHHHHHHHHhcCC---CcCccceeeeEEeCCeEEEEEEecCCC
Q 021771 2 ESCLQGKLADG-KEIAVKRLSR------T-SGQGLQEFKNEVTLIAKLQ---HKNLVRLFGCCLEENESLLIYEYMPNK 69 (308)
Q Consensus 2 g~v~~~~~~~g-~~vavK~~~~------~-~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 69 (308)
..||.....+| +.++||.-.. . .+...++...|.+.|+.+. ..++++++.+.. ...++||||+++.
T Consensus 40 N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lVME~L~~~ 116 (401)
T PRK09550 40 NLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTVMEDLSDH 116 (401)
T ss_pred EEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEEEecCCCc
Confidence 35788777666 5899997421 1 1335567788888888873 245777777643 4578999999763
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00064 Score=59.45 Aligned_cols=128 Identities=16% Similarity=0.224 Sum_probs=88.6
Q ss_pred CccEEeeeCCCCEEEEEEeccCC-----------c-----------ccHHH----HHHHHHHHhcCCCcCccceeeeEEe
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTS-----------G-----------QGLQE----FKNEVTLIAKLQHKNLVRLFGCCLE 55 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~-----------~-----------~~~~~----~~~e~~~l~~l~h~~i~~~~~~~~~ 55 (308)
+.||-+.-.+|..+|||+++... . ..++. ...|+..|+++....|.-.--+...
T Consensus 158 ANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlLk 237 (520)
T KOG2270|consen 158 ANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILLK 237 (520)
T ss_pred ceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceeee
Confidence 46899888899999999875420 0 01121 2368888888876665544333333
Q ss_pred CCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeeccc
Q 021771 56 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFG 135 (308)
Q Consensus 56 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg 135 (308)
+ -.|||+++..... ..-..+...++...+..+-.+++.-+.-|.+.+ .+||.||+--|+|+.+ |.+.++|-+
T Consensus 238 ~--hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G~lyiIDVS 309 (520)
T KOG2270|consen 238 N--HVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-GKLYIIDVS 309 (520)
T ss_pred c--ceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-CEEEEEEcc
Confidence 2 3799999953222 111223445777788888899999999888887 7999999999998765 568888865
Q ss_pred ce
Q 021771 136 MA 137 (308)
Q Consensus 136 ~~ 137 (308)
-+
T Consensus 310 QS 311 (520)
T KOG2270|consen 310 QS 311 (520)
T ss_pred cc
Confidence 44
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0013 Score=57.09 Aligned_cols=133 Identities=17% Similarity=0.172 Sum_probs=73.6
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcC--ccceeee------EEeCCeEEEEEEecCCCChhh-
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLFGC------CLEENESLLIYEYMPNKSLDV- 73 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~------~~~~~~~~lv~e~~~~~~L~~- 73 (308)
.+|.... ++..+++|+... ...+.+..|+.++..+...+ +.+++.. ...++..++|++|++|..+..
T Consensus 29 ~~y~v~~-~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~ 104 (296)
T cd05153 29 TNYFVTT-DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRP 104 (296)
T ss_pred ceEEEEe-CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCC
Confidence 4666554 344788898754 23456778888888885322 4444432 223445689999998876532
Q ss_pred ---Hh----------hcCCCccc--------cChHHH----------HHHHHHHHHHHHhchhC----CCCceeecCCCC
Q 021771 74 ---FL----------FDSTRSVQ--------LDWKRR----------ISIINGIARGLLYLHED----SRLKIIHRDLKA 118 (308)
Q Consensus 74 ---~l----------~~~~~~~~--------~~~~~~----------~~~~~qi~~~l~~lH~~----g~~~i~H~di~p 118 (308)
.. +....... ..+... ......+..++.++... -...++|+|++|
T Consensus 105 ~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~ 184 (296)
T cd05153 105 TAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFR 184 (296)
T ss_pred CHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCc
Confidence 00 00000000 000000 00111122333333321 012499999999
Q ss_pred CceEeCCCCCeeeecccceee
Q 021771 119 SNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 119 ~nilv~~~~~~kl~dfg~~~~ 139 (308)
.||++++++.+.|+||+.+..
T Consensus 185 ~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 185 DNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred ccEEEeCCceEEEeehhhhcC
Confidence 999999877678999987643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00053 Score=56.39 Aligned_cols=30 Identities=33% Similarity=0.520 Sum_probs=21.5
Q ss_pred ceeecCCCCCceEe-CCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLL-NHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv-~~~~~~kl~dfg~~~~ 139 (308)
-++|+|+.+.||++ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8888999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0017 Score=56.55 Aligned_cols=65 Identities=20% Similarity=0.380 Sum_probs=41.6
Q ss_pred ccEEeeeCC-------CCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcC-ccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 3 SCLQGKLAD-------GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN-LVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 3 ~v~~~~~~~-------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
.+|+....+ ++.+++|+..... ........|+.+++.+...+ ..+++.++.. .+|++|++|..+.
T Consensus 13 ~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~G~~l~ 85 (302)
T cd05156 13 AVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIPSRTLT 85 (302)
T ss_pred eeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeCCCcCC
Confidence 456665544 5889999865433 33345678988998886333 3455555542 3589999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0031 Score=55.27 Aligned_cols=30 Identities=33% Similarity=0.363 Sum_probs=24.9
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.+||+|++++||+++.+...-++||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 399999999999999665457999987743
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0024 Score=55.75 Aligned_cols=29 Identities=34% Similarity=0.458 Sum_probs=25.7
Q ss_pred ceeecCCCCCceEeCCCCCeeeeccccee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMAR 138 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~ 138 (308)
.++|+|+++.||+++.++...++||+.+.
T Consensus 188 ~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 188 GVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred ccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 49999999999999988767899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0027 Score=56.35 Aligned_cols=132 Identities=17% Similarity=0.256 Sum_probs=73.1
Q ss_pred ccEEeeeC-----CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCc-cceeeeEEeCCeEEEEEEecCCCChhhH--
Q 021771 3 SCLQGKLA-----DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL-VRLFGCCLEENESLLIYEYMPNKSLDVF-- 74 (308)
Q Consensus 3 ~v~~~~~~-----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~-- 74 (308)
.+|+..+. .++.+++|+......... ....|..+++.+...++ .++++.+..+ .|.+|+++.++...
T Consensus 51 ~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l 125 (344)
T PLN02236 51 EVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADL 125 (344)
T ss_pred eeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHc
Confidence 35665542 246889997754433322 23679999998864343 4556665432 58999987666421
Q ss_pred ---------------hhcCC-Cc-c-ccChHHHHHHHHHH-----------------HHHHHh----chhCC-CCceeec
Q 021771 75 ---------------LFDST-RS-V-QLDWKRRISIINGI-----------------ARGLLY----LHEDS-RLKIIHR 114 (308)
Q Consensus 75 ---------------l~~~~-~~-~-~~~~~~~~~~~~qi-----------------~~~l~~----lH~~g-~~~i~H~ 114 (308)
++... .. . .....++..++.++ ...+.. +...+ ...++|+
T Consensus 126 ~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~ 205 (344)
T PLN02236 126 RDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHN 205 (344)
T ss_pred CChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeC
Confidence 11100 00 0 11122232332221 111111 12111 2358999
Q ss_pred CCCCCceEeCC-CCCeeeecccceee
Q 021771 115 DLKASNVLLNH-EMNPKISDFGMARI 139 (308)
Q Consensus 115 di~p~nilv~~-~~~~kl~dfg~~~~ 139 (308)
|+++.||++++ ++.+.++||.++..
T Consensus 206 Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 206 DLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCcCcEEEeCCCCcEEEEeehhccc
Confidence 99999999986 46799999988754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0028 Score=55.11 Aligned_cols=119 Identities=19% Similarity=0.299 Sum_probs=75.8
Q ss_pred CCEEEEEEecc--CCcccHHHHHHHHHHHhcCCC--cCccceeeeEEeCC--eEEEEEEecCCCChhhHhhcCCCccccC
Q 021771 12 GKEIAVKRLSR--TSGQGLQEFKNEVTLIAKLQH--KNLVRLFGCCLEEN--ESLLIYEYMPNKSLDVFLFDSTRSVQLD 85 (308)
Q Consensus 12 g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 85 (308)
++.+++. ... ...........|+.+++.+.- --+...++.+.++. ..+.||+|+.|..+.+...... ..
T Consensus 48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~----~~ 122 (321)
T COG3173 48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPES----LG 122 (321)
T ss_pred CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCccc----ch
Confidence 6777777 432 223344567788888888753 33456666777665 5699999998854433221100 00
Q ss_pred hHHHHHHHH-HHHHHHHhchh--------------------------------------------------C-----CCC
Q 021771 86 WKRRISIIN-GIARGLLYLHE--------------------------------------------------D-----SRL 109 (308)
Q Consensus 86 ~~~~~~~~~-qi~~~l~~lH~--------------------------------------------------~-----g~~ 109 (308)
.+++. .+++.|+.||+ + +..
T Consensus 123 ----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~ 198 (321)
T COG3173 123 ----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPP 198 (321)
T ss_pred ----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCc
Confidence 11222 44445555553 1 123
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.++|||+++.|++++..+.+=++||+.+..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 699999999999999998899999999876
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0078 Score=52.51 Aligned_cols=28 Identities=25% Similarity=0.386 Sum_probs=24.4
Q ss_pred ceeecCCCCCceEeCCCCCeeeeccccee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMAR 138 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~ 138 (308)
.++|||++++||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4899999999999988 678999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.00092 Score=40.40 Aligned_cols=45 Identities=47% Similarity=0.728 Sum_probs=39.8
Q ss_pred CCCCCCCCCCCCcccCccCCCCCCCCCCC--cccccCceeeccccCC
Q 021771 264 DTVTLPQPTEPAFSVGRNVARPGQFSSGA--EVCSVNEVTLSNVTPR 308 (308)
Q Consensus 264 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 308 (308)
....||.|..|++..++.......+++.. +.+++|++++|-+++|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 34679999999999999988887777766 8999999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.012 Score=50.55 Aligned_cols=30 Identities=20% Similarity=0.520 Sum_probs=25.3
Q ss_pred ceeecCCCCCceEeCCCCCe-eeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNP-KISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~-kl~dfg~~~~ 139 (308)
.++|+|++++||+++.++++ -|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 48999999999999975664 5999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.91 E-value=8.7e-05 Score=75.02 Aligned_cols=163 Identities=11% Similarity=-0.020 Sum_probs=113.5
Q ss_pred HHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHH-HHHHHhchh
Q 021771 29 QEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGI-ARGLLYLHE 105 (308)
Q Consensus 29 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi-~~~l~~lH~ 105 (308)
+....|.+.++...|+++...+.-.... ...+..++++.+|.+.+.+....+..+--........+++ .....-+|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 3344555566667888876665544332 2357889999999999988765443333333444555555 455555554
Q ss_pred CC--CCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHH
Q 021771 106 DS--RLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183 (308)
Q Consensus 106 ~g--~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 183 (308)
.. +..-+|.++++-|.+|..+.+++++++|+.+..+ ......+...+++.|+.+++.+.-.++.++|+|.+|+-+|
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 42 2356899999999999999999999999998322 2223334456677888888777777888899999999999
Q ss_pred HHHhCCcCCC
Q 021771 184 EIISGKKNTG 193 (308)
Q Consensus 184 ~l~~~~~p~~ 193 (308)
.+..|..+|-
T Consensus 1432 ~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1432 LRSDGNAYFI 1441 (2724)
T ss_pred HHhcccHHHH
Confidence 9998887763
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0049 Score=50.33 Aligned_cols=101 Identities=15% Similarity=0.188 Sum_probs=64.5
Q ss_pred EEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHH
Q 021771 15 IAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93 (308)
Q Consensus 15 vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 93 (308)
..+|++....-. ....+.+++.++.++. .|+++..- ++..+.++.|+|....... ..++
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~~----------------~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKINF----------------SNFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccch----------------hHHH
Confidence 345555333222 2345677888887664 45555522 3445789999985532210 1122
Q ss_pred HHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccc
Q 021771 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGM 136 (308)
Q Consensus 94 ~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~ 136 (308)
..=+++|.-.|+. +....|||..|+|||.+..|.+||.|-+.
T Consensus 148 ~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 2225778888944 23799999999999999999999999654
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.035 Score=48.90 Aligned_cols=67 Identities=12% Similarity=0.111 Sum_probs=42.4
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcC--cccee---e--eEEeCCeEEEEEEecCCCC
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLF---G--CCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~---~--~~~~~~~~~lv~e~~~~~~ 70 (308)
.||.....+|+.+++|+.... ......+..|...+..|.... ++... + ....++..+.|+++++|..
T Consensus 40 ~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 40 RVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred eEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 467777677889999987432 234567788888888774222 22222 1 1223456778899998754
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0017 Score=56.05 Aligned_cols=120 Identities=12% Similarity=0.153 Sum_probs=81.1
Q ss_pred CccEEeeeCCCCEEEEEEeccCC-----------------c-c----cHHHHHHHHHHHhcCC-Cc-CccceeeeEEeCC
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTS-----------------G-Q----GLQEFKNEVTLIAKLQ-HK-NLVRLFGCCLEEN 57 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~-----------------~-~----~~~~~~~e~~~l~~l~-h~-~i~~~~~~~~~~~ 57 (308)
+.||++...+|+..++|.-.-.. . . .+-...+|+..|+.|. |. -|++.+++ +
T Consensus 106 SDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD~----~ 181 (465)
T KOG2268|consen 106 SDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKPIDH----N 181 (465)
T ss_pred cceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCcccc----c
Confidence 45788888889999999431110 0 0 1112346888888885 32 24555543 3
Q ss_pred eEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 58 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 58 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
..++|||++.+..|...-+- ...-.+...+...+..|..+| ++|||..-=||++.+++.++++||--.
T Consensus 182 RH~Vvmelv~g~Pl~~v~~v---------~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 182 RHCVVMELVDGYPLRQVRHV---------EDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred ceeeHHHhhcccceeeeeec---------CChHHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeechHh
Confidence 45899999999887654311 122334455566667778888 999999999999999999999999643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.009 Score=52.73 Aligned_cols=30 Identities=30% Similarity=0.396 Sum_probs=26.0
Q ss_pred ceeecCCCCCceEeCC-CCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNH-EMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~-~~~~kl~dfg~~~~ 139 (308)
-++|+|+.+.||++++ ++.++++||.++..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 5899999999999975 46899999998754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0071 Score=53.05 Aligned_cols=103 Identities=16% Similarity=0.152 Sum_probs=70.6
Q ss_pred CeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccc
Q 021771 57 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGM 136 (308)
Q Consensus 57 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~ 136 (308)
.+.+++|++- |+++... .....+++..++.+.+..+.-+..+- ++-|+|++..||+|+ +|+|.|+||.+
T Consensus 299 ~y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 3567788875 5565432 22456788899999999998888765 799999999999999 99999999999
Q ss_pred eeeeCCCCCccccceeecccCccCchhhccCcccccccchhh
Q 021771 137 ARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSF 178 (308)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 178 (308)
++.-. ..... .-.+.--|.++.|.. +.+-+||-+
T Consensus 368 sRl~~-~q~~i------sy~rldhp~lF~G~d-d~QFeIYrl 401 (488)
T COG5072 368 SRLSY-SQGII------SYNRLDHPDLFNGVD-DYQFEIYRL 401 (488)
T ss_pred eeccc-CCcee------eccccCchhhhcCcc-ceeeeHHHH
Confidence 88421 11111 112334566555433 566667654
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0033 Score=57.38 Aligned_cols=48 Identities=19% Similarity=0.281 Sum_probs=38.9
Q ss_pred HHHHHHHHHHhcCCCcCccceeeeEEeCC-eEEEEEEecCCCChhhHhhc
Q 021771 29 QEFKNEVTLIAKLQHKNLVRLFGCCLEEN-ESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 29 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~ 77 (308)
.++...+..++.+.|+|...++++-.... ...+|||++ +.+|.+.+..
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 56778899999999999999998876433 478899999 6689888743
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.052 Score=47.39 Aligned_cols=30 Identities=20% Similarity=0.301 Sum_probs=27.0
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.+||+|+.++|++++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.028 Score=45.55 Aligned_cols=111 Identities=25% Similarity=0.374 Sum_probs=70.4
Q ss_pred CccEEeeeCCCCEEEEEEe---ccCCcc------------------cHHHHHHHHHHHhcC---CCcCc--cceeeeEEe
Q 021771 2 ESCLQGKLADGKEIAVKRL---SRTSGQ------------------GLQEFKNEVTLIAKL---QHKNL--VRLFGCCLE 55 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~---~~~~~~------------------~~~~~~~e~~~l~~l---~h~~i--~~~~~~~~~ 55 (308)
|.||++++ +|+.||+|++ ....+. -.+-|..|-...-+| .+.++ +++++++.=
T Consensus 52 ~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L 130 (207)
T PF13095_consen 52 GYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLL 130 (207)
T ss_pred eEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEE
Confidence 56788777 7889999983 211110 112345565555555 45556 889888742
Q ss_pred C------------------CeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCC
Q 021771 56 E------------------NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117 (308)
Q Consensus 56 ~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~ 117 (308)
. ....||.||.+... .+. ..-+.+|.+-+..+|..| |+-+|++
T Consensus 131 ~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~~~k~g---I~~~Dv~ 191 (207)
T PF13095_consen 131 TEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKILHKLG---IVPRDVK 191 (207)
T ss_pred chHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHHHHHCC---eeeccCc
Confidence 1 01356667664433 122 223456777888999998 9999999
Q ss_pred CCceEeCCCCCeeeecccce
Q 021771 118 ASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 118 p~nilv~~~~~~kl~dfg~~ 137 (308)
+.|.. .-+|+|||.+
T Consensus 192 ~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 192 PRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ccccc-----CCEEEecccC
Confidence 99987 3488999753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.057 Score=47.48 Aligned_cols=134 Identities=21% Similarity=0.296 Sum_probs=76.9
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCc--cce--------eeeEEeCCeEEEEEEecCCCChh
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL--VRL--------FGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~--------~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
.+|.....+|.. ++|+.... ....++..|...|..|.-..| ... +..+......+-+++|++|..+.
T Consensus 40 ~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~ 116 (331)
T COG2334 40 SNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLE 116 (331)
T ss_pred ceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcC
Confidence 467777767766 88987544 556788899999999853222 111 11122223667888999988776
Q ss_pred h-Hh--------------hcCCCcc---------ccChH-------------HHHHHHHHHHHHHHhchhC-------CC
Q 021771 73 V-FL--------------FDSTRSV---------QLDWK-------------RRISIINGIARGLLYLHED-------SR 108 (308)
Q Consensus 73 ~-~l--------------~~~~~~~---------~~~~~-------------~~~~~~~qi~~~l~~lH~~-------g~ 108 (308)
. .. +....+. ...+. .-.....++...+..+.+. +.
T Consensus 117 ~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~ 196 (331)
T COG2334 117 RDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALG 196 (331)
T ss_pred CCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCccc
Confidence 2 10 0000000 11111 0011233333333333322 11
Q ss_pred CceeecCCCCCceEeCCCCC-eeeecccceee
Q 021771 109 LKIIHRDLKASNVLLNHEMN-PKISDFGMARI 139 (308)
Q Consensus 109 ~~i~H~di~p~nilv~~~~~-~kl~dfg~~~~ 139 (308)
..++|+|+.|+||+++.+.. .-++||+.+..
T Consensus 197 ~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 197 DQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred ceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 22899999999999999885 78999987643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.037 Score=49.00 Aligned_cols=64 Identities=13% Similarity=0.105 Sum_probs=40.4
Q ss_pred ccEEeeeCCC-CEEEEEEec-------cCCcccHHHHHHHHHHHhcCC--Cc-CccceeeeEEeCCeEEEEEEecCC
Q 021771 3 SCLQGKLADG-KEIAVKRLS-------RTSGQGLQEFKNEVTLIAKLQ--HK-NLVRLFGCCLEENESLLIYEYMPN 68 (308)
Q Consensus 3 ~v~~~~~~~g-~~vavK~~~-------~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~e~~~~ 68 (308)
.||++...+| +.++||.-. ...+...++..-|...|+... .| .++++|.+-. ....+|||+++.
T Consensus 10 ~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~--e~~~~vMEdL~~ 84 (370)
T TIGR01767 10 LVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT--EMAVTVMEDLSH 84 (370)
T ss_pred EEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc--ccceehHhhCcc
Confidence 4777776544 689999531 122455566677888887764 34 4566654443 345789999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.056 Score=48.76 Aligned_cols=62 Identities=8% Similarity=-0.016 Sum_probs=39.6
Q ss_pred cEEeeeCCCCEEEEEEecc-----C--CcccHHHHHHHHHHHhcCC---CcCccceeeeEEeCCeEEEEEEecCC
Q 021771 4 CLQGKLADGKEIAVKRLSR-----T--SGQGLQEFKNEVTLIAKLQ---HKNLVRLFGCCLEENESLLIYEYMPN 68 (308)
Q Consensus 4 v~~~~~~~g~~vavK~~~~-----~--~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~ 68 (308)
||.... ++..++||.-.. . .+....+-..|...|+.+. -.++++++.++.+. .+++||++++
T Consensus 48 VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvME~L~~ 119 (418)
T PLN02756 48 VYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGMRYLEP 119 (418)
T ss_pred EEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEEeecCC
Confidence 455443 455788996431 1 1234455556677777764 24788888888743 5788999976
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.067 Score=49.09 Aligned_cols=30 Identities=20% Similarity=0.430 Sum_probs=24.9
Q ss_pred CceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 109 LKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 109 ~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
..++|+|+.+.||+.+.++ ++|+||..+..
T Consensus 284 ~VfCHNDl~~~NiL~~~~~-l~LIDfEYAg~ 313 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNKC-LRLIDFEYSGY 313 (442)
T ss_pred eeEEeCCCCccceeecCCC-EEEEeeccccc
Confidence 3589999999999876554 99999988753
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.069 Score=48.08 Aligned_cols=29 Identities=28% Similarity=0.302 Sum_probs=24.2
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.++|.|+.+.||+.+++ .+.++||..+..
T Consensus 228 VfCHNDL~~gNIL~~~~-~l~lID~EYA~~ 256 (383)
T PTZ00384 228 LFCHNDLFFTNILDFNQ-GIYFIDFDFAGF 256 (383)
T ss_pred eeeeccCCcccEEecCC-CEEEEEeccccC
Confidence 48999999999987654 599999987743
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.032 Score=50.00 Aligned_cols=64 Identities=6% Similarity=-0.020 Sum_probs=41.2
Q ss_pred ccEEeeeC-CCCEEEEEEe----c--cCCcccHHHHHHHHHHHhcCC--Cc-CccceeeeEEeCCeEEEEEEecCC
Q 021771 3 SCLQGKLA-DGKEIAVKRL----S--RTSGQGLQEFKNEVTLIAKLQ--HK-NLVRLFGCCLEENESLLIYEYMPN 68 (308)
Q Consensus 3 ~v~~~~~~-~g~~vavK~~----~--~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~~~~~~~~~~~~lv~e~~~~ 68 (308)
-||++... +++.++||.- . .+.+-..++..-|.+.|+... .| .++++|.+-.+ ...+|||+++.
T Consensus 44 ~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e--~~~~vMEdL~~ 117 (409)
T PRK12396 44 YVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSV--MNCCVMEDLSD 117 (409)
T ss_pred EEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcH--HhhHHHHhCcc
Confidence 36777653 3668999843 1 123556677788888888774 44 46666654443 45788888854
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.087 Score=45.43 Aligned_cols=57 Identities=19% Similarity=0.282 Sum_probs=37.5
Q ss_pred CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC---CcCccceeeeEEeCCeEEEEEEecCCC
Q 021771 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ---HKNLVRLFGCCLEENESLLIYEYMPNK 69 (308)
Q Consensus 10 ~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~ 69 (308)
.+++.+.||.-. ......+..|+.-|+.|. .-.+++++.+...++..+|||||++.+
T Consensus 38 ~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 38 TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 578899999765 233457888999888884 456889999888777789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.084 Score=43.57 Aligned_cols=59 Identities=22% Similarity=0.315 Sum_probs=43.9
Q ss_pred CCCEEEEEEeccCCcccHHHHHHHHHHHhcCC---CcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ---HKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 11 ~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
+..++.+|+= .......+..|+.-|..+. .-++.+++.+-.+..+.++||||++.+.++
T Consensus 38 g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 38 GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 4567777742 2233456778888777774 456889999999999999999999886664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 308 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-44 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-36 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-31 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-31 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-30 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-22 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-22 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-22 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-19 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-19 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-11 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-11 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 6e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 7e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 7e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 379 bits (977), Expect = e-133
Identities = 89/266 (33%), Positives = 137/266 (51%), Gaps = 13/266 (4%)
Query: 7 GKLADGKEIAVKRLS----RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62
G + + +AVK+L+ T+ + Q+F E+ ++AK QH+NLV L G + ++ L+
Sbjct: 50 GYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108
Query: 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
Y YMPN SL L + L W R I G A G+ +LHE+ IHRD+K++N+L
Sbjct: 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
L+ KISDFG+AR T+RIVGT YMAPE + G + KSD++SFGV+L
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVL 224
Query: 183 LEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALE-LMEPVLKQSCVAAELLKFIHIGL 241
LEII+G + Q LL ++ E + +E ++ + + + +
Sbjct: 225 LEIITGLPAVDEHREP--QLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVAS 281
Query: 242 LCVQADSADRPTMSSVVVMLASDTVT 267
C+ RP + V +L T +
Sbjct: 282 QCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-128
Identities = 104/264 (39%), Positives = 152/264 (57%), Gaps = 5/264 (1%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
G+LADG +AVKRL QG + +F+ EV +I+ H+NL+RL G C+ E LL+Y Y
Sbjct: 49 GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108
Query: 66 MPNKSLDVFLFDSTRS-VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
M N S+ L + S LDW +R I G ARGL YLH+ KIIHRD+KA+N+LL+
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
E + DFG+A++ + T + GT G++APEY G S K+DVF +GV+LLE
Sbjct: 169 EEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLE 227
Query: 185 IISGKKNT--GFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL 242
+I+G++ ++ LL + L E + L++ L+ + E+ + I + LL
Sbjct: 228 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL 287
Query: 243 CVQADSADRPTMSSVVVMLASDTV 266
C Q+ +RP MS VV ML D +
Sbjct: 288 CTQSSPMERPKMSEVVRMLEGDGL 311
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-111
Identities = 93/257 (36%), Positives = 147/257 (57%), Gaps = 6/257 (2%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
G L DG ++A+KR + S QG++EF+ E+ ++ +H +LV L G C E NE +LIY+YM
Sbjct: 58 GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 67 PNKSLDVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
N +L L+ S + W++R+ I G ARGL YLH + IIHRD+K+ N+LL+
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174
Query: 126 EMNPKISDFGMARIF-GGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
PKI+DFG+++ +Q+ +T + GT GY+ PEY ++G + KSDV+SFGV+L E
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 185 IISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCV 244
++ + L +L + + G+ ++++P L L KF + C+
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 245 QADSADRPTMSSVVVML 261
S DRP+M V+ L
Sbjct: 294 ALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 7e-89
Identities = 66/278 (23%), Positives = 113/278 (40%), Gaps = 33/278 (11%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN----ESLLIYEYM 66
+ +AVK Q + + EV + ++H+N+++ G + LI +
Sbjct: 46 LNEYVAVKIFPIQDKQS-WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH 104
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-------SRLKIIHRDLKAS 119
SL FL + + W I +ARGL YLHED + I HRD+K+
Sbjct: 105 EKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160
Query: 120 NVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-----FSVKSD 174
NVLL + + I+DFG+A F +S +T+ VGT YMAPE + ++ D
Sbjct: 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220
Query: 175 VFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELME--------PVLKQ 226
+++ G++L E+ S + E +L + ++ ++ E PVL+
Sbjct: 221 MYAMGLVLWELASRCTAADGPVDEY---MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277
Query: 227 SCVAAELLK-FIHIGLLCVQADSADRPTMSSVVVMLAS 263
+ C D+ R + V +
Sbjct: 278 YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 5e-72
Identities = 62/299 (20%), Positives = 111/299 (37%), Gaps = 40/299 (13%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-----ENESLLIYEY 65
D + +AVK S + Q K + + ++H N+ R E LL+ EY
Sbjct: 35 DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED------SRLKIIHRDLKAS 119
PN SL +L T DW + + + RGL YLH + + I HRDL +
Sbjct: 94 YPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149
Query: 120 NVLLNHEMNPKISDFGMARIFGGN------QSEANTNRIVGTYGYMAPEYAMEGL----- 168
NVL+ ++ ISDFG++ GN + + VGT YMAPE +
Sbjct: 150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDX 209
Query: 169 --FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226
+ D+++ G++ EI + + + +++ ++ ++ V ++
Sbjct: 210 ESALKQVDMYALGLIYWEIFMRCTDLFPG-ESVPEYQMAFQTEVGNHPTFEDMQVLVSRE 268
Query: 227 ----------SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQPTEPA 275
+ + C D+ R T +A + + +
Sbjct: 269 KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-61
Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 31/262 (11%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
G+ + +K L R + + F EV ++ L+H N+++ G ++ I EY+ +L
Sbjct: 35 GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
+ Q W +R+S IA G+ YLH + IIHRDL + N L+ N +
Sbjct: 95 RGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVV 149
Query: 132 SDFGMARIFGGNQSEANTNR------------IVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
+DFG+AR+ +++ R +VG +MAPE + K DVFSFG
Sbjct: 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209
Query: 180 VLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239
++L EII YL L+ ++ +C + F I
Sbjct: 210 IVLCEIIGRVNADPDYLPRTMDFGLNVR----------GFLDRYCPPNCPPS----FFPI 255
Query: 240 GLLCVQADSADRPTMSSVVVML 261
+ C D RP+ + L
Sbjct: 256 TVRCCDLDPEKRPSFVKLEHWL 277
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-61
Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 35/275 (12%)
Query: 12 GKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
G ++AVK L + + EF EV ++ +L+H N+V G + ++ EY+
Sbjct: 60 GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
SL L S QLD +RR+S+ +A+G+ YLH I+HR+LK+ N+L++ +
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
K+ DFG++R+ + + GT +MAPE + + KSDV+SFGV+L E+ + +
Sbjct: 179 KVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
Query: 190 KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ-------SCVAAELLKFIHIGLL 242
+ W +++ V + + ++ I
Sbjct: 237 -------------------QPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE---G 274
Query: 243 CVQADSADRPTMSSVVVMLAS-DTVTLPQPTEPAF 276
C + RP+ ++++ +L +P P
Sbjct: 275 CWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-61
Identities = 71/264 (26%), Positives = 116/264 (43%), Gaps = 24/264 (9%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
K++A+K++ S + F E+ ++++ H N+V+L+G CL L+ EY SL
Sbjct: 31 AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSL 86
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN-PK 130
L + +S ++G+ YLH +IHRDLK N+LL K
Sbjct: 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 146
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 190
I DFG A + + G+ +MAPE +S K DVFS+G++L E+I+ +K
Sbjct: 147 ICDFGTACD-----IQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
Query: 191 NTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSAD 250
+ E+G W + G L++ + K L+ C D +
Sbjct: 202 ---PF-DEIGGPAFRIMWAV-HNGTRPPLIKNLPKP---IESLMT------RCWSKDPSQ 247
Query: 251 RPTMSSVVVMLASDTVTLPQPTEP 274
RP+M +V ++ P EP
Sbjct: 248 RPSMEEIVKIMTHLMRYFPGADEP 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-58
Identities = 66/266 (24%), Positives = 125/266 (46%), Gaps = 37/266 (13%)
Query: 10 ADGKEIAVKRLSRTSGQG-------LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62
D +A+K L +G QEF+ EV +++ L H N+V+L+G ++
Sbjct: 42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV 99
Query: 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
E++P L L D ++ + W ++ ++ IA G+ Y+ + I+HRDL++ N+
Sbjct: 100 MEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIF 156
Query: 123 L-----NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE--YAMEGLFSVKSDV 175
L N + K++DFG+++ S + + ++G + +MAPE A E ++ K+D
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADT 211
Query: 176 FSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235
+SF ++L I++G+ + E + + + EG + P + C +
Sbjct: 212 YSFAMILYTILTGEG---PF-DEYSYGKIKFINMIREEGLRPTI--P---EDCPP----R 258
Query: 236 FIHIGLLCVQADSADRPTMSSVVVML 261
++ LC D RP S +V L
Sbjct: 259 LRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 8e-58
Identities = 64/256 (25%), Positives = 118/256 (46%), Gaps = 28/256 (10%)
Query: 14 EIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
++AVK L + + Q LQ FKNEV ++ K +H N++ G ++ + ++ SL
Sbjct: 48 DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSL 106
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
L + + K+ I I ARG+ YLH IIHRDLK++N+ L+ + KI
Sbjct: 107 YHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKI 161
Query: 132 SDFGMARIFGGNQSEANTNRIVGTYGYMAPE---YAMEGLFSVKSDVFSFGVLLLEIISG 188
DFG+A ++ G+ +MAPE +S +SDV++FG++L E+++G
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221
Query: 189 K---KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
+ N ++ Q + + +L ++ +C + C++
Sbjct: 222 QLPYSN----INNRDQII----EMV--GRGSLSPDLSKVRSNCPKR----MKRLMAECLK 267
Query: 246 ADSADRPTMSSVVVML 261
+RP+ ++ +
Sbjct: 268 KKRDERPSFPRILAEI 283
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-57
Identities = 72/269 (26%), Positives = 118/269 (43%), Gaps = 49/269 (18%)
Query: 12 GKEIAVKRL----SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
G E+AVK Q ++ + E L A L+H N++ L G CL+E L+ E+
Sbjct: 30 GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
L+ L ++ ++ IARG+ YLH+++ + IIHRDLK+SN+L+ ++
Sbjct: 90 GGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145
Query: 128 NP--------KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
KI+DFG+AR + + G Y +MAPE +FS SDV+S+G
Sbjct: 146 ENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSYG 201
Query: 180 VLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ-------SCVAAE 232
VLL E+++G+ + + L + V S
Sbjct: 202 VLLWELLTGE-------------------VPFRGIDGLAVAYGVAMNKLALPIPSTCPEP 242
Query: 233 LLKFIHIGLLCVQADSADRPTMSSVVVML 261
K + C D RP+ ++++ L
Sbjct: 243 FAKLME---DCWNPDPHSRPSFTNILDQL 268
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-56
Identities = 58/258 (22%), Positives = 106/258 (41%), Gaps = 33/258 (12%)
Query: 12 GKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL--IYEYMP 67
G +I VK L S + ++F E + H N++ + G C I +MP
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
SL L + T V +D + + +ARG+ +LH I L + +V+++ +M
Sbjct: 93 YGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDM 150
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG----LFSVKSDVFSFGVLLL 183
+IS + F + + ++APE A++ +D++SF VLL
Sbjct: 151 TARISMADVKFSF-------QSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLW 202
Query: 184 EIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLC 243
E+++ + + S + K+ EG + P ++ + K + I C
Sbjct: 203 ELVTREV---PF---ADLSNMEIGMKVALEGLRPTI--P----PGISPHVSKLMKI---C 247
Query: 244 VQADSADRPTMSSVVVML 261
+ D A RP +V +L
Sbjct: 248 MNEDPAKRPKFDMIVPIL 265
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 1e-53
Identities = 58/267 (21%), Positives = 109/267 (40%), Gaps = 45/267 (16%)
Query: 14 EIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
E+A++ + R + L+ FK EV + +H+N+V G C+ +I ++L
Sbjct: 57 EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116
Query: 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131
+ D + LD + I I +G+ YLH I+H+DLK+ NV + I
Sbjct: 117 YSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVI 170
Query: 132 SDFGMARIFGGNQSEANTNRI---VGTYGYMAPE---------YAMEGLFSVKSDVFSFG 179
+DFG+ I G Q+ +++ G ++APE + FS SDVF+ G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230
Query: 180 VLLLEIISGKK-----NTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234
+ E+ + + + ++G + ++ E +++
Sbjct: 231 TIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILL------------- 277
Query: 235 KFIHIGLLCVQADSADRPTMSSVVVML 261
C + +RPT + ++ ML
Sbjct: 278 -------FCWAFEQEERPTFTKLMDML 297
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-49
Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 43/282 (15%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNE--VTLIAKLQHKNLVRLFGCCLEENES----LLIYEY 65
G+ +AVK S + + + E + L+H+N++ + S LI Y
Sbjct: 31 GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKASN 120
SL +L + LD + I+ IA GL +LH + + I HRDLK+ N
Sbjct: 88 HEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
Query: 121 VLLNHEMNPKISDFGMARIF--GGNQSEANTNRIVGTYGYMAPE------YAMEGLFSVK 172
+L+ I+D G+A + NQ + N VGT YMAPE +
Sbjct: 144 ILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR 203
Query: 173 SDVFSFGVLLLEIISGKKNTGF-------YLSELG-QSLLSYTWKLWC-EGEALELMEPV 223
D+++FG++L E+ + G + + K+ C + + +
Sbjct: 204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRW 263
Query: 224 LKQSCVA--AELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263
+ A+L+K C + + R T + L
Sbjct: 264 FSDPTLTSLAKLMK------ECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-48
Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 45/283 (15%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNE--VTLIAKLQHKNLVRLFGCCLEENES----LLIYEY 65
G+++AVK + E + ++H+N++ ++ S LI +Y
Sbjct: 60 GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKASN 120
N SL +L +S LD K + + GL +LH + + I HRDLK+ N
Sbjct: 117 HENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 121 VLLNHEMNPKISDFGMARIF--GGNQSEANTNRIVGTYGYMAPEYAMEGLFSV------- 171
+L+ I+D G+A F N+ + N VGT YM PE ++ +
Sbjct: 173 ILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYI 231
Query: 172 KSDVFSFGVLLLEIISGKKNTGF-------YLSELG-QSLLSYTWKLWC-EGEALELMEP 222
+D++SFG++L E+ + G Y + ++ C +
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR 291
Query: 223 VLKQSCVA--AELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263
C+ +L+ C + A R T V LA
Sbjct: 292 WSSDECLRQMGKLMT------ECWAHNPASRLTALRVKKTLAK 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-46
Identities = 62/284 (21%), Positives = 116/284 (40%), Gaps = 45/284 (15%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNE--VTLIAKLQHKNLVRLFGCCLEENES----LLIYE 64
G+E+AVK S + + + E + L+H+N++ ++N + L+ +
Sbjct: 64 RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKAS 119
Y + SL +L + + I + A GL +LH + + I HRDLK+
Sbjct: 121 YHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176
Query: 120 NVLLNHEMNPKISDFGMARIF--GGNQSEANTNRIVGTYGYMAPEYAMEGLFSV------ 171
N+L+ I+D G+A + + N VGT YMAPE ++ ++
Sbjct: 177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESF 235
Query: 172 -KSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELME--------- 221
++D+++ G++ EI G + L Y + L ++E M
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIH----EDYQLPY-YDLVPSDPSVEEMRKVVCEQKLR 290
Query: 222 PVLKQSCVAAELLKFIHIGLL--CVQADSADRPTMSSVVVMLAS 263
P + + E L+ + ++ C A+ A R T + L+
Sbjct: 291 PNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-45
Identities = 69/297 (23%), Positives = 118/297 (39%), Gaps = 54/297 (18%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES--LLIYEYMPNK 69
G +AVK+L + ++F+ E+ ++ L +V+ G L+ EY+P+
Sbjct: 52 GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
L FL +LD R + + I +G+ YL + +HRDL A N+L+ E +
Sbjct: 112 CLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHV 166
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLE 184
KI+DFG+A++ ++ +V G + APE + +FS +SDV+SFGV+L E
Sbjct: 167 KIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 222
Query: 185 IISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG---- 240
+ + K M + + LL+ + G
Sbjct: 223 LFT-----------YCD-------KSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLP 264
Query: 241 -------------LLCVQADSADRPTMSSVVVML---ASDTVTLPQPTEPAFSVGRN 281
LC DRP+ S++ L S + A G++
Sbjct: 265 APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKH 321
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-44
Identities = 69/265 (26%), Positives = 121/265 (45%), Gaps = 32/265 (12%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES--LLIYEYMPNK 69
G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V+ G C LI EY+P
Sbjct: 39 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
SL +L ++D + + + I +G+ YL + IHRDL N+L+ +E
Sbjct: 99 SLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRV 153
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLE 184
KI DFG+ ++ ++ V G + APE E FSV SDV+SFGV+L E
Sbjct: 154 KIGDFGLTKVLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 209
Query: 185 IISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELME-------PVLKQSCVAAELLKFI 237
+ + + + +E + + + +EL++ P C I
Sbjct: 210 LFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP---DGCPDE-----I 261
Query: 238 H-IGLLCVQADSADRPTMSSVVVML 261
+ I C + RP+ + + +
Sbjct: 262 YMIMTECWNNNVNQRPSFRDLALRV 286
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 69/266 (25%), Positives = 121/266 (45%), Gaps = 32/266 (12%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES--LLIYEYMPN 68
G+ +AVK+L ++ + L++F+ E+ ++ LQH N+V+ G C LI EY+P
Sbjct: 69 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
SL +L ++D + + + I +G+ YL + IHRDL N+L+ +E
Sbjct: 129 GSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 183
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLL 183
KI DFG+ ++ ++ V G + APE E FSV SDV+SFGV+L
Sbjct: 184 VKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
Query: 184 EIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELME-------PVLKQSCVAAELLKF 236
E+ + + + +E + + + +EL++ P C
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP---DGCPDE----- 291
Query: 237 IH-IGLLCVQADSADRPTMSSVVVML 261
I+ I C + RP+ + + +
Sbjct: 292 IYMIMTECWNNNVNQRPSFRDLALRV 317
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-44
Identities = 65/274 (23%), Positives = 108/274 (39%), Gaps = 56/274 (20%)
Query: 16 AVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES--LLIYEYMPNKSLD 72
AVK L +G Q +K E+ ++ L H+++++ GCC + + L+ EY+P SL
Sbjct: 64 AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123
Query: 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132
+L + + + I G+ YLH IHRDL A NVLL+++ KI
Sbjct: 124 DYL----PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIG 176
Query: 133 DFGMARIFGGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
DFG+A+ V G + APE E F SDV+SFGV L E+++
Sbjct: 177 DFGLAKAVPEGHEYYR----VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
Query: 188 -GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG------ 240
+ L ++ L + + G
Sbjct: 233 HCDSSQSPPTKFLELIGIAQ-------------------GQMTVLRLTELLERGERLPRP 273
Query: 241 -----------LLCVQADSADRPTMSSVVVMLAS 263
C + +++ RPT +++ +L +
Sbjct: 274 DKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-44
Identities = 61/268 (22%), Positives = 119/268 (44%), Gaps = 36/268 (13%)
Query: 11 DGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES--LLIYEYMP 67
G+++AVK L + G + + K E+ ++ L H+N+V+ G C E+ + LI E++P
Sbjct: 49 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
+ SL +L +++ K+++ I +G+ YL + +HRDL A NVL+ E
Sbjct: 109 SGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEH 163
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLL 182
KI DFG+ + ++ V + APE M+ F + SDV+SFGV L
Sbjct: 164 QVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
Query: 183 LEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELME-------PVLKQSCVAAELL 234
E+++ ++ L ++ + ++ P +C
Sbjct: 220 HELLTYCDSDSSPMALFLKMIGPTHGQMTVT--RLVNTLKEGKRLPCP---PNCPDE--- 271
Query: 235 KFIH-IGLLCVQADSADRPTMSSVVVML 261
++ + C + ++R + +++
Sbjct: 272 --VYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-44
Identities = 58/184 (31%), Positives = 84/184 (45%), Gaps = 7/184 (3%)
Query: 6 QGKL-ADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
G+L AD +AVK +F E ++ + H N+VRL G C ++ ++
Sbjct: 132 SGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
E + FL T +L K + ++ A G+ YL IHRDL A N L+
Sbjct: 192 ELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLV 246
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
+ KISDFGM+R A+ + APE G +S +SDV+SFG+LL
Sbjct: 247 TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306
Query: 184 EIIS 187
E S
Sbjct: 307 ETFS 310
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 61/189 (32%), Positives = 95/189 (50%), Gaps = 25/189 (13%)
Query: 16 AVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75
AVK L S Q+F+ E L+ LQH+++VR FG C E L+++EYM + L+ FL
Sbjct: 75 AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFL 134
Query: 76 ------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
+ L + +++ + +A G++YL + L +HRDL N L+
Sbjct: 135 RSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLV 191
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSF 178
+ KI DFGM+R + + R VG +M PE + F+ +SDV+SF
Sbjct: 192 GQGLVVKIGDFGMSR----DIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSF 246
Query: 179 GVLLLEIIS 187
GV+L EI +
Sbjct: 247 GVVLWEIFT 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-43
Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 28/191 (14%)
Query: 16 AVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75
AVK L + ++F+ E L+ LQH+++V+ +G C + + ++++EYM + L+ FL
Sbjct: 49 AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFL 108
Query: 76 -------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
+L + + I + IA G++YL + +HRDL N L
Sbjct: 109 RAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCL 165
Query: 123 LNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEGLFSVKSDVF 176
+ + KI DFGM+R ++ + + R +M PE M F+ +SDV+
Sbjct: 166 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVW 219
Query: 177 SFGVLLLEIIS 187
SFGV+L EI +
Sbjct: 220 SFGVILWEIFT 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-42
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 31/205 (15%)
Query: 5 LQGKLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
L G + A+K L + G +EF++E L A+LQH N+V L G ++ +
Sbjct: 30 LFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 89
Query: 62 IYEYMPNKSLDVFL-------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSR 108
I+ Y + L FL D T L+ + ++ IA G+ YL S
Sbjct: 90 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SS 146
Query: 109 LKIIHRDLKASNVLLNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPE 162
++H+DL NVL+ ++N KISD G+ R ++ + + N R +MAPE
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR------WMAPE 200
Query: 163 YAMEGLFSVKSDVFSFGVLLLEIIS 187
M G FS+ SD++S+GV+L E+ S
Sbjct: 201 AIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 58/189 (30%), Positives = 102/189 (53%), Gaps = 19/189 (10%)
Query: 8 KLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
++ +++ A+K L + + + ++F +E +++ + H N++RL G ++++ E
Sbjct: 71 RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTE 130
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
YM N SLD FL T Q + + ++ G+ G+ YL S L +HRDL A NVL++
Sbjct: 131 YMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYVHRDLAARNVLVD 185
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSF 178
+ K+SDFG++R+ + A T T G + APE FS SDV+SF
Sbjct: 186 SNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEAIAFRTFSSASDVWSF 240
Query: 179 GVLLLEIIS 187
GV++ E+++
Sbjct: 241 GVVMWEVLA 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-42
Identities = 62/179 (34%), Positives = 91/179 (50%), Gaps = 16/179 (8%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMPNKS 70
G ++AVK + + Q F E +++ +L+H NLV+L G +EE L ++ EYM S
Sbjct: 216 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273
Query: 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
L +L RS L + + + YL +HRDL A NVL++ + K
Sbjct: 274 LVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAK 329
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGY--MAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+SDFG+ + EA++ + G APE E FS KSDV+SFG+LL EI S
Sbjct: 330 VSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-42
Identities = 55/177 (31%), Positives = 90/177 (50%), Gaps = 16/177 (9%)
Query: 16 AVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75
AVK L + ++EF E ++ +++H NLV+L G C E +I E+M +L +L
Sbjct: 42 AVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
Query: 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFG 135
+ R ++ + + I+ + YL + IHRDL A N L+ K++DFG
Sbjct: 101 RECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFG 156
Query: 136 MARIFGGNQSEANTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
++R+ G+ A+ + + APE FS+KSDV++FGVLL EI +
Sbjct: 157 LSRLMTGDTYTAHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 8e-42
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 23/186 (12%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
A+K + S + EF NE +++ + ++VRL G + +L+I E M L +
Sbjct: 59 AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 75 L-------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
L ++ + I + IA G+ YL+ K +HRDL A N ++ +
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDF 175
Query: 128 NPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
KI DFGM R I+ + R +M+PE +G+F+ SDV+SFGV+
Sbjct: 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVV 229
Query: 182 LLEIIS 187
L EI +
Sbjct: 230 LWEIAT 235
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-41
Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
GK ++A+K + + EF E ++ L H+ LV+L+G C ++ +I EY
Sbjct: 42 YGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
M N L +L + ++ + + + + YL + +HRDL A N L+N
Sbjct: 101 MANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVND 155
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ K+SDFG++R ++ ++ G+ + PE M FS KSD+++FGVL+
Sbjct: 156 QGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 183 LEIIS 187
EI S
Sbjct: 212 WEIYS 216
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 54/172 (31%), Positives = 90/172 (52%), Gaps = 6/172 (3%)
Query: 16 AVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75
AVK L + + ++EF E ++ +++H NLV+L G C E +I E+M +L +L
Sbjct: 249 AVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
Query: 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFG 135
+ R ++ + + I+ + YL + IHR+L A N L+ K++DFG
Sbjct: 308 RECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFG 363
Query: 136 MARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
++R+ G+ A+ + APE FS+KSDV++FGVLL EI +
Sbjct: 364 LSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 52/182 (28%), Positives = 96/182 (52%), Gaps = 18/182 (9%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
A+K L TS + +E +E ++A + + ++ RL G CL LI + MP L +
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDY 106
Query: 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134
+ + ++ + ++ IA+G+ YL +++HRDL A NVL+ + KI+DF
Sbjct: 107 VREHKDNIGS--QYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 135 GMARIFGGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-G 188
G+A++ G + E + G +MA E + +++ +SDV+S+GV + E+++ G
Sbjct: 162 GLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216
Query: 189 KK 190
K
Sbjct: 217 SK 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-41
Identities = 61/186 (32%), Positives = 99/186 (53%), Gaps = 13/186 (6%)
Query: 8 KLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
KL KEI A+K L + + ++F E +++ + H N++RL G + +++ E
Sbjct: 67 KLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTE 126
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
YM N SLD FL Q + + ++ GIA G+ YL S + +HRDL A N+L+N
Sbjct: 127 YMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILIN 181
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVL 181
+ K+SDFG+ R+ + A T R G + +PE F+ SDV+S+G++
Sbjct: 182 SNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239
Query: 182 LLEIIS 187
L E++S
Sbjct: 240 LWEVMS 245
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 53/179 (29%), Positives = 94/179 (52%), Gaps = 17/179 (9%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
A+K L + + + +F E ++ + H N++RL G + ++I EYM N +LD F
Sbjct: 77 AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134
L + + + + ++ GIA G+ YL + + +HRDL A N+L+N + K+SDF
Sbjct: 137 L--REKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDF 191
Query: 135 GMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
G++R+ + T T G + APE F+ SDV+SFG+++ E+++
Sbjct: 192 GLSRVLEDDPEATYT-----TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 58/185 (31%), Positives = 94/185 (50%), Gaps = 13/185 (7%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
++AVK + + ++ F E ++ LQH LV+L +E +I E+
Sbjct: 206 MATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEF 263
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
M SL FL S + + I IA G+ ++ + IHRDL+A+N+L++
Sbjct: 264 MAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVSA 319
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ KI+DFG+AR+ N+ A G + APE G F++KSDV+SFG+LL
Sbjct: 320 SLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375
Query: 183 LEIIS 187
+EI++
Sbjct: 376 MEIVT 380
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 25/199 (12%)
Query: 5 LQGKLADGKEIAVKRLSR--TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN----- 57
L+ + ++AVK + +S + ++EF +E + H N++RL G C+E +
Sbjct: 55 LKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114
Query: 58 ESLLIYEYMPNKSLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 114
+ ++I +M L +L S T + + + + IA G+ YL S +HR
Sbjct: 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHR 171
Query: 115 DLKASNVLLNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEGL 168
DL A N +L +M ++DFG+++ I+ G+ + ++A E + +
Sbjct: 172 DLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK------WIAIESLADRV 225
Query: 169 FSVKSDVFSFGVLLLEIIS 187
++ KSDV++FGV + EI +
Sbjct: 226 YTSKSDVWAFGVTMWEIAT 244
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-41
Identities = 58/185 (31%), Positives = 92/185 (49%), Gaps = 13/185 (7%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
G + ++A+K + R ++F E ++ KL H LV+L+G CLE+ L+ E+
Sbjct: 26 LGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
M + L +L T+ + + + + G+ YL +IHRDL A N L+
Sbjct: 85 MEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGE 139
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLL 182
K+SDFGM R +Q ++T GT + +PE +S KSDV+SFGVL+
Sbjct: 140 NQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLM 195
Query: 183 LEIIS 187
E+ S
Sbjct: 196 WEVFS 200
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-41
Identities = 63/185 (34%), Positives = 99/185 (53%), Gaps = 13/185 (7%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
G ++AVK L + F E L+ +LQH+ LVRL+ +E +I EY
Sbjct: 31 MGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEY 88
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
M N SL FL + ++L + + + IA G+ ++ IHRDL+A+N+L++
Sbjct: 89 MENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSD 144
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLL 182
++ KI+DFG+AR+ N+ A G + APE G F++KSDV+SFG+LL
Sbjct: 145 TLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200
Query: 183 LEIIS 187
EI++
Sbjct: 201 TEIVT 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-41
Identities = 60/186 (32%), Positives = 85/186 (45%), Gaps = 24/186 (12%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI-YEYMP 67
G ++AVK + + Q F E +++ +L+H NLV+L G +EE L I EYM
Sbjct: 41 DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
SL +L RS L + + + YL +HRDL A NVL++ +
Sbjct: 99 KGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDN 154
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVL 181
K+SDFG+ + + APE E FS KSDV+SFG+L
Sbjct: 155 VAKVSDFGLTK-----------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 203
Query: 182 LLEIIS 187
L EI S
Sbjct: 204 LWEIYS 209
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-41
Identities = 61/190 (32%), Positives = 91/190 (47%), Gaps = 19/190 (10%)
Query: 8 KLADGKEI--AVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL-IY 63
DGK+I AVK L+R T + +F E ++ H N++ L G CL S L +
Sbjct: 47 LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
YM + L F+ + T K I +A+G+ YL K +HRDL A N +L
Sbjct: 107 PYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCML 161
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDVFS 177
+ + K++DFG+AR + + G +MA E F+ KSDV+S
Sbjct: 162 DEKFTVKVADFGLARDM----YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 217
Query: 178 FGVLLLEIIS 187
FGVLL E+++
Sbjct: 218 FGVLLWELMT 227
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-41
Identities = 55/185 (29%), Positives = 91/185 (49%), Gaps = 13/185 (7%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
GK ++AVK + + EF E + KL H LV+ +G C +E ++ EY
Sbjct: 26 LGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ N L +L + L+ + + + + G+ +L + IHRDL A N L++
Sbjct: 85 ISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDR 139
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFGVLL 182
++ K+SDFGM R +Q ++ GT + APE +S KSDV++FG+L+
Sbjct: 140 DLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILM 195
Query: 183 LEIIS 187
E+ S
Sbjct: 196 WEVFS 200
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-41
Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 30/193 (15%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
AVK L + + L + +E+ ++ + +HKN++ L G C ++ +I EY +L
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 74 FL-------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
+L + Q+ +K +S +ARG+ YL + K IHRDL A N
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARN 187
Query: 121 VLLNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEGLFSVKSD 174
VL+ KI+DFG+AR I + + TN + +MAPE + +++ +SD
Sbjct: 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSD 241
Query: 175 VFSFGVLLLEIIS 187
V+SFGVL+ EI +
Sbjct: 242 VWSFGVLMWEIFT 254
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 66/198 (33%), Positives = 87/198 (43%), Gaps = 23/198 (11%)
Query: 5 LQGKLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
+ G D + AVK L S Q +F E +I+K H+N+VR G L+ +
Sbjct: 51 VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 110
Query: 62 IYEYMPNKSLDVFL----FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
+ E M L FL ++ L + + IA G YL IHRD+
Sbjct: 111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIA 167
Query: 118 ASNVLLN---HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY-----MAPEYAMEGLF 169
A N LL KI DFGMAR + A+ R G M PE MEG+F
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYR-KGGCAMLPVKWMPPEAFMEGIF 222
Query: 170 SVKSDVFSFGVLLLEIIS 187
+ K+D +SFGVLL EI S
Sbjct: 223 TSKTDTWSFGVLLWEIFS 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-40
Identities = 57/187 (30%), Positives = 88/187 (47%), Gaps = 9/187 (4%)
Query: 5 LQGKLADGKEIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI- 62
+ + + A+K LSR T Q ++ F E L+ L H N++ L G L +
Sbjct: 42 YIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101
Query: 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
YM + L F+ R+ + K IS +ARG+ YL + K +HRDL A N +
Sbjct: 102 LPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL---AEQKFVHRDLAARNCM 156
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY--GYMAPEYAMEGLFSVKSDVFSFGV 180
L+ K++DFG+AR + + + A E F+ KSDV+SFGV
Sbjct: 157 LDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGV 216
Query: 181 LLLEIIS 187
LL E+++
Sbjct: 217 LLWELLT 223
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-40
Identities = 59/193 (30%), Positives = 97/193 (50%), Gaps = 30/193 (15%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
AVK L + + L + +E+ ++ + +HKN++ L G C ++ +I EY +L
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 74 FL-------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
+L + Q+ +K +S +ARG+ YL + K IHRDL A N
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARN 233
Query: 121 VLLNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEGLFSVKSD 174
VL+ KI+DFG+AR I + + TN + +MAPE + +++ +SD
Sbjct: 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSD 287
Query: 175 VFSFGVLLLEIIS 187
V+SFGVL+ EI +
Sbjct: 288 VWSFGVLMWEIFT 300
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-40
Identities = 66/198 (33%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 5 LQGKLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
+ G D + AVK L S Q +F E +I+K H+N+VR G L+ +
Sbjct: 92 VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151
Query: 62 IYEYMPNKSLDVFL----FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
+ E M L FL ++ L + + IA G YL IHRD+
Sbjct: 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL---EENHFIHRDIA 208
Query: 118 ASNVLLN---HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY-----MAPEYAMEGLF 169
A N LL KI DFGMAR + A R G M PE MEG+F
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYR-KGGCAMLPVKWMPPEAFMEGIF 263
Query: 170 SVKSDVFSFGVLLLEIIS 187
+ K+D +SFGVLL EI S
Sbjct: 264 TSKTDTWSFGVLLWEIFS 281
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-40
Identities = 59/200 (29%), Positives = 90/200 (45%), Gaps = 37/200 (18%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
AVK L S +F+ E L+A+ + N+V+L G C L++EYM L+ F
Sbjct: 81 AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 140
Query: 75 L---------------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 113
L S L ++ I +A G+ YL S K +H
Sbjct: 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVH 197
Query: 114 RDLKASNVLLNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEG 167
RDL N L+ M KI+DFG++R I+ + +A+ N R +M PE
Sbjct: 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR------WMPPESIFYN 251
Query: 168 LFSVKSDVFSFGVLLLEIIS 187
++ +SDV+++GV+L EI S
Sbjct: 252 RYTTESDVWAYGVVLWEIFS 271
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 26/200 (13%)
Query: 5 LQGKLADGKEIAVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES--- 59
L+ + ++AVK L + ++EF E + + H ++ +L G L
Sbjct: 44 LKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103
Query: 60 ---LLIYEYMPNKSLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 113
++I +M + L FL S L + + + IA G+ YL S IH
Sbjct: 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIH 160
Query: 114 RDLKASNVLLNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEG 167
RDL A N +L +M ++DFG++R I+ G+ + ++A E +
Sbjct: 161 RDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK------WLALESLADN 214
Query: 168 LFSVKSDVFSFGVLLLEIIS 187
L++V SDV++FGV + EI++
Sbjct: 215 LYTVHSDVWAFGVTMWEIMT 234
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-40
Identities = 44/189 (23%), Positives = 85/189 (44%), Gaps = 32/189 (16%)
Query: 14 EIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
E+ +K L + + F ++++KL HK+LV +G C+ +E++L+ E++ SLD
Sbjct: 42 EVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDT 101
Query: 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP---- 129
+L + + + WK + + +A + +L +IH ++ A N+LL E +
Sbjct: 102 YLKKNKNCINILWK--LEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGN 156
Query: 130 ----KISDFGMARIFGGNQSEANTNRIVGTYGY------MAPEYAMEG-LFSVKSDVFSF 178
K+SD G++ ++ + PE ++ +D +SF
Sbjct: 157 PPFIKLSDPGISIT------------VLPKDILQERIPWVPPECIENPKNLNLATDKWSF 204
Query: 179 GVLLLEIIS 187
G L EI S
Sbjct: 205 GTTLWEICS 213
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-40
Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 18/186 (9%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
AVK L S + +E+ +++ L QH+N+V L G C L+I EY L
Sbjct: 80 AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 74 FLFDSTRSVQ-----------LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
FL +R ++ + + + +A+G+ +L + IHRD+ A NVL
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVL 196
Query: 123 LNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
L + KI DFG+AR I + N + +MAPE + +++V+SDV+S+G+L
Sbjct: 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-PVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 182 LLEIIS 187
L EI S
Sbjct: 256 LWEIFS 261
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 37/200 (18%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
AVK L S L++ +E ++ ++ H ++++L+G C ++ LLI EY SL F
Sbjct: 57 AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 75 L---------------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 113
L D L IS I++G+ YL + +K++H
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVH 173
Query: 114 RDLKASNVLLNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEG 167
RDL A N+L+ KISDFG++R ++ + + + +MA E +
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDH 227
Query: 168 LFSVKSDVFSFGVLLLEIIS 187
+++ +SDV+SFGVLL EI++
Sbjct: 228 IYTTQSDVWSFGVLLWEIVT 247
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-40
Identities = 46/178 (25%), Positives = 84/178 (47%), Gaps = 17/178 (9%)
Query: 16 AVKRLSRTSG-QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
+K + SG Q Q + + I L H ++VRL G C L+ +Y+P SL
Sbjct: 46 CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDH 104
Query: 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134
+ ++ + ++ IA+G+ YL ++HR+L A NVLL +++DF
Sbjct: 105 VRQHRGALGP--QLLLNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADF 159
Query: 135 GMARIFGGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
G+A + + + + +MA E G ++ +SDV+S+GV + E+++
Sbjct: 160 GVADLLPPDDKQLLYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-40
Identities = 57/188 (30%), Positives = 77/188 (40%), Gaps = 16/188 (8%)
Query: 8 KLADGKEI--AVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62
GK + AVK L + + + +F EV + L H+NL+RL+G L ++
Sbjct: 40 DAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMV 98
Query: 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
E P SL L L +A G+ YL E R IHRDL A N+L
Sbjct: 99 TELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYL-ESKRF--IHRDLAARNLL 153
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSFG 179
L KI DFG+ R N + + APE FS SD + FG
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFG 211
Query: 180 VLLLEIIS 187
V L E+ +
Sbjct: 212 VTLWEMFT 219
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-40
Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 22/190 (11%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
AVK L + +E+ +++ L H N+V L G C +L+I EY L
Sbjct: 57 AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 74 FL---------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
FL + LD + +S +A+G+ +L + IHRDL A
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAA 173
Query: 119 SNVLLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177
N+LL H KI DFG+AR I + N + +MAPE +++ +SDV+S
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWS 232
Query: 178 FGVLLLEIIS 187
+G+ L E+ S
Sbjct: 233 YGIFLWELFS 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-40
Identities = 60/190 (31%), Positives = 93/190 (48%), Gaps = 19/190 (10%)
Query: 8 KLADGKEI--AVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL-IY 63
DGK+I AVK L+R T + +F E ++ H N++ L G CL S L +
Sbjct: 111 LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
YM + L F+ + T K I +A+G+ +L + K +HRDL A N +L
Sbjct: 171 PYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCML 225
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDVFS 177
+ + K++DFG+AR + + + G +MA E F+ KSDV+S
Sbjct: 226 DEKFTVKVADFGLARDM----YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWS 281
Query: 178 FGVLLLEIIS 187
FGVLL E+++
Sbjct: 282 FGVLLWELMT 291
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-40
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 31/194 (15%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESL-LIYEYMPNKSLD 72
AVK L + + +E+ ++ + H N+V L G C + L +I E+ +L
Sbjct: 61 AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 73 VFL-------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
+L + L + I +A+G+ +L + K IHRDL A
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAAR 177
Query: 120 NVLLNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEGLFSVKS 173
N+LL+ + KI DFG+AR I+ + + +MAPE + +++++S
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQS 231
Query: 174 DVFSFGVLLLEIIS 187
DV+SFGVLL EI S
Sbjct: 232 DVWSFGVLLWEIFS 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-40
Identities = 50/178 (28%), Positives = 93/178 (52%), Gaps = 17/178 (9%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74
A+K L TS + +E +E ++A + + ++ RL G CL LI + MP L +
Sbjct: 48 AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDY 106
Query: 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDF 134
+ + + + ++ IA+G+ YL +++HRDL A NVL+ + KI+DF
Sbjct: 107 VREHKD--NIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 135 GMARIFGGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
G+A++ G + E + G +MA E + +++ +SDV+S+GV + E+++
Sbjct: 162 GLAKLLGAEEKEYHAEG-----GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 1e-39
Identities = 59/182 (32%), Positives = 96/182 (52%), Gaps = 7/182 (3%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
G +A+K L + + F E ++ KL+H+ LV+L+ EE ++ EY
Sbjct: 285 MGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEY 342
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
M SL FL T L + + + IA G+ Y+ R+ +HRDL+A+N+L+
Sbjct: 343 MSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGE 398
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ K++DFG+AR+ N+ A + APE A+ G F++KSDV+SFG+LL E+
Sbjct: 399 NLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 186 IS 187
+
Sbjct: 458 TT 459
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 55/192 (28%), Positives = 86/192 (44%), Gaps = 21/192 (10%)
Query: 6 QGKL-ADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
QG K+I A+K L T +E E ++ +L + +VRL G C E +L
Sbjct: 28 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LML 86
Query: 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
+ E L FL + ++ +++ ++ G+ YL +HRDL A NV
Sbjct: 87 VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNV 141
Query: 122 LLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDV 175
LL + KISDFG+++ G + S + APE FS +SDV
Sbjct: 142 LLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECINFRKFSSRSDV 196
Query: 176 FSFGVLLLEIIS 187
+S+GV + E +S
Sbjct: 197 WSYGVTMWEALS 208
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 59/182 (32%), Positives = 96/182 (52%), Gaps = 7/182 (3%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
G +A+K L + + F E ++ KL+H+ LV+L+ EE ++ EY
Sbjct: 202 MGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEY 259
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
M SL FL T L + + + IA G+ Y+ R+ +HRDL+A+N+L+
Sbjct: 260 MSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGE 315
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ K++DFG+AR+ N+ A + APE A+ G F++KSDV+SFG+LL E+
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 186 IS 187
+
Sbjct: 375 TT 376
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 62/193 (32%), Positives = 97/193 (50%), Gaps = 30/193 (15%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
AVK L S + + L + +E+ ++ + +HKN++ L G C ++ +I EY +L
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 74 FL-------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
+L QL K +S +ARG+ YL + K IHRDL A N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARN 221
Query: 121 VLLNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEGLFSVKSD 174
VL+ + KI+DFG+AR I + + TN + +MAPE + +++ +SD
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSD 275
Query: 175 VFSFGVLLLEIIS 187
V+SFGVLL EI +
Sbjct: 276 VWSFGVLLWEIFT 288
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-39
Identities = 52/180 (28%), Positives = 83/180 (46%), Gaps = 20/180 (11%)
Query: 16 AVKRL--SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
AVK L E E ++ +L + +VR+ G C E+ +L+ E L+
Sbjct: 48 AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNK 106
Query: 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISD 133
+L ++ + K I +++ ++ G+ YL +HRDL A NVLL + KISD
Sbjct: 107 YL---QQNRHVKDKNIIELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISD 160
Query: 134 FGMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
FG+++ +++ + APE FS KSDV+SFGVL+ E S
Sbjct: 161 FGLSKALRADENYYKAQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 31/192 (16%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
A+KR+ S ++F E+ ++ KL H N++ L G C L EY P+ +L
Sbjct: 56 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115
Query: 74 FL-------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
FL ++ + L ++ + +ARG+ YL S+ + IHRDL A N
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARN 172
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG-----YMAPEYAMEGLFSVKSDV 175
+L+ KI+DFG++R T G +MA E +++ SDV
Sbjct: 173 ILVGENYVAKIADFGLSR-------GQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDV 224
Query: 176 FSFGVLLLEIIS 187
+S+GVLL EI+S
Sbjct: 225 WSYGVLLWEIVS 236
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-38
Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 14/185 (7%)
Query: 8 KLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
+ + A+K + TS ++F E + + H ++V+L G E +I E
Sbjct: 37 MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIME 95
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
L FL R LD I ++ L YL + +HRD+ A NVL++
Sbjct: 96 LCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVS 150
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTY--GYMAPEYAMEGLFSVKSDVFSFGVLL 182
K+ DFG++R + G +MAPE F+ SDV+ FGV +
Sbjct: 151 SNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 207
Query: 183 LEIIS 187
EI+
Sbjct: 208 WEILM 212
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-38
Identities = 45/189 (23%), Positives = 82/189 (43%), Gaps = 22/189 (11%)
Query: 8 KLADGKEI--AVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
G++I AVK + + ++F +E ++ L H ++V+L G EE + +I E
Sbjct: 34 TNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIME 92
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
P L +L + S+++ + I + + YL + +HRD+ N+L+
Sbjct: 93 LYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL---ESINCVHRDIAVRNILVA 147
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYG------YMAPEYAMEGLFSVKSDVFSF 178
K+ DFG++R + +M+PE F+ SDV+ F
Sbjct: 148 SPECVKLGDFGLSRYIEDEDYYKAS-------VTRLPIKWMSPESINFRRFTTASDVWMF 200
Query: 179 GVLLLEIIS 187
V + EI+S
Sbjct: 201 AVCMWEILS 209
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-38
Identities = 57/200 (28%), Positives = 89/200 (44%), Gaps = 37/200 (18%)
Query: 16 AVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
AVK L + + +E+ ++ +L H+N+V L G C LI+EY L
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 74 FL--------------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 113
+L + L ++ + +A+G+ +L +H
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVH 195
Query: 114 RDLKASNVLLNHEMNPKISDFGMAR-IFGGNQSEANTN-----RIVGTYGYMAPEYAMEG 167
RDL A NVL+ H KI DFG+AR I + N + +MAPE EG
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEG 249
Query: 168 LFSVKSDVFSFGVLLLEIIS 187
++++KSDV+S+G+LL EI S
Sbjct: 250 IYTIKSDVWSYGILLWEIFS 269
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-37
Identities = 54/189 (28%), Positives = 86/189 (45%), Gaps = 15/189 (7%)
Query: 6 QGKL-ADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
QG K+I A+K L T +E E ++ +L + +VRL G C E +L
Sbjct: 354 QGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 412
Query: 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
+ E L FL + ++ +++ ++ G+ YL +HR+L A NV
Sbjct: 413 VMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNV 467
Query: 122 LLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT---YGYMAPEYAMEGLFSVKSDVFSF 178
LL + KISDFG+++ G + S + APE FS +SDV+S+
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSY 525
Query: 179 GVLLLEIIS 187
GV + E +S
Sbjct: 526 GVTMWEALS 534
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 44/271 (16%)
Query: 10 ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE---------S 59
D A+KR+ ++ EV +AKL+H +VR F LE+N
Sbjct: 28 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87
Query: 60 LLIY---EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL 116
+ +Y + ++L ++ + + + I IA + +LH ++HRDL
Sbjct: 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDL 144
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANT----------NRIVGTYGYMAPEYAME 166
K SN+ + K+ DFG+ ++ E VGT YM+PE
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204
Query: 167 GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226
+S K D+FS G++L E++ F Q T + P+ Q
Sbjct: 205 NSYSHKVDIFSLGLILFELL-----YPFS----TQMERVRTLTDVRNLK----FPPLFTQ 251
Query: 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSV 257
+ + +RP ++
Sbjct: 252 KY--PCEYVMVQ---DMLSPSPMERPEAINI 277
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 10/183 (5%)
Query: 8 KLADGKEI--AVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
+ + A+K + TS ++F E + + H ++V+L G E +I E
Sbjct: 412 MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIME 470
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
L FL R LD I ++ L YL + +HRD+ A NVL++
Sbjct: 471 LCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVS 525
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
K+ DFG++R + + + +MAPE F+ SDV+ FGV + E
Sbjct: 526 SNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWE 584
Query: 185 IIS 187
I+
Sbjct: 585 ILM 587
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-37
Identities = 59/250 (23%), Positives = 107/250 (42%), Gaps = 30/250 (12%)
Query: 11 DGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCL---EENESLLIY-E 64
E+A + + + Q FK E ++ LQH N+VR + + + +++ E
Sbjct: 50 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
M + +L +L R + K S I +GL +LH + IIHRDLK N+ +
Sbjct: 110 LMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFIT 165
Query: 125 HEM-NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
+ KI D G+A + S A ++GT +MAPE E + DV++FG+ +L
Sbjct: 166 GPTGSVKIGDLGLATLK--RASFAKA--VIGTPEFMAPEMYEEK-YDESVDVYAFGMCML 220
Query: 184 EIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLC 243
E+ + + Y + + ++ G +P E+ + I C
Sbjct: 221 EMATSEYP---YSECQNAAQI---YRRVTSGV-----KPASFDKVAIPEVKEIIE---GC 266
Query: 244 VQADSADRPT 253
++ + +R +
Sbjct: 267 IRQNKDERYS 276
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 57/263 (21%), Positives = 105/263 (39%), Gaps = 48/263 (18%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL---------- 60
DGK +KR+ + ++ + EV +AKL H N+V GC +
Sbjct: 35 DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90
Query: 61 ------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 114
+ E+ +L+ ++ + R +LD + + I +G+ Y+H K+I+R
Sbjct: 91 KTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINR 146
Query: 115 DLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSD 174
DLK SN+ L KI DFG+ +++ R GT YM+PE + + D
Sbjct: 147 DLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGTLRYMSPEQISSQDYGKEVD 203
Query: 175 VFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234
+++ G++L E++ T F S+ +L + ++ +
Sbjct: 204 LYALGLILAELLHVCD-TAFETSKF----------------FTDLRDGII-SDIFDKKEK 245
Query: 235 KFIHIGLLCVQADSADRPTMSSV 257
+ + DRP S +
Sbjct: 246 TLLQ---KLLSKKPEDRPNTSEI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 57/252 (22%), Positives = 114/252 (45%), Gaps = 24/252 (9%)
Query: 8 KLADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
DG++ +K +SR S + +E + EV ++A ++H N+V+ E ++ +Y
Sbjct: 45 STEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
L + ++ + V + + I L ++H+ KI+HRD+K+ N+ L
Sbjct: 105 CEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTK 160
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ ++ DFG+AR+ A +GT Y++PE ++ KSD+++ G +L E+
Sbjct: 161 DGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYEL 218
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
+ K F S+ + K+ G PV + +L + +
Sbjct: 219 CTLKH--AFE----AGSMKNLVLKI-ISGS----FPPV--SLHYSYDLRSLVS---QLFK 262
Query: 246 ADSADRPTMSSV 257
+ DRP+++S+
Sbjct: 263 RNPRDRPSVNSI 274
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-35
Identities = 60/255 (23%), Positives = 115/255 (45%), Gaps = 24/255 (9%)
Query: 8 KLADGKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY- 63
L DG +A+K++ + + E+ L+ +L H N+++ + E+ L I
Sbjct: 53 CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-FIEDNELNIVL 111
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRI-SIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
E L + + +L +R + + L ++H +++HRD+K +NV
Sbjct: 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVF 168
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ K+ D G+ R F + A++ +VGT YM+PE E ++ KSD++S G LL
Sbjct: 169 ITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLL 226
Query: 183 LEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL 242
E+ + + FY ++ L K+ + + P L + EL + ++ +
Sbjct: 227 YEMAALQS--PFYGDKMNLYSLCK--KI-EQCDY-----PPLPSDHYSEELRQLVN---M 273
Query: 243 CVQADSADRPTMSSV 257
C+ D RP ++ V
Sbjct: 274 CINPDPEKRPDVTYV 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 70/255 (27%), Positives = 113/255 (44%), Gaps = 25/255 (9%)
Query: 10 ADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE-NESLLIY-EY 65
+DGK + K + Q +EV L+ +L+H N+VR + ++ N +L I EY
Sbjct: 29 SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 66 MPNKSLDVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHE--DSRLKIIHRDLKASNVL 122
L + T+ Q LD + + ++ + L H D ++HRDLK +NV
Sbjct: 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
L+ + N K+ DFG+ARI + S A T VGT YM+PE ++ KSD++S G LL
Sbjct: 149 LDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLL 206
Query: 183 LEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL 242
E+ + F S K+ EG+ + + EL + I
Sbjct: 207 YELCALMP--PFT----AFSQKELAGKI-REGKFRRIP------YRYSDELNEIIT---R 250
Query: 243 CVQADSADRPTMSSV 257
+ RP++ +
Sbjct: 251 MLNLKDYHRPSVEEI 265
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-34
Identities = 63/273 (23%), Positives = 109/273 (39%), Gaps = 43/273 (15%)
Query: 12 GKEIAVKRLSRTSGQGLQEF-KNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
G +A K + ++ E+ ++ + +V +G + E + E+M S
Sbjct: 58 GLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
LD L + ++SI + +GL YL E KI+HRD+K SN+L+N K
Sbjct: 118 LDQVL-KKAGRIPEQILGKVSI--AVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIK 172
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK- 189
+ DFG++ S AN+ VGT YM+PE +SV+SD++S G+ L+E+ G+
Sbjct: 173 LCDFGVSGQL--IDSMANSF--VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 228
Query: 190 ----KNTGFYLSELGQSLLSYTWKLWCEGEA------------------LELME------ 221
+ G + + EL++
Sbjct: 229 PIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP 288
Query: 222 -PVLKQSCVAAELLKFIHIGLLCVQADSADRPT 253
P L + E F++ C+ + A+R
Sbjct: 289 PPKLPSGVFSLEFQDFVN---KCLIKNPAERAD 318
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
L++ IA+K + + Q E+ L L+HKN+V+ G E + E +P
Sbjct: 44 LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEM 127
SL L ++ + + I GL YLH++ +I+HRD+K NVL+N +
Sbjct: 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSG 160
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE---YAMEGLFSVKSDVFSFGVLLLE 184
KISDFG ++ G T GT YMAPE G + +D++S G ++E
Sbjct: 161 VLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIE 217
Query: 185 IISGK 189
+ +GK
Sbjct: 218 MATGK 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 36/206 (17%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL--------- 61
D + A+K++ T + L +EV L+A L H+ +VR + LE +
Sbjct: 30 DSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88
Query: 62 -IY---EYMPNKSLDVFLFD--STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRD 115
++ EY N +L +D + ++ + I L Y+H IIHRD
Sbjct: 89 TLFIQMEYCENGTL----YDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRD 141
Query: 116 LKASNVLLNHEMNPKISDFGMARIF------------GGNQSEANTNRIVGTYGYMAPE- 162
LK N+ ++ N KI DFG+A+ S N +GT Y+A E
Sbjct: 142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201
Query: 163 YAMEGLFSVKSDVFSFGVLLLEIISG 188
G ++ K D++S G++ E+I
Sbjct: 202 LDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-32
Identities = 66/259 (25%), Positives = 106/259 (40%), Gaps = 47/259 (18%)
Query: 12 GKEIAVKRLSRTSG-----QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
G+ +AVKR+ T + L + + + V +G E + + E M
Sbjct: 32 GQIMAVKRIRATVNSQEQKRLLMDLD---ISMRTVDCPFTVTFYGALFREGDVWICMELM 88
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKASN 120
+ SLD F + I I I + L +LH S+L +IHRD+K SN
Sbjct: 89 -DTSLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSN 140
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE----YAMEGLFSVKSDVF 176
VL+N K+ DFG++ + + + G YMAPE + +SVKSD++
Sbjct: 141 VLINALGQVKMCDFGISGYL-VDDVAKDID--AGCKPYMAPERINPELNQKGYSVKSDIW 197
Query: 177 SFGVLLLEIISGKKNTGFYLSELGQ--SLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234
S G+ ++E+ + F G L E + P L +AE +
Sbjct: 198 SLGITMIELAILR----FPYDSWGTPFQQLKQV----VEEPS-----PQLPADKFSAEFV 244
Query: 235 KFIHIGLLCVQADSADRPT 253
F C++ +S +RPT
Sbjct: 245 DFTS---QCLKKNSKERPT 260
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-31
Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 34/204 (16%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES----LLIYE 64
L DG A+KR+ Q +E + E + H N++RL CL E + L+
Sbjct: 51 LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKA 118
+ +L + D ++ ++ GI RGL +H HRDLK
Sbjct: 111 FFKRGTLWNEI-----ERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKP 162
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV-------GTYGYMAPE------YAM 165
+N+LL E P + D G + + + T Y APE + +
Sbjct: 163 TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222
Query: 166 EGLFSVKSDVFSFGVLLLEIISGK 189
++DV+S G +L ++ G+
Sbjct: 223 ID---ERTDVWSLGCVLYAMMFGE 243
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 47/187 (25%), Positives = 69/187 (36%), Gaps = 15/187 (8%)
Query: 8 KLADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIY- 63
DG+ AVK + EV K+ QH VRL EE L +
Sbjct: 78 SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGILYLQT 136
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
E SL L + + L +LH ++H D+K +N+ L
Sbjct: 137 ELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFL 190
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
K+ DFG+ G G YMAPE ++G + +DVFS G+ +L
Sbjct: 191 GPRGRCKLGDFGLLVEL-GTAGAGEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTIL 246
Query: 184 EIISGKK 190
E+ +
Sbjct: 247 EVACNME 253
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 22/190 (11%)
Query: 12 GKEIAVKRLSRTSG-QGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNK 69
G+ +AVKR+ T + ++ ++ ++ + +V+ +G E + + E M +
Sbjct: 47 GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-ST 105
Query: 70 SLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
S D F + V I I + L +L E+ LKIIHRD+K SN+LL
Sbjct: 106 SFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILL 159
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE----YAMEGLFSVKSDVFSFG 179
+ N K+ DFG++ S A T G YMAPE A + V+SDV+S G
Sbjct: 160 DRSGNIKLCDFGISGQL--VDSIAKTR-DAGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216
Query: 180 VLLLEIISGK 189
+ L E+ +G+
Sbjct: 217 ITLYELATGR 226
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 45/195 (23%), Positives = 83/195 (42%), Gaps = 20/195 (10%)
Query: 4 CLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLI 62
+G D +++AVKR+ + EV L+ + +H N++R F + +
Sbjct: 41 VYRGMF-DNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96
Query: 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
E + + I+++ GL +LH L I+HRDLK N+L
Sbjct: 97 IELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNIL 150
Query: 123 L-----NHEMNPKISDFGMARIFGGNQSE-ANTNRIVGTYGYMAPEY---AMEGLFSVKS 173
+ + ++ ISDFG+ + + + + + GT G++APE + +
Sbjct: 151 ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV 210
Query: 174 DVFSFGVLLLEIISG 188
D+FS G + +IS
Sbjct: 211 DIFSAGCVFYYVISE 225
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 48/179 (26%), Positives = 96/179 (53%), Gaps = 11/179 (6%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
G+E+A+++++ + NE+ ++ + ++ N+V L +E ++ EY+ SL
Sbjct: 45 GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 72 DVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
D +D + +I+ + + L +LH + ++IHRD+K+ N+LL + + K
Sbjct: 105 T----DVVTETCMD-EGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVK 156
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
++DFG QS+ +T +VGT +MAPE + K D++S G++ +E+I G+
Sbjct: 157 LTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 49/179 (27%), Positives = 96/179 (53%), Gaps = 11/179 (6%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
G+++AVK + Q + NEV ++ QH N+V ++ L E ++ E++ +L
Sbjct: 70 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 72 DVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
D V+L+ + +I+ + + + L YLH +IHRD+K+ ++LL + K
Sbjct: 130 T----DIVSQVRLN-EEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVK 181
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+SDFG + + + +VGT +MAPE L++ + D++S G++++E++ G+
Sbjct: 182 LSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 23/194 (11%)
Query: 11 DGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNL--VRLFGCCLEENESLLIYEYM 66
+ A+K L Q L ++NE+ + KLQ + +RL+ + + ++ E
Sbjct: 51 KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG 110
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
N L+ +L + +D R S + + +H+ I+H DLK +N L+ +
Sbjct: 111 -NIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLI-VD 162
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-----------YAMEGLFSVKSDV 175
K+ DFG+A + + + VGT YM PE + S KSDV
Sbjct: 163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222
Query: 176 FSFGVLLLEIISGK 189
+S G +L + GK
Sbjct: 223 WSLGCILYYMTYGK 236
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-30
Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 17/183 (9%)
Query: 12 GKEIAVKRLSRTSGQGLQEFK-NEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
G + AVK++ L+ F+ E+ A L +V L+G E + E + S
Sbjct: 83 GFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP- 129
L + + L R + + GL YLH +I+H D+KA NVLL+ + +
Sbjct: 137 LGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRA 190
Query: 130 KISDFGMARIF---GGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
+ DFG A G +S + I GT +MAPE M K D++S ++L ++
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
Query: 187 SGK 189
+G
Sbjct: 251 NGC 253
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 49/199 (24%), Positives = 82/199 (41%), Gaps = 23/199 (11%)
Query: 6 QGKLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNL--VRLFGCCLEENESLL 61
Q + A+K L Q L ++NE+ + KLQ + +RL+ + + +
Sbjct: 74 QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133
Query: 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
+ E N L+ +L +D R S + + +H+ I+H DLK +N
Sbjct: 134 VMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANF 186
Query: 122 LLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-----------YAMEGLFS 170
L+ + K+ DFG+A + + + VG YM PE + S
Sbjct: 187 LI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245
Query: 171 VKSDVFSFGVLLLEIISGK 189
KSDV+S G +L + GK
Sbjct: 246 PKSDVWSLGCILYYMTYGK 264
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 54/183 (29%), Positives = 97/183 (53%), Gaps = 12/183 (6%)
Query: 9 LADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
K +A+K + + +++ + E+T++++ + + +G L++ + +I EY+
Sbjct: 44 NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
S D LD + +I+ I I +GL YLH + K IHRD+KA+NVLL+
Sbjct: 104 GGSAL----DLLEPGPLD-ETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEH 155
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
K++DFG+A Q + NT VGT +MAPE + + K+D++S G+ +E+
Sbjct: 156 GEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 213
Query: 187 SGK 189
G+
Sbjct: 214 RGE 216
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 23/199 (11%)
Query: 6 QGKLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNL--VRLFGCCLEENESLL 61
Q + A+K L Q L ++NE+ + KLQ + +RL+ + + +
Sbjct: 27 QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86
Query: 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
+ E N L+ +L + +D R S + + +H+ I+H DLK +N
Sbjct: 87 VMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANF 139
Query: 122 LLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-----------YAMEGLFS 170
L+ + K+ DFG+A + + + VGT YM PE + S
Sbjct: 140 LI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS 198
Query: 171 VKSDVFSFGVLLLEIISGK 189
KSDV+S G +L + GK
Sbjct: 199 PKSDVWSLGCILYYMTYGK 217
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 46/186 (24%), Positives = 92/186 (49%), Gaps = 14/186 (7%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
G A K + S + L+++ E+ ++A H +V+L G + + ++ E+ P
Sbjct: 42 ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGG 101
Query: 70 SLDVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
++D + + R + I ++ + L +LH +IIHRDLKA NVL+ E +
Sbjct: 102 AVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGD 155
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVLLL 183
+++DFG++ + ++ +GT +MAPE + + K+D++S G+ L+
Sbjct: 156 IRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 213
Query: 184 EIISGK 189
E+ +
Sbjct: 214 EMAQIE 219
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-29
Identities = 51/179 (28%), Positives = 96/179 (53%), Gaps = 11/179 (6%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
G+ +A+K++ LQE E++++ + ++V+ +G + + ++ EY S+
Sbjct: 54 GQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111
Query: 72 DVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
+ +++ D I+ I +GL YLH + IHRD+KA N+LLN E + K
Sbjct: 112 SDIIRLRNKTLTEDE---IATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAK 165
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
++DFG+A ++ NT ++GT +MAPE E ++ +D++S G+ +E+ GK
Sbjct: 166 LADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 44/194 (22%), Positives = 83/194 (42%), Gaps = 23/194 (11%)
Query: 12 GKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY---EYMP 67
G A+K + S + E ++ KL HKN+V+LF EE + E+ P
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCP 92
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---- 123
SL L + + + L + ++ + G+ +L E I+HR++K N++
Sbjct: 93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGE 149
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE--------YAMEGLFSVKSDV 175
+ + K++DFG AR ++ + + + GT Y+ P+ + + D+
Sbjct: 150 DGQSVYKLTDFGAARELEDDE-QFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 176 FSFGVLLLEIISGK 189
+S GV +G
Sbjct: 207 WSIGVTFYHAATGS 220
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 44/188 (23%), Positives = 86/188 (45%), Gaps = 21/188 (11%)
Query: 12 GKEIAVKRLSRTSG-----QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
G IAVK++ R+ + L + ++ +V+ FG + + + E M
Sbjct: 50 GHVIAVKQMRRSGNKEENKRILMDLD---VVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
+ + ++++ I + L YL E +IHRD+K SN+LL+
Sbjct: 107 -GTCAEKLKKRMQGPIPERILGKMTV--AIVKALYYLKEK--HGVIHRDVKPSNILLDER 161
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVL 181
K+ DFG++ ++++ +R G YMAPE + + +++DV+S G+
Sbjct: 162 GQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218
Query: 182 LLEIISGK 189
L+E+ +G+
Sbjct: 219 LVELATGQ 226
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-28
Identities = 44/194 (22%), Positives = 82/194 (42%), Gaps = 23/194 (11%)
Query: 12 GKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY---EYMP 67
G A+K + S + E ++ KL HKN+V+LF EE + E+ P
Sbjct: 34 GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCP 92
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---- 123
SL L + + + L + ++ + G+ +L E I+HR++K N++
Sbjct: 93 CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGE 149
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE--------YAMEGLFSVKSDV 175
+ + K++DFG AR + + + + GT Y+ P+ + + D+
Sbjct: 150 DGQSVYKLTDFGAAREL-EDDEQFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 176 FSFGVLLLEIISGK 189
+S GV +G
Sbjct: 207 WSIGVTFYHAATGS 220
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 55/212 (25%), Positives = 81/212 (38%), Gaps = 35/212 (16%)
Query: 4 CLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLI 62
QG G+ +AVKR+ E+ L+ + H N++R + + +
Sbjct: 32 VFQGSF-QGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87
Query: 63 YEYMPNKSLDVFL----FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
E N +L + IS++ IA G+ +LH LKIIHRDLK
Sbjct: 88 LELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKP 143
Query: 119 SNVLLNHEMNP-------------KISDFGMARIFGGNQS--EANTNRIVGTYGYMAPEY 163
N+L++ ISDFG+ + QS N N GT G+ APE
Sbjct: 144 QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPEL 203
Query: 164 AMEGLFSV-------KSDVFSFGVLLLEIISG 188
E D+FS G + I+S
Sbjct: 204 LEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 41/247 (16%), Positives = 82/247 (33%), Gaps = 31/247 (12%)
Query: 21 SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80
+S + ++ + KN V + + + ++L ++
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIF 140
+ + I IA + +LH ++HRDLK SN+ + K+ DFG+
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 141 GGNQSEANTN----------RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 190
++ E VGT YM+PE +S K D+FS G++L E++
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
Query: 191 NTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSAD 250
T + + + + Q + + + +
Sbjct: 275 -TQMERVRIITDV--------RNLK----FPLLFTQKY--PQEHMMVQ---DMLSPSPTE 316
Query: 251 RPTMSSV 257
RP + +
Sbjct: 317 RPEATDI 323
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-28
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 35/207 (16%)
Query: 8 KLADGKEIAVKR--LSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIY- 63
K DG A+KR Q EV A L QH ++VR F E++ +LI
Sbjct: 32 KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-AEDDHMLIQN 90
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRI-SIINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
EY SL + ++ R + + + ++ + RGL Y+H ++H D+K SN+
Sbjct: 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIF 147
Query: 123 LNHEMNP-------------------KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEY 163
++ P KI D G Q E G ++A E
Sbjct: 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE------EGDSRFLANEV 201
Query: 164 AMEGL-FSVKSDVFSFGVLLLEIISGK 189
E K+D+F+ + ++ +
Sbjct: 202 LQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 47/190 (24%), Positives = 87/190 (45%), Gaps = 29/190 (15%)
Query: 12 GKEIAVKRLSRTS--GQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+ A K + ++ +E E+++ L H+++V G + + ++ E
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125
Query: 69 KSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
+SL + + ++ ++ + I G YLH R ++IHRDLK N+
Sbjct: 126 RSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLF 173
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNR---IVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
LN ++ KI DFG+A + E + R + GT Y+APE + S + DV+S G
Sbjct: 174 LNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 180 VLLLEIISGK 189
++ ++ GK
Sbjct: 229 CIMYTLLVGK 238
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 53/184 (28%), Positives = 95/184 (51%), Gaps = 16/184 (8%)
Query: 12 GKEIAVKRLSRTS--GQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
G E+A+K + + + G+ + +NEV + +L+H +++ L+ + N L+ E N
Sbjct: 36 GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
++ +L + + + R ++ I G+LYLH I+HRDL SN+LL MN
Sbjct: 96 GEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMN 150
Query: 129 PKISDFGMARIFGGNQSEANTNR---IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
KI+DFG+A Q + + + GT Y++PE A ++SDV+S G + +
Sbjct: 151 IKIADFGLA-----TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTL 205
Query: 186 ISGK 189
+ G+
Sbjct: 206 LIGR 209
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 47/190 (24%), Positives = 87/190 (45%), Gaps = 29/190 (15%)
Query: 12 GKEIAVKRLSRTS--GQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+ A K + ++ +E E+++ L H+++V G + + ++ E
Sbjct: 40 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99
Query: 69 KSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKASNVL 122
+SL + + ++ ++ + I G YLH R ++IHRDLK N+
Sbjct: 100 RSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLF 147
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNR---IVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
LN ++ KI DFG+A + E + R + GT Y+APE + S + DV+S G
Sbjct: 148 LNEDLEVKIGDFGLA-----TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202
Query: 180 VLLLEIISGK 189
++ ++ GK
Sbjct: 203 CIMYTLLVGK 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-27
Identities = 50/181 (27%), Positives = 92/181 (50%), Gaps = 10/181 (5%)
Query: 12 GKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
++A+K + R + L+ F+ EV ++L H+N+V + E++ L+ EY+
Sbjct: 36 NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
+L ++ L I+ N I G+ + H ++I+HRD+K N+L++
Sbjct: 96 PTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKT 149
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
KI DFG+A+ S TN ++GT Y +PE A +D++S G++L E++ G
Sbjct: 150 LKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208
Query: 189 K 189
+
Sbjct: 209 E 209
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 41/185 (22%), Positives = 76/185 (41%), Gaps = 22/185 (11%)
Query: 11 DGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRL--FGCCLEENESLLIY---E 64
+G+ + +K L + Q E +A++ H ++V++ F + + + Y E
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
Y+ +SL +L I+ + I L YLH + +++ DLK N++L
Sbjct: 165 YVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLT 216
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
E K+ D G + GT G+ APE G +V +D+++ G L
Sbjct: 217 EE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAA 268
Query: 185 IISGK 189
+
Sbjct: 269 LTLDL 273
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 16/188 (8%)
Query: 12 GKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLF------GCCLEENESLLIYE 64
G+++A+K+ + +E + E+ ++ KL H N+V + LL E
Sbjct: 39 GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL- 123
Y L +L L ++++ I+ L YLHE +IIHRDLK N++L
Sbjct: 99 YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQ 155
Query: 124 --NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181
+ KI D G A+ VGT Y+APE + ++V D +SFG L
Sbjct: 156 PGPQRLIHKIIDLGYAKELD-QGELCTE--FVGTLQYLAPELLEQKKYTVTVDYWSFGTL 212
Query: 182 LLEIISGK 189
E I+G
Sbjct: 213 AFECITGF 220
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 59/185 (31%), Positives = 94/185 (50%), Gaps = 20/185 (10%)
Query: 12 GKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+ +A+K++S + S + Q+ EV + KL+H N ++ GC L E+ + L+ EY
Sbjct: 79 SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 138
Query: 69 KSLDVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
+ D+ L + I+ + +G +GL YLH +IHRD+KA N+LL+
Sbjct: 139 SASDLLE---VHKKPLQ-EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPG 191
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE---YAMEGLFSVKSDVFSFGVLLLE 184
K+ DFG A + AN+ VGT +MAPE EG + K DV+S G+ +E
Sbjct: 192 LVKLGDFGSA----SIMAPANS--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
Query: 185 IISGK 189
+ K
Sbjct: 246 LAERK 250
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 14/190 (7%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
L ++ + S + + FKNE+ +I ++++ + G +E +IYEYM
Sbjct: 66 LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125
Query: 67 PNKSL-----DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
N S+ F+ D + + + II + Y+H + I HRD+K SN+
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNI 183
Query: 122 LLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-YAMEGLFS-VKSDVFSFG 179
L++ K+SDFG + + GTY +M PE ++ E ++ K D++S G
Sbjct: 184 LMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG 239
Query: 180 VLLLEIISGK 189
+ L +
Sbjct: 240 ICLYVMFYNV 249
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 11/164 (6%)
Query: 31 FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY----EYMPNKSLDVFLFDSTRSVQLDW 86
F+ E A L H +V ++ E + + EY+ +L + +
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTP 115
Query: 87 KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146
KR I +I + L + H + IIHRD+K +N++++ K+ DFG+AR + +
Sbjct: 116 KRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 147 -ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
T ++GT Y++PE A +SDV+S G +L E+++G+
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 39/189 (20%), Positives = 80/189 (42%), Gaps = 17/189 (8%)
Query: 12 GKEIAVKR--LSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
G+ + V+R L S + + + E+ + H N+V + +NE ++ +M
Sbjct: 52 GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 111
Query: 70 SL-DVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
S D L + ++ + I+ I G+ + L Y+H +HR +KAS++L++ +
Sbjct: 112 SAKD--LICTHFMDGMN-ELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDG 165
Query: 128 NPKISDFGMARIFGGNQSEANT-----NRIVGTYGYMAPEYAMEGL--FSVKSDVFSFGV 180
+S + V +++PE + L + KSD++S G+
Sbjct: 166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225
Query: 181 LLLEIISGK 189
E+ +G
Sbjct: 226 TACELANGH 234
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 42/184 (22%), Positives = 76/184 (41%), Gaps = 16/184 (8%)
Query: 12 GKEIAVKRLSR--TSGQGLQE-FKNEVTLIAKLQHKNLVRLF--GCCLEENESL-LIYEY 65
+ +A+K +S +S + + E +LQ ++V + G E + L +
Sbjct: 59 ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG---EIDGQLYVDMRL 115
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ L L L R ++I+ I L H HRD+K N+L++
Sbjct: 116 INGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSA 169
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ + DFG+A + VGT YMAPE E + ++D+++ +L E
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYEC 228
Query: 186 ISGK 189
++G
Sbjct: 229 LTGS 232
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 61/301 (20%), Positives = 104/301 (34%), Gaps = 59/301 (19%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENES-------L 60
+ G+E A+KRL + + EV + KL H N+V+ E
Sbjct: 50 VGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 61 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
L+ + L FL L + I R + ++H + IIHRDLK N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVEN 168
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRI----------VGTYGYMAPEYAMEGLFS 170
+LL+++ K+ DFG A + + + T Y PE + L+S
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE--IIDLYS 226
Query: 171 -----VKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL-----SYTWKLWCEGEALELM 220
K D+++ G +L + + F + L Y+
Sbjct: 227 NFPIGEKQDIWALGCILYLLCFRQ--HPFE----DGAKLRIVNGKYSIP----------- 269
Query: 221 EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV----VMLASDTVTLPQPTEPAF 276
P Q V L++ +Q + +R +++ VV + A+ V P
Sbjct: 270 -PHDTQYTVFHSLIRA------MLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELL 322
Query: 277 S 277
Sbjct: 323 E 323
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 54/192 (28%), Positives = 93/192 (48%), Gaps = 23/192 (11%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESL------LIYE 64
G+ A+K + +G +E K E+ ++ K H+N+ +G +++N L+ E
Sbjct: 49 GQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107
Query: 65 YMPNKSL-DVFLFDSTRSVQLDWKRRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVL 122
+ S+ D+ +++ +W I+ I I RGL +LH+ K+IHRD+K NVL
Sbjct: 108 FCGAGSVTDLIKNTKGNTLKEEW---IAYICREILRGLSHLHQH---KVIHRDIKGQNVL 161
Query: 123 LNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-----YAMEGLFSVKSDVFS 177
L K+ DFG++ NT +GT +MAPE + + KSD++S
Sbjct: 162 LTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWS 219
Query: 178 FGVLLLEIISGK 189
G+ +E+ G
Sbjct: 220 LGITAIEMAEGA 231
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 17/178 (9%)
Query: 13 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72
K + V + + + G ++ K E ++ L+H ++V L + +++E+M
Sbjct: 55 KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD-- 112
Query: 73 VFLFD-----STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
L + + I L Y H+ IIHRD+K VLL +
Sbjct: 113 --LCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKE 167
Query: 128 NP---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
N K+ FG+A G + A VGT +MAPE + DV+ GV+L
Sbjct: 168 NSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 13/188 (6%)
Query: 12 GKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
+++A+KR++ Q + E E+ +++ H N+V + + ++E L+ + + S
Sbjct: 40 KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99
Query: 71 L-DVFLFDSTRSVQLDWK---RRISII-NGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ D+ + I+ I + GL YLH++ IHRD+KA N+LL
Sbjct: 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGE 156
Query: 126 EMNPKISDFGM-ARIFGGNQSEANTNR--IVGTYGYMAPEYAMEGL-FSVKSDVFSFGVL 181
+ + +I+DFG+ A + G N R VGT +MAPE + + K+D++SFG+
Sbjct: 157 DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216
Query: 182 LLEIISGK 189
+E+ +G
Sbjct: 217 AIELATGA 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 27/191 (14%)
Query: 10 ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
E A+K + +T S + EV ++ L H N+++L+ ++ L+ E
Sbjct: 60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 68 NKSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKASNV 121
LFD + + + + II + G+ YLH+ I+HRDLK N+
Sbjct: 120 GGE----LFD--EIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENL 167
Query: 122 LL---NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSF 178
LL + KI DFG++ +F + +GT Y+APE + + K DV+S
Sbjct: 168 LLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSI 223
Query: 179 GVLLLEIISGK 189
GV+L +++G
Sbjct: 224 GVILFILLAGY 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 4e-24
Identities = 27/192 (14%), Positives = 62/192 (32%), Gaps = 16/192 (8%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
+ ++ +K + + + ++ + L +N S+L+ E +
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 71 LD--VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
L + L+ +T + IS + + +H+ +IIH D+K N +L +
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFL 210
Query: 129 P-----------KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177
+ D G + T G+ E ++ + D F
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG 270
Query: 178 FGVLLLEIISGK 189
+ ++ G
Sbjct: 271 VAATVYCMLFGT 282
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-24
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 23/186 (12%)
Query: 12 GKEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
+A+K L + +G Q + EV + + L+H N++RL+G + LI EY P
Sbjct: 34 KFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 92
Query: 68 NKSLDVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
++ + + + D +R + I +A L Y H ++IHRD+K N+LL
Sbjct: 93 LGTV----YRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSA 145
Query: 127 MNPKISDFGMARIFGGNQSEANTNR---IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
KI+DFG + A ++R + GT Y+ PE + K D++S GVL
Sbjct: 146 GELKIADFGWS-------VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 198
Query: 184 EIISGK 189
E + GK
Sbjct: 199 EFLVGK 204
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 28/191 (14%)
Query: 10 ADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
G+E AVK +S+ + EV L+ +L H N+++L+ ++ L+ E
Sbjct: 49 ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 108
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKASN 120
LFD + ++R S II + G+ Y+H+ KI+HRDLK N
Sbjct: 109 TGGE----LFD--EIIS---RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPEN 156
Query: 121 VLL---NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177
+LL + + N +I DFG++ F ++ +GT Y+APE + G + K DV+S
Sbjct: 157 LLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPE-VLHGTYDEKCDVWS 212
Query: 178 FGVLLLEIISG 188
GV+L ++SG
Sbjct: 213 TGVILYILLSG 223
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 41/177 (23%), Positives = 75/177 (42%), Gaps = 14/177 (7%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
A G+ K ++ KNE++++ +L H L+ L ++ E +LI E++
Sbjct: 74 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133
Query: 70 SLDVFLFD--STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
LFD + ++ I+ + GL ++HE I+H D+K N++ +
Sbjct: 134 E----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKK 186
Query: 128 NP--KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
KI DFG+A ++ T + APE +D+++ GVL
Sbjct: 187 ASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 29/191 (15%)
Query: 10 ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYM 66
+E AVK +++ + EV L+ KL H N+++LF E++ S ++ E
Sbjct: 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-EDSSSFYIVGELY 103
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLKASN 120
LFD ++ ++R S II + G+ Y+H+ I+HRDLK N
Sbjct: 104 TGGE----LFD--EIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPEN 151
Query: 121 VLL---NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177
+LL + + KI DFG++ F N +GT Y+APE + G + K DV+S
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLRGTYDEKCDVWS 207
Query: 178 FGVLLLEIISG 188
GV+L ++SG
Sbjct: 208 AGVILYILLSG 218
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-23
Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 14/177 (7%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
A G ++A K + + +E KNE++++ +L H NL++L+ +N+ +L+ EY+
Sbjct: 112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 70 SLDVFLFDS--TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
LFD S L I + I G+ ++H+ + I+H DLK N+L +
Sbjct: 172 E----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRD 224
Query: 128 NP--KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
KI DFG+AR + + GT ++APE S +D++S GV+
Sbjct: 225 AKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 3e-23
Identities = 43/177 (24%), Positives = 77/177 (43%), Gaps = 14/177 (7%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
A G A K + + + E+ ++ L+H LV L ++NE ++IYE+M
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239
Query: 70 SLDVFLFD--STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
LF+ + ++ + + + +GL ++HE +H DLK N++ +
Sbjct: 240 E----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKR 292
Query: 128 NP--KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ K+ DFG+ Q + GT + APE A +D++S GVL
Sbjct: 293 SNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-23
Identities = 53/190 (27%), Positives = 82/190 (43%), Gaps = 39/190 (20%)
Query: 10 ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
+E AVK +++ + EV L+ KL H N+++LF + + ++ E
Sbjct: 45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT 104
Query: 68 NKSLDVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRD 115
LFD I II + G+ Y+H+ I+HRD
Sbjct: 105 GGE----LFD-----------EIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRD 146
Query: 116 LKASNVLLNH---EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVK 172
LK N+LL + + KI DFG++ F N +GT Y+APE + G + K
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPE-VLRGTYDEK 202
Query: 173 SDVFSFGVLL 182
DV+S GV+L
Sbjct: 203 CDVWSAGVIL 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-23
Identities = 44/186 (23%), Positives = 79/186 (42%), Gaps = 37/186 (19%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
A K++ + + + FK E+ ++ L H N++RL+ + + L+ E
Sbjct: 34 RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE- 92
Query: 72 DVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRDLKAS 119
LF+ R+ I+ + + Y H+ L + HRDLK
Sbjct: 93 ---LFE-----------RVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPE 135
Query: 120 NVLL---NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVF 176
N L + + K+ DFG+A F + VGT Y++P+ +EGL+ + D +
Sbjct: 136 NFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQ-VLEGLYGPECDEW 191
Query: 177 SFGVLL 182
S GV++
Sbjct: 192 SAGVMM 197
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 7e-23
Identities = 44/182 (24%), Positives = 83/182 (45%), Gaps = 15/182 (8%)
Query: 12 GKEIAVKRLSRT--SGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+A+K L ++ +G++ + E+ + + L+H N++R++ + L+ E+ P
Sbjct: 39 KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98
Query: 69 KSLDVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
L + + D +R + + +A L Y H K+IHRD+K N+L+ ++
Sbjct: 99 GEL----YKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKG 151
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
KI+DFG + + + GT Y+ PE K D++ GVL E +
Sbjct: 152 ELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207
Query: 188 GK 189
G
Sbjct: 208 GM 209
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 8e-23
Identities = 27/281 (9%), Positives = 57/281 (20%), Gaps = 50/281 (17%)
Query: 12 GKEIAVKRL---SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCC--------------- 53
++ A+K + S L+ A+L ++
Sbjct: 87 LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146
Query: 54 -----------LEENESLLIYEYMP---NKSLDVFLFDSTRSVQLDWKRRISIINGIARG 99
LL+ F + + R
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206
Query: 100 LLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159
L ++H N+ + + + D G Y
Sbjct: 207 AANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYA 258
Query: 160 APEYAM--EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEAL 217
E+ F+ + + G+ + + F L + +WK
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVW-----CLFLPFGLVTPGIKGSWKRPSLRVPG 313
Query: 218 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 258
+ + + I L D R +
Sbjct: 314 TDSLAFGSCTPLPDFVKTLIG-RFLNF--DRRRRLLPLEAM 351
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 41/184 (22%), Positives = 83/184 (45%), Gaps = 24/184 (13%)
Query: 10 ADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+ G E +K +++ Q +++ + E+ ++ L H N++++F + + ++ E
Sbjct: 45 SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104
Query: 69 KSLDVFLFDSTRSVQLDWKRR-------ISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
L + R V + + ++ + L Y H ++H+DLK N+
Sbjct: 105 GE----LLE--RIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENI 155
Query: 122 LL---NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSF 178
L + KI DFG+A +F ++ + GT YMAPE + + K D++S
Sbjct: 156 LFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPE-VFKRDVTFKCDIWSA 211
Query: 179 GVLL 182
GV++
Sbjct: 212 GVVM 215
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-22
Identities = 38/177 (21%), Positives = 78/177 (44%), Gaps = 15/177 (8%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
+ K K + + G K E++++ +H+N++ L E ++I+E++
Sbjct: 28 SSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86
Query: 70 SLDVFLFD--STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
+F+ +T + +L+ + +S ++ + L +LH I H D++ N++
Sbjct: 87 D----IFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRR 139
Query: 128 NP--KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ KI +FG AR N + Y APE + S +D++S G L+
Sbjct: 140 SSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-22
Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 38/188 (20%)
Query: 12 GKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
G E A K ++ S + Q+ + E + KLQH N+VRL EE+ L+++ +
Sbjct: 31 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90
Query: 70 SLDVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRDLK 117
LF+ I I I + Y H I+HR+LK
Sbjct: 91 E----LFE-----------DIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLK 132
Query: 118 ASNVLLNHEMNP---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSD 174
N+LL + K++DFG+A +++ + GT GY++PE + +S D
Sbjct: 133 PENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVD 189
Query: 175 VFSFGVLL 182
+++ GV+L
Sbjct: 190 IWACGVIL 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 47/176 (26%), Positives = 78/176 (44%), Gaps = 16/176 (9%)
Query: 13 KEIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
K I ++ + G +E + EV+++ ++ H N++ L + +LI E +
Sbjct: 43 KFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGE- 101
Query: 72 DVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP- 129
LFD + L + S I I G+ YLH KI H DLK N++L + P
Sbjct: 102 ---LFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPI 155
Query: 130 ---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
K+ DFG+A I GT ++APE +++D++S GV+
Sbjct: 156 PHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 38/188 (20%)
Query: 12 GKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
G E A K ++ S + Q+ + E + KLQH N+VRL EE+ L+++ +
Sbjct: 54 GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113
Query: 70 SLDVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRDLK 117
LF+ I I I + Y H I+HR+LK
Sbjct: 114 E----LFE-----------DIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLK 155
Query: 118 ASNVLLNHEMNP---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSD 174
N+LL + K++DFG+A +++ + GT GY++PE + +S D
Sbjct: 156 PENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVD 212
Query: 175 VFSFGVLL 182
+++ GV+L
Sbjct: 213 IWACGVIL 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-22
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 13 KEIAVKRLS-RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
K I ++ G +E + EV+++ ++ H N++ L + +LI E +
Sbjct: 43 KFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGE- 101
Query: 72 DVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP- 129
LFD + L + S I I G+ YLH KI H DLK N++L + P
Sbjct: 102 ---LFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPI 155
Query: 130 ---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
K+ DFG+A I GT ++APE +++D++S GV+
Sbjct: 156 PHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-22
Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 38/201 (18%)
Query: 10 ADGKEIAVKRLSR-------------TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE 56
E A+K + + + +E NE++L+ L H N+++LF ++
Sbjct: 59 NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118
Query: 57 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLK 110
L+ E+ LF+ Q+ + + I+ I G+ YLH+
Sbjct: 119 KYFYLVTEFYEGGE----LFE-----QIINRHKFDECDAANIMKQILSGICYLHK---HN 166
Query: 111 IIHRDLKASNVLL---NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG 167
I+HRD+K N+LL N +N KI DFG++ F + +GT Y+APE ++
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKK 222
Query: 168 LFSVKSDVFSFGVLLLEIISG 188
++ K DV+S GV++ ++ G
Sbjct: 223 KYNEKCDVWSCGVIMYILLCG 243
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-21
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 21/196 (10%)
Query: 8 KLA----DGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES 59
K AVK L + G K E+ L+ +L+HKN+++L E +
Sbjct: 22 KEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81
Query: 60 --LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRI--SIINGIARGLLYLHEDSRLKIIHRD 115
++ EY ++ + + +I+G+ YLH I+H+D
Sbjct: 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH---SQGIVHKD 134
Query: 116 LKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM-EGLFS-VKS 173
+K N+LL KIS G+A ++ G+ + PE A FS K
Sbjct: 135 IKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKV 194
Query: 174 DVFSFGVLLLEIISGK 189
D++S GV L I +G
Sbjct: 195 DIWSAGVTLYNITTGL 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 57/189 (30%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 12 GKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
+ +AVK + E K E+ + L H+N+V+ +G E N L EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 71 LDVFLFDSTRSVQLDWKRRIS----------IINGIARGLLYLHEDSRLKIIHRDLKASN 120
L FD R + ++ G+ YLH + I HRD+K N
Sbjct: 92 L----FD--RIEP---DIGMPEPDAQRFFHQLMAGVV----YLH---GIGITHRDIKPEN 135
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFS-VKSDVFSFG 179
+LL+ N KISDFG+A +F N E N++ GT Y+APE F DV+S G
Sbjct: 136 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 180 VLLLEIISG 188
++L +++G
Sbjct: 196 IVLTAMLAG 204
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-21
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 37/186 (19%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
GK A+K + ++ +NE+ ++ K++H+N+V L L+ + +
Sbjct: 34 GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE- 92
Query: 72 DVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRDLKAS 119
LFD RI +I + + YLHE I+HRDLK
Sbjct: 93 ---LFD-----------RILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPE 135
Query: 120 NVLL-NHEMNP--KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVF 176
N+L E N I+DFG++++ + GT GY+APE + +S D +
Sbjct: 136 NLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCW 191
Query: 177 SFGVLL 182
S GV+
Sbjct: 192 SIGVIT 197
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 47/220 (21%), Positives = 77/220 (35%), Gaps = 46/220 (20%)
Query: 13 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM------ 66
K + ++ + + + ++ K EV L+ KL H N+ RL+ +E L+ E
Sbjct: 57 KIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLL 116
Query: 67 -------------------------PNKSLDVFLFDSTRSVQLDWKRRIS------IING 95
+ + + S + I+
Sbjct: 117 DKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQ 176
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLL--NHEMNPKISDFGMARIFGGNQSEANT--NR 151
I L YLH I HRD+K N L N K+ DFG+++ F +
Sbjct: 177 IFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 152 IVGTYGYMAPE--YAMEGLFSVKSDVFSFGVLLLEIISGK 189
GT ++APE + K D +S GVLL ++ G
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 47/188 (25%), Positives = 81/188 (43%), Gaps = 37/188 (19%)
Query: 12 GKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
G+E A ++ S + Q+ + E + L+H N+VRL EE LI++ +
Sbjct: 36 GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95
Query: 70 SLDVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRDLK 117
LF+ I I I +L+ H+ + ++HR+LK
Sbjct: 96 E----LFE-----------DIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLK 137
Query: 118 ASNVLLNHEMNP---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSD 174
N+LL ++ K++DFG+A G Q GT GY++PE + + D
Sbjct: 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVD 195
Query: 175 VFSFGVLL 182
+++ GV+L
Sbjct: 196 LWACGVIL 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 20/178 (11%)
Query: 13 KEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
K I +RLS + +E + EV ++ +++H N++ L + + +LI E +
Sbjct: 36 KFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGE- 94
Query: 72 DVFLFDSTRSVQLDW---KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
LFD + + + I G+ YLH +I H DLK N++L +
Sbjct: 95 ---LFD--FLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNV 146
Query: 129 P----KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
P K+ DFG+A I GT ++APE +++D++S GV+
Sbjct: 147 PNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-21
Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 27/188 (14%)
Query: 12 GKEIAVKRLSRTSGQGL---------QEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLL 61
KE AVK + T G + EV ++ K+ H N+++L L
Sbjct: 42 CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101
Query: 62 IYEYMPNKSLDVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
+++ M L FD T V L K I+ + + LH+ L I+HRDLK N
Sbjct: 102 VFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPEN 154
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE------YAMEGLFSVKSD 174
+LL+ +MN K++DFG + + + GT Y+APE + + D
Sbjct: 155 ILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVD 211
Query: 175 VFSFGVLL 182
++S GV++
Sbjct: 212 MWSTGVIM 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-21
Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 20/178 (11%)
Query: 13 KEIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
K I +R S G ++ + EV+++ ++QH N++ L + + +LI E +
Sbjct: 42 KFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGE- 100
Query: 72 DVFLFDSTRSVQLDW---KRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
LFD + + + + I G+ YLH L+I H DLK N++L
Sbjct: 101 ---LFD--FLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNV 152
Query: 129 P----KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
P KI DFG+A I GT ++APE +++D++S GV+
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-21
Identities = 40/161 (24%), Positives = 67/161 (41%), Gaps = 17/161 (10%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E+ ++ +L+H NLV L + L++EY V + SI
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSIT 108
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
+ + + H + IHRD+K N+L+ K+ DFG AR+ G S+ + +
Sbjct: 109 WQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG-PSDYYDDEVA 164
Query: 154 GTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 189
T Y +PE L DV++ G + E++SG
Sbjct: 165 -TRWYRSPEL----LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-21
Identities = 57/189 (30%), Positives = 85/189 (44%), Gaps = 28/189 (14%)
Query: 12 GKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
+ +AVK + E K E+ + L H+N+V+ +G E N L EY
Sbjct: 32 EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91
Query: 71 LDVFLFDSTRSVQLDWKRRIS----------IINGIARGLLYLHEDSRLKIIHRDLKASN 120
L FD R + ++ G+ YLH + I HRD+K N
Sbjct: 92 L----FD--RIEP---DIGMPEPDAQRFFHQLMAGVV----YLH---GIGITHRDIKPEN 135
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFS-VKSDVFSFG 179
+LL+ N KISDFG+A +F N E N++ GT Y+APE F DV+S G
Sbjct: 136 LLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 180 VLLLEIISG 188
++L +++G
Sbjct: 196 IVLTAMLAG 204
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-21
Identities = 48/200 (24%), Positives = 76/200 (38%), Gaps = 44/200 (22%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMP 67
L +E AVK + + G EV ++ + Q H+N++ L EE+ L++E M
Sbjct: 35 LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
Query: 68 NKSLDVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRD 115
S+ I ++ +A L +LH I HRD
Sbjct: 95 GGSI----LS-----------HIHKRRHFNELEASVVVQDVASALDFLHN---KGIAHRD 136
Query: 116 LKASNVLLNHEMNP---KISDFGMARIFGGNQSEANTNR-----IVGTYGYMAPE----- 162
LK N+L H KI DF + N + + G+ YMAPE
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 163 YAMEGLFSVKSDVFSFGVLL 182
++ + D++S GV+L
Sbjct: 197 SEEASIYDKRCDLWSLGVIL 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 8e-21
Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 17/161 (10%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E++L+ +L H N+V L E L++E+M K L L L + +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYL 125
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
+ RG+ + H+ +I+HRDLK N+L+N + K++DFG+AR F G + T+ +V
Sbjct: 126 YQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV 181
Query: 154 GTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 189
T Y AP+ L K D++S G + E+I+GK
Sbjct: 182 -TLWYRAPDV----LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 21/163 (12%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E+ L+ +L+H+NLV L C ++ L++E++ + LD++ +
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV---DHTILDDLELFPNGLDYQVVQKYL 130
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
I G+ + H IIHRD+K N+L++ K+ DFG AR E + +
Sbjct: 131 FQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA 186
Query: 154 GTYGYMAPE-------YAMEGLFSVKSDVFSFGVLLLEIISGK 189
T Y APE Y +V DV++ G L+ E+ G+
Sbjct: 187 -TRWYRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 47/191 (24%), Positives = 81/191 (42%), Gaps = 36/191 (18%)
Query: 12 GKEIAVKRLSR--------TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
K++A++ +S+ + E+ ++ KL H ++++ + + ++
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLK 117
E M L FD + V +R+ + + YLHE IIHRDLK
Sbjct: 219 ELMEGGEL----FD--KVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLK 266
Query: 118 ASNVLLNHEMNP---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPE---YAMEGLFSV 171
NVLL+ + KI+DFG ++I G + GT Y+APE ++
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNR 323
Query: 172 KSDVFSFGVLL 182
D +S GV+L
Sbjct: 324 AVDCWSLGVIL 334
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESL--------LIYEYMPNKSLDVFLFDSTRSVQLD 85
E+ ++ L+H+N+V L C + L++++ D+ S V+
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC---EHDLAGLLSNVLVKFT 122
Query: 86 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS 145
++ + GL Y+H + KI+HRD+KA+NVL+ + K++DFG+AR F ++
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 146 EAN---TNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 189
TNR+V T Y PE + E + D++ G ++ E+ +
Sbjct: 180 SQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-20
Identities = 37/93 (39%), Positives = 57/93 (61%), Gaps = 5/93 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR-IFGGNQSEANTNRIVG 154
+A+G+ +L + K IHRDL A N+LL+ + KI DFG+AR I+ + +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL- 257
Query: 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+MAPE + +++++SDV+SFGVLL EI S
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 27/142 (19%), Positives = 51/142 (35%), Gaps = 13/142 (9%)
Query: 8 KLADGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESL-LIYE 64
K A + +AVK L + + +E+ ++ + H N+V L G C + L +I E
Sbjct: 48 KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 107
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
+ +L +L +R + +G + + I DLK +
Sbjct: 108 FCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSIT 157
Query: 125 HEMNPKISDFGMARIFGGNQSE 146
+ S F + + E
Sbjct: 158 SSQSSASSGFVEEKSLSDVEEE 179
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 1e-20
Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E+ L+ +L+HKN+VRL + + L++E+ + L + + + LD + S +
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFL 107
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
+ +GL + H ++HRDLK N+L+N K+++FG+AR F G + +V
Sbjct: 108 FQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
Query: 154 GTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGKK 190
T Y P+ LF K D++S G + E+ + +
Sbjct: 164 -TLWYRPPDV----LFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-20
Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 24/168 (14%)
Query: 32 KNEVTLIAKLQHKNLVRLFGCCLEENESLLIY---EYMPNKSLDVFLFDSTRSVQLDWK- 87
E+ ++ KL H N+V+L L++ +Y E + + + L
Sbjct: 84 YQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSEDQ 138
Query: 88 -RRI--SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQ 144
R +I GI YLH KIIHRD+K SN+L+ + + KI+DFG++ F G+
Sbjct: 139 ARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 145 SEANTNRIVGTYGYMAPE--YAMEGLFS-VKSDVFSFGVLLLEIISGK 189
+ + VGT +MAPE +FS DV++ GV L + G+
Sbjct: 192 ALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-20
Identities = 44/198 (22%), Positives = 79/198 (39%), Gaps = 48/198 (24%)
Query: 12 GKEIAVKRLSRTSGQGLQE--------FKNEVTLIAKL-QHKNLVRLFGCCLEENESLLI 62
G E AVK + T+ + E + E ++ ++ H +++ L + L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLK 110
++ M L FD + SI+ + + +LH
Sbjct: 179 FDLMRKGEL----FD-----------YLTEKVALSEKETRSIMRSLLEAVSFLHA---NN 220
Query: 111 IIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE------YA 164
I+HRDLK N+LL+ M ++SDFG + + + GT GY+APE
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDE 277
Query: 165 MEGLFSVKSDVFSFGVLL 182
+ + D+++ GV+L
Sbjct: 278 THPGYGKEVDLWACGVIL 295
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 52/165 (31%), Positives = 89/165 (53%), Gaps = 20/165 (12%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E++L+ +L+H+N+VRL+ EN+ L++E+M L ++ DS ++++
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYM-DSRTVGNTPRGLELNLV 110
Query: 94 NGIA----RGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149
+GL + HE+ KI+HRDLK N+L+N K+ DFG+AR F G +
Sbjct: 111 KYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFS 166
Query: 150 NRIVGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 189
+ +V T Y AP+ L ++ D++S G +L E+I+GK
Sbjct: 167 SEVV-TLWYRAPDV----LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 2e-20
Identities = 46/161 (28%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E++++ +L+H N+V+L+ + +L++E++ D+ L+ S +
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFL 106
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
+ G+ Y H+ +++HRDLK N+L+N E KI+DFG+AR F G T+ IV
Sbjct: 107 LQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV 162
Query: 154 GTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 189
T Y AP+ L K D++S G + E+++G
Sbjct: 163 -TLWYRAPDV----LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 31/224 (13%), Positives = 64/224 (28%), Gaps = 53/224 (23%)
Query: 10 ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQ------------------------ 42
G+ V T +++ K EV + L+
Sbjct: 96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155
Query: 43 -HKNLVRLFGCCLEENES--LLIYEYMPNKSLDVF--LFD-STRSVQLDWKRRISIINGI 96
K ++R+ + +Y M + L S+ L R+ + +
Sbjct: 156 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 215
Query: 97 ARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156
R L LH ++H L+ +++L+ ++ F G +
Sbjct: 216 IRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV------SSVSR 266
Query: 157 GYMAPEY-----------AMEGLFSVKSDVFSFGVLLLEIISGK 189
G+ PE L + D ++ G+++ I
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 55/235 (23%)
Query: 8 KLAD----GKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
KLA G+E+A+K + +T + LQ+ EV ++ L H N+V+LF E L
Sbjct: 32 KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91
Query: 62 IYEYMPNKSLDVFLFD---STRSVQLDWKRRI--SIINGIARGLLYLHEDSRLKIIHRDL 116
I EY + FD + ++ R I++ + Y H + +I+HRDL
Sbjct: 92 IMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH---QKRIVHRDL 140
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFS------ 170
KA N+LL+ +MN KI+DFG + F + G Y APE LF
Sbjct: 141 KAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPE-----LFQGKKYDG 192
Query: 171 VKSDVFSFGVLL-------------------LEIISGKKNTGFYLSELGQSLLSY 206
+ DV+S GV+L ++ GK FY+S ++LL
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR 247
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 29/218 (13%), Positives = 64/218 (29%), Gaps = 42/218 (19%)
Query: 10 ADGKEIAVKRLS---RTSGQGLQEFKNEVTLIAKLQ----------------------HK 44
G+ V R +++ K EV + L+
Sbjct: 101 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160
Query: 45 NLVRLFGCCLEENESLLIYEY--MPNKSLDVFLF------DSTRSVQLDWKRRISIINGI 96
++ L+E + ++ + P ++ F S+ L R+ + +
Sbjct: 161 QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQV 220
Query: 97 ARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156
R L LH ++H L+ +++L+ ++ F G + + R
Sbjct: 221 IRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-GASAVSPIGRGFAPP 276
Query: 157 GYMAPE-----YAMEGLFSVKSDVFSFGVLLLEIISGK 189
A L + D ++ G+ + I
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 45/190 (23%), Positives = 74/190 (38%), Gaps = 41/190 (21%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPN 68
A E AVK + ++ E+ ++ + QH N++ L + ++ E M
Sbjct: 45 ATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100
Query: 69 KSLDVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRDL 116
L D +I +++ I + + YLH ++HRDL
Sbjct: 101 GEL----LD-----------KILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDL 142
Query: 117 KASNVLL-NHEMNP---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVK 172
K SN+L + NP +I DFG A+ T T ++APE +
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAA 200
Query: 173 SDVFSFGVLL 182
D++S GVLL
Sbjct: 201 CDIWSLGVLL 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-20
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 40/203 (19%)
Query: 6 QGKLADGKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLVRLFGCCLEENESL---- 60
Q KL + E+A+K++ + + FKN E+ ++ ++H N+V L +
Sbjct: 58 QAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112
Query: 61 --LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIING------IARGLLYLHEDSRLKII 112
L+ EY+P +++ + K+ + ++ + R L Y+H + I
Sbjct: 113 LNLVLEYVP-ETVYRASRHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIH---SIGIC 163
Query: 113 HRDLKASNVLLNHEMNP-KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLF-- 169
HRD+K N+LL+ K+ DFG A+I E N + I Y Y APE +F
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPEL----IFGA 216
Query: 170 ---SVKSDVFSFGVLLLEIISGK 189
+ D++S G ++ E++ G+
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-20
Identities = 45/157 (28%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
EV+L+ L+H N+V L E L++EY+ +K L +L ++ +
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFL 106
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
+ RGL Y H K++HRDLK N+L+N K++DFG+AR ++ N +V
Sbjct: 107 FQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV 162
Query: 154 GTYGYMAPEYAM-EGLFSVKSDVFSFGVLLLEIISGK 189
T Y P+ + +S + D++ G + E+ +G+
Sbjct: 163 -TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-20
Identities = 44/189 (23%), Positives = 77/189 (40%), Gaps = 39/189 (20%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPN 68
+ AVK +S+ + E+T + + H N+V+L ++ + L+ E +
Sbjct: 34 KSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90
Query: 69 KSLDVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRDL 116
L F+ RI I+ + + ++H+ + ++HRDL
Sbjct: 91 GEL----FE-----------RIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDL 132
Query: 117 KASNVLLNHEMNP---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKS 173
K N+L E + KI DFG AR+ + T T Y APE + +
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYDESC 190
Query: 174 DVFSFGVLL 182
D++S GV+L
Sbjct: 191 DLWSLGVIL 199
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-20
Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 36/191 (18%)
Query: 12 GKEIAVKRLSRTSGQGLQE--------FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
K++A+K +S+ + E+ ++ KL H ++++ + + ++
Sbjct: 35 CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRIS------IINGIARGLLYLHEDSRLKIIHRDLK 117
E M L FD + V +R+ + + YLHE IIHRDLK
Sbjct: 94 ELMEGGEL----FD--KVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLK 141
Query: 118 ASNVLLNH---EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE---YAMEGLFSV 171
NVLL+ + KI+DFG ++I G + GT Y+APE ++
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNR 198
Query: 172 KSDVFSFGVLL 182
D +S GV+L
Sbjct: 199 AVDCWSLGVIL 209
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 9e-20
Identities = 46/234 (19%), Positives = 87/234 (37%), Gaps = 54/234 (23%)
Query: 8 KLA----DGKEIAVKRLSRT--------SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE 55
A KE+ VK + + L + E+ ++++++H N++++
Sbjct: 41 WTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100
Query: 56 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS----------IINGIARGLLYLHE 105
+ L+ E + LD LF +D R+ +++ + YL
Sbjct: 101 QGFFQLVMEKHGS-GLD--LFA-----FIDRHPRLDEPLASYIFRQLVSAVG----YLR- 147
Query: 106 DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-YA 164
IIHRD+K N+++ + K+ DFG A + GT Y APE
Sbjct: 148 --LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL---ERGKLFYTFCGTIEYCAPEVLM 202
Query: 165 MEGLFSVKSDVFSFGVLL-------------LEIISGKKNTGFYLSELGQSLLS 205
+ +++S GV L E + + + +S+ SL+S
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVS 256
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 49/199 (24%), Positives = 98/199 (49%), Gaps = 32/199 (16%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE-SL-LIYEYMPN 68
D K+ A+K++ +G + + E+ L+ +L+H N++ L L + + L+++Y
Sbjct: 47 DDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-- 102
Query: 69 KSLDVF-LFDSTRSVQLDWKRRI-------SIINGIARGLLYLHEDSRLKIIHRDLKASN 120
D++ + R+ + + K S++ I G+ YLH + ++HRDLK +N
Sbjct: 103 -EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPAN 158
Query: 121 VLLNHEMNP----KISDFGMARIFGG-NQSEANTNRIVGTYGYMAPEYAMEGLFSVKS-- 173
+L+ E KI+D G AR+F + A+ + +V T+ Y APE L +
Sbjct: 159 ILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL----LLGARHYT 214
Query: 174 ---DVFSFGVLLLEIISGK 189
D+++ G + E+++ +
Sbjct: 215 KAIDIWAIGCIFAELLTSE 233
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 47/186 (25%), Positives = 76/186 (40%), Gaps = 38/186 (20%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71
K A+K L +T + + + E+ ++ +L H N+++L E L+ E +
Sbjct: 78 QKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE- 134
Query: 72 DVFLFDSTRSVQLDWKRRI------------SIINGIARGLLYLHEDSRLKIIHRDLKAS 119
LFD RI + I + YLHE I+HRDLK
Sbjct: 135 ---LFD-----------RIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPE 177
Query: 120 NVLLNHEMNP---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVF 176
N+L KI+DFG+++I + GT GY APE + + D++
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMW 234
Query: 177 SFGVLL 182
S G++
Sbjct: 235 SVGIIT 240
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-19
Identities = 49/193 (25%), Positives = 83/193 (43%), Gaps = 25/193 (12%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQEF---KNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
+LA +E A+K L + + E ++++L H V+L+ ++ +
Sbjct: 51 ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 110
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIAR--------GLLYLHEDSRLKIIHRDL 116
Y N L + R L YLH IIHRDL
Sbjct: 111 YAKNGE----LLK-----YIRKIGSFD--ETCTRFYTAEIVSALEYLHG---KGIIHRDL 156
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVF 176
K N+LLN +M+ +I+DFG A++ +A N VGT Y++PE E SD++
Sbjct: 157 KPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLW 216
Query: 177 SFGVLLLEIISGK 189
+ G ++ ++++G
Sbjct: 217 ALGCIIYQLVAGL 229
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 48/161 (29%), Positives = 85/161 (52%), Gaps = 17/161 (10%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
E+ L+ +L H N++ L ++ L++++M L+V + S+ L + +
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVII--KDNSLVLTPSHIKAYM 118
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153
+GL YLH+ I+HRDLK +N+LL+ K++DFG+A+ F G+ + A T+++V
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV 174
Query: 154 GTYGYMAPEYAMEGLF-----SVKSDVFSFGVLLLEIISGK 189
T Y APE LF V D+++ G +L E++
Sbjct: 175 -TRWYRAPEL----LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 10 ADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQH-KNLVRLFGCCLEENESLLIYEYM 66
+ G+E A K + R E +E+ ++ + ++ L +E +LI EY
Sbjct: 52 STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYA 111
Query: 67 PNKSLDVFLFDSTRSVQLDWKRR-----ISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
+ F + + I +I I G+ YLH+ I+H DLK N+
Sbjct: 112 AGGEI----FS--LCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNI 162
Query: 122 LL--NHEMNP-KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSF 178
LL + + KI DFGM+R G I+GT Y+APE + +D+++
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNI 219
Query: 179 GVLL 182
G++
Sbjct: 220 GIIA 223
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 44/199 (22%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLVRLFGCCLEENESL------LIYE 64
G+ +A+K++ + + FKN E+ ++ KL H N+VRL E L+ +
Sbjct: 79 GELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIING------IARGLLYLHEDSRLKIIHRDLKA 118
Y+P +++ +R+ Q + +I + R L Y+H I HRD+K
Sbjct: 134 YVP-ETVYRVARHYSRAKQ-----TLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKP 184
Query: 119 SNVLLNHEMNP-KISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-------YAMEGLFS 170
N+LL+ + K+ DFG A+ + E N + I Y Y APE Y +
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRY-YRAPELIFGATDY------T 235
Query: 171 VKSDVFSFGVLLLEIISGK 189
DV+S G +L E++ G+
Sbjct: 236 SSIDVWSAGCVLAELLLGQ 254
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-19
Identities = 46/164 (28%), Positives = 84/164 (51%), Gaps = 16/164 (9%)
Query: 34 EVTLIAKLQ---HKNLVRLF----GCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLD 85
EV ++ L+ H N+VRLF + L L++E++ ++ L +L D +
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVP 118
Query: 86 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS 145
+ ++ + RGL +LH +++HRDLK N+L+ K++DFG+ARI+ +
Sbjct: 119 TETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 146 EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
T+ +V T Y APE ++ ++ D++S G + E+ K
Sbjct: 176 L--TSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 8e-19
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 34 EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISII 93
EV+L+ +LQH+N++ L + LI+EY L ++ D V + + S +
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIK--SFL 138
Query: 94 NGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP-----KISDFGMARIFGGNQSEAN 148
+ G+ + H + +HRDLK N+LL+ KI DFG+AR F G
Sbjct: 139 YQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQF 194
Query: 149 TNRIVGTYGYMAPEYAMEGLFSVKS-----DVFSFGVLLLEIISGK 189
T+ I+ T Y PE L + D++S + E++
Sbjct: 195 THEII-TLWYRPPEI----LLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 34/97 (35%), Positives = 54/97 (55%), Gaps = 12/97 (12%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I GL ++H +++RDLK +N+LL+ + +ISD G+A F + + VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
Query: 156 YGYMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGK 189
+GYMAPE +G+ S D FS G +L +++ G
Sbjct: 354 HGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-18
Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 16/164 (9%)
Query: 34 EVTLIAKLQ---HKNLVRLFGCCLEENESL-----LIYEYMPNKSLDVFLFDSTRSVQLD 85
EV L+ +L+ H N+VRL C L++E++ ++ L +L D L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLP 118
Query: 86 WKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS 145
+ ++ RGL +LH + I+HRDLK N+L+ K++DFG+ARI+ +
Sbjct: 119 AETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175
Query: 146 EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
T +V T Y APE ++ ++ D++S G + E+ K
Sbjct: 176 --LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 4e-18
Identities = 36/94 (38%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I GL +LH+ II+RDLK NVLL+ + N +ISD G+A Q++ GT
Sbjct: 298 IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGT 352
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
G+MAPE + + D F+ GV L E+I+ +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-18
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 17/210 (8%)
Query: 4 CLQGKLADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL 60
C A GK A K+L + +G NE ++ K+ + +V L E ++L
Sbjct: 201 CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDAL 259
Query: 61 -LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
L+ M L ++ ++ R + I GL LH +I++RDLK
Sbjct: 260 CLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPE 315
Query: 120 NVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
N+LL+ + +ISD G+A Q+ VGT GYMAPE ++ D ++ G
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 180 VLLLEIISGK-----KNTGFYLSELGQSLL 204
LL E+I+G+ + E+ + +
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-18
Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 46/203 (22%)
Query: 12 GKEIAVKRL-------SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES----- 59
G +A+K++ +R LQ + +A L H N+V+L E
Sbjct: 48 GMSVAIKKVIQDPRFRNRE----LQIMQ----DLAVLHHPNIVQLQSYFYTLGERDRRDI 99
Query: 60 --LLIYEYMP---NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 114
++ EY+P ++ + R V + + R + LH S + + HR
Sbjct: 100 YLNVVMEYVPDTLHRCCRNY---YRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHR 155
Query: 115 DLKASNVLLNHEMNP-KISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-------YAME 166
D+K NVL+N K+ DFG A+ + SE N I Y Y APE Y
Sbjct: 156 DIKPHNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYICSRY-YRAPELIFGNQHY--- 209
Query: 167 GLFSVKSDVFSFGVLLLEIISGK 189
+ D++S G + E++ G+
Sbjct: 210 ---TTAVDIWSVGCIFAEMMLGE 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 47/235 (20%), Positives = 80/235 (34%), Gaps = 56/235 (23%)
Query: 8 KLA----DGKEIAVKRLSRTSGQGLQEFKN------EVTLIAKLQHK--NLVRLFGCCLE 55
D +A+K + + E N EV L+ K+ ++RL
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119
Query: 56 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS----------IINGIARGLLYLHE 105
+ +LI E P D LFD + + + ++ + + H
Sbjct: 120 PDSFVLILER-PEPVQD--LFD-----FITERGALQEELARSFFWQVLEAVR----HCH- 166
Query: 106 DSRLKIIHRDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYA 164
++HRD+K N+L++ K+ DFG + GT Y PE+
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 220
Query: 165 MEGLFS-VKSDVFSFGVLL-------------LEIISGKKNTGFYLSELGQSLLS 205
+ + V+S G+LL EII G+ +S Q L+
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIR 275
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-17
Identities = 49/194 (25%), Positives = 87/194 (44%), Gaps = 36/194 (18%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLF------GCCLEE 56
G ++A+K+L R F++ E+ L+ ++H+N++ L +
Sbjct: 50 GAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102
Query: 57 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL 116
+ L+ +M L + +L R ++ + +GL Y+H IIHRDL
Sbjct: 103 TDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDL 154
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME-GLFSVKSDV 175
K N+ +N + KI DFG+AR + V T Y APE + ++ D+
Sbjct: 155 KPGNLAVNEDCELKILDFGLARQADSEMTGY-----VVTRWYRAPEVILNWMRYTQTVDI 209
Query: 176 FSFGVLLLEIISGK 189
+S G ++ E+I+GK
Sbjct: 210 WSVGCIMAEMITGK 223
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-17
Identities = 55/193 (28%), Positives = 88/193 (45%), Gaps = 34/193 (17%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLF------GCCLEE 56
+ +A+K+LSR F+N E+ L+ + HKN++ L E
Sbjct: 50 ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102
Query: 57 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL 116
+ ++ E M D L + +LD +R ++ + G+ +LH IIHRDL
Sbjct: 103 QDVYIVMELM-----DANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 153
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVF 176
K SN+++ + KI DFG+AR G S T V T Y APE + + D++
Sbjct: 154 KPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY-VVTRYYRAPEVILGMGYKENVDIW 210
Query: 177 SFGVLLLEIISGK 189
S G ++ E+I G
Sbjct: 211 SVGCIMGEMIKGG 223
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-17
Identities = 45/237 (18%), Positives = 82/237 (34%), Gaps = 58/237 (24%)
Query: 8 KLA----DGKEIAVKRLSRT------SGQGLQEFKNEVTLIAKL----QHKNLVRLFGCC 53
D ++A+K + R EV L+ K+ H ++RL
Sbjct: 48 FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107
Query: 54 LEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRIS----------IINGIARGLLYL 103
+ +L+ E P + D LFD K + ++ I +
Sbjct: 108 ETQEGFMLVLER-PLPAQD--LFDYITE-----KGPLGEGPSRCFFGQVVAAIQ----HC 155
Query: 104 HEDSRLKIIHRDLKASNVLLNHEMNP-KISDFGMARIFGGNQSEANTNRIVGTYGYMAPE 162
H ++HRD+K N+L++ K+ DFG + GT Y PE
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPE 208
Query: 163 YAMEGLFS-VKSDVFSFGVLL-------------LEIISGKKNTGFYLSELGQSLLS 205
+ + + + V+S G+LL EI+ + + ++S +L+
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALIR 265
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-17
Identities = 41/195 (21%), Positives = 68/195 (34%), Gaps = 49/195 (25%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENES----LLIYE 64
G++ A+K L + + + EV + ++V + + L+I E
Sbjct: 52 RTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRI--------------SIINGIARGLLYLHEDSRLK 110
M L F RI I+ I + +LH
Sbjct: 107 CMEGGEL----FS-----------RIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HN 148
Query: 111 IIHRDLKASNVLLNHE---MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG 167
I HRD+K N+L + K++DFG A+ N T Y+APE
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPE 204
Query: 168 LFSVKSDVFSFGVLL 182
+ D++S GV++
Sbjct: 205 KYDKSCDMWSLGVIM 219
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 42/196 (21%), Positives = 70/196 (35%), Gaps = 50/196 (25%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFG----CCLEENESLLIYE 64
++ A+K L + + EV L + ++VR+ L++ E
Sbjct: 85 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRI--------------SIINGIARGLLYLHEDSRLK 110
+ L F RI I+ I + YLH +
Sbjct: 140 CLDGGEL----FS-----------RIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 181
Query: 111 IIHRDLKASNVLLNHEMNP----KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME 166
I HRD+K N+L + P K++DFG A+ + S T Y+APE
Sbjct: 182 IAHRDVKPENLLYTSK-RPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGP 237
Query: 167 GLFSVKSDVFSFGVLL 182
+ D++S GV++
Sbjct: 238 EKYDKSCDMWSLGVIM 253
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 34/193 (17%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLF-----GCCLEEN 57
+ +A+K+LSR F+N E+ L+ + HKN++ L LEE
Sbjct: 87 DRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139
Query: 58 ESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL 116
+ + L+ E M D L + +LD +R ++ + G+ +LH IIHRDL
Sbjct: 140 QDVYLVMELM-----DANLCQVIQM-ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDL 190
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVF 176
K SN+++ + KI DFG+AR G S T V T Y APE + + D++
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY-VVTRYYRAPEVILGMGYKENVDIW 247
Query: 177 SFGVLLLEIISGK 189
S G ++ E++ K
Sbjct: 248 SVGCIMGEMVRHK 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 36/194 (18%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLF-----GCCLEEN 57
G +AVK+LSR F++ E+ L+ ++H+N++ L LEE
Sbjct: 54 GLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 58 ESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL 116
+ L+ M L + + +L +I I RGL Y+H S IIHRDL
Sbjct: 107 NDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--SA-DIIHRDL 158
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME-GLFSVKSDV 175
K SN+ +N + KI DFG+AR + V T Y APE + ++ D+
Sbjct: 159 KPSNLAVNEDCELKILDFGLARHTADEMTGY-----VATRWYRAPEIMLNWMHYNQTVDI 213
Query: 176 FSFGVLLLEIISGK 189
+S G ++ E+++G+
Sbjct: 214 WSVGCIMAELLTGR 227
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 53/198 (26%), Positives = 81/198 (40%), Gaps = 49/198 (24%)
Query: 8 KLA----DGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62
+L + +AVK + R G + E + E+ L+H N+VR L +I
Sbjct: 37 RLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94
Query: 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRIS----------IINGIARGLLYLHEDSRLKII 112
EY L ++ R R S +++G++ Y H ++I
Sbjct: 95 MEYASGGEL----YE--RICN---AGRFSEDEARFFFQQLLSGVS----YCH---SMQIC 138
Query: 113 HRDLKASNVLL--NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE------YA 164
HRDLK N LL + KI DFG ++ + S+ + VGT Y+APE Y
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST--VGTPAYIAPEVLLRQEYD 195
Query: 165 MEGLFSVKSDVFSFGVLL 182
+DV+S GV L
Sbjct: 196 -----GKIADVWSCGVTL 208
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 47/194 (24%), Positives = 87/194 (44%), Gaps = 37/194 (19%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLF-----GCCLEEN 57
G+++A+K+LSR F++ E+ L+ +QH+N++ L L
Sbjct: 49 GEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101
Query: 58 ESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL 116
L+ +M L + ++ ++ + +GL Y+H ++HRDL
Sbjct: 102 YDFYLVMPFM-----QTDLQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDL 152
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME-GLFSVKSDV 175
K N+ +N + KI DFG+AR + V T Y APE + ++ D+
Sbjct: 153 KPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWYRAPEVILSWMHYNQTVDI 207
Query: 176 FSFGVLLLEIISGK 189
+S G ++ E+++GK
Sbjct: 208 WSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 49/199 (24%), Positives = 92/199 (46%), Gaps = 42/199 (21%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLFGC----CLEENE 58
+A+K++S F++ E+ ++ + +H+N++ + +E+ +
Sbjct: 52 KVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103
Query: 59 SL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
+ ++ + M + L+ ++ L + I RGL Y+H S ++HRDLK
Sbjct: 104 DVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH--SA-NVLHRDLK 155
Query: 118 ASNVLLNHEMNPKISDFGMARIFGGNQSEAN--TNRIVGTYGYMAPEYAMEGLFSVKS-- 173
SN+LLN + KI DFG+AR+ + T V T Y APE + + K
Sbjct: 156 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY-VATRWYRAPEI----MLNSKGYT 210
Query: 174 ---DVFSFGVLLLEIISGK 189
D++S G +L E++S +
Sbjct: 211 KSIDIWSVGCILAEMLSNR 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 7e-16
Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 33/192 (17%)
Query: 12 GKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
G ++AVK L+R S + + K E+ + +H ++++L+ + ++ EY+
Sbjct: 36 GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 69 KSLDVFLFDSTRSVQLDWKRRIS----------IINGIARGLLYLHEDSRLKIIHRDLKA 118
L FD + R+ I++ + Y H R ++HRDLK
Sbjct: 96 GEL----FD-----YICKHGRVEEMEARRLFQQILSAVD----YCH---RHMVVHRDLKP 139
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFS-VKSDVFS 177
NVLL+ MN KI+DFG++ + + T+ G+ Y APE L++ + D++S
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMSDGE-FLRTS--CGSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 178 FGVLLLEIISGK 189
GV+L ++ G
Sbjct: 197 CGVILYALLCGT 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 52/192 (27%), Positives = 92/192 (47%), Gaps = 33/192 (17%)
Query: 12 GKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
G ++AVK L+R S + + + E+ + +H ++++L+ ++ ++ EY+
Sbjct: 41 GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100
Query: 69 KSLDVFLFD---STRSVQLDWKRRI--SIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
L FD + RR+ I++G+ Y H R ++HRDLK NVLL
Sbjct: 101 GEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCH---RHMVVHRDLKPENVLL 149
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE------YAMEGLFSVKSDVFS 177
+ MN KI+DFG++ + + T+ G+ Y APE YA + D++S
Sbjct: 150 DAHMNAKIADFGLSNMMSDGEF-LRTS--CGSPNYAAPEVISGRLYA-----GPEVDIWS 201
Query: 178 FGVLLLEIISGK 189
GV+L ++ G
Sbjct: 202 SGVILYALLCGT 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 62/206 (30%)
Query: 12 GKEIAVKRLSRT--SGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+++A+K +SR + + E++ + L+H ++++L Y+ +
Sbjct: 34 QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-------------YDVITT 80
Query: 69 KSLDVF---------LFDSTRSVQLDWKRRIS----------IINGIARGLLYLHEDSRL 109
+ D+ LFD + K+R++ II I Y H R
Sbjct: 81 PT-DIVMVIEYAGGELFD-----YIVEKKRMTEDEGRRFFQQIICAIE----YCH---RH 127
Query: 110 KIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE------Y 163
KI+HRDLK N+LL+ +N KI+DFG++ I T+ G+ Y APE Y
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTS--CGSPNYAAPEVINGKLY 184
Query: 164 AMEGLFSVKSDVFSFGVLLLEIISGK 189
A + DV+S G++L ++ G+
Sbjct: 185 A-----GPEVDVWSCGIVLYVMLVGR 205
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 13/99 (13%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
+ L YL +IIHRD+K N+LL+ + I+DF +A + + GT
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 156 YGYMAPE--YAMEGL---FSVKSDVFSFGVLLLEIISGK 189
YMAPE + +G F+V D +S GV E++ G+
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR 214
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 44/200 (22%), Positives = 86/200 (43%), Gaps = 35/200 (17%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLFGCCLEENESLLI 62
K +A+K++ + E+ +I +L H N+V++F L
Sbjct: 36 DKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86
Query: 63 YEYMPNKSLDVFLF----DS-----TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIH 113
+ V++ ++ L + + + RGL Y+H + ++H
Sbjct: 87 DVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLH 143
Query: 114 RDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEAN--TNRIVGTYGYMAPEYAMEGL-F 169
RDLK +N+ +N E + KI DFG+ARI + S + +V T Y +P + +
Sbjct: 144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNY 202
Query: 170 SVKSDVFSFGVLLLEIISGK 189
+ D+++ G + E+++GK
Sbjct: 203 TKAIDMWAAGCIFAEMLTGK 222
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 48/196 (24%), Positives = 80/196 (40%), Gaps = 26/196 (13%)
Query: 11 DGKEIAVKRLSRTSGQGLQE--FKN---------EVTLIAKLQHKNLVRLFGC----CLE 55
+G +A+KR+ T G + E+ L+ H N++ L
Sbjct: 45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104
Query: 56 ENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 114
L L+ E M D+ + + + + + I GL LHE ++HR
Sbjct: 105 AMHKLYLVTELMRT---DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHR 158
Query: 115 DLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME-GLFSVKS 173
DL N+LL + I DF +AR + ++AN V Y APE M+ F+
Sbjct: 159 DLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTHRWYRAPELVMQFKGFTKLV 215
Query: 174 DVFSFGVLLLEIISGK 189
D++S G ++ E+ + K
Sbjct: 216 DMWSAGCVMAEMFNRK 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 47/205 (22%), Positives = 81/205 (39%), Gaps = 47/205 (22%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLFGC----CLEENE 58
G+ +A+K++ F E+ ++ +H+N++ +F E
Sbjct: 36 GEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87
Query: 59 SL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
+ +I E M L + L I R + LH + +IHRDLK
Sbjct: 88 EVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLK 139
Query: 118 ASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI--------VGTYGYMAPEYAMEGLF 169
SN+L+N + K+ DFG+ARI + ++ + V T Y APE +
Sbjct: 140 PSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV----ML 195
Query: 170 SVKS-----DVFSFGVLLLEIISGK 189
+ DV+S G +L E+ +
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 55/227 (24%), Positives = 90/227 (39%), Gaps = 68/227 (29%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN-EVTLIAKLQHKNLVRL---FGCCLEENESL------- 60
GK A+K++ + +KN E+ ++ L H N+++L F +E
Sbjct: 32 GKRFALKKVLQD-----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86
Query: 61 ----------------------------LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISI 92
+I EY+P +L L RS + I +
Sbjct: 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGR-----SIPM 140
Query: 93 ING------IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP-KISDFGMARIFGGNQS 145
+ R + ++H L I HRD+K N+L+N + N K+ DFG A+ S
Sbjct: 141 NLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPS 195
Query: 146 EANTNRIVGTYGYMAPEY---AMEGLFSVKSDVFSFGVLLLEIISGK 189
E + I + Y APE A E ++ D++S G + E+I GK
Sbjct: 196 EPSVAYICSRF-YRAPELMLGATE--YTPSIDLWSIGCVFGELILGK 239
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 39/203 (19%), Positives = 78/203 (38%), Gaps = 56/203 (27%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGC---CLEENESLLIYEYM 66
+ +++ VK L ++ K E+ ++ L+ N++ L + +L+
Sbjct: 60 NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRI---------SIINGIARGLLYLHEDSRLKIIHRDLK 117
D+K+ + I + L Y H S I+HRD+K
Sbjct: 117 ----------------NTDFKQLYQTLTDYDIRFYMYEILKALDYCH--SM-GIMHRDVK 157
Query: 118 ASNVLLNHE-MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE---------YAMEG 167
NV+++HE ++ D+G+A + + R+ Y + PE Y++
Sbjct: 158 PHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGPELLVDYQMYDYSL-- 212
Query: 168 LFSVKSDVFSFGVLLLEIISGKK 190
D++S G +L +I K+
Sbjct: 213 ------DMWSLGCMLASMIFRKE 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 3e-14
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I+ L +LH+ II+RDLK N++LNH+ + K++DFG+ + + + +T GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
YMAPE M + D +S G L+ ++++G
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 3e-14
Identities = 35/94 (37%), Positives = 57/94 (60%), Gaps = 5/94 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
+A L +LH L II+RDLK N+LL+ E + K++DFG+++ ++ +A + GT
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGT 189
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
YMAPE + +D +SFGVL+ E+++G
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIV 153
IA GL +L II+RDLK NV+L+ E + KI+DFGM + I+ G T
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFC 503
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
GT Y+APE + D ++FGVLL E+++G+
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-14
Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIV 153
IA GL +L II+RDLK NV+L+ E + KI+DFGM + I+ G T
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFC 182
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
GT Y+APE + D ++FGVLL E+++G+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I L YLH S +++RDLK N++L+ + + KI+DFG+ + G + A GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 312
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
Y+APE + + D + GV++ E++ G+
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-14
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 9/96 (9%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIV 153
I L YLH +++RD+K N++L+ + + KI+DFG+ + I G
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT----MKTFC 166
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
GT Y+APE + + D + GV++ E++ G+
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-14
Identities = 38/94 (40%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I L++LH+ II+RDLK NVLL+HE + K++DFGM + N T GT
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGT 187
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
Y+APE E L+ D ++ GVLL E++ G
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 7e-14
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I+ L YLHE II+RDLK NVLL+ E + K++D+GM + +T GT
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 173
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
Y+APE + D ++ GVL+ E+++G+
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 8e-14
Identities = 37/95 (38%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIV 153
I GL +LH I++RDLK N+LL+ + + KI+DFGM + + G + TN
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK----TNTFC 179
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
GT Y+APE + ++ D +SFGVLL E++ G
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-14
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIV 153
IA L YLH L I++RDLK N+LL+ + + ++DFG+ + I + T+
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST----TSTFC 200
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
GT Y+APE + + D + G +L E++ G
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-14
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I+ L YLHE II+RDLK NVLL+ E + K++D+GM + +T GT
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGT 216
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
Y+APE + D ++ GVL+ E+++G+
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 32/172 (18%), Positives = 71/172 (41%), Gaps = 34/172 (19%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLFGCCLEENESL-- 60
+ +A+K++ R F++ E+ ++ +L H ++V++ + ++
Sbjct: 78 KRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130
Query: 61 ---LIYEYMP---NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHR 114
++ E K LF + + + +++ + G+ Y+H I+HR
Sbjct: 131 ELYVVLEIADSDFKK-----LFRTPVYLTELHIK--TLLYNLLVGVKYVHSAG---ILHR 180
Query: 115 DLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME 166
DLK +N L+N + + K+ DFG+AR ++ + I M
Sbjct: 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH 232
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 36/171 (21%), Positives = 73/171 (42%), Gaps = 30/171 (17%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQHKNLVRLFGCCLEENESL-- 60
K +A+K+++R F++ E+T++ +L+ ++RL+ + ++
Sbjct: 51 EKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103
Query: 61 ---LIYEYMPNKSLDVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHEDSRLKIIHRDL 116
++ E D L ++ L + +I+ + G ++HE IIHRDL
Sbjct: 104 ELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDL 155
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG 167
K +N LLN + + K+ DFG+AR + N + ++
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 47/210 (22%)
Query: 12 GKEIAVKRLSRTSGQGLQEFKN---------EVTLIAKLQ-HKNLVRLFGCCLEEN--ES 59
G+ +AVK++ F+N E+ ++ +L H+N+V L +N +
Sbjct: 34 GEVVAVKKIFDA-------FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86
Query: 60 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
L+++YM + L R+ L+ + ++ + + + YLH S ++HRD+K S
Sbjct: 87 YLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLH--SG-GLLHRDMKPS 138
Query: 120 NVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAP--------EY-------A 164
N+LLN E + K++DFG++R F + N + +Y A
Sbjct: 139 NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRA 198
Query: 165 MEGLFSVKS-----DVFSFGVLLLEIISGK 189
E L D++S G +L EI+ GK
Sbjct: 199 PEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 14/100 (14%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR--IFGGNQSEANTNRIV 153
I L +LH+ L II+RD+K N+LL+ + ++DFG+++ + +
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER---AYDFC 221
Query: 154 GTYGYMAPEYAMEGL----FSVKSDVFSFGVLLLEIISGK 189
GT YMAP+ G +V D +S GVL+ E+++G
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-13
Identities = 19/181 (10%), Positives = 50/181 (27%), Gaps = 40/181 (22%)
Query: 12 GKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+++A+ + LQE + ++++ + R+ L++ E++
Sbjct: 56 DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
SL I + +A H R + S V ++ + +
Sbjct: 116 GSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGD 167
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
++ M + + D+ G L ++
Sbjct: 168 VVLAYP----------------------ATMPDA-------NPQDDIRGIGASLYALLVN 198
Query: 189 K 189
+
Sbjct: 199 R 199
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 27/105 (25%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
+ + +H+ L +HRD+K N+L++ + +++DFG + ++ VGT
Sbjct: 184 MVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGT 239
Query: 156 YGYMAPE-----YAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195
Y++PE +G + + D +S GV + E++ G+ T FY
Sbjct: 240 PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFY 282
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-13
Identities = 28/107 (26%), Positives = 48/107 (44%), Gaps = 13/107 (12%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I + +H L +HRD+K N+LL+ + +++DFG + + VGT
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD-GTVRSLVAVGT 226
Query: 156 YGYMAPE-------YAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195
Y++PE G + + D ++ GV E+ G+ T FY
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--TPFY 271
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 32/178 (17%)
Query: 31 FKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMPNKSLDVFLFDSTRSVQLDWKRR 89
F E ++A +V+LF +++ L ++ EYMP L V L
Sbjct: 116 FWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL----------VNLMSNYD 164
Query: 90 ISIINGIAR--------GLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFG 141
+ AR L +H + IHRD+K N+LL+ + K++DFG
Sbjct: 165 VP--EKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 142 GNQSEANTNRIVGTYGYMAPE----YAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195
+ VGT Y++PE +G + + D +S GV L E++ G T FY
Sbjct: 220 KEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFY 274
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
I YLH L +I+RDLK N+L++ + +++DFG A+ G T + GT
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGT 201
Query: 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
+APE + ++ D ++ GVL+ E+ +G
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-12
Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 20/99 (20%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155
+ L YLH II+RDLK N+LL+ + KI+DFG A+ T + GT
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGT 166
Query: 156 YGYMAPE------YAMEGLFSVKSDVFSFGVLLLEIISG 188
Y+APE Y S+ D +SFG+L+ E+++G
Sbjct: 167 PDYIAPEVVSTKPYNK----SI--DWWSFGILIYEMLAG 199
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 17/110 (15%)
Query: 90 ISIINGIAR----GLLYLHEDSRLKIIHRDLKASNVLLNHEMNP------KISDFGMARI 139
+ + I++ GL Y+H R IIH D+K NVL+ +P KI+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 140 FGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+ + + + T Y +PE + + +D++S L+ E+I+G
Sbjct: 188 YDEHYTN-----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 32/153 (20%), Positives = 51/153 (33%), Gaps = 51/153 (33%)
Query: 10 ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPN 68
++ A+K L + + EV L + Q ++VR+ E + +
Sbjct: 41 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLI-- 92
Query: 69 KSLDVF-------LFDSTRSVQLDWKRRI--------------SIINGIARGLLYLHEDS 107
V LF RI I+ I + YLH
Sbjct: 93 ----VMECLDGGELFS-----------RIQDRGDQAFTEREASEIMKSIGEAIQYLHS-- 135
Query: 108 RLKIIHRDLKASNVLLNHE---MNPKISDFGMA 137
+ I HRD+K N+L + K++DFG A
Sbjct: 136 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 18/100 (18%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP--KISDFGMARIFGGNQSEANTNRIV 153
I + L LH + +IIH DLK N+LL + K+ DFG S ++ V
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG---------SSCYEHQRV 256
Query: 154 GTY----GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
TY Y APE + + + D++S G +L E+++G
Sbjct: 257 YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 4e-08
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP--KISDFGMARIFGGNQSEANTNRIV 153
+ LL+L L IIH DLK N+LL + KI DFG + G + +
Sbjct: 166 MCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ-----YI 219
Query: 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+ Y +PE + + + D++S G +L+E+ +G+
Sbjct: 220 QSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 28/148 (18%), Positives = 52/148 (35%), Gaps = 56/148 (37%)
Query: 91 SIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-------------------------- 124
II + +GL YLH ++ +IIH D+K N+LL+
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 125 -----------------------HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAP 161
++ KI+D G A + +E + T Y +
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSL 262
Query: 162 EYAMEGLFSVKSDVFSFGVLLLEIISGK 189
E + ++ +D++S + E+ +G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 1e-06
Identities = 22/136 (16%), Positives = 42/136 (30%), Gaps = 19/136 (13%)
Query: 61 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
++ E+ + R+ SI++ + L L+ HRDL N
Sbjct: 139 IVLEFEFGGID----LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAP--EYAMEGLFSVKSDVFSF 178
VLL K+ + + + G +Y + L VF
Sbjct: 193 VLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIVVFCD 241
Query: 179 GVLLLEIISGKKNTGF 194
+ ++ +G + F
Sbjct: 242 VSMDEDLFTGDGDYQF 257
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 26/117 (22%), Positives = 41/117 (35%), Gaps = 35/117 (29%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP-------------------KISDFGM 136
+ L +LHE ++ H DLK N+L + +++DFG
Sbjct: 132 LCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG- 187
Query: 137 ARIFGGNQSEANTNRIVGTY----GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
S + T Y PE +E ++ DV+S G +L E G
Sbjct: 188 --------SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 4e-05
Identities = 51/317 (16%), Positives = 88/317 (27%), Gaps = 78/317 (24%)
Query: 32 KNEVTLIAKLQHK--NLVRLFGCCLEENESLLIYEYMPNKSLDV---FLFDS----TRSV 82
K E+ I + +RLF L + E + + + L + FL R
Sbjct: 48 KEEIDHIIMSKDAVSGTLRLFWTLLSKQEE--MVQKFVEEVLRINYKFLMSPIKTEQRQP 105
Query: 83 QLDWKRRISIINGIARG--LLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIF 140
+ + I + + + + SRL+ + L+ LL + G+
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK-LR--QALLELRPAKNVLIDGVL--- 159
Query: 141 G-GNQSEANTNRIVGTYGYMAPEYAMEGLFSVK-SDVFSFGVLLLEIISGKKNTGFYLSE 198
G G A++ S K F + L + N+ + E
Sbjct: 160 GSGKTW-----------------VALDVCLSYKVQCKMDFKIFWLNL--KNCNSPETVLE 200
Query: 199 LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH-----IGLL----------- 242
+ Q LL W + S + AEL + + LL
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHS-IQAELRRLLKSKPYENCLLVLLNVQNAKAW 259
Query: 243 ------C----------VQADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGRNVARPG 286
C V D T + + + S T+T + +
Sbjct: 260 NAFNLSCKILLTTRFKQV-TDFLSAATTTHISLDHHSMTLTPDE-VKSLLL---KYLDCR 314
Query: 287 QFSSGAEVCSVNEVTLS 303
EV + N LS
Sbjct: 315 PQDLPREVLTTNPRRLS 331
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 29/114 (25%), Positives = 43/114 (37%), Gaps = 23/114 (20%)
Query: 96 IARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR---- 151
I + L YL + + + H DLK N+LL+ K G T
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 152 ----------------IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
I+ T Y APE + + V SD++SFG +L E+ +G
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 6e-05
Identities = 30/123 (24%), Positives = 46/123 (37%), Gaps = 31/123 (25%)
Query: 90 ISIINGIARGLL----YLHEDSRLKIIHRDLKASNVLLNHEMNP---------------- 129
+ I +A + +LH K+ H DLK N+L
Sbjct: 117 LDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 130 ---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
K+ DFG A + + + +V T Y APE + +S DV+S G +L+E
Sbjct: 174 PDIKVVDFGSA-TYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228
Query: 187 SGK 189
G
Sbjct: 229 LGF 231
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 9e-04
Identities = 30/144 (20%), Positives = 56/144 (38%), Gaps = 26/144 (18%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH-KNLVRLFGCCLEENESLLIYEYMP 67
L + +A+K S + E +L + +++ + ++ E +
Sbjct: 31 LYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISI--INGIARGLL----YLHEDSRLKIIHRDLKASNV 121
SL+ LFD R S+ + IA L+ Y+H + +I+RD+K N
Sbjct: 88 GPSLE-DLFDLC-------DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENF 136
Query: 122 LLNHEMNPK-----ISDFGMARIF 140
L+ N I DF +A+ +
Sbjct: 137 LIGRPGNKTQQVIHIIDFALAKEY 160
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 308 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.22 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.91 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.7 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.47 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.33 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.27 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.06 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.88 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.67 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 92.07 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.05 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.11 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-55 Score=376.93 Aligned_cols=245 Identities=27% Similarity=0.419 Sum_probs=201.4
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|++. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+||||||++|+|.++
T Consensus 26 fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~ 105 (299)
T 4asz_A 26 FGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 105 (299)
T ss_dssp CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred CcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHH
Confidence 8999999863 4788999999877666778899999999999999999999999999999999999999999999
Q ss_pred hhcCC----------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCC
Q 021771 75 LFDST----------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQ 144 (308)
Q Consensus 75 l~~~~----------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~ 144 (308)
+.... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 182 (299)
T 4asz_A 106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182 (299)
T ss_dssp HHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred HHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCC
Confidence 97532 2346999999999999999999999997 9999999999999999999999999998654333
Q ss_pred CccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccc
Q 021771 145 SEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 145 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
.........||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +. .. ...+.....
T Consensus 183 ~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~---~~-i~~~~~~~~---- 251 (299)
T 4asz_A 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI---EC-ITQGRVLQR---- 251 (299)
T ss_dssp CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HH---HH-HHHTCCCCC----
T ss_pred ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---HH-HHcCCCCCC----
Confidence 3333334568999999999999999999999999999999998 899986543221 11 11 111111111
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+......+.+|+.+||+.||++|||+++|++.|+..
T Consensus 252 -----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 252 -----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 112234588899999999999999999999999875
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=377.72 Aligned_cols=246 Identities=29% Similarity=0.405 Sum_probs=193.8
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|+++ +++.||||+++..+....+.+.+|+.+|++++|||||++++++.+.+.++||||||++|+|.++
T Consensus 54 fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~ 133 (329)
T 4aoj_A 54 FGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 133 (329)
T ss_dssp SEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred CcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHH
Confidence 8999999864 5889999999877777778899999999999999999999999999999999999999999999
Q ss_pred hhcCCC------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 75 LFDSTR------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 75 l~~~~~------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 134 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~ 210 (329)
T 4aoj_A 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210 (329)
T ss_dssp HHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred HHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccC
Confidence 976432 245899999999999999999999997 99999999999999999999999999987654
Q ss_pred CCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELME 221 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
...........||+.|+|||++.+..++.++|||||||++|||++ |+.||....... + ..... .+....
T Consensus 211 ~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~---~~~i~-~g~~~~--- 280 (329)
T 4aoj_A 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---A---IDCIT-QGRELE--- 280 (329)
T ss_dssp ---------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---H---HHHHH-HTCCCC---
T ss_pred CCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---H---HHHHH-cCCCCC---
Confidence 433333444578999999999999999999999999999999998 899986543221 1 11111 111111
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
.+......+.+|+.+||+.||++|||++||++.|+...
T Consensus 281 ------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 281 ------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp ------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 11112345888999999999999999999999998763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=371.14 Aligned_cols=236 Identities=21% Similarity=0.307 Sum_probs=194.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+|+. .+|+.||||+++.......+.+.+|+.+|+.++||||++++++|.+++.+|||||||++|+|.+++..
T Consensus 87 fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-- 164 (346)
T 4fih_A 87 TGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-- 164 (346)
T ss_dssp SCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--
T ss_pred CeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--
Confidence 899999996 58999999999766656667789999999999999999999999999999999999999999998854
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++..+..... ......||+.|+
T Consensus 165 --~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~Ym 237 (346)
T 4fih_A 165 --TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWM 237 (346)
T ss_dssp --SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGC
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcC
Confidence 34999999999999999999999998 99999999999999999999999999988653322 233467999999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||++.+..++.++|||||||++|+|++|.+||....... ........ .... +. ........+.+|
T Consensus 238 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~-~~~~-~~------~~~~~s~~~~dl 303 (346)
T 4fih_A 238 APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDN-LPPR-LK------NLHKVSPSLKGF 303 (346)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-SCCC-CS------CGGGSCHHHHHH
T ss_pred CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcC-CCCC-CC------ccccCCHHHHHH
Confidence 9999999999999999999999999999999996432221 11111111 0000 00 011122358889
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
|.+||+.||++|||++|+++
T Consensus 304 i~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 304 LDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-54 Score=372.08 Aligned_cols=245 Identities=27% Similarity=0.395 Sum_probs=198.6
Q ss_pred CCccEEeeeC------CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+|++. +++.||||+++.. .....+.+.+|+.+|++++|||||++++++.+++.++||||||++|+|.+
T Consensus 39 fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~ 118 (308)
T 4gt4_A 39 FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 118 (308)
T ss_dssp SCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHH
T ss_pred CcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHH
Confidence 8999999863 5789999999654 34456789999999999999999999999999999999999999999999
Q ss_pred HhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeee
Q 021771 74 FLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIF 140 (308)
Q Consensus 74 ~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~ 140 (308)
++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 119 ~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~ 195 (308)
T 4gt4_A 119 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREV 195 (308)
T ss_dssp HHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGG
T ss_pred HHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceec
Confidence 9965321 245899999999999999999999997 999999999999999999999999999876
Q ss_pred CCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccc
Q 021771 141 GGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALEL 219 (308)
Q Consensus 141 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (308)
.............||+.|+|||++.+..++.++||||+||++|||++ |..||....... + ... ...+....
T Consensus 196 ~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~---~~~-i~~~~~~~- 267 (308)
T 4gt4_A 196 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V---VEM-IRNRQVLP- 267 (308)
T ss_dssp GGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---H---HHH-HHTTCCCC-
T ss_pred cCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---H---HHH-HHcCCCCC-
Confidence 43333333344578999999999999999999999999999999998 889986543221 1 111 11111111
Q ss_pred ccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 220 MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+......+.+|+.+||+.||++|||++||++.|+..
T Consensus 268 --------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 268 --------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122234588899999999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-54 Score=368.54 Aligned_cols=235 Identities=23% Similarity=0.310 Sum_probs=195.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||||++.+. .....+.+.+|+.+|+.++||||++++++|.+++.+|+|||||+||+|.+++.
T Consensus 45 fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~ 124 (311)
T 4aw0_A 45 FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 124 (311)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH
Confidence 899999995 68999999999654 34456789999999999999999999999999999999999999999999996
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..+.............||+
T Consensus 125 ~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp 198 (311)
T 4aw0_A 125 KI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 198 (311)
T ss_dssp HH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCG
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCc
Confidence 43 35999999999999999999999998 9999999999999999999999999999876544444445568999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||...... ......... .. .. +.....++
T Consensus 199 ~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~-~~-~~---------p~~~s~~~ 261 (311)
T 4aw0_A 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LIFAKIIKL-EY-DF---------PEKFFPKA 261 (311)
T ss_dssp GGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHT-CC-CC---------CTTCCHHH
T ss_pred ccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC-CC-CC---------CcccCHHH
Confidence 999999999999999999999999999999999999643222 111111111 10 10 11122357
Q ss_pred HHHHhhcccCCCCCCCCHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVV 258 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil 258 (308)
.+||.+||+.||++|||++|++
T Consensus 262 ~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 262 RDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp HHHHHHHSCSSGGGSTTSGGGT
T ss_pred HHHHHHHccCCHhHCcChHHHc
Confidence 8899999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=372.96 Aligned_cols=237 Identities=21% Similarity=0.338 Sum_probs=192.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+++.+|||||||++|+|.+++..
T Consensus 37 fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~ 116 (350)
T 4b9d_A 37 FGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA 116 (350)
T ss_dssp --CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH
Confidence 899999995 68999999999754 344567899999999999999999999999999999999999999999999965
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. +...+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++.+... ........||+.
T Consensus 117 ~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~ 190 (350)
T 4b9d_A 117 Q-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPY 190 (350)
T ss_dssp T-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCT
T ss_pred c-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCcc
Confidence 3 3345789999999999999999999998 999999999999999999999999999875321 111233579999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||++.+..++.++|||||||++|+|++|..||...... ........ ...... ......++.
T Consensus 191 YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~-~~~~~~---------~~~~s~~~~ 254 (350)
T 4b9d_A 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLVLKIIS-GSFPPV---------SLHYSYDLR 254 (350)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH-TCCCCC---------CTTSCHHHH
T ss_pred ccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHc-CCCCCC---------CccCCHHHH
Confidence 99999999999999999999999999999999999654222 11111111 111111 111223588
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+||.+||+.||++|||++|+++
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 8999999999999999999985
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-53 Score=364.25 Aligned_cols=250 Identities=25% Similarity=0.387 Sum_probs=190.6
Q ss_pred CCccEEeeeCCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+|++++ .||||+++.. +....+.+.+|+.+|++++||||+++++++.+ +.++||||||++|+|.+++...
T Consensus 49 fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~ 125 (307)
T 3omv_A 49 FGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQ 125 (307)
T ss_dssp SSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTS
T ss_pred CcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhc
Confidence 89999998753 5899998644 34456789999999999999999999998765 5689999999999999999653
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...............||+.|
T Consensus 126 ~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~y 200 (307)
T 3omv_A 126 E--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLW 200 (307)
T ss_dssp C--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTS
T ss_pred C--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCc
Confidence 3 35999999999999999999999997 999999999999999999999999999876433333334446799999
Q ss_pred cCchhhcc---CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 159 MAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 159 ~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+|||++.+ ..++.++|||||||++|+|++|+.||....... ..............+ ...+......
T Consensus 201 mAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~p~~-----~~~~~~~~~~ 269 (307)
T 3omv_A 201 MAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYASPDL-----SKLYKNCPKA 269 (307)
T ss_dssp CCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCCCCS-----TTSCTTSCHH
T ss_pred cCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCCc-----ccccccchHH
Confidence 99999864 358999999999999999999999996432211 011111111000000 0111122345
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLASDTVTLP 269 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~ 269 (308)
+.+|+.+||+.||++|||+.||++.|+....++|
T Consensus 270 l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 270 MKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp HHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 8889999999999999999999999887655553
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=372.73 Aligned_cols=236 Identities=21% Similarity=0.304 Sum_probs=195.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|||||||+||+|.+++..
T Consensus 164 fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-- 241 (423)
T 4fie_A 164 TGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-- 241 (423)
T ss_dssp SCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--
T ss_pred CcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--
Confidence 899999996 58999999999876666677899999999999999999999999999999999999999999999853
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++..+..... .....+||+.|+
T Consensus 242 --~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~Ym 314 (423)
T 4fie_A 242 --TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWM 314 (423)
T ss_dssp --SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTC
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcC
Confidence 24999999999999999999999998 99999999999999999999999999988653322 233468999999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||++.+..|+.++|||||||++|+|++|..||....... ......... ... +. ........+.+|
T Consensus 315 APEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~~~~i~~~~-~~~-~~------~~~~~s~~~~dl 380 (423)
T 4fie_A 315 APELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK------AMKMIRDNL-PPR-LK------NLHKVSPSLKGF 380 (423)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-CCC-CS------CTTSSCHHHHHH
T ss_pred CHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcCC-CCC-Cc------ccccCCHHHHHH
Confidence 9999999999999999999999999999999996432221 111111110 000 00 011122358889
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
|.+||+.||++|||+.|+++
T Consensus 381 i~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 381 LDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHcCCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=361.48 Aligned_cols=239 Identities=22% Similarity=0.216 Sum_probs=190.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.||||+++.... ..+|+.+|+.++|||||++++++.+++.++||||||++|+|.+++...
T Consensus 71 fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~- 144 (336)
T 4g3f_A 71 FGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM- 144 (336)
T ss_dssp TEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-
T ss_pred CeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc-
Confidence 899999996 5799999999965422 246999999999999999999999999999999999999999999653
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCcc---ccceeecc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSEA---NTNRIVGT 155 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~~---~~~~~~~~ 155 (308)
..+++..+..++.||+.||+|||++| |+||||||+|||++.+| .+||+|||++..+....... ......||
T Consensus 145 --~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT 219 (336)
T 4g3f_A 145 --GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219 (336)
T ss_dssp --SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCC
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccC
Confidence 35999999999999999999999998 99999999999999988 59999999998875432211 12335799
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+.|+|||++.+..++.++|||||||++|+|++|.+||......... . ......... ...+......
T Consensus 220 ~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~---~i~~~~~~~--------~~~~~~~s~~ 285 (336)
T 4g3f_A 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---L---KIASEPPPI--------REIPPSCAPL 285 (336)
T ss_dssp GGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---H---HHHHSCCGG--------GGSCTTSCHH
T ss_pred ccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---H---HHHcCCCCc--------hhcCccCCHH
Confidence 9999999999999999999999999999999999999654332211 1 111111000 0111122345
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+||.+||+.||++|||+.||++.|...
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 88899999999999999999999887544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=350.93 Aligned_cols=232 Identities=19% Similarity=0.319 Sum_probs=179.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||||+++.. .......+.+|+.+|+.++||||+++++++.+++.+++||||| +|+|.+++.
T Consensus 26 fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~ 104 (275)
T 3hyh_A 26 FGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIV 104 (275)
T ss_dssp -CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHH
Confidence 899999995 68999999999654 2344678999999999999999999999999999999999999 678988885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++...... ......||+
T Consensus 105 ~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~ 175 (275)
T 3hyh_A 105 QR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSP 175 (275)
T ss_dssp HS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------------------C
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECc
Confidence 53 35999999999999999999999998 9999999999999999999999999998754322 223357999
Q ss_pred CccCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 157 GYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 157 ~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
.|+|||++.+..+ +.++|||||||++|+|++|..||....... ...... .... .. .. ....+
T Consensus 176 ~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~------~~~~i~-~~~~-~~-----p~----~~s~~ 238 (275)
T 3hyh_A 176 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV------LFKNIS-NGVY-TL-----PK----FLSPG 238 (275)
T ss_dssp TTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTCC-CC-----CT----TSCHH
T ss_pred ccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cCCC-CC-----CC----CCCHH
Confidence 9999999988765 579999999999999999999996432211 111111 1110 00 01 11235
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHHc
Confidence 788999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=350.29 Aligned_cols=236 Identities=24% Similarity=0.367 Sum_probs=186.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe----CCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE----ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+|.. .+|..||+|++... .....+.+.+|+.+|+.++|||||+++++|.+ +..++||||||++|+|.+
T Consensus 39 fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~ 118 (290)
T 3fpq_A 39 FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT 118 (290)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHH
T ss_pred CcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHH
Confidence 899999996 57999999998644 34456789999999999999999999999875 345899999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-CCCeeeecccceeeeCCCCCcccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
++... ..+++..+..++.||+.||+|||+++ ..|+||||||+|||++. ++.+||+|||+++.... ......
T Consensus 119 ~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~ 190 (290)
T 3fpq_A 119 YLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAV 190 (290)
T ss_dssp HHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEES
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC----CccCCc
Confidence 99653 35999999999999999999999873 34999999999999984 78999999999975322 123345
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.||+.|+|||++.+ .++.++|||||||++|+|++|..||....... . ..........+..++ ...
T Consensus 191 ~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~-~~~~i~~~~~~~~~~----~~~---- 255 (290)
T 3fpq_A 191 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----Q-IYRRVTSGVKPASFD----KVA---- 255 (290)
T ss_dssp CSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----H-HHHHHTTTCCCGGGG----GCC----
T ss_pred ccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----H-HHHHHHcCCCCCCCC----ccC----
Confidence 79999999998865 58999999999999999999999995432211 1 111111111111111 111
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..++.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 124788899999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=354.07 Aligned_cols=234 Identities=21% Similarity=0.220 Sum_probs=182.2
Q ss_pred CCccEEeee----CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL----ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~----~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+++. .+++.||||+++... ......+.+|+.+|+.++||||+++++++.+++.+++|||||+||+|.++
T Consensus 37 fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~ 116 (304)
T 3ubd_A 37 FGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR 116 (304)
T ss_dssp GCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHH
T ss_pred CeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHH
Confidence 799999985 257899999996542 23345688899999999999999999999999999999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+... ..+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+++....... ......|
T Consensus 117 l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~G 188 (304)
T 3ubd_A 117 LSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCG 188 (304)
T ss_dssp HHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCC
T ss_pred HHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--ccccccc
Confidence 9643 35999999999999999999999998 99999999999999999999999999986533221 2233579
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
|+.|+|||++.+..++.++|||||||++|+|++|..||....... ........ .. .. +.....
T Consensus 189 T~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~-~~-~~---------p~~~s~ 251 (304)
T 3ubd_A 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILKA-KL-GM---------PQFLSP 251 (304)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-CC-CC---------CTTSCH
T ss_pred CcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHcC-CC-CC---------CCcCCH
Confidence 999999999999999999999999999999999999996543221 11111111 00 00 111223
Q ss_pred HHHHHHhhcccCCCCCCCCH-----HHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTM-----SSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~-----~eil~ 259 (308)
++.+|+.+||+.||++|||+ +|+++
T Consensus 252 ~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred HHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 57889999999999999985 67764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=359.94 Aligned_cols=246 Identities=26% Similarity=0.369 Sum_probs=195.6
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCC-cCccceeeeEEeC-CeEEEEEEecCCCCh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQH-KNLVRLFGCCLEE-NESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~-~~~~lv~e~~~~~~L 71 (308)
||.||+|++. .++.||||++.... ......+.+|+.+|++++| ||||+++++|.+. +.+++|||||++|+|
T Consensus 77 fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L 156 (353)
T 4ase_A 77 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 156 (353)
T ss_dssp SEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEH
T ss_pred CeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCH
Confidence 8999999853 24689999997553 3445678999999999975 8999999998764 568999999999999
Q ss_pred hhHhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeeccccee
Q 021771 72 DVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR 138 (308)
Q Consensus 72 ~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~ 138 (308)
.++++.... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 157 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar 233 (353)
T 4ase_A 157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR 233 (353)
T ss_dssp HHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred HHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhh
Confidence 999975422 245899999999999999999999997 9999999999999999999999999998
Q ss_pred eeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccc
Q 021771 139 IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEAL 217 (308)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (308)
.+.............||+.|+|||++.+..++.++|||||||++|||++ |..||....... ........+...
T Consensus 234 ~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~------~~~~~i~~g~~~ 307 (353)
T 4ase_A 234 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRM 307 (353)
T ss_dssp CTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCC
T ss_pred hcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH------HHHHHHHcCCCC
Confidence 7654443333445678999999999999999999999999999999998 899996543221 111111111111
Q ss_pred ccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 218 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.. +.....++.+|+.+||+.||++|||++||++.|+..
T Consensus 308 ~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 308 RA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11 111223588889999999999999999999988753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=347.72 Aligned_cols=238 Identities=22% Similarity=0.314 Sum_probs=178.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------------eEEEEEEec
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------------ESLLIYEYM 66 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------------~~~lv~e~~ 66 (308)
||+||+++. .+|+.||||+++... ....+.+.+|+.+|+.++||||++++++|.+.+ .+++|||||
T Consensus 18 fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~ 97 (299)
T 4g31_A 18 FGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLC 97 (299)
T ss_dssp --EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECC
T ss_pred CeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecC
Confidence 899999995 589999999997553 334567899999999999999999999987654 368999999
Q ss_pred CCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 67 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
++++|.+++.........++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.+......
T Consensus 98 ~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~ 174 (299)
T 4g31_A 98 RKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174 (299)
T ss_dssp CSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC---------
T ss_pred CCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccc
Confidence 99999999976544444566778999999999999999998 999999999999999999999999999876533221
Q ss_pred c----------ccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccc
Q 021771 147 A----------NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 147 ~----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
. ......||+.|+|||++.+..++.++|||||||++|+|++ ||...... ... .........
T Consensus 175 ~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-----~~~-~~~~~~~~~ 245 (299)
T 4g31_A 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-----VRT-LTDVRNLKF 245 (299)
T ss_dssp -----------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-----HHH-HHHHHTTCC
T ss_pred cccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-----HHH-HHHHhcCCC
Confidence 1 1223479999999999999999999999999999999995 66422110 000 000111111
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+ .........+.+|+.+||+.||++|||+.|+++
T Consensus 246 p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 246 P---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp C---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 112223344678999999999999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=345.28 Aligned_cols=254 Identities=24% Similarity=0.289 Sum_probs=187.6
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC----eEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN----ESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+|++ +|+.||||+++.... .......|+..+..++||||+++++++.+++ .++||||||++|+|.++++
T Consensus 16 fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~ 93 (303)
T 3hmm_A 16 FGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 93 (303)
T ss_dssp SSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH
T ss_pred CeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHH
Confidence 899999998 689999999964422 1223345666667889999999999998654 5799999999999999995
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCC-----CCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc--cc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDS-----RLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA--NT 149 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g-----~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~--~~ 149 (308)
.. .+++..+..++.|++.||+|||+++ +.+|+||||||+|||++.++.+||+|||+++......... ..
T Consensus 94 ~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~ 169 (303)
T 3hmm_A 94 RY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169 (303)
T ss_dssp HC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-
T ss_pred hC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeec
Confidence 42 4899999999999999999999871 1239999999999999999999999999998775433221 22
Q ss_pred ceeecccCccCchhhccC------cccccccchhhhHHHHHHHhCCcCCCcccccccc--------chhHHHHHhhhccc
Q 021771 150 NRIVGTYGYMAPEYAMEG------LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQ--------SLLSYTWKLWCEGE 215 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~--------~~~~~~~~~~~~~~ 215 (308)
....||+.|+|||++.+. .++.++|||||||++|||++|.+||+........ ............
T Consensus 170 ~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-- 247 (303)
T 3hmm_A 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE-- 247 (303)
T ss_dssp ----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT--
T ss_pred ccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhc--
Confidence 335799999999998653 4678999999999999999999887543322110 001111111111
Q ss_pred cccccccccccc-chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 216 ALELMEPVLKQS-CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 216 ~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+++.+... ...+....+.+|+.+||+.||++|||+.||++.|+..
T Consensus 248 --~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 248 --QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp --SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred --ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1111212111 1234556788999999999999999999999999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=344.88 Aligned_cols=252 Identities=18% Similarity=0.246 Sum_probs=186.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEe------CCeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE------ENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L 71 (308)
||+||+|+. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.. .+.+|||||||+ |+|
T Consensus 67 fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L 145 (398)
T 4b99_A 67 YGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDL 145 (398)
T ss_dssp SCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEH
T ss_pred CeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCH
Confidence 899999995 689999999996542 3345678899999999999999999998764 357899999996 578
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC--cccc
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS--EANT 149 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~--~~~~ 149 (308)
.+++.. ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.+..... ....
T Consensus 146 ~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~ 219 (398)
T 4b99_A 146 HQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 219 (398)
T ss_dssp HHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCC
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCcccccccc
Confidence 888844 346999999999999999999999998 99999999999999999999999999987643321 2223
Q ss_pred ceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccc--------ccc
Q 021771 150 NRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEAL--------ELM 220 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 220 (308)
....||+.|+|||++.+. .++.++||||+||++|+|++|.+||...........+...........+. ..+
T Consensus 220 ~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~ 299 (398)
T 4b99_A 220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYI 299 (398)
T ss_dssp CSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHH
T ss_pred ccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhh
Confidence 346899999999998875 56899999999999999999999996543221111100000000000000 000
Q ss_pred cccc---c---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 221 EPVL---K---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 221 ~~~~---~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.... . ..........+.+||.+||+.||++|||++|+|+
T Consensus 300 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 300 QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0 0000111245788999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=328.68 Aligned_cols=261 Identities=35% Similarity=0.609 Sum_probs=221.8
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC-
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST- 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 79 (308)
||+||+++.++|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++....
T Consensus 52 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 131 (321)
T 2qkw_B 52 FGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131 (321)
T ss_dssp SSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCC
T ss_pred CeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCC
Confidence 7999999988899999999877666677889999999999999999999999999999999999999999999986542
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
....+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++................|+..|+
T Consensus 132 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 208 (321)
T 2qkw_B 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYI 208 (321)
T ss_dssp CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTC
T ss_pred CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCcccc
Confidence 2335899999999999999999999998 9999999999999999999999999998754333333334456899999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||++.+..++.++||||||+++|+|++|..||.............+.............+++.............+.++
T Consensus 209 aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 288 (321)
T 2qkw_B 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDT 288 (321)
T ss_dssp CHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHH
T ss_pred CHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHH
Confidence 99999888899999999999999999999999977665555555444444444555556666666566677788889999
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+||+.||++|||+.|+++.|+..
T Consensus 289 i~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 289 AVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCcccCcCHHHHHHHHHHH
Confidence 9999999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=351.92 Aligned_cols=238 Identities=21% Similarity=0.286 Sum_probs=194.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.||+|++........+.+.+|+.+|+.++||||++++++|.++..++||||||++|+|.+++...
T Consensus 170 fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~- 248 (573)
T 3uto_A 170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE- 248 (573)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCT-
T ss_pred CeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHh-
Confidence 899999996 589999999997776666788999999999999999999999999999999999999999999988543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC--CCeeeecccceeeeCCCCCccccceeecccC
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE--MNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..+..++.||+.||.|||++| |+||||||+|||++.+ +.+||+|||++..+.... ......||+.
T Consensus 249 -~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~ 321 (573)
T 3uto_A 249 -HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAE 321 (573)
T ss_dssp -TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGG
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECcc
Confidence 335999999999999999999999998 9999999999999854 789999999999875332 2334579999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||++.+..++.++|||||||++|+|++|.+||........ ...... ... .. . ..........+.
T Consensus 322 y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~-~~~-~~-~----~~~~~~~s~~~~ 388 (573)
T 3uto_A 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKS-CDW-NM-D----DSAFSGISEDGK 388 (573)
T ss_dssp GCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHT-TCC-CC-C----SGGGTTSCHHHH
T ss_pred ccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHh-CCC-CC-C----cccccCCCHHHH
Confidence 9999999999999999999999999999999999965432211 111111 100 00 0 011111223578
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+||.+||+.||++|||+.|+++
T Consensus 389 dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 8999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=327.42 Aligned_cols=183 Identities=23% Similarity=0.320 Sum_probs=156.0
Q ss_pred CCccEEeee----CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL----ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+|+. .+++.||+|++.... ....+.+|+.+|+.+ .||||++++++|.+++++++|||||++++|.+++
T Consensus 34 fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~ 111 (361)
T 4f9c_A 34 FSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL 111 (361)
T ss_dssp SEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH
T ss_pred CcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH
Confidence 899999974 257899999885543 345688999999998 5999999999999999999999999999999988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC-CCeeeecccceeeeCCCCCcc-------
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEA------- 147 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~-~~~kl~dfg~~~~~~~~~~~~------- 147 (308)
. .+++..+..++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||+++.........
T Consensus 112 ~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 182 (361)
T 4f9c_A 112 N------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSE 182 (361)
T ss_dssp T------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC---
T ss_pred c------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccc
Confidence 2 3889999999999999999999998 9999999999999877 789999999998764322110
Q ss_pred -------------------ccceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCc
Q 021771 148 -------------------NTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGF 194 (308)
Q Consensus 148 -------------------~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~ 194 (308)
......||+.|+|||++.+. .++.++||||+||++|+|++|..||..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 183 AQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp -----------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 11224689999999998775 589999999999999999999999854
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=344.84 Aligned_cols=235 Identities=22% Similarity=0.221 Sum_probs=185.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHH---HHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKN---EVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.||||++.+.. ........+ ++.+++.++||||++++++|.+.+.+|||||||+||+|.+
T Consensus 202 fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~ 281 (689)
T 3v5w_A 202 FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY 281 (689)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHH
Confidence 899999996 589999999996431 222233334 4666777899999999999999999999999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
++... ..+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++..+.... ....+
T Consensus 282 ~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~ 351 (689)
T 3v5w_A 282 HLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 351 (689)
T ss_dssp HHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCC
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCcc
Confidence 99653 35999999999999999999999998 9999999999999999999999999998865332 23357
Q ss_pred cccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 154 GTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 154 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..........+ ........ . . .+...
T Consensus 352 GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~i~~~~-~-~---------~p~~~ 417 (689)
T 3v5w_A 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMA-V-E---------LPDSF 417 (689)
T ss_dssp SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHHHHHCC-C-C---------CCTTS
T ss_pred CCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHhhcCCC-C-C---------CCccC
Confidence 9999999999865 5789999999999999999999999965433221111 11111110 0 0 01112
Q ss_pred HHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRPT-----MSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs-----~~eil~ 259 (308)
...+.+||.+||+.||++|++ ++||++
T Consensus 418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 235788999999999999998 688774
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=318.73 Aligned_cols=260 Identities=39% Similarity=0.637 Sum_probs=213.6
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+++..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++....
T Consensus 43 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 122 (326)
T 3uim_A 43 FGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122 (326)
T ss_dssp SSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCS
T ss_pred CcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhcc
Confidence 799999998899999999986553 2233468899999999999999999999999999999999999999999997653
Q ss_pred -CccccChHHHHHHHHHHHHHHHhchhC---CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 80 -RSVQLDWKRRISIINGIARGLLYLHED---SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 80 -~~~~~~~~~~~~~~~qi~~~l~~lH~~---g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
....+++..++.++.|++.||+|||++ | ++|+||||+||+++.++.+||+|||++......... ......|+
T Consensus 123 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt 198 (326)
T 3uim_A 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 198 (326)
T ss_dssp TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSC
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCEEeccCccccccCccccc-ccccccCC
Confidence 344599999999999999999999999 7 999999999999999999999999999876533222 22334589
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccc--cccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSE--LGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
..|+|||++.+..++.++||||||+++|+|++|..||...... .......+..............+............
T Consensus 199 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 3uim_A 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 278 (326)
T ss_dssp GGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHH
T ss_pred cCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHH
Confidence 9999999998888999999999999999999999999643222 12222233333344445555556666666778888
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+++.+||+.||++|||+++|++.|+..
T Consensus 279 ~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 279 EQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 8999999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=314.49 Aligned_cols=248 Identities=27% Similarity=0.444 Sum_probs=199.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+++. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++....
T Consensus 23 ~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 102 (310)
T 3s95_A 23 FGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD 102 (310)
T ss_dssp SEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC
T ss_pred CEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc
Confidence 799999996 5799999999877677777889999999999999999999999999999999999999999999996632
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc-----------
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN----------- 148 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~----------- 148 (308)
..+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++...........
T Consensus 103 --~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~ 177 (310)
T 3s95_A 103 --SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177 (310)
T ss_dssp --TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------------------
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccc
Confidence 35899999999999999999999998 99999999999999999999999999987643322111
Q ss_pred -cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccccc
Q 021771 149 -TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS 227 (308)
Q Consensus 149 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
.....|+..|+|||++.+..++.++||||||+++|+|++|..|+................. ....
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~----------~~~~---- 243 (310)
T 3s95_A 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----------LDRY---- 243 (310)
T ss_dssp --CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH----------HHHT----
T ss_pred cccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc----------cccc----
Confidence 1134688999999999999999999999999999999999999865443322111110000 0000
Q ss_pred chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCC
Q 021771 228 CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVT 267 (308)
Q Consensus 228 ~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~ 267 (308)
.+......+.+++.+||+.||++|||+.++++.|+.....
T Consensus 244 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 244 CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0111122488899999999999999999999999876433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=308.11 Aligned_cols=236 Identities=22% Similarity=0.348 Sum_probs=193.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||++.. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++...
T Consensus 33 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~- 111 (297)
T 3fxz_A 33 SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET- 111 (297)
T ss_dssp TEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-
T ss_pred CeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-
Confidence 799999984 689999999997666666788999999999999999999999999999999999999999999998542
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
.+++..+..++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++........ ......|+..|+
T Consensus 112 ---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~ 183 (297)
T 3fxz_A 112 ---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWM 183 (297)
T ss_dssp ---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGC
T ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCcc
Confidence 4899999999999999999999998 99999999999999999999999999987653322 223356899999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||++.+..++.++||||||+++|+|++|..||........ ........ .... ..+......+.+|
T Consensus 184 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~~~~~-~~~~-------~~~~~~~~~~~~l 249 (297)
T 3fxz_A 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG-TPEL-------QNPEKLSAIFRDF 249 (297)
T ss_dssp CHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC-SCCC-------SCGGGSCHHHHHH
T ss_pred ChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC-CCCC-------CCccccCHHHHHH
Confidence 99999999999999999999999999999999964432211 11111000 0000 0011123358889
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
+.+||+.||++|||++|+++
T Consensus 250 i~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhh
Confidence 99999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=312.21 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=190.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+++. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++...
T Consensus 50 ~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 128 (309)
T 3p86_A 50 FGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128 (309)
T ss_dssp SEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHST
T ss_pred CeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhc
Confidence 799999987 68899999986553 334567889999999999999999999999999999999999999999999765
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
.....+++..++.++.|++.||+|||++| ..++||||||+||+++.++.+||+|||++....... .......|+..|
T Consensus 129 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y 205 (309)
T 3p86_A 129 GAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEW 205 (309)
T ss_dssp THHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTT
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccc
Confidence 44455999999999999999999999983 239999999999999999999999999997643221 112335689999
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
+|||++.+..++.++||||||+++|+|++|..||........ ............ .+......+.+
T Consensus 206 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~~~~~~~~~~~~---------~~~~~~~~l~~ 270 (309)
T 3p86_A 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------VAAVGFKCKRLE---------IPRNLNPQVAA 270 (309)
T ss_dssp SCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHHSCCCCC---------CCTTSCHHHHH
T ss_pred cChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhcCCCCC---------CCccCCHHHHH
Confidence 999999998899999999999999999999999965432211 111100111111 11112235888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhhcCCCCCCCC
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLASDTVTLPQP 271 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~ 271 (308)
|+.+||+.||++|||+++|++.|+.......+|
T Consensus 271 li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 271 IIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876555443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=312.95 Aligned_cols=240 Identities=24% Similarity=0.329 Sum_probs=188.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++..
T Consensus 20 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 98 (323)
T 3tki_A 20 YGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP- 98 (323)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT-
T ss_pred CEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh-
Confidence 799999996 489999999986543 33346788999999999999999999999999999999999999999998843
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+++..++.++.||+.||+|||++| |+|+||||+||+++.++.+||+|||++..+.............|+..|
T Consensus 99 --~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 173 (323)
T 3tki_A 99 --DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173 (323)
T ss_dssp --TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGG
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCc
Confidence 345999999999999999999999998 999999999999999999999999999876433333333345789999
Q ss_pred cCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 159 MAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 159 ~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
+|||++.+..+ +.++|||||||++|+|++|..||......... ...+...... ... .......+.
T Consensus 174 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~--~~~------~~~~~~~~~ 239 (323)
T 3tki_A 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY--LNP------WKKIDSAPL 239 (323)
T ss_dssp SCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH------HHHHHTTCTT--STT------GGGSCHHHH
T ss_pred cCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHhccccc--CCc------cccCCHHHH
Confidence 99999887665 78899999999999999999999654332111 0111111000 000 011223477
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+|+.+||+.||++|||+.|+++.
T Consensus 240 ~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 240 ALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHccCChhhCcCHHHHhhC
Confidence 89999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=318.74 Aligned_cols=245 Identities=29% Similarity=0.407 Sum_probs=196.1
Q ss_pred CCccEEeee--------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKL--------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||.||+++. .++..||+|++.... ....+.+.+|+.+|+.+ +||||+++++++.+.+.+++||||+++++
T Consensus 94 fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~ 173 (370)
T 2psq_A 94 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173 (370)
T ss_dssp SSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred CeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCC
Confidence 799999974 346679999996553 33456789999999999 89999999999999999999999999999
Q ss_pred hhhHhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 71 LDVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 71 L~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
|.+++..... ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++
T Consensus 174 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 250 (370)
T 2psq_A 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA 250 (370)
T ss_dssp HHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSC
T ss_pred HHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCC
Confidence 9999976431 235889999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................++..|+|||++.+..++.++|||||||++|+|++ |..||........ . ........
T Consensus 251 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~---~----~~~~~~~~ 323 (370)
T 2psq_A 251 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---F----KLLKEGHR 323 (370)
T ss_dssp EETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H----HHHHTTCC
T ss_pred cccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H----HHHhcCCC
Confidence 87654433333333456778999999999899999999999999999998 9999865432211 1 11111111
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.. .+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 324 ~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 324 MD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp CC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 1112233588899999999999999999999999764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=314.05 Aligned_cols=252 Identities=25% Similarity=0.329 Sum_probs=194.0
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC----eEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN----ESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+|+.. ++.||||++.... ........|+.+++.++||||+++++++.+.. .+++||||+++++|.+++.
T Consensus 37 ~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 114 (322)
T 3soc_A 37 FGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114 (322)
T ss_dssp TCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH
T ss_pred ceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHH
Confidence 7999999874 7899999986443 33445667899999999999999999998754 3699999999999999995
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhC----------CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHED----------SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----------g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
. ..+++..++.++.|++.||+|||+. | ++|+||||+||+++.++.+||+|||++..+......
T Consensus 115 ~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~ 187 (322)
T 3soc_A 115 A----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187 (322)
T ss_dssp H----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCC
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCc
Confidence 4 2489999999999999999999998 7 999999999999999999999999999887654443
Q ss_pred cccceeecccCccCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHH---------HHHhhh
Q 021771 147 ANTNRIVGTYGYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY---------TWKLWC 212 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~---------~~~~~~ 212 (308)
.......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.............. ......
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (322)
T 3soc_A 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 267 (322)
T ss_dssp CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHT
T ss_pred cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhh
Confidence 33444578999999999876 3567789999999999999999999976443322111110 001111
Q ss_pred cccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 213 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.......+.... ........+.+|+.+||+.||++|||+.||++.|+..
T Consensus 268 ~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 268 HKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp TSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111111111110 1223455689999999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=304.57 Aligned_cols=257 Identities=33% Similarity=0.487 Sum_probs=204.0
Q ss_pred CCccEEeeeCCCCEEEEEEeccC----CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+|+. +++.+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 44 ~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 122 (307)
T 2nru_A 44 FGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122 (307)
T ss_dssp SEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred CeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHH
Confidence 789999987 6889999998643 23345788999999999999999999999999999999999999999999987
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.......+++..++.++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++................|+.
T Consensus 123 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~ 199 (307)
T 2nru_A 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT 199 (307)
T ss_dssp TGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCG
T ss_pred hccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCc
Confidence 6544556999999999999999999999998 9999999999999999999999999998765433332233456889
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh-cccccccccccccccchHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC-EGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
.|+|||.+.+ .++.++||||||+++|+|++|..||......... ......... ...+...++... ..........
T Consensus 200 ~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 275 (307)
T 2nru_A 200 AYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEA 275 (307)
T ss_dssp GGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHH
T ss_pred CcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--HHHHHHhhhhhhhhhhhccccc-cccchHHHHH
Confidence 9999998765 5788999999999999999999999765433211 111111111 111222222222 2234556778
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
+.+++.+||+.||++|||+++|++.|+...
T Consensus 276 l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 276 MYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=300.66 Aligned_cols=243 Identities=27% Similarity=0.392 Sum_probs=196.2
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+++.+++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++...
T Consensus 21 ~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 97 (268)
T 3sxs_A 21 FGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-- 97 (268)
T ss_dssp TEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHH--
T ss_pred CceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHc--
Confidence 799999999889899999996543 34567899999999999999999999999999999999999999999998653
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.++|+|||++.......... .....++..|+|
T Consensus 98 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~a 173 (268)
T 3sxs_A 98 GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSA 173 (268)
T ss_dssp GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCC
Confidence 235899999999999999999999998 9999999999999999999999999998765432221 222345667999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++||||||+++|+|++ |..||........ ..... ..... .. ... ....+.++
T Consensus 174 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~-~~~~~--~~---~~~----~~~~l~~l 237 (268)
T 3sxs_A 174 PEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLKVS-QGHRL--YR---PHL----ASDTIYQI 237 (268)
T ss_dssp HHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHHH-TTCCC--CC---CTT----SCHHHHHH
T ss_pred HHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHHHH-cCCCC--CC---CCc----ChHHHHHH
Confidence 999998889999999999999999998 9999865433211 11111 11000 00 011 12358889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcCCC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASDTV 266 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~~~ 266 (308)
+.+||+.||++|||+.++++.|+....
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 238 MYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 999999999999999999999998644
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=320.74 Aligned_cols=243 Identities=28% Similarity=0.381 Sum_probs=194.3
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+|+.. +|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+.+..++||||+++++|.+++...
T Consensus 127 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 206 (377)
T 3cbl_A 127 FGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE 206 (377)
T ss_dssp TEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH
T ss_pred CCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhc
Confidence 7999999975 89999999986543 334456889999999999999999999999999999999999999999998643
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
+..+++..++.++.|++.||+|||++| ++||||||+||+++.++.+||+|||++................++..|
T Consensus 207 --~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y 281 (377)
T 3cbl_A 207 --GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281 (377)
T ss_dssp --GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGG
T ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCc
Confidence 335899999999999999999999998 999999999999999999999999999875433222222223456789
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
+|||.+.+..++.++||||||+++|+|++ |..||........ ........... .+......+.
T Consensus 282 ~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~l~ 345 (377)
T 3cbl_A 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REFVEKGGRLP---------CPELCPDAVF 345 (377)
T ss_dssp SCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHHHHTTCCCC---------CCTTCCHHHH
T ss_pred CCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCCC---------CCCCCCHHHH
Confidence 99999998889999999999999999998 8999865432211 11111111100 1111223588
Q ss_pred HHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 238 HIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+|+.+||+.||++|||+++|++.|+..
T Consensus 346 ~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 346 RLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 899999999999999999999999764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=302.91 Aligned_cols=237 Identities=22% Similarity=0.342 Sum_probs=193.8
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+|+.. +|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++..
T Consensus 58 ~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-- 135 (321)
T 2c30_A 58 TGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-- 135 (321)
T ss_dssp TEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--
T ss_pred CeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--
Confidence 7999999965 8999999999777666778899999999999999999999999999999999999999999998843
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++........ ......|+..|+
T Consensus 136 --~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~ 208 (321)
T 2c30_A 136 --VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWM 208 (321)
T ss_dssp --CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGC
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCcccc
Confidence 35899999999999999999999998 99999999999999999999999999987653322 123356899999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||++.+..++.++||||||+++|+|++|..||....... ..... .......... .......+.++
T Consensus 209 aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~------~~~~~-~~~~~~~~~~-------~~~~~~~l~~l 274 (321)
T 2c30_A 209 APEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKRL-RDSPPPKLKN-------SHKVSPVLRDF 274 (321)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHH-HHSSCCCCTT-------GGGSCHHHHHH
T ss_pred CHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-hcCCCCCcCc-------cccCCHHHHHH
Confidence 9999998889999999999999999999999986432211 11111 1111000000 11112357888
Q ss_pred HhhcccCCCCCCCCHHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~ 260 (308)
+.+||+.||++|||++++++.
T Consensus 275 i~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 275 LERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHccCChhhCcCHHHHhcC
Confidence 999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=314.42 Aligned_cols=262 Identities=25% Similarity=0.363 Sum_probs=192.4
Q ss_pred CCccEEeee-----CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe--CCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 73 (308)
||+||++++ .+|+.||||++........+.+.+|+.+++.++||||+++++++.. ....++||||+++++|.+
T Consensus 23 ~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 102 (295)
T 3ugc_A 23 FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 102 (295)
T ss_dssp SEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHH
T ss_pred CEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHH
Confidence 799999973 4799999999987766667789999999999999999999999865 356899999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-ccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 152 (308)
++.... ..+++..++.++.|++.||+|||+.| ++|+||||+||+++.++.+||+|||++......... ......
T Consensus 103 ~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 177 (295)
T 3ugc_A 103 YLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177 (295)
T ss_dssp HHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CT
T ss_pred HHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCC
Confidence 996542 35899999999999999999999998 999999999999999999999999999876433221 112223
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.++..|+|||.+.+..++.++||||||+++|+|++|..|+.........................+.+........+...
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 3ugc_A 178 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGC 257 (295)
T ss_dssp TCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTC
T ss_pred CCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCc
Confidence 45677999999999999999999999999999999999876432221000000000000000000000000001111222
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCC
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVT 267 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~ 267 (308)
...+.+++.+||+.||++|||++||++.|+.....
T Consensus 258 ~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 258 PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 34588899999999999999999999999875443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=302.84 Aligned_cols=257 Identities=20% Similarity=0.280 Sum_probs=199.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC--eEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN--ESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.... ..++||||+++++|.+++.
T Consensus 22 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 101 (319)
T 4euu_A 22 TANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE 101 (319)
T ss_dssp SEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHH
T ss_pred CeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHH
Confidence 799999996 469999999997543 345677889999999999999999999998765 6899999999999999997
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe----CCCCCeeeecccceeeeCCCCCcccccee
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL----NHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
.......+++..++.++.||+.||+|||++| |+|+||||+||++ +.++.+||+|||++........ ....
T Consensus 102 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~ 175 (319)
T 4euu_A 102 EPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSL 175 (319)
T ss_dssp SGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCC
T ss_pred HhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeec
Confidence 6544445999999999999999999999998 9999999999999 7777899999999987653322 2234
Q ss_pred ecccCccCchhhc--------cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh--cccccccc--
Q 021771 153 VGTYGYMAPEYAM--------EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC--EGEALELM-- 220 (308)
Q Consensus 153 ~~~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-- 220 (308)
.++..|+|||++. +..++.++|||||||++|+|++|..||........... ....... .......+
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~p~~~~~~~~~ 253 (319)
T 4euu_A 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE--VMYKIITGKPSGAISGVQK 253 (319)
T ss_dssp CSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH--HHHHHHHHCCTTCCEEEEC
T ss_pred ccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH--HHHHHhcCCCcccchhhhc
Confidence 6889999999886 46788999999999999999999999964433221111 1111111 00000000
Q ss_pred ----------cccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 221 ----------EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 221 ----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
...............+.+++.+||+.||++|||++|+++-.+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred ccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 000111234556677889999999999999999999999887653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=310.42 Aligned_cols=244 Identities=27% Similarity=0.415 Sum_probs=192.4
Q ss_pred CCccEEeeeC----CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|+.. .+..||||++... .....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++
T Consensus 62 ~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 141 (325)
T 3kul_A 62 SGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141 (325)
T ss_dssp TEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHH
T ss_pred CcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHH
Confidence 7999999963 3445999999755 3445667899999999999999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-ccceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-NTNRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~ 154 (308)
.... ..+++..++.++.||+.||+|||+.| |+|+||||+||+++.++.+||+|||++.......... ......+
T Consensus 142 ~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 216 (325)
T 3kul_A 142 RTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216 (325)
T ss_dssp HTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---C
T ss_pred Hhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCC
Confidence 6532 35899999999999999999999998 9999999999999999999999999998865432211 1222345
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||++.+..++.++||||||+++|+|++ |..||........ ..... .... ...+....
T Consensus 217 t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------~~~~~-~~~~---------~~~~~~~~ 280 (325)
T 3kul_A 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV------ISSVE-EGYR---------LPAPMGCP 280 (325)
T ss_dssp CGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------HHHHH-TTCC---------CCCCTTCC
T ss_pred cccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH------HHHHH-cCCC---------CCCCCCcC
Confidence 678999999998899999999999999999998 9999854432211 11111 1100 00111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
..+.+|+.+||+.||++|||+++|++.|+...
T Consensus 281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 45888999999999999999999999998763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=308.07 Aligned_cols=245 Identities=28% Similarity=0.402 Sum_probs=197.0
Q ss_pred CCccEEeee------CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+
T Consensus 36 ~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 115 (314)
T 2ivs_A 36 FGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115 (314)
T ss_dssp SSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred CeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHH
Confidence 799999985 35689999999754 34455778899999999999999999999999999999999999999999
Q ss_pred HhhcCCC---------------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeee
Q 021771 74 FLFDSTR---------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132 (308)
Q Consensus 74 ~l~~~~~---------------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~ 132 (308)
++..... ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+
T Consensus 116 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~ 192 (314)
T 2ivs_A 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKIS 192 (314)
T ss_dssp HHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEEC
T ss_pred HHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEc
Confidence 9976432 234899999999999999999999998 9999999999999999999999
Q ss_pred cccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhh
Q 021771 133 DFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLW 211 (308)
Q Consensus 133 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~ 211 (308)
|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ...
T Consensus 193 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-------~~~ 265 (314)
T 2ivs_A 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF-------NLL 265 (314)
T ss_dssp CCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-------HHH
T ss_pred cccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHh
Confidence 9999987754433333333456788999999998889999999999999999999 99998654332111 111
Q ss_pred hcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 212 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
....... .+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 266 ~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 266 KTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111 1112234588899999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=310.77 Aligned_cols=237 Identities=21% Similarity=0.268 Sum_probs=190.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc------ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+....++||||+++++|.+
T Consensus 25 fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~ 104 (361)
T 2yab_A 25 FAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD 104 (361)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHH
Confidence 799999996 5799999999875432 245789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC----CeeeecccceeeeCCCCCcccc
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM----NPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~----~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
++.. ...+++..+..++.||+.||.|||++| |+|+||||+||+++.++ .+||+|||++....... ..
T Consensus 105 ~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~ 175 (361)
T 2yab_A 105 FLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EF 175 (361)
T ss_dssp HHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CC
T ss_pred HHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---cc
Confidence 9854 345999999999999999999999998 99999999999998877 79999999998765332 12
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
....|++.|+|||++.+..++.++|||||||++|+|++|..||....... ...... .... . +. ....
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i~-~~~~-~-~~----~~~~ 242 (361)
T 2yab_A 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANIT-AVSY-D-FD----EEFF 242 (361)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHH-TTCC-C-CC----HHHH
T ss_pred ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hcCC-C-CC----chhc
Confidence 23468999999999988889999999999999999999999996432221 111110 0000 0 00 0001
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
......+.+||.+||+.||++|||+.|+++
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 112335888999999999999999999985
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=310.46 Aligned_cols=234 Identities=25% Similarity=0.335 Sum_probs=190.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+.+..++||||+++++|.+++..
T Consensus 28 ~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 107 (328)
T 3fe3_A 28 FAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA 107 (328)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH
T ss_pred CEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH
Confidence 799999996 68999999998654 344566788999999999999999999999999999999999999999999855
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ..+++..+..++.|++.||+|||++| ++||||||+||+++.++.+||+|||++....... ......|++.
T Consensus 108 ~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~ 178 (328)
T 3fe3_A 108 H---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPP 178 (328)
T ss_dssp H---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGG
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcc
Confidence 3 34899999999999999999999998 9999999999999999999999999997654322 2233468999
Q ss_pred ccCchhhccCccc-ccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 158 YMAPEYAMEGLFS-VKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 158 y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
|+|||++.+..+. .++|||||||++|+|++|..||....... ........ .. ..+......+
T Consensus 179 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~-~~----------~~p~~~s~~~ 241 (328)
T 3fe3_A 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERVLRG-KY----------RIPFYMSTDC 241 (328)
T ss_dssp GCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-CC----------CCCTTSCHHH
T ss_pred eeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-CC----------CCCCCCCHHH
Confidence 9999999887664 79999999999999999999996543221 11111111 00 0011122357
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+|+.+||+.||++|||++|+++-
T Consensus 242 ~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 242 ENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred HHHHHHHCCCChhHCcCHHHHhcC
Confidence 889999999999999999999863
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=306.01 Aligned_cols=247 Identities=15% Similarity=0.152 Sum_probs=195.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.||||++..... ...+..|+.+++.+ +|+||+++++++.++...++||||+ +++|.+++...
T Consensus 22 ~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~ 98 (330)
T 2izr_A 22 FGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC 98 (330)
T ss_dssp TTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred CceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc
Confidence 799999995 6899999999865432 24578999999999 8999999999999999999999999 89999998654
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC-----eeeecccceeeeCCCCCcc-----c
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN-----PKISDFGMARIFGGNQSEA-----N 148 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~-----~kl~dfg~~~~~~~~~~~~-----~ 148 (308)
...+++..++.++.|++.||+|||++| |+||||||+||+++.++. +||+|||++..+....... .
T Consensus 99 --~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~ 173 (330)
T 2izr_A 99 --DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173 (330)
T ss_dssp --TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCC
T ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccc
Confidence 235999999999999999999999998 999999999999998887 9999999998765432211 1
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||........................ + .....
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~----~-~~~~~- 247 (330)
T 2izr_A 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI----E-VLCEN- 247 (330)
T ss_dssp CCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH----H-HHTTT-
T ss_pred cCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH----H-HHhcc-
Confidence 23457899999999999988999999999999999999999999765333221111111110000000 0 00001
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
.. .+.+++.+||+.||.+||++.+|++.|+...
T Consensus 248 ---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 248 ---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp ---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 11 6888999999999999999999999986553
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=302.19 Aligned_cols=241 Identities=27% Similarity=0.384 Sum_probs=193.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+++..+++.||+|++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++....
T Consensus 23 ~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~- 100 (269)
T 4hcu_A 23 FGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR- 100 (269)
T ss_dssp SCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT-
T ss_pred ccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC-
Confidence 799999998889999999996543 345678999999999999999999999999999999999999999999986533
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
..+++..++.++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++........ .......++..|+|
T Consensus 101 -~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~a 175 (269)
T 4hcu_A 101 -GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 175 (269)
T ss_dssp -TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCC
T ss_pred -cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCC
Confidence 35899999999999999999999998 99999999999999999999999999876532211 11222345678999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++||||||+++|+|++ |..||....... ...... ... .... +......+.++
T Consensus 176 PE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~~~~~~-~~~-----~~~~----~~~~~~~~~~l 239 (269)
T 4hcu_A 176 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDIS-TGF-----RLYK----PRLASTHVYQI 239 (269)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHH-TTC-----CCCC----CTTSCHHHHHH
T ss_pred HHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHh-cCc-----cCCC----CCcCCHHHHHH
Confidence 999998899999999999999999999 899986543221 111111 110 0000 11112358889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+||+.||++|||++++++.|+..
T Consensus 240 i~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 240 MNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHccCCcccCcCHHHHHHHHHHH
Confidence 9999999999999999999999764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=304.65 Aligned_cols=251 Identities=24% Similarity=0.267 Sum_probs=187.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+++..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.++...++||||+++ +|.+++...
T Consensus 34 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~ 112 (311)
T 3niz_A 34 YGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN 112 (311)
T ss_dssp SCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTC
T ss_pred CeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhc
Confidence 799999998889999999986542 23346788999999999999999999999999999999999975 777776543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+++..+..++.|++.||+|||++| |+|+||||+||+++.++.+||+|||++......... .....++..|
T Consensus 113 --~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~t~~y 185 (311)
T 3niz_A 113 --KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLWY 185 (311)
T ss_dssp --TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTT
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCccc--ccCCcccCCc
Confidence 235899999999999999999999998 999999999999999999999999999876433221 2234678999
Q ss_pred cCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccc-------------ccccccc
Q 021771 159 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEAL-------------ELMEPVL 224 (308)
Q Consensus 159 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~ 224 (308)
+|||++.+ ..++.++|||||||++|+|++|..||.......................+. .......
T Consensus 186 ~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (311)
T 3niz_A 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKP 265 (311)
T ss_dssp CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCC
T ss_pred CCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCc
Confidence 99998876 568999999999999999999999996544332111110000000000000 0000000
Q ss_pred cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 225 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 225 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..........++.+|+.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 266 WSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00011112345889999999999999999999996
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=305.24 Aligned_cols=238 Identities=22% Similarity=0.302 Sum_probs=187.8
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC---------------------
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN--------------------- 57 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--------------------- 57 (308)
||.||+++.. +|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 19 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (332)
T 3qd2_B 19 FGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98 (332)
T ss_dssp CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-----------
T ss_pred CeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhcccccccc
Confidence 7999999974 89999999986543 345678999999999999999999999986543
Q ss_pred ------------------------------------eEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHH
Q 021771 58 ------------------------------------ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLL 101 (308)
Q Consensus 58 ------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~ 101 (308)
..++|||||++++|.+++..........+..++.++.||+.||+
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 178 (332)
T 3qd2_B 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178 (332)
T ss_dssp ---------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHH
T ss_pred ccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHH
Confidence 37999999999999999977655556677778999999999999
Q ss_pred hchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc----------cccceeecccCccCchhhccCcccc
Q 021771 102 YLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE----------ANTNRIVGTYGYMAPEYAMEGLFSV 171 (308)
Q Consensus 102 ~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~ 171 (308)
|||++| ++|+||||+||+++.++.+||+|||++......... .......|+..|+|||++.+..++.
T Consensus 179 ~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 255 (332)
T 3qd2_B 179 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255 (332)
T ss_dssp HHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCT
T ss_pred HHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcc
Confidence 999998 999999999999999999999999999887543211 1122346899999999999989999
Q ss_pred cccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCC
Q 021771 172 KSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADR 251 (308)
Q Consensus 172 ~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 251 (308)
++||||||+++|+|++|..|+..... ......... ...........+.+|+.+||+.||++|
T Consensus 256 ~~Di~slG~il~el~~~~~~~~~~~~---------~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 256 KVDIFSLGLILFELLYSFSTQMERVR---------IITDVRNLK---------FPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp HHHHHHHHHHHHHHHSCCCCHHHHHH---------HHHHHHTTC---------CCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred hhhHHHHHHHHHHHHHcCCChhHHHH---------HHHHhhccC---------CCcccccCChhHHHHHHHHccCCCCcC
Confidence 99999999999999998766421100 000000000 011122334457889999999999999
Q ss_pred CCHHHHHH
Q 021771 252 PTMSSVVV 259 (308)
Q Consensus 252 Ps~~eil~ 259 (308)
||++|+++
T Consensus 318 ps~~~~l~ 325 (332)
T 3qd2_B 318 PEATDIIE 325 (332)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhh
Confidence 99999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.76 Aligned_cols=238 Identities=21% Similarity=0.267 Sum_probs=190.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc------ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+....++||||+++++|.+
T Consensus 24 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 103 (326)
T 2y0a_A 24 FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 103 (326)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHH
Confidence 799999996 5799999999865422 246789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC----CeeeecccceeeeCCCCCcccc
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM----NPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~----~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
++.. ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++ .+||+|||++........ .
T Consensus 104 ~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~ 174 (326)
T 2y0a_A 104 FLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 174 (326)
T ss_dssp HHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---C
T ss_pred HHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---c
Confidence 9854 345999999999999999999999998 99999999999999887 799999999988643221 2
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
....|++.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ... .. .....
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~~~~-~~~-~~-----~~~~~ 241 (326)
T 2y0a_A 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSA-VNY-EF-----EDEYF 241 (326)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHH-TCC-CC-----CHHHH
T ss_pred ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHHh-cCC-Cc-----Ccccc
Confidence 234689999999999888899999999999999999999999864322110 000000 000 00 00001
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
......+.+|+.+||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1123457889999999999999999999973
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=299.59 Aligned_cols=255 Identities=15% Similarity=0.169 Sum_probs=199.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++.+....++||||+ +++|.+++...
T Consensus 23 ~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~ 99 (298)
T 1csn_A 23 FGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC 99 (298)
T ss_dssp SCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred CEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh
Confidence 799999995 689999999986443 224578899999999 6999999999999999999999999 99999999654
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC-----eeeecccceeeeCCCCCc-----cc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN-----PKISDFGMARIFGGNQSE-----AN 148 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~-----~kl~dfg~~~~~~~~~~~-----~~ 148 (308)
. ..+++..++.++.||+.||+|||++| ++|+||||+||+++.++. +||+|||++......... ..
T Consensus 100 ~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 174 (298)
T 1csn_A 100 G--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174 (298)
T ss_dssp T--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCC
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccC
Confidence 2 34899999999999999999999998 999999999999987776 999999999887543221 11
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
.....|+..|+|||++.+..++.++||||||+++|+|++|..||...........................
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 245 (298)
T 1csn_A 175 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL--------- 245 (298)
T ss_dssp CCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH---------
T ss_pred ccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH---------
Confidence 23456899999999999888999999999999999999999999764333221111111111100111000
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQPT 272 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~~ 272 (308)
.......+.+++.+||+.||++|||+++|++.|+.....+....
T Consensus 246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 01123458889999999999999999999999988755554433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=304.14 Aligned_cols=253 Identities=20% Similarity=0.216 Sum_probs=198.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .......+.+|+.+|+.++||||+++++++.+.+..++||||+++++|..++.
T Consensus 18 fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~ 97 (337)
T 1o6l_A 18 FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97 (337)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence 799999996 57999999999654 23456778899999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.||+.||+|||++| |+||||||+||+++.+|.+||+|||++....... .......|++
T Consensus 98 ~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~ 169 (337)
T 1o6l_A 98 RE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTP 169 (337)
T ss_dssp HH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECG
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC--CcccccccCh
Confidence 43 35899999999999999999999998 9999999999999999999999999997643221 1233457899
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||....... ........ .. . .+......+
T Consensus 170 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~-~~-~---------~p~~~s~~~ 232 (337)
T 1o6l_A 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILME-EI-R---------FPRTLSPEA 232 (337)
T ss_dssp GGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-CC-C---------CCTTSCHHH
T ss_pred hhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHHHHHcC-CC-C---------CCCCCCHHH
Confidence 9999999998889999999999999999999999996432221 11111111 00 0 011122358
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHHH--hhcC------CCCCCCCCCCCccc
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVVM--LASD------TVTLPQPTEPAFSV 278 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~~--L~~~------~~~~~~~~~p~~~~ 278 (308)
.+||.+||+.||++|| +++||++- +... ...+.+|-.|....
T Consensus 233 ~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~ 287 (337)
T 1o6l_A 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTS 287 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSS
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCC
Confidence 8899999999999999 89999853 1111 13455666665543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=311.90 Aligned_cols=250 Identities=27% Similarity=0.396 Sum_probs=194.5
Q ss_pred CCccEEeee------CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+++.||+|++... .....+.+.+|+.+++.+ +||||+++++++.+.+..++||||+++++|.
T Consensus 58 ~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 137 (344)
T 1rjb_A 58 FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137 (344)
T ss_dssp SEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred CceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHH
Confidence 789999985 25668999999754 344567899999999999 8999999999999999999999999999999
Q ss_pred hHhhcCCCc--------------------cccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeee
Q 021771 73 VFLFDSTRS--------------------VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132 (308)
Q Consensus 73 ~~l~~~~~~--------------------~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~ 132 (308)
+++...... ..+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+
T Consensus 138 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~ 214 (344)
T 1rjb_A 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKIC 214 (344)
T ss_dssp HHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEEC
T ss_pred HHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeC
Confidence 999764321 34789999999999999999999998 9999999999999999999999
Q ss_pred cccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhh
Q 021771 133 DFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLW 211 (308)
Q Consensus 133 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~ 211 (308)
|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||........ .....
T Consensus 215 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------~~~~~ 288 (344)
T 1rjb_A 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN------FYKLI 288 (344)
T ss_dssp CCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHH
T ss_pred CCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH------HHHHH
Confidence 9999987654333333334566788999999988889999999999999999998 9999865432210 11111
Q ss_pred hcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 212 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
...... ..+......+.+|+.+||+.||++|||+.+|++.|+......
T Consensus 289 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 289 QNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 111000 011112345888999999999999999999999998765443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=305.15 Aligned_cols=237 Identities=18% Similarity=0.254 Sum_probs=190.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+++. .+|+.+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|||||++++|.+++...
T Consensus 18 ~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~- 95 (321)
T 1tki_A 18 FGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS- 95 (321)
T ss_dssp SEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS-
T ss_pred CeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhc-
Confidence 799999996 57999999998644 344567889999999999999999999999999999999999999999998542
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC--CCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH--EMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..++.++.|++.||.|||++| ++|+||||+||+++. ++.+||+|||++..+.... ......+++.
T Consensus 96 -~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~ 168 (321)
T 1tki_A 96 -AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPE 168 (321)
T ss_dssp -SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGG
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChh
Confidence 235899999999999999999999998 999999999999997 7889999999998864322 2334568999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||++.+..++.++||||||+++|+|++|..||....... ........ ... . . ..........+.
T Consensus 169 y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~-~~~-~-~----~~~~~~~s~~~~ 235 (321)
T 1tki_A 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNA-EYT-F-D----EEAFKEISIEAM 235 (321)
T ss_dssp GSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHT-CCC-C-C----HHHHTTSCHHHH
T ss_pred hcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcC-CCC-C-C----hhhhccCCHHHH
Confidence 999999988888999999999999999999999996533221 11111110 000 0 0 000011234588
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+|+.+||+.||++|||+.|+++
T Consensus 236 ~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 236 DFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHhc
Confidence 9999999999999999999996
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=311.91 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=196.7
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+
T Consensus 60 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 139 (343)
T 1luf_A 60 FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139 (343)
T ss_dssp SCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred CeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHH
Confidence 7999999963 35899999997553 3445678999999999999999999999999999999999999999999
Q ss_pred HhhcCCC---------------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeee
Q 021771 74 FLFDSTR---------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132 (308)
Q Consensus 74 ~l~~~~~---------------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~ 132 (308)
++..... ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++.+||+
T Consensus 140 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~ 216 (343)
T 1luf_A 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIA 216 (343)
T ss_dssp HHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred HHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEe
Confidence 9976421 146899999999999999999999998 9999999999999999999999
Q ss_pred cccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhh
Q 021771 133 DFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLW 211 (308)
Q Consensus 133 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~ 211 (308)
|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||....... .. ...
T Consensus 217 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~-~~~ 289 (343)
T 1luf_A 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE------VI-YYV 289 (343)
T ss_dssp CCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HH-HHH
T ss_pred ecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH------HH-HHH
Confidence 9999876543322222333467888999999998889999999999999999998 889986432221 11 111
Q ss_pred hcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 021771 212 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLP 269 (308)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~ 269 (308)
........ +......+.+++.+||+.||++|||+.+|++.|+.......
T Consensus 290 ~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 290 RDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred hCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 11111111 11122358889999999999999999999999998765543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=309.93 Aligned_cols=238 Identities=23% Similarity=0.271 Sum_probs=191.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.||+|++........+.+.+|+.+|+.++||||+++++++.+.+..++||||+++++|.+++...
T Consensus 102 ~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~- 180 (373)
T 2x4f_A 102 FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE- 180 (373)
T ss_dssp --CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHT-
T ss_pred CEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-
Confidence 799999985 679999999998766566778999999999999999999999999999999999999999998888543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe--CCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL--NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..++.++.||+.||+|||+.| |+|+||||+||++ +.++.+||+|||++..+..... .....|++.
T Consensus 181 -~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~ 253 (373)
T 2x4f_A 181 -SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPE 253 (373)
T ss_dssp -GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCT
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCc
Confidence 345899999999999999999999998 9999999999999 5677899999999988653322 223468999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||++.+..++.++|||||||++|+|++|..||....... ........ .. .... .........+.
T Consensus 254 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~-~~-~~~~-----~~~~~~~~~~~ 320 (373)
T 2x4f_A 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE------TLNNILAC-RW-DLED-----EEFQDISEEAK 320 (373)
T ss_dssp TCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHT-CC-CSCS-----GGGTTSCHHHH
T ss_pred EeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc-cC-CCCh-----hhhccCCHHHH
Confidence 999999988889999999999999999999999996543221 11111111 00 0000 00111234588
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+|+.+||+.||++|||+.|+++
T Consensus 321 ~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 321 EFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhhCCCHHHHhc
Confidence 8999999999999999999996
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=304.63 Aligned_cols=266 Identities=25% Similarity=0.330 Sum_probs=197.3
Q ss_pred CCccEEeee-----CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEE--eCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCL--EENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||++++ .+|+.||+|++........+.+.+|+.+++.++|+||+++++++. +....++||||+++++|.+
T Consensus 36 ~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 115 (327)
T 3lxl_A 36 FGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD 115 (327)
T ss_dssp TEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHH
T ss_pred CeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHH
Confidence 789999983 479999999998776667778999999999999999999999987 4556899999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-ccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 152 (308)
++.... ..+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++......... ......
T Consensus 116 ~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 190 (327)
T 3lxl_A 116 FLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190 (327)
T ss_dssp HHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCC
T ss_pred HHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccC
Confidence 986532 35899999999999999999999998 999999999999999999999999999886533221 122234
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.++..|+|||++.+..++.++||||||+++|+|++|..||............. ...........+.+........+...
T Consensus 191 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (327)
T 3lxl_A 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGC-ERDVPALSRLLELLEEGQRLPAPPAC 269 (327)
T ss_dssp CSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHHHHTTCCCCCCTTC
T ss_pred CccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccc-ccccccHHHHHHHhhcccCCCCCCcc
Confidence 56778999999998889999999999999999999999985433221000000 00000000000000000011112223
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQPT 272 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~~ 272 (308)
...+.+|+.+||+.||++|||++++++.|+..........
T Consensus 270 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 309 (327)
T 3lxl_A 270 PAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--------
T ss_pred cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcc
Confidence 3458889999999999999999999999998866554443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=308.84 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=181.7
Q ss_pred CCccEEeeeCC-CC---EEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeE------EEEEEecCC
Q 021771 1 MESCLQGKLAD-GK---EIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES------LLIYEYMPN 68 (308)
Q Consensus 1 ~g~v~~~~~~~-g~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~ 68 (308)
||+||+++... +. .||+|++... .....+.+.+|+.+++.++||||+++++++.+.... ++||||+.+
T Consensus 36 ~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~ 115 (323)
T 3qup_A 36 FGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKH 115 (323)
T ss_dssp TEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTT
T ss_pred CeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccC
Confidence 79999998643 33 7999998654 344567899999999999999999999999887655 999999999
Q ss_pred CChhhHhhcCC---CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC
Q 021771 69 KSLDVFLFDST---RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS 145 (308)
Q Consensus 69 ~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~ 145 (308)
++|.+++.... ....+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++........
T Consensus 116 ~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~ 192 (323)
T 3qup_A 116 GDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192 (323)
T ss_dssp CBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeecccccccccccc
Confidence 99999986532 1225899999999999999999999998 99999999999999999999999999987654333
Q ss_pred ccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccc
Q 021771 146 EANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVL 224 (308)
Q Consensus 146 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .... .......
T Consensus 193 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~------~~~~-~~~~~~~------ 259 (323)
T 3qup_A 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI------YNYL-IGGNRLK------ 259 (323)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------HHHH-HTTCCCC------
T ss_pred ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH------HHHH-hcCCCCC------
Confidence 332333456778999999999899999999999999999999 8999865433211 1111 1111111
Q ss_pred cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCC
Q 021771 225 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVT 267 (308)
Q Consensus 225 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~ 267 (308)
.+......+.+|+.+||+.||++|||+.++++.|+.....
T Consensus 260 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 260 ---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111224588999999999999999999999999876433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.10 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=193.7
Q ss_pred CCccEEeee------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCe-EEEEEEecCCCCh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENE-SLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L 71 (308)
||.||++++ .+++.||||++.... ....+.+.+|+.+++.+ +||||+++++++.+.+. .++|||||++++|
T Consensus 35 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L 114 (359)
T 3vhe_A 35 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 114 (359)
T ss_dssp SEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEH
T ss_pred CceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcH
Confidence 799999962 467899999997543 33456789999999999 68999999999987654 8999999999999
Q ss_pred hhHhhcCCC---------------------------------------------------------------ccccChHH
Q 021771 72 DVFLFDSTR---------------------------------------------------------------SVQLDWKR 88 (308)
Q Consensus 72 ~~~l~~~~~---------------------------------------------------------------~~~~~~~~ 88 (308)
.+++..... ...+++..
T Consensus 115 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 194 (359)
T 3vhe_A 115 STYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194 (359)
T ss_dssp HHHHHTTTTSBCSCC------------------------------------------------------CTTTTCBCHHH
T ss_pred HHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHH
Confidence 999976432 11288999
Q ss_pred HHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccCc
Q 021771 89 RISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL 168 (308)
Q Consensus 89 ~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 168 (308)
++.++.||+.||+|||++| |+|+||||+||+++.++.+||+|||++................++..|+|||++.+..
T Consensus 195 ~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 271 (359)
T 3vhe_A 195 LICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV 271 (359)
T ss_dssp HHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCC
Confidence 9999999999999999998 9999999999999999999999999998764443333344456788999999999989
Q ss_pred ccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCC
Q 021771 169 FSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQAD 247 (308)
Q Consensus 169 ~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 247 (308)
++.++||||||+++|+|++ |..||....... .............. +......+.+++.+||+.|
T Consensus 272 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~d 336 (359)
T 3vhe_A 272 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGE 336 (359)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSS
T ss_pred CCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCCC---------CCCCCHHHHHHHHHHccCC
Confidence 9999999999999999998 999986543221 01111111111111 1112235888899999999
Q ss_pred CCCCCCHHHHHHHhhcC
Q 021771 248 SADRPTMSSVVVMLASD 264 (308)
Q Consensus 248 p~~RPs~~eil~~L~~~ 264 (308)
|++|||++||++.|+..
T Consensus 337 P~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 337 PSQRPTFSELVEHLGNL 353 (359)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHH
Confidence 99999999999999764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=315.68 Aligned_cols=247 Identities=29% Similarity=0.396 Sum_probs=197.3
Q ss_pred CCccEEeee--------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKL--------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||+||+++. .++..||+|++.... ......+.+|+.+++.+ +||||+++++++.+++..++||||+++++
T Consensus 82 ~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~ 161 (382)
T 3tt0_A 82 FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161 (382)
T ss_dssp SEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred CeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCc
Confidence 799999984 234679999986553 34457788999999999 89999999999999999999999999999
Q ss_pred hhhHhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 71 LDVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 71 L~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
|.+++..... ...+++..++.++.||+.||+|||++| |+|+||||+||+++.++.+||+|||++
T Consensus 162 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a 238 (382)
T 3tt0_A 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLA 238 (382)
T ss_dssp HHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCC
T ss_pred HHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcc
Confidence 9999976431 235899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................++..|+|||++.+..++.++|||||||++|+|++ |..||....... ..........
T Consensus 239 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~ 311 (382)
T 3tt0_A 239 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLLKEGHR 311 (382)
T ss_dssp CCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTCC
T ss_pred cccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 87654333333333456788999999999899999999999999999999 999986443221 1111111111
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCC
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTV 266 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~ 266 (308)
... +......+.+|+.+||+.||++|||+++|++.|+....
T Consensus 312 ~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 312 MDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp CCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 11122358889999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.92 Aligned_cols=238 Identities=21% Similarity=0.244 Sum_probs=189.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||++.. .+|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||||.+++|.+.+..
T Consensus 24 fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~ 103 (444)
T 3soa_A 24 FSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA 103 (444)
T ss_dssp -CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH
T ss_pred CeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH
Confidence 799999985 689999999987553 33456788999999999999999999999999999999999999999998865
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC---CCCCeeeecccceeeeCCCCCccccceeec
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN---HEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
. ..+++..+..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++........ ......|
T Consensus 104 ~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~g 175 (444)
T 3soa_A 104 R---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAG 175 (444)
T ss_dssp C---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCS
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccC
Confidence 3 34999999999999999999999998 99999999999998 457899999999977643322 1223568
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
++.|+|||++.+..++.++|||||||++|+|++|.+||........ ..... .... ....+ .......
T Consensus 176 t~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~------~~~i~-~~~~-~~~~~-----~~~~~s~ 242 (444)
T 3soa_A 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL------YQQIK-AGAY-DFPSP-----EWDTVTP 242 (444)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHH-HTCC-CCCTT-----TTTTSCH
T ss_pred CcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH------HHHHH-hCCC-CCCcc-----ccccCCH
Confidence 9999999999988899999999999999999999999864332211 11111 1100 00000 0011123
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhc
Confidence 5888999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=302.92 Aligned_cols=250 Identities=27% Similarity=0.399 Sum_probs=192.3
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+++. .++.||+|++... ...+.+.+|+.+++.++||||+++++++.+ ..++||||+++++|.+++.....
T Consensus 21 ~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~ 95 (307)
T 2eva_A 21 FGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEP 95 (307)
T ss_dssp SSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSS
T ss_pred CceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCC
Confidence 799999987 4789999998543 345778999999999999999999998874 47899999999999999976554
Q ss_pred ccccChHHHHHHHHHHHHHHHhchh---CCCCceeecCCCCCceEeCCCCC-eeeecccceeeeCCCCCccccceeeccc
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHE---DSRLKIIHRDLKASNVLLNHEMN-PKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~---~g~~~i~H~di~p~nilv~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
...++...++.++.|++.||+|||+ +| ++|+||||+||+++.++. +||+|||++...... .....|+.
T Consensus 96 ~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~ 167 (307)
T 2eva_A 96 LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSA 167 (307)
T ss_dssp EECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCT
T ss_pred CCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCC
Confidence 4568889999999999999999999 66 999999999999998887 799999998765322 12235789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++||||||+++|+|++|..||........ ...... ........ ... ....+
T Consensus 168 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~-----~~~----~~~~l 233 (307)
T 2eva_A 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAV-HNGTRPPL-----IKN----LPKPI 233 (307)
T ss_dssp TSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHH-HTTCCCCC-----BTT----CCHHH
T ss_pred ceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHH-hcCCCCCc-----ccc----cCHHH
Confidence 99999999988899999999999999999999999864322211 111111 11111111 111 12358
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCcc
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQPTEPAFS 277 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~~~p~~~ 277 (308)
.+++.+||+.||++|||++++++.|+.....++....|...
T Consensus 234 ~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~ 274 (307)
T 2eva_A 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274 (307)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCC
T ss_pred HHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcccc
Confidence 88999999999999999999999999887767666655543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=308.70 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=188.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+++..
T Consensus 42 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~ 121 (362)
T 2bdw_A 42 FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 121 (362)
T ss_dssp TEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT
T ss_pred CeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH
Confidence 799999996 579999999996543 34556788999999999999999999999999999999999999999988854
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC---CeeeecccceeeeCCCCCccccceeec
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM---NPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
...+++..+..++.||+.||.|||++| |+|+||||+||+++.++ .+||+|||++....... ......|
T Consensus 122 ---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~g 192 (362)
T 2bdw_A 122 ---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAG 192 (362)
T ss_dssp ---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCS
T ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCC
Confidence 345899999999999999999999998 99999999999998654 49999999998764322 1223468
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
++.|+|||++.+..++.++|||||||++|+|++|..||....... ...... .... ....+ .......
T Consensus 193 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------~~~~i~-~~~~-~~~~~-----~~~~~~~ 259 (362)
T 2bdw_A 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYAQIK-AGAY-DYPSP-----EWDTVTP 259 (362)
T ss_dssp CTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTCC-CCCTT-----GGGGSCH
T ss_pred CccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hCCC-CCCcc-----cccCCCH
Confidence 999999999998889999999999999999999999986433211 111111 1100 00000 0011123
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+.+|+.+||+.||++|||+.++++
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 5888999999999999999999985
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=300.36 Aligned_cols=246 Identities=23% Similarity=0.322 Sum_probs=191.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.
T Consensus 24 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 103 (294)
T 4eqm_A 24 MSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE 103 (294)
T ss_dssp TEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred CEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHH
Confidence 789999995 589999999985432 3345678899999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++........ .......|+.
T Consensus 104 ~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~ 176 (294)
T 4eqm_A 104 SH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTV 176 (294)
T ss_dssp HH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CC
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccc-cccCccccCc
Confidence 43 35899999999999999999999998 99999999999999999999999999876542221 1223346899
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||.+.+..++.++||||||+++|+|++|..||....... ....... ...... ...........+
T Consensus 177 ~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~-~~~~~~-----~~~~~~~~~~~l 244 (294)
T 4eqm_A 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQ-DSVPNV-----TTDVRKDIPQSL 244 (294)
T ss_dssp SSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHS-SCCCCH-----HHHSCTTSCHHH
T ss_pred cccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhh-ccCCCc-----chhcccCCCHHH
Confidence 9999999999889999999999999999999999996543211 1111110 111100 001111123458
Q ss_pred HHHHhhcccCCCCCCC-CHHHHHHHhhcCC
Q 021771 237 IHIGLLCVQADSADRP-TMSSVVVMLASDT 265 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-s~~eil~~L~~~~ 265 (308)
.+++.+||+.||++|| +++++.+.|+...
T Consensus 245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 245 SNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 8899999999999998 9999999998763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=309.74 Aligned_cols=239 Identities=19% Similarity=0.215 Sum_probs=192.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||++.. .+|+.+|+|++..........+.+|+.+|+.++||||+++++++.+....++||||+.+++|.+++...
T Consensus 64 ~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~- 142 (387)
T 1kob_A 64 FGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE- 142 (387)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT-
T ss_pred CEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhh-
Confidence 799999996 579999999997766666678999999999999999999999999999999999999999999988543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC--CCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH--EMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..++.++.||+.||+|||++| |+|+||||+||+++. ++.+||+|||++....... ......++..
T Consensus 143 -~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~ 215 (387)
T 1kob_A 143 -DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAE 215 (387)
T ss_dssp -TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGG
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc---ceeeeccCCC
Confidence 235899999999999999999999998 999999999999974 4679999999998864332 1233468999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||++.+..++.++|||||||++|+|++|..||....... ....... .... .. ..........+.
T Consensus 216 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~~~~i~~-~~~~--~~----~~~~~~~s~~~~ 282 (387)
T 1kob_A 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKR-CDWE--FD----EDAFSSVSPEAK 282 (387)
T ss_dssp GCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHH-CCCC--CC----SSTTTTSCHHHH
T ss_pred ccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------HHHHHHh-CCCC--CC----ccccccCCHHHH
Confidence 999999998889999999999999999999999996543211 1111110 0000 00 001111233588
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+|+.+||+.||++|||+.|+++-
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCChhHCcCHHHHhhC
Confidence 99999999999999999999964
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=312.56 Aligned_cols=243 Identities=28% Similarity=0.442 Sum_probs=182.8
Q ss_pred CCccEEeeeC----CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|+.. ++..||||+++.. .......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++
T Consensus 58 fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l 137 (373)
T 2qol_A 58 FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137 (373)
T ss_dssp SSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHH
T ss_pred CeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHH
Confidence 7999999864 6788999999754 3445567899999999999999999999999999999999999999999999
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-ccceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-NTNRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~ 154 (308)
... ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.......... ......+
T Consensus 138 ~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 212 (373)
T 2qol_A 138 RKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212 (373)
T ss_dssp HTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------
T ss_pred HhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCc
Confidence 653 335899999999999999999999998 9999999999999999999999999998764332211 1112234
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||++.+..++.++||||||+++|+|++ |..||....... . . ....... ....+....
T Consensus 213 ~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~---~-~~i~~~~---------~~~~~~~~~ 276 (373)
T 2qol_A 213 PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---V---I-KAVDEGY---------RLPPPMDCP 276 (373)
T ss_dssp -CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---H---H-HHHHTTE---------ECCCCTTCB
T ss_pred CCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H---H-HHHHcCC---------CCCCCcccc
Confidence 678999999998899999999999999999997 999986443221 0 1 1111110 001111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+++.+||+.||++|||+++|++.|+..
T Consensus 277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 4588899999999999999999999998765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=305.49 Aligned_cols=246 Identities=27% Similarity=0.400 Sum_probs=196.5
Q ss_pred CCccEEeee------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++.+++..++||||+++++|.
T Consensus 36 ~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 115 (313)
T 1t46_A 36 FGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115 (313)
T ss_dssp SEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHH
T ss_pred CcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHH
Confidence 789999974 467899999997553 34567889999999999 8999999999999999999999999999999
Q ss_pred hHhhcCCC---------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 73 VFLFDSTR---------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 73 ~~l~~~~~---------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
+++..... ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++
T Consensus 116 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 192 (313)
T 1t46_A 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLA 192 (313)
T ss_dssp HHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGG
T ss_pred HHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEcccccc
Confidence 99876432 224899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ........ .
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~-~ 265 (313)
T 1t46_A 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------FYKMIKEG-F 265 (313)
T ss_dssp SCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH------HHHHHHHT-C
T ss_pred ccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH------HHHHhccC-C
Confidence 87654433333334456788999999988899999999999999999998 9999865432210 11111111 0
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
. ... .......+.+++.+||+.||++|||+.++++.|+..
T Consensus 266 ~----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 266 R----MLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp C----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0 000 111224588899999999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=307.49 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=189.4
Q ss_pred CCccEEeee-CCCCE----EEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKE----IAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|+. .+|+. +++|.+.... ......+.+|+.+++.++||||+++++++.+ ...++||||+.+++|.++
T Consensus 26 ~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~ 104 (325)
T 3kex_A 26 FGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDH 104 (325)
T ss_dssp SCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHH
T ss_pred CceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHH
Confidence 799999995 45655 7788775432 3334567789999999999999999998864 568999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+... ...+++..++.++.||+.||+|||++| ++||||||+||+++.++.+||+|||++................+
T Consensus 105 l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 179 (325)
T 3kex_A 105 VRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179 (325)
T ss_dssp HHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----C
T ss_pred HHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCC
Confidence 8653 346899999999999999999999998 99999999999999999999999999987654443333444567
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||.+.+..++.++||||||+++|+|++ |..||......... ........... +....
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~~---------~~~~~ 243 (325)
T 3kex_A 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DLLEKGERLAQ---------PQICT 243 (325)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HHHHTTCBCCC---------CTTBC
T ss_pred cccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCCCCCC---------CCcCc
Confidence 789999999998899999999999999999999 99998754322111 11111111000 00111
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASDTV 266 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~ 266 (308)
..+.+++.+||+.||++|||+.++++.|+....
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 247788899999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=313.87 Aligned_cols=245 Identities=29% Similarity=0.388 Sum_probs=193.2
Q ss_pred CCccEEeeeC------CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+|++. +++.||||++... .......+.+|+.+++.++||||+++++++.+....++||||+++++|.+
T Consensus 84 fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~ 163 (367)
T 3l9p_A 84 FGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 163 (367)
T ss_dssp SSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred CEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHH
Confidence 7999999843 5778999999654 34445578899999999999999999999999999999999999999999
Q ss_pred HhhcCC----CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC---CeeeecccceeeeCCCCCc
Q 021771 74 FLFDST----RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM---NPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 74 ~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~---~~kl~dfg~~~~~~~~~~~ 146 (308)
++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++.........
T Consensus 164 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~ 240 (367)
T 3l9p_A 164 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240 (367)
T ss_dssp HHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSC
T ss_pred HHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCcccccccccccc
Confidence 997642 2245899999999999999999999998 99999999999999655 4999999999755322222
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||....... ... ..........
T Consensus 241 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~------~~~-~i~~~~~~~~------ 307 (367)
T 3l9p_A 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE------VLE-FVTSGGRMDP------ 307 (367)
T ss_dssp TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HHH-HHHTTCCCCC------
T ss_pred ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHH-HHHcCCCCCC------
Confidence 22333456889999999999899999999999999999998 989986543221 111 1111111110
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+......+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 308 ---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 308 ---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111223488899999999999999999999998765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=300.33 Aligned_cols=241 Identities=26% Similarity=0.386 Sum_probs=193.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||+||+++..++..||+|++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||||+++++|.+++...
T Consensus 37 ~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-- 113 (283)
T 3gen_A 37 FGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-- 113 (283)
T ss_dssp CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCG--
T ss_pred CceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHh--
Confidence 799999999899999999996543 34467899999999999999999999999999999999999999999998653
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.|++.+|+|||++| ++|+||||+||+++.++.++|+|||++......... ......++..|+|
T Consensus 114 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~a 189 (283)
T 3gen_A 114 RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP 189 (283)
T ss_dssp GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH-STTSTTSCGGGCC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc-cccCCccCcccCC
Confidence 335999999999999999999999998 999999999999999999999999998765322111 1122345678999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||++.+..++.++||||||+++|+|++ |..||........ ..... ... .... +......+.++
T Consensus 190 PE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~------~~~~~-~~~-----~~~~----~~~~~~~l~~l 253 (283)
T 3gen_A 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIA-QGL-----RLYR----PHLASEKVYTI 253 (283)
T ss_dssp HHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHHH-TTC-----CCCC----CTTCCHHHHHH
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH------HHHHh-ccc-----CCCC----CCcCCHHHHHH
Confidence 999998889999999999999999998 9999865432211 11111 110 0000 11112358889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+||+.||++|||++++++.|...
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHHHHHH
Confidence 9999999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=304.87 Aligned_cols=240 Identities=23% Similarity=0.277 Sum_probs=189.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-----CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-----SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+++. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.+++..++|||||++++|.+.
T Consensus 37 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~ 116 (351)
T 3c0i_A 37 FSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFE 116 (351)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHH
T ss_pred CEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHH
Confidence 799999985 57999999998532 223467899999999999999999999999999999999999999999887
Q ss_pred hhcC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC---eeeecccceeeeCCCCCccccc
Q 021771 75 LFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN---PKISDFGMARIFGGNQSEANTN 150 (308)
Q Consensus 75 l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~---~kl~dfg~~~~~~~~~~~~~~~ 150 (308)
+... .....+++..++.++.||+.||+|||++| |+|+||||+||+++.++. +||+|||++........ ...
T Consensus 117 l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~ 191 (351)
T 3c0i_A 117 IVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAG 191 (351)
T ss_dssp HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCC
T ss_pred HHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eec
Confidence 7543 23345899999999999999999999998 999999999999987655 99999999988654322 123
Q ss_pred eeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 151 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
...|++.|+|||++.+..++.++|||||||++|+|++|..||...... . ..... ...... .+ ....
T Consensus 192 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~---~~~i~-~~~~~~--~~----~~~~ 257 (351)
T 3c0i_A 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----L---FEGII-KGKYKM--NP----RQWS 257 (351)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----H---HHHHH-HTCCCC--CH----HHHT
T ss_pred CCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----H---HHHHH-cCCCCC--Cc----cccc
Confidence 346899999999999888999999999999999999999999653211 0 01110 010000 00 0001
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.....+.+|+.+||+.||++|||+.++++
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 12345888999999999999999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=297.40 Aligned_cols=249 Identities=20% Similarity=0.260 Sum_probs=184.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++||||+++ ++.+.+..
T Consensus 15 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 93 (292)
T 3o0g_A 15 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS 93 (292)
T ss_dssp SSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH
T ss_pred CeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh
Confidence 799999996 579999999986543 33346788999999999999999999999999999999999976 45444433
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ...+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++......... .....++..
T Consensus 94 ~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t~~ 166 (292)
T 3o0g_A 94 C--NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLW 166 (292)
T ss_dssp T--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC--CCSCCSCGG
T ss_pred C--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccc--ccCCccccC
Confidence 2 235999999999999999999999998 999999999999999999999999999876433222 223467889
Q ss_pred ccCchhhccCc-ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh---cccccccc---c---------
Q 021771 158 YMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC---EGEALELM---E--------- 221 (308)
Q Consensus 158 y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---~--------- 221 (308)
|+|||++.+.. ++.++|||||||++|+|++|..|+....... ........... ...+.... +
T Consensus 167 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T 3o0g_A 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244 (292)
T ss_dssp GCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCT
T ss_pred CcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcccccccccccccC
Confidence 99999987755 7999999999999999998887753221111 01111111000 00000000 0
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..............+.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000011122345788999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=319.66 Aligned_cols=243 Identities=26% Similarity=0.358 Sum_probs=196.6
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+|+.+ ++..||||++... ....+.+.+|+.+|+.++||||+++++++.+....++||||+++++|.+++....
T Consensus 233 fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~ 311 (495)
T 1opk_A 233 YGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 311 (495)
T ss_dssp TSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC
T ss_pred CeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcC
Confidence 7999999975 5899999999654 3456789999999999999999999999999999999999999999999996542
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.......... .....++..|+
T Consensus 312 -~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~ 386 (495)
T 1opk_A 312 -RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWT 386 (495)
T ss_dssp -TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC-CTTCCCCGGGC
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceee-cCCCcCCccee
Confidence 345899999999999999999999998 9999999999999999999999999998764332211 12234567899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
|||++.+..++.++||||||+++|+|++ |..||....... +.. ....... ...+......+.+
T Consensus 387 aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~---------~~~~~~~~~~l~~ 450 (495)
T 1opk_A 387 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYR---------MERPEGCPEKVYE 450 (495)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCC---------CCCCTTCCHHHHH
T ss_pred CHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCC---------CCCCCCCCHHHHH
Confidence 9999998889999999999999999998 889986543221 111 1111100 0111122345888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
|+.+||+.||++|||+.+|++.|+...
T Consensus 451 li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 451 LMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 999999999999999999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=306.14 Aligned_cols=236 Identities=23% Similarity=0.305 Sum_probs=183.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||+|++.... ....+.+..|..+|..+ +||||+++++++.+.+.+++||||+++++|..++
T Consensus 65 fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 144 (396)
T 4dc2_A 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 144 (396)
T ss_dssp SEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHH
Confidence 799999996 578899999997542 23345678899999887 7999999999999999999999999999999988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...... ........||
T Consensus 145 ~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~gt 216 (396)
T 4dc2_A 145 QRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGT 216 (396)
T ss_dssp HHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCBC
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC--CCccccccCC
Confidence 643 34999999999999999999999998 999999999999999999999999999753222 1223345789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccc--cchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELG--QSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+.|+|||++.+..++.++|||||||++|+|++|..||........ ................ ..+....
T Consensus 217 ~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~p~~~s 286 (396)
T 4dc2_A 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RIPRSLS 286 (396)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----------CCCTTSC
T ss_pred cccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----------CCCCcCC
Confidence 999999999999999999999999999999999999964322211 1111111111111110 0111122
Q ss_pred HHHHHHHhhcccCCCCCCCCH
Q 021771 234 LKFIHIGLLCVQADSADRPTM 254 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~ 254 (308)
..+.+||.+||+.||++||++
T Consensus 287 ~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 287 VKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHHHHHhcCCHhHcCCC
Confidence 358889999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=306.33 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=194.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||||++... .....+.+..|..+|+.+ +||||+++++++.+.+.+++||||+++++|..++
T Consensus 36 fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 115 (353)
T 3txo_A 36 FGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115 (353)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred CEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 799999996 57999999998654 234556788999999988 6999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... .......|+
T Consensus 116 ~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt 187 (353)
T 3txo_A 116 QKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGT 187 (353)
T ss_dssp HHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CC
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCC
Confidence 553 34999999999999999999999998 9999999999999999999999999997533221 223345789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+.|+|||++.+..++.++|||||||++|+|++|..||....... ........ .. ..+......
T Consensus 188 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~-~~----------~~p~~~~~~ 250 (353)
T 3txo_A 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILND-EV----------VYPTWLHED 250 (353)
T ss_dssp GGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC-CC----------CCCTTSCHH
T ss_pred cCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHcC-CC----------CCCCCCCHH
Confidence 99999999998889999999999999999999999996543221 11111111 00 001112235
Q ss_pred HHHHHhhcccCCCCCCCCH------HHHHHH--hhcC------CCCCCCCCCCCccc
Q 021771 236 FIHIGLLCVQADSADRPTM------SSVVVM--LASD------TVTLPQPTEPAFSV 278 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~------~eil~~--L~~~------~~~~~~~~~p~~~~ 278 (308)
+.+|+.+||+.||++||++ ++|++- ++.. ...+++|-.|....
T Consensus 251 ~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~~ 307 (353)
T 3txo_A 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKS 307 (353)
T ss_dssp HHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred HHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCCC
Confidence 7889999999999999998 777742 2222 23456666666543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=304.31 Aligned_cols=245 Identities=29% Similarity=0.407 Sum_probs=193.9
Q ss_pred CCccEEeee--------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKL--------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~--------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||.||+++. .++..||+|++.... ......+.+|+.+++.+ +||||+++++++.+.+..++||||+++++
T Consensus 48 ~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 127 (334)
T 2pvf_A 48 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 127 (334)
T ss_dssp SCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCB
T ss_pred ceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCc
Confidence 799999985 357889999997543 34556788999999999 89999999999999999999999999999
Q ss_pred hhhHhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 71 LDVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 71 L~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
|.+++..... ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++
T Consensus 128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 204 (334)
T 2pvf_A 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLA 204 (334)
T ss_dssp HHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred HHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEcccccc
Confidence 9999975432 234889999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................++..|+|||++.+..++.++||||||+++|+|++ |..||....... .. ........
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~-~~~~~~~~ 277 (334)
T 2pvf_A 205 RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE------LF-KLLKEGHR 277 (334)
T ss_dssp EECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------HH-HHHHHTCC
T ss_pred ccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH------HH-HHHhcCCC
Confidence 87654433222333456778999999988889999999999999999999 999986443221 11 11111111
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.. .+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 278 ~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 278 MD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp CC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 0111223588899999999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=318.29 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=193.2
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+|+.+++..||||+++... ...+.+.+|+.+|+.++||||+++++++.+ +..++||||+++++|.+++... .
T Consensus 197 fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~-~ 273 (452)
T 1fmk_A 197 FGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-T 273 (452)
T ss_dssp SCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH-H
T ss_pred CeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc-C
Confidence 799999999888899999996543 345789999999999999999999999876 6789999999999999999542 2
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.||+.||+|||++| ++||||||+||+++.++.+||+|||++.......... .....++..|+|
T Consensus 274 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~~~~~y~a 349 (452)
T 1fmk_A 274 GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTA 349 (452)
T ss_dssp HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceec-ccCCcccccccC
Confidence 234889999999999999999999998 9999999999999999999999999998754322111 222345678999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++||||||+++|+|++ |..||....... . ... ...... ...+......+.+|
T Consensus 350 PE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~---~~~-i~~~~~---------~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V---LDQ-VERGYR---------MPCPPECPESLHDL 413 (452)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H---HHH-HHTTCC---------CCCCTTSCHHHHHH
T ss_pred HhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---H---HHH-HHcCCC---------CCCCCCCCHHHHHH
Confidence 999998899999999999999999999 899986443221 1 111 111100 01111223458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASDTVTLPQPT 272 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~~ 272 (308)
+.+||+.||++|||+++|++.|+.......+..
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~ 446 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHhccCCccc
Confidence 999999999999999999999998866555444
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=298.44 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=185.5
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+++..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+++ +|.+++...
T Consensus 15 ~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~ 93 (288)
T 1ob3_A 15 YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC 93 (288)
T ss_dssp TEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTS
T ss_pred CEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhc
Confidence 799999998889999999986543 23446788999999999999999999999999999999999975 888887543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
. ..+++..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++........ ......++..|
T Consensus 94 ~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y 166 (288)
T 1ob3_A 94 E--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWY 166 (288)
T ss_dssp T--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTT
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccc
Confidence 2 35899999999999999999999998 99999999999999999999999999876542211 12234678999
Q ss_pred cCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc---ccccc-----ccc-------c
Q 021771 159 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE---GEALE-----LME-------P 222 (308)
Q Consensus 159 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~~-------~ 222 (308)
+|||++.+ ..++.++|||||||++|+|++|..||........ .......... ..+.. ..+ +
T Consensus 167 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T 1ob3_A 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243 (288)
T ss_dssp CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCC
T ss_pred cCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHHCCCChhhchhhhcccccccccccccC
Confidence 99998876 4589999999999999999999999965432211 0000000000 00000 000 0
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.............+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000011112345788999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=301.40 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=195.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe----CCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE----ENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.. ....++||||+.+++|.+++
T Consensus 42 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 121 (317)
T 2buj_A 42 FSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121 (317)
T ss_dssp CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHH
T ss_pred CeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHH
Confidence 789999995 6899999999877666677889999999999999999999999873 34689999999999999988
Q ss_pred hcC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-------
Q 021771 76 FDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA------- 147 (308)
Q Consensus 76 ~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~------- 147 (308)
... .....+++..++.++.||+.||+|||++| ++|+||||+||+++.++.++|+|||++..........
T Consensus 122 ~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 198 (317)
T 2buj_A 122 ERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198 (317)
T ss_dssp HHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHH
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhccccccccccccccc
Confidence 653 23456899999999999999999999998 9999999999999999999999999987643211110
Q ss_pred ccceeecccCccCchhhccCc---ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccc
Q 021771 148 NTNRIVGTYGYMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVL 224 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
......++..|+|||++.+.. ++.++||||||+++|+|++|..||........... .. ... .. .
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~----~~~-~~-~------ 265 (317)
T 2buj_A 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA-LA----VQN-QL-S------ 265 (317)
T ss_dssp HHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH-HH----HHC-C---------
T ss_pred ccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh-HH----hhc-cC-C------
Confidence 011234688999999887543 68899999999999999999999854322211100 00 000 00 0
Q ss_pred cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 021771 225 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQPT 272 (308)
Q Consensus 225 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~~ 272 (308)
..........+.+++.+||+.||++|||++++++.|+....+.++..
T Consensus 266 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 266 -IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC--
T ss_pred -CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCCC
Confidence 00011122358889999999999999999999999998765554443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=307.17 Aligned_cols=258 Identities=25% Similarity=0.338 Sum_probs=193.6
Q ss_pred CCccEEeee-----CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-----ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~ 72 (308)
||+||++.+ .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+. ...++||||+++++|.
T Consensus 44 ~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (318)
T 3lxp_A 44 FGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123 (318)
T ss_dssp SEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHH
T ss_pred CeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHH
Confidence 789977753 378999999997553 34567789999999999999999999999874 5789999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 151 (308)
+++... .+++..++.++.||+.+|+|||+.| ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 124 ~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 196 (318)
T 3lxp_A 124 DYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196 (318)
T ss_dssp HHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---
T ss_pred HHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccC
Confidence 998542 3899999999999999999999998 999999999999999999999999999887543221 12233
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..++..|+|||++.+..++.++||||||+++|+|++|..||........... .............+.+........+..
T Consensus 197 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (318)
T 3lxp_A 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI-GIAQGQMTVLRLTELLERGERLPRPDK 275 (318)
T ss_dssp CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-CSCCHHHHHHHHHHHHHTTCCCCCCTT
T ss_pred CCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh-cccccchhHHHHHHHHhcccCCCCCcc
Confidence 4567789999999988899999999999999999999999864322210000 000000000000111111111111222
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTV 266 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~ 266 (308)
....+.+|+.+||+.||++|||+.++++.|+....
T Consensus 276 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 276 CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 33468899999999999999999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=305.16 Aligned_cols=242 Identities=25% Similarity=0.419 Sum_probs=185.4
Q ss_pred CCccEEeee-CCCCE----EEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKE----IAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|+. .+|+. |++|.+... .......+.+|+.+++.++||||+++++++.++. .++|++|+.+++|.++
T Consensus 28 ~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~ 106 (327)
T 3poz_A 28 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDY 106 (327)
T ss_dssp TEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHH
T ss_pred CeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHH
Confidence 799999995 45554 588877543 3456678999999999999999999999998764 7899999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+.... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++................+
T Consensus 107 l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 181 (327)
T 3poz_A 107 VREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181 (327)
T ss_dssp HHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CC
T ss_pred HHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCc
Confidence 86643 35899999999999999999999998 99999999999999999999999999987654443333334456
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||.+.+..++.++||||||+++|+|++ |..||......... ......... ..+....
T Consensus 182 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~~~---------~~~~~~~ 245 (327)
T 3poz_A 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGERL---------PQPPICT 245 (327)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTCCC---------CCCTTBC
T ss_pred cccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------HHHHcCCCC---------CCCccCC
Confidence 778999999999999999999999999999999 99999654332211 111111100 0111122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+++.+||+.||++|||++++++.|+..
T Consensus 246 ~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 246 IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 3588899999999999999999999998765
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=299.48 Aligned_cols=253 Identities=20% Similarity=0.222 Sum_probs=200.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.+....++||||+++++|.+++.
T Consensus 54 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 133 (350)
T 1rdq_E 54 FGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133 (350)
T ss_dssp SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred CcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 799999996 57999999998644 23455778899999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++...... .....|++
T Consensus 134 ~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~ 202 (350)
T 1rdq_E 134 RI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTP 202 (350)
T ss_dssp HH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECG
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCc
Confidence 53 34899999999999999999999998 999999999999999999999999999876432 22346899
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||...... ........ ... . .+......+
T Consensus 203 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~-~~~-~---------~p~~~~~~~ 265 (350)
T 1rdq_E 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVS-GKV-R---------FPSHFSSDL 265 (350)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC-C---------CCTTCCHHH
T ss_pred cccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHHc-CCC-C---------CCCCCCHHH
Confidence 999999999888999999999999999999999999643221 11111111 110 0 011123358
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHHH--hhcC------CCCCCCCCCCCcccCcc
Q 021771 237 IHIGLLCVQADSADRPT-----MSSVVVM--LASD------TVTLPQPTEPAFSVGRN 281 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs-----~~eil~~--L~~~------~~~~~~~~~p~~~~~~~ 281 (308)
.+||.+||+.||++||+ +++|++- +... ....++|-.|....+..
T Consensus 266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~ 323 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGD 323 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTC
T ss_pred HHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCccc
Confidence 88999999999999998 8888853 2221 23456666666554433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=295.99 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=192.2
Q ss_pred CCccEEee-----eCCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChh
Q 021771 1 MESCLQGK-----LADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~-----~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~ 72 (308)
||.||+++ ..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+. ...++||||+++++|.
T Consensus 34 ~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 113 (302)
T 4e5w_A 34 FGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113 (302)
T ss_dssp SEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHH
T ss_pred ceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHH
Confidence 78999998 357999999998744 344567899999999999999999999999876 6689999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 151 (308)
+++.... ..+++..++.++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++......... .....
T Consensus 114 ~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 188 (302)
T 4e5w_A 114 EYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 188 (302)
T ss_dssp HHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCC
T ss_pred HHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCC
Confidence 9985533 34899999999999999999999998 999999999999999999999999999886543321 12223
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcccccc--------ccchhHHHHHhhhccccccccccc
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSEL--------GQSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
..++..|+|||++.+..++.++||||||+++|+|++|..|+....... ................
T Consensus 189 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 260 (302)
T 4e5w_A 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK-------- 260 (302)
T ss_dssp TTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC--------
T ss_pred CCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC--------
Confidence 456778999999999899999999999999999999998864332110 0000000111111110
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
....+......+.+|+.+||+.||++|||++++++.|+..
T Consensus 261 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 261 -RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp -CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0111122234588999999999999999999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=293.93 Aligned_cols=235 Identities=22% Similarity=0.278 Sum_probs=182.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc--------------------------ccHHHHHHHHHHHhcCCCcCccceeeeE
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG--------------------------QGLQEFKNEVTLIAKLQHKNLVRLFGCC 53 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 53 (308)
||.||+++. .+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++
T Consensus 26 ~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 105 (298)
T 2zv2_A 26 YGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVL 105 (298)
T ss_dssp CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 799999995 5799999999865421 1235688999999999999999999999
Q ss_pred Ee--CCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeee
Q 021771 54 LE--ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKI 131 (308)
Q Consensus 54 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl 131 (308)
.+ ....++||||+++++|.+++ ....+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||
T Consensus 106 ~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 178 (298)
T 2zv2_A 106 DDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKI 178 (298)
T ss_dssp ECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEE
T ss_pred EcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCCEEE
Confidence 87 56789999999999998765 2346999999999999999999999998 999999999999999999999
Q ss_pred ecccceeeeCCCCCccccceeecccCccCchhhccCc---ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH
Q 021771 132 SDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL---FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW 208 (308)
Q Consensus 132 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~ 208 (308)
+|||++........ ......|+..|+|||++.+.. .+.++||||||+++|+|++|..||...... ....
T Consensus 179 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~ 250 (298)
T 2zv2_A 179 ADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM------CLHS 250 (298)
T ss_dssp CCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred ecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH------HHHH
Confidence 99999987653322 122346899999999887654 477899999999999999999998643221 1111
Q ss_pred HhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 209 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
... .... .... .. .....+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~-~~~~-~~~~---~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 251 KIK-SQAL-EFPD---QP----DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHH-HCCC-CCCS---SS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHh-cccC-CCCC---cc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111 1100 0000 01 11235888999999999999999999974
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=292.73 Aligned_cols=239 Identities=24% Similarity=0.334 Sum_probs=190.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++..
T Consensus 20 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 98 (276)
T 2yex_A 20 YGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP- 98 (276)
T ss_dssp SSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-
T ss_pred CcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh-
Confidence 799999996 489999999986443 34457889999999999999999999999999999999999999999998843
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++..+.............++..|
T Consensus 99 --~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 173 (276)
T 2yex_A 99 --DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173 (276)
T ss_dssp --TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGG
T ss_pred --ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCc
Confidence 345899999999999999999999998 999999999999999999999999999875433222223345678899
Q ss_pred cCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 159 MAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 159 ~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
+|||.+.+..+ +.++||||||+++|+|++|..||......... ...+...... ... .......+.
T Consensus 174 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~--~~~------~~~~~~~~~ 239 (276)
T 2yex_A 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YSDWKEKKTY--LNP------WKKIDSAPL 239 (276)
T ss_dssp CCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------HHHHHTTCTT--STT------GGGSCHHHH
T ss_pred cChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHhhhcccc--cCc------hhhcCHHHH
Confidence 99999887664 78999999999999999999999654332110 0111111000 000 011123578
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+|+.+||+.||++|||++++++
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHCCCCchhCCCHHHHhc
Confidence 8999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=295.25 Aligned_cols=239 Identities=29% Similarity=0.435 Sum_probs=181.0
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC----cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.
T Consensus 20 ~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 98 (271)
T 3dtc_A 20 FGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS 98 (271)
T ss_dssp TEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT
T ss_pred CeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh
Confidence 789999987 48899999986542 2345778899999999999999999999999999999999999999999883
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC--------CCCeeeecccceeeeCCCCCccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH--------EMNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~--------~~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
...+++..++.++.|++.||+|||++|..+++|+||||+||+++. ++.++|+|||++.......
T Consensus 99 ----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---- 170 (271)
T 3dtc_A 99 ----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---- 170 (271)
T ss_dssp ----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------------
T ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----
Confidence 335899999999999999999999986333889999999999986 6779999999998654322
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ......... ... ..
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~--------~~ 235 (271)
T 3dtc_A 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVAMNK-LAL--------PI 235 (271)
T ss_dssp -----CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHTSC-CCC--------CC
T ss_pred ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhhcCC-CCC--------CC
Confidence 123467899999999998889999999999999999999999986433221 111111111 100 01
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+......+.+++.+||+.||++|||+.|+++.|+.
T Consensus 236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11122358889999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=305.41 Aligned_cols=236 Identities=21% Similarity=0.305 Sum_probs=189.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .......+.+|+.+|+.++||||+++++++.+.+..++||||+.+++|..++.
T Consensus 28 fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~ 107 (384)
T 4fr4_A 28 FGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ 107 (384)
T ss_dssp TCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHH
Confidence 799999995 57999999998643 23456778899999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ...+++..+..++.||+.||.|||++| |+||||||+||+++.+|.+||+|||++..+.... ......|++
T Consensus 108 ~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~ 178 (384)
T 4fr4_A 108 Q---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTK 178 (384)
T ss_dssp T---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCG
T ss_pred h---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCc
Confidence 4 335999999999999999999999998 9999999999999999999999999998764322 223457899
Q ss_pred CccCchhhcc---CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 157 GYMAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 157 ~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.|+|||++.+ ..++.++|||||||++|+|++|..||.............. . .... . ..+....
T Consensus 179 ~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~-~~~~-~---------~~p~~~s 244 (384)
T 4fr4_A 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---F-ETTV-V---------TYPSAWS 244 (384)
T ss_dssp GGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH---H-HHCC-C---------CCCTTSC
T ss_pred cccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH---H-hhcc-c---------CCCCcCC
Confidence 9999999864 4588999999999999999999999965433322111111 1 0000 0 0111123
Q ss_pred HHHHHHHhhcccCCCCCCCC-HHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPT-MSSVVV 259 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs-~~eil~ 259 (308)
..+.+|+.+||+.||++||+ +++|++
T Consensus 245 ~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 245 QEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 45888999999999999998 777764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.73 Aligned_cols=259 Identities=14% Similarity=0.137 Sum_probs=193.1
Q ss_pred CCccEEeeeC----CCCEEEEEEeccCCcc-----------cHHHHHHHHHHHhcCCCcCccceeeeEEe----CCeEEE
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRTSGQ-----------GLQEFKNEVTLIAKLQHKNLVRLFGCCLE----ENESLL 61 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 61 (308)
||.||+++.. ++..+|+|++...... ....+.+|+..++.++||||+++++++.+ ....++
T Consensus 50 ~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l 129 (345)
T 2v62_A 50 FGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFM 129 (345)
T ss_dssp --CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEE
T ss_pred CeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEE
Confidence 7999999964 6889999998655321 11235578888999999999999999988 678999
Q ss_pred EEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC--Ceeeecccceee
Q 021771 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM--NPKISDFGMARI 139 (308)
Q Consensus 62 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~--~~kl~dfg~~~~ 139 (308)
||||+ +++|.+++... ..+++..++.++.||+.||+|||++| |+|+||||+||+++.++ .+||+|||++..
T Consensus 130 v~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~ 202 (345)
T 2v62_A 130 VMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202 (345)
T ss_dssp EEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEE
T ss_pred EEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCcee
Confidence 99999 99999998543 26999999999999999999999998 99999999999999887 999999999987
Q ss_pred eCCCCCc-----cccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcc
Q 021771 140 FGGNQSE-----ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEG 214 (308)
Q Consensus 140 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 214 (308)
+...... .......++..|+|||++.+..++.++|||||||++|+|++|..||......... ........ ..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~-~~ 279 (345)
T 2v62_A 203 YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA--VQTAKTNL-LD 279 (345)
T ss_dssp SSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH--HHHHHHHH-HH
T ss_pred cccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH--HHHHHHhh-cc
Confidence 6432111 1123457899999999999888999999999999999999999999643222110 00000000 00
Q ss_pred cccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 021771 215 EALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQPT 272 (308)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~~ 272 (308)
.....+...... ......+.+++.+||+.||++|||+++|++.|+....++.+..
T Consensus 280 ~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d 334 (345)
T 2v62_A 280 ELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLD 334 (345)
T ss_dssp TTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCC
T ss_pred cccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCC
Confidence 111111100000 0122358889999999999999999999999998765554444
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=299.87 Aligned_cols=248 Identities=22% Similarity=0.245 Sum_probs=186.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+++. .+|+.||||++........+.+.+|+.+++++ +||||+++++++.+++..++||||+++++|.+++...
T Consensus 26 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 105 (316)
T 2ac3_A 26 HARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR 105 (316)
T ss_dssp SEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH
T ss_pred eEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc
Confidence 789999984 68999999999777666778899999999985 7999999999999999999999999999999998653
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC---eeeecccceeeeCCCCC-----ccccc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN---PKISDFGMARIFGGNQS-----EANTN 150 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~---~kl~dfg~~~~~~~~~~-----~~~~~ 150 (308)
..+++..+..++.||+.||+|||++| ++|+||||+||+++.++. +||+|||++........ .....
T Consensus 106 ---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 179 (316)
T 2ac3_A 106 ---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179 (316)
T ss_dssp ---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------------
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccc
Confidence 34899999999999999999999998 999999999999998776 99999999876532211 11112
Q ss_pred eeecccCccCchhhcc-----CcccccccchhhhHHHHHHHhCCcCCCccccccccchh--------HHHHHhhhccccc
Q 021771 151 RIVGTYGYMAPEYAME-----GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL--------SYTWKLWCEGEAL 217 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 217 (308)
...|+..|+|||++.+ ..++.++|||||||++|+|++|..||............ ............
T Consensus 180 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~- 258 (316)
T 2ac3_A 180 TPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY- 258 (316)
T ss_dssp --CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC-
T ss_pred cccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc-
Confidence 2458899999998875 45788999999999999999999999765432211000 000000101000
Q ss_pred ccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 218 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.... .........+.+|+.+||+.||++|||+.|+++-
T Consensus 259 ~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 259 EFPD-----KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCCH-----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccCc-----hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 0001123458899999999999999999999873
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.93 Aligned_cols=238 Identities=24% Similarity=0.367 Sum_probs=192.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+|+. .+|+.||||++... .......+.+|+.+|+.++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 29 fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~ 108 (476)
T 2y94_A 29 FGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYIC 108 (476)
T ss_dssp SSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTT
T ss_pred CeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 799999996 48999999998644 22345678999999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++........ .....|++
T Consensus 109 ~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~ 179 (476)
T 2y94_A 109 K---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSP 179 (476)
T ss_dssp S---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCS
T ss_pred h---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCc
Confidence 3 345999999999999999999999998 99999999999999999999999999987653321 22346899
Q ss_pred CccCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 157 GYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 157 ~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
.|+|||++.+..+ +.++|||||||++|+|++|..||....... ...... .... .. +......
T Consensus 180 ~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~-~~~~-~~---------p~~~s~~ 242 (476)
T 2y94_A 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKIC-DGIF-YT---------PQYLNPS 242 (476)
T ss_dssp TTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHHH-TTCC-CC---------CTTCCHH
T ss_pred CeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHHh-cCCc-CC---------CccCCHH
Confidence 9999999988765 689999999999999999999996432221 111111 1100 00 0111235
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH--HhhcC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVV--MLASD 264 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~--~L~~~ 264 (308)
+.+|+.+||+.||++|||++++++ .+...
T Consensus 243 ~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 243 VISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 788999999999999999999996 45543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=300.01 Aligned_cols=253 Identities=26% Similarity=0.331 Sum_probs=188.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||++.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++||||++ ++|.+++...
T Consensus 18 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~ 96 (317)
T 2pmi_A 18 YATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSR 96 (317)
T ss_dssp -CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHH
T ss_pred CEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhc
Confidence 799999985 579999999986543 3345778899999999999999999999999999999999997 5888887543
Q ss_pred C---CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 79 T---RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 79 ~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
. ....+++..+..++.||+.||+|||++| |+|+||||+||+++.++.+||+|||++......... .....++
T Consensus 97 ~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~t 171 (317)
T 2pmi_A 97 TVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVT 171 (317)
T ss_dssp HSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC--CCCCCSC
T ss_pred cccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCccc--CCCCccc
Confidence 2 1235889999999999999999999998 999999999999999999999999999876432221 2234678
Q ss_pred cCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH-----hhhcc-ccc-----------
Q 021771 156 YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK-----LWCEG-EAL----------- 217 (308)
Q Consensus 156 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~-----~~~~~-~~~----------- 217 (308)
..|+|||++.+ ..++.++|||||||++|+|++|..||................. .+... ...
T Consensus 172 ~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (317)
T 2pmi_A 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPP 251 (317)
T ss_dssp CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCC
T ss_pred ccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccc
Confidence 99999999876 4689999999999999999999999965433211100000000 00000 000
Q ss_pred ccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 218 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..+...+...........+.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 252 RDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000001112346889999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=305.23 Aligned_cols=243 Identities=25% Similarity=0.415 Sum_probs=185.1
Q ss_pred CCccEEeee-CCCCEE----EEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEI----AVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~v----avK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+++. .+|+.+ ++|.+... .......+.+|+.+++.++||||+++++++.++. .++|++++.+++|.++
T Consensus 28 ~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~ 106 (327)
T 3lzb_A 28 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDY 106 (327)
T ss_dssp SEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHH
T ss_pred CeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHH
Confidence 799999995 456554 77766543 4456778999999999999999999999998764 7899999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+.... ..+++..++.++.||+.||.|||++| ++|+||||+||+++.++.+||+|||++................+
T Consensus 107 l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~ 181 (327)
T 3lzb_A 107 VREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181 (327)
T ss_dssp HHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----------------CC
T ss_pred HHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCc
Confidence 86543 35899999999999999999999998 99999999999999999999999999987654433333333456
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||.+.+..++.++||||||+++|+|++ |..||.......... ......... .+....
T Consensus 182 t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-------~~~~~~~~~---------~~~~~~ 245 (327)
T 3lzb_A 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-------ILEKGERLP---------QPPICT 245 (327)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-------HHHTTCCCC---------CCTTBC
T ss_pred cccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-------HHHcCCCCC---------CCccCC
Confidence 778999999999999999999999999999999 999996543332111 111111000 011122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
..+.+++.+||+.||++|||+.|+++.|+...
T Consensus 246 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 246 IDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 35888999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=303.89 Aligned_cols=232 Identities=20% Similarity=0.282 Sum_probs=186.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .......+.+|+.+++.++||||+++++++.+....++||||+ +++|.+++.
T Consensus 22 ~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~ 100 (336)
T 3h4j_B 22 FGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIV 100 (336)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHH
Confidence 799999995 68999999998643 2233467889999999999999999999999999999999999 678888775
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.|++.||.|||++| ++||||||+||+++.++.+||+|||++....... ......|++
T Consensus 101 ~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~ 171 (336)
T 3h4j_B 101 EK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSP 171 (336)
T ss_dssp HH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTST
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCc
Confidence 43 35999999999999999999999998 9999999999999999999999999997654322 123346899
Q ss_pred CccCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 157 GYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 157 ~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
.|+|||++.+..+ +.++||||||+++|+|++|..||............ ... . ...+......
T Consensus 172 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------------~~~-~----~~~p~~~s~~ 234 (336)
T 3h4j_B 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV------------NSC-V----YVMPDFLSPG 234 (336)
T ss_dssp TTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC------------CSS-C----CCCCTTSCHH
T ss_pred CcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH------------HcC-C----CCCcccCCHH
Confidence 9999999988765 68999999999999999999999654322211100 000 0 0011112235
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 235 AQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHcCCChhHCcCHHHHHh
Confidence 788999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=306.76 Aligned_cols=254 Identities=16% Similarity=0.209 Sum_probs=189.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||||++++|.+++..
T Consensus 40 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 119 (389)
T 3gni_B 40 LMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT 119 (389)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH
T ss_pred ceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhh
Confidence 689999996 489999999996542 34456788899999999999999999999999999999999999999999866
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC-----cccccee
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS-----EANTNRI 152 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~ 152 (308)
.. ...+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||.+........ .......
T Consensus 120 ~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 195 (389)
T 3gni_B 120 HF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195 (389)
T ss_dssp TC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTC
T ss_pred hc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccc
Confidence 42 235899999999999999999999998 99999999999999999999999999875432211 1111223
Q ss_pred ecccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh---------cc-------
Q 021771 153 VGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC---------EG------- 214 (308)
Q Consensus 153 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---------~~------- 214 (308)
.|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... ......... ..
T Consensus 196 ~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (389)
T 3gni_B 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTSTIPAEELTMSPS 273 (389)
T ss_dssp TTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC------------------------
T ss_pred cccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCcccccccccccccccccc
Confidence 67888999999887 57899999999999999999999999653322110 000000000 00
Q ss_pred ------cccccccc---------cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 215 ------EALELMEP---------VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 215 ------~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
........ .............+.+|+.+||+.||++|||++|+++-
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 274 RSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000000 00000112223458899999999999999999999854
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=299.05 Aligned_cols=231 Identities=22% Similarity=0.274 Sum_probs=189.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .....+.+.+|..+++.++||||+++++++.+....++||||+++++|.+++.
T Consensus 19 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 98 (318)
T 1fot_A 19 FGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 98 (318)
T ss_dssp SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHH
Confidence 799999996 58999999998654 23456778899999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.||+.||+|||++| |+||||||+||+++.+|.+||+|||++...... .....|++
T Consensus 99 ~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~ 167 (318)
T 1fot_A 99 KS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTP 167 (318)
T ss_dssp HT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCT
T ss_pred Hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCc
Confidence 53 34899999999999999999999998 999999999999999999999999999875432 22346899
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||...... ......... .. . .+......+
T Consensus 168 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~-~~-~---------~p~~~~~~~ 230 (318)
T 1fot_A 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNA-EL-R---------FPPFFNEDV 230 (318)
T ss_dssp TTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHC-CC-C---------CCTTSCHHH
T ss_pred cccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-CC-C---------CCCCCCHHH
Confidence 999999999888999999999999999999999999643221 111111111 00 0 011122358
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHH
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~ 259 (308)
.+|+.+||+.||++|| ++++|++
T Consensus 231 ~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 231 KDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 8899999999999999 8999984
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=300.91 Aligned_cols=242 Identities=21% Similarity=0.241 Sum_probs=171.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+++. .+|+.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++++|.+++...
T Consensus 24 ~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 100 (325)
T 3kn6_A 24 FSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100 (325)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC
T ss_pred CeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc
Confidence 799999996 57999999998543 3466789999999997 999999999999999999999999999999998653
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC---CeeeecccceeeeCCCCCccccceeecc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM---NPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
..+++..+..++.||+.||+|||++| |+|+||||+||+++.++ .+||+|||++........ ......++
T Consensus 101 ---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t 172 (325)
T 3kn6_A 101 ---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFT 172 (325)
T ss_dssp ---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------------
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCC
Confidence 35999999999999999999999998 99999999999998766 799999999987543322 12234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++||||||+++|+|++|..||......................... ............
T Consensus 173 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~s~~ 246 (325)
T 3kn6_A 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEAWKNVSQE 246 (325)
T ss_dssp -----------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHHHHTSCHH
T ss_pred cCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcccccCCCHH
Confidence 99999999998889999999999999999999999997644332111111111111111110 001111122346
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+.+|+.+||+.||++|||++++++
T Consensus 247 ~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 247 AKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred HHHHHHHHCCCChhHCCCHHHHhc
Confidence 889999999999999999999984
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.88 Aligned_cols=244 Identities=26% Similarity=0.394 Sum_probs=194.6
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+|+.+++..||||+++... ...+.+.+|+.+|+.++||||+++++++. ....++||||+++++|.+++... .
T Consensus 201 fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~ 277 (454)
T 1qcf_A 201 FGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD-E 277 (454)
T ss_dssp SEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH-H
T ss_pred ceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc-c
Confidence 799999999889999999996543 45788999999999999999999999986 55789999999999999999643 2
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.||+.||+|||+++ ++||||||+|||++.++.+||+|||++.......... .....++..|+|
T Consensus 278 ~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~a 353 (454)
T 1qcf_A 278 GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTA 353 (454)
T ss_dssp HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT-TCSSSSCGGGSC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec-cCCCcccccccC
Confidence 235888999999999999999999998 9999999999999999999999999997654221111 122345678999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||++....++.++||||||+++|+|++ |..||....... .. .. ....... ..+......+.+|
T Consensus 354 PE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~---~~-i~~~~~~---------~~~~~~~~~l~~l 417 (454)
T 1qcf_A 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VI---RA-LERGYRM---------PRPENCPEELYNI 417 (454)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH---HH-HHHTCCC---------CCCTTSCHHHHHH
T ss_pred HHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HH---HH-HHcCCCC---------CCCCCCCHHHHHH
Confidence 999998889999999999999999999 999986543221 11 11 1111000 0111223458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcCCCC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASDTVT 267 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~~~~ 267 (308)
+.+||+.||++|||+++|++.|+.....
T Consensus 418 i~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 418 MMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999987544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=291.33 Aligned_cols=236 Identities=19% Similarity=0.228 Sum_probs=189.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .++..+|+|++........+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++...
T Consensus 22 ~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~- 100 (277)
T 3f3z_A 22 WGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK- 100 (277)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-
T ss_pred CEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc-
Confidence 799999996 568899999997766667788999999999999999999999999999999999999999999988543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe---CCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---NHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
..+++..++.++.|++.||+|||++| ++|+||||+||++ +.++.++|+|||++..+.... ......++.
T Consensus 101 --~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~ 172 (277)
T 3f3z_A 101 --RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTP 172 (277)
T ss_dssp --CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCT
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCC
Confidence 34899999999999999999999998 9999999999999 788899999999998765332 222346789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+. ++.++||||||+++|+|++|..||....... ...... ..... .. ..........+
T Consensus 173 ~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~-~~-----~~~~~~~~~~~ 238 (277)
T 3f3z_A 173 YYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE------VMLKIR-EGTFT-FP-----EKDWLNVSPQA 238 (277)
T ss_dssp TTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCCC-CC-----HHHHTTSCHHH
T ss_pred CccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hCCCC-CC-----chhhhcCCHHH
Confidence 99999987654 8999999999999999999999996543221 111111 11000 00 00000123458
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+|+.+||+.||++|||+.++++
T Consensus 239 ~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 239 ESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 88999999999999999999984
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=296.97 Aligned_cols=242 Identities=26% Similarity=0.352 Sum_probs=195.3
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+++.. +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++...
T Consensus 26 ~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~- 103 (288)
T 3kfa_A 26 YGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC- 103 (288)
T ss_dssp TCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC-
T ss_pred ceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc-
Confidence 7999999964 6899999998643 345678899999999999999999999999999999999999999999998653
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
....+++..++.++.|++.+|+|||++| ++|+||||+||+++.++.++|+|||++......... ......++..|+
T Consensus 104 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~ 179 (288)
T 3kfa_A 104 NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWT 179 (288)
T ss_dssp CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE-EETTEEECGGGC
T ss_pred ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCccc-cccCCccccCcC
Confidence 2345899999999999999999999998 999999999999999999999999999765433222 222345677899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
|||.+.+..++.++||||||+++|+|++ |..||.......... ....... ...+......+.+
T Consensus 180 aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-------~~~~~~~---------~~~~~~~~~~l~~ 243 (288)
T 3kfa_A 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------LLEKDYR---------MERPEGCPEKVYE 243 (288)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-------HHHTTCC---------CCCCTTCCHHHHH
T ss_pred ChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------HHhccCC---------CCCCCCCCHHHHH
Confidence 9999998889999999999999999999 889986543322111 1111100 0111112245888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
|+.+||+.||++|||+.++++.|+..
T Consensus 244 li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 244 LMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=295.34 Aligned_cols=240 Identities=26% Similarity=0.377 Sum_probs=188.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++....
T Consensus 35 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 114 (295)
T 2clq_A 35 YGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW 114 (295)
T ss_dssp SSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT
T ss_pred cEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc
Confidence 799999995 6899999999987766667889999999999999999999999999999999999999999999997654
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-CCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-EMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
....+++..+..++.|++.||.|||++| ++|+||+|+||+++. ++.++|+|||++........ ......++..|
T Consensus 115 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y 189 (295)
T 2clq_A 115 GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQY 189 (295)
T ss_dssp CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGG
T ss_pred cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccc
Confidence 4456788899999999999999999998 999999999999987 88999999999987643221 12234678899
Q ss_pred cCchhhccCc--ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 159 MAPEYAMEGL--FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 159 ~aPE~~~~~~--~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
+|||++.+.. ++.++||||||+++|+|++|..||........ . ......... .+.. +......+
T Consensus 190 ~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~-~~~~~~~~~-----~~~~----~~~~~~~~ 255 (295)
T 2clq_A 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----A-MFKVGMFKV-----HPEI----PESMSAEA 255 (295)
T ss_dssp CCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----H-HHHHHHHCC-----CCCC----CTTSCHHH
T ss_pred cChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----H-HHhhccccc-----cccc----cccCCHHH
Confidence 9999987643 78899999999999999999999854322110 0 000000000 0011 11122358
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.||++|||+.++++
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHccCChhhCCCHHHHhc
Confidence 88999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=303.51 Aligned_cols=247 Identities=24% Similarity=0.378 Sum_probs=195.4
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+
T Consensus 38 ~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 117 (322)
T 1p4o_A 38 FGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117 (322)
T ss_dssp SSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred ceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHH
Confidence 7999999854 47889999986543 3345678899999999999999999999999999999999999999999
Q ss_pred HhhcCCC-------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 74 FLFDSTR-------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 74 ~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
++..... ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++.........
T Consensus 118 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 194 (322)
T 1p4o_A 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194 (322)
T ss_dssp HHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE
T ss_pred HHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCcccccccccccc
Confidence 9865321 134688999999999999999999998 999999999999999999999999998765433222
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||....... .............
T Consensus 195 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~------ 261 (322)
T 1p4o_A 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVMEGGLLDK------ 261 (322)
T ss_dssp EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHHHHTTCCCCC------
T ss_pred ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-------HHHHHHcCCcCCC------
Confidence 22333456788999999998889999999999999999999 888886442221 1111111111111
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCC
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTV 266 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~ 266 (308)
+......+.+++.+||+.||++|||+.++++.|+....
T Consensus 262 ---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 262 ---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11123358889999999999999999999999987644
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=304.04 Aligned_cols=239 Identities=22% Similarity=0.219 Sum_probs=178.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+++. .+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++...
T Consensus 33 ~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 110 (361)
T 3uc3_A 33 FGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA- 110 (361)
T ss_dssp TSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-
T ss_pred CEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc-
Confidence 799999996 489999999996543 33367889999999999999999999999999999999999999999988543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC--eeeecccceeeeCCCCCccccceeecccC
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN--PKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
..+++..++.++.|++.||+|||++| |+||||||+||+++.++. +||+|||++...... .......|+..
T Consensus 111 --~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~ 182 (361)
T 3uc3_A 111 --GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPA 182 (361)
T ss_dssp --SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CT
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc---CCCCCCcCCCC
Confidence 34999999999999999999999998 999999999999987765 999999998753221 12233468999
Q ss_pred ccCchhhccCccccc-ccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVK-SDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 158 y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
|+|||++.+..++.+ +|||||||++|+|++|..||......... ........... . .... .......+
T Consensus 183 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~-~-~~~~-------~~~~s~~~ 251 (361)
T 3uc3_A 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVK-Y-SIPD-------DIRISPEC 251 (361)
T ss_dssp TSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTC-C-CCCT-------TSCCCHHH
T ss_pred cCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCC-C-CCCC-------cCCCCHHH
Confidence 999999888776555 89999999999999999999654332211 11111111100 0 0000 00112357
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+|+.+||+.||++|||+.|+++-
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 252 CHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHccCChhHCcCHHHHHhC
Confidence 889999999999999999999953
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=294.45 Aligned_cols=241 Identities=27% Similarity=0.378 Sum_probs=193.2
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+++..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++....
T Consensus 21 ~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~- 98 (267)
T 3t9t_A 21 FGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR- 98 (267)
T ss_dssp TEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT-
T ss_pred ceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc-
Confidence 789999998889999999996543 345788999999999999999999999999999999999999999999986542
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
..+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++........ .......++..|+|
T Consensus 99 -~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~a 173 (267)
T 3t9t_A 99 -GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 173 (267)
T ss_dssp -TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCC
T ss_pred -ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccC
Confidence 35889999999999999999999998 99999999999999999999999999876532211 11122345678999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||++.+..++.++||||||+++|+|++ |..||....... ..... ..... ... +......+.++
T Consensus 174 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~i-~~~~~-----~~~----~~~~~~~l~~l 237 (267)
T 3t9t_A 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVEDI-STGFR-----LYK----PRLASTHVYQI 237 (267)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHH-HTTCC-----CCC----CTTSCHHHHHH
T ss_pred hhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHHH-hcCCc-----CCC----CccCcHHHHHH
Confidence 999988889999999999999999999 899986533221 11111 11100 000 11112358889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+||+.||++|||++++++.|+..
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=295.23 Aligned_cols=244 Identities=30% Similarity=0.432 Sum_probs=193.3
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+++..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+ +..++||||+++++|.+++... .
T Consensus 26 ~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~-~ 102 (279)
T 1qpc_A 26 FGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-S 102 (279)
T ss_dssp TEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH-H
T ss_pred CeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcC-C
Confidence 789999998888899999986443 446789999999999999999999999875 4689999999999999998542 2
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++.......... .....++..|+|
T Consensus 103 ~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~a 178 (279)
T 1qpc_A 103 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTA 178 (279)
T ss_dssp HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC-CTTCCCCTTTSC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccccc-ccCCCCccCccC
Confidence 235899999999999999999999998 9999999999999999999999999998765332211 222345678999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||.+.+..++.++||||||+++|+|++ |..||....... .. ........ ... +......+.++
T Consensus 179 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~-~~~~~~~~-----~~~----~~~~~~~l~~l 242 (279)
T 1qpc_A 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VI-QNLERGYR-----MVR----PDNCPEELYQL 242 (279)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------HH-HHHHTTCC-----CCC----CTTCCHHHHHH
T ss_pred hhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------HH-HHHhcccC-----CCC----cccccHHHHHH
Confidence 999988889999999999999999999 888986432221 01 11111100 000 11122458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcCCCC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASDTVT 267 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~~~~ 267 (308)
+.+||+.||++|||+.++++.|+.....
T Consensus 243 i~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 243 MRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999999999999999876433
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=300.29 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=185.1
Q ss_pred CCccEEeeeC----CCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-----eEEEEEEecCCC
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-----ESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~ 69 (308)
||.||+++.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.. ..++||||++++
T Consensus 47 ~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~ 126 (313)
T 3brb_A 47 FGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYG 126 (313)
T ss_dssp CCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTC
T ss_pred CeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCC
Confidence 7999999853 3558999998654 2334567889999999999999999999998755 359999999999
Q ss_pred ChhhHhhcC---CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 70 SLDVFLFDS---TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 70 ~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
+|.+++... .....+++..++.++.||+.||.|||++| ++|+||||+||+++.++.+||+|||++.........
T Consensus 127 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~ 203 (313)
T 3brb_A 127 DLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203 (313)
T ss_dssp BHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC---------
T ss_pred CHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceeccccccc
Confidence 999998543 23356999999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ..... ......
T Consensus 204 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~~-~~~~~~------- 269 (313)
T 3brb_A 204 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM------YDYLL-HGHRLK------- 269 (313)
T ss_dssp -------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------HHHHH-TTCCCC-------
T ss_pred CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHH-cCCCCC-------
Confidence 22333456778999999998889999999999999999999 8888865433211 11111 111111
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLP 269 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~ 269 (308)
.+......+.+++.+||+.||++|||+.++++.|+.....+|
T Consensus 270 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 270 --QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp --CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 111122358889999999999999999999999987644443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=292.53 Aligned_cols=247 Identities=25% Similarity=0.311 Sum_probs=186.0
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhc--CCCcCccceeeeEEeC----CeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK--LQHKNLVRLFGCCLEE----NESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|+. +|+.||||++... ....+..|.+++.. ++||||+++++++.+. ...++||||+++++|.++
T Consensus 21 ~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 96 (301)
T 3q4u_A 21 YGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY 96 (301)
T ss_dssp SEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHH
T ss_pred CcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHH
Confidence 799999988 7999999998543 33455566666666 7899999999986643 457999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhch--------hCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLH--------EDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
+.. ..+++..++.++.|++.||+||| +.| ++|+||||+||+++.++.+||+|||++.........
T Consensus 97 l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 169 (301)
T 3q4u_A 97 LQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169 (301)
T ss_dssp HTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred Hhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeeccccccc
Confidence 832 35899999999999999999999 776 999999999999999999999999999876543322
Q ss_pred c--ccceeecccCccCchhhccC------cccccccchhhhHHHHHHHhC----------CcCCCccccccccchhHHHH
Q 021771 147 A--NTNRIVGTYGYMAPEYAMEG------LFSVKSDVFSFGVLLLEIISG----------KKNTGFYLSELGQSLLSYTW 208 (308)
Q Consensus 147 ~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~~----------~~p~~~~~~~~~~~~~~~~~ 208 (308)
. ......|+..|+|||++.+. .++.++||||||+++|+|++| ..||......... .....
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~--~~~~~ 247 (301)
T 3q4u_A 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS--FEDMR 247 (301)
T ss_dssp EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHH
T ss_pred ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc--hhhhh
Confidence 1 12234689999999998876 566799999999999999999 6666433222111 11111
Q ss_pred Hhhhc-ccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 209 KLWCE-GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 209 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..... ...... ............+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 248 ~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 248 KVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11111 111111 11112334566799999999999999999999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=311.77 Aligned_cols=236 Identities=28% Similarity=0.381 Sum_probs=189.3
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC-eEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN-ESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+|+.. |+.||||+++... ..+.+.+|+.+|+.++||||+++++++.+.. ..++||||+++++|.+++....
T Consensus 206 fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~ 282 (450)
T 1k9a_A 206 FGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282 (450)
T ss_dssp SEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHC
T ss_pred CeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcC
Confidence 7999999884 7899999996543 4578899999999999999999999987765 6899999999999999996542
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
...+++..++.++.||+.||+|||++| ++||||||+||+++.++.+||+|||++...... .....++..|+
T Consensus 283 -~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~ 353 (450)
T 1k9a_A 283 -RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWT 353 (450)
T ss_dssp -TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTS
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCccee
Confidence 234788999999999999999999998 999999999999999999999999999864322 11124578899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
|||++.+..++.++||||||+++|+|++ |..||....... .... ...+... ..+......+.+
T Consensus 354 aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~~~---------~~p~~~~~~l~~ 417 (450)
T 1k9a_A 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKM---------DAPDGCPPAVYD 417 (450)
T ss_dssp CHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHHH----HHTTCCC---------CCCTTCCHHHHH
T ss_pred CHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCCC---------CCCCcCCHHHHH
Confidence 9999999999999999999999999998 999986543221 1111 1111100 111122345888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
|+.+||+.||++|||+.+|++.|+..
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999999999999999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.42 Aligned_cols=240 Identities=20% Similarity=0.268 Sum_probs=187.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .......+.+|+.+++.+. ||||+++++++.+....++||||+.+++|.+++.
T Consensus 42 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 121 (327)
T 3lm5_A 42 FAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL 121 (327)
T ss_dssp TEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGS
T ss_pred CeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHH
Confidence 799999996 57999999998654 3445678899999999995 6999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC---CCCeeeecccceeeeCCCCCccccceee
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH---EMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
.. ....+++..++.++.||+.||+|||++| ++|+||||+||+++. ++.+||+|||++....... ......
T Consensus 122 ~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~ 194 (327)
T 3lm5_A 122 PE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIM 194 (327)
T ss_dssp SC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------C
T ss_pred Hh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc---cccccc
Confidence 42 2346899999999999999999999998 999999999999998 7899999999998764322 122346
Q ss_pred cccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
++..|+|||++.+..++.++||||||+++|+|++|..||......... ..... ... .. .........
T Consensus 195 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~-~~~-~~-----~~~~~~~~~ 261 (327)
T 3lm5_A 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY------LNISQ-VNV-DY-----SEETFSSVS 261 (327)
T ss_dssp CCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-TCC-CC-----CTTTTTTSC
T ss_pred CCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH------HHHHh-ccc-cc-----CchhhcccC
Confidence 889999999999889999999999999999999999999654322110 00000 000 00 001111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+.+|+.+||+.||++|||++++++-
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 262 QLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 358889999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.20 Aligned_cols=241 Identities=23% Similarity=0.296 Sum_probs=187.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||+|++.... ....+.+..|..+++.+ +||||+++++++.+....++||||+++++|.+++
T Consensus 22 fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l 101 (345)
T 3a8x_A 22 YAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 101 (345)
T ss_dssp SEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 799999996 579999999997542 33456688999999988 7999999999999999999999999999999988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++....... .......|+
T Consensus 102 ~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt 173 (345)
T 3a8x_A 102 QRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGT 173 (345)
T ss_dssp HHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSC
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCC
Confidence 543 34899999999999999999999998 9999999999999999999999999997643221 123345789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcccccccc--chhHHHHHhhhcccccccccccccccchHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQ--SLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+.|+|||++.+..++.++|||||||++|+|++|..||......... ............... . .+....
T Consensus 174 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~---------~p~~~s 243 (345)
T 3a8x_A 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R---------IPRSLS 243 (345)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-C---------CCTTSC
T ss_pred ccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-C---------CCCCCC
Confidence 9999999999888999999999999999999999999643221110 001111111111110 0 111123
Q ss_pred HHHHHHHhhcccCCCCCCCCH------HHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTM------SSVVV 259 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~------~eil~ 259 (308)
..+.+|+.+||+.||++||++ +++++
T Consensus 244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 358889999999999999996 56663
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=297.39 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=195.1
Q ss_pred CCccEEeeeC---CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++.. ++..||+|++.... ....+.+.+|+.+++.++||||+++++++. .+..++||||+++++|.+++.
T Consensus 23 ~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~ 101 (287)
T 1u59_A 23 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLV 101 (287)
T ss_dssp TEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHT
T ss_pred ceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEEeCCCCCHHHHHH
Confidence 7899999853 68889999997653 345678899999999999999999999994 557899999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccceeecc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRIVGT 155 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~ 155 (308)
.. ...+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++......... .......++
T Consensus 102 ~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 176 (287)
T 1u59_A 102 GK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176 (287)
T ss_dssp TC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCC
T ss_pred hC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccccccc
Confidence 43 345899999999999999999999998 999999999999999999999999999887533221 112223457
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||++.+..++.++||||||+++|+|++ |..||........ . .......... .+.....
T Consensus 177 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~----~~i~~~~~~~---------~~~~~~~ 240 (287)
T 1u59_A 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---M----AFIEQGKRME---------CPPECPP 240 (287)
T ss_dssp GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---H----HHHHTTCCCC---------CCTTCCH
T ss_pred ccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---H----HHHhcCCcCC---------CCCCcCH
Confidence 88999999988889999999999999999998 9999865432211 1 1111111111 1112234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLP 269 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~ 269 (308)
.+.+++.+||+.||++|||+.++++.|+.......
T Consensus 241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 241 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 58889999999999999999999999987644433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=304.46 Aligned_cols=257 Identities=20% Similarity=0.280 Sum_probs=197.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC--eEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN--ESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.. ..++||||+++++|.+++.
T Consensus 22 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 101 (396)
T 4eut_A 22 TANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE 101 (396)
T ss_dssp SEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTT
T ss_pred CeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHH
Confidence 799999996 469999999997543 345677889999999999999999999998765 6799999999999999996
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe----CCCCCeeeecccceeeeCCCCCcccccee
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL----NHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
.......+++..++.++.||+.||+|||++| |+||||||+||++ +.++.+||+|||++....... .....
T Consensus 102 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~ 175 (396)
T 4eut_A 102 EPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSL 175 (396)
T ss_dssp SGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCS
T ss_pred hhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccc
Confidence 6544445999999999999999999999998 9999999999999 777789999999998764322 22234
Q ss_pred ecccCccCchhhcc--------CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcc--ccccccc-
Q 021771 153 VGTYGYMAPEYAME--------GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEG--EALELME- 221 (308)
Q Consensus 153 ~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~- 221 (308)
.|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......... .......... .......
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~ 253 (396)
T 4eut_A 176 YGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKIITGKPSGAISGVQK 253 (396)
T ss_dssp SSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHHHHSCCTTCCEEEEC
T ss_pred cCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHHhcCCCcccchhhee
Confidence 68999999998865 567889999999999999999999996543322111 1111111110 0000000
Q ss_pred -----------ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 222 -----------PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 222 -----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
..............+.+++.+||+.||++|||+.++++.+....
T Consensus 254 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 254 AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 00111233556677889999999999999999999998886653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=304.56 Aligned_cols=238 Identities=22% Similarity=0.336 Sum_probs=181.2
Q ss_pred CCccEEeeeCCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCC--cCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQH--KNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++...+++.||+|++... .....+.+.+|+.+|+.++| +||+++++++.+++..++|||+ .+++|.+++.
T Consensus 22 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~ 100 (343)
T 3dbq_A 22 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK 100 (343)
T ss_dssp SEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHH
T ss_pred CeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHH
Confidence 79999999889999999998654 33345678899999999986 9999999999999999999995 5789999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.||+.||+|||++| |+||||||+||+++ ++.+||+|||++..+.............|++
T Consensus 101 ~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 173 (343)
T 3dbq_A 101 KK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173 (343)
T ss_dssp HS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCC
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCc
Confidence 53 35899999999999999999999998 99999999999997 5789999999998765433332333457899
Q ss_pred CccCchhhcc-----------CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 157 GYMAPEYAME-----------GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 157 ~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..............
T Consensus 174 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~-------- 240 (343)
T 3dbq_A 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHEI-------- 240 (343)
T ss_dssp SSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCTTSCC--------
T ss_pred CcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHhcCCccc--------
Confidence 9999999865 56888999999999999999999999643221 11111111110000
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+......+.+|+.+||+.||++|||+.|+++.
T Consensus 241 -~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 241 -EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0011112357889999999999999999999854
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.44 Aligned_cols=243 Identities=21% Similarity=0.186 Sum_probs=186.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-----CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-----SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+++. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.++
T Consensus 39 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~ 118 (345)
T 3hko_A 39 YGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK 118 (345)
T ss_dssp SCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred CeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHH
Confidence 799999995 68999999998543 345567899999999999999999999999999999999999999999998
Q ss_pred hhcCC-------------------------------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCC
Q 021771 75 LFDST-------------------------------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117 (308)
Q Consensus 75 l~~~~-------------------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~ 117 (308)
+.... ....+++..++.++.||+.||+|||++| ++|+|||
T Consensus 119 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 195 (345)
T 3hko_A 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIK 195 (345)
T ss_dssp EEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred HHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCC
Confidence 85210 1223467788999999999999999998 9999999
Q ss_pred CCceEeCCCC--CeeeecccceeeeCCCCCc--cccceeecccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcC
Q 021771 118 ASNVLLNHEM--NPKISDFGMARIFGGNQSE--ANTNRIVGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKN 191 (308)
Q Consensus 118 p~nilv~~~~--~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p 191 (308)
|+||+++.++ .+||+|||++..+...... .......++..|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 196 p~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p 275 (345)
T 3hko_A 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275 (345)
T ss_dssp GGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred hhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999998776 7999999999876432211 12234568899999999875 6788999999999999999999999
Q ss_pred CCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 192 TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
|....... ............. . .........+.+|+.+||+.||++|||+.++++
T Consensus 276 f~~~~~~~------~~~~~~~~~~~~~--~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 276 FPGVNDAD------TISQVLNKKLCFE--N-----PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp SCCSSHHH------HHHHHHHCCCCTT--S-----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred CCCCChHH------HHHHHHhcccccC--C-----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 96443221 1111111110000 0 001112335888999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.04 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=193.4
Q ss_pred CCccEEeee-----CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC--eEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-----ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN--ESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.... ..++||||+++++|.+
T Consensus 54 ~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 133 (326)
T 2w1i_A 54 FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133 (326)
T ss_dssp SEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHH
T ss_pred CeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHH
Confidence 789999983 479999999998766666778999999999999999999999987654 6899999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-ccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 152 (308)
++.... ..+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++......... ......
T Consensus 134 ~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~ 208 (326)
T 2w1i_A 134 YLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 208 (326)
T ss_dssp HHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCC
T ss_pred HHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCC
Confidence 996543 34899999999999999999999998 999999999999999999999999999886543221 112223
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccc---------cchhHHHHHhhhccccccccccc
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELG---------QSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
.++..|+|||.+.+..++.++||||||+++|+|++|..|+........ ................
T Consensus 209 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 281 (326)
T 2w1i_A 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR------- 281 (326)
T ss_dssp SCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC-------
T ss_pred CCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCC-------
Confidence 456779999999888899999999999999999999988754321100 0000000000100000
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
...+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 282 --~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 282 --LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011112234588899999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=303.38 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=182.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe----EEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE----SLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+|+.||||++.... ......+.+|+.+++.++||||+++++++..... .++||||+++++|.
T Consensus 25 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~ 104 (311)
T 3ork_A 25 MSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR 104 (311)
T ss_dssp SEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHH
T ss_pred CEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHH
Confidence 799999995 689999999997553 2334578899999999999999999999886543 49999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 151 (308)
+++... ..+++..++.++.|++.+|+|||++| ++|+||||+||+++.++.+||+|||++..+...... .....
T Consensus 105 ~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 178 (311)
T 3ork_A 105 DIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178 (311)
T ss_dssp HHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---------------
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccc
Confidence 998643 34899999999999999999999998 999999999999999999999999999876433221 22233
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..|+..|+|||++.+..++.++||||||+++|+|++|..||...... .............. ......
T Consensus 179 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~-------~~~~~~ 245 (311)
T 3ork_A 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPP-------SARHEG 245 (311)
T ss_dssp ---CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCH-------HHHSTT
T ss_pred cCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCCc-------ccccCC
Confidence 46899999999999989999999999999999999999999644322 11111111111100 000011
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHH-HHhhcC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVV-VMLASD 264 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil-~~L~~~ 264 (308)
....+.+++.+||+.||++||++.+++ +.|...
T Consensus 246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 233588899999999999999666555 455443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=295.17 Aligned_cols=239 Identities=22% Similarity=0.320 Sum_probs=189.0
Q ss_pred CCccEEeeeC-CC-------CEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLA-DG-------KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||+||+++.. ++ ..||+|++........+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.
T Consensus 21 ~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 100 (289)
T 4fvq_A 21 FTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100 (289)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHH
T ss_pred CceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHH
Confidence 7999999854 34 479999997766677788999999999999999999999999999999999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC--------eeeecccceeeeCCCC
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN--------PKISDFGMARIFGGNQ 144 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~--------~kl~dfg~~~~~~~~~ 144 (308)
+++... ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++. +||+|||++.....
T Consensus 101 ~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~-- 173 (289)
T 4fvq_A 101 TYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-- 173 (289)
T ss_dssp HHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC--
T ss_pred HHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccCcccccccC--
Confidence 999653 234899999999999999999999998 999999999999998887 99999999854321
Q ss_pred CccccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCc-CCCccccccccchhHHHHHhhhcccccccccc
Q 021771 145 SEANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKK-NTGFYLSELGQSLLSYTWKLWCEGEALELMEP 222 (308)
Q Consensus 145 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (308)
.....++..|+|||++.+ ..++.++||||||+++|+|++|.. |+........ .............
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~------~~~~~~~~~~~~~--- 240 (289)
T 4fvq_A 174 ----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK------LQFYEDRHQLPAP--- 240 (289)
T ss_dssp ----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHHHHTTCCCCCC---
T ss_pred ----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH------HHHhhccCCCCCC---
Confidence 122356888999999887 678999999999999999999654 4433221110 0000001111110
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
....+.+|+.+||+.||++|||++++++.|+....+.
T Consensus 241 ---------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 241 ---------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp ---------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 0124788899999999999999999999999875533
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=295.94 Aligned_cols=237 Identities=21% Similarity=0.267 Sum_probs=190.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc------ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+
T Consensus 25 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (321)
T 2a2a_A 25 FAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104 (321)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHH
Confidence 799999996 5799999999865432 246789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC----CeeeecccceeeeCCCCCcccc
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM----NPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~----~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
++... ..+++..++.++.|++.||+|||++| ++|+||||+||+++.++ .++|+|||++........ .
T Consensus 105 ~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~ 175 (321)
T 2a2a_A 105 FLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---F 175 (321)
T ss_dssp HHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---C
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---c
Confidence 98543 35899999999999999999999998 99999999999999888 799999999987653321 2
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
....++..|+|||++.+..++.++||||||+++|+|++|..||....... ...... .... . ... ...
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~-~~~~-~-~~~----~~~ 242 (321)
T 2a2a_A 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANIT-SVSY-D-FDE----EFF 242 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHH-TTCC-C-CCH----HHH
T ss_pred cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hccc-c-cCh----hhh
Confidence 23467899999999988889999999999999999999999986432221 011110 0000 0 000 001
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
......+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 112245888999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.31 Aligned_cols=246 Identities=28% Similarity=0.412 Sum_probs=193.2
Q ss_pred CCccEEeeeC-CC-----CEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLA-DG-----KEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~-~g-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++.. +| +.||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.+++..++||||+++++|.
T Consensus 59 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~ 138 (333)
T 2i1m_A 59 FGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138 (333)
T ss_dssp SEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHH
T ss_pred CcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHH
Confidence 7899999853 33 479999986553 34567789999999999 8999999999999999999999999999999
Q ss_pred hHhhcCCC-----------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeC
Q 021771 73 VFLFDSTR-----------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFG 141 (308)
Q Consensus 73 ~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~ 141 (308)
+++..... ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++....
T Consensus 139 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 215 (333)
T 2i1m_A 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215 (333)
T ss_dssp HHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGG
T ss_pred HHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccc
Confidence 99865321 235789999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccc
Q 021771 142 GNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELM 220 (308)
Q Consensus 142 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (308)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ...........
T Consensus 216 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~--- 286 (333)
T 2i1m_A 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK------FYKLVKDGYQM--- 286 (333)
T ss_dssp GCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH------HHHHHHHTCCC---
T ss_pred cccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH------HHHHHhcCCCC---
Confidence 3333222333456788999999988889999999999999999998 8889865432210 01111111000
Q ss_pred cccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 221 EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 287 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 287 ------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 00111123588899999999999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=292.80 Aligned_cols=246 Identities=27% Similarity=0.424 Sum_probs=180.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+++..+ .+|+|++.... ....+.+.+|+.+++.++|+||++++++. .....++||||+++++|.+++...
T Consensus 37 ~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~ 113 (289)
T 3og7_A 37 FGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHAS 113 (289)
T ss_dssp SEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC
T ss_pred CeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhc
Confidence 78999998643 59999986543 34457789999999999999999999965 455789999999999999988543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+++..++.++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++................++..|
T Consensus 114 --~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 188 (289)
T 3og7_A 114 --ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188 (289)
T ss_dssp -----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTT
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccc
Confidence 345899999999999999999999998 999999999999999999999999999865433323333345689999
Q ss_pred cCchhhc---cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 159 MAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 159 ~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+|||++. +..++.++||||||+++|+|++|..||....... ................. ........
T Consensus 189 ~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~-----~~~~~~~~ 257 (289)
T 3og7_A 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPDLSK-----VRSNCPKR 257 (289)
T ss_dssp CCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCCTTS-----SCTTSCHH
T ss_pred cCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcchhh-----ccccCCHH
Confidence 9999886 5668889999999999999999999996543221 11111111111111110 01112345
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
+.+|+.+||+.||++|||+.++++.|+...
T Consensus 258 l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 258 MKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 888999999999999999999999998764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.68 Aligned_cols=252 Identities=19% Similarity=0.233 Sum_probs=186.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|..++..
T Consensus 16 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~ 95 (311)
T 4agu_A 16 YGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY 95 (311)
T ss_dssp SEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT
T ss_pred CeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh
Confidence 789999996 569999999986543 23356678999999999999999999999999999999999999999988754
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ..+++..+..++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++......... .....++..
T Consensus 96 ~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~ 167 (311)
T 4agu_A 96 Q---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRW 167 (311)
T ss_dssp S---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GG
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCcc
Confidence 3 34899999999999999999999998 999999999999999999999999999876432221 223467889
Q ss_pred ccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHH--------HHHhhhccccccc---cccccc
Q 021771 158 YMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSY--------TWKLWCEGEALEL---MEPVLK 225 (308)
Q Consensus 158 y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~---~~~~~~ 225 (308)
|+|||++.+ ..++.++||||||+++|+|++|..||.............. ....+........ .++...
T Consensus 168 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 4agu_A 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDM 247 (311)
T ss_dssp GCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSC
T ss_pred ccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCcccc
Confidence 999998876 5679999999999999999999999965443321111100 0000111000000 000000
Q ss_pred ---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 226 ---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 226 ---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..........+.+|+.+||+.||++|||++|+++-
T Consensus 248 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 248 EPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred chhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00001223458889999999999999999999953
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=293.71 Aligned_cols=241 Identities=24% Similarity=0.318 Sum_probs=179.9
Q ss_pred CCccEEeeeC----CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||++... .+..||+|++... .....+.+.+|+.+++.++||||+++++++. ++..++||||+++++|.+++
T Consensus 28 ~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l 106 (281)
T 1mp8_A 28 FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFL 106 (281)
T ss_dssp SSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHH
T ss_pred CeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHH
Confidence 7999999864 2557999998654 3345667899999999999999999999985 45789999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ...+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++......... ......++
T Consensus 107 ~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~ 180 (281)
T 1mp8_A 107 QVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLP 180 (281)
T ss_dssp HHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CC
T ss_pred Hhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCc
Confidence 653 235899999999999999999999998 999999999999999999999999999876433221 12223456
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||++.+..++.++||||||+++|+|++ |..||........ .. .. ....... .+.....
T Consensus 181 ~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~---~i-~~~~~~~---------~~~~~~~ 244 (281)
T 1mp8_A 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG---RI-ENGERLP---------MPPNCPP 244 (281)
T ss_dssp GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH---HH-HTTCCCC---------CCTTCCH
T ss_pred ccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH---HH-HcCCCCC---------CCCCCCH
Confidence 78999999988889999999999999999996 8899865433211 11 11 1111110 1111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+.+++.+||+.||++|||+.++++.|+..
T Consensus 245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 588899999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=296.89 Aligned_cols=247 Identities=21% Similarity=0.325 Sum_probs=185.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.
T Consensus 45 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 124 (310)
T 2wqm_A 45 FSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124 (310)
T ss_dssp -CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHH
T ss_pred CceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHH
Confidence 799999995 68999999998653 33455678899999999999999999999999999999999999999999886
Q ss_pred cC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. .....+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++......... .....++
T Consensus 125 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~ 199 (310)
T 2wqm_A 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGT 199 (310)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------------------C
T ss_pred HhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc--ccccCCC
Confidence 42 22345899999999999999999999998 999999999999999999999999998765432211 2234678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||.+.+..++.++||||||+++|+|++|..||....... .... ............. . .....
T Consensus 200 ~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~-~~~~~~~~~~~~~----~----~~~~~ 266 (310)
T 2wqm_A 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLC-KKIEQCDYPPLPS----D----HYSEE 266 (310)
T ss_dssp CSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH----HHHH-HHHHTTCSCCCCT----T----TSCHH
T ss_pred eeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH----HHHH-HHhhcccCCCCcc----c----ccCHH
Confidence 89999999988889999999999999999999999985432211 1111 1111111111110 1 12235
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
+.+|+.+||+.||++|||+++|++.|+...
T Consensus 267 l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 888999999999999999999999998763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=289.22 Aligned_cols=240 Identities=26% Similarity=0.473 Sum_probs=186.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCccc-------HHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQG-------LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||+||+++. .+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+.. ++||||+++++|.
T Consensus 32 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~ 109 (287)
T 4f0f_A 32 FGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLY 109 (287)
T ss_dssp SSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHH
T ss_pred ceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHH
Confidence 799999996 689999999986543221 267889999999999999999999997665 6999999999998
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC-----eeeecccceeeeCCCCCcc
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN-----PKISDFGMARIFGGNQSEA 147 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~-----~kl~dfg~~~~~~~~~~~~ 147 (308)
+++... ...+++..++.++.|++.||+|||++| ..++|+||||+||+++.++. +||+|||++.....
T Consensus 110 ~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~----- 181 (287)
T 4f0f_A 110 HRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----- 181 (287)
T ss_dssp HHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----
T ss_pred HHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----
Confidence 887553 335899999999999999999999984 23999999999999988776 99999999875332
Q ss_pred ccceeecccCccCchhhc--cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 148 NTNRIVGTYGYMAPEYAM--EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
......++..|+|||++. ...++.++||||||+++|+|++|..||......... ......... ... ..
T Consensus 182 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~-~~~----~~- 251 (287)
T 4f0f_A 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FINMIREEG-LRP----TI- 251 (287)
T ss_dssp CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHHHHHHSC-CCC----CC-
T ss_pred cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHHHHhccC-CCC----CC-
Confidence 223346789999999884 456788999999999999999999999654332111 011111111 110 11
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+......+.+++.+||+.||++|||++++++.|+.
T Consensus 252 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 252 ---PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11122358889999999999999999999999975
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=306.23 Aligned_cols=259 Identities=20% Similarity=0.204 Sum_probs=197.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .....+.+.+|..+++.++||||+++++++.+...+++|||||++++|.+++.
T Consensus 82 fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~ 161 (410)
T 3v8s_A 82 FGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 161 (410)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred CEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 799999996 47999999998642 12233557899999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||++........ .......|++
T Consensus 162 ~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~ 233 (410)
T 3v8s_A 162 N----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTP 233 (410)
T ss_dssp H----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCG
T ss_pred c----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCc
Confidence 4 24899999999999999999999998 99999999999999999999999999987653321 1223457899
Q ss_pred CccCchhhccCc----ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 157 GYMAPEYAMEGL----FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 157 ~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.|+|||++.+.. ++.++|||||||++|+|++|..||....... ................ ....
T Consensus 234 ~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~p~-------~~~~ 300 (410)
T 3v8s_A 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHKNSLTFPD-------DNDI 300 (410)
T ss_dssp GGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHHHHCCCCT-------TCCC
T ss_pred cccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HHHHHHhccccccCCC-------cccc
Confidence 999999987654 7899999999999999999999996433221 1111111000000000 0011
Q ss_pred HHHHHHHHhhcccCCCCC--CCCHHHHHHH--hhcCC------CCCCCCCCCCcccCc
Q 021771 233 LLKFIHIGLLCVQADSAD--RPTMSSVVVM--LASDT------VTLPQPTEPAFSVGR 280 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~--RPs~~eil~~--L~~~~------~~~~~~~~p~~~~~~ 280 (308)
...+.+||.+||+.+|++ ||+++||++- +.... ...++|-.|......
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~ 358 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDI 358 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTT
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCCCCcCCCcc
Confidence 235888889999988988 9999999964 23221 234566666654433
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=307.10 Aligned_cols=238 Identities=22% Similarity=0.344 Sum_probs=182.2
Q ss_pred CCccEEeeeCCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCC--CcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQ--HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||++...+|+.||||++... .....+.+.+|+.+|+.++ |+||+++++++..++..++||| +.+++|.+++.
T Consensus 69 fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~ 147 (390)
T 2zmd_A 69 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK 147 (390)
T ss_dssp SEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHH
T ss_pred CeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHH
Confidence 79999999878999999998654 3345577899999999996 5999999999999999999999 56889999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... .+++..+..++.||+.||.|||++| |+||||||+|||++ ++.+||+|||++..+.............|++
T Consensus 148 ~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~ 220 (390)
T 2zmd_A 148 KKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220 (390)
T ss_dssp HCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCG
T ss_pred hcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCC
Confidence 543 5888999999999999999999998 99999999999995 5789999999998765333222233457899
Q ss_pred CccCchhhcc-----------CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 157 GYMAPEYAME-----------GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 157 ~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.|+|||++.+ ..++.++|||||||++|+|++|..||...... ................ .
T Consensus 221 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~~~~~~~~~-~---- 290 (390)
T 2zmd_A 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNHEIEF-P---- 290 (390)
T ss_dssp GGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHCTTSCCCC-C----
T ss_pred CccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHhCccccCCC-C----
Confidence 9999998865 36888999999999999999999999643211 1111111111100000 0
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 291 ~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 291 DI----PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc----chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 01 12357889999999999999999999954
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=290.12 Aligned_cols=237 Identities=22% Similarity=0.276 Sum_probs=188.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||++.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+.+..
T Consensus 19 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~ 98 (284)
T 3kk8_A 19 FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA 98 (284)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred CeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh
Confidence 789999986 57999999998654 334456788999999999999999999999999999999999999999888854
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC---eeeecccceeeeCCCCCccccceeec
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN---PKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
. ..+++..+..++.|++.||+|||++| ++|+||||+||+++.++. +||+|||++........ .....+
T Consensus 99 ~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~ 169 (284)
T 3kk8_A 99 R---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169 (284)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCS
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCC
Confidence 3 34899999999999999999999998 999999999999987665 99999999987643221 223467
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
+..|+|||++.+..++.++||||||+++|+|++|..||........ .... ..... ....+ .......
T Consensus 170 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~-~~~~~-~~~~~-----~~~~~~~ 236 (284)
T 3kk8_A 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YAQI-KAGAY-DYPSP-----EWDTVTP 236 (284)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHH-HHTCC-CCCTT-----TTTTSCH
T ss_pred CcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH------HHHH-Hhccc-cCCch-----hhcccCH
Confidence 8999999999988899999999999999999999999854332211 1111 01100 00000 0011123
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHcccChhhCCCHHHHhc
Confidence 5788999999999999999999996
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=302.37 Aligned_cols=268 Identities=15% Similarity=0.161 Sum_probs=195.4
Q ss_pred CCccEEeeeCC------CCEEEEEEeccCCcccH-----------HHHHHHHHHHhcCCCcCccceeeeEEeC----CeE
Q 021771 1 MESCLQGKLAD------GKEIAVKRLSRTSGQGL-----------QEFKNEVTLIAKLQHKNLVRLFGCCLEE----NES 59 (308)
Q Consensus 1 ~g~v~~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~~ 59 (308)
||.||++...+ ++.||||++........ .....|+..++.++|+||+++++++... ...
T Consensus 48 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~ 127 (364)
T 3op5_A 48 FGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR 127 (364)
T ss_dssp CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEE
T ss_pred CeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceE
Confidence 79999998754 58899999865532111 1223455667778899999999998764 458
Q ss_pred EEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC--CCCCeeeecccce
Q 021771 60 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN--HEMNPKISDFGMA 137 (308)
Q Consensus 60 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~--~~~~~kl~dfg~~ 137 (308)
++||||+ +++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++
T Consensus 128 ~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a 201 (364)
T 3op5_A 128 FMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201 (364)
T ss_dssp EEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTTCEEECCCTTC
T ss_pred EEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCCeEEEEECCcc
Confidence 9999999 99999998653 235999999999999999999999998 99999999999999 8899999999999
Q ss_pred eeeCCCCCcc-----ccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh
Q 021771 138 RIFGGNQSEA-----NTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC 212 (308)
Q Consensus 138 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 212 (308)
..+....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ........ .
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~--~~~~~~~~-~ 278 (364)
T 3op5_A 202 YRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK--YVRDSKIR-Y 278 (364)
T ss_dssp EESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--HHHHHHHH-H
T ss_pred eecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH--HHHHHHHH-h
Confidence 8765322111 11234589999999999998899999999999999999999999975322211 11111111 1
Q ss_pred cccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCcccCc
Q 021771 213 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVGR 280 (308)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~~~p~~~~~~ 280 (308)
.......++..+.. ......+.+++..||+.+|++|||+.+|++.|+...............+..
T Consensus 279 ~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 343 (364)
T 3op5_A 279 RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSV 343 (364)
T ss_dssp HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC--
T ss_pred hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEe
Confidence 11122222211111 111235888889999999999999999999998776555555544444443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=302.47 Aligned_cols=233 Identities=22% Similarity=0.284 Sum_probs=188.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++++|.+++
T Consensus 30 fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 109 (345)
T 1xjd_A 30 FGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 109 (345)
T ss_dssp SSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 799999996 579999999996542 34556788899999887 8999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.||+.||+|||++| |+||||||+||+++.+|.+||+|||++....... .......|+
T Consensus 110 ~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt 181 (345)
T 1xjd_A 110 QSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGT 181 (345)
T ss_dssp HHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSC
T ss_pred HHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--CcccCCCCC
Confidence 643 34899999999999999999999998 9999999999999999999999999997643221 123345789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+.|+|||++.+..++.++|||||||++|+|++|..||....... ......... . . . +......
T Consensus 182 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~-~-~-----~----p~~~s~~ 244 (345)
T 1xjd_A 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDN-P-F-----Y----PRWLEKE 244 (345)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCC-C-C-----C----CTTSCHH
T ss_pred cccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHhCC-C-C-----C----CcccCHH
Confidence 99999999999889999999999999999999999996443221 111111110 0 0 0 1112235
Q ss_pred HHHHHhhcccCCCCCCCCHH-HHH
Q 021771 236 FIHIGLLCVQADSADRPTMS-SVV 258 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~-eil 258 (308)
+.+|+.+||+.||++||++. +|+
T Consensus 245 ~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 245 AKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred HHHHHHHHhcCCHhHcCCChHHHH
Confidence 88899999999999999998 776
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=300.28 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=193.6
Q ss_pred CCccEEeee------CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCC-eEEEEEEecCCCCh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEEN-ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L 71 (308)
||+||+++. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++...+ ..++||||+++++|
T Consensus 40 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L 119 (316)
T 2xir_A 40 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119 (316)
T ss_dssp SEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEH
T ss_pred ceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcH
Confidence 789999973 467899999997553 33456788999999999 6999999999988755 48999999999999
Q ss_pred hhHhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeeccccee
Q 021771 72 DVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR 138 (308)
Q Consensus 72 ~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~ 138 (308)
.+++..... ...+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++.
T Consensus 120 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 196 (316)
T 2xir_A 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR 196 (316)
T ss_dssp HHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred HHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCcccc
Confidence 999976432 122889999999999999999999998 9999999999999999999999999998
Q ss_pred eeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccc
Q 021771 139 IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEAL 217 (308)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (308)
...............++..|+|||++.+..++.++||||||+++|+|++ |..||....... ............
T Consensus 197 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~~~~~~ 270 (316)
T 2xir_A 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRM 270 (316)
T ss_dssp CTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHHHHHHTCCC
T ss_pred ccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH------HHHHHhccCccC
Confidence 7654433333344567889999999998899999999999999999998 999986543221 011111111111
Q ss_pred ccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 218 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.. +......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 271 ~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 271 RA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 10 111223588899999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=295.23 Aligned_cols=231 Identities=23% Similarity=0.233 Sum_probs=177.6
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCC--cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+|+.. +|+.||||++.... .........|+..+..+ +|+||+++++++.+++..++||||+ +++|.+++.
T Consensus 70 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~ 148 (311)
T 3p1a_A 70 YGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCE 148 (311)
T ss_dssp TEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHH
T ss_pred CeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHH
Confidence 7999999964 89999999986542 23334455555555555 8999999999999999999999999 668888876
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... ..+++..++.++.||+.||+|||++| |+|+||||+||+++.++.+||+|||++....... ......|+.
T Consensus 149 ~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~ 220 (311)
T 3p1a_A 149 AWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDP 220 (311)
T ss_dssp HHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCG
T ss_pred hcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCc
Confidence 542 35999999999999999999999998 9999999999999999999999999998764322 122345889
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+ .++.++|||||||++|+|++|..++..... ......... ...........+
T Consensus 221 ~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~--------~~~~~~~~~~~l 281 (311)
T 3p1a_A 221 RYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYL--------PPEFTAGLSSEL 281 (311)
T ss_dssp GGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCC--------CHHHHTTSCHHH
T ss_pred cccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCC--------CcccccCCCHHH
Confidence 9999998876 689999999999999999999766532111 011111100 011111223458
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.||++|||++|+++
T Consensus 282 ~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 282 RSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHHh
Confidence 89999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=288.68 Aligned_cols=253 Identities=17% Similarity=0.198 Sum_probs=194.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeE-EeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCC-LEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.||+|++...... ..+.+|+.+++.++|++++..+..+ ..+...++||||+ +++|.+++...
T Consensus 22 ~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~ 98 (296)
T 3uzp_A 22 FGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC 98 (296)
T ss_dssp TEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred CeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhh
Confidence 789999995 78999999998654332 4688999999999988766665555 5667789999999 88999998643
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC---CCCCeeeecccceeeeCCCCCcc-----ccc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN---HEMNPKISDFGMARIFGGNQSEA-----NTN 150 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~---~~~~~kl~dfg~~~~~~~~~~~~-----~~~ 150 (308)
. ..+++..++.++.|++.||+|||++| ++|+||||+||+++ .++.+||+|||++.......... ...
T Consensus 99 ~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 173 (296)
T 3uzp_A 99 S--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173 (296)
T ss_dssp T--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSC
T ss_pred c--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccc
Confidence 3 35899999999999999999999998 99999999999994 78899999999998865443211 123
Q ss_pred eeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 151 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
...++..|+|||++.+..++.++||||||+++|+|++|..||......................... ....
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~---- 244 (296)
T 3uzp_A 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-----VLCK---- 244 (296)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-----HHTT----
T ss_pred ccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-----HHHh----
Confidence 4568999999999999889999999999999999999999997654333222222111111000000 0001
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCCC
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQ 270 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~ 270 (308)
.....+.+++.+||+.||++|||+++|++.|+........
T Consensus 245 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 245 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 1123588899999999999999999999999876544443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=300.12 Aligned_cols=236 Identities=22% Similarity=0.288 Sum_probs=173.9
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+++.. +++.||||++.... ..+.+.+|+.+|+.++||||+++++++.+....++||||+++++|.+++..
T Consensus 66 ~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-- 141 (349)
T 2w4o_A 66 TSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE-- 141 (349)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT--
T ss_pred CEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh--
Confidence 7999999964 68999999986543 345688999999999999999999999999999999999999999998854
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC---CCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH---EMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
...+++..++.++.||+.||.|||++| ++|+||||+||+++. ++.+||+|||++....... ......|+.
T Consensus 142 -~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~ 214 (349)
T 2w4o_A 142 -KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTP 214 (349)
T ss_dssp -CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CG
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCC
Confidence 335899999999999999999999998 999999999999975 7889999999998654221 122346789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||....... ........... ....+ ........+
T Consensus 215 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~-~~~~~-----~~~~~~~~~ 282 (349)
T 2w4o_A 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEY-YFISP-----WWDEVSLNA 282 (349)
T ss_dssp GGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCC-CCCTT-----TTTTSCHHH
T ss_pred CccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCC-ccCCc-----hhhhCCHHH
Confidence 9999999998889999999999999999999999985433221 00111111110 00000 011123358
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+|+.+||+.||++|||+.++++
T Consensus 283 ~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 283 KDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHhc
Confidence 88999999999999999999987
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=300.38 Aligned_cols=258 Identities=21% Similarity=0.250 Sum_probs=183.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+++. .+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||||+++ +|.+++...
T Consensus 15 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~ 93 (324)
T 3mtl_A 15 YATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC 93 (324)
T ss_dssp SEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHHT
T ss_pred CEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-CHHHHHHhc
Confidence 799999996 48999999998644322 122345799999999999999999999999999999999974 888877653
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
. ..+++..+..++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++........ ......++..|
T Consensus 94 ~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y 166 (324)
T 3mtl_A 94 G--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWY 166 (324)
T ss_dssp T--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGG
T ss_pred C--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccc
Confidence 2 35899999999999999999999998 99999999999999999999999999986542221 12234678999
Q ss_pred cCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccc---------ccc---
Q 021771 159 MAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEP---------VLK--- 225 (308)
Q Consensus 159 ~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~--- 225 (308)
+|||++.+ ..++.++|||||||++|+|++|..||.......................+...... ...
T Consensus 167 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (324)
T 3mtl_A 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEA 246 (324)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCC
T ss_pred cChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchh
Confidence 99998876 56899999999999999999999999764433211110000000000001100000 000
Q ss_pred -ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH--HhhcCCC
Q 021771 226 -QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV--MLASDTV 266 (308)
Q Consensus 226 -~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~--~L~~~~~ 266 (308)
..........+.+|+.+||+.||++|||++|+++ .+.....
T Consensus 247 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 247 LLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0001112345788999999999999999999996 4444433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=289.79 Aligned_cols=235 Identities=25% Similarity=0.385 Sum_probs=170.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 24 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 103 (278)
T 3cok_A 24 FAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK 103 (278)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHH
T ss_pred ceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHh
Confidence 789999995 689999999986432 2345778999999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ...+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++......... .....++.
T Consensus 104 ~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~ 176 (278)
T 3cok_A 104 NR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTP 176 (278)
T ss_dssp TC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---------------
T ss_pred hc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCC
Confidence 53 235899999999999999999999998 999999999999999999999999999876432211 22346788
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||.+.+..++.++||||||+++|+|++|..||.......... ... .. . .. .+......+
T Consensus 177 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~-~~---~---~~----~~~~~~~~~ 239 (278)
T 3cok_A 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVV-LA---D---YE----MPSFLSIEA 239 (278)
T ss_dssp ---------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC-SS---C---CC----CCTTSCHHH
T ss_pred CcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHh-hc---c---cC----CccccCHHH
Confidence 9999999988888999999999999999999999986543221100 000 00 0 00 011122357
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.||++|||++++++
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHcccCHhhCCCHHHHhc
Confidence 88999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=293.70 Aligned_cols=242 Identities=28% Similarity=0.384 Sum_probs=189.5
Q ss_pred CCccEEeee---CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL---ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~---~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||++.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++ ..+..++||||+++++|.+++
T Consensus 30 ~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l 108 (291)
T 1xbb_A 30 FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL 108 (291)
T ss_dssp SEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHH
T ss_pred CeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHH
Confidence 789999953 457899999986543 33457889999999999999999999999 556789999999999999999
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-ccceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-NTNRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~ 154 (308)
... ..+++..++.++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++.......... ......+
T Consensus 109 ~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 182 (291)
T 1xbb_A 109 QQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182 (291)
T ss_dssp HHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CC
T ss_pred HhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCC
Confidence 653 34899999999999999999999998 9999999999999999999999999998765432211 1222345
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||.+.+..++.++||||||+++|+|++ |..||........ ........... .+....
T Consensus 183 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~ 246 (291)
T 1xbb_A 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGERMG---------CPAGCP 246 (291)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCCCC---------CCTTCC
T ss_pred CceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCCCC---------CCCCCC
Confidence 678999999988889999999999999999999 9999865433211 11111111111 111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
..+.+++.+||+.||++|||+.++++.|+...
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 45888999999999999999999999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=287.50 Aligned_cols=238 Identities=20% Similarity=0.300 Sum_probs=184.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.+|+|++.... ....+.+.+|+.+|+.++||||+++++++.+....++||||+++++|.+++...
T Consensus 35 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 114 (285)
T 3is5_A 35 FGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSA 114 (285)
T ss_dssp SCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHH
T ss_pred CeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhh
Confidence 799999995 579999999986553 445688999999999999999999999999999999999999999999888543
Q ss_pred -CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe---CCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 79 -TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---NHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 79 -~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
.....+++..++.++.|++.||+|||++| ++|+||||+||++ +.++.+||+|||++..+.... ......+
T Consensus 115 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~ 188 (285)
T 3is5_A 115 QARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAG 188 (285)
T ss_dssp HHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CT
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCccc
Confidence 22346999999999999999999999998 9999999999999 456789999999997654321 1233467
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
+..|+|||++. ..++.++||||||+++|+|++|..||....... ................ .. ...
T Consensus 189 t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~----~~----~~~ 253 (285)
T 3is5_A 189 TALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKEPNYAVEC----RP----LTP 253 (285)
T ss_dssp TGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCC------CC----CCH
T ss_pred ccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCCccccccc----Cc----CCH
Confidence 89999999875 467899999999999999999999996543221 1111111110000000 00 123
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 254 QAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHccCChhhCcCHHHHhc
Confidence 5788999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=294.23 Aligned_cols=247 Identities=28% Similarity=0.333 Sum_probs=190.4
Q ss_pred CCccEEeee-CCCC---EEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeE-EEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGK---EIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES-LLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~ 74 (308)
||+||+|+. .+++ .+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.. ++||||+.+++|.++
T Consensus 34 ~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 113 (298)
T 3pls_A 34 FGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQF 113 (298)
T ss_dssp TEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHH
T ss_pred CceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHH
Confidence 799999985 3333 79999986543 34557788999999999999999999999876665 999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC--cccccee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS--EANTNRI 152 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~ 152 (308)
+... ...+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++........ .......
T Consensus 114 ~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 188 (298)
T 3pls_A 114 IRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188 (298)
T ss_dssp HHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCT
T ss_pred Hhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCC
Confidence 8653 345889999999999999999999998 99999999999999999999999999976543221 1122234
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcC-CCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.++..|+|||.+.+..++.++||||||+++|+|++|..| |....... .. ... ...... ..+..
T Consensus 189 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~---~~~-~~~~~~---------~~~~~ 252 (298)
T 3pls_A 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LT---HFL-AQGRRL---------PQPEY 252 (298)
T ss_dssp TCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HH---HHH-HTTCCC---------CCCTT
T ss_pred CCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HH---HHh-hcCCCC---------CCCcc
Confidence 567889999999988999999999999999999996555 43322211 10 000 011000 00111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
....+.+++.+||+.||++|||++++++.|+.....+
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 2235888999999999999999999999998765444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=305.06 Aligned_cols=239 Identities=17% Similarity=0.170 Sum_probs=188.6
Q ss_pred CCccEEeeeC-CCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++.+ +|+.||+|++... .......+.+|..++..++||||++++++|.+.+.+++|||||++++|.+++.
T Consensus 87 fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~ 166 (437)
T 4aw2_A 87 FGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS 166 (437)
T ss_dssp SEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH
T ss_pred CEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHH
Confidence 7999999964 6899999998643 12233457899999999999999999999999999999999999999999996
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ...+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++........ .......||+
T Consensus 167 ~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~ 240 (437)
T 4aw2_A 167 KF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTP 240 (437)
T ss_dssp TT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCG
T ss_pred Hc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCc
Confidence 53 235999999999999999999999998 99999999999999999999999999987643322 1223357899
Q ss_pred CccCchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc---ccccccccccccccc
Q 021771 157 GYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE---GEALELMEPVLKQSC 228 (308)
Q Consensus 157 ~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 228 (308)
.|+|||++. ...++.++|||||||++|+|++|..||........ ....... ...+...
T Consensus 241 ~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~p~~~-------- 306 (437)
T 4aw2_A 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKERFQFPTQV-------- 306 (437)
T ss_dssp GGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHHHHCCCCSSC--------
T ss_pred CeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHhhhhccccccCCccc--------
Confidence 999999987 45689999999999999999999999965432211 1111110 0111100
Q ss_pred hHHHHHHHHHHHhhcccCCCCC--CCCHHHHHHH
Q 021771 229 VAAELLKFIHIGLLCVQADSAD--RPTMSSVVVM 260 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~--RPs~~eil~~ 260 (308)
......+.+||.+||+.+|++ ||+++|+++-
T Consensus 307 -~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 307 -TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp -CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred -ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 011234788899999988888 9999999953
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.73 Aligned_cols=250 Identities=17% Similarity=0.201 Sum_probs=191.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeE-EeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCC-LEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.||+|++...... ..+..|+.+++.++|++++..+..+ .+....++||||+ +++|.+++...
T Consensus 22 ~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~ 98 (296)
T 4hgt_A 22 FGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC 98 (296)
T ss_dssp SSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred CeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh
Confidence 799999995 68999999987544322 3578899999999987766666555 6677789999999 88999998643
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe---CCCCCeeeecccceeeeCCCCCcc-----ccc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---NHEMNPKISDFGMARIFGGNQSEA-----NTN 150 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv---~~~~~~kl~dfg~~~~~~~~~~~~-----~~~ 150 (308)
. ..+++..++.++.||+.||+|||++| ++|+||||+||++ +.++.+||+|||++.......... ...
T Consensus 99 ~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~ 173 (296)
T 4hgt_A 99 S--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173 (296)
T ss_dssp T--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSC
T ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCccc
Confidence 2 34899999999999999999999998 9999999999999 788899999999998875433211 223
Q ss_pred eeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 151 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
...++..|+|||.+.+..++.++|||||||++|+|++|..||.......................... ....
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--- 245 (296)
T 4hgt_A 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-----LCKG--- 245 (296)
T ss_dssp CCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH-----HTTT---
T ss_pred ccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh-----hhcc---
Confidence 45789999999999998899999999999999999999999976544433322222111111100000 0011
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCC
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVT 267 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~ 267 (308)
....+.+++.+||+.||++|||+++|++.|+.....
T Consensus 246 -~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 246 -YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp -SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 123588899999999999999999999999876433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.10 Aligned_cols=239 Identities=19% Similarity=0.192 Sum_probs=179.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhc-CCCcCccceeeeEEe----CCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK-LQHKNLVRLFGCCLE----ENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||++.. .+|+.||||++... ..+.+|+.++.+ .+||||+++++++.. ...+++|||||++++|.++
T Consensus 75 ~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~ 149 (400)
T 1nxk_A 75 NGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 149 (400)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHH
Confidence 799999996 57999999998532 456788888754 479999999999875 5578999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC---CCCeeeecccceeeeCCCCCccccce
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH---EMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~---~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
+... ....+++..+..++.||+.||.|||++| |+||||||+||+++. ++.+||+|||++....... ....
T Consensus 150 l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~ 222 (400)
T 1nxk_A 150 IQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTT 222 (400)
T ss_dssp HHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----------
T ss_pred HHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC---cccc
Confidence 9653 2345899999999999999999999998 999999999999997 7889999999998754221 1233
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..|+..|+|||++.+..++.++|||||||++|+|++|..||............. ........ .... .....
T Consensus 223 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~i~~~~~-~~~~-----~~~~~ 293 (400)
T 1nxk_A 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQY-EFPN-----PEWSE 293 (400)
T ss_dssp ----CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH---HHHHHTCC-CCCT-----TTTTT
T ss_pred CCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH---HHHHcCcc-cCCC-----ccccc
Confidence 567999999999988899999999999999999999999996543322111000 00000100 0000 00011
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
....+.+||.+||+.||++|||+.|+++.
T Consensus 294 ~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 23358889999999999999999999964
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=305.86 Aligned_cols=188 Identities=27% Similarity=0.419 Sum_probs=155.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCC--eEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEEN--ESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~ 74 (308)
||.||++.. .+|+.||||++... .......+.+|+.+|+.+. ||||+++++++...+ .+++|||||+ ++|..+
T Consensus 22 ~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~ 100 (388)
T 3oz6_A 22 YGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAV 100 (388)
T ss_dssp --CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHH
Confidence 799999985 68999999998543 3445567889999999997 999999999998544 6899999997 588888
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC---------
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS--------- 145 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~--------- 145 (308)
+.. ..+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||++..+.....
T Consensus 101 ~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 173 (388)
T 3oz6_A 101 IRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173 (388)
T ss_dssp HHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCC
T ss_pred HHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccc
Confidence 854 35889999999999999999999998 99999999999999999999999999987642110
Q ss_pred ----------ccccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccc
Q 021771 146 ----------EANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYL 196 (308)
Q Consensus 146 ----------~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 196 (308)
........||..|+|||++.+ ..++.++|||||||++|+|++|.+||....
T Consensus 174 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp C---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 111233478999999998876 678999999999999999999999996543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=293.36 Aligned_cols=247 Identities=28% Similarity=0.388 Sum_probs=188.2
Q ss_pred CCccEEeeeCC----CCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEE-eCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLAD----GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCL-EENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|+..+ +..+++|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+++++|.++
T Consensus 38 ~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~ 117 (298)
T 3f66_A 38 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 117 (298)
T ss_dssp TEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHH
T ss_pred CceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHH
Confidence 79999998532 235899988654 3345577899999999999999999999864 45678999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc--ccccee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--ANTNRI 152 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~ 152 (308)
+... ...+++..++.++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++......... ......
T Consensus 118 l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 192 (298)
T 3f66_A 118 IRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192 (298)
T ss_dssp HHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----C
T ss_pred HHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCC
Confidence 9653 345889999999999999999999998 999999999999999999999999999876433211 112234
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.++..|+|||.+.+..++.++||||||+++|+|++ +.+||........ ..... ..... . ....
T Consensus 193 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~------~~~~~-~~~~~-~----~~~~---- 256 (298)
T 3f66_A 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVYLL-QGRRL-L----QPEY---- 256 (298)
T ss_dssp CBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH------HHHHH-TTCCC-C----CCTT----
T ss_pred CCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH------HHHHh-cCCCC-C----CCcc----
Confidence 56778999999998899999999999999999999 5556543322211 01110 00000 0 0011
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
....+.+++.+||+.||++|||++++++.|+.....+
T Consensus 257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1235888999999999999999999999998765444
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=296.55 Aligned_cols=234 Identities=23% Similarity=0.239 Sum_probs=179.0
Q ss_pred CCccEEeee----CCCCEEEEEEeccCC----cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.+++..++||||+++++|.
T Consensus 30 ~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 109 (327)
T 3a62_A 30 YGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELF 109 (327)
T ss_dssp TEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHH
T ss_pred CEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHH
Confidence 799999986 589999999997542 234456788999999999999999999999999999999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++.++.+||+|||++........ .....
T Consensus 110 ~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 181 (327)
T 3a62_A 110 MQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTF 181 (327)
T ss_dssp HHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC------------CTT
T ss_pred HHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--ccccc
Confidence 998543 34889999999999999999999998 99999999999999999999999999875432211 12234
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.|+..|+|||++.+..++.++||||||+++|+|++|..||....... ........ .. . .+...
T Consensus 182 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~-~~-~---------~p~~~ 244 (327)
T 3a62_A 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDKILKC-KL-N---------LPPYL 244 (327)
T ss_dssp SSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHT-CC-C---------CCTTS
T ss_pred CCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhC-CC-C---------CCCCC
Confidence 68899999999988889999999999999999999999996543221 11111110 00 0 01112
Q ss_pred HHHHHHHHhhcccCCCCCCC-----CHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRP-----TMSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RP-----s~~eil~ 259 (308)
...+.+|+.+||+.||++|| ++.++++
T Consensus 245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 23588899999999999999 7778875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.06 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=185.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|..++..
T Consensus 38 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~ 117 (331)
T 4aaa_A 38 YGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF 117 (331)
T ss_dssp TSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS
T ss_pred CEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh
Confidence 799999996 469999999986543 22345678999999999999999999999999999999999999999887643
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
. ..+++..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++........ ......++..
T Consensus 118 ~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~ 189 (331)
T 4aaa_A 118 P---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRW 189 (331)
T ss_dssp T---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCT
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCcc
Confidence 2 34899999999999999999999998 99999999999999999999999999976543221 1223467889
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchh--------HHHHHhhhcc------cccccccc
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL--------SYTWKLWCEG------EALELMEP 222 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~--------~~~~~~~~~~------~~~~~~~~ 222 (308)
|+|||++.+. .++.++||||||+++|+|++|..||............ ......+... ........
T Consensus 190 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
T 4aaa_A 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKER 269 (331)
T ss_dssp TCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSC
T ss_pred ccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcccccc
Confidence 9999988775 6889999999999999999999999654432111000 0000001110 01111110
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.............+.+|+.+||+.||++|||++|+++
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 270 EPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred chhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000111123456889999999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=297.72 Aligned_cols=228 Identities=20% Similarity=0.269 Sum_probs=186.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc--------ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCC-C
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG--------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK-S 70 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~ 70 (308)
||+||+++. .+|+.||||++..... .....+.+|+.+|+.++||||+++++++.+.+..++||||+.++ +
T Consensus 37 ~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~ 116 (335)
T 3dls_A 37 FGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLD 116 (335)
T ss_dssp SCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCB
T ss_pred CEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCcc
Confidence 799999985 6899999999865421 13345678999999999999999999999999999999998766 9
Q ss_pred hhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccc
Q 021771 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTN 150 (308)
Q Consensus 71 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~ 150 (308)
|.+++... ..+++..++.++.||+.||.|||++| ++|+||||+||+++.++.+||+|||++....... ...
T Consensus 117 l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~ 187 (335)
T 3dls_A 117 LFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFY 187 (335)
T ss_dssp HHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBC
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceECCCCC---cee
Confidence 99988543 34999999999999999999999998 9999999999999999999999999998765332 223
Q ss_pred eeecccCccCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 151 RIVGTYGYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
...|+..|+|||++.+..+ +.++||||||+++|+|++|..||......... .... +
T Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-----------------~~~~------~ 244 (335)
T 3dls_A 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEA-----------------AIHP------P 244 (335)
T ss_dssp EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTT-----------------CCCC------S
T ss_pred ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhh-----------------ccCC------C
Confidence 3568999999999988766 78999999999999999999998642211100 0000 0
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
......+.+|+.+||+.||++|||++++++.
T Consensus 245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0012358889999999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=288.68 Aligned_cols=247 Identities=18% Similarity=0.186 Sum_probs=185.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.
T Consensus 47 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 126 (309)
T 2h34_A 47 MGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR 126 (309)
T ss_dssp SSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHH
T ss_pred CeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHH
Confidence 799999996 579999999986543 2234678899999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.|++.+|.|||++| ++|+||+|+||+++.++.+||+|||++......... ......++.
T Consensus 127 ~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~ 199 (309)
T 2h34_A 127 RQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTL 199 (309)
T ss_dssp HH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCG
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCc
Confidence 53 34899999999999999999999998 999999999999999999999999998765432211 122346788
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||.+.+..++.++||||||+++|+|++|..||....... ....... ..... ..........+
T Consensus 200 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~-~~~~~------~~~~~~~~~~l 265 (309)
T 2h34_A 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQ-AIPRP------STVRPGIPVAF 265 (309)
T ss_dssp GGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHS-CCCCG------GGTSTTCCTHH
T ss_pred CccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhcc-CCCCc------cccCCCCCHHH
Confidence 9999999988889999999999999999999999996543221 0111110 00000 00011112348
Q ss_pred HHHHhhcccCCCCCCC-CHHHHHHHhhcCCCCC
Q 021771 237 IHIGLLCVQADSADRP-TMSSVVVMLASDTVTL 268 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-s~~eil~~L~~~~~~~ 268 (308)
.+++.+||+.||++|| |++++++.|+......
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred HHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 8899999999999999 9999999999764433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=293.56 Aligned_cols=251 Identities=23% Similarity=0.286 Sum_probs=184.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-----cccHHHHHHHHHHHhcCC---CcCccceeeeEEeCC-----eEEEEEEec
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-----GQGLQEFKNEVTLIAKLQ---HKNLVRLFGCCLEEN-----ESLLIYEYM 66 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~-----~~~lv~e~~ 66 (308)
||+||+++. .+|+.||+|++.... ......+.+|+.+++.++ ||||+++++++.... ..++||||+
T Consensus 22 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 101 (308)
T 3g33_A 22 YGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV 101 (308)
T ss_dssp SCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECC
T ss_pred CeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhh
Confidence 799999995 689999999986432 222346677887777764 999999999998765 479999999
Q ss_pred CCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 67 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
. ++|.+++.... ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++.......
T Consensus 102 ~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-- 174 (308)
T 3g33_A 102 D-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-- 174 (308)
T ss_dssp C-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC--
T ss_pred h-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc--
Confidence 6 59999886532 234899999999999999999999998 9999999999999999999999999997654222
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccc---ccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELM---EPV 223 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 223 (308)
......++..|+|||++.+..++.++|||||||++|+|++|..||.......................+.... ...
T Consensus 175 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (308)
T 3g33_A 175 -ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 253 (308)
T ss_dssp -CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGG
T ss_pred -ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence 2233467999999999999899999999999999999999999996543321111000000000000010000 000
Q ss_pred cc-------ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 224 LK-------QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 224 ~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. ..........+.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 254 FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp SCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 0001122346888999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=297.77 Aligned_cols=237 Identities=21% Similarity=0.286 Sum_probs=184.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.||+|++...... ..+|++++.++ +||||+++++++.++...++|||||++++|.+++...
T Consensus 35 ~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~ 110 (342)
T 2qr7_A 35 YSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ 110 (342)
T ss_dssp SEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC
T ss_pred CEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc
Confidence 799999996 57999999999755432 34688888887 7999999999999999999999999999999988543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC-C---CeeeecccceeeeCCCCCccccceeec
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-M---NPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~-~---~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
..+++..+..++.||+.||+|||++| |+||||||+||++... + .+||+|||++......... .....+
T Consensus 111 ---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~g 182 (342)
T 2qr7_A 111 ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL--LMTPCY 182 (342)
T ss_dssp ---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC--BCCSSC
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc--eeccCC
Confidence 35899999999999999999999998 9999999999998543 3 4999999999876533221 223467
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
+..|+|||++.+..++.++|||||||++|+|++|..||..........+.. .. ...... . ..........
T Consensus 183 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i-~~~~~~-~-----~~~~~~~~s~ 252 (342)
T 2qr7_A 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RI-GSGKFS-L-----SGGYWNSVSD 252 (342)
T ss_dssp CSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HH-HHCCCC-C-----CSTTTTTSCH
T ss_pred CccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HH-ccCCcc-c-----CccccccCCH
Confidence 899999999988888999999999999999999999997543221111111 11 111110 0 0001111233
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+.+|+.+||+.||++|||+.++++
T Consensus 253 ~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 253 TAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 5888999999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=300.34 Aligned_cols=185 Identities=26% Similarity=0.318 Sum_probs=160.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-----CcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-----HKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+++. .+|+.||||++... .........|+.+++.++ ||||+++++++...+..++||||+ +++|.++
T Consensus 48 ~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~ 125 (360)
T 3llt_A 48 FGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEI 125 (360)
T ss_dssp SEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHH
T ss_pred CeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHH
Confidence 799999996 68999999998532 344456778999999996 999999999999999999999999 8899999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-------------------------CCCe
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-------------------------EMNP 129 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-------------------------~~~~ 129 (308)
+.... ...+++..+..++.||+.||+|||++| |+|+||||+||+++. ++.+
T Consensus 126 ~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (360)
T 3llt_A 126 ITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201 (360)
T ss_dssp HHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCE
T ss_pred HHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCE
Confidence 86543 235899999999999999999999998 999999999999975 7889
Q ss_pred eeecccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccc
Q 021771 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYL 196 (308)
Q Consensus 130 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 196 (308)
||+|||++...... .....|+..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 202 kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 202 KLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp EECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 99999999874322 223467899999999999899999999999999999999999996543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=290.24 Aligned_cols=234 Identities=22% Similarity=0.308 Sum_probs=190.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.+|+|++... .....+.+.+|+.+++.++|+||+++++++.+.+..++||||+++++|.+++.
T Consensus 54 ~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 133 (335)
T 2owb_A 54 FAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 133 (335)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHh
Confidence 799999996 56899999998654 23456778899999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.||+.+|.|||++| ++|+||||+||+++.++.+||+|||++........ ......++.
T Consensus 134 ~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~ 205 (335)
T 2owb_A 134 RR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTP 205 (335)
T ss_dssp HH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCC
T ss_pred cc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCc
Confidence 43 35899999999999999999999998 99999999999999999999999999987643222 123356789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++||||||+++|+|++|..||....... ...... .... . .... ....+
T Consensus 206 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~-~~~~-~-----~~~~----~~~~~ 268 (335)
T 2owb_A 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRIK-KNEY-S-----IPKH----INPVA 268 (335)
T ss_dssp SSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH-HTCC-C-----CCTT----SCHHH
T ss_pred cccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHHHh-cCCC-C-----CCcc----CCHHH
Confidence 9999999988889999999999999999999999996543221 111111 0000 0 0011 12347
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+|+.+||+.||++|||++++++
T Consensus 269 ~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 269 ASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 88899999999999999999996
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=320.72 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=195.9
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+|++.++..||||++.... ...+.+.+|+.+|+.++|+||+++++++.+ +..++||||+.+++|.+++... .
T Consensus 280 fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~-~ 356 (535)
T 2h8h_A 280 FGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-T 356 (535)
T ss_dssp SEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH-H
T ss_pred CeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc-C
Confidence 799999999888899999996543 345789999999999999999999999876 6789999999999999999542 2
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......... ......++..|+|
T Consensus 357 ~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~a 432 (535)
T 2h8h_A 357 GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTA 432 (535)
T ss_dssp HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee-cccCCcCcccccC
Confidence 234889999999999999999999998 999999999999999999999999999765321111 1112245678999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||++.+..++.++||||||+++|+|++ |..||....... + ... ....... ..+......+.+|
T Consensus 433 PE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~---~~~-i~~~~~~---------~~~~~~~~~l~~l 496 (535)
T 2h8h_A 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V---LDQ-VERGYRM---------PCPPECPESLHDL 496 (535)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---H---HHH-HHTTCCC---------CCCTTCCHHHHHH
T ss_pred HHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHH-HHcCCCC---------CCCCCCCHHHHHH
Confidence 999998899999999999999999999 899986543221 1 111 1111000 1111223458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcCCCCCCCC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASDTVTLPQP 271 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~ 271 (308)
+.+||+.||++|||+++|++.|+.......+.
T Consensus 497 i~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 99999999999999999999999876555443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=297.10 Aligned_cols=243 Identities=26% Similarity=0.414 Sum_probs=185.5
Q ss_pred CCccEEeeeCC-----CCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLAD-----GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|+... +..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||||+++++|.++
T Consensus 57 ~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 136 (333)
T 1mqb_A 57 FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136 (333)
T ss_dssp SSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHH
T ss_pred CeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHH
Confidence 79999998642 2359999987543 33456788999999999999999999999999999999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-ccceee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-NTNRIV 153 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~ 153 (308)
+.... ..+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++.......... ......
T Consensus 137 l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 211 (333)
T 1mqb_A 137 LREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 211 (333)
T ss_dssp HHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------C
T ss_pred HHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCC
Confidence 86532 35899999999999999999999998 9999999999999999999999999998764332211 112234
Q ss_pred cccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. .......... .+...
T Consensus 212 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~-~~~~~~~~~~---------~~~~~ 275 (333)
T 1mqb_A 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VM-KAINDGFRLP---------TPMDC 275 (333)
T ss_dssp CCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH-HHHHTTCCCC---------CCTTC
T ss_pred ccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH------HH-HHHHCCCcCC---------CcccC
Confidence 5678999999988889999999999999999998 999985432211 01 1111110000 01112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
...+.+++.+||+.||++|||+.+|++.|+..
T Consensus 276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 33588899999999999999999999998765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=297.43 Aligned_cols=246 Identities=27% Similarity=0.375 Sum_probs=189.6
Q ss_pred CCccEEeee-CCCCEE--EEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEI--AVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|..+ ++|.+... .......+.+|+.+++.+ +||||+++++++.+.+..++||||+++++|.+++
T Consensus 38 ~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 117 (327)
T 1fvr_A 38 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117 (327)
T ss_dssp GCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH
T ss_pred CceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHH
Confidence 799999995 467655 99988653 334556788999999999 8999999999999999999999999999999998
Q ss_pred hcCC-------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 76 FDST-------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 76 ~~~~-------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
.... ....+++..++.++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++.....
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~ 194 (327)
T 1fvr_A 118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV 194 (327)
T ss_dssp HTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCE
T ss_pred HhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccc
Confidence 6542 2246899999999999999999999998 99999999999999999999999999874321
Q ss_pred CCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELME 221 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
........++..|+|||++.+..++.++||||||+++|+|++ |..||....... ... ........
T Consensus 195 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~-~~~~~~~~---- 260 (327)
T 1fvr_A 195 ---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE-KLPQGYRL---- 260 (327)
T ss_dssp ---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH-HGGGTCCC----
T ss_pred ---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HHH-HhhcCCCC----
Confidence 111222345778999999988889999999999999999998 999986443221 011 11111000
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
..+......+.+|+.+||+.||++|||++++++.|.......
T Consensus 261 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 261 -----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 011112235888999999999999999999999987764443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=289.90 Aligned_cols=235 Identities=24% Similarity=0.385 Sum_probs=191.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+|+. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++|.+++..
T Consensus 35 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~- 113 (303)
T 3a7i_A 35 FGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP- 113 (303)
T ss_dssp SSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-
T ss_pred CeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-
Confidence 799999985 579999999987553 44567899999999999999999999999999999999999999999998843
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
..+++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|
T Consensus 114 ---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y 185 (303)
T 3a7i_A 114 ---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFW 185 (303)
T ss_dssp ---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGG
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCc
Confidence 35899999999999999999999998 99999999999999999999999999987653322 12334678899
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
+|||++.+..++.++||||||+++|+|++|..||....... ..... ...... ...... ...+.+
T Consensus 186 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~-----~~~~~~----~~~l~~ 249 (303)
T 3a7i_A 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VLFLI-PKNNPP-----TLEGNY----SKPLKE 249 (303)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHH-HHSCCC-----CCCSSC----CHHHHH
T ss_pred cCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HHHHh-hcCCCC-----CCcccc----CHHHHH
Confidence 99999998889999999999999999999999986432211 01110 011110 111111 234888
Q ss_pred HHhhcccCCCCCCCCHHHHHHH
Q 021771 239 IGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~ 260 (308)
|+.+||+.||++|||+.++++.
T Consensus 250 li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 250 FVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHHcCCChhhCcCHHHHhhC
Confidence 9999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=290.57 Aligned_cols=236 Identities=23% Similarity=0.338 Sum_probs=189.1
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe----------------CCeEEEEE
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE----------------ENESLLIY 63 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~ 63 (308)
||.||+++.. +|+.||+|++.... +.+.+|+.+++.++||||+++++++.. ....++||
T Consensus 24 ~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 99 (284)
T 2a19_B 24 FGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99 (284)
T ss_dssp SCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEE
T ss_pred ceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEE
Confidence 7999999974 89999999986543 346789999999999999999998864 34579999
Q ss_pred EecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCC
Q 021771 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGN 143 (308)
Q Consensus 64 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~ 143 (308)
||+++++|.+++.... ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+|||++......
T Consensus 100 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 100 EFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175 (284)
T ss_dssp CCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCC
T ss_pred eccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheecccc
Confidence 9999999999986532 345899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccc
Q 021771 144 QSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 144 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..|+.... ............
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~~~~~~~~~------ 237 (284)
T 2a19_B 176 GK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------KFFTDLRDGIIS------ 237 (284)
T ss_dssp SC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------HHHHHHHTTCCC------
T ss_pred cc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------HHHHHhhccccc------
Confidence 21 223457899999999998889999999999999999999998863211 001111111111
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
.. ....+.+++.+||+.||++|||+.|+++.|.......
T Consensus 238 --~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 238 --DI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp --TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred --cc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 11 1234778899999999999999999999998765443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=309.90 Aligned_cols=252 Identities=21% Similarity=0.211 Sum_probs=187.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||||++... .......+..|+.+++.++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 161 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~ 240 (446)
T 4ejn_A 161 FGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 240 (446)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHH
T ss_pred CEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHH
Confidence 799999995 68999999998643 33445667889999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.. ..+++..+..++.||+.||+|||+ .| |+||||||+|||++.++.+||+|||++....... .......|+
T Consensus 241 ~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt 312 (446)
T 4ejn_A 241 RE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGT 312 (446)
T ss_dssp HH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSC
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCC
Confidence 43 358999999999999999999998 87 9999999999999999999999999987532221 122335789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
..|+|||++.+..++.++|||||||++|+|++|..||........ ....... .. . .+......
T Consensus 313 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~~-~~-~---------~p~~~~~~ 375 (446)
T 4ejn_A 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILME-EI-R---------FPRTLGPE 375 (446)
T ss_dssp GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHC-CC-C---------CCTTSCHH
T ss_pred ccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHHhC-CC-C---------CCccCCHH
Confidence 999999999999999999999999999999999999964432211 1111111 00 0 01112235
Q ss_pred HHHHHhhcccCCCCCCC-----CHHHHHHH--hhcC------CCCCCCCCCCCcc
Q 021771 236 FIHIGLLCVQADSADRP-----TMSSVVVM--LASD------TVTLPQPTEPAFS 277 (308)
Q Consensus 236 l~~li~~cl~~~p~~RP-----s~~eil~~--L~~~------~~~~~~~~~p~~~ 277 (308)
+.+||.+||+.||++|| |++|+++- +.+. ...+++|-.|...
T Consensus 376 ~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~ 430 (446)
T 4ejn_A 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVT 430 (446)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCS
T ss_pred HHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCCC
Confidence 88899999999999999 99999852 2222 2345556556544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=297.85 Aligned_cols=245 Identities=29% Similarity=0.400 Sum_probs=190.1
Q ss_pred CCccEEeee------CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+....++||||+++++|.+
T Consensus 43 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 122 (327)
T 2yfx_A 43 FGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKS 122 (327)
T ss_dssp SSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred CeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHH
Confidence 799999983 36789999999654 33455678899999999999999999999999999999999999999999
Q ss_pred HhhcCCC----ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC---CCeeeecccceeeeCCCCCc
Q 021771 74 FLFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE---MNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 74 ~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~---~~~kl~dfg~~~~~~~~~~~ 146 (308)
++..... ...+++..++.++.|++.||.|||++| ++|+||||+||+++.+ ..++|+|||++.........
T Consensus 123 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~ 199 (327)
T 2yfx_A 123 FLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199 (327)
T ss_dssp HHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC----
T ss_pred HHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECcccccccccccccc
Confidence 9976432 245889999999999999999999998 9999999999999954 45999999998765433322
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||....... . ............
T Consensus 200 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~~~~~~~~~~------ 266 (327)
T 2yfx_A 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---V----LEFVTSGGRMDP------ 266 (327)
T ss_dssp --CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H----HHHHHTTCCCCC------
T ss_pred ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---H----HHHHhcCCCCCC------
Confidence 22333456788999999988889999999999999999998 889986443221 0 111111111110
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.......+.+++.+||+.||++|||+.+|++.|+..
T Consensus 267 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 267 ---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111223588899999999999999999999998765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=319.73 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=189.6
Q ss_pred CCccEEeeeC---CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+|.++ ++..||||+++... ....+.+.+|+.+|+.++||||+++++++.+ +..++||||+++++|.+++.
T Consensus 349 fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~ 427 (613)
T 2ozo_A 349 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLV 427 (613)
T ss_dssp SSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHT
T ss_pred CcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHh
Confidence 8999999853 56789999997653 4467889999999999999999999999986 56899999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccceeecc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRIVGT 155 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~ 155 (308)
.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......... .......++
T Consensus 428 ~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 502 (613)
T 2ozo_A 428 GK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502 (613)
T ss_dssp TC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------C
T ss_pred hc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCc
Confidence 43 345899999999999999999999998 999999999999999999999999999765432211 111222346
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||++.+..++.++||||||+++|+|++ |..||....... +. .....+... ..+.....
T Consensus 503 ~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~~~~---------~~p~~~~~ 566 (613)
T 2ozo_A 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKRM---------ECPPECPP 566 (613)
T ss_dssp CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HH----HHHHTTCCC---------CCCTTCCH
T ss_pred cceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCC---------CCCCcCCH
Confidence 78999999998899999999999999999998 999986543321 11 111111111 11112234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 567 ~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 567 ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 588899999999999999999999999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=298.66 Aligned_cols=234 Identities=21% Similarity=0.249 Sum_probs=188.4
Q ss_pred CCccEEeeeC-CCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++.+ +|+.||||++... .....+.+..|..+|..+ +||+|+++++++.+.+..++||||+++++|.+++
T Consensus 33 fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 112 (353)
T 2i0e_A 33 FGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 112 (353)
T ss_dssp TEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred CEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 7999999964 6899999998654 234567788999999988 7999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..++.++.||+.||+|||++| |+||||||+||+++.+|.+||+|||++....... .......|+
T Consensus 113 ~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt 184 (353)
T 2i0e_A 113 QQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGT 184 (353)
T ss_dssp HHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSC
T ss_pred Hhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCC
Confidence 643 34899999999999999999999998 9999999999999999999999999997643221 123345789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+.|+|||++.+..++.++|||||||++|+|++|..||...... ......... .. . .+......
T Consensus 185 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~-~~-~---------~p~~~s~~ 247 (353)
T 2i0e_A 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEH-NV-A---------YPKSMSKE 247 (353)
T ss_dssp GGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-CC-C---------CCTTSCHH
T ss_pred ccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHhC-CC-C---------CCCCCCHH
Confidence 9999999999888999999999999999999999999643222 111111111 10 0 01112335
Q ss_pred HHHHHhhcccCCCCCCCC-----HHHHHH
Q 021771 236 FIHIGLLCVQADSADRPT-----MSSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs-----~~eil~ 259 (308)
+.+|+.+||+.||++||+ +++|++
T Consensus 248 ~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 248 AVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp HHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 888999999999999995 577764
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=301.76 Aligned_cols=247 Identities=22% Similarity=0.228 Sum_probs=176.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEE--------eCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCL--------EENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~ 70 (308)
||.||+++. .+|+.||+|++..........+.+|+.+++.+. ||||+++++++. .....++||||+. ++
T Consensus 41 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~ 119 (337)
T 3ll6_A 41 FAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQ 119 (337)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EE
T ss_pred ceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CC
Confidence 789999995 589999999987666666678899999999996 999999999984 3345799999995 68
Q ss_pred hhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc---
Q 021771 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA--- 147 (308)
Q Consensus 71 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~--- 147 (308)
|.+++........+++..++.++.||+.||+|||++| .+++|+||||+||+++.++.+||+|||++..........
T Consensus 120 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 198 (337)
T 3ll6_A 120 LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198 (337)
T ss_dssp HHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------
T ss_pred HHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccc
Confidence 8888865444456999999999999999999999873 239999999999999999999999999998765332211
Q ss_pred -------ccceeecccCccCchhh---ccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccc
Q 021771 148 -------NTNRIVGTYGYMAPEYA---MEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEAL 217 (308)
Q Consensus 148 -------~~~~~~~~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (308)
......++..|+|||++ .+..++.++||||||+++|+|++|..||........ .. ....
T Consensus 199 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~-----~~~~ 267 (337)
T 3ll6_A 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI------VN-----GKYS 267 (337)
T ss_dssp -------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------------CC
T ss_pred cccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh------hc-----Cccc
Confidence 11134578899999988 456788999999999999999999999864322110 00 0000
Q ss_pred ccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 218 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
. .........+.+|+.+||+.||++|||+.|+++.|+......
T Consensus 268 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 268 I--------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp C--------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred C--------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 000011123778889999999999999999999998765443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=288.88 Aligned_cols=233 Identities=24% Similarity=0.325 Sum_probs=185.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+....++||||+++++|.+++.
T Consensus 22 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~ 101 (279)
T 3fdn_A 22 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 101 (279)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred CeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHH
Confidence 789999985 57889999998543 22345678899999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.++|+|||++...... ......++.
T Consensus 102 ~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~ 171 (279)
T 3fdn_A 102 KL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTL 171 (279)
T ss_dssp HH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCC
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc----cccccCCCC
Confidence 43 34899999999999999999999998 999999999999999999999999988654322 122346789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||.+.+..++.++||||||+++|+|++|..||........ .... ..... ..+......+
T Consensus 172 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~~~~~----------~~~~~~~~~~ 234 (279)
T 3fdn_A 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRI-SRVEF----------TFPDFVTEGA 234 (279)
T ss_dssp TTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH-HHTCC----------CCCTTSCHHH
T ss_pred CccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------HHHH-HhCCC----------CCCCcCCHHH
Confidence 99999999988899999999999999999999999864322211 1111 00000 0011122357
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 235 RDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHHHHHhccChhhCCCHHHHhhC
Confidence 889999999999999999999954
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=286.81 Aligned_cols=237 Identities=22% Similarity=0.291 Sum_probs=187.3
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCC------cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTS------GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+++.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+
T Consensus 18 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 97 (283)
T 3bhy_A 18 FAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD 97 (283)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred ceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHH
Confidence 7899999964 79999999986542 1246789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC----CeeeecccceeeeCCCCCcccc
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM----NPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~----~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
++... ..+++..++.++.||+.||.|||++| ++|+||+|+||+++.++ .++|+|||++....... ..
T Consensus 98 ~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~ 168 (283)
T 3bhy_A 98 FLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EF 168 (283)
T ss_dssp HHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---cc
Confidence 98543 35899999999999999999999998 99999999999999877 79999999998764322 12
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
....++..|+|||++.+..++.++||||||+++|+|++|..||....... .... ...... . .. ....
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~-~-~~----~~~~ 235 (283)
T 3bhy_A 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TLTN-ISAVNY-D-FD----EEYF 235 (283)
T ss_dssp ---CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHTTCC-C-CC----HHHH
T ss_pred cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HHHH-hHhccc-C-Cc----chhc
Confidence 23457889999999988889999999999999999999999986543221 0000 000000 0 00 0011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
......+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 112345888999999999999999999996
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=289.38 Aligned_cols=240 Identities=22% Similarity=0.326 Sum_probs=188.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeC--CeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. +|+.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+. ...++||||+++++|.+++.
T Consensus 23 ~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 101 (271)
T 3kmu_A 23 SGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH 101 (271)
T ss_dssp TEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHH
T ss_pred cceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHh
Confidence 799999998 48899999987553 34456789999999999999999999999887 67899999999999999996
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ....+++..++.++.|++.||+|||++| ..++|+||||+||+++.++.++|+|||++.... .....++.
T Consensus 102 ~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-------~~~~~~t~ 172 (271)
T 3kmu_A 102 EG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAP 172 (271)
T ss_dssp SC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-------CTTCBSCG
T ss_pred hc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-------ccCccCCc
Confidence 53 2335899999999999999999999873 249999999999999999999999988865422 12235688
Q ss_pred CccCchhhccCcccc---cccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 157 GYMAPEYAMEGLFSV---KSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~---~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.|+|||.+.+...+. ++||||||+++|+|++|..||....... ............. . +....
T Consensus 173 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~-----~----~~~~~ 237 (271)
T 3kmu_A 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEGLRPT-----I----PPGIS 237 (271)
T ss_dssp GGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSCCCCC-----C----CTTCC
T ss_pred cccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcCCCCC-----C----CCCCC
Confidence 999999988755443 7999999999999999999986432221 1111111111111 1 11122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
..+.+++..||+.||++|||++++++.|+...
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 238 PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 35888999999999999999999999998753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=302.98 Aligned_cols=241 Identities=18% Similarity=0.203 Sum_probs=187.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++.+. .....+.+.+|..++..++||||+++++++.+.+.+++||||+++++|.+++.
T Consensus 74 fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~ 153 (412)
T 2vd5_A 74 FSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLS 153 (412)
T ss_dssp SCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHH
Confidence 799999996 58999999998643 12234557899999999999999999999999999999999999999999996
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++........ .......||+
T Consensus 154 ~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~ 227 (412)
T 2vd5_A 154 KFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTP 227 (412)
T ss_dssp HHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCG
T ss_pred hcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceecccc
Confidence 532 25899999999999999999999998 99999999999999999999999999987653322 1122357899
Q ss_pred CccCchhhc-------cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 157 GYMAPEYAM-------EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 157 ~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
.|+|||++. ...++.++|||||||++|+|++|..||........ ............. +.. .
T Consensus 228 ~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~~~~--p~~----~ 295 (412)
T 2vd5_A 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------YGKIVHYKEHLSL--PLV----D 295 (412)
T ss_dssp GGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHHHHCCC--C-------
T ss_pred CcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------HHHHHhcccCcCC--Ccc----c
Confidence 999999887 35689999999999999999999999965432211 1111100000000 000 0
Q ss_pred HHHHHHHHHHHhhcccCCCCCC---CCHHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADR---PTMSSVVVM 260 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~R---Ps~~eil~~ 260 (308)
......+.+||.+||+ +|++| |+++||++-
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1122358889999999 99998 589999853
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=301.39 Aligned_cols=230 Identities=22% Similarity=0.230 Sum_probs=175.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHH-HhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTL-IAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+++.||+|++.... ......+..|..+ ++.++||||+++++++.+.+.+++||||+++++|.+++
T Consensus 51 fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 130 (373)
T 2r5t_A 51 FGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL 130 (373)
T ss_dssp TCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred CeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 799999996 578999999996543 2233455666666 56789999999999999999999999999999999988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..++.++.||+.||+|||++| |+||||||+||+++.+|.+||+|||++....... .......|+
T Consensus 131 ~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt 202 (373)
T 2r5t_A 131 QRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGT 202 (373)
T ss_dssp HHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCC
T ss_pred Hhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCC
Confidence 543 34889999999999999999999998 9999999999999999999999999987532221 123345789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+.|+|||++.+..++.++|||||||++|+|++|..||...... ......... .. . .... ....
T Consensus 203 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~-~~-~-----~~~~----~~~~ 265 (373)
T 2r5t_A 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNK-PL-Q-----LKPN----ITNS 265 (373)
T ss_dssp CCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHHS-CC-C-----CCSS----SCHH
T ss_pred ccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHhc-cc-C-----CCCC----CCHH
Confidence 9999999999988999999999999999999999999643222 111111111 00 0 0011 1235
Q ss_pred HHHHHhhcccCCCCCCCCHH
Q 021771 236 FIHIGLLCVQADSADRPTMS 255 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~ 255 (308)
+.+|+.+||+.||++||++.
T Consensus 266 ~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 266 ARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp HHHHHHHHTCSSGGGSTTTT
T ss_pred HHHHHHHHcccCHHhCCCCC
Confidence 78889999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=291.80 Aligned_cols=236 Identities=22% Similarity=0.280 Sum_probs=185.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++...
T Consensus 22 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 100 (304)
T 2jam_A 22 FSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER- 100 (304)
T ss_dssp SEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-
T ss_pred CceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc-
Confidence 789999996 589999999997665455567889999999999999999999999999999999999999999988543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe---CCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---NHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
..+++..++.++.|++.||.|||++| ++|+||+|+||++ +.++.++|+|||++...... ......++.
T Consensus 101 --~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~ 171 (304)
T 2jam_A 101 --GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTP 171 (304)
T ss_dssp --SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCC
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCC
Confidence 34899999999999999999999998 9999999999999 77889999999998654321 122345789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++||||||+++|+|++|..||....... ...... .... .. . ..........+
T Consensus 172 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~i~-~~~~-~~-~----~~~~~~~~~~~ 238 (304)
T 2jam_A 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK------LFEKIK-EGYY-EF-E----SPFWDDISESA 238 (304)
T ss_dssp CBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HCCC-CC-C----TTTTTTSCHHH
T ss_pred CccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cCCC-CC-C----ccccccCCHHH
Confidence 9999999988889999999999999999999999986432211 011111 1100 00 0 00011123458
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+++.+||+.||++|||++++++
T Consensus 239 ~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHHHHHcCCChhHCcCHHHHhc
Confidence 88999999999999999999996
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=307.75 Aligned_cols=236 Identities=25% Similarity=0.328 Sum_probs=184.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+|..+|+|++.... ......+.+|+.+|+.++||||+++++++.+....++|||||.+++|.+++..
T Consensus 50 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~ 129 (494)
T 3lij_A 50 YGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129 (494)
T ss_dssp --EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred CEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH
Confidence 799999996 589999999986542 34467889999999999999999999999999999999999999999888854
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC---CCeeeecccceeeeCCCCCccccceeec
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE---MNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
. ..+++..+..++.||+.||.|||++| |+||||||+||+++.. +.+||+|||++..+.... ......|
T Consensus 130 ~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~g 200 (494)
T 3lij_A 130 R---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLG 200 (494)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCS
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCC
Confidence 3 34899999999999999999999998 9999999999999764 449999999998765332 2233468
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
++.|+|||++. ..++.++|||||||++|+|++|..||....... ...... ..... ...+ .......
T Consensus 201 t~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~-~~~~~-~~~~-----~~~~~s~ 266 (494)
T 3lij_A 201 TAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE------ILRKVE-KGKYT-FDSP-----EWKNVSE 266 (494)
T ss_dssp CTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTCCC-CCSG-----GGTTSCH
T ss_pred CcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCCC-CCch-----hcccCCH
Confidence 99999999876 468999999999999999999999996543321 111111 11000 0000 0011223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+.+|+.+||+.||++|||+.++++
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhhCccHHHHhc
Confidence 5888999999999999999999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=301.22 Aligned_cols=247 Identities=28% Similarity=0.414 Sum_probs=181.9
Q ss_pred CCccEEeeeC--CC--CEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEe-CCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLA--DG--KEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-ENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~--~g--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|+.. ++ ..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+ ++..++||||+++++|.++
T Consensus 102 fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 181 (373)
T 3c1x_A 102 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181 (373)
T ss_dssp SSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHH
T ss_pred CeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHH
Confidence 7999999853 22 36899988654 34456788999999999999999999998654 4578999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc--cccee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA--NTNRI 152 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~ 152 (308)
+... ...+++..++.++.||+.||+|||++| |+||||||+||+++.++.+||+|||++.......... .....
T Consensus 182 l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~ 256 (373)
T 3c1x_A 182 IRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256 (373)
T ss_dssp HHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------------------
T ss_pred Hhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCC
Confidence 9643 335888999999999999999999998 9999999999999999999999999998654322111 12233
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.++..|+|||.+.+..++.++||||||+++|+|++ |.+||....... .... .. ...... ....
T Consensus 257 ~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~---~~-~~~~~~-----~p~~---- 320 (373)
T 3c1x_A 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY---LL-QGRRLL-----QPEY---- 320 (373)
T ss_dssp -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHH---HH-TTCCCC-----CCTT----
T ss_pred CCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHH---HH-cCCCCC-----CCCC----
Confidence 56778999999999899999999999999999999 667775433221 1110 10 111000 0111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTL 268 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~ 268 (308)
....+.+++.+||+.||++|||++++++.|+.....+
T Consensus 321 ~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 2235888999999999999999999999998764444
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.57 Aligned_cols=237 Identities=23% Similarity=0.349 Sum_probs=186.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc--------ccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG--------QGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||.||+++. .+|+.||||++..... ...+.+..|+.+++.+ +||||+++++++......++||||+++++
T Consensus 107 ~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~ 186 (365)
T 2y7j_A 107 SSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186 (365)
T ss_dssp SEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCB
T ss_pred CEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCc
Confidence 789999997 4899999999865431 1245678899999999 79999999999999999999999999999
Q ss_pred hhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccc
Q 021771 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTN 150 (308)
Q Consensus 71 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~ 150 (308)
|.+++... ..+++..+..++.||+.||.|||+.| ++|+||||+||+++.++.++|+|||++..+.... ...
T Consensus 187 L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~ 257 (365)
T 2y7j_A 187 LFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLR 257 (365)
T ss_dssp HHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBC
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccc
Confidence 99998643 35899999999999999999999998 9999999999999999999999999998765332 123
Q ss_pred eeecccCccCchhhcc------CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccc
Q 021771 151 RIVGTYGYMAPEYAME------GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVL 224 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
...|+..|+|||++.+ ..++.++|||||||++|+|++|..||....... ...... ..... ...+.
T Consensus 258 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~------~~~~i~-~~~~~-~~~~~- 328 (365)
T 2y7j_A 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL------MLRMIM-EGQYQ-FSSPE- 328 (365)
T ss_dssp CCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTCCC-CCHHH-
T ss_pred cCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-hCCCC-CCCcc-
Confidence 3568999999998864 357889999999999999999999986432211 000000 00000 00000
Q ss_pred cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 225 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 225 ~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.......+.+|+.+||+.||++|||+.++++
T Consensus 329 ----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 329 ----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011235888999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=287.45 Aligned_cols=244 Identities=19% Similarity=0.266 Sum_probs=193.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 27 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 106 (284)
T 2vgo_A 27 FGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ 106 (284)
T ss_dssp SEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred CeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHH
Confidence 789999996 47889999998543 22345678999999999999999999999999999999999999999999886
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.++|+|||++....... .....++.
T Consensus 107 ~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~ 176 (284)
T 2vgo_A 107 KH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTL 176 (284)
T ss_dssp HH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCG
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCC
Confidence 53 34899999999999999999999998 9999999999999999999999999987654321 22346789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++||||||+++|+|++|..||....... ....... ... . .+......+
T Consensus 177 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~-~~~-~---------~~~~~~~~~ 239 (284)
T 2vgo_A 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THRRIVN-VDL-K---------FPPFLSDGS 239 (284)
T ss_dssp GGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHT-TCC-C---------CCTTSCHHH
T ss_pred CcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHHHHhc-ccc-C---------CCCcCCHHH
Confidence 9999999998889999999999999999999999996543221 1111111 000 0 011122357
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH--HhhcCCCCCCCC
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV--MLASDTVTLPQP 271 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~--~L~~~~~~~~~~ 271 (308)
.+++.+||+.||++|||++++++ .+.....+..+|
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~ 276 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCC
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCC
Confidence 88999999999999999999995 455444444333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=309.38 Aligned_cols=239 Identities=23% Similarity=0.285 Sum_probs=192.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++... .......+.+|+.+|+.++||||+++++++.+.+.+++||||+++++|.+++.
T Consensus 197 fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~ 276 (576)
T 2acx_A 197 FGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 276 (576)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred CEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHH
Confidence 799999996 58999999998653 23345678899999999999999999999999999999999999999999886
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
... ...+++..++.++.||+.||+|||++| |+||||||+||+++.+|.+||+|||++....... ......|++
T Consensus 277 ~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~ 349 (576)
T 2acx_A 277 HMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTV 349 (576)
T ss_dssp SSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCG
T ss_pred hcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCc
Confidence 532 335899999999999999999999998 9999999999999999999999999998764332 122347899
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||...........+ ....... . . ..+......+
T Consensus 350 ~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i--~~~i~~~-~--~--------~~p~~~s~~~ 416 (576)
T 2acx_A 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV--ERLVKEV-P--E--------EYSERFSPQA 416 (576)
T ss_dssp GGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHH--HHHHHHC-C--C--------CCCTTSCHHH
T ss_pred cccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHH--HHHhhcc-c--c--------cCCccCCHHH
Confidence 999999999888999999999999999999999999754332111111 1111100 0 0 0011122358
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHH
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~ 259 (308)
.+||.+||+.||++|| +++||++
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 8899999999999999 7888884
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=288.27 Aligned_cols=241 Identities=23% Similarity=0.328 Sum_probs=186.4
Q ss_pred CCccEEeeeCC----CCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLAD----GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+++..+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.++ ..++||||+++++|.+++
T Consensus 25 ~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l 103 (281)
T 3cc6_A 25 FGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYL 103 (281)
T ss_dssp SSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHH
T ss_pred CeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHH
Confidence 79999998532 345999998755 344567889999999999999999999998754 568999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.... ..+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++......... ......++
T Consensus 104 ~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~ 177 (281)
T 3cc6_A 104 ERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLP 177 (281)
T ss_dssp HHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCC
T ss_pred Hhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCC
Confidence 6532 34899999999999999999999998 999999999999999999999999998765432211 12223457
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||.+.+..++.++||||||+++|+|++ |..||........ ... ........ .+.....
T Consensus 178 ~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~~----~~~~~~~~---------~~~~~~~ 241 (281)
T 3cc6_A 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IGV----LEKGDRLP---------KPDLCPP 241 (281)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HHH----HHHTCCCC---------CCTTCCH
T ss_pred cceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HHH----HhcCCCCC---------CCCCCCH
Confidence 78999999988889999999999999999998 9999864333211 110 00110000 0111223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+.+++.+||+.||++|||+.++++.|+..
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 588899999999999999999999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=297.18 Aligned_cols=250 Identities=20% Similarity=0.220 Sum_probs=178.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+|+.||||++.... ......+.+|+.+++.++||||+++++++.+++..++||||+++ +|.+++..
T Consensus 47 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~ 125 (329)
T 3gbz_A 47 YGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDK 125 (329)
T ss_dssp SSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH
T ss_pred CeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhh
Confidence 799999985 689999999996543 22345677999999999999999999999999999999999975 89888855
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC-----CCCCeeeecccceeeeCCCCCcccccee
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-----HEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~-----~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
.. .+++..++.++.||+.||+|||++| |+|+||||+||+++ .++.+||+|||++..+..... .....
T Consensus 126 ~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~ 197 (329)
T 3gbz_A 126 NP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHE 197 (329)
T ss_dssp CT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------
T ss_pred cC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCC
Confidence 33 4899999999999999999999998 99999999999994 445599999999976542221 12234
Q ss_pred ecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcc-------------cccc
Q 021771 153 VGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEG-------------EALE 218 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~ 218 (308)
.++..|+|||++.+. .++.++|||||||++|+|++|..||...................... ....
T Consensus 198 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (329)
T 3gbz_A 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPK 277 (329)
T ss_dssp --CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhh
Confidence 578999999998774 58999999999999999999999996543321100000000000000 0000
Q ss_pred cccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 219 LMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.....+...........+.+|+.+||+.||++|||++|+++
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 278 FRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000001112345789999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=307.90 Aligned_cols=237 Identities=24% Similarity=0.278 Sum_probs=186.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+|+.||||++... .......+.+|+.+|+.++||||+++++++.+....++|||||.+++|.+.+..
T Consensus 35 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 114 (486)
T 3mwu_A 35 FGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114 (486)
T ss_dssp SSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred CEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh
Confidence 799999996 58999999998643 234567889999999999999999999999999999999999999999888854
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC---CCCCeeeecccceeeeCCCCCccccceeec
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN---HEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
. ..+++..+..++.||+.||.|||++| |+||||||+||+++ .++.+||+|||++..+.... ......|
T Consensus 115 ~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~g 185 (486)
T 3mwu_A 115 R---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIG 185 (486)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTT
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcC
Confidence 3 35899999999999999999999998 99999999999995 45579999999987654322 1223468
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
++.|+|||++.+ .++.++|||||||++|+|++|..||....... ...... ......... .......
T Consensus 186 t~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~-~~~~~~~~~------~~~~~s~ 251 (486)
T 3mwu_A 186 TAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRVE-TGKYAFDLP------QWRTISD 251 (486)
T ss_dssp GGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTCCCSCSG------GGGGSCH
T ss_pred CCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCCCCCCCc------ccCCCCH
Confidence 999999998875 58999999999999999999999996432221 111111 111100000 0011223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+.+|+.+||+.||++|||+.++++.
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 58889999999999999999999963
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=297.96 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=188.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++...
T Consensus 46 ~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 125 (360)
T 3eqc_A 46 GGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 125 (360)
T ss_dssp SCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH
T ss_pred CeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc
Confidence 799999996 48999999998755 3445677899999999999999999999999999999999999999999998653
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhC-CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~-g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
..+++..+..++.|++.+|+|||+. | ++|+||||+||+++.++.++|+|||++...... ......++..
T Consensus 126 ---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~ 195 (360)
T 3eqc_A 126 ---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 195 (360)
T ss_dssp ---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCT
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCC
Confidence 2489999999999999999999985 7 999999999999999999999999998654211 1223467899
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH-----------------------Hhhhcc
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW-----------------------KLWCEG 214 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~-----------------------~~~~~~ 214 (308)
|+|||++.+..++.++||||||+++|+|++|..||................ ......
T Consensus 196 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (360)
T 3eqc_A 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPM 275 (360)
T ss_dssp TCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CC
T ss_pred eECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcc
Confidence 999999999899999999999999999999999997543321110000000 000000
Q ss_pred ccccccccccc----ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 215 EALELMEPVLK----QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 215 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...+.++.... ..........+.+|+.+||+.||++|||++|+++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 276 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp CHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000 0000112335888999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=297.50 Aligned_cols=255 Identities=13% Similarity=0.150 Sum_probs=191.0
Q ss_pred CCccEEeeeC---------CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccc---------------eeeeEEe-
Q 021771 1 MESCLQGKLA---------DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVR---------------LFGCCLE- 55 (308)
Q Consensus 1 ~g~v~~~~~~---------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------------~~~~~~~- 55 (308)
||.||+++.. +++.||+|++... ..+.+|+.+++.++||||++ +++++..
T Consensus 55 ~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~ 129 (352)
T 2jii_A 55 QGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ 129 (352)
T ss_dssp TEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEET
T ss_pred CeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccC
Confidence 7899999975 3899999998644 45789999999999999887 5667765
Q ss_pred CCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC--Ceeeec
Q 021771 56 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM--NPKISD 133 (308)
Q Consensus 56 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~--~~kl~d 133 (308)
+...++||||+ +++|.+++... ....+++..++.++.||+.||+|||++| ++|+||||+||+++.++ .+||+|
T Consensus 130 ~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~D 204 (352)
T 2jii_A 130 DKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAG 204 (352)
T ss_dssp TTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECC
T ss_pred CcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEec
Confidence 67889999999 99999999654 2346999999999999999999999998 99999999999999998 899999
Q ss_pred ccceeeeCCCCCc-----cccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH
Q 021771 134 FGMARIFGGNQSE-----ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW 208 (308)
Q Consensus 134 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~ 208 (308)
||++..+...... .......++..|+|||++.+..++.++||||||+++|+|++|..||........ ..... .
T Consensus 205 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~-~ 282 (352)
T 2jii_A 205 YGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE-DIMKQ-K 282 (352)
T ss_dssp GGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH-HHHHH-H
T ss_pred CcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHH-HHHHH-H
Confidence 9999876432211 111234688999999999988899999999999999999999999975532211 11111 1
Q ss_pred HhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCCCC
Q 021771 209 KLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQP 271 (308)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~ 271 (308)
..+. .............. .....+.+|+.+||+.||++|||+++|++.|+.........
T Consensus 283 ~~~~-~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 283 QKFV-DKPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp HHHH-HSCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred Hhcc-CChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 1111 11111111110000 11235888889999999999999999999998775444433
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.34 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=186.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEe--------CCeEEEEEEecCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--------ENESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~ 69 (308)
||.||+++. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+ .+..++||||+++
T Consensus 30 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~- 108 (351)
T 3mi9_A 30 FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH- 108 (351)
T ss_dssp TTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-
T ss_pred CcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-
Confidence 799999996 689999999986543 2334677899999999999999999999987 3468999999976
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc--c
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--A 147 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--~ 147 (308)
+|...+.... ..+++..++.++.||+.||+|||++| |+|+||||+||+++.++.+||+|||++..+...... .
T Consensus 109 ~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 183 (351)
T 3mi9_A 109 DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183 (351)
T ss_dssp EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCC
T ss_pred CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhccccccccccccc
Confidence 6666664432 34899999999999999999999998 999999999999999999999999999876532221 1
Q ss_pred ccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccc--------cc
Q 021771 148 NTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEA--------LE 218 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 218 (308)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+...........+ .+
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 263 (351)
T 3mi9_A 184 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 263 (351)
T ss_dssp CCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGT
T ss_pred ccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhc
Confidence 2233467899999998876 45799999999999999999999999754332211111100000000000 00
Q ss_pred ccccccc-ccchHHH------HHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 219 LMEPVLK-QSCVAAE------LLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 219 ~~~~~~~-~~~~~~~------~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+..... ....... ...+.+|+.+||+.||++|||++|+++-
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 264 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp SSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000 0001111 2347889999999999999999999974
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=287.78 Aligned_cols=231 Identities=23% Similarity=0.297 Sum_probs=182.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++||||+++++|.+++.
T Consensus 24 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 103 (289)
T 1x8b_A 24 FGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAIS 103 (289)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred ceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHH
Confidence 789999996 48999999998754 233456788899999999 89999999999999999999999999999999986
Q ss_pred cCCC-ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-------------------Ceeeecccc
Q 021771 77 DSTR-SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-------------------NPKISDFGM 136 (308)
Q Consensus 77 ~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-------------------~~kl~dfg~ 136 (308)
.... ...+++..++.++.||+.||+|||++| ++|+||||+||+++.++ .++|+|||.
T Consensus 104 ~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 180 (289)
T 1x8b_A 104 ENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180 (289)
T ss_dssp HHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CCCEEECCCTT
T ss_pred hhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEccccc
Confidence 5321 245899999999999999999999998 99999999999998544 799999999
Q ss_pred eeeeCCCCCccccceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccc
Q 021771 137 ARIFGGNQSEANTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGE 215 (308)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 215 (308)
+....... ...++..|+|||++.+. .++.++||||||+++|+|++|.+++..... ........
T Consensus 181 ~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----------~~~~~~~~ 244 (289)
T 1x8b_A 181 VTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----------WHEIRQGR 244 (289)
T ss_dssp CEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----------HHHHHTTC
T ss_pred ccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----------HHHHHcCC
Confidence 98764322 12478899999998765 667899999999999999999877543211 11111111
Q ss_pred ccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 216 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.... ... ....+.+++.+||+.||++|||+.++++
T Consensus 245 ~~~~-----~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 245 LPRI-----PQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCC-----SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC-----Ccc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1111 111 1235888999999999999999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=298.70 Aligned_cols=233 Identities=29% Similarity=0.402 Sum_probs=184.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+. +++.+++.
T Consensus 67 ~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~ 145 (348)
T 1u5q_A 67 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE 145 (348)
T ss_dssp SEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHH
T ss_pred CEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHH
Confidence 799999995 689999999986542 2334578899999999999999999999999999999999997 57777664
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ...+++..+..++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++..... .....|+.
T Consensus 146 ~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~ 214 (348)
T 1u5q_A 146 VH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTP 214 (348)
T ss_dssp HH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCG
T ss_pred Hh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC------CCcccCCc
Confidence 32 235899999999999999999999998 99999999999999999999999999976532 12346889
Q ss_pred CccCchhhc---cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 157 GYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 157 ~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.|+|||++. +..++.++|||||||++|+|++|..||...... ........ ........ .. ..
T Consensus 215 ~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~-~~~~~~~~----~~----~~ 279 (348)
T 1u5q_A 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ-NESPALQS----GH----WS 279 (348)
T ss_dssp GGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-SCCCCCCC----TT----SC
T ss_pred ceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHh-cCCCCCCC----CC----CC
Confidence 999999885 467889999999999999999999998543221 11111111 11111111 11 12
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+.+|+.+||+.||++|||++++++.
T Consensus 280 ~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 280 EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 347888999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=309.26 Aligned_cols=236 Identities=23% Similarity=0.278 Sum_probs=188.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||||.+++|.+++.
T Consensus 39 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 118 (484)
T 3nyv_A 39 FGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118 (484)
T ss_dssp TEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred CEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH
Confidence 799999996 589999999986542 4456789999999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe---CCCCCeeeecccceeeeCCCCCccccceee
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---NHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
.. ..+++..+..++.||+.||+|||++| |+||||||+||++ +.++.+||+|||++..+.... ......
T Consensus 119 ~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~ 189 (484)
T 3nyv_A 119 SR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKI 189 (484)
T ss_dssp TC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHT
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCC
Confidence 43 35899999999999999999999998 9999999999999 567889999999998764332 122346
Q ss_pred cccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
|++.|+|||++.+ .++.++|||||||++|+|++|.+||....... ...... ........ .......
T Consensus 190 gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~-~~~~~~~~------~~~~~~s 255 (484)
T 3nyv_A 190 GTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD------ILKKVE-KGKYTFEL------PQWKKVS 255 (484)
T ss_dssp TGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCCCCCS------GGGGGSC
T ss_pred CCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHH-cCCCCCCC------cccccCC
Confidence 8999999998866 68999999999999999999999996543221 111111 11110000 0001122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..+.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 256 ESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 35888999999999999999999995
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=284.38 Aligned_cols=236 Identities=23% Similarity=0.342 Sum_probs=189.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++...
T Consensus 42 ~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~- 118 (314)
T 3com_A 42 YGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR- 118 (314)
T ss_dssp -CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH-
T ss_pred CeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhc-
Confidence 799999996 469999999986543 3467889999999999999999999999999999999999999999998532
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
...+++..++.++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||++........ ......++..|+
T Consensus 119 -~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~ 192 (314)
T 3com_A 119 -NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWM 192 (314)
T ss_dssp -TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGC
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCcc
Confidence 235899999999999999999999998 99999999999999999999999999987653322 122346788999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||++.+..++.++||||||+++|+|++|..||....... ...... ........ .+......+.+|
T Consensus 193 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~~-------~~~~~~~~l~~l 258 (314)
T 3com_A 193 APEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIP-TNPPPTFR-------KPELWSDNFTDF 258 (314)
T ss_dssp CHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHH-HSCCCCCS-------SGGGSCHHHHHH
T ss_pred ChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHh-cCCCcccC-------CcccCCHHHHHH
Confidence 9999988889999999999999999999999986432211 011100 00000000 011112358889
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
+.+||+.||++|||+.++++
T Consensus 259 i~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 259 VKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHccCChhhCcCHHHHHh
Confidence 99999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=288.53 Aligned_cols=248 Identities=26% Similarity=0.336 Sum_probs=183.0
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcC--CCcCccceeeeEEeC----CeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL--QHKNLVRLFGCCLEE----NESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+++.. |+.||||++... .......|.+++..+ +||||+++++++.+. ...++||||+++++|.++
T Consensus 50 ~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 125 (337)
T 3mdy_A 50 YGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY 125 (337)
T ss_dssp TEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHH
T ss_pred CeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHH
Confidence 7999999874 899999998533 223445566666555 899999999999887 678999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhC--------CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHED--------SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--------g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
+... .+++..++.++.|++.||+|||++ | ++|+||||+||+++.++.+||+|||++..+......
T Consensus 126 l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 198 (337)
T 3mdy_A 126 LKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198 (337)
T ss_dssp HHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred hhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeecccccc
Confidence 9542 489999999999999999999998 7 999999999999999999999999999876433222
Q ss_pred cc--cceeecccCccCchhhccCccccc------ccchhhhHHHHHHHhCCc----------CCCccccccccchhHHHH
Q 021771 147 AN--TNRIVGTYGYMAPEYAMEGLFSVK------SDVFSFGVLLLEIISGKK----------NTGFYLSELGQSLLSYTW 208 (308)
Q Consensus 147 ~~--~~~~~~~~~y~aPE~~~~~~~~~~------~Di~slG~~l~~l~~~~~----------p~~~~~~~~~~~~~~~~~ 208 (308)
.. .....|+..|+|||++.+...... +|||||||++|+|++|.. ||......... .....
T Consensus 199 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~~ 276 (337)
T 3mdy_A 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS--YEDMR 276 (337)
T ss_dssp ----CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHH
T ss_pred ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc--hhhhH
Confidence 11 123468999999999887655544 999999999999999944 44322211110 11111
Q ss_pred Hhhhcccccccccccccc-cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 209 KLWCEGEALELMEPVLKQ-SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
........ .+.... .........+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 277 ~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 277 EIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp HHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 11111111 111111 112345667899999999999999999999999998653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=288.83 Aligned_cols=236 Identities=28% Similarity=0.368 Sum_probs=181.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeC-CeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE-NESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+++. +|+.||+|++... ...+.+.+|+.+++.++||||+++++++.+. +..++||||+++++|.+++...
T Consensus 34 ~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 109 (278)
T 1byg_A 34 FGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR- 109 (278)
T ss_dssp SCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH-
T ss_pred CceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc-
Confidence 789999987 5889999998644 3457789999999999999999999997654 4689999999999999998543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
....+++..++.++.|++.||+|||++| ++|+||||+||+++.++.++|+|||++....... ....++..|+
T Consensus 110 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~ 181 (278)
T 1byg_A 110 GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWT 181 (278)
T ss_dssp HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTS
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCcccccc
Confidence 2234788999999999999999999998 9999999999999999999999999987643221 1234577899
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
|||.+.+..++.++||||||+++|+|++ |..||........ . ......... ..+......+.+
T Consensus 182 aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~----~~~~~~~~~---------~~~~~~~~~l~~ 245 (278)
T 1byg_A 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V----PRVEKGYKM---------DAPDGCPPAVYE 245 (278)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H----HHHTTTCCC---------CCCTTCCHHHHH
T ss_pred CHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHhcCCCC---------CCcccCCHHHHH
Confidence 9999988889999999999999999998 9999865432211 1 011111000 011112335888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
++.+||+.||++|||+.++++.|+..
T Consensus 246 li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=319.73 Aligned_cols=241 Identities=28% Similarity=0.383 Sum_probs=188.5
Q ss_pred CCccEEeee---CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL---ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~---~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|.+ ..++.||||+++.. .....+.+.+|+.+|+.++||||+++++++.+ ...++||||+++++|.+++
T Consensus 382 fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l 460 (635)
T 4fl3_A 382 FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL 460 (635)
T ss_dssp SEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHH
T ss_pred CEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHH
Confidence 799999964 35789999999754 33446789999999999999999999999975 4588999999999999999
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~ 154 (308)
... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..+...... .......+
T Consensus 461 ~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~ 534 (635)
T 4fl3_A 461 QQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534 (635)
T ss_dssp HHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------
T ss_pred hhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCC
Confidence 643 34899999999999999999999998 999999999999999999999999999876433211 11222345
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
+..|+|||++.+..++.++||||||+++|+|++ |..||........ .......... ..+....
T Consensus 535 t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~~~---------~~p~~~~ 598 (635)
T 4fl3_A 535 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGERM---------GCPAGCP 598 (635)
T ss_dssp CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCCC---------CCCTTCC
T ss_pred ceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCCC---------CCCCCCC
Confidence 678999999999899999999999999999998 9999965433211 1111111111 1111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+|+.+||+.||++|||+++|++.|+..
T Consensus 599 ~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 599 REMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 4588899999999999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=294.77 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=185.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc-----cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ-----GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+++. .+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+....++||||+++ +|..+
T Consensus 23 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~ 101 (346)
T 1ua2_A 23 FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVI 101 (346)
T ss_dssp TEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHH
T ss_pred CEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHH
Confidence 789999996 57999999998643211 124677999999999999999999999999999999999976 78877
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+... ...+++..+..++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++..+..... ......+
T Consensus 102 ~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~ 174 (346)
T 1ua2_A 102 IKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVV 174 (346)
T ss_dssp HTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCC
T ss_pred HHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccc
Confidence 7543 335888999999999999999999998 99999999999999999999999999986543221 1223467
Q ss_pred ccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhh---hccccccc---cccc---c
Q 021771 155 TYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLW---CEGEALEL---MEPV---L 224 (308)
Q Consensus 155 ~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---~~~~---~ 224 (308)
+..|+|||++.+. .++.++|||||||++|+|++|.+||......... ....... ....+... .+.. .
T Consensus 175 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T 1ua2_A 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLPDYVTFKS 251 (346)
T ss_dssp CCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred cccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHcCCCChhhhhhhccCcccccccc
Confidence 8999999988764 5889999999999999999999998654322110 1010000 00001000 0000 0
Q ss_pred ccc-----chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHh
Q 021771 225 KQS-----CVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 261 (308)
Q Consensus 225 ~~~-----~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L 261 (308)
... ........+.+|+.+||+.||++|||++|+++.-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 252 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred cCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 0112235688999999999999999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=283.29 Aligned_cols=235 Identities=22% Similarity=0.302 Sum_probs=190.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+++.+|+|++... .....+.+.+|+.+++.++|+||+++++++.+.+..++||||+++++|.+++.
T Consensus 28 ~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 107 (294)
T 2rku_A 28 FAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 107 (294)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred CEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHH
Confidence 789999996 47899999998654 23455678899999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.+||+|||++........ ......++.
T Consensus 108 ~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~ 179 (294)
T 2rku_A 108 RR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTP 179 (294)
T ss_dssp HH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCC
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCC
Confidence 43 35899999999999999999999998 99999999999999999999999999987643222 123346789
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||.+.+..++.++||||||+++|+|++|..||....... ..... ..... . ... .....+
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~~-~-----~~~----~~~~~~ 242 (294)
T 2rku_A 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLRI-KKNEY-S-----IPK----HINPVA 242 (294)
T ss_dssp SSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHH-HTTCC-C-----CCT----TSCHHH
T ss_pred CcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-hhccC-C-----Ccc----ccCHHH
Confidence 9999999988889999999999999999999999986543221 01111 11100 0 001 112357
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+++.+||+.||++|||++++++.
T Consensus 243 ~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 243 ASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHcccChhhCcCHHHHhhC
Confidence 888999999999999999999963
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=305.50 Aligned_cols=241 Identities=24% Similarity=0.302 Sum_probs=192.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||+|++.... ......+..|+.+|+.++||||+++++++.+...+++||||+++++|..++.
T Consensus 198 fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~ 277 (543)
T 3c4z_A 198 FGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277 (543)
T ss_dssp SSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH
T ss_pred CeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHH
Confidence 799999996 579999999996442 2345678899999999999999999999999999999999999999999886
Q ss_pred cCC-CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DST-RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ....+++..++.++.||+.||.|||++| |+||||||+||+++.+|.+||+|||++..+..... ......||
T Consensus 278 ~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT 352 (543)
T 3c4z_A 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGT 352 (543)
T ss_dssp TSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC--CBCCCCSC
T ss_pred HhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCc--ccccccCC
Confidence 543 2346999999999999999999999998 99999999999999999999999999987653322 12334789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+.|+|||++.+..++.++|||||||++|+|++|..||........ ............ . ..+......
T Consensus 353 ~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~-~----------~~p~~~s~~ 419 (543)
T 3c4z_A 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQA-V----------TYPDKFSPA 419 (543)
T ss_dssp TTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCC-C----------CCCTTSCHH
T ss_pred ccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcc-c----------CCCcccCHH
Confidence 999999999998999999999999999999999999975432211 111111111110 0 011112335
Q ss_pred HHHHHhhcccCCCCCCCCH-----HHHHH
Q 021771 236 FIHIGLLCVQADSADRPTM-----SSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~-----~eil~ 259 (308)
+.+|+.+||+.||++||++ ++|++
T Consensus 420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 7888999999999999965 66763
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=301.11 Aligned_cols=228 Identities=15% Similarity=0.181 Sum_probs=174.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHH---HHhcCCCcCcccee-------eeEEeCCe--------
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVT---LIAKLQHKNLVRLF-------GCCLEENE-------- 58 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~i~~~~-------~~~~~~~~-------- 58 (308)
||.||+|+. .+|+.||||++... .....+.+.+|+. .|+.++||||++++ +++.+.+.
T Consensus 86 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (377)
T 3byv_A 86 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 165 (377)
T ss_dssp TEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC--
T ss_pred CEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCcccccccc
Confidence 799999995 67999999998743 3445678889995 45555799999998 66665532
Q ss_pred ---------EEEEEEecCCCChhhHhhcCCC----ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC
Q 021771 59 ---------SLLIYEYMPNKSLDVFLFDSTR----SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125 (308)
Q Consensus 59 ---------~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~ 125 (308)
.++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 166 ~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~ 241 (377)
T 3byv_A 166 DERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQ 241 (377)
T ss_dssp ----CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred CCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 78999999 6799999865311 123445888899999999999999998 999999999999999
Q ss_pred CCCeeeecccceeeeCCCCCccccceeecccCccCchhhccC-----------cccccccchhhhHHHHHHHhCCcCCCc
Q 021771 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG-----------LFSVKSDVFSFGVLLLEIISGKKNTGF 194 (308)
Q Consensus 126 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Di~slG~~l~~l~~~~~p~~~ 194 (308)
++.+||+|||++..... ......| ..|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 242 ~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~ 315 (377)
T 3byv_A 242 RGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315 (377)
T ss_dssp TCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcc
Confidence 99999999999986322 2223456 899999999877 789999999999999999999999864
Q ss_pred cccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 195 YLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
......... .... . ... ...+.+|+.+||+.||++|||+.++++
T Consensus 316 ~~~~~~~~~---------------~~~~-~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 316 DAALGGSEW---------------IFRS-C-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp ----CCSGG---------------GGSS-C-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred cccccchhh---------------hhhh-c-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 432221110 0000 0 111 235888999999999999999999985
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=306.04 Aligned_cols=248 Identities=22% Similarity=0.221 Sum_probs=181.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeC------CeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE------NESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L 71 (308)
||+||++.. .+|+.||||++... .......+.+|+.+|+.++||||+++++++... ...++||||++++ +
T Consensus 75 ~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l 153 (464)
T 3ttj_A 75 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-L 153 (464)
T ss_dssp SCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-H
T ss_pred CeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-H
Confidence 799999985 57999999999654 344556788999999999999999999999754 3579999999764 5
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
...+.. .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... ....
T Consensus 154 ~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~ 222 (464)
T 3ttj_A 154 CQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTP 222 (464)
T ss_dssp HHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC--
T ss_pred HHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCC
Confidence 555521 3889999999999999999999998 9999999999999999999999999998754321 2233
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhH----------------HHHHhhhcc-
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLS----------------YTWKLWCEG- 214 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~----------------~~~~~~~~~- 214 (308)
..|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+. .........
T Consensus 223 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~ 302 (464)
T 3ttj_A 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 302 (464)
T ss_dssp --CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSC
T ss_pred CcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhccc
Confidence 578999999999999899999999999999999999999997543221100000 000000000
Q ss_pred -----cccccccccc-c--ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 215 -----EALELMEPVL-K--QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 215 -----~~~~~~~~~~-~--~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.....+.... . ..........+.+|+.+||+.||++|||++|+++-
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 303 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 0 00111224568899999999999999999999963
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=304.21 Aligned_cols=247 Identities=17% Similarity=0.215 Sum_probs=191.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCC-cCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH-KNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++. .+|+.||||++...... ..+..|+.+++.++| ++|..+..++......++||||+ +++|.+++...
T Consensus 20 fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~ 96 (483)
T 3sv0_A 20 FGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC 96 (483)
T ss_dssp SCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred CEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhh
Confidence 799999995 68999999988654332 357889999999986 55666666777788899999999 88999998653
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe---CCCCCeeeecccceeeeCCCCCcc-----ccc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL---NHEMNPKISDFGMARIFGGNQSEA-----NTN 150 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv---~~~~~~kl~dfg~~~~~~~~~~~~-----~~~ 150 (308)
. ..+++..++.++.||+.||+|||++| |+|+||||+|||+ +.++.+||+|||++..+....... ...
T Consensus 97 ~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 171 (483)
T 3sv0_A 97 S--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171 (483)
T ss_dssp T--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCC
T ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccccccccc
Confidence 3 35999999999999999999999998 9999999999999 588899999999998875433221 122
Q ss_pred eeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 151 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
...|+..|+|||++.+..++.++|||||||++|+|++|..||................... ....+.... .
T Consensus 172 ~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----~~~~~~~l~-~---- 242 (483)
T 3sv0_A 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----VATSIEALC-R---- 242 (483)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH----HHSCHHHHH-T----
T ss_pred ccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc----ccccHHHHh-c----
Confidence 4578999999999999999999999999999999999999997654432221111111111 111111000 1
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.....+.+|+..||+.+|++||++.+|++.|+..
T Consensus 243 ~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 243 GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1124588999999999999999999999988654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=297.61 Aligned_cols=246 Identities=22% Similarity=0.278 Sum_probs=184.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------eEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L 71 (308)
||.||+++. .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.... .+++||||+ +++|
T Consensus 38 ~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L 116 (367)
T 1cm8_A 38 YGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL 116 (367)
T ss_dssp --CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEH
T ss_pred CeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCH
Confidence 799999996 68999999998544 2334567889999999999999999999998753 469999999 7899
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++.. ..+++..+..++.||+.||+|||++| ++||||||+||+++.++.+||+|||++...... ...
T Consensus 117 ~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~ 184 (367)
T 1cm8_A 117 GKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTG 184 (367)
T ss_dssp HHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCS
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCc
Confidence 998854 34899999999999999999999998 999999999999999999999999999875432 223
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHH--------HHhhhcc-------c
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYT--------WKLWCEG-------E 215 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~-------~ 215 (308)
..++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+... ....... .
T Consensus 185 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 264 (367)
T 1cm8_A 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264 (367)
T ss_dssp SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH
T ss_pred CcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHh
Confidence 467899999998877 67899999999999999999999999754332110000000 0000000 0
Q ss_pred ccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 216 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
......... ..........+.+|+.+||+.||++|||++|+++-
T Consensus 265 ~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 265 LPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp SCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000000 00111223458889999999999999999999973
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=294.51 Aligned_cols=241 Identities=21% Similarity=0.257 Sum_probs=187.7
Q ss_pred CCccEEeee----CCCCEEEEEEeccCC----cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL----ADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
||.||+++. .+|+.||||+++... ....+.+..|+.+|+.+ .||||+++++++.+....++||||+++++|
T Consensus 67 ~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 146 (355)
T 1vzo_A 67 YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 146 (355)
T ss_dssp TEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred CEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCH
Confidence 799999986 479999999986432 23445677899999999 699999999999999999999999999999
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++... ..+++..+..++.||+.||.|||++| |+|+||||+||+++.++.+||+|||++..+...... ....
T Consensus 147 ~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~ 219 (355)
T 1vzo_A 147 FTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYD 219 (355)
T ss_dssp HHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCG
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-cccC
Confidence 9998653 34899999999999999999999998 999999999999999999999999999876422211 1223
Q ss_pred eecccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 152 IVGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
..|+..|+|||++.+ ..++.++|||||||++|+|++|..||......... ........... . ..+
T Consensus 220 ~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~-------~----~~~ 286 (355)
T 1vzo_A 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSE-------P----PYP 286 (355)
T ss_dssp GGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCC-------C----CCC
T ss_pred cccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccC-------C----CCC
Confidence 468999999999875 34788999999999999999999999654332211 11111111110 0 011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHHHh
Q 021771 230 AAELLKFIHIGLLCVQADSADRP-----TMSSVVVML 261 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~~L 261 (308)
......+.+|+.+||+.||++|| |++|+++..
T Consensus 287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 11223578899999999999999 999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.93 Aligned_cols=238 Identities=22% Similarity=0.358 Sum_probs=183.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.+|+|++........+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++....
T Consensus 32 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 111 (302)
T 2j7t_A 32 FGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD 111 (302)
T ss_dssp TCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT
T ss_pred CeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc
Confidence 799999996 4699999999977777777889999999999999999999999999999999999999999999886532
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..++.++.|++.||.|||++| ++|+||+|+||+++.++.+||+|||++...... ........++..|+
T Consensus 112 --~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~ 184 (302)
T 2j7t_A 112 --RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWM 184 (302)
T ss_dssp --SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGC
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhc
Confidence 34899999999999999999999998 999999999999999999999999987532111 01122346788999
Q ss_pred Cchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 160 APEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 160 aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
|||++. +..++.++||||||+++|+|++|..||....... ........ ...... .+.....
T Consensus 185 aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~~~~~~-------~~~~~~~ 250 (302)
T 2j7t_A 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAKS-DPPTLL-------TPSKWSV 250 (302)
T ss_dssp CHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-CCCCCS-------SGGGSCH
T ss_pred CCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhcc-CCcccC-------CccccCH
Confidence 999884 5668899999999999999999999986543221 11111111 111100 0111223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+.+++.+||+.||++|||+.++++
T Consensus 251 ~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHcccChhhCCCHHHHhc
Confidence 5888999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=306.37 Aligned_cols=236 Identities=25% Similarity=0.322 Sum_probs=186.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc-------------ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEec
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG-------------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 66 (308)
||+||+++. .+++.+|+|++..... ...+.+.+|+.+|+.++||||+++++++.+....++|||||
T Consensus 49 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 128 (504)
T 3q5i_A 49 YGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128 (504)
T ss_dssp CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecC
Confidence 799999996 5789999999865421 34567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC---CeeeecccceeeeCCC
Q 021771 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM---NPKISDFGMARIFGGN 143 (308)
Q Consensus 67 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~---~~kl~dfg~~~~~~~~ 143 (308)
++++|.+++... ..+++..+..++.||+.||+|||++| |+||||||+||+++.++ .+||+|||++..+...
T Consensus 129 ~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 129 EGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202 (504)
T ss_dssp TTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC
Confidence 999999888543 34999999999999999999999998 99999999999999776 6999999999876533
Q ss_pred CCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccc
Q 021771 144 QSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 144 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
. ......|++.|+|||++. ..++.++|||||||++|+|++|..||....... ...... ...... .
T Consensus 203 ~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~-~~~~~~--~-- 267 (504)
T 3q5i_A 203 Y---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD------IIKKVE-KGKYYF--D-- 267 (504)
T ss_dssp S---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HCCCCC--C--
T ss_pred C---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-cCCCCC--C--
Confidence 2 222346899999999876 468999999999999999999999996543221 111111 110000 0
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..........+.+|+.+||+.||++|||++|+++
T Consensus 268 --~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 268 --FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp --HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000111245888999999999999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.86 Aligned_cols=185 Identities=24% Similarity=0.405 Sum_probs=153.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeC-----CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE-----NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+|+.||||++... .....+.+.+|+.+|+.++|+||+++++++... ...++||||++ ++|.
T Consensus 39 ~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 117 (432)
T 3n9x_A 39 YGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLK 117 (432)
T ss_dssp TEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHH
T ss_pred CEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHH
Confidence 799999995 57999999999654 334556788999999999999999999999876 56899999996 5999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc------
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE------ 146 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~------ 146 (308)
+++.. ...+++..+..++.||+.||.|||++| |+||||||+||+++.++.+||+|||++.........
T Consensus 118 ~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 191 (432)
T 3n9x_A 118 KLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191 (432)
T ss_dssp HHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC------------
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccc
Confidence 98854 345999999999999999999999998 999999999999999999999999999876533211
Q ss_pred --------------cccceeecccCccCchhh-ccCcccccccchhhhHHHHHHHhCCcCC
Q 021771 147 --------------ANTNRIVGTYGYMAPEYA-MEGLFSVKSDVFSFGVLLLEIISGKKNT 192 (308)
Q Consensus 147 --------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~~~~p~ 192 (308)
.......+|..|+|||++ .+..++.++|||||||++|+|++|..||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 112345789999999986 4567999999999999999999865554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=285.83 Aligned_cols=236 Identities=24% Similarity=0.357 Sum_probs=184.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe----CCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE----ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+|.. .++..|++|++... .....+.+.+|+.+++.++||||+++++++.. ....++||||+++++|.+
T Consensus 39 ~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 118 (290)
T 1t4h_A 39 FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT 118 (290)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHH
T ss_pred CeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHH
Confidence 799999985 67899999998644 34456788999999999999999999999875 345899999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC-CCCCeeeecccceeeeCCCCCcccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
++... ..+++..++.++.||+.||.|||+.| ..++|+||||+||+++ .++.+||+|||++...... .....
T Consensus 119 ~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~ 190 (290)
T 1t4h_A 119 YLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAV 190 (290)
T ss_dssp HHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEES
T ss_pred HHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccc
Confidence 99543 34889999999999999999999883 2399999999999998 7889999999998654322 22334
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.++..|+|||++.+ .++.++||||||+++|+|++|..||....... . .............. ....
T Consensus 191 ~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~-~~~~~~~~~~~~~~--------~~~~ 255 (290)
T 1t4h_A 191 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----Q-IYRRVTSGVKPASF--------DKVA 255 (290)
T ss_dssp CSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----H-HHHHHTTTCCCGGG--------GGCC
T ss_pred cCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----H-HHHHHhccCCcccc--------CCCC
Confidence 67899999998764 58899999999999999999999986432211 1 11111111111111 1111
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...+.+++.+||+.||++|||++++++
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 235888999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=284.75 Aligned_cols=238 Identities=21% Similarity=0.216 Sum_probs=184.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC----cccHHHHHHHHHHHhcCCCcCccceeeeEE--eCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHKNLVRLFGCCL--EENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||++.. .+|+.+|+|++.... ......+.+|+.+++.++|+||+++++++. +....++||||++++ +.+
T Consensus 18 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~ 96 (305)
T 2wtk_C 18 YGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQE 96 (305)
T ss_dssp SCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHH
T ss_pred CeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHH
Confidence 799999996 579999999986442 345578899999999999999999999984 445789999999876 666
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
++... ....+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+|||++................
T Consensus 97 ~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 172 (305)
T 2wtk_C 97 MLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172 (305)
T ss_dssp HHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCC
T ss_pred HHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCC
Confidence 66543 2346899999999999999999999998 9999999999999999999999999998765433333333456
Q ss_pred cccCccCchhhccCc--ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 154 GTYGYMAPEYAMEGL--FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
++..|+|||++.+.. .+.++||||||+++|+|++|..||....... ..... ..... . ....
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~i-~~~~~-~-----~~~~---- 235 (305)
T 2wtk_C 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK------LFENI-GKGSY-A-----IPGD---- 235 (305)
T ss_dssp SCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHH-HHCCC-C-----CCSS----
T ss_pred CCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH------HHHHH-hcCCC-C-----CCCc----
Confidence 889999999887643 4779999999999999999999986532211 11111 11100 0 0111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
....+.+++.+||+.||++|||++++++.
T Consensus 236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 22357889999999999999999999963
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=289.98 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=173.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||++.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++...
T Consensus 28 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 107 (303)
T 2vwi_A 28 TAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHI 107 (303)
T ss_dssp CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHH
T ss_pred ceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHH
Confidence 799999985 589999999886442 334567889999999999999999999999999999999999999999988641
Q ss_pred -----CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC---ccccc
Q 021771 79 -----TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS---EANTN 150 (308)
Q Consensus 79 -----~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~---~~~~~ 150 (308)
.....+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 108 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 184 (303)
T 2vwi_A 108 VAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184 (303)
T ss_dssp HHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC------------
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhc
Confidence 12345899999999999999999999998 99999999999999999999999999876543211 11123
Q ss_pred eeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 151 RIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
...++..|+|||++.+ ..++.++||||||+++|+|++|..||........ . ...... ...............
T Consensus 185 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~~~-~~~~~~~~~~~~~~~ 257 (303)
T 2vwi_A 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L---MLTLQN-DPPSLETGVQDKEML 257 (303)
T ss_dssp ---CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H---HHHHTS-SCCCTTC-----CCC
T ss_pred ccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H---HHHhcc-CCCccccccccchhh
Confidence 3467899999998876 5678999999999999999999999865433211 0 000000 000000000000001
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
......+.+++.+||+.||++|||+.++++
T Consensus 258 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 258 KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111235888999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=300.59 Aligned_cols=181 Identities=22% Similarity=0.394 Sum_probs=145.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeC-----CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE-----NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~ 72 (308)
||+||+++. .+|+.||||++... .....+.+.+|+.+|+.++|+||+++++++... ..+++||||+ +++|.
T Consensus 66 ~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~ 144 (458)
T 3rp9_A 66 YGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFK 144 (458)
T ss_dssp --CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHH
T ss_pred CeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchh
Confidence 799999985 58999999998654 334556788999999999999999999998543 5689999998 56888
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc------
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE------ 146 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~------ 146 (308)
.++.. ...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++.........
T Consensus 145 ~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 218 (458)
T 3rp9_A 145 KLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218 (458)
T ss_dssp HHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-
T ss_pred hhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccCcccccccccc
Confidence 88854 345999999999999999999999998 999999999999999999999999999876422111
Q ss_pred -------------------cccceeecccCccCchhh-ccCcccccccchhhhHHHHHHHhC
Q 021771 147 -------------------ANTNRIVGTYGYMAPEYA-MEGLFSVKSDVFSFGVLLLEIISG 188 (308)
Q Consensus 147 -------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~~ 188 (308)
.......||..|+|||++ .+..++.++|||||||++|+|++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp --------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 112334679999999976 456799999999999999999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.37 Aligned_cols=250 Identities=27% Similarity=0.331 Sum_probs=179.9
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHH--HhcCCCcCccceeeeEEe-----CCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTL--IAKLQHKNLVRLFGCCLE-----ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+|+. +|+.||||++.... ...+..|.++ +..++|+||+++++.+.. ...+++||||+++++|.+
T Consensus 26 ~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 101 (336)
T 3g2f_A 26 YGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK 101 (336)
T ss_dssp SEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHH
T ss_pred CeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHH
Confidence 799999977 78999999986432 2334444444 445789999999986542 235789999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhC---------CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCC
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHED---------SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQ 144 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---------g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~ 144 (308)
++... ..++..++.++.||+.||+|||+. | |+|+||||+||+++.++.+||+|||++..+....
T Consensus 102 ~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~ 174 (336)
T 3g2f_A 102 YLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174 (336)
T ss_dssp HHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSS
T ss_pred HHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeeccccc
Confidence 98543 358889999999999999999998 8 9999999999999999999999999998765332
Q ss_pred Cc------cccceeecccCccCchhhcc-------CcccccccchhhhHHHHHHHhCCcCCCccccccc-cchhH-----
Q 021771 145 SE------ANTNRIVGTYGYMAPEYAME-------GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELG-QSLLS----- 205 (308)
Q Consensus 145 ~~------~~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-~~~~~----- 205 (308)
.. .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||........ .....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3g2f_A 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN 254 (336)
T ss_dssp CC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCS
T ss_pred ccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCC
Confidence 11 11223468899999999876 4567889999999999999999776533222111 11100
Q ss_pred -----HHHHhhhccc-ccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 206 -----YTWKLWCEGE-ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 206 -----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.......... ........ .........+.+|+.+||+.||++|||++|+++.|+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 255 HPTFEDMQVLVSREKQRPKFPEAW---KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCTTC---CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CchHHHHHhhhcccccCCCCCccc---ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 0000000000 01110100 11223455689999999999999999999999998775
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=286.61 Aligned_cols=243 Identities=19% Similarity=0.252 Sum_probs=184.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEe--CCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLE--ENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||+|++... ..+.+.+|+.+++.++ ||||+++++++.+ ....++||||+++++|.+++.
T Consensus 49 ~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 125 (330)
T 3nsz_A 49 YSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 125 (330)
T ss_dssp SEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG
T ss_pred CeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH
Confidence 799999985 68999999998633 3467889999999997 9999999999998 667899999999999998873
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
.+++..+..++.||+.||+|||++| ++|+||||+||+++.++ .+||+|||++........ .....++
T Consensus 126 ------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~ 193 (330)
T 3nsz_A 126 ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVAS 193 (330)
T ss_dssp ------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSC
T ss_pred ------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---ccccccc
Confidence 2888999999999999999999998 99999999999999777 799999999987643322 2234678
Q ss_pred cCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH--------Hhhhc-------------
Q 021771 156 YGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW--------KLWCE------------- 213 (308)
Q Consensus 156 ~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~--------~~~~~------------- 213 (308)
..|+|||++.+ ..++.++|||||||++|+|++|..||......... +..... .....
T Consensus 194 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (330)
T 3nsz_A 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272 (330)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHH
T ss_pred ccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHHHhccccccchhhhh
Confidence 89999999877 67899999999999999999999998433222100 000000 00000
Q ss_pred -ccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 214 -GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
......................+.+|+.+||+.||++|||++|+++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 273 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp CCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000001111111112346889999999999999999999996
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=297.89 Aligned_cols=250 Identities=19% Similarity=0.215 Sum_probs=180.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe------EEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE------SLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~ 74 (308)
||+||+++..++..+|+|++..... ...+|+.+++.++||||+++++++..... .++||||++++.+...
T Consensus 53 ~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~ 128 (394)
T 4e7w_A 53 FGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRAS 128 (394)
T ss_dssp TEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHH
T ss_pred CeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHH
Confidence 7999999987777799998854322 12369999999999999999999965433 7899999987655444
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC-CCCCeeeecccceeeeCCCCCccccceee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
.........+++..++.++.||+.||+|||++| |+||||||+||+++ .++.+||+|||++........ .....
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~ 202 (394)
T 4e7w_A 129 RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYI 202 (394)
T ss_dssp HHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSC
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---Ccccc
Confidence 332233456999999999999999999999998 99999999999999 789999999999987643322 22346
Q ss_pred cccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHH--------HHhhh----cccccccc
Q 021771 154 GTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYT--------WKLWC----EGEALELM 220 (308)
Q Consensus 154 ~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------~~~~~----~~~~~~~~ 220 (308)
++..|+|||++.+. .++.++|||||||++|+|++|..||............... ..... ........
T Consensus 203 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 282 (394)
T 4e7w_A 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIR 282 (394)
T ss_dssp SCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCC
T ss_pred cCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhcccccc
Confidence 78899999988764 5899999999999999999999999754322110000000 00000 00000000
Q ss_pred cccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 221 EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
...............+.+|+.+||+.||++|||+.|+++-
T Consensus 283 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 283 PHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000111123468899999999999999999999963
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=298.90 Aligned_cols=237 Identities=22% Similarity=0.290 Sum_probs=176.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--------cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--------GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
||.||++.. .+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.. ...++||||+++++|
T Consensus 148 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L 226 (419)
T 3i6u_A 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGEL 226 (419)
T ss_dssp SSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBG
T ss_pred CeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcH
Confidence 799999985 679999999986431 1122357899999999999999999999865 468999999999999
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC---CeeeecccceeeeCCCCCccc
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM---NPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~---~~kl~dfg~~~~~~~~~~~~~ 148 (308)
.+++.. ...+++..++.++.|++.||+|||++| |+|+||||+||+++.++ .+||+|||++...... ..
T Consensus 227 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~---~~ 297 (419)
T 3i6u_A 227 FDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SL 297 (419)
T ss_dssp GGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------
T ss_pred HHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccceecCCC---cc
Confidence 988843 345999999999999999999999998 99999999999997654 4999999999875422 12
Q ss_pred cceeecccCccCchhhcc---CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 149 TNRIVGTYGYMAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|..||........ ... ........ ..
T Consensus 298 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~----~i~~~~~~-~~----- 365 (419)
T 3i6u_A 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----QITSGKYN-FI----- 365 (419)
T ss_dssp -------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH----HHHTTCCC-CC-----
T ss_pred ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH----HHhcCCCC-CC-----
Confidence 233568999999998753 5678899999999999999999999965332211 110 00011000 00
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..........+.+|+.+||+.||++|||++|+++
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000112345888999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.86 Aligned_cols=243 Identities=28% Similarity=0.348 Sum_probs=185.5
Q ss_pred CCccEEeeeC--CCC--EEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA--DGK--EIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+||++++. +++ .||+|++... .....+.+.+|+.+++.++||||+++++++.++. .++||||+++++|.+
T Consensus 31 ~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~ 109 (291)
T 1u46_A 31 FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLD 109 (291)
T ss_dssp -CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHH
T ss_pred ceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHH
Confidence 7999999852 344 6899988654 2345678889999999999999999999998765 889999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-cccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-NTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~ 152 (308)
++... ...+++..++.++.|++.||.|||++| ++|+||||+||+++.++.+||+|||++.......... .....
T Consensus 110 ~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 184 (291)
T 1u46_A 110 RLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184 (291)
T ss_dssp HHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC----
T ss_pred HHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccC
Confidence 98653 235899999999999999999999998 9999999999999999999999999998765432211 12233
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.++..|+|||++.+..++.++||||||+++|+|++ |..||....... ............. ....
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~~---------~~~~ 249 (291)
T 1u46_A 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGERLP---------RPED 249 (291)
T ss_dssp -CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCCCCC---------CCTT
T ss_pred CCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccCCCCC---------CCcC
Confidence 56778999999988889999999999999999999 999986543221 1111111110000 0111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
....+.+++.+||+.||++|||+.++++.|+..
T Consensus 250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 234588899999999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=284.32 Aligned_cols=237 Identities=22% Similarity=0.277 Sum_probs=186.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---------cccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---------GQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 69 (308)
||.||+++. .+|+.||||++.... ....+.+.+|+.+++++. ||||+++++++.++...++||||++++
T Consensus 30 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 109 (298)
T 1phk_A 30 SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG 109 (298)
T ss_dssp SEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCC
Confidence 689999996 579999999986543 122456788999999996 999999999999999999999999999
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
+|.+++... ..+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 110 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~ 180 (298)
T 1phk_A 110 ELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KL 180 (298)
T ss_dssp BHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CB
T ss_pred cHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhcCCCc---cc
Confidence 999998643 35899999999999999999999998 9999999999999999999999999998764322 12
Q ss_pred ceeecccCccCchhhc------cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccc
Q 021771 150 NRIVGTYGYMAPEYAM------EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
....++..|+|||++. ...++.++||||||+++|+|++|..||....... ...... ..... ...
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~-~~~-- 250 (298)
T 1phk_A 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIM-SGNYQ-FGS-- 250 (298)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-HTCCC-CCT--
T ss_pred ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH------HHHHHh-cCCcc-cCc--
Confidence 2346788999999875 3467889999999999999999999986432211 111111 11000 000
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.........+.+|+.+||+.||++|||+.++++
T Consensus 251 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 251 ---PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ---TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 001112345888999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=292.78 Aligned_cols=237 Identities=14% Similarity=0.114 Sum_probs=187.9
Q ss_pred CCccEEee------eCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC---CcCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 1 MESCLQGK------LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ---HKNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~------~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
||+||+|. ..+++.||+|++... ....+..|..+++.++ |+||+.+++++..++..++|||||++++|
T Consensus 78 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L 154 (365)
T 3e7e_A 78 FAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154 (365)
T ss_dssp SEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBH
T ss_pred CEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcH
Confidence 79999993 568999999998644 3456777888888886 89999999999999999999999999999
Q ss_pred hhHhhcCC--CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-----------CCCeeeeccccee
Q 021771 72 DVFLFDST--RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-----------EMNPKISDFGMAR 138 (308)
Q Consensus 72 ~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-----------~~~~kl~dfg~~~ 138 (308)
.+++.... ....+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||++.
T Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~ 231 (365)
T 3e7e_A 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231 (365)
T ss_dssp HHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCE
T ss_pred HHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhh
Confidence 99996521 2446999999999999999999999998 999999999999998 8999999999998
Q ss_pred eeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccc
Q 021771 139 IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALE 218 (308)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (308)
.+.............||..|+|||++.+..++.++|||||||++|+|++|..||........ .
T Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--------------~--- 294 (365)
T 3e7e_A 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--------------K--- 294 (365)
T ss_dssp EGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--------------E---
T ss_pred hhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--------------e---
Confidence 76433333333445789999999999998899999999999999999999999853322110 0
Q ss_pred cccccccccchHHHHHHHHHHHhhcccCCCCCC-CCHHHHHHHhhcC
Q 021771 219 LMEPVLKQSCVAAELLKFIHIGLLCVQADSADR-PTMSSVVVMLASD 264 (308)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Ps~~eil~~L~~~ 264 (308)
+......... ...+.+++..|++.+|.+| |+++++.+.|+..
T Consensus 295 -~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 295 -PEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp -ECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred -echhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0111111111 2346677788999999999 6788888777654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=287.59 Aligned_cols=247 Identities=25% Similarity=0.318 Sum_probs=188.8
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhc--CCCcCccceeeeEEeCC----eEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAK--LQHKNLVRLFGCCLEEN----ESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~ 74 (308)
||.||+++. +|+.||||++... ....+..|.++++. ++||||+++++++.... ..++||||+++++|.++
T Consensus 55 ~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 130 (342)
T 1b6c_B 55 FGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY 130 (342)
T ss_dssp TEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHH
T ss_pred CcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHH
Confidence 789999988 6899999998543 34567788888887 68999999999998876 78999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhch--------hCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLH--------EDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--------~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
+.. ..+++..++.++.|++.||+||| +.| ++|+||||+||+++.++.+||+|||++.........
T Consensus 131 l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 203 (342)
T 1b6c_B 131 LNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203 (342)
T ss_dssp HHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred Hhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccc
Confidence 954 24899999999999999999999 776 999999999999999999999999999876543322
Q ss_pred c--ccceeecccCccCchhhccC------cccccccchhhhHHHHHHHhC----------CcCCCccccccccchhHHHH
Q 021771 147 A--NTNRIVGTYGYMAPEYAMEG------LFSVKSDVFSFGVLLLEIISG----------KKNTGFYLSELGQSLLSYTW 208 (308)
Q Consensus 147 ~--~~~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~~----------~~p~~~~~~~~~~~~~~~~~ 208 (308)
. ......++..|+|||++.+. .++.++||||||+++|+|++| ..||......... .....
T Consensus 204 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~--~~~~~ 281 (342)
T 1b6c_B 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMR 281 (342)
T ss_dssp EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC--HHHHH
T ss_pred cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc--HHHHH
Confidence 1 12334688999999998765 344789999999999999999 5565433221110 11111
Q ss_pred Hhhhccccccccccccccc-chHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 209 KLWCEGEALELMEPVLKQS-CVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
........ .+..... ........+.+|+.+||+.||++|||+++|++.|+..
T Consensus 282 ~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 282 KVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp HHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 11111111 1111111 1234556789999999999999999999999999865
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=282.56 Aligned_cols=234 Identities=22% Similarity=0.346 Sum_probs=181.2
Q ss_pred CCccEEeeeC-CCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||.++.. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++.
T Consensus 24 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 103 (276)
T 2h6d_A 24 FGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC 103 (276)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred CeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHh
Confidence 7899999964 8999999998643 23445688999999999999999999999999999999999999999999985
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++....... ......++.
T Consensus 104 ~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~ 174 (276)
T 2h6d_A 104 KH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSP 174 (276)
T ss_dssp HH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------
T ss_pred cc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCc
Confidence 53 34899999999999999999999998 9999999999999999999999999987654322 122346788
Q ss_pred CccCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 157 GYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 157 ~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
.|+|||.+.+..+ +.++||||||+++|+|++|..||....... ..... .... .. . +......
T Consensus 175 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~-~~-----~----~~~~~~~ 237 (276)
T 2h6d_A 175 NYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT------LFKKI-RGGV-FY-----I----PEYLNRS 237 (276)
T ss_dssp --CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCC-CC-----C----CTTSCHH
T ss_pred cccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHh-hcCc-cc-----C----chhcCHH
Confidence 9999999887654 689999999999999999999986432211 11111 1110 00 0 0111235
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+.+++.+||+.||++|||++++++.
T Consensus 238 l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 238 VATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCChhhCCCHHHHHhC
Confidence 7889999999999999999999973
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=292.97 Aligned_cols=244 Identities=23% Similarity=0.329 Sum_probs=188.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCccc-----------------HHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEE
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQG-----------------LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 63 (308)
||.||+++. +|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 44 ~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 122 (348)
T 2pml_X 44 FNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIY 122 (348)
T ss_dssp SCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEE
T ss_pred CeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 799999999 99999999986442111 178999999999999999999999999999999999
Q ss_pred EecCCCChhhH------hhcCCCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccc
Q 021771 64 EYMPNKSLDVF------LFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGM 136 (308)
Q Consensus 64 e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~ 136 (308)
||+++++|.++ +.. .....+++..++.++.|++.||.|||+ +| ++|+||+|+||+++.++.++|+|||+
T Consensus 123 e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 198 (348)
T 2pml_X 123 EYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGE 198 (348)
T ss_dssp ECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred eccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCCCcEEEecccc
Confidence 99999999998 432 124569999999999999999999999 87 99999999999999999999999999
Q ss_pred eeeeCCCCCccccceeecccCccCchhhccC-cccc-cccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcc
Q 021771 137 ARIFGGNQSEANTNRIVGTYGYMAPEYAMEG-LFSV-KSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEG 214 (308)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 214 (308)
+...... ......++..|+|||++.+. .++. ++||||||+++|+|++|..||....... ...... ...
T Consensus 199 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~i-~~~ 268 (348)
T 2pml_X 199 SEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-----ELFNNI-RTK 268 (348)
T ss_dssp CEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-----HHHHHH-TSC
T ss_pred ccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHHH-hcc
Confidence 9876433 22334678899999998876 5666 9999999999999999999997543310 001111 011
Q ss_pred cc--cc----cccccc---cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 215 EA--LE----LMEPVL---KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 215 ~~--~~----~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. .. ...... ...........+.+|+.+||+.||++|||++|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00 000000 00001222345888999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=288.13 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=189.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe--CCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+ +...++||||+++++|.+++
T Consensus 19 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 98 (279)
T 2w5a_A 19 YGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI 98 (279)
T ss_dssp SSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHH
T ss_pred CcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHH
Confidence 799999996 58999999998654 33456778999999999999999999998854 56789999999999999998
Q ss_pred hcCC-CccccChHHHHHHHHHHHHHHHhchhCC--CCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 76 FDST-RSVQLDWKRRISIINGIARGLLYLHEDS--RLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 76 ~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g--~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
.... ....+++..++.++.|++.||+|||++| ...++|+||+|+||+++.++.+||+|||++........ .....
T Consensus 99 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~ 176 (279)
T 2w5a_A 99 TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTF 176 (279)
T ss_dssp HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHH
T ss_pred HhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--ccccc
Confidence 6532 2345899999999999999999999985 12399999999999999999999999999876542211 12234
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.++..|+|||.+.+..++.++||||||+++|+|++|..||....... ... .......... +...
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~-~i~~~~~~~~---------~~~~ 240 (279)
T 2w5a_A 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAG-KIREGKFRRI---------PYRY 240 (279)
T ss_dssp HSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH-HHHHTCCCCC---------CTTS
T ss_pred CCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH------HHH-HHhhcccccC---------Cccc
Confidence 57889999999988889999999999999999999999986543211 111 1111111111 1112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
...+.+++.+||+.||++|||+.||++.+..
T Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 241 SDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 2358889999999999999999999987654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=288.75 Aligned_cols=238 Identities=24% Similarity=0.319 Sum_probs=172.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cc-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQ-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+++. .+|+.||+|++.... .. ....+.++...++.++||||+++++++.+++..++||||+++ +|.+++..
T Consensus 20 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~ 98 (290)
T 3fme_A 20 YGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQ 98 (290)
T ss_dssp SEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHH
T ss_pred CeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHH
Confidence 799999995 689999999986542 22 233445556668888999999999999999999999999975 77776644
Q ss_pred C-CCccccChHHHHHHHHHHHHHHHhchhC-CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 78 S-TRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 78 ~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~-g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
. .....+++..++.++.|++.||+|||++ | ++|+||||+||+++.++.+||+|||++........ .....++
T Consensus 99 ~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t 172 (290)
T 3fme_A 99 VIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGC 172 (290)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------------------CCC
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCC
Confidence 2 2345699999999999999999999998 8 99999999999999999999999999987543221 2223678
Q ss_pred cCccCchhh----ccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 156 YGYMAPEYA----MEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 156 ~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..|+|||++ .+..++.++||||||+++|+|++|..||....... ......... ....... ..
T Consensus 173 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~-~~~~~~~--------~~ 238 (290)
T 3fme_A 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEE-PSPQLPA--------DK 238 (290)
T ss_dssp CCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHS-CCCCCCT--------TT
T ss_pred ccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhcc-CCCCccc--------cc
Confidence 999999986 45678899999999999999999999996432211 111111111 1111110 11
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
....+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 2235888999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=298.60 Aligned_cols=190 Identities=26% Similarity=0.416 Sum_probs=148.1
Q ss_pred CCccEEeeeC---CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe--CCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+++.+ +++.||||++.... ....+.+|+.+|+.++||||+++++++.. +...++||||+.+ +|.+++
T Consensus 34 ~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 110 (405)
T 3rgf_A 34 YGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII 110 (405)
T ss_dssp --EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHH
T ss_pred CeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHH
Confidence 7999999965 68899999996543 23567899999999999999999999964 6689999999965 777666
Q ss_pred hcCC------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe----CCCCCeeeecccceeeeCCCCC
Q 021771 76 FDST------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL----NHEMNPKISDFGMARIFGGNQS 145 (308)
Q Consensus 76 ~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv----~~~~~~kl~dfg~~~~~~~~~~ 145 (308)
.... ....+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 111 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~ 187 (405)
T 3rgf_A 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187 (405)
T ss_dssp HHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-------
T ss_pred HHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCc
Confidence 4321 2234899999999999999999999998 9999999999999 6778999999999987653221
Q ss_pred c-cccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccc
Q 021771 146 E-ANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYL 196 (308)
Q Consensus 146 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 196 (308)
. .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 188 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 1 22234578999999999887 458999999999999999999999996543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=288.53 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=184.3
Q ss_pred CCccEEeeeCCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+++..+ .+++|++... .....+.+.+|+.+++.++|+||+++++++.+....++||||+++++|.+++...
T Consensus 46 ~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~ 123 (319)
T 2y4i_B 46 FGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA 123 (319)
T ss_dssp SSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSS
T ss_pred ceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhc
Confidence 79999998743 4999998644 2334456788999999999999999999999999999999999999999998543
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCC---Cccccceeecc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQ---SEANTNRIVGT 155 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~ 155 (308)
...+++..++.++.||+.||+|||++| ++|+||||+||+++ ++.++|+|||++....... .........|+
T Consensus 124 --~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~ 197 (319)
T 2y4i_B 124 --KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGW 197 (319)
T ss_dssp --CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGG
T ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCc
Confidence 335899999999999999999999998 99999999999998 6799999999987543211 11222334578
Q ss_pred cCccCchhhcc---------CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccc
Q 021771 156 YGYMAPEYAME---------GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226 (308)
Q Consensus 156 ~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
..|+|||++.+ ..++.++||||||+++|+|++|..||........ .... ...........
T Consensus 198 ~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~-~~~~~~~~~~~---- 266 (319)
T 2y4i_B 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------IWQM-GTGMKPNLSQI---- 266 (319)
T ss_dssp GGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH------HHHH-HTTCCCCCCCS----
T ss_pred ccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHh-ccCCCCCCCcC----
Confidence 89999998864 3478899999999999999999999865432211 1111 11111111111
Q ss_pred cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCCCCCCCCcccC
Q 021771 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDTVTLPQPTEPAFSVG 279 (308)
Q Consensus 227 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~~~p~~~~~ 279 (308)
. ....+.+++.+||+.||++|||+.++++.|+...........|...+.
T Consensus 267 ~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 267 G----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp S----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred C----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 1 112488899999999999999999999999998766655555554443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=293.51 Aligned_cols=248 Identities=19% Similarity=0.187 Sum_probs=186.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC--------CcCccceeeeEE----eCCeEEEEEEecC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ--------HKNLVRLFGCCL----EENESLLIYEYMP 67 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~ 67 (308)
||+||+++. .+|+.||||++... ....+.+.+|+.+++.++ |+||+++++++. +....++||||+.
T Consensus 50 ~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 128 (397)
T 1wak_A 50 FSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG 128 (397)
T ss_dssp SEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred CeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC
Confidence 799999985 67999999998643 344567889999999985 788999999988 5567899999994
Q ss_pred CCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhC-CCCceeecCCCCCceEeCCCC-------------------
Q 021771 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLNHEM------------------- 127 (308)
Q Consensus 68 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-g~~~i~H~di~p~nilv~~~~------------------- 127 (308)
+++.+.+... ....+++..++.++.||+.||+|||++ | |+||||||+|||++.++
T Consensus 129 -~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 203 (397)
T 1wak_A 129 -HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203 (397)
T ss_dssp -CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC--------
T ss_pred -ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCC
Confidence 4555555432 223589999999999999999999998 7 99999999999999775
Q ss_pred ------------------------------CeeeecccceeeeCCCCCccccceeecccCccCchhhccCcccccccchh
Q 021771 128 ------------------------------NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177 (308)
Q Consensus 128 ------------------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 177 (308)
.+||+|||++...... .....++..|+|||++.+..++.++||||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diws 278 (397)
T 1wak_A 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWS 278 (397)
T ss_dssp -------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHH
T ss_pred CCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHH
Confidence 7999999999875422 22346789999999999988999999999
Q ss_pred hhHHHHHHHhCCcCCCccccccccchhHHHHHh-----------hhccc-----------cccccccc---------ccc
Q 021771 178 FGVLLLEIISGKKNTGFYLSELGQSLLSYTWKL-----------WCEGE-----------ALELMEPV---------LKQ 226 (308)
Q Consensus 178 lG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~-----------~~~~~~~~---------~~~ 226 (308)
|||++|+|++|..||.................. +.... .....+.. -..
T Consensus 279 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (397)
T 1wak_A 279 TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358 (397)
T ss_dssp HHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTS
T ss_pred HHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhc
Confidence 999999999999999765433221111110000 00000 00000000 001
Q ss_pred cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 227 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.........+.+|+.+||+.||++|||++|+++
T Consensus 359 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 224556678999999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=294.22 Aligned_cols=240 Identities=10% Similarity=0.047 Sum_probs=166.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHhcC--CCcCcccee-------eeEEeC-----------
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKL--QHKNLVRLF-------GCCLEE----------- 56 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~~~----------- 56 (308)
||+||+++. .+|+.||||++..... ...+.+.+|+.+++.+ +||||++++ +++...
T Consensus 75 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~ 154 (371)
T 3q60_A 75 RSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG 154 (371)
T ss_dssp SEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC
T ss_pred CEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCC
Confidence 799999995 5899999999976532 3455677885544444 699988755 444433
Q ss_pred ------CeEEEEEEecCCCChhhHhhcCCCccccChHHH------HHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC
Q 021771 57 ------NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRR------ISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124 (308)
Q Consensus 57 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~------~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~ 124 (308)
...++||||++ ++|.+++.... ..+....+ ..++.||+.||+|||++| |+||||||+|||++
T Consensus 155 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~ 228 (371)
T 3q60_A 155 QDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIM 228 (371)
T ss_dssp ---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEC
T ss_pred cccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEEC
Confidence 23799999998 79999996532 23445555 677899999999999998 99999999999999
Q ss_pred CCCCeeeecccceeeeCCCCCccccceeecccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCCCccccccccc
Q 021771 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQS 202 (308)
Q Consensus 125 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~ 202 (308)
.++.+||+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 229 ~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~ 303 (371)
T 3q60_A 229 PDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303 (371)
T ss_dssp TTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC
T ss_pred CCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc
Confidence 9999999999999875321 112345689999999987 678999999999999999999999997653332111
Q ss_pred hhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 203 LLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. .......................+.+|+.+||+.||++|||+.++++
T Consensus 304 ~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 304 WK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 00000000000000001122345888999999999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.23 Aligned_cols=247 Identities=25% Similarity=0.290 Sum_probs=172.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeC------CeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE------NESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L 71 (308)
||.||+|.. .+|+.||||++... .......+.+|+.+|+.++||||+++++++... ...++|+|++ +++|
T Consensus 42 ~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L 120 (367)
T 2fst_X 42 YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL 120 (367)
T ss_dssp -CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEEC
T ss_pred CeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCH
Confidence 799999984 68999999998654 333456788999999999999999999998754 5679999999 6799
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++.. ..+++..+..++.||+.||.|||++| ++||||||+||+++.++.+||+|||++...... ...
T Consensus 121 ~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~ 188 (367)
T 2fst_X 121 NNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTG 188 (367)
T ss_dssp C---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------------------
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCC
Confidence 888743 35899999999999999999999998 999999999999999999999999999765322 223
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH-----Hhhh---cccccccccc
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW-----KLWC---EGEALELMEP 222 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~~~ 222 (308)
..++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+.... ..+. .......+..
T Consensus 189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 268 (367)
T 2fst_X 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 268 (367)
T ss_dssp --CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHT
T ss_pred cCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhc
Confidence 467899999998877 678999999999999999999999996544321110000000 0000 0000000000
Q ss_pred c---ccc---cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 223 V---LKQ---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 223 ~---~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
. ... .........+.+|+.+||+.||++|||+.++++-
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 269 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp SCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000 0001113458899999999999999999999964
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=288.19 Aligned_cols=238 Identities=23% Similarity=0.340 Sum_probs=180.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCC--CcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQ--HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++..+|+.||+|++... .....+.+.+|+.+++.++ |+||+++++++.+++..++||| +.+++|.+++.
T Consensus 41 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~ 119 (313)
T 3cek_A 41 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK 119 (313)
T ss_dssp SEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHH
T ss_pred CEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHH
Confidence 78999999888999999998654 3345577899999999997 5999999999999999999999 55789999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.|++.||.|||++| ++|+||||+||++++ +.+||+|||++................++.
T Consensus 120 ~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~ 192 (313)
T 3cek_A 120 KK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTV 192 (313)
T ss_dssp HC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCG
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCC
Confidence 53 35899999999999999999999998 999999999999965 789999999998764333222233456889
Q ss_pred CccCchhhcc-----------CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 157 GYMAPEYAME-----------GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 157 ~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.|+|||++.+ ..++.++||||||+++|+|++|..||....... ............... .
T Consensus 193 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~-----~ 262 (313)
T 3cek_A 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAIIDPNHEIEF-----P 262 (313)
T ss_dssp GGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHCTTSCCCC-----C
T ss_pred CcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHHHHHhcccccCC-----c
Confidence 9999998865 467889999999999999999999986432211 111111111100000 0
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.. ....+.+++.+||+.||++|||+.|+++.
T Consensus 263 ~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 263 DI----PEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc----chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11 12358888999999999999999999953
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=288.68 Aligned_cols=237 Identities=24% Similarity=0.399 Sum_probs=181.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEe------CCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLE------ENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .+|+.||+|++.... ...+.+.+|+.+++.+ +||||+++++++.. ....++||||+++++|.
T Consensus 37 ~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 115 (326)
T 2x7f_A 37 YGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115 (326)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHH
T ss_pred CEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHH
Confidence 789999996 689999999986543 3457788999999999 79999999999987 45789999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+++... ....+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.+||+|||++........ .....
T Consensus 116 ~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 189 (326)
T 2x7f_A 116 DLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTF 189 (326)
T ss_dssp HHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC--------------
T ss_pred HHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccc
Confidence 998654 2346899999999999999999999998 99999999999999999999999999876542211 12234
Q ss_pred ecccCccCchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccccc
Q 021771 153 VGTYGYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQS 227 (308)
Q Consensus 153 ~~~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
.++..|+|||++. +..++.++||||||+++|+|++|..||....... ..... .......... ..
T Consensus 190 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~~~~~----~~ 258 (326)
T 2x7f_A 190 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFLI-PRNPAPRLKS----KK 258 (326)
T ss_dssp -CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHH-HHSCCCCCSC----SC
T ss_pred cCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHHh-hcCccccCCc----cc
Confidence 6789999999886 4568899999999999999999999985432211 11111 1111111111 11
Q ss_pred chHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 228 CVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 228 ~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
. ...+.+|+.+||+.||++|||+.++++
T Consensus 259 ~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 259 W----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp S----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred c----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 235888999999999999999999996
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=286.11 Aligned_cols=237 Identities=23% Similarity=0.299 Sum_probs=180.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--------cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--------GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
||.||+++. .+|+.||||++.... ......+.+|+.+|+.++||||+++++++..+. .++||||+++++|
T Consensus 23 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L 101 (322)
T 2ycf_A 23 CGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL 101 (322)
T ss_dssp SEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEET
T ss_pred CEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcH
Confidence 799999996 578999999986432 122345789999999999999999999987764 8999999999999
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC---eeeecccceeeeCCCCCccc
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN---PKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~---~kl~dfg~~~~~~~~~~~~~ 148 (308)
.+++.. ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++. +||+|||++....... .
T Consensus 102 ~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~ 172 (322)
T 2ycf_A 102 FDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---L 172 (322)
T ss_dssp HHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---H
T ss_pred HHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---c
Confidence 998843 345899999999999999999999998 999999999999987665 9999999998764321 1
Q ss_pred cceeecccCccCchhhc---cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 149 TNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.....++..|+|||++. ...++.++||||||+++|+|++|..||........ ..... ...... ..
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~----~~~~~~-~~----- 240 (322)
T 2ycf_A 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----TSGKYN-FI----- 240 (322)
T ss_dssp HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH----HHTCCC-CC-----
T ss_pred cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH----HhCccc-cC-----
Confidence 22345789999999874 45688999999999999999999999965432211 11100 001000 00
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..........+.+|+.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0001112345889999999999999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=293.65 Aligned_cols=250 Identities=20% Similarity=0.218 Sum_probs=177.9
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCc-----------ccHHHHHHHHHHHhcCCCcCccceeeeEEe-----CCeEEEEEE
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSG-----------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-----ENESLLIYE 64 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e 64 (308)
||.||++...+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 35 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 114 (362)
T 3pg1_A 35 YGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE 114 (362)
T ss_dssp TEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEE
T ss_pred CEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEc
Confidence 7999999988899999998854321 123778999999999999999999999854 336899999
Q ss_pred ecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCC
Q 021771 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQ 144 (308)
Q Consensus 65 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~ 144 (308)
|+. ++|.+++... ...+++..+..++.||+.||.|||++| ++|+||||+||+++.++.+||+|||++.......
T Consensus 115 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (362)
T 3pg1_A 115 LMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188 (362)
T ss_dssp CCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTTC--------
T ss_pred cCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecCccccccccc
Confidence 997 5777777543 345899999999999999999999998 9999999999999999999999999997543221
Q ss_pred CccccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHH----------------
Q 021771 145 SEANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYT---------------- 207 (308)
Q Consensus 145 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~---------------- 207 (308)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 189 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 265 (362)
T 3pg1_A 189 ---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPS 265 (362)
T ss_dssp ----------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHH
T ss_pred ---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchh
Confidence 2233467889999998877 67899999999999999999999999654322110000000
Q ss_pred HHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 208 WKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
...+........ ...............+.+|+.+||+.||++|||++|+++.
T Consensus 266 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 266 ARDYLRNSLSNV-PARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHTTTCCCCC-CCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhHHHHhhcccC-ChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000000000 0000000111123458889999999999999999999963
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=292.09 Aligned_cols=252 Identities=20% Similarity=0.225 Sum_probs=186.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeC-----CeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE-----NESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++... ...++||||+. ++|.+
T Consensus 40 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~ 118 (364)
T 3qyz_A 40 YGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYK 118 (364)
T ss_dssp SEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHH
T ss_pred CeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHH
Confidence 799999985 589999999986443 33456788999999999999999999999765 36899999996 48888
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-cccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA-NTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~ 152 (308)
++.. ..+++..++.++.||+.||+|||++| |+|+||||+||+++.++.+||+|||++.......... .....
T Consensus 119 ~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 191 (364)
T 3qyz_A 119 LLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191 (364)
T ss_dssp HHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCC
T ss_pred HHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcccccccc
Confidence 8743 34899999999999999999999998 9999999999999999999999999998764322211 12334
Q ss_pred ecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccc------------cc
Q 021771 153 VGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEAL------------EL 219 (308)
Q Consensus 153 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~ 219 (308)
.|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......................+. ..
T Consensus 192 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (364)
T 3qyz_A 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 271 (364)
T ss_dssp CSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS
T ss_pred ccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhc
Confidence 78999999998654 458999999999999999999999996544332111100000000000000 00
Q ss_pred ccc--cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 220 MEP--VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 220 ~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
... .............+.+|+.+||+.||++|||++|+++-
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 272 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000011123458899999999999999999999963
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=292.02 Aligned_cols=248 Identities=22% Similarity=0.234 Sum_probs=178.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------eEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L 71 (308)
||.||++.. .+|+.||||++... .......+.+|+.+++.++||||+++++++.... ..++||||+++ +|
T Consensus 38 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 116 (371)
T 2xrw_A 38 QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NL 116 (371)
T ss_dssp SEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EH
T ss_pred CEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CH
Confidence 799999985 57999999998654 3344567889999999999999999999998665 68999999975 67
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+.+. ..+++..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++....... ....
T Consensus 117 ~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~ 185 (371)
T 2xrw_A 117 CQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTP 185 (371)
T ss_dssp HHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---------------
T ss_pred HHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCC
Confidence 77763 23888999999999999999999998 9999999999999999999999999998654221 1223
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchh----------------HHHHHhhhcc-
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL----------------SYTWKLWCEG- 214 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~----------------~~~~~~~~~~- 214 (308)
..++..|+|||++.+..++.++|||||||++|+|++|..||............ ..........
T Consensus 186 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (371)
T 2xrw_A 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP 265 (371)
T ss_dssp ----CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSC
T ss_pred ceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCc
Confidence 46789999999999888999999999999999999999999754332100000 0000000000
Q ss_pred -----ccccccccccc---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 215 -----EALELMEPVLK---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 215 -----~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
........... ..........+.+|+.+||+.||++|||++|+++-
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 266 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000 01112235678999999999999999999999963
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=310.99 Aligned_cols=252 Identities=21% Similarity=0.247 Sum_probs=198.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+++. .+|+.||||++... .....+.+..|..+|..+ +|++|+++++++.+.+.+++||||+++++|..++
T Consensus 354 fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l 433 (674)
T 3pfq_A 354 FGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433 (674)
T ss_dssp TBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHH
T ss_pred CEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHH
Confidence 899999996 57899999998643 234556788899999988 6999999999999999999999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... .......||
T Consensus 434 ~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT 505 (674)
T 3pfq_A 434 QQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGT 505 (674)
T ss_dssp HHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSC
T ss_pred Hhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCC--cccccccCC
Confidence 653 34999999999999999999999998 9999999999999999999999999998643222 223345789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+.|+|||++.+..++.++||||||+++|+|++|..||...... ......... .. ..+......
T Consensus 506 ~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~-~~----------~~p~~~s~~ 568 (674)
T 3pfq_A 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEH-NV----------AYPKSMSKE 568 (674)
T ss_dssp SSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHSS-CC----------CCCTTSCHH
T ss_pred CcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHhC-CC----------CCCccCCHH
Confidence 9999999999999999999999999999999999999654322 111111111 10 011122345
Q ss_pred HHHHHhhcccCCCCCCCCH-----HHHHHH--hhcC------CCCCCCCCCCCcc
Q 021771 236 FIHIGLLCVQADSADRPTM-----SSVVVM--LASD------TVTLPQPTEPAFS 277 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~-----~eil~~--L~~~------~~~~~~~~~p~~~ 277 (308)
+.+||.+||+.||++||++ +||++- ++.. ...+.+|-.|...
T Consensus 569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~ 623 (674)
T 3pfq_A 569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS 623 (674)
T ss_dssp HHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC
T ss_pred HHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC
Confidence 8889999999999999998 777742 1111 2445666666553
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=279.84 Aligned_cols=236 Identities=24% Similarity=0.278 Sum_probs=185.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++..
T Consensus 35 ~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 114 (287)
T 2wei_A 35 FGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114 (287)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred CEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh
Confidence 789999996 48999999998654 344567899999999999999999999999999999999999999999888854
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC---CeeeecccceeeeCCCCCccccceeec
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM---NPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
. ..+++..++.++.||+.||.|||++| ++|+||+|+||+++.++ .+||+|||++........ .....+
T Consensus 115 ~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~ 185 (287)
T 2wei_A 115 R---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIG 185 (287)
T ss_dssp H---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHH
T ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccC
Confidence 3 34899999999999999999999998 99999999999997644 699999999876543221 122357
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
+..|+|||.+.+. ++.++||||||+++|+|++|..||....... ..... .......... .......
T Consensus 186 ~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~~~~~------~~~~~~~ 251 (287)
T 2wei_A 186 TAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD------ILKRV-ETGKYAFDLP------QWRTISD 251 (287)
T ss_dssp HHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH-HHCCCCCCSG------GGTTSCH
T ss_pred cccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHH-HcCCCCCCch------hhhhcCH
Confidence 8899999987654 8899999999999999999999986543221 11111 1111100000 0011123
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+.+++.+||+.||++|||+.++++
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhc
Confidence 5888999999999999999999996
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=287.30 Aligned_cols=250 Identities=21% Similarity=0.277 Sum_probs=182.0
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEE--------------eCCeEEEEEEe
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCL--------------EENESLLIYEY 65 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~ 65 (308)
||.||+++.. +|+.||+|++........+.+.+|+.+++.++||||+++++++. +....++||||
T Consensus 24 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 103 (320)
T 2i6l_A 24 NGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY 103 (320)
T ss_dssp --CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEEC
T ss_pred CeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeec
Confidence 7999999964 69999999997776667788899999999999999999999874 34678999999
Q ss_pred cCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC-CCCCeeeecccceeeeCCCC
Q 021771 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEMNPKISDFGMARIFGGNQ 144 (308)
Q Consensus 66 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~-~~~~~kl~dfg~~~~~~~~~ 144 (308)
++ ++|.+++.. ..+++..++.++.|++.||+|||++| ++|+||||+||+++ .++.+||+|||++.......
T Consensus 104 ~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 175 (320)
T 2i6l_A 104 ME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175 (320)
T ss_dssp CS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC----
T ss_pred cC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCc
Confidence 97 589988842 35899999999999999999999998 99999999999997 56789999999998754321
Q ss_pred C-ccccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHH--------HHhhhcc
Q 021771 145 S-EANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYT--------WKLWCEG 214 (308)
Q Consensus 145 ~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 214 (308)
. ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||............... ..... .
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 254 (320)
T 2i6l_A 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELL-S 254 (320)
T ss_dssp ----CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHH-T
T ss_pred ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhh-h
Confidence 1 111223356888999998765 67899999999999999999999999754332110000000 00000 0
Q ss_pred ccccccccccc------ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 215 EALELMEPVLK------QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 215 ~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.....+..... ..........+.+|+.+||+.||++|||++++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 255 VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 00000000000 0000112346889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=292.89 Aligned_cols=248 Identities=19% Similarity=0.187 Sum_probs=180.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe------------------------
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE------------------------ 55 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------------------------ 55 (308)
||+||+++. .+|+.||||++...... ..+|+.+|+.++||||+++++++..
T Consensus 20 fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (383)
T 3eb0_A 20 FGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG 95 (383)
T ss_dssp CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC-----------------------
T ss_pred CEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccc
Confidence 799999985 68999999998644222 2379999999999999999999844
Q ss_pred --------------CCeEEEEEEecCCCChhhHhhcC-CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCc
Q 021771 56 --------------ENESLLIYEYMPNKSLDVFLFDS-TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120 (308)
Q Consensus 56 --------------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~n 120 (308)
....++||||+++ +|.+.+... .....+++..++.++.||+.||+|||++| |+||||||+|
T Consensus 96 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~N 171 (383)
T 3eb0_A 96 VNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQN 171 (383)
T ss_dssp --------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGG
T ss_pred cccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHH
Confidence 3348899999975 777666542 23456999999999999999999999998 9999999999
Q ss_pred eEeC-CCCCeeeecccceeeeCCCCCccccceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccc
Q 021771 121 VLLN-HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSE 198 (308)
Q Consensus 121 ilv~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~ 198 (308)
|+++ .++.+||+|||++..+..... .....++..|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 172 il~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 248 (383)
T 3eb0_A 172 LLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI 248 (383)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH
Confidence 9997 678999999999987643322 2234678899999988764 5899999999999999999999999754332
Q ss_pred cccchhHHH--------HHhh----hcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 199 LGQSLLSYT--------WKLW----CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 199 ~~~~~~~~~--------~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
......-.. .... .................+......+.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 249 DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 110000000 0000 000000000000000111122345889999999999999999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=293.65 Aligned_cols=185 Identities=19% Similarity=0.245 Sum_probs=157.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC------CCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL------QHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||++.. .+|+.||||++... ......+.+|+.+++.+ .|+||+++++++......++||||+. ++|.+
T Consensus 110 fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~ 187 (429)
T 3kvw_A 110 FGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYE 187 (429)
T ss_dssp SEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHH
T ss_pred cEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHH
Confidence 799999985 57999999998643 33445677888888877 46799999999999999999999995 58888
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC--eeeecccceeeeCCCCCccccce
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN--PKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~--~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
++.... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||++...... ...
T Consensus 188 ~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~ 258 (429)
T 3kvw_A 188 LIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYT 258 (429)
T ss_dssp HHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCS
T ss_pred HHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccc
Confidence 886542 234899999999999999999999998 999999999999999987 999999999764322 222
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccc
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYL 196 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 196 (308)
..++..|+|||++.+..++.++|||||||++|+|++|.+||....
T Consensus 259 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 467889999999999889999999999999999999999996554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=295.70 Aligned_cols=246 Identities=22% Similarity=0.225 Sum_probs=177.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeC------CeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE------NESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.||||++..... ...+|+.+|+.++|+||+++++++... ..+++||||+++ ++..
T Consensus 67 fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 141 (420)
T 1j1b_A 67 FGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYR 141 (420)
T ss_dssp SEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHH
T ss_pred CEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHH
Confidence 799999997 5799999999864321 234799999999999999999998542 236799999976 5555
Q ss_pred Hhhc-CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC-CCeeeecccceeeeCCCCCccccce
Q 021771 74 FLFD-STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 74 ~l~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~-~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+.. ......+++..++.++.||+.||+|||++| |+||||||+|||++.+ +.+||+|||++..+..... ...
T Consensus 142 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~ 215 (420)
T 1j1b_A 142 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 215 (420)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCS
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---cee
Confidence 5432 123456999999999999999999999998 9999999999999965 5689999999987643221 223
Q ss_pred eecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH-------hhh--ccccccccc
Q 021771 152 IVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK-------LWC--EGEALELME 221 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~-------~~~--~~~~~~~~~ 221 (308)
..++..|+|||++.+. .++.++|||||||++|+|++|+.||........ +...... .+. .....+..-
T Consensus 216 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~~~~~~~~~~~~~~ 293 (420)
T 1j1b_A 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREMNPNYTEFKF 293 (420)
T ss_dssp CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHHHHHHCSCCCCCCC
T ss_pred eeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChhhhhhcc
Confidence 4678999999988764 789999999999999999999999975432211 1010000 000 000000000
Q ss_pred ccccc-----cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 222 PVLKQ-----SCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 222 ~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+.... .........+.+|+.+||+.||++|||+.|+++
T Consensus 294 p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 294 PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000 011112346889999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=283.82 Aligned_cols=248 Identities=19% Similarity=0.243 Sum_probs=187.0
Q ss_pred CCccEEeee--CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCc------CccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL--ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK------NLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~--~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||+||++.. .+|+.||+|++... ....+.+.+|+.+++.++|+ +|+++++++.+.+..++||||+ +++|.
T Consensus 27 ~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~ 104 (339)
T 1z57_A 27 FGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTY 104 (339)
T ss_dssp TEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred CeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHH
Confidence 789999985 37899999998543 34456788999999998765 4999999999999999999999 88999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-------------------CCCeeeec
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-------------------EMNPKISD 133 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-------------------~~~~kl~d 133 (308)
+++.... ...+++..+..++.||+.||+|||++| ++|+||||+||+++. ++.+||+|
T Consensus 105 ~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 180 (339)
T 1z57_A 105 DFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180 (339)
T ss_dssp HHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECC
T ss_pred HHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEee
Confidence 8886542 235889999999999999999999998 999999999999987 66799999
Q ss_pred ccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH----
Q 021771 134 FGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK---- 209 (308)
Q Consensus 134 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~---- 209 (308)
||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||.................
T Consensus 181 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~ 255 (339)
T 1z57_A 181 FGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPK 255 (339)
T ss_dssp CSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCH
T ss_pred CcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9999874322 2234678999999999988899999999999999999999999975443321111100000
Q ss_pred -hhh---ccc--------ccc----------cccccc-cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 210 -LWC---EGE--------ALE----------LMEPVL-KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 210 -~~~---~~~--------~~~----------~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+. ... +.. ...+.. ...........+.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 256 HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 000 000 000 000000 00112234567889999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.50 Aligned_cols=251 Identities=23% Similarity=0.251 Sum_probs=183.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeC-----CeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE-----NESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.||||++.... ......+.+|+.+++.++||||+++++++... ...++||||+. ++|.+
T Consensus 24 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~ 102 (353)
T 2b9h_A 24 YGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHR 102 (353)
T ss_dssp SEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHH
T ss_pred CeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHH
Confidence 799999996 479999999996443 33456778999999999999999999987754 57899999996 58888
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc------
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA------ 147 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~------ 147 (308)
++.. ..+++..+..++.|++.||+|||++| ++|+||||+||+++.++.+||+|||++..........
T Consensus 103 ~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 175 (353)
T 2b9h_A 103 VIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175 (353)
T ss_dssp HHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC------------
T ss_pred HHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCcccc
Confidence 8754 35899999999999999999999998 9999999999999999999999999998765322111
Q ss_pred --ccceeecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccc-------
Q 021771 148 --NTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEAL------- 217 (308)
Q Consensus 148 --~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 217 (308)
......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.........................
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (353)
T 2b9h_A 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255 (353)
T ss_dssp ----CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHH
T ss_pred ccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccch
Confidence 1122467889999998765 678999999999999999999999997543221100000000000000000
Q ss_pred --cccccc------ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 218 --ELMEPV------LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 218 --~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+..... ............+.+|+.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 256 AREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 000001122345888999999999999999999996
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=290.22 Aligned_cols=253 Identities=18% Similarity=0.185 Sum_probs=178.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe-------EEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE-------SLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~ 72 (308)
||+||+++. .+|+.||||++... .........++..+..++||||+++++++..... .++||||++++.+.
T Consensus 36 ~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~ 114 (360)
T 3e3p_A 36 FGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHR 114 (360)
T ss_dssp ---CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHH
Confidence 799999996 57999999988543 2333456778888899999999999999976433 78999999774333
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhch--hCCCCceeecCCCCCceEeCC-CCCeeeecccceeeeCCCCCcccc
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLH--EDSRLKIIHRDLKASNVLLNH-EMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~g~~~i~H~di~p~nilv~~-~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
.+.........+++..+..++.|++.||.||| ++| |+|+||||+||+++. ++.+||+|||++........ .
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~ 188 (360)
T 3e3p_A 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---N 188 (360)
T ss_dssp HHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---C
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---c
Confidence 33222234556899999999999999999999 887 999999999999996 88999999999987643322 2
Q ss_pred ceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHH--------HHhhhcc-ccccc
Q 021771 150 NRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYT--------WKLWCEG-EALEL 219 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~--------~~~~~~~-~~~~~ 219 (308)
....++..|+|||++.+. .++.++|||||||++|+|++|..||............... ....... .....
T Consensus 189 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3e3p_A 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDL 268 (360)
T ss_dssp CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGG
T ss_pred ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccc
Confidence 224578899999988664 4899999999999999999999999754332111100000 0000000 00000
Q ss_pred cc------ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 220 ME------PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 220 ~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.. ..............+.+|+.+||+.||++|||+.|+++-
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 269 YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp GCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000001111134568899999999999999999999953
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=279.95 Aligned_cols=239 Identities=23% Similarity=0.355 Sum_probs=177.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe-------------CCeEEEEEEec
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-------------ENESLLIYEYM 66 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~ 66 (308)
||.||+++. .+|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+ ....++||||+
T Consensus 19 ~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 97 (303)
T 1zy4_A 19 FGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYC 97 (303)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECC
T ss_pred cEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecC
Confidence 789999996 58999999998543 3445778899999999999999999998865 34679999999
Q ss_pred CCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC-
Q 021771 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS- 145 (308)
Q Consensus 67 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~- 145 (308)
++++|.+++... ...+++..++.++.|++.||+|||++| ++|+||+|+||+++.++.+||+|||++........
T Consensus 98 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 172 (303)
T 1zy4_A 98 ENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172 (303)
T ss_dssp CSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC----
T ss_pred CCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccch
Confidence 999999999653 345788999999999999999999998 99999999999999999999999999876542210
Q ss_pred -----------ccccceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc
Q 021771 146 -----------EANTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE 213 (308)
Q Consensus 146 -----------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 213 (308)
........++..|+|||++.+. .++.++||||||+++|+|++ ||...... ...... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~-----~~~~~~-~~~ 243 (303)
T 1zy4_A 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER-----VNILKK-LRS 243 (303)
T ss_dssp ---------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-----HHHHHH-HHS
T ss_pred hccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH-----HHHHHh-ccc
Confidence 1112234678899999998764 68999999999999999998 43211100 000011 100
Q ss_pred ccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 214 GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.. ..............+.+++.+||+.||++|||+.++++.
T Consensus 244 ~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 244 VS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp TT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00 001111222233457889999999999999999999973
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=289.67 Aligned_cols=243 Identities=21% Similarity=0.274 Sum_probs=180.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeE------EEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES------LLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L 71 (308)
||.||++.. .+|+.||||++.... ......+.+|+.+++.++||||+++++++...+.. ++||||+. ++|
T Consensus 55 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l 133 (371)
T 4exu_A 55 YGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDL 133 (371)
T ss_dssp SEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEH
T ss_pred CeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccH
Confidence 799999985 579999999996542 33456788999999999999999999999877654 99999996 578
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++. ..+++..+..++.||+.||+|||++| |+|+||||+||+++.++.+||+|||++...... ...
T Consensus 134 ~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~ 200 (371)
T 4exu_A 134 QKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTG 200 (371)
T ss_dssp HHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------C
T ss_pred HHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCC
Confidence 77762 23899999999999999999999998 999999999999999999999999999865322 222
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc--cccccc---------
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE--GEALEL--------- 219 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--------- 219 (308)
..++..|+|||++.+ ..++.++|||||||++|+|++|..||.......... ........ ......
T Consensus 201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~ 277 (371)
T 4exu_A 201 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPGTEFVQKLNDKAAKSY 277 (371)
T ss_dssp TTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCHHHHTTCSCHHHHHH
T ss_pred cccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCcHHHHHHhhhhhhhhh
Confidence 457889999998877 678999999999999999999999996543221100 00000000 000000
Q ss_pred ---ccccccc---cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 220 ---MEPVLKQ---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 220 ---~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+...... .........+.+|+.+||+.||++|||++|+++-
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000000 0011123468899999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=282.48 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=183.1
Q ss_pred CCccEEeee--CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcC---CCcCccceeeeEE-----eCCeEEEEEEecCC
Q 021771 1 MESCLQGKL--ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL---QHKNLVRLFGCCL-----EENESLLIYEYMPN 68 (308)
Q Consensus 1 ~g~v~~~~~--~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~ 68 (308)
||.||+++. .+|+.||+|++.... ......+.+|+.+++.+ +||||+++++++. .....++||||++
T Consensus 24 ~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~- 102 (326)
T 1blx_A 24 YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD- 102 (326)
T ss_dssp TEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-
T ss_pred cEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-
Confidence 799999996 468899999886432 22233556777777666 8999999999987 4567899999997
Q ss_pred CChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc
Q 021771 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 69 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
++|.+++.... ...+++..++.++.||+.||.|||++| ++|+||||+||+++.++.+||+|||++...... ..
T Consensus 103 ~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~ 175 (326)
T 1blx_A 103 QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MA 175 (326)
T ss_dssp CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GG
T ss_pred CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCC---CC
Confidence 59999886543 234899999999999999999999998 999999999999999999999999998765321 12
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh---ccccccc------
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC---EGEALEL------ 219 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~------ 219 (308)
.....++..|+|||++.+..++.++||||||+++|+|++|..||......... ........ ...+...
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~ 252 (326)
T 1blx_A 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGEEDWPRDVALPRQ 252 (326)
T ss_dssp GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCGGGSCTTCSSCGG
T ss_pred ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCcccCccccccchh
Confidence 23346789999999998888999999999999999999999999754332110 00000000 0000000
Q ss_pred -cc---ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 220 -ME---PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 220 -~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.. ..............+.+|+.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 253 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 00000111122345788999999999999999999995
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=281.29 Aligned_cols=238 Identities=18% Similarity=0.190 Sum_probs=160.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe----CCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE----ENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+++. .+|+.||||++... .....+....++.+.|+||+++++++.. ....++||||+++++|.+++
T Consensus 42 ~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l 117 (336)
T 3fhr_A 42 NGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117 (336)
T ss_dssp TEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHH
Confidence 799999996 47999999998543 1222333344667789999999999986 44589999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC---CCeeeecccceeeeCCCCCcccccee
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE---MNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
.... ...+++..++.++.||+.||.|||++| ++|+||||+||+++.+ +.+||+|||++....... ....
T Consensus 118 ~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~ 189 (336)
T 3fhr_A 118 QERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTP 189 (336)
T ss_dssp HTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------------
T ss_pred HhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccC
Confidence 6542 246999999999999999999999998 9999999999999864 459999999998754222 2234
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.++..|+|||++.+..++.++||||||+++|+|++|..||............. ....... .. .........
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~-~~-----~~~~~~~~~ 260 (336)
T 3fhr_A 190 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRLGQ-YG-----FPNPEWSEV 260 (336)
T ss_dssp --------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------C-----CCTTTSTTC
T ss_pred CCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhccc-cc-----cCchhhccC
Confidence 57889999999988889999999999999999999999986543322110000 0000000 00 000001112
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...+.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 261 SEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 335888999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=282.41 Aligned_cols=248 Identities=18% Similarity=0.226 Sum_probs=184.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-----------CcCccceeeeEEeCC----eEEEEEE
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-----------HKNLVRLFGCCLEEN----ESLLIYE 64 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e 64 (308)
||+||+++. .+|+.||||++... ....+.+.+|+.++++++ |+||+++++++.... ..++|||
T Consensus 32 ~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e 110 (373)
T 1q8y_A 32 FSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 110 (373)
T ss_dssp SEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEEC
T ss_pred CeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEe
Confidence 799999995 68999999998643 334567889999999886 789999999998654 6899999
Q ss_pred ecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhC-CCCceeecCCCCCceEeC------CCCCeeeecccce
Q 021771 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLN------HEMNPKISDFGMA 137 (308)
Q Consensus 65 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-g~~~i~H~di~p~nilv~------~~~~~kl~dfg~~ 137 (308)
++ +++|.+++.... ...+++..+..++.||+.||+|||++ | |+|+||||+||+++ ..+.+||+|||++
T Consensus 111 ~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a 185 (373)
T 1q8y_A 111 VL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185 (373)
T ss_dssp CC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTC
T ss_pred cC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccc
Confidence 99 889999886543 23489999999999999999999998 8 99999999999995 3447999999999
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhh------
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLW------ 211 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~------ 211 (308)
...... .....++..|+|||++.+..++.++|||||||++|+|++|..||...................
T Consensus 186 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (373)
T 1q8y_A 186 CWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 260 (373)
T ss_dssp EETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSC
T ss_pred cccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCC
Confidence 875432 222367899999999999889999999999999999999999997544322111111100000
Q ss_pred ---------------hcccccccccc--------c--ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 212 ---------------CEGEALELMEP--------V--LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 212 ---------------~~~~~~~~~~~--------~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
........+.. . .....+......+.+||.+||+.||++|||++|+++
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 261 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp CHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred CHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 00000000000 0 001233556778999999999999999999999997
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=290.63 Aligned_cols=240 Identities=26% Similarity=0.302 Sum_probs=175.2
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||.+...+|+.||||++... ..+.+.+|+.+|+.+ +||||+++++++.+++..++|||||+ ++|.+++....
T Consensus 28 ~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~ 103 (434)
T 2rio_A 28 SGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKN 103 (434)
T ss_dssp TTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC-
T ss_pred CeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccC
Confidence 79998776778999999998543 235678899999886 79999999999999999999999996 59999986542
Q ss_pred Cc----cccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC-------------CCeeeecccceeeeCC
Q 021771 80 RS----VQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-------------MNPKISDFGMARIFGG 142 (308)
Q Consensus 80 ~~----~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~-------------~~~kl~dfg~~~~~~~ 142 (308)
.. ...++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++.....
T Consensus 104 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~ 180 (434)
T 2rio_A 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180 (434)
T ss_dssp -----------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC
T ss_pred CCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCC
Confidence 21 11234456789999999999999998 9999999999999754 4799999999988754
Q ss_pred CCCcc--ccceeecccCccCchhhcc-------CcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhh
Q 021771 143 NQSEA--NTNRIVGTYGYMAPEYAME-------GLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWC 212 (308)
Q Consensus 143 ~~~~~--~~~~~~~~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~ 212 (308)
..... ......|+..|+|||++.+ ..++.++|||||||++|+|++ |..||+...... ........
T Consensus 181 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~i~~~~~- 255 (434)
T 2rio_A 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----SNIIRGIF- 255 (434)
T ss_dssp --------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----HHHHHTCC-
T ss_pred CCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----HHHhcCCC-
Confidence 32211 1223468999999999865 568899999999999999998 899986432221 00000000
Q ss_pred cccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 213 EGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.... . ...........+.+|+.+||+.||++|||+.+|++
T Consensus 256 --~~~~-~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 256 --SLDE-M----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --CCCC-C----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --Cccc-c----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0000 0 11112344567889999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=306.58 Aligned_cols=241 Identities=24% Similarity=0.312 Sum_probs=186.8
Q ss_pred CCccEEeeeC----CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA----DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|+.. .+..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+ +..++||||+++++|.+++
T Consensus 403 fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l 481 (656)
T 2j0j_A 403 FGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL 481 (656)
T ss_dssp SCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHH
T ss_pred CEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHH
Confidence 7999999864 2567999988654 33445778999999999999999999999854 5689999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ...+++..++.++.|++.||.|||++| |+||||||+||+++.++.+||+|||++......... ......++
T Consensus 482 ~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t 555 (656)
T 2j0j_A 482 QVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLP 555 (656)
T ss_dssp HHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CC
T ss_pred Hhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCC
Confidence 653 235899999999999999999999998 999999999999999999999999999876433221 12223456
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||++.+..++.++||||||+++|+|++ |..||....... ...... ...... .+.....
T Consensus 556 ~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~~~i~-~~~~~~---------~~~~~~~ 619 (656)
T 2j0j_A 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIE-NGERLP---------MPPNCPP 619 (656)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHH-HTCCCC---------CCTTCCH
T ss_pred cceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHH-cCCCCC---------CCccccH
Confidence 78999999988899999999999999999997 889986443221 111111 111111 1111223
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 588899999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=282.58 Aligned_cols=241 Identities=26% Similarity=0.352 Sum_probs=164.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHH-HHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVT-LIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.||||++.... ......+..|+. +++.++||||+++++++.+.+..++||||+++ +|.+++..
T Consensus 35 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 113 (327)
T 3aln_A 35 YGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKY 113 (327)
T ss_dssp SEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHH
T ss_pred CEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHH
Confidence 799999996 589999999997553 333345555655 77778999999999999999999999999975 77776643
Q ss_pred C--CCccccChHHHHHHHHHHHHHHHhchhC-CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 78 S--TRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 78 ~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~-g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
. .....+++..+..++.|++.||.|||++ | ++|+||||+||+++.++.+||+|||++........ .....+
T Consensus 114 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g 187 (327)
T 3aln_A 114 VYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAG 187 (327)
T ss_dssp HHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC---------------
T ss_pred HHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCC
Confidence 1 1234689999999999999999999998 8 99999999999999999999999999976543221 222367
Q ss_pred ccCccCchhh----ccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 155 TYGYMAPEYA----MEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 155 ~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
+..|+|||++ .+..++.++||||||+++|+|++|..||......... ... ........ +......
T Consensus 188 t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~-~~~~~~~~-----~~~~~~~ 256 (327)
T 3aln_A 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LTQ-VVKGDPPQ-----LSNSEER 256 (327)
T ss_dssp ------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCCCC-----CCCCSSC
T ss_pred CccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HHH-HhcCCCCC-----CCCcccc
Confidence 8899999988 4556889999999999999999999998653221000 000 00000000 0010011
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.....+.+|+.+||+.||++|||+.+|++
T Consensus 257 ~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 257 EFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 12235888999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=284.56 Aligned_cols=242 Identities=21% Similarity=0.264 Sum_probs=180.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe------EEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE------SLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L 71 (308)
||.||+++. .+|+.||||++.... ......+.+|+.+++.++||||+++++++..... .++||||+. ++|
T Consensus 37 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l 115 (353)
T 3coi_A 37 YGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDL 115 (353)
T ss_dssp SEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEG
T ss_pred CeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCH
Confidence 799999996 579999999986542 3345678899999999999999999999987654 499999996 588
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++. ..+++..+..++.||+.||+|||++| ++|+||||+||+++.++.+||+|||++...... ...
T Consensus 116 ~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~ 182 (353)
T 3coi_A 116 QKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTG 182 (353)
T ss_dssp GGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC------------
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccc
Confidence 77662 23899999999999999999999998 999999999999999999999999998764322 223
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc-----------------
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE----------------- 213 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~----------------- 213 (308)
..++..|+|||++.+ ..++.++||||||+++|+|++|..||........ ..........
T Consensus 183 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~ 259 (353)
T 3coi_A 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQKLNDKAAKSY 259 (353)
T ss_dssp -CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHTTCSCHHHHHH
T ss_pred cccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHHhhHHHHHH
Confidence 467899999998877 6789999999999999999999999975432211 0000000000
Q ss_pred -ccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 214 -GEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
........... ..........+.+|+.+||+.||++|||++++++.
T Consensus 260 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 260 IQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000000 00111223468899999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=282.19 Aligned_cols=185 Identities=23% Similarity=0.298 Sum_probs=155.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-Cc-----CccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HK-----NLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+++. .+|+.||||++... ......+..|+.+++.++ |+ +|+++++++...+..++||||++ ++|.+
T Consensus 67 ~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~ 144 (382)
T 2vx3_A 67 FGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYD 144 (382)
T ss_dssp TEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHH
T ss_pred CEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHH
Confidence 799999985 57899999999643 334466778888888885 44 49999999999999999999996 49988
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchh--CCCCceeecCCCCCceEeC--CCCCeeeecccceeeeCCCCCcccc
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHE--DSRLKIIHRDLKASNVLLN--HEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~g~~~i~H~di~p~nilv~--~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
++.... ...+++..+..++.|++.||.|||+ .| |+||||||+||+++ .++.+||+|||++...... .
T Consensus 145 ~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~ 215 (382)
T 2vx3_A 145 LLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----I 215 (382)
T ss_dssp HHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----C
T ss_pred HHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----c
Confidence 886543 2348999999999999999999995 55 99999999999995 4678999999999876432 2
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccc
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYL 196 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 196 (308)
....++..|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 216 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 23467889999999999889999999999999999999999997543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=280.15 Aligned_cols=248 Identities=19% Similarity=0.247 Sum_probs=182.9
Q ss_pred CCccEEeee-CCC-CEEEEEEeccCCcccHHHHHHHHHHHhcCCCcC------ccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADG-KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN------LVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||+||++.. .++ +.||+|++... ....+.+..|+.+++.++|++ ++.+++++...+..++||||+ ++++.
T Consensus 32 ~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~ 109 (355)
T 2eu9_A 32 FGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTF 109 (355)
T ss_dssp TEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred CeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChH
Confidence 789999985 344 68999998543 344567888999999997665 899999999999999999999 55666
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEe-------------------CCCCCeeeec
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL-------------------NHEMNPKISD 133 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv-------------------~~~~~~kl~d 133 (308)
+++... ....+++..++.++.||+.||+|||++| |+|+||||+||++ +.++.+||+|
T Consensus 110 ~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 185 (355)
T 2eu9_A 110 EFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185 (355)
T ss_dssp HHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECC
T ss_pred HHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEee
Confidence 666443 2235899999999999999999999998 9999999999999 5678899999
Q ss_pred ccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH-----
Q 021771 134 FGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW----- 208 (308)
Q Consensus 134 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~----- 208 (308)
||++...... .....++..|+|||++.+..++.++|||||||++|+|++|..||................
T Consensus 186 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~ 260 (355)
T 2eu9_A 186 FGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPS 260 (355)
T ss_dssp CTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcH
Confidence 9999874322 223467899999999998889999999999999999999999997543321111100000
Q ss_pred Hhhhcccccc---------------------cccccc-cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 209 KLWCEGEALE---------------------LMEPVL-KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 209 ~~~~~~~~~~---------------------~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..+....... ...+.. ...........+.+|+.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 261 HMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 000000 00011223457889999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=278.30 Aligned_cols=227 Identities=20% Similarity=0.332 Sum_probs=177.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc------cHHHHHHHHHHHhcC----CCcCccceeeeEEeCCeEEEEEEe-cCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ------GLQEFKNEVTLIAKL----QHKNLVRLFGCCLEENESLLIYEY-MPN 68 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~ 68 (308)
||.||+++. .+|+.||+|++...... ....+..|+.+++.+ +|+||+++++++.+.+..++|||+ +.+
T Consensus 44 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 123 (312)
T 2iwi_A 44 FGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA 123 (312)
T ss_dssp TEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSE
T ss_pred CEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCC
Confidence 789999985 68999999999654321 223455789999988 899999999999999999999999 788
Q ss_pred CChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC-CCCCeeeecccceeeeCCCCCcc
Q 021771 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEMNPKISDFGMARIFGGNQSEA 147 (308)
Q Consensus 69 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~-~~~~~kl~dfg~~~~~~~~~~~~ 147 (308)
++|.+++... ..+++..++.++.||+.||+|||++| ++|+||+|+||+++ .++.++|+|||++.......
T Consensus 124 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~--- 194 (312)
T 2iwi_A 124 QDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--- 194 (312)
T ss_dssp EEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC---
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc---
Confidence 9999998653 34899999999999999999999998 99999999999999 88899999999998765332
Q ss_pred ccceeecccCccCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccc
Q 021771 148 NTNRIVGTYGYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ 226 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
.....++..|+|||++.+..+ +.++||||||+++|+|++|..||...... .. .. .. .
T Consensus 195 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------~~-~~-~~-----~-- 252 (312)
T 2iwi_A 195 -YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------------LE-AE-LH-----F-- 252 (312)
T ss_dssp -BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------HH-TC-CC-----C--
T ss_pred -ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------------hh-hc-cC-----C--
Confidence 223457889999998877655 45899999999999999999998643110 00 00 00 0
Q ss_pred cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 227 SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 227 ~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.......+.+++.+||+.||++|||++|+++.
T Consensus 253 --~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 253 --PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122357889999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=286.94 Aligned_cols=236 Identities=23% Similarity=0.317 Sum_probs=173.0
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+|+.....+|+.||||++...... .+.+|+.+|+.+ +||||+++++++.+....++|||||. ++|.+++....
T Consensus 37 ~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~ 112 (432)
T 3p23_A 37 EGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKD 112 (432)
T ss_dssp GGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSS
T ss_pred CEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcC
Confidence 68876665678999999998654322 346899999999 79999999999999999999999996 58999886543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC---C--CCeeeecccceeeeCCCCCc-cccceee
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH---E--MNPKISDFGMARIFGGNQSE-ANTNRIV 153 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~---~--~~~kl~dfg~~~~~~~~~~~-~~~~~~~ 153 (308)
.......++.++.||+.||+|||++| |+||||||+||+++. + ..+||+|||++......... .......
T Consensus 113 --~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~ 187 (432)
T 3p23_A 113 --FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187 (432)
T ss_dssp --CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CC
T ss_pred --CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccC
Confidence 23555667899999999999999998 999999999999953 2 34779999999876533211 2223356
Q ss_pred cccCccCchhhcc---CcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 154 GTYGYMAPEYAME---GLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 154 ~~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
|+..|+|||++.+ ..++.++|||||||++|+|++ |..||+....... .... ......... ..
T Consensus 188 gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~-~~~~~~~~~------~~ 253 (432)
T 3p23_A 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILL-GACSLDCLH------PE 253 (432)
T ss_dssp SCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHT-TCCCCTTSC------TT
T ss_pred CCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHh-ccCCccccC------cc
Confidence 8999999999873 567789999999999999999 8899854322211 0000 000001000 01
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
......+.+|+.+||+.||++|||++++++
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 254 KHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 122345778999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=279.09 Aligned_cols=227 Identities=21% Similarity=0.311 Sum_probs=182.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc------cHHHHHHHHHHHhcCC--CcCccceeeeEEeCCeEEEEEEecCC-CC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ------GLQEFKNEVTLIAKLQ--HKNLVRLFGCCLEENESLLIYEYMPN-KS 70 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~ 70 (308)
||.||+++. .+|+.||||++...... ....+..|+.+++.++ |+||+++++++.+.+..++|||++.+ ++
T Consensus 56 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~ 135 (320)
T 3a99_A 56 FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD 135 (320)
T ss_dssp SCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEE
T ss_pred CeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCcc
Confidence 799999985 68999999998654221 2245678999999996 59999999999999999999999976 89
Q ss_pred hhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC-CCCCeeeecccceeeeCCCCCcccc
Q 021771 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 71 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~-~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
|.+++... ..+++..++.++.||+.||+|||++| ++|+||||+||+++ .++.+||+|||++....... .
T Consensus 136 L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~ 205 (320)
T 3a99_A 136 LFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----Y 205 (320)
T ss_dssp HHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----B
T ss_pred HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----c
Confidence 99988543 35899999999999999999999998 99999999999999 77899999999998765322 2
Q ss_pred ceeecccCccCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 150 NRIVGTYGYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
....++..|+|||++.+..+ +.++||||||+++|+|++|..||...... .. ... . .....
T Consensus 206 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------------~~-~~~--~----~~~~~ 266 (320)
T 3a99_A 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------IR-GQV--F----FRQRV 266 (320)
T ss_dssp CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------HH-CCC--C----CSSCC
T ss_pred cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh------------hc-ccc--c----ccccC
Confidence 23457899999998877655 78899999999999999999998643211 00 000 0 01111
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
...+.+|+.+||+.||++|||+++|++.
T Consensus 267 ----~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 267 ----SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2358889999999999999999999873
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=272.48 Aligned_cols=237 Identities=22% Similarity=0.334 Sum_probs=169.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc-c-cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG-Q-GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~-~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||.||+++. .+|+.||||++..... . ....+.++..+++.++||||+++++++.+++..++||||+ ++.+..+...
T Consensus 38 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~ 116 (318)
T 2dyl_A 38 CGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR 116 (318)
T ss_dssp --CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH
T ss_pred CeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH
Confidence 799999996 5899999999965532 2 2234445556788889999999999999999999999999 5566655533
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhC-CCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHED-SRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. ...+++..++.++.|++.||.|||++ | ++|+||+|+||+++.++.+||+|||++....... ......++.
T Consensus 117 ~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~ 188 (318)
T 2dyl_A 117 M--QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCA 188 (318)
T ss_dssp H--TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CC
T ss_pred h--ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCc
Confidence 2 23589999999999999999999995 7 9999999999999999999999999987654322 122346789
Q ss_pred CccCchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 157 GYMAPEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 157 ~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.|+|||++. +..++.++||||||+++|+|++|..||...... .......... ....... ...
T Consensus 189 ~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~-~~~~~~~---~~~---- 255 (318)
T 2dyl_A 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQE-EPPLLPG---HMG---- 255 (318)
T ss_dssp TTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHS-CCCCCCS---SSC----
T ss_pred cccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhcc-CCCCCCc---cCC----
Confidence 999999984 456788999999999999999999998643221 1111111111 1000000 001
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
....+.+|+.+||+.||++|||++++++
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1234888899999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=297.03 Aligned_cols=251 Identities=23% Similarity=0.259 Sum_probs=186.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEe------CCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE------ENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~ 72 (308)
||+||++.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.. ++..++||||+++++|.
T Consensus 27 fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~ 106 (676)
T 3qa8_A 27 FGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLR 106 (676)
T ss_dssp SSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHH
T ss_pred CeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHH
Confidence 799999996 57999999998654 44456778999999999999999999998765 66789999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC---eeeecccceeeeCCCCCcccc
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN---PKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~---~kl~dfg~~~~~~~~~~~~~~ 149 (308)
+++........+++..++.++.|++.||+|||+.| ++|+||+|+||+++.++. ++|+|||++....... ..
T Consensus 107 ~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~ 180 (676)
T 3qa8_A 107 KYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LC 180 (676)
T ss_dssp HHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CC
T ss_pred HHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccccc---cc
Confidence 99977555556999999999999999999999998 999999999999997765 8999999998764332 22
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCcccccccc--chhHHHHH-hhhcccccc---cccc-
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQ--SLLSYTWK-LWCEGEALE---LMEP- 222 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~--~~~~~~~~-~~~~~~~~~---~~~~- 222 (308)
....++..|+|||++.+..++.++||||||+++|+|++|..||......... ........ ......... ....
T Consensus 181 ~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~l 260 (676)
T 3qa8_A 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVL 260 (676)
T ss_dssp CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSS
T ss_pred ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcccccccccc
Confidence 3356889999999999889999999999999999999999998543211000 00000000 000000000 0000
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHH
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 257 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~ei 257 (308)
.............+.+|+..||+.||++|||++++
T Consensus 261 p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 261 PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00111223345678899999999999999999773
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=294.09 Aligned_cols=224 Identities=20% Similarity=0.267 Sum_probs=177.9
Q ss_pred CCccEEeeeC--CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCe-----EEEEEEecCCCChh
Q 021771 1 MESCLQGKLA--DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENE-----SLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~--~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~ 72 (308)
||.||++... +|+.||||++... .......+..|+.+++.++||||+++++++...+. .++||||+++++|.
T Consensus 93 ~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~ 172 (681)
T 2pzi_A 93 LGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK 172 (681)
T ss_dssp TEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC
T ss_pred CeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHH
Confidence 7999999964 6899999998644 33455678899999999999999999999987665 79999999999998
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+++.. .+++..++.++.||+.+|.|||++| |+|+||||+||+++.+ .+||+|||++...... ...
T Consensus 173 ~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~ 237 (681)
T 2pzi_A 173 RSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYL 237 (681)
T ss_dssp ----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCC
T ss_pred HHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC------Ccc
Confidence 87632 5899999999999999999999998 9999999999999985 8999999999876432 234
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.|++.|+|||++.+.. +.++|||||||++|+|++|.+||........ . ........
T Consensus 238 ~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------------~-------~~~~~~~~ 293 (681)
T 2pzi_A 238 YGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------------P-------EDDPVLKT 293 (681)
T ss_dssp CCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------------C-------TTCHHHHH
T ss_pred CCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc----------------c-------cccccccc
Confidence 6899999999887654 8899999999999999999888753221110 0 00111122
Q ss_pred HHHHHHHHhhcccCCCCCCCC-HHHHHHHhhc
Q 021771 233 LLKFIHIGLLCVQADSADRPT-MSSVVVMLAS 263 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs-~~eil~~L~~ 263 (308)
...+.+++.+||+.||++||+ ++++.+.|..
T Consensus 294 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 294 YDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 346888999999999999995 5556555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=262.63 Aligned_cols=217 Identities=18% Similarity=0.183 Sum_probs=165.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHH-hcCCCcCccceeeeEEe----CCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLI-AKLQHKNLVRLFGCCLE----ENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||++.. .+|+.||+|++... ..+.+|+.++ +.++||||+++++++.. ....++||||+++++|.++
T Consensus 31 ~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 105 (299)
T 3m2w_A 31 NGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 105 (299)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHH
T ss_pred CeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHH
Confidence 789999995 68999999998532 4567888887 55689999999999987 6678999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC---CCCeeeecccceeeeCCCCCccccce
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH---EMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~---~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
+.... ...+++..++.++.|++.||+|||++| ++|+||||+||+++. ++.++|+|||++....
T Consensus 106 l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------- 171 (299)
T 3m2w_A 106 IQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------- 171 (299)
T ss_dssp HHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----------
T ss_pred HHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc----------
Confidence 97642 335899999999999999999999998 999999999999998 7889999999986532
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
+..++.++|||||||++|+|++|..||............ ...... ............
T Consensus 172 --------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--------~~~~~~-~~~~~~~~~~~~ 228 (299)
T 3m2w_A 172 --------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------KTRIRM-GQYEFPNPEWSE 228 (299)
T ss_dssp --------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS--------CCSSCT-TCCSSCHHHHTT
T ss_pred --------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH--------HHHHhh-ccccCCchhccc
Confidence 134577899999999999999999998644322110000 000000 000000000011
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
....+.+|+.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 229 VSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 2345888999999999999999999996
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=262.46 Aligned_cols=217 Identities=14% Similarity=0.097 Sum_probs=168.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG---QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||||++..... .....+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++.
T Consensus 44 ~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 123 (286)
T 3uqc_A 44 PLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD 123 (286)
T ss_dssp TCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT
T ss_pred CeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHh
Confidence 799999996 4699999999975532 334678899999999999999999999999999999999999999999984
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
. + .....+..++.|++.||+|||++| |+|+||||+||+++.++.+||++++.
T Consensus 124 ~---~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~-------------------- 175 (286)
T 3uqc_A 124 T---S--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPAT-------------------- 175 (286)
T ss_dssp T---C--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCC--------------------
T ss_pred c---C--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccc--------------------
Confidence 2 1 355678899999999999999998 99999999999999999999985432
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
++| ++.++|||||||++|+|++|..||............. ... ..... . ...........+
T Consensus 176 --~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~-~~~~~---~---~~~~~~~~~~~l 236 (286)
T 3uqc_A 176 --MPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDT-AGQPI---E---PADIDRDIPFQI 236 (286)
T ss_dssp --CTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCT-TSCBC---C---HHHHCTTSCHHH
T ss_pred --cCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHh-ccCCC---C---hhhcccCCCHHH
Confidence 222 5789999999999999999999997544322110000 000 00000 0 000011123358
Q ss_pred HHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 237 IHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
.+++.+||+.||++| |+.|+++.|+...
T Consensus 237 ~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 237 SAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred HHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 889999999999999 9999999998753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=278.15 Aligned_cols=227 Identities=17% Similarity=0.187 Sum_probs=166.5
Q ss_pred CCccEEee-eCCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCC-cCcc---------ceeee------------EE
Q 021771 1 MESCLQGK-LADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQH-KNLV---------RLFGC------------CL 54 (308)
Q Consensus 1 ~g~v~~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h-~~i~---------~~~~~------------~~ 54 (308)
||+||+++ ..+|+.||||++... .....+.+.+|+.+++.++| .+.. ...+. +.
T Consensus 91 fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (413)
T 3dzo_A 91 PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRL 170 (413)
T ss_dssp TEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------
T ss_pred CEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccC
Confidence 79999999 468999999998733 23346789999999999976 2211 11111 11
Q ss_pred e-----CCeEEEEEEecCCCChhhHhhc----CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC
Q 021771 55 E-----ENESLLIYEYMPNKSLDVFLFD----STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125 (308)
Q Consensus 55 ~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~ 125 (308)
. ....+++|+++ +++|.+++.. ......+++..++.++.||+.||+|||++| |+||||||+|||++.
T Consensus 171 ~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~ 246 (413)
T 3dzo_A 171 DERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQ 246 (413)
T ss_dssp ------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred CCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEec
Confidence 1 12357777776 6789888842 123456888899999999999999999998 999999999999999
Q ss_pred CCCeeeecccceeeeCCCCCccccceeecccCccCchhh----------ccCcccccccchhhhHHHHHHHhCCcCCCcc
Q 021771 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYA----------MEGLFSVKSDVFSFGVLLLEIISGKKNTGFY 195 (308)
Q Consensus 126 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 195 (308)
++.+||+|||++...... .....| ..|+|||++ .+..++.++|||||||++|+|++|..||...
T Consensus 247 ~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~ 320 (413)
T 3dzo_A 247 RGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320 (413)
T ss_dssp TCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred CCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999998874322 233456 899999998 4456888999999999999999999999654
Q ss_pred ccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHH
Q 021771 196 LSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVV 258 (308)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil 258 (308)
........ .+... ... ...+.+|+.+||+.||++|||+.+++
T Consensus 321 ~~~~~~~~---------------~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 321 AALGGSEW---------------IFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp GGGSCSGG---------------GGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred chhhhHHH---------------HHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence 33211110 00000 011 24588899999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=263.20 Aligned_cols=228 Identities=13% Similarity=0.078 Sum_probs=168.1
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC--------cccHHHHHHHHHHHhcCC---------CcC-----------------c
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS--------GQGLQEFKNEVTLIAKLQ---------HKN-----------------L 46 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~-----------------i 46 (308)
||.||+++. +|+.||||++.... ....+.+.+|+.+++.++ |+| |
T Consensus 33 ~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~i 111 (336)
T 2vuw_A 33 FGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLL 111 (336)
T ss_dssp TEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHH
T ss_pred ceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHH
Confidence 799999988 78999999997542 234478889999999886 444 4
Q ss_pred cceeeeEEe-------------CCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhch-hCCCCcee
Q 021771 47 VRLFGCCLE-------------ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLH-EDSRLKII 112 (308)
Q Consensus 47 ~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~g~~~i~ 112 (308)
+++++++.+ .+..++|||||++|++.+.+.. ..+++..++.++.||+.||+||| ++| |+
T Consensus 112 v~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~~---iv 184 (336)
T 2vuw_A 112 LKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEASLR---FE 184 (336)
T ss_dssp HHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHHHHHHHHHC---CB
T ss_pred HHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 555554443 6789999999999866555522 35899999999999999999999 897 99
Q ss_pred ecCCCCCceEeCCCC--------------------CeeeecccceeeeCCCCCccccceeecccCccCchhhccCccccc
Q 021771 113 HRDLKASNVLLNHEM--------------------NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVK 172 (308)
Q Consensus 113 H~di~p~nilv~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 172 (308)
||||||+|||++.++ .+||+|||++...... ...|+..|+|||++.+.. +.+
T Consensus 185 HrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~ 256 (336)
T 2vuw_A 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQ 256 (336)
T ss_dssp CSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHH
T ss_pred ECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccc
Confidence 999999999999887 8999999999876422 347899999999988766 889
Q ss_pred ccchhhhHH-HHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHHhhcccCCCCCC
Q 021771 173 SDVFSFGVL-LLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADR 251 (308)
Q Consensus 173 ~Di~slG~~-l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 251 (308)
+||||||++ .++++.|..||...... ............. ...............+.+||.+||+.|
T Consensus 257 ~Diwsl~~~~~~~~~~g~~p~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~dli~~~L~~d---- 323 (336)
T 2vuw_A 257 FDIYRLMKKENNNRWGEYHPYSNVLWL-----HYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQEFHRTMLNFS---- 323 (336)
T ss_dssp HHHHHHHHHHHTTCTTSCCTHHHHHHH-----HHHHHHHHHTCCC----SSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred eehhhhhCCCCcccccccCCCcchhhh-----hHHHHhhhhhhcc----CcccchhhhhhcCHHHHHHHHHHhccC----
Confidence 999998777 77788898887421000 0000000000000 001111223345667999999999976
Q ss_pred CCHHHHH
Q 021771 252 PTMSSVV 258 (308)
Q Consensus 252 Ps~~eil 258 (308)
|++|++
T Consensus 324 -sa~e~l 329 (336)
T 2vuw_A 324 -SATDLL 329 (336)
T ss_dssp -SHHHHH
T ss_pred -CHHHHH
Confidence 999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=251.87 Aligned_cols=170 Identities=18% Similarity=0.198 Sum_probs=125.7
Q ss_pred CCCCEEEEEEeccCC----------cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 10 ADGKEIAVKRLSRTS----------GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 10 ~~g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
--|+.+++|++.... ....+.+.+|+++|+++ .|+||+++++++++++..||||||++|++|.+++...
T Consensus 257 ~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~ 336 (569)
T 4azs_A 257 FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG 336 (569)
T ss_dssp EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT
T ss_pred cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC
Confidence 368899999986541 12345688999999999 6999999999999999999999999999999999643
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
..++.. .++.||+.||+|+|++| |+||||||+|||++.+|.+||+|||+++....... ......||+.|
T Consensus 337 ---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~Y 405 (569)
T 4azs_A 337 ---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFV 405 (569)
T ss_dssp ---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHH
T ss_pred ---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhh
Confidence 346554 47899999999999998 99999999999999999999999999987643322 22335789999
Q ss_pred cCchhhccCcccccccchhhhHHHHHHHhCCcC
Q 021771 159 MAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN 191 (308)
Q Consensus 159 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 191 (308)
+|||++.+. +..++|+|++|++++.+.++..+
T Consensus 406 mAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 406 FVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHC------------------CCCCTTHHH
T ss_pred ccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 999988764 56789999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-26 Score=210.69 Aligned_cols=175 Identities=15% Similarity=0.177 Sum_probs=141.2
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcc--------cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQ--------GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+++. .++.+++|+....... ..+.+.+|+.+|++++||||+++..++.+.+..++||||+++++|.
T Consensus 349 fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~ 427 (540)
T 3en9_A 349 EADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAK 427 (540)
T ss_dssp CEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHH
T ss_pred CEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHH
Confidence 799999954 6788999976433211 1345789999999999999996666666777789999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc-----
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA----- 147 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~----- 147 (308)
+++.. +..++.|++.+|+|||++| |+||||||+||+++. .+||+|||+++.........
T Consensus 428 ~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~ 491 (540)
T 3en9_A 428 DVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIV 491 (540)
T ss_dssp HHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHH
T ss_pred HHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhh
Confidence 99843 5689999999999999998 999999999999999 99999999999864321111
Q ss_pred ccceeecccCccCchhhcc--CcccccccchhhhHHHHHHHhCCcCC
Q 021771 148 NTNRIVGTYGYMAPEYAME--GLFSVKSDVFSFGVLLLEIISGKKNT 192 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~ 192 (308)
......||+.|+|||++.. ..|+..+|+|+...-..+-+.++.+|
T Consensus 492 ~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 492 FKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1134578999999999987 56888899999888877777666554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.9e-22 Score=171.42 Aligned_cols=132 Identities=18% Similarity=0.092 Sum_probs=106.6
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCc------------------ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEE
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSG------------------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 62 (308)
||.||+++..+|+.||+|++..... .....+.+|+.+|+.++ | +++.+++.. +..++|
T Consensus 103 ~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lv 178 (282)
T 1zar_A 103 ESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVL 178 (282)
T ss_dssp SEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEE
T ss_pred CceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEE
Confidence 6899999997899999999864321 13456889999999999 5 667776654 456999
Q ss_pred EEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 63 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
|||+++++|.+ +.. .....++.|++.||.|||+.| |+|+||||+||+++ ++.+||+|||++..
T Consensus 179 mE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~DFG~a~~--- 241 (282)
T 1zar_A 179 MELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVE--- 241 (282)
T ss_dssp EECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECCCTTCEE---
T ss_pred EEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEECCCCeE---
Confidence 99999999988 411 234579999999999999998 99999999999999 99999999999864
Q ss_pred CCCccccceeecccCccCchhhc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAM 165 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~ 165 (308)
+..+.|||++.
T Consensus 242 ------------~~~~~a~e~l~ 252 (282)
T 1zar_A 242 ------------VGEEGWREILE 252 (282)
T ss_dssp ------------TTSTTHHHHHH
T ss_pred ------------CCCCCHHHHHH
Confidence 23467888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.5e-18 Score=144.21 Aligned_cols=125 Identities=18% Similarity=0.220 Sum_probs=96.0
Q ss_pred CCccEEeee-CCCCE--EEEEEeccCCcc------------------------cHHHHHHHHHHHhcCCCcCc--cceee
Q 021771 1 MESCLQGKL-ADGKE--IAVKRLSRTSGQ------------------------GLQEFKNEVTLIAKLQHKNL--VRLFG 51 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~i--~~~~~ 51 (308)
||.||+|.. .+|+. ||||++...... ....+..|+.+|+.+.|+++ +.+++
T Consensus 60 ~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~ 139 (258)
T 1zth_A 60 EANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYT 139 (258)
T ss_dssp SEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEE
T ss_pred eEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEE
Confidence 789999997 78999 999987543111 11357889999999988764 34443
Q ss_pred eEEeCCeEEEEEEecCC-C----ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhch-hCCCCceeecCCCCCceEeCC
Q 021771 52 CCLEENESLLIYEYMPN-K----SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLH-EDSRLKIIHRDLKASNVLLNH 125 (308)
Q Consensus 52 ~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~g~~~i~H~di~p~nilv~~ 125 (308)
. ...+|||||+.+ | .|.++... .++..+..++.|++.+|.+|| +.| |+||||||+|||++.
T Consensus 140 ~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlkp~NILl~~ 206 (258)
T 1zth_A 140 Y----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHADLSEYNIMYID 206 (258)
T ss_dssp E----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCSTTSEEESS
T ss_pred c----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEEcC
Confidence 2 246899999942 3 56655421 235577899999999999999 888 999999999999998
Q ss_pred CCCeeeecccceeee
Q 021771 126 EMNPKISDFGMARIF 140 (308)
Q Consensus 126 ~~~~kl~dfg~~~~~ 140 (308)
.++|+|||++...
T Consensus 207 --~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 --KVYFIDMGQAVTL 219 (258)
T ss_dssp --SEEECCCTTCEET
T ss_pred --cEEEEECcccccC
Confidence 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=3.6e-15 Score=131.33 Aligned_cols=125 Identities=14% Similarity=0.107 Sum_probs=87.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCc--------------ccHH--------HHHHHHHHHhcCCCcCccceeeeEEeCCe
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSG--------------QGLQ--------EFKNEVTLIAKLQHKNLVRLFGCCLEENE 58 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 58 (308)
||.||.|...+|+.||||+++.... .... ....|...|.++.+.++.-..-+... .
T Consensus 108 ~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~--~ 185 (397)
T 4gyi_A 108 ESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQS--R 185 (397)
T ss_dssp SEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEE--T
T ss_pred ceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeecc--C
Confidence 6899999988999999998753210 0011 12346667777754443222211222 2
Q ss_pred EEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCC----------
Q 021771 59 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN---------- 128 (308)
Q Consensus 59 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~---------- 128 (308)
.+|||||++|.+|..+.. ......++.|++.+|.+||+.| |+||||||.|||++++|.
T Consensus 186 ~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~ 253 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLT 253 (397)
T ss_dssp TEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred ceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccc
Confidence 379999999988865431 1234568899999999999998 999999999999988763
Q ss_pred eeeecccceee
Q 021771 129 PKISDFGMARI 139 (308)
Q Consensus 129 ~kl~dfg~~~~ 139 (308)
+.++||+-+-.
T Consensus 254 ~~iID~~Q~V~ 264 (397)
T 4gyi_A 254 PIIIXFPQMVS 264 (397)
T ss_dssp EEECCCTTCEE
T ss_pred eEEEEeCCccc
Confidence 78999986544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.9e-12 Score=109.04 Aligned_cols=129 Identities=14% Similarity=0.072 Sum_probs=98.0
Q ss_pred CccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
+.||.... +|..+++|+...........+..|+.+++.+. +..++++++++.+.+..++||||++|.++.+.+.
T Consensus 28 ~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~---- 102 (263)
T 3tm0_A 28 AKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE---- 102 (263)
T ss_dssp SEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC----
T ss_pred CeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC----
Confidence 45777664 47899999886432233346889999999985 6778899999998889999999999999877531
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCC-----------------------------------------------------
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDS----------------------------------------------------- 107 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g----------------------------------------------------- 107 (308)
+......++.+++++++.||+..
T Consensus 103 ----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~ 178 (263)
T 3tm0_A 103 ----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEK 178 (263)
T ss_dssp ----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCC
T ss_pred ----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcC
Confidence 11233467889999999999810
Q ss_pred ---CCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 108 ---RLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 108 ---~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
...++|||+++.||++++++.+.|+||+.+..
T Consensus 179 ~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 179 PEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 02389999999999998755567999987654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=4.4e-11 Score=100.30 Aligned_cols=124 Identities=16% Similarity=0.182 Sum_probs=91.3
Q ss_pred CccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcC--ccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN--LVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
+.||+....+|..+++|+.... ....+..|+.+++.+.+.+ +.+++.+..+++..++||||++|.++. ..
T Consensus 34 ~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~--- 105 (264)
T 1nd4_A 34 AAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS--- 105 (264)
T ss_dssp CEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---
T ss_pred ceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---
Confidence 5688887777888999987543 2245778999999886434 567888888877889999999998884 21
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCC----------------------------------------------------
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDS---------------------------------------------------- 107 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g---------------------------------------------------- 107 (308)
. .+ ...++.+++..++.||+..
T Consensus 106 ~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 179 (264)
T 1nd4_A 106 H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMP 179 (264)
T ss_dssp C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCC
T ss_pred c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcC
Confidence 1 11 1245677777777777642
Q ss_pred ---CCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 108 ---RLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 108 ---~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 180 ~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 180 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998765567999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=7.3e-10 Score=97.57 Aligned_cols=132 Identities=13% Similarity=0.261 Sum_probs=96.7
Q ss_pred CccEEeeeCCCCEEEEEEec--cCC-cccHHHHHHHHHHHhcCC--CcCccceeeeEEeC---CeEEEEEEecCCCChhh
Q 021771 2 ESCLQGKLADGKEIAVKRLS--RTS-GQGLQEFKNEVTLIAKLQ--HKNLVRLFGCCLEE---NESLLIYEYMPNKSLDV 73 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~ 73 (308)
+.+|..+.. +..+++|+.. ... ......+..|+.+++.+. +..+++++.++.+. +..++||||++|..+.+
T Consensus 52 n~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~ 130 (359)
T 3dxp_A 52 NPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWD 130 (359)
T ss_dssp SCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCC
T ss_pred ceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCC
Confidence 567877664 4688889765 221 122356788999999997 45578888888776 34799999999987744
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCC----------------------------------------------
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDS---------------------------------------------- 107 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---------------------------------------------- 107 (308)
.. ...++......++.+++..|+.||+..
T Consensus 131 ~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 205 (359)
T 3dxp_A 131 QS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLP 205 (359)
T ss_dssp TT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGG
T ss_pred Cc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHH
Confidence 21 113677788889999999999999731
Q ss_pred ---------CCceeecCCCCCceEeCCCCC--eeeecccceee
Q 021771 108 ---------RLKIIHRDLKASNVLLNHEMN--PKISDFGMARI 139 (308)
Q Consensus 108 ---------~~~i~H~di~p~nilv~~~~~--~kl~dfg~~~~ 139 (308)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 206 ~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 206 QHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp GCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 135999999999999997764 58999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=3.7e-09 Score=90.85 Aligned_cols=167 Identities=17% Similarity=0.209 Sum_probs=105.8
Q ss_pred CEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcC--ccceeeeEEeCC---eEEEEEEecCCCChhhHhhcCCCccccCh
Q 021771 13 KEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKN--LVRLFGCCLEEN---ESLLIYEYMPNKSLDVFLFDSTRSVQLDW 86 (308)
Q Consensus 13 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 86 (308)
..+++|+-.. ......+..|+.+|+.+. +.. +.+++....... ..++||++++|.++..... ..++.
T Consensus 41 ~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~-----~~l~~ 113 (304)
T 3sg8_A 41 RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL-----NNLPK 113 (304)
T ss_dssp TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH-----HTSCH
T ss_pred CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc-----ccCCH
Confidence 5688887532 234567889999998884 333 445544433333 2478999999988865332 12566
Q ss_pred HHHHHHHHHHHHHHHhchhCC-------------------------------------------------------CCce
Q 021771 87 KRRISIINGIARGLLYLHEDS-------------------------------------------------------RLKI 111 (308)
Q Consensus 87 ~~~~~~~~qi~~~l~~lH~~g-------------------------------------------------------~~~i 111 (308)
.....++.+++..++.||+.. ...+
T Consensus 114 ~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~ 193 (304)
T 3sg8_A 114 QSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCL 193 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEE
T ss_pred HHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCcee
Confidence 677777888888888887511 1248
Q ss_pred eecCCCCCceEeCC--CCCeeeecccceeeeCCCCCccccceeecccCc---cCchhhcc----C----------ccccc
Q 021771 112 IHRDLKASNVLLNH--EMNPKISDFGMARIFGGNQSEANTNRIVGTYGY---MAPEYAME----G----------LFSVK 172 (308)
Q Consensus 112 ~H~di~p~nilv~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y---~aPE~~~~----~----------~~~~~ 172 (308)
+|+|+++.||+++. .+.+.++||+.+....... .-. ..... ..|+.... . ....-
T Consensus 194 ~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~---~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~ 267 (304)
T 3sg8_A 194 IHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFI---SLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMK 267 (304)
T ss_dssp ECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHH---TTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHH
T ss_pred EeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHH---HHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHH
Confidence 99999999999998 4557899999987642110 000 00000 12221110 0 01122
Q ss_pred ccchhhhHHHHHHHhCCcCC
Q 021771 173 SDVFSFGVLLLEIISGKKNT 192 (308)
Q Consensus 173 ~Di~slG~~l~~l~~~~~p~ 192 (308)
.+.|+++.++|.+.+|..+|
T Consensus 268 ~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 268 EKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHcCCHHH
Confidence 58899999999999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=3.5e-07 Score=76.92 Aligned_cols=127 Identities=16% Similarity=0.122 Sum_probs=90.4
Q ss_pred ccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 3 SCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 3 ~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
.||.... .++..+++|+-.. .....+..|...|+.+. +--+.+++.++.+.+..++|||+++|.++.+.....
T Consensus 40 ~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-- 114 (272)
T 4gkh_A 40 TIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-- 114 (272)
T ss_dssp EEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--
T ss_pred eEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC--
Confidence 3676554 3567899997542 23456788999999885 444788899999988999999999998877654221
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhC------------------------------------------------------
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHED------------------------------------------------------ 106 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~------------------------------------------------------ 106 (308)
......+..++...|+.||+.
T Consensus 115 -----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 189 (272)
T 4gkh_A 115 -----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF 189 (272)
T ss_dssp -----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred -----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence 122334556666666666641
Q ss_pred -CCCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 107 -SRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 107 -g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
....++|||+++.||+++.++.+-|+||+.+..
T Consensus 190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999876667999988754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=2.1e-06 Score=73.69 Aligned_cols=121 Identities=21% Similarity=0.185 Sum_probs=79.6
Q ss_pred CCEEEEEEeccCCcccHHHHHHHHHHHhcCCCc---CccceeeeEE-eCCeEEEEEEecCCCChhhHhhcCCCccccChH
Q 021771 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK---NLVRLFGCCL-EENESLLIYEYMPNKSLDVFLFDSTRSVQLDWK 87 (308)
Q Consensus 12 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 87 (308)
|..+++|+- ........+..|+.+|+.+.+. .+.+++.+.. ..+..++||++++|..+...... .++..
T Consensus 39 g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~-----~l~~~ 111 (306)
T 3tdw_A 39 NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA-----VLPDD 111 (306)
T ss_dssp TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT-----TSCHH
T ss_pred CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh-----hCCHH
Confidence 567888874 2233456788999999999742 3566666664 34457899999999888653211 12333
Q ss_pred HHHHHHHHHHHHHHhchhCC---------------------------------------------------------CCc
Q 021771 88 RRISIINGIARGLLYLHEDS---------------------------------------------------------RLK 110 (308)
Q Consensus 88 ~~~~~~~qi~~~l~~lH~~g---------------------------------------------------------~~~ 110 (308)
....++.++...|+.||+.. ...
T Consensus 112 ~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~ 191 (306)
T 3tdw_A 112 AKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPR 191 (306)
T ss_dssp HHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCE
T ss_pred HHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCe
Confidence 34444444444444444321 124
Q ss_pred eeecCCCCCceEeCC---CCCe-eeecccceee
Q 021771 111 IIHRDLKASNVLLNH---EMNP-KISDFGMARI 139 (308)
Q Consensus 111 i~H~di~p~nilv~~---~~~~-kl~dfg~~~~ 139 (308)
++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp EECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 799999999999997 4555 7999998765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=1.7e-06 Score=75.73 Aligned_cols=62 Identities=5% Similarity=0.020 Sum_probs=41.9
Q ss_pred CCEEEEEEeccCC---cccHHHHHHHHHHHhcCC-C--cCccceeeeEEeC---CeEEEEEEecCCCChhh
Q 021771 12 GKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQ-H--KNLVRLFGCCLEE---NESLLIYEYMPNKSLDV 73 (308)
Q Consensus 12 g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~ 73 (308)
|..+++|+..... ......+..|+.+++.+. + -.+.+++.+..+. +..++||||++|..+.+
T Consensus 52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 6788998764322 001245778999998885 3 3577788877665 34689999998876653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.22 E-value=7.6e-06 Score=70.98 Aligned_cols=30 Identities=20% Similarity=0.325 Sum_probs=26.9
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.++|||+++.||+++.++.+.|+||+.+..
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 499999999999998888899999987754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=3.5e-05 Score=68.45 Aligned_cols=66 Identities=8% Similarity=0.095 Sum_probs=40.8
Q ss_pred CccEEeeeC-CCCEEEEEEeccCC-------cccHHHHHHHHHHHhcCCC--c-CccceeeeEEeCCeEEEEEEecCCC
Q 021771 2 ESCLQGKLA-DGKEIAVKRLSRTS-------GQGLQEFKNEVTLIAKLQH--K-NLVRLFGCCLEENESLLIYEYMPNK 69 (308)
Q Consensus 2 g~v~~~~~~-~g~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h--~-~i~~~~~~~~~~~~~~lv~e~~~~~ 69 (308)
+.||+++.. +++.+++|...... +...+.+..|..+|+.+.. + .+++++.+ +....++|||++++.
T Consensus 44 n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 44 NYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp EEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred EEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence 567887653 57899999754221 1233566788888888742 3 34556543 344568999999763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00029 Score=56.40 Aligned_cols=103 Identities=11% Similarity=0.046 Sum_probs=65.1
Q ss_pred CChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc
Q 021771 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 69 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
-+|.+.+... +.+++++++|.++.|.+.+|.-+-... .+ ...=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence 3788888654 347999999999999999987762211 01 1222457899999999888764 1110
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcC
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKN 191 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p 191 (308)
.....+.|||... ...+.+.=|||||+++|..+--+.|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888652 3446778899999999999865544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.0003 Score=60.26 Aligned_cols=65 Identities=18% Similarity=0.158 Sum_probs=49.6
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC---CcCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ---HKNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
.+|+... ++..+++|+.... ....+..|+..|+.+. ...+++++.+....+..++||||+++..+
T Consensus 51 ~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 51 EIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred eeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 4566554 5678899976432 3567889999999884 35688899888887889999999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00027 Score=59.78 Aligned_cols=66 Identities=20% Similarity=0.211 Sum_probs=47.3
Q ss_pred CccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCC---cCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 2 ESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH---KNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 2 g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
+.||+.+..+|+.+++|+-..........+..|+..|+.+.. -.+++++.+ + ..++||||+++...
T Consensus 29 ~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 29 WHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERPP 97 (288)
T ss_dssp EEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCCC
T ss_pred eEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccCC
Confidence 468998889999999998765555555678899999998852 234555543 2 23789999876543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00046 Score=60.75 Aligned_cols=123 Identities=18% Similarity=0.240 Sum_probs=72.5
Q ss_pred CCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhH----------------
Q 021771 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVF---------------- 74 (308)
Q Consensus 12 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---------------- 74 (308)
++.+++|+.- ........+.+|+.+++.+. +.-..++++.+.+ .+||||++|..+..-
T Consensus 82 ~~~~vlR~~g-~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La 156 (379)
T 3feg_A 82 PREVLLRLYG-AILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMA 156 (379)
T ss_dssp CSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHH
T ss_pred CCeEEEEECC-CccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHH
Confidence 5789999863 22234566778999998885 3334666666543 299999988655321
Q ss_pred -hhcCC-C-cccc--ChHHHHHHHHHHHH-------------------HHHh----chhCC-CCceeecCCCCCceEeCC
Q 021771 75 -LFDST-R-SVQL--DWKRRISIINGIAR-------------------GLLY----LHEDS-RLKIIHRDLKASNVLLNH 125 (308)
Q Consensus 75 -l~~~~-~-~~~~--~~~~~~~~~~qi~~-------------------~l~~----lH~~g-~~~i~H~di~p~nilv~~ 125 (308)
++... . .... -+..+..++.++.. .+.. |...+ ...++|+|+.++||+++.
T Consensus 157 ~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~ 236 (379)
T 3feg_A 157 QFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLS 236 (379)
T ss_dssp HHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEES
T ss_pred HHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcC
Confidence 01100 0 1111 12334444443321 1122 22221 235999999999999987
Q ss_pred C----CCeeeecccceee
Q 021771 126 E----MNPKISDFGMARI 139 (308)
Q Consensus 126 ~----~~~kl~dfg~~~~ 139 (308)
+ +.+.++||..+..
T Consensus 237 ~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 237 EPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CC---CCEEECCCTTCEE
T ss_pred CCCccCcEEEEecccCCc
Confidence 6 6899999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0014 Score=56.47 Aligned_cols=31 Identities=32% Similarity=0.429 Sum_probs=26.9
Q ss_pred ceeecCCCCCceEeCCC----CCeeeecccceeee
Q 021771 110 KIIHRDLKASNVLLNHE----MNPKISDFGMARIF 140 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~----~~~kl~dfg~~~~~ 140 (308)
.++|||+++.||+++.+ +.+.|+||+.+..-
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 59999999999999875 67899999988763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0017 Score=55.67 Aligned_cols=68 Identities=9% Similarity=0.058 Sum_probs=43.2
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCc--Cccceeee-----EEeCCeEEEEEEecCCCCh
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHK--NLVRLFGC-----CLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~-----~~~~~~~~lv~e~~~~~~L 71 (308)
.+|.....+|+.+++|+..... .....+..|..+++.+... .+++++.. ...++..+++|++++|..+
T Consensus 40 ~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 40 RVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 114 (328)
T ss_dssp EEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCC
Confidence 4676666678789999885331 2345677788888887421 24444443 2234556889999987543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00063 Score=57.87 Aligned_cols=29 Identities=21% Similarity=0.195 Sum_probs=25.2
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5899999999999 5667789999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.001 Score=59.36 Aligned_cols=30 Identities=20% Similarity=0.337 Sum_probs=26.8
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceeee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARIF 140 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~~ 140 (308)
.++|||++++||+++.++ ++++||+.+..-
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 499999999999999876 999999988763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.001 Score=57.05 Aligned_cols=30 Identities=30% Similarity=0.319 Sum_probs=25.4
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.++|+|++++||+++.++.+.++||+.+..
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 499999999999999875567999987654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00091 Score=59.99 Aligned_cols=54 Identities=15% Similarity=0.277 Sum_probs=34.9
Q ss_pred CCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcC-ccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN-LVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 12 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
+..+++|+.... ...+.+..|+.+++.+...+ .+++++.+.+ .+|++|++|.++
T Consensus 105 ~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 105 PNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp CSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 578999987332 12245567999998885333 3566665542 289999986444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0024 Score=57.71 Aligned_cols=63 Identities=16% Similarity=0.146 Sum_probs=38.9
Q ss_pred cEEeeeCC-CCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCc-cceeeeEEeCCeEEEEEEecCCCCh
Q 021771 4 CLQGKLAD-GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL-VRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 4 v~~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
+|+....+ +..+++|+........ -....|+.+++.+...++ +++++.+. + .+||||++|..+
T Consensus 124 ~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 124 LIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 56665543 4788898774322221 123588999998864444 56776663 2 259999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0053 Score=53.13 Aligned_cols=31 Identities=29% Similarity=0.422 Sum_probs=27.4
Q ss_pred CceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 109 LKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 109 ~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3599999999999999888899999987765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.002 Score=56.46 Aligned_cols=29 Identities=21% Similarity=0.432 Sum_probs=24.5
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.++|+|+++.||+++.++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 599999999999998655 89999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.67 E-value=0.056 Score=48.18 Aligned_cols=30 Identities=30% Similarity=0.526 Sum_probs=26.4
Q ss_pred CceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 109 LKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 109 ~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
..++|+|+.++||+ +.++.+.++||..+..
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 35899999999999 7778899999998865
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=92.07 E-value=0.92 Score=36.19 Aligned_cols=81 Identities=10% Similarity=0.096 Sum_probs=58.5
Q ss_pred CCcCccceeeeEEeCCeEEEEEEecCC-CChhhHhhcCCCccccChHHHHHHHHHHHHHHH-hchhCCCCceeecCCCCC
Q 021771 42 QHKNLVRLFGCCLEENESLLIYEYMPN-KSLDVFLFDSTRSVQLDWKRRISIINGIARGLL-YLHEDSRLKIIHRDLKAS 119 (308)
Q Consensus 42 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~-~lH~~g~~~i~H~di~p~ 119 (308)
.||++ -..+-.+++.+.+.++.-++ .++.. + ..++....++++.+|+.... +++. -+|--++|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 47777 44445666666666665322 23332 2 23777899999999999888 6654 488899999
Q ss_pred ceEeCCCCCeeeecccc
Q 021771 120 NVLLNHEMNPKISDFGM 136 (308)
Q Consensus 120 nilv~~~~~~kl~dfg~ 136 (308)
|++++.++.+++.-.|+
T Consensus 114 NL~f~~~~~p~i~hRGi 130 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGV 130 (219)
T ss_dssp GEEECTTCCEEESCCEE
T ss_pred eEEEeCCCcEEEEEcCC
Confidence 99999999999987665
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.05 E-value=0.59 Score=37.19 Aligned_cols=83 Identities=7% Similarity=0.015 Sum_probs=58.9
Q ss_pred CCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCce
Q 021771 42 QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121 (308)
Q Consensus 42 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~ni 121 (308)
.||+++.. .+-.+.+.+.+.++.- .....+- .-...+....++++.+|+....++++ -+|--++|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcC--cccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 47888876 5566666555555543 2222221 12247788999999999998866664 38889999999
Q ss_pred EeCCCCCeeeecccc
Q 021771 122 LLNHEMNPKISDFGM 136 (308)
Q Consensus 122 lv~~~~~~kl~dfg~ 136 (308)
+++.++.+++.-.|+
T Consensus 111 ~f~~~~~p~i~~RGi 125 (215)
T 4ann_A 111 FFTRDGLPIAKTRGL 125 (215)
T ss_dssp EECTTSCEEESCCEE
T ss_pred EEcCCCCEEEEEccC
Confidence 999999999986665
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.11 E-value=0.17 Score=44.61 Aligned_cols=30 Identities=23% Similarity=0.390 Sum_probs=25.3
Q ss_pred ceeecCCCCCceEe------CCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLL------NHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv------~~~~~~kl~dfg~~~~ 139 (308)
.++|+|+.+.||++ +++..++++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 47899999999999 3456799999998865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 308 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-58 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-53 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-41 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-40 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-33 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-25 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-65
Identities = 61/267 (22%), Positives = 120/267 (44%), Gaps = 20/267 (7%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
GK + + ++ + Q LQ FKNEV ++ K +H N++ G + ++ ++
Sbjct: 27 GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 85
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
SL L + + + I I A+G+ YLH IIHRDLK++N+ L+ +
Sbjct: 86 EGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHED 140
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLLL 183
+ KI DFG+A + ++ G+ +MAPE + +S +SDV++FG++L
Sbjct: 141 LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLY 200
Query: 184 EIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLC 243
E+++G+ + + + G + V +S + + + C
Sbjct: 201 ELMTGQLP--YS----NINNRDQIIFMVGRGYLSPDLSKV--RSNCPKAMKRLM---AEC 249
Query: 244 VQADSADRPTMSSVVVMLASDTVTLPQ 270
++ +RP ++ + +LP+
Sbjct: 250 LKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-62
Identities = 72/255 (28%), Positives = 119/255 (46%), Gaps = 22/255 (8%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
G ++AVK L + S F E L+ +LQH+ LVRL+ + +I EYM
Sbjct: 32 GYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYM 89
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
N SL FL ++L + + + IA G+ ++ E IHRDL+A+N+L++
Sbjct: 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDT 145
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
++ KI+DFG+AR+ N+ A + APE G F++KSDV+SFG+LL EI+
Sbjct: 146 LSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 187 SGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQA 246
+ + Y ++ + G + + ++ + LC +
Sbjct: 205 THGRI--PYPGMTNPEVI----QNLERGYRMVRPDNCPEE---------LYQLMRLCWKE 249
Query: 247 DSADRPTMSSVVVML 261
DRPT + +L
Sbjct: 250 RPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-58
Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 22/255 (8%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
G + ++A+K + R ++F E ++ KL H LV+L+G CLE+ L++E+M
Sbjct: 24 GYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
+ L + T+ + + + + G+ YL E +IHRDL A N L+
Sbjct: 83 EHGCL--SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGEN 137
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
K+SDFGM R +Q ++ + +PE +S KSDV+SFGVL+ E+
Sbjct: 138 QVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196
Query: 187 SGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQA 246
S K ++ E +E + + I C +
Sbjct: 197 SEGK---------------IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241
Query: 247 DSADRPTMSSVVVML 261
DRP S ++ L
Sbjct: 242 RPEDRPAFSRLLRQL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 3e-58
Identities = 63/280 (22%), Positives = 111/280 (39%), Gaps = 43/280 (15%)
Query: 9 LADGKEIAVKRLSRTSGQGL-QEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
G +A K + + + E+ ++ + +V +G + E + E+M
Sbjct: 28 KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
SLD L + R + + + + +GL YL + KI+HRD+K SN+L+N
Sbjct: 88 GGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRG 142
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
K+ DFG++ + N VGT YM+PE +SV+SD++S G+ L+E+
Sbjct: 143 EIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
Query: 188 GK-----------------------KNTGFYLSELGQSLLSYTWKLWCEGEALELME--- 221
G+ T G+ L SY EL++
Sbjct: 199 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIV 258
Query: 222 ----PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 257
P L + E F++ C+ + A+R + +
Sbjct: 259 NEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERADLKQL 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 8e-58
Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 22/269 (8%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
G +A+K L + + F E ++ KL+H+ LV+L+ E ++ EYM
Sbjct: 36 GTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYM 93
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
SL FL T + + + IA G+ Y+ R+ +HRDL+A+N+L+
Sbjct: 94 SKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGEN 149
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
+ K++DFG+AR+ N+ A + APE A+ G F++KSDV+SFG+LL E+
Sbjct: 150 LVCKVADFGLARLIEDNEYTARQG-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 208
Query: 187 SGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQA 246
+ + + E L+ +E + C + C +
Sbjct: 209 TKGRV---------------PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 253
Query: 247 DSADRPTMSSVVVMLASDTVTLPQPTEPA 275
+ +RPT + L + +P
Sbjct: 254 EPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-57
Identities = 58/273 (21%), Positives = 108/273 (39%), Gaps = 27/273 (9%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL----LIYEYM 66
G+E+AVK S + + E+ L+H+N++ ++N + L+ +Y
Sbjct: 25 RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHED-----SRLKIIHRDLKASNV 121
+ SL +L + + I + A GL +LH + + I HRDLK+ N+
Sbjct: 84 EHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139
Query: 122 LLNHEMNPKISDFGMARIF--GGNQSEANTNRIVGTYGYMAPEYAMEGL------FSVKS 173
L+ I+D G+A + + N VGT YMAPE + + ++
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199
Query: 174 DVFSFGVLLLEIISGKKNTGFYLSE----LGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229
D+++ G++ EI G + + + + + + P +
Sbjct: 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQ 259
Query: 230 AAELLKFIH-IGLLCVQADSADRPTMSSVVVML 261
+ E L+ + I C A+ A R T + L
Sbjct: 260 SCEALRVMAKIMRECWYANGAARLTALRIKKTL 292
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-57
Identities = 63/255 (24%), Positives = 110/255 (43%), Gaps = 22/255 (8%)
Query: 7 GKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
GK ++A+K + S EF E ++ L H+ LV+L+G C ++ +I EYM
Sbjct: 23 GKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
N L +L + + ++ + + + + YL + +HRDL A N L+N +
Sbjct: 82 ANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQ 136
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
K+SDFG++R ++ ++ + PE M FS KSD+++FGVL+ EI
Sbjct: 137 GVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 195
Query: 187 SGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQA 246
S K ++ + E E + L+ K I C
Sbjct: 196 SLGK---------------MPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHE 240
Query: 247 DSADRPTMSSVVVML 261
+ +RPT ++ +
Sbjct: 241 KADERPTFKILLSNI 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-57
Identities = 69/252 (27%), Positives = 108/252 (42%), Gaps = 27/252 (10%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL-LIYEYMPNK 69
G ++AVK + + Q F E +++ +L+H NLV+L G +EE L ++ EYM
Sbjct: 29 RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
SL +L RSV L + + + YL +HRDL A NVL++ +
Sbjct: 87 SLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVA 142
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
K+SDFG+ + Q + APE E FS KSDV+SFG+LL EI S
Sbjct: 143 KVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 197
Query: 190 KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA 249
+ Y + ++ +G ++ + + C D+A
Sbjct: 198 RV--PYPRIPLKDVV----PRVEKGYKMDAPDGCPPA---------VYEVMKNCWHLDAA 242
Query: 250 DRPTMSSVVVML 261
RP+ + L
Sbjct: 243 MRPSFLQLREQL 254
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-56
Identities = 68/272 (25%), Positives = 110/272 (40%), Gaps = 34/272 (12%)
Query: 7 GKLADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYE 64
K +AVK L ++ + +E+ +++ L H N+V L G C +L+I E
Sbjct: 48 IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107
Query: 65 YMPNKSLDVFLFDSTRS---------------VQLDWKRRISIINGIARGLLYLHEDSRL 109
Y L FL S + LD + +S +A+G+ +L
Sbjct: 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---K 164
Query: 110 KIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLF 169
IHRDL A N+LL H KI DFG+AR + + +MAPE ++
Sbjct: 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224
Query: 170 SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229
+ +SDV+S+G+ L E+ S + + + +K+ EG + E +
Sbjct: 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKMIKEGFRMLSPEHAPAE--- 276
Query: 230 AAELLKFIHIGLLCVQADSADRPTMSSVVVML 261
I C AD RPT +V ++
Sbjct: 277 ------MYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-56
Identities = 60/268 (22%), Positives = 109/268 (40%), Gaps = 23/268 (8%)
Query: 11 DGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
++A+K L + + + +E E ++ +L + +VRL G C + +L+ E
Sbjct: 35 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 93
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
L FL + ++ +++ ++ G+ YL +HRDL A NVLL +
Sbjct: 94 PLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYA 148
Query: 130 KISDFGMARIFGGNQSEAN-TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
KISDFG+++ G + S + + APE FS +SDV+S+GV + E +S
Sbjct: 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 208
Query: 189 KKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADS 248
+ Y G ++ +G+ +E + + C
Sbjct: 209 GQK--PYKKMKGPEVM----AFIEQGKRMECPPECPPE---------LYALMSDCWIYKW 253
Query: 249 ADRPTMSSVVVMLASDTVTLPQPTEPAF 276
DRP +V + + +L E
Sbjct: 254 EDRPDFLTVEQRMRACYYSLASKVEGHH 281
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (460), Expect = 4e-56
Identities = 64/251 (25%), Positives = 111/251 (44%), Gaps = 21/251 (8%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
+AVK L + + ++EF E ++ +++H NLV+L G C E +I E+M +
Sbjct: 41 YSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99
Query: 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
L +L + R ++ + + I+ + YL + IHRDL A N L+ K
Sbjct: 100 LLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVK 155
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK 190
++DFG++R+ G+ A+ + APE FS+KSDV++FGVLL EI +
Sbjct: 156 VADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
Query: 191 NTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSAD 250
+ + + EL+E + K + C Q + +D
Sbjct: 215 S---------------PYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSD 259
Query: 251 RPTMSSVVVML 261
RP+ + +
Sbjct: 260 RPSFAEIHQAF 270
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (457), Expect = 1e-55
Identities = 66/276 (23%), Positives = 107/276 (38%), Gaps = 40/276 (14%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQ-EFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
+AVK L + +Q +F+ E L+A+ + N+V+L G C L++EYM
Sbjct: 39 PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 98
Query: 67 PNKSLDVFLFDSTR---------------------SVQLDWKRRISIINGIARGLLYLHE 105
L+ FL + L ++ I +A G+ YL E
Sbjct: 99 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158
Query: 106 DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM 165
K +HRDL N L+ M KI+DFG++R +M PE
Sbjct: 159 R---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF 215
Query: 166 EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225
++ +SDV+++GV+L EI S Y + ++ +G L E
Sbjct: 216 YNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMAHEEVI----YYVRDGNILACPENCPL 269
Query: 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVML 261
+ ++ LC ADRP+ S+ +L
Sbjct: 270 E---------LYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-55
Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 39/279 (13%)
Query: 7 GKLADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYE 64
K ++AVK L + + +E+ ++ +L H+N+V L G C LI+E
Sbjct: 62 SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121
Query: 65 YMPNKSLDVFLFDSTRSVQ--------------------LDWKRRISIINGIARGLLYLH 104
Y L +L L ++ + +A+G+ +L
Sbjct: 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181
Query: 105 EDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYA 164
+HRDL A NVL+ H KI DFG+AR + + +MAPE
Sbjct: 182 F---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 238
Query: 165 MEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVL 224
EG++++KSDV+S+G+LL EI S N + G + + +KL G ++
Sbjct: 239 FEGIYTIKSDVWSYGILLWEIFSLGVNP-YP----GIPVDANFYKLIQNGFKMDQPFYAT 293
Query: 225 KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263
++ I C DS RP+ ++ L
Sbjct: 294 EE---------IYIIMQSCWAFDSRKRPSFPNLTSFLGC 323
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-55
Identities = 64/254 (25%), Positives = 107/254 (42%), Gaps = 25/254 (9%)
Query: 11 DGKEIAVKRLSRTSGQG--LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
K +AVK L + E E ++ +L + +VR+ G C E +L+ E
Sbjct: 33 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL 91
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
L+ +L + + K I +++ ++ G+ YL +HRDL A NVLL +
Sbjct: 92 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHY 145
Query: 129 PKISDFGMARIFGGNQSEANTN-RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
KISDFG+++ +++ + APE FS KSDV+SFGVL+ E S
Sbjct: 146 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205
Query: 188 GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQAD 247
+ Y G + + +GE + ++ + LC D
Sbjct: 206 YGQK--PYRGMKGSEVT----AMLEKGERMGCPAGCPRE---------MYDLMNLCWTYD 250
Query: 248 SADRPTMSSVVVML 261
+RP ++V + L
Sbjct: 251 VENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 180 bits (457), Expect = 2e-55
Identities = 69/256 (26%), Positives = 115/256 (44%), Gaps = 33/256 (12%)
Query: 9 LADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+ + + +A+K++S + Q Q+ EV + KL+H N ++ GC L E+ + L+ EY
Sbjct: 37 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ D+ L ++ +G +GL YLH +IHRD+KA N+LL+
Sbjct: 97 CLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSE 150
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM---EGLFSVKSDVFSFGVLL 182
K+ DFG A I A N VGT +MAPE + EG + K DV+S G+
Sbjct: 151 PGLVKLGDFGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 183 LEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL 242
+E+ K + + +S + + + P L+ + F+
Sbjct: 205 IELAERK--PPLF----NMNAMSALYHI------AQNESPALQSGHWSEYFRNFV---DS 249
Query: 243 CVQADSADRPTMSSVV 258
C+Q DRPT ++
Sbjct: 250 CLQKIPQDRPTSEVLL 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-55
Identities = 59/252 (23%), Positives = 109/252 (43%), Gaps = 26/252 (10%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
A K + S + L+++ E+ ++A H N+V+L EN ++ E+ +
Sbjct: 36 TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA 95
Query: 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
+D + + R L + + L YLH+ KIIHRDLKA N+L + + K
Sbjct: 96 VDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIK 150
Query: 131 ISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVLLLEI 185
++DFG++ ++ +GT +MAPE M + + K+DV+S G+ L+E+
Sbjct: 151 LADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 208
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
+ + +L + E L +P S ++ F+ C++
Sbjct: 209 AEIEP---PHHELNPMRVL----LKIAKSEPPTLAQP----SRWSSNFKDFL---KKCLE 254
Query: 246 ADSADRPTMSSV 257
+ R T S +
Sbjct: 255 KNVDARWTTSQL 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 179 bits (454), Expect = 4e-55
Identities = 62/255 (24%), Positives = 113/255 (44%), Gaps = 24/255 (9%)
Query: 11 DGKEIAVKRL-SRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
+A+K L S + + ++F +E +++ + H N++ L G + ++I E+M N
Sbjct: 53 REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENG 112
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
SLD FL + Q + + ++ GIA G+ YL + +HRDL A N+L+N +
Sbjct: 113 SLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVC 167
Query: 130 KISDFGMARIFGGNQSEANTNRIVG---TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
K+SDFG++R + S+ +G + APE F+ SDV+S+G+++ E++
Sbjct: 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 227
Query: 187 SGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQA 246
S + + + + +E + + L C Q
Sbjct: 228 SYGE---------------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQK 272
Query: 247 DSADRPTMSSVVVML 261
D RP +V L
Sbjct: 273 DRNHRPKFGQIVNTL 287
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-54
Identities = 70/259 (27%), Positives = 114/259 (44%), Gaps = 27/259 (10%)
Query: 8 KLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL--IY 63
+ +DGK + K L S Q +EV L+ +L+H N+VR + ++ + L +
Sbjct: 25 RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84
Query: 64 EYMPNKSLDVFLFDSTRSVQ-LDWKRRISIINGIARGLLYLHE--DSRLKIIHRDLKASN 120
EY L + T+ Q LD + + ++ + L H D ++HRDLK +N
Sbjct: 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPAN 144
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
V L+ + N K+ DFG+ARI + S A VGT YM+PE ++ KSD++S G
Sbjct: 145 VFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMNRMSYNEKSDIWSLGC 202
Query: 181 LLLEIISGKK-NTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239
LL E+ + T F EL EG+ + + EL + I
Sbjct: 203 LLYELCALMPPFTAFSQKEL--------AGKIREGKFRRIPYR------YSDELNEII-- 246
Query: 240 GLLCVQADSADRPTMSSVV 258
+ RP++ ++
Sbjct: 247 -TRMLNLKDYHRPSVEEIL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 3e-54
Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 22/252 (8%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
+ +AVK + E K E+ + L H+N+V+ +G E N L EY
Sbjct: 26 NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
L + + + + G++YLH + I HRD+K N+LL+
Sbjct: 86 SGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDER 139
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLF-SVKSDVFSFGVLLLEI 185
N KISDFG+A +F N E N++ GT Y+APE F + DV+S G++L +
Sbjct: 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
++G+ S + W E + + P K LL +
Sbjct: 200 LAGELPWD------QPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLH------KILV 245
Query: 246 ADSADRPTMSSV 257
+ + R T+ +
Sbjct: 246 ENPSARITIPDI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 6e-54
Identities = 61/254 (24%), Positives = 106/254 (41%), Gaps = 24/254 (9%)
Query: 12 GKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLE-ENESLLIYEYMPNK 69
AVK L+R + G + +F E ++ H N++ L G CL E L++ YM +
Sbjct: 55 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
L F+ + T + + + + + K +HRDL A N +L+ +
Sbjct: 115 DLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLASKKFVHRDLAARNCMLDEKFTV 169
Query: 130 KISDFGMARIFGGNQSEANTNR--IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
K++DFG+AR + ++ N+ +MA E F+ KSDV+SFGVLL E+++
Sbjct: 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229
Query: 188 GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQAD 247
Y + Y + +L+ L + + L C
Sbjct: 230 RGAP--PYPDVNTFDITVYLLQ----------GRRLLQPEYCPDPLYEVM---LKCWHPK 274
Query: 248 SADRPTMSSVVVML 261
+ RP+ S +V +
Sbjct: 275 AEMRPSFSELVSRI 288
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-53
Identities = 61/252 (24%), Positives = 114/252 (45%), Gaps = 22/252 (8%)
Query: 12 GKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKS 70
+A+K L + +F E ++ + H N++RL G + ++I EYM N +
Sbjct: 36 EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 95
Query: 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPK 130
LD FL + + + + + ++ GIA G+ YL + +HRDL A N+L+N + K
Sbjct: 96 LDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCK 150
Query: 131 ISDFGMARIFGGNQSEANT-NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
+SDFG++R+ + T + + APE F+ SDV+SFG+++ E+++
Sbjct: 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 210
Query: 190 KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA 249
+ + LS E ++ + + + + C Q + A
Sbjct: 211 ERPYWELS---------------NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERA 255
Query: 250 DRPTMSSVVVML 261
RP + +V +L
Sbjct: 256 RRPKFADIVSIL 267
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-53
Identities = 58/255 (22%), Positives = 108/255 (42%), Gaps = 30/255 (11%)
Query: 11 DGKEIAVKRLS--RTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES----LLIYE 64
E+A L + + Q FK E ++ LQH N+VR + + +L+ E
Sbjct: 33 TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
M + +L +L R + K S I +GL +LH + IIHRDLK N+ +
Sbjct: 93 LMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFIT 148
Query: 125 HE-MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
+ KI D G+A + + ++GT +MAPE E + DV++FG+ +L
Sbjct: 149 GPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCML 203
Query: 184 EIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLC 243
E+ + + + + ++ G ++P E+ + I C
Sbjct: 204 EMATSEYP--YS----ECQNAAQIYRRVTSG-----VKPASFDKVAIPEVKEII---EGC 249
Query: 244 VQADSADRPTMSSVV 258
++ + +R ++ ++
Sbjct: 250 IRQNKDERYSIKDLL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-52
Identities = 61/278 (21%), Positives = 116/278 (41%), Gaps = 36/278 (12%)
Query: 15 IAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73
+A+K L TS + +E +E ++A + + ++ RL G CL LI + MP L
Sbjct: 41 VAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCL-- 97
Query: 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISD 133
+ + + ++ IA+G+ YL +++HRDL A NVL+ + KI+D
Sbjct: 98 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITD 154
Query: 134 FGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTG 193
FG+A++ G + E + +MA E + +++ +SDV+S+GV + E+++
Sbjct: 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS--- 211
Query: 194 FYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPT 253
+ E ++E + + I + C D+ RP
Sbjct: 212 ------------KPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK 259
Query: 254 MSSVVVML--------------ASDTVTLPQPTEPAFS 277
+++ + + LP PT+ F
Sbjct: 260 FRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFY 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 5e-52
Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 28/279 (10%)
Query: 7 GKLADGKEIAVKRLSR-TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
K +A+K ++ S + EF NE +++ + ++VRL G + +L+I E
Sbjct: 45 VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 104
Query: 66 MPNKSLDVFLF-------DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
M L +L ++ + I + IA G+ YL+ + K +HRDL A
Sbjct: 105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 161
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSF 178
N ++ + KI DFGM R + + +M+PE +G+F+ SDV+SF
Sbjct: 162 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF 221
Query: 179 GVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238
GV+L EI + + LS + EG L+ +
Sbjct: 222 GVVLWEIATLAEQPYQGLSN------EQVLRFVMEGGLLDKPDNCPDM---------LFE 266
Query: 239 IGLLCVQADSADRPTMSSVVVMLASDTVTLPQPTEPAFS 277
+ +C Q + RP+ ++ + + P E +F
Sbjct: 267 LMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFREVSFY 303
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-51
Identities = 67/261 (25%), Positives = 100/261 (38%), Gaps = 24/261 (9%)
Query: 5 LQGKLADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
+AVK L + + + +F EV + L H+NL+RL+G L +
Sbjct: 29 WDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KM 87
Query: 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
+ E P SL L L R ++ +A G+ YL + IHRDL A N+
Sbjct: 88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLES---KRFIHRDLAARNL 142
Query: 122 LLNHEMNPKISDFGMARIFGGNQSE-ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
LL KI DFG+ R N + + APE FS SD + FGV
Sbjct: 143 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGV 202
Query: 181 LLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG 240
L E+ + + +G + K+ EGE L E + ++
Sbjct: 203 TLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLPRPEDCPQ---------DIYNVM 248
Query: 241 LLCVQADSADRPTMSSVVVML 261
+ C DRPT ++ L
Sbjct: 249 VQCWAHKPEDRPTFVALRDFL 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 6e-51
Identities = 60/250 (24%), Positives = 116/250 (46%), Gaps = 23/250 (9%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
+A G+E+A+++++ + NE+ ++ + ++ N+V L +E ++ EY+
Sbjct: 41 DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
SL + ++ D + ++ + L +LH ++IHRD+K+ N+LL +
Sbjct: 101 GGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDG 153
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+ K++DFG QS+ +T +VGT +MAPE + K D++S G++ +E+I
Sbjct: 154 SVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
Query: 188 GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQAD 247
G+ YL+E L L EL P ++A F+ C+ D
Sbjct: 212 GEP---PYLNENPLRAL----YLIATNGTPELQNP----EKLSAIFRDFL---NRCLDMD 257
Query: 248 SADRPTMSSV 257
R + +
Sbjct: 258 VEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 2e-50
Identities = 57/256 (22%), Positives = 100/256 (39%), Gaps = 40/256 (15%)
Query: 11 DGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
+A+K L + + + EV + + L+H N++RL+G + LI EY P
Sbjct: 30 SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
++ L ++ D +R + I +A L Y H ++IHRD+K N+LL
Sbjct: 90 LGTVYRELQKLSK---FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAG 143
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
KI+DFG + ++ + GT Y+ PE + K D++S GVL E +
Sbjct: 144 ELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199
Query: 188 GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ-----SCVAAELLKFIHIGLL 242
GK + E + + + V I
Sbjct: 200 GK-------------------PPFEANTYQETYKRISRVEFTFPDFVTEGARDLI---SR 237
Query: 243 CVQADSADRPTMSSVV 258
++ + + RP + V+
Sbjct: 238 LLKHNPSQRPMLREVL 253
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 3e-50
Identities = 65/271 (23%), Positives = 108/271 (39%), Gaps = 33/271 (12%)
Query: 7 GKLADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAK-LQHKNLVRLFGCCLEENESLLI-Y 63
K A + +AVK L + + +E+ ++ H N+V L G C + L++
Sbjct: 38 DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97
Query: 64 EYMPNKSLDVFLF-------------DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 110
E+ +L +L + L + I +A+G+ +L K
Sbjct: 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RK 154
Query: 111 IIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFS 170
IHRDL A N+LL+ + KI DFG+AR + +MAPE + +++
Sbjct: 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214
Query: 171 VKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230
++SDV+SFGVLL EI + G + + EG + + +
Sbjct: 215 IQSDVWSFGVLLWEIF-----SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE---- 265
Query: 231 AELLKFIHIGLLCVQADSADRPTMSSVVVML 261
L C + + RPT S +V L
Sbjct: 266 -----MYQTMLDCWHGEPSQRPTFSELVEHL 291
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-50
Identities = 65/264 (24%), Positives = 111/264 (42%), Gaps = 36/264 (13%)
Query: 13 KEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70
+ A+KR+ S ++F E+ ++ KL H N++ L G C L EY P+ +
Sbjct: 38 MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97
Query: 71 LDVFL-------------FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
L FL ++ + L ++ + +ARG+ YL + + IHRDL
Sbjct: 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLA 154
Query: 118 ASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177
A N+L+ KI+DFG++R G + +MA E +++ SDV+S
Sbjct: 155 ARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 211
Query: 178 FGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237
+GVLL EI+S Y L ++ +G LE +
Sbjct: 212 YGVLLWEIVSLGGT--PYCGMTCAEL----YEKLPQGYRLEKPLNCDDE---------VY 256
Query: 238 HIGLLCVQADSADRPTMSSVVVML 261
+ C + +RP+ + ++V L
Sbjct: 257 DLMRQCWREKPYERPSFAQILVSL 280
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 6e-50
Identities = 73/271 (26%), Positives = 116/271 (42%), Gaps = 33/271 (12%)
Query: 6 QGKLADGKEIAVKRLSR-TSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIY 63
+ K ++AVK L + + L + +E+ ++ + +HKN++ L G C ++ +I
Sbjct: 39 KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 98
Query: 64 EYMPNKSLDVFLF-------------DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLK 110
EY +L +L QL K +S +ARG+ YL K
Sbjct: 99 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KK 155
Query: 111 IIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFS 170
IHRDL A NVL+ + KI+DFG+AR T +MAPE + +++
Sbjct: 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
Query: 171 VKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230
+SDV+SFGVLL EI + + Y + L +KL EG ++ +
Sbjct: 216 HQSDVWSFGVLLWEIFTLGGS--PYPGVPVEEL----FKLLKEGHRMDKPSNCTNE---- 265
Query: 231 AELLKFIHIGLLCVQADSADRPTMSSVVVML 261
+ C A + RPT +V L
Sbjct: 266 -----LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-48
Identities = 57/254 (22%), Positives = 95/254 (37%), Gaps = 23/254 (9%)
Query: 11 DGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
+A+K + ++E F E + + H ++V+L G EN +I E
Sbjct: 34 PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLG 92
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
L FL S LD I ++ L YL + +HRD+ A NVL++
Sbjct: 93 ELRSFLQVRKYS--LDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCV 147
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
K+ DFG++R + ++ +MAPE F+ SDV+ FGV + EI+
Sbjct: 148 KLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206
Query: 190 KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSA 249
+ + GE L + L + C D +
Sbjct: 207 VKPFQGVKN------NDVIGRIENGERLPMPP------NCPPTLYSLM---TKCWAYDPS 251
Query: 250 DRPTMSSVVVMLAS 263
RP + + L++
Sbjct: 252 RRPRFTELKAQLST 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 160 bits (405), Expect = 3e-47
Identities = 57/252 (22%), Positives = 100/252 (39%), Gaps = 25/252 (9%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
A G A K + + + E+ ++ L+H LV L ++NE ++IYE+M
Sbjct: 48 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
L + D ++ + + + +GL ++HE +H DLK N++ + +
Sbjct: 108 GELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRS 162
Query: 129 P--KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
K+ DFG+ QS GT + APE A +D++S GVL ++
Sbjct: 163 NELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219
Query: 187 SGKK-NTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
SG G E +++ S W + S ++ + FI +
Sbjct: 220 SGLSPFGGENDDETLRNVKSCDWNM-----------DDSAFSGISEDGKDFI---RKLLL 265
Query: 246 ADSADRPTMSSV 257
AD R T+
Sbjct: 266 ADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-46
Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 9/185 (4%)
Query: 8 KLADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYE 64
+LA +E A+K L + + E ++++L H V+L+ ++ +
Sbjct: 29 ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
Y N L ++ D I L YLH IIHRDLK N+LLN
Sbjct: 89 YAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLN 142
Query: 125 HEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLE 184
+M+ +I+DFG A++ +A N VGT Y++PE E SD+++ G ++ +
Sbjct: 143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202
Query: 185 IISGK 189
+++G
Sbjct: 203 LVAGL 207
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (392), Expect = 3e-45
Identities = 53/252 (21%), Positives = 97/252 (38%), Gaps = 25/252 (9%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
A G+ K ++ KNE++++ +L H L+ L ++ E +LI E++
Sbjct: 51 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
L + + ++ I+ + GL ++HE I+H D+K N++ +
Sbjct: 111 GELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKA 165
Query: 129 P--KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
KI DFG+A ++ T + APE +D+++ GVL ++
Sbjct: 166 SSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 222
Query: 187 SGKKN-TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
SG G E Q++ W+ S V+ E FI +Q
Sbjct: 223 SGLSPFAGEDDLETLQNVKRCDWEF-----------DEDAFSSVSPEAKDFIK---NLLQ 268
Query: 246 ADSADRPTMSSV 257
+ R T+
Sbjct: 269 KEPRKRLTVHDA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-41
Identities = 56/267 (20%), Positives = 104/267 (38%), Gaps = 20/267 (7%)
Query: 8 KLADGKEIAVKRLSRTSGQG-LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
+ +A+K++S Q Q E+ ++ + +H+N++ + + Y+
Sbjct: 29 DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
+ L+ ++ L + I RGL Y+H ++HRDLK SN+LLN
Sbjct: 89 VTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTT 145
Query: 127 MNPKISDFGMARIFGGNQSEANT-NRIVGTYGYMAPEYAMEGLFSVKS-DVFSFGVLLLE 184
+ KI DFG+AR+ + V T Y APE + KS D++S G +L E
Sbjct: 146 CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205
Query: 185 IISGK-----KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL----- 234
++S + K+ L+ + L S + + L+ +L
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265
Query: 235 ----KFIHIGLLCVQADSADRPTMSSV 257
K + + + + R +
Sbjct: 266 NADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 142 bits (360), Expect = 2e-41
Identities = 60/253 (23%), Positives = 111/253 (43%), Gaps = 27/253 (10%)
Query: 9 LADGKEIAVKRLSRTSGQG---LQEFKNEVTLIAKLQHKNLVRLFGCCLEENESL----L 61
L +++AVK L + F+ E A L H +V ++ E + +
Sbjct: 29 LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88
Query: 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
+ EY+ +L + + KR I +I + L + H+ IIHRD+K +N+
Sbjct: 89 VMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANI 142
Query: 122 LLNHEMNPKISDFGMARIFG-GNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
+++ K+ DFG+AR S T ++GT Y++PE A +SDV+S G
Sbjct: 143 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 202
Query: 181 LLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG 240
+L E+++G+ F G S +S ++ E + + P + ++A+L +
Sbjct: 203 VLYEVLTGEPP--FT----GDSPVSVAYQHVRE----DPIPPSARHEGLSADLDAVV--- 249
Query: 241 LLCVQADSADRPT 253
L + + +R
Sbjct: 250 LKALAKNPENRYQ 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-41
Identities = 50/252 (19%), Positives = 105/252 (41%), Gaps = 24/252 (9%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
+ + K K + + G K E++++ +H+N++ L E ++I+E++
Sbjct: 26 ETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
+ + +T + +L+ + +S ++ + L +LH I H D++ N++
Sbjct: 85 GLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRR 139
Query: 128 NP--KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ KI +FG AR N + Y APE + S +D++S G L+ +
Sbjct: 140 SSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVL 196
Query: 186 ISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQ 245
+SG +L+E Q ++ + E E K+ ++ E + F+ +
Sbjct: 197 LSGIN---PFLAETNQQII----ENIMNAE-YTFDEEAFKE--ISIEAMDFVD---RLLV 243
Query: 246 ADSADRPTMSSV 257
+ R T S
Sbjct: 244 KERKSRMTASEA 255
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 141 bits (357), Expect = 1e-40
Identities = 45/185 (24%), Positives = 84/185 (45%), Gaps = 14/185 (7%)
Query: 9 LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+G+ A+K L + + ++ +E +++ + H ++R++G + + +I +Y
Sbjct: 26 RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ L L S R K + + L L II+RDLK N+LL+
Sbjct: 86 IEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEYLHSKDIIYRDLKPENILLDK 139
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ KI+DFG A+ + GT Y+APE ++ D +SFG+L+ E+
Sbjct: 140 NGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEM 194
Query: 186 ISGKK 190
++G
Sbjct: 195 LAGYT 199
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 6e-40
Identities = 45/261 (17%), Positives = 94/261 (36%), Gaps = 24/261 (9%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+A G+E+A+K + + E + +Q + C E + ++ +
Sbjct: 29 IAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVL---LNH 125
SL+ +R + K + + + + + Y+H IHRD+K N L
Sbjct: 87 PSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKK 141
Query: 126 EMNPKISDFGMARIFGGNQSEAN-----TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
I DFG+A+ + ++ + + GT Y + + S + D+ S G
Sbjct: 142 GNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGY 201
Query: 181 LLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG 240
+L+ G L + ++ E + + VL + +E +++
Sbjct: 202 VLMYFNLGS----LPWQGLKAATKRQKYERISEKK-MSTPIEVLCKGY-PSEFATYLN-- 253
Query: 241 LLCVQADSADRPTMSSVVVML 261
C D+P S + +
Sbjct: 254 -FCRSLRFDDKPDYSYLRQLF 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 2e-39
Identities = 44/249 (17%), Positives = 94/249 (37%), Gaps = 22/249 (8%)
Query: 11 DGKEIAVKRLSRTSGQGLQE-FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNK 69
K +A+K +++ + +G + +NE+ ++ K++H N+V L LI + +
Sbjct: 33 TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92
Query: 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNP 129
L + + + +I + + YLH+ + + L+ +
Sbjct: 93 ELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI 149
Query: 130 KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK 189
ISDFG++++ + GT GY+APE + +S D +S GV+ ++ G
Sbjct: 150 MISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
Query: 190 KN-TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADS 248
++L + +L ++ ++ FI ++ D
Sbjct: 207 PPFYDENDAKLFEQILKAEYEF-----------DSPYWDDISDSAKDFI---RHLMEKDP 252
Query: 249 ADRPTMSSV 257
R T
Sbjct: 253 EKRFTCEQA 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 138 bits (348), Expect = 7e-39
Identities = 58/254 (22%), Positives = 99/254 (38%), Gaps = 31/254 (12%)
Query: 8 KLADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQ---HKNLVRLFGCCLEENESLL 61
K GK A+K L + QG NE +++ + +V + ++
Sbjct: 25 KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84
Query: 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
I + M L L + D + I GL ++H +++RDLK +N+
Sbjct: 85 ILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGLEHMHN---RFVVYRDLKPANI 138
Query: 122 LLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSFGV 180
LL+ + +ISD G+A F + + VGT+GYMAPE +G+ + +D FS G
Sbjct: 139 LLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 194
Query: 181 LLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG 240
+L +++ G + K E + + L V + EL +
Sbjct: 195 MLFKLLRGH-----------SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE-- 241
Query: 241 LLCVQADSADRPTM 254
+Q D R
Sbjct: 242 -GLLQRDVNRRLGC 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (342), Expect = 8e-39
Identities = 57/266 (21%), Positives = 100/266 (37%), Gaps = 38/266 (14%)
Query: 8 KLADGKEIAVKRLSRTSGQGL---------QEFKNEVTLIAKLQ-HKNLVRLFGCCLEEN 57
KE AVK + T G + EV ++ K+ H N+++L
Sbjct: 24 HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83
Query: 58 ESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLK 117
L+++ M L +L T V L K I+ + + LH+ L I+HRDLK
Sbjct: 84 FFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLK 137
Query: 118 ASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL------FSV 171
N+LL+ +MN K++DFG + + + GT Y+APE + +
Sbjct: 138 PENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGK 194
Query: 172 KSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231
+ D++S GV++ +++G F+ + ++ G S
Sbjct: 195 EVDMWSTGVIMYTLLAGS--PPFWHRKQML-----MLRMIMSGNYQFGSPEWDDYSDTVK 247
Query: 232 ELLKFIHIGLLCVQADSADRPTMSSV 257
+L+ + R T
Sbjct: 248 DLVS------RFLVVQPQKRYTAEEA 267
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-38
Identities = 59/288 (20%), Positives = 113/288 (39%), Gaps = 38/288 (13%)
Query: 11 DGKEIAVKRLSRTSGQGLQE-----FKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
+ +A+K++ ++ E+ L+ +L H N++ L ++ L++++
Sbjct: 22 TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
M S+ L + + +GL YLH+ I+HRDLK +N+LL+
Sbjct: 82 METDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDE 135
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLE 184
K++DFG+A+ FG V T Y APE ++ V D+++ G +L E
Sbjct: 136 NGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 193
Query: 185 IISGK-----KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ---------SCVA 230
++ + L+ + ++L + T + W + +L S
Sbjct: 194 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAG 253
Query: 231 AELLKFIHIGLLCVQADSADRPTMSSVVVM-------LASDTVTLPQP 271
+LL I + R T + + M + LP+P
Sbjct: 254 DDLLDLIQ---GLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-38
Identities = 57/268 (21%), Positives = 106/268 (39%), Gaps = 24/268 (8%)
Query: 8 KLADGKEIAVKRLSRTSGQG--LQEFKNEVTLIAKL---QHKNLVRLFGCCLEENESLLI 62
G+ +A+KR+ +G+ EV ++ L +H N+VRLF C
Sbjct: 29 LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88
Query: 63 YEYMPNKSLD---VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
+ + +D D + + ++ + RGL +LH +++HRDLK
Sbjct: 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQ 145
Query: 120 NVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
N+L+ K++DFG+ARI+ + +V T Y APE ++ ++ D++S G
Sbjct: 146 NILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 202
Query: 180 VLLLEIISGK-----KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234
+ E+ K + L ++ + + W AL K + + +
Sbjct: 203 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 262
Query: 235 KFIHIGLL-----CVQADSADRPTMSSV 257
I C+ + A R + S
Sbjct: 263 TDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 8e-38
Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 12/183 (6%)
Query: 11 DGKEIAVKRLSR---TSGQGLQEFKNEV-TLIAKLQHKNLVRLFGCCLEENESLLIYEYM 66
+ A+K L + ++ E L +H L +F + + EY+
Sbjct: 26 TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL 85
Query: 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE 126
L + + D R I GL +LH I++RDLK N+LL+ +
Sbjct: 86 NGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKD 139
Query: 127 MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEII 186
+ KI+DFGM + ++ NT GT Y+APE + ++ D +SFGVLL E++
Sbjct: 140 GHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197
Query: 187 SGK 189
G+
Sbjct: 198 IGQ 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (335), Expect = 1e-37
Identities = 40/264 (15%), Positives = 86/264 (32%), Gaps = 26/264 (9%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
L + +++A+K R S + ++E L + +E ++ +
Sbjct: 26 NLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
SL+ L R + K + + +HE +++RD+K N L+
Sbjct: 84 GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPN 138
Query: 128 NP-----KISDFGMARIFGGNQSEAN-----TNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177
+ + DFGM + + ++ + + GT YM+ + S + D+ +
Sbjct: 139 SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA 198
Query: 178 FGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237
G + + + G G + K GE + + E K++
Sbjct: 199 LGHVFMYFLRGSLPWQ------GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYM 252
Query: 238 HIGLLCVQADSADRPTMSSVVVML 261
H P + +
Sbjct: 253 H---YARNLAFDATPDYDYLQGLF 273
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 2e-37
Identities = 55/265 (20%), Positives = 109/265 (41%), Gaps = 28/265 (10%)
Query: 11 DGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
G+ +A+K RL + E++L+ +L H N+V+L EN+ L++E++
Sbjct: 26 TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 85
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
D++ + S + + +GL + H +++HRDLK N+L+N E
Sbjct: 86 DLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGA 140
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPE-YAMEGLFSVKSDVFSFGVLLLEIIS 187
K++DFG+AR FG V T Y APE +S D++S G + E+++
Sbjct: 141 IKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198
Query: 188 GK-----KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ----------SCVAAE 232
+ + L + ++L + +W ++ +P + + +
Sbjct: 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDED 258
Query: 233 LLKFIHIGLLCVQADSADRPTMSSV 257
+ + D R + +
Sbjct: 259 GRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (329), Expect = 7e-37
Identities = 56/270 (20%), Positives = 109/270 (40%), Gaps = 29/270 (10%)
Query: 6 QGKLADGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIY 63
+ + G+ A+K RL + E++++ +L+H N+V+L+ + +L++
Sbjct: 20 KAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79
Query: 64 EYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLL 123
E++ + L+ S + + G+ Y H+ +++HRDLK N+L+
Sbjct: 80 EHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLI 133
Query: 124 NHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM-EGLFSVKSDVFSFGVLL 182
N E KI+DFG+AR FG + + T Y AP+ M +S D++S G +
Sbjct: 134 NREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIF 191
Query: 183 LEIISGK-----KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQ----------S 227
E+++G + L + + L + K W L +P
Sbjct: 192 AEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLK 251
Query: 228 CVAAELLKFIHIGLLCVQADSADRPTMSSV 257
+ + + ++ D R T
Sbjct: 252 GLDESGIDLLS---KMLKLDPNQRITAKQA 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 5e-36
Identities = 58/260 (22%), Positives = 103/260 (39%), Gaps = 32/260 (12%)
Query: 8 KLADGKEIAVKRLSRTS------GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLL 61
+ + G + A K + + G ++ + EV+++ ++QH N++ L + + +L
Sbjct: 31 EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90
Query: 62 IYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNV 121
I E + L FL + L + + I G+ YLH L+I H DLK N+
Sbjct: 91 ILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENI 144
Query: 122 LLNHEMNP----KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFS 177
+L P KI DFG+A I GT ++APE +++D++S
Sbjct: 145 MLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWS 201
Query: 178 FGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237
GV+ ++SG +L + Q L E S +A + ++
Sbjct: 202 IGVITYILLSGAS---PFLGDTKQETL----ANVSAVNYEFEDEYFSNTSALAKDFIR-- 252
Query: 238 HIGLLCVQADSADRPTMSSV 257
+ D R T+
Sbjct: 253 ----RLLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-36
Identities = 56/266 (21%), Positives = 97/266 (36%), Gaps = 28/266 (10%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENES------LLIYE 64
G+ +A+K++ + + E+ ++ KL H N+VRL E L+ +
Sbjct: 44 SGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
Y+P V S L + + R L Y+H I HRD+K N+LL+
Sbjct: 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLD 156
Query: 125 HE-MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLL 183
+ K+ DFG A+ + E N + I Y ++ DV+S G +L
Sbjct: 157 PDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 184 EIISGK-----KNTGFYLSELGQSLLSYTWKLWCEG--EALELMEPVLKQSCVAAELLKF 236
E++ G+ + L E+ + L + T + E E P +K
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR 274
Query: 237 IHIGLL-----CVQADSADRPTMSSV 257
+ ++ R T
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 1e-35
Identities = 51/255 (20%), Positives = 95/255 (37%), Gaps = 29/255 (11%)
Query: 11 DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCC----LEENESLLIYEY 65
++ A+K L + + EV L + Q ++VR+ L++ E
Sbjct: 36 TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ L + D + I+ I + YLH + I HRD+K N+L
Sbjct: 91 LDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTS 146
Query: 126 EMNP---KISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLL 182
+ K++DFG A+ + S T Y+APE + D++S GV++
Sbjct: 147 KRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIM 203
Query: 183 LEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIGLL 242
++ G FY L+ + + + P + S V+ E+ I
Sbjct: 204 YILLCGY--PPFY----SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIR---N 254
Query: 243 CVQADSADRPTMSSV 257
++ + R T++
Sbjct: 255 LLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-35
Identities = 48/260 (18%), Positives = 90/260 (34%), Gaps = 42/260 (16%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQE------FKNEVTLIAKLQ--HKNLVRLFGCCLEENES 59
+++D +A+K + + E EV L+ K+ ++RL +
Sbjct: 25 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84
Query: 60 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
+LI E T L + S + + + H ++HRD+K
Sbjct: 85 VLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDE 139
Query: 120 NVLLNHE-MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAM-EGLFSVKSDVFS 177
N+L++ K+ DFG + + GT Y PE+ + V+S
Sbjct: 140 NILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWS 195
Query: 178 FGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237
G+LL +++ G + E + + V + V++E I
Sbjct: 196 LGILLYDMVCG--------------------DIPFEHDEEIIRGQVFFRQRVSSECQHLI 235
Query: 238 HIGLLCVQADSADRPTMSSV 257
C+ +DRPT +
Sbjct: 236 ---RWCLALRPSDRPTFEEI 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 8e-35
Identities = 57/280 (20%), Positives = 109/280 (38%), Gaps = 40/280 (14%)
Query: 9 LADGKEIAVKRLSRTSGQG--LQEFKNEVTLIAKLQHKNLVRLFGCCLE--------ENE 58
G+++A+K++ + + E+ ++ L+H+N+V L C +
Sbjct: 32 RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91
Query: 59 SLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKA 118
L++++ + + + + KR + ++ L L+ R KI+HRD+KA
Sbjct: 92 IYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML------LNGLYYIHRNKILHRDMKA 145
Query: 119 SNVLLNHEMNPKISDFGMARIFGGNQSEANTNR--IVGTYGYMAPEYAM-EGLFSVKSDV 175
+NVL+ + K++DFG+AR F ++ V T Y PE + E + D+
Sbjct: 146 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL 205
Query: 176 FSFGVLLLEIISGK-----KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV------- 223
+ G ++ E+ + L+ + Q S T ++W + EL E +
Sbjct: 206 WGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQK 265
Query: 224 ------LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 257
LK L I + D A R
Sbjct: 266 RKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDSDDA 302
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 6e-33
Identities = 52/262 (19%), Positives = 101/262 (38%), Gaps = 22/262 (8%)
Query: 11 DGKEIAVK--RLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPN 68
+ +A+K RL E+ L+ +L+HKN+VRL + + L++E+
Sbjct: 26 THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85
Query: 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMN 128
F + D + S + + +GL + H ++HRDLK N+L+N
Sbjct: 86 DLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGE 139
Query: 129 PKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISG 188
K+++FG+AR FG + +V + L+S D++S G + E+ +
Sbjct: 140 LKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198
Query: 189 K------KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG-- 240
+ L + + L + T + W L +P + + +
Sbjct: 199 GRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNAT 258
Query: 241 ---LL--CVQADSADRPTMSSV 257
LL ++ + R +
Sbjct: 259 GRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 8e-33
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 11/184 (5%)
Query: 9 LADGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEY 65
A G+ A+K L + + + E ++ +H L L + + EY
Sbjct: 27 KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
L L +R +R I L YLH +++RD+K N++L+
Sbjct: 87 ANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDK 140
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEI 185
+ + KI+DFG+ + G A GT Y+APE + + D + GV++ E+
Sbjct: 141 DGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 198
Query: 186 ISGK 189
+ G+
Sbjct: 199 MCGR 202
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-31
Identities = 60/279 (21%), Positives = 109/279 (39%), Gaps = 48/279 (17%)
Query: 8 KLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ES 59
G ++A+K+L R S + E+ L+ ++H+N++ L + +
Sbjct: 39 DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98
Query: 60 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
L+ +M + + +L R ++ + +GL Y+H IIHRDLK
Sbjct: 99 YLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPG 150
Query: 120 NVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL-FSVKSDVFSF 178
N+ +N + KI DFG+AR Q+++ V T Y APE + + ++ D++S
Sbjct: 151 NLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205
Query: 179 GVLLLEIISGK--------------------KNTGFYLSELGQSLLSYTWKLWCEGEALE 218
G ++ E+I+GK ++ L K E E +
Sbjct: 206 GCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD 265
Query: 219 LMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 257
+ S +A LL+ + D+ R T
Sbjct: 266 FASILTNASPLAVNLLE------KMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (288), Expect = 2e-30
Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 14/182 (7%)
Query: 11 DGKEIAVKRLSR---TSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMP 67
G A+K L + + ++ NE ++ + LV+L + + ++ EY+
Sbjct: 65 SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124
Query: 68 NKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM 127
+ L R I YLH L +I+RDLK N+L++ +
Sbjct: 125 GGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 128 NPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS 187
+++DFG A+ G + GT +APE + ++ D ++ GVL+ E+ +
Sbjct: 179 YIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 188 GK 189
G
Sbjct: 234 GY 235
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-27
Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 20/190 (10%)
Query: 8 KLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCL------EENES 59
+ +A+K+LSR + + E+ L+ + HKN++ L E +
Sbjct: 38 DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97
Query: 60 LLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKAS 119
L+ E M V +LD +R ++ + G+ +LH IIHRDLK S
Sbjct: 98 YLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPS 148
Query: 120 NVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFG 179
N+++ + KI DFG+AR G + V T Y APE + + D++S G
Sbjct: 149 NIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205
Query: 180 VLLLEIISGK 189
++ E++ K
Sbjct: 206 CIMGEMVRHK 215
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-27
Identities = 46/186 (24%), Positives = 84/186 (45%), Gaps = 14/186 (7%)
Query: 11 DGKEIAVKRLSRTS----GQGLQEFKNEVTLIAKLQHK-NLVRLFGCCLEENESLLIYEY 65
GK A+K L + + + + + E ++ ++ LV L E + LI +Y
Sbjct: 51 TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 110
Query: 66 MPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH 125
+ L L R + + + + +L L +L II+RD+K N+LL+
Sbjct: 111 INGGELFTHLSQRERFTEHEVQIYV------GEIVLALEHLHKLGIIYRDIKLENILLDS 164
Query: 126 EMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGL--FSVKSDVFSFGVLLL 183
+ ++DFG+++ F +++E GT YMAP+ G D +S GVL+
Sbjct: 165 NGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 223
Query: 184 EIISGK 189
E+++G
Sbjct: 224 ELLTGA 229
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (265), Expect = 3e-27
Identities = 51/279 (18%), Positives = 103/279 (36%), Gaps = 47/279 (16%)
Query: 8 KLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESL--LIYE 64
+ + +++ VK L ++ K E+ ++ L+ N++ L + L++E
Sbjct: 56 NITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112
Query: 65 YMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN 124
++ N L + I + L Y H + I+HRD+K NV+++
Sbjct: 113 HVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMID 163
Query: 125 HE-MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAME-GLFSVKSDVFSFGVLL 182
HE ++ D+G+A + Q N V + + PE ++ ++ D++S G +L
Sbjct: 164 HEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 220
Query: 183 LEIISGK------KNTGFYLSELGQSLLSYTWKLWCEGEALEL----------------- 219
+I K + L + + L + + + +EL
Sbjct: 221 ASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 280
Query: 220 -MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSV 257
Q V+ E L F+ ++ D R T
Sbjct: 281 RFVHSENQHLVSPEALDFLD---KLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-25
Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 44/275 (16%)
Query: 8 KLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCC-----LEENESL 60
G +AVK+LSR S + E+ L+ ++H+N++ L LEE +
Sbjct: 39 DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98
Query: 61 LIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASN 120
+ ++ L+ + + +L +I I RGL Y+H IIHRDLK SN
Sbjct: 99 YLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSN 151
Query: 121 VLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGV 180
+ +N + KI DFG+AR T + + ++ D++S G
Sbjct: 152 LAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 207
Query: 181 LLLEIISGK----------------KNTGFYLSELGQSLLSYTWKLWCEG----EALELM 220
++ E+++G+ + G +EL + + S + + + + +
Sbjct: 208 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA 267
Query: 221 EPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMS 255
+ + +A +LL+ + DS R T +
Sbjct: 268 NVFIGANPLAVDLLE------KMLVLDSDKRITAA 296
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.1 bits (235), Expect = 6e-23
Identities = 31/195 (15%), Positives = 69/195 (35%), Gaps = 17/195 (8%)
Query: 9 LADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE------------- 55
+ + +A+K + + ++E+ L+ ++ + +
Sbjct: 35 MVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93
Query: 56 ENESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRD 115
N ++ + + L + I + GL Y+H R IIH D
Sbjct: 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTD 151
Query: 116 LKASNVLLNHE-MNPKISDFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSD 174
+K NVL+ + +A + + + + T Y +PE + + +D
Sbjct: 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGAD 211
Query: 175 VFSFGVLLLEIISGK 189
++S L+ E+I+G
Sbjct: 212 IWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.3 bits (192), Expect = 5e-18
Identities = 34/189 (17%), Positives = 65/189 (34%), Gaps = 27/189 (14%)
Query: 7 GKLADGKEIAVK--RLSRTSGQ--------GLQEFKNEVTLIAKLQHKNLVRLFGCCLEE 56
E VK ++ TS + G F A+ + + L +L G + +
Sbjct: 19 CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78
Query: 57 NESLLIYEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDL 116
Y + N ++ + L D+ ++ + +++ I + + I+H DL
Sbjct: 79 V-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHR---GIVHGDL 129
Query: 117 KASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR-IVGTYGYMAPEYAMEGLFSVKSDV 175
NVL+ E I DF + G R + Y + Y + D+
Sbjct: 130 SQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTY------RTEKDI 182
Query: 176 FSFGVLLLE 184
S +L+
Sbjct: 183 NSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 308 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.73 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.65 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.24 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.58 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-53 Score=356.70 Aligned_cols=239 Identities=24% Similarity=0.298 Sum_probs=189.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+|+. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+++..++|||||++++|.+++..
T Consensus 18 fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~- 96 (271)
T d1nvra_ 18 YGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP- 96 (271)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-
T ss_pred CeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc-
Confidence 899999996 579999999987553 33456788999999999999999999999999999999999999999999843
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++................||+.|
T Consensus 97 --~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y 171 (271)
T d1nvra_ 97 --DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171 (271)
T ss_dssp --TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGG
T ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCc
Confidence 346999999999999999999999998 999999999999999999999999999876544333334456799999
Q ss_pred cCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 159 MAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 159 ~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
+|||++.+..+ +.++|||||||++|+|++|..||.......... ........... ........+.
T Consensus 172 ~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------~~~~~~~~~~~--------~~~~~s~~~~ 237 (271)
T d1nvra_ 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY------SDWKEKKTYLN--------PWKKIDSAPL 237 (271)
T ss_dssp SCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH------HHHHTTCTTST--------TGGGSCHHHH
T ss_pred cCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCCCCCC--------ccccCCHHHH
Confidence 99999988765 678999999999999999999996543321110 00111100000 0011123577
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+|+.+||+.||++|||++|+++
T Consensus 238 ~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 238 ALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHcCCChhHCcCHHHHhc
Confidence 8899999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=351.01 Aligned_cols=236 Identities=22% Similarity=0.341 Sum_probs=194.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+++. .+|+.||||++........+.+.+|+.+|+.++||||+++++++.+++..++|||||++++|.+++..
T Consensus 33 fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-- 110 (293)
T d1yhwa1 33 SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-- 110 (293)
T ss_dssp SCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--
T ss_pred CcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--
Confidence 899999995 68999999999766666678899999999999999999999999999999999999999999998743
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..+..... ......||+.|+
T Consensus 111 --~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~ 183 (293)
T d1yhwa1 111 --TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWM 183 (293)
T ss_dssp --SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGC
T ss_pred --cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCcc
Confidence 24899999999999999999999998 99999999999999999999999999998653322 233457899999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||++.+..++.++|||||||++|+|++|..||....... ......... .... ..+......+.+|
T Consensus 184 aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~~~~~~-~~~~-------~~~~~~s~~~~~l 249 (293)
T d1yhwa1 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG-TPEL-------QNPEKLSAIFRDF 249 (293)
T ss_dssp CHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHC-SCCC-------SSGGGSCHHHHHH
T ss_pred ChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHHHHHhCC-CCCC-------CCcccCCHHHHHH
Confidence 9999999999999999999999999999999996432221 111111111 0010 0011123458889
Q ss_pred HhhcccCCCCCCCCHHHHHH
Q 021771 240 GLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~ 259 (308)
+.+||+.||++|||++|+++
T Consensus 250 i~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 250 LNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHccCChhHCcCHHHHhc
Confidence 99999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=348.80 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=189.5
Q ss_pred CCccEEeeeCCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+|+.++ .||||+++.. +....+.+.+|+.+|++++||||+++++++.+ +.+++|||||++|+|.+++...
T Consensus 21 fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~ 97 (276)
T d1uwha_ 21 FGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHII 97 (276)
T ss_dssp SCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTS
T ss_pred CcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhc
Confidence 89999998643 5999998654 34556789999999999999999999998754 5689999999999999998653
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++................||+.|
T Consensus 98 ~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y 172 (276)
T d1uwha_ 98 E--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172 (276)
T ss_dssp C--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGG
T ss_pred c--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCccc
Confidence 3 35999999999999999999999997 999999999999999999999999999876543333334445789999
Q ss_pred cCchhhcc---CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 159 MAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 159 ~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+|||++.+ ..++.++||||+||++|+|++|+.||........ .............+. .........
T Consensus 173 ~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~p~~~-----~~~~~~~~~ 241 (276)
T d1uwha_ 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSPDLS-----KVRSNCPKA 241 (276)
T ss_dssp CCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCCCCGG-----GSCTTCCHH
T ss_pred CCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCCCcch-----hccccchHH
Confidence 99999864 3578999999999999999999999965322210 111111111100000 111112345
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHHHhhcCCCCCC
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVVMLASDTVTLP 269 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~~L~~~~~~~~ 269 (308)
+.+|+.+||+.||++|||++||++.|+.....+|
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 8889999999999999999999999987654443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=346.68 Aligned_cols=241 Identities=27% Similarity=0.387 Sum_probs=185.2
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||+||+|++.+++.||||++... ....+.+.+|+.+++.++||||+++++++.+++..++|||||++|+|.+++...
T Consensus 18 fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~-- 94 (263)
T d1sm2a_ 18 FGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-- 94 (263)
T ss_dssp SCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT--
T ss_pred CeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcc--
Confidence 89999999988999999999643 345578999999999999999999999999999999999999999999988653
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++........ ......|+..|+|
T Consensus 95 ~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~a 170 (263)
T d1sm2a_ 95 RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWAS 170 (263)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCC
T ss_pred ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCC
Confidence 345889999999999999999999997 999999999999999999999999999876533222 2233467899999
Q ss_pred chhhccCcccccccchhhhHHHHHHHhC-CcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIISG-KKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||++.+..++.++||||+||++|+|+++ .+||....... .. .... .... .. .+......+.+|
T Consensus 171 PE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~---~~i~-~~~~--~~-------~p~~~~~~l~~l 234 (263)
T d1sm2a_ 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV---EDIS-TGFR--LY-------KPRLASTHVYQI 234 (263)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HH---HHHH-HTCC--CC-------CCTTSCHHHHHH
T ss_pred hHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HH---HHHH-hcCC--CC-------CccccCHHHHHH
Confidence 9999999999999999999999999995 45554322111 11 1111 1100 00 011112358889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+||+.||++|||++||++.|+..
T Consensus 235 i~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 235 MNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHccCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=345.97 Aligned_cols=232 Identities=24% Similarity=0.324 Sum_probs=191.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|||||++|+|.+++.
T Consensus 19 fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~ 98 (263)
T d2j4za1 19 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 98 (263)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred CcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHh
Confidence 799999996 57999999998643 23456788999999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++...... ......||+
T Consensus 99 ~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~ 168 (263)
T d2j4za1 99 KL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTL 168 (263)
T ss_dssp HH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC----CCEETTEEG
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC----cccccCCCC
Confidence 43 34999999999999999999999998 999999999999999999999999999765432 223356899
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||....... ...... .... . . +......+
T Consensus 169 ~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~-~~~~-~-----~----p~~~s~~~ 231 (263)
T d2j4za1 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRIS-RVEF-T-----F----PDFVTEGA 231 (263)
T ss_dssp GGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHH-TTCC-C-----C----CTTSCHHH
T ss_pred cccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------HHHHHH-cCCC-C-----C----CccCCHHH
Confidence 9999999999899999999999999999999999996432221 111111 1110 0 0 11122358
Q ss_pred HHHHhhcccCCCCCCCCHHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+|+.+||+.||++|||++|+++
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCCHhHCcCHHHHHc
Confidence 88999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=347.00 Aligned_cols=238 Identities=23% Similarity=0.332 Sum_probs=193.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+|+. .+|+.||||++........+.+.+|+.+|+.++||||+++++++.+++..++|||||++|+|.+++....
T Consensus 25 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~ 104 (288)
T d2jfla1 25 FGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 104 (288)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT
T ss_pred CcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC
Confidence 899999996 5899999999987777777889999999999999999999999999999999999999999999875432
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...... ........||+.|+
T Consensus 105 --~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~ 177 (288)
T d2jfla1 105 --RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWM 177 (288)
T ss_dssp --SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSCCTTC
T ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC--cccccccccccccC
Confidence 35999999999999999999999998 999999999999999999999999999765321 11223457899999
Q ss_pred Cchhhc-----cCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 160 APEYAM-----EGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 160 aPE~~~-----~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
|||++. +..++.++|||||||++|+|++|..||....... . ....... ..... ..+.....
T Consensus 178 APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~---~~~i~~~-~~~~~-------~~~~~~s~ 243 (288)
T d2jfla1 178 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V---LLKIAKS-EPPTL-------AQPSRWSS 243 (288)
T ss_dssp CHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHHHS-CCCCC-------SSGGGSCH
T ss_pred CHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H---HHHHHcC-CCCCC-------CccccCCH
Confidence 999884 4567899999999999999999999996543221 1 1111111 11111 01112234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 244 NFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 5888999999999999999999976
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-51 Score=348.94 Aligned_cols=243 Identities=26% Similarity=0.369 Sum_probs=195.7
Q ss_pred CCccEEeeeC-CCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLA-DGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||+|+.+ +|+.||||+++.. ....+.+.+|+.+|+.++||||+++++++.+++..++|||||++|+|.+++...
T Consensus 30 fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~- 107 (287)
T d1opja_ 30 YGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC- 107 (287)
T ss_dssp TSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS-
T ss_pred CeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhc-
Confidence 8999999964 6899999998644 445678999999999999999999999999999999999999999999998653
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......... ......++..|+
T Consensus 108 ~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~ 183 (287)
T d1opja_ 108 NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWT 183 (287)
T ss_dssp CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGC
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCce-eecccccccccc
Confidence 2346899999999999999999999998 999999999999999999999999999876433222 223345788999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
|||++.+..++.++||||+||++|+|++|+.|+...... .........+.... .+......+.+|
T Consensus 184 aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~------~~~~~~i~~~~~~~---------~~~~~~~~l~~l 248 (287)
T d1opja_ 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELLEKDYRME---------RPEGCPEKVYEL 248 (287)
T ss_dssp CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHTTCCCC---------CCTTCCHHHHHH
T ss_pred ChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH------HHHHHHHhcCCCCC---------CCccchHHHHHH
Confidence 999999999999999999999999999977665322111 00111111111111 111223458889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 240 GLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+.+||+.||++|||++||++.|+..
T Consensus 249 i~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 249 MRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 9999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=349.77 Aligned_cols=235 Identities=23% Similarity=0.315 Sum_probs=189.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++.+++..++|||||++|+|.+++.
T Consensus 21 fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~ 100 (288)
T d1uu3a_ 21 FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 100 (288)
T ss_dssp SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhh
Confidence 799999996 58999999998643 23456789999999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.|++.||+|||++| |+||||||+|||+++++.+||+|||++..+.............||+
T Consensus 101 ~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~ 174 (288)
T d1uu3a_ 101 KI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174 (288)
T ss_dssp HH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCG
T ss_pred cc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCc
Confidence 43 35999999999999999999999998 9999999999999999999999999999875443333344457999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ... .. +.....++
T Consensus 175 ~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~-~~~-~~---------p~~~s~~~ 237 (288)
T d1uu3a_ 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIK-LEY-DF---------PEKFFPKA 237 (288)
T ss_dssp GGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHT-TCC-CC---------CTTCCHHH
T ss_pred cccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHHc-CCC-CC---------CccCCHHH
Confidence 9999999999999999999999999999999999996442221 1111111 110 00 11122358
Q ss_pred HHHHhhcccCCCCCCCCHHHHH
Q 021771 237 IHIGLLCVQADSADRPTMSSVV 258 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs~~eil 258 (308)
.+||.+||+.||++|||++|++
T Consensus 238 ~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 238 RDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp HHHHHTTSCSSGGGSTTSGGGT
T ss_pred HHHHHHHccCCHhHCcCHHHHc
Confidence 8899999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=343.92 Aligned_cols=240 Identities=29% Similarity=0.432 Sum_probs=190.9
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||+||+|++++++.||||+++.. ....+.+.+|+.+|++++||||+++++++.+ +..++|||||++|+|.+++... .
T Consensus 26 fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~-~ 102 (272)
T d1qpca_ 26 FGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-S 102 (272)
T ss_dssp TEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH-H
T ss_pred CcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhc-C
Confidence 89999999988999999999644 3456789999999999999999999998765 5679999999999999877442 2
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++........ ......++..|+|
T Consensus 103 ~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~A 178 (272)
T d1qpca_ 103 GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTA 178 (272)
T ss_dssp HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc-cccccCCcccccC
Confidence 345899999999999999999999997 999999999999999999999999999987543222 2233467889999
Q ss_pred chhhccCcccccccchhhhHHHHHHHhCCcC-CCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKN-TGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||++.+..++.++|||||||++|+|++|+.| +....... . ... ...... ... +......+.+|
T Consensus 179 PE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~---~~~-i~~~~~-----~~~----p~~~~~~l~~l 242 (272)
T d1qpca_ 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V---IQN-LERGYR-----MVR----PDNCPEELYQL 242 (272)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H---HHH-HHTTCC-----CCC----CTTCCHHHHHH
T ss_pred hHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---H---HHH-HHhcCC-----CCC----cccChHHHHHH
Confidence 9999988999999999999999999996655 43222111 1 111 111111 111 11122358889
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||+.||++|||+++|++.|+.
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhh
Confidence 999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=347.06 Aligned_cols=241 Identities=26% Similarity=0.356 Sum_probs=181.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe--CCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--ENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+++. .+|+.||+|++... .....+.+.+|+.+|++++||||+++++++.+ ++.+++|||||++|+|.+++
T Consensus 17 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i 96 (269)
T d2java1 17 YGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI 96 (269)
T ss_dssp SEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHH
Confidence 799999995 58999999998655 34456678899999999999999999999865 45689999999999999998
Q ss_pred hcCC-CccccChHHHHHHHHHHHHHHHhchhCC--CCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 76 FDST-RSVQLDWKRRISIINGIARGLLYLHEDS--RLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 76 ~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g--~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
.... ....+++..++.++.||+.||+|||+.| ..+|+||||||+|||++.++.+||+|||++..+..... .....
T Consensus 97 ~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~ 174 (269)
T d2java1 97 TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAF 174 (269)
T ss_dssp HHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC------------
T ss_pred HhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccC
Confidence 6532 2446999999999999999999999864 12499999999999999999999999999987643222 22345
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.||+.|+|||++.+..++.++|||||||++|+|++|..||....... .... ......... .. ..
T Consensus 175 ~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~------~~~~-i~~~~~~~~-----~~----~~ 238 (269)
T d2java1 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------LAGK-IREGKFRRI-----PY----RY 238 (269)
T ss_dssp -CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHH-HHHTCCCCC-----CT----TS
T ss_pred CCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH------HHHH-HHcCCCCCC-----Cc----cc
Confidence 78999999999999899999999999999999999999996543221 1111 111111111 11 12
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...+.+|+.+||+.||++|||++||++
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 235888999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=352.59 Aligned_cols=186 Identities=26% Similarity=0.346 Sum_probs=164.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+|+. .+|+.||+|+++.. .....+.+.+|+.+|+.++||||++++++|.+++.+++|||||++++|.+++...
T Consensus 19 fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~ 98 (322)
T d1s9ja_ 19 GGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 98 (322)
T ss_dssp SCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH
T ss_pred CeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc
Confidence 899999995 58999999999755 3444678899999999999999999999999999999999999999999998643
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
..+++..+..++.|++.||.|||+ +| |+||||||+|||++.++.+||+|||++..+... ......||..
T Consensus 99 ---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~ 168 (322)
T d1s9ja_ 99 ---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 168 (322)
T ss_dssp ---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSC
T ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCcc
Confidence 349999999999999999999997 47 999999999999999999999999999865321 2234579999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccc
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYL 196 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 196 (308)
|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus 169 Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp CCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999999999999999999996543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=338.71 Aligned_cols=240 Identities=26% Similarity=0.394 Sum_probs=196.5
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||+||+|++++++.||||+++.. ....+.+.+|+.++++++||||+++++++.+++.+++||||+++|+|..++...
T Consensus 17 fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~-- 93 (258)
T d1k2pa_ 17 FGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-- 93 (258)
T ss_dssp TEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSG--
T ss_pred CeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhcc--
Confidence 89999999989999999999754 344578999999999999999999999999999999999999999999987543
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.||++||+|||++| |+||||||+||++++++.+||+|||++..+...... ......++..|+|
T Consensus 94 ~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~a 169 (258)
T d1k2pa_ 94 RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSP 169 (258)
T ss_dssp GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCC
T ss_pred ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCC
Confidence 335889999999999999999999998 999999999999999999999999999876543222 2233567889999
Q ss_pred chhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHI 239 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (308)
||++.+..++.++||||+|+++|+|++ |+.||+....... ..... ...... .+......+.+|
T Consensus 170 PE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~------~~~i~-~~~~~~---------~p~~~~~~l~~l 233 (258)
T d1k2pa_ 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIA-QGLRLY---------RPHLASEKVYTI 233 (258)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH------HHHHH-TTCCCC---------CCTTCCHHHHHH
T ss_pred cHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH------HHHHH-hCCCCC---------CcccccHHHHHH
Confidence 999999999999999999999999998 7889865533311 11111 111111 111122358899
Q ss_pred HhhcccCCCCCCCCHHHHHHHhhc
Q 021771 240 GLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 240 i~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
+.+||+.||++|||+++|++.|..
T Consensus 234 i~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 234 MYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HHHHccCCHhHCcCHHHHHHHhhC
Confidence 999999999999999999998864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-50 Score=347.06 Aligned_cols=243 Identities=26% Similarity=0.411 Sum_probs=183.0
Q ss_pred CCccEEeeeC-CCC---EEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGK---EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+|+++ +|+ .||||.+... .....+.+.+|+.+|++++||||+++++++.+++..++|||||++|+|.+++
T Consensus 39 fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~ 118 (299)
T d1jpaa_ 39 FGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL 118 (299)
T ss_dssp SSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHH
T ss_pred CeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeee
Confidence 8999999964 343 5888988654 3445678999999999999999999999999999999999999999999988
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc---ccee
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN---TNRI 152 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~---~~~~ 152 (308)
... ...+++..+..++.||+.||+|||+++ ++||||||+|||++.++.+||+|||+++.+........ ....
T Consensus 119 ~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~ 193 (299)
T d1jpaa_ 119 RQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193 (299)
T ss_dssp HTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------------------
T ss_pred ccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccc
Confidence 643 335899999999999999999999997 99999999999999999999999999987654322211 1223
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.+++.|+|||.+.+..++.++|||||||++|+|++ |..||....... +.. . ...+.. ...+..
T Consensus 194 ~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~---~-i~~~~~---------~~~~~~ 257 (299)
T d1jpaa_ 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VIN---A-IEQDYR---------LPPPMD 257 (299)
T ss_dssp --CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---H-HHTTCC---------CCCCTT
T ss_pred cCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHH---H-HHcCCC---------CCCCcc
Confidence 56889999999999999999999999999999997 889986543221 111 1 111111 011122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
....+.+|+.+||+.||++|||+.||++.|+..
T Consensus 258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 334588899999999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-50 Score=339.51 Aligned_cols=236 Identities=24% Similarity=0.364 Sum_probs=185.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe----CCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE----ENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+|+. .+|+.||+|++... .....+.+.+|+++|++++||||+++++++.+ +..+++|||||++++|.+
T Consensus 22 fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~ 101 (270)
T d1t4ha_ 22 FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT 101 (270)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHH
T ss_pred CcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHH
Confidence 899999996 57999999998654 34456778999999999999999999999875 345799999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC-CCCCeeeecccceeeeCCCCCcccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN-HEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
++... ..+++..+..++.||+.||+|||+++ ..|+||||||+|||++ +++.+||+|||++...... .....
T Consensus 102 ~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~ 173 (270)
T d1t4ha_ 102 YLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAV 173 (270)
T ss_dssp HHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEES
T ss_pred HHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCc
Confidence 98653 35899999999999999999999873 3499999999999997 5789999999999754322 23345
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.||+.|+|||++.+ .++.++|||||||++|+|++|..||....... . ............. .... .
T Consensus 174 ~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~-~~~~i~~~~~~~~----~~~~----~ 238 (270)
T d1t4ha_ 174 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----Q-IYRRVTSGVKPAS----FDKV----A 238 (270)
T ss_dssp CSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----H-HHHHHTTTCCCGG----GGGC----C
T ss_pred ccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----H-HHHHHHcCCCCcc----cCcc----C
Confidence 78999999998865 58999999999999999999999996432211 1 1111111111111 1111 1
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..++.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 224788999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=343.04 Aligned_cols=242 Identities=26% Similarity=0.381 Sum_probs=193.5
Q ss_pred CCccEEeeeC---CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+|.++ ++..||||+++.. .....+.+.+|+.+|++++||||+++++++.++ ..++|||||++|+|.+++.
T Consensus 22 fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~ 100 (285)
T d1u59a_ 22 FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLV 100 (285)
T ss_dssp TEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHT
T ss_pred CeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhh
Confidence 8999999753 4557999999754 344567899999999999999999999998754 6899999999999999875
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccceeecc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRIVGT 155 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~ 155 (308)
.. +..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+...... .......|+
T Consensus 101 ~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt 175 (285)
T d1u59a_ 101 GK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175 (285)
T ss_dssp TC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCC
T ss_pred cc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccC
Confidence 43 335899999999999999999999997 999999999999999999999999999987643322 222334578
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
..|+|||++.+..++.++||||+||++|+|++ |..||....... +. .....+..... +.....
T Consensus 176 ~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~----~~i~~~~~~~~---------p~~~~~ 239 (285)
T d1u59a_ 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKRMEC---------PPECPP 239 (285)
T ss_dssp GGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTCCCCC---------CTTCCH
T ss_pred ccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCCCC---------CCcCCH
Confidence 89999999999999999999999999999997 899997543221 11 11111111111 112234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
++.+|+.+||+.||++|||+.+|++.|+..
T Consensus 240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 240 ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 588899999999999999999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=350.97 Aligned_cols=244 Identities=27% Similarity=0.410 Sum_probs=191.9
Q ss_pred CCccEEeeeCC-C-----CEEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKLAD-G-----KEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||+||+|+... + ..||+|.+... .......+.+|+.+|.++ +||||+++++++.+.+..++|||||++|+|.
T Consensus 50 fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~ 129 (325)
T d1rjba_ 50 FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 129 (325)
T ss_dssp SEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred CeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHH
Confidence 89999998642 2 36899988644 344567789999999998 8999999999999999999999999999999
Q ss_pred hHhhcCCC--------------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeee
Q 021771 73 VFLFDSTR--------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132 (308)
Q Consensus 73 ~~l~~~~~--------------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~ 132 (308)
+++..... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+
T Consensus 130 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~ 206 (325)
T d1rjba_ 130 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKIC 206 (325)
T ss_dssp HHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEEC
T ss_pred HHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEe
Confidence 99976432 235889999999999999999999997 9999999999999999999999
Q ss_pred cccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhh
Q 021771 133 DFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLW 211 (308)
Q Consensus 133 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~ 211 (308)
|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||........ . ....
T Consensus 207 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~--~----~~~~ 280 (325)
T d1rjba_ 207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--F----YKLI 280 (325)
T ss_dssp CCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--H----HHHH
T ss_pred eccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH--H----HHHH
Confidence 9999987654433333344567999999999999999999999999999999997 8999865432211 1 1111
Q ss_pred hcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhh
Q 021771 212 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLA 262 (308)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~ 262 (308)
...... ..+......+.+|+.+||+.||++|||++||++.|.
T Consensus 281 ~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 281 QNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 111111 111112345888999999999999999999999985
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=341.93 Aligned_cols=240 Identities=28% Similarity=0.380 Sum_probs=189.7
Q ss_pred CCccEEeeeC---CCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA---DGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~---~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+|.++ .++.||||+++.. ++...+.+.+|+.+|++++||||+++++++.++ ..++|||||++|+|.+++
T Consensus 20 fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l 98 (277)
T d1xbba_ 20 FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYL 98 (277)
T ss_dssp SEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHH
T ss_pred CeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHH
Confidence 8999999853 3568999998654 344467899999999999999999999998654 578999999999999998
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccceeec
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRIVG 154 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~ 154 (308)
... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.+...... .......|
T Consensus 99 ~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~g 172 (277)
T d1xbba_ 99 QQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172 (277)
T ss_dssp HHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CC
T ss_pred hhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCC
Confidence 653 34999999999999999999999997 999999999999999999999999999886543322 22233467
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
++.|+|||++.+..++.++|||||||++|+|++ |..||....... + ......+..... +....
T Consensus 173 t~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~----~~~i~~~~~~~~---------p~~~~ 236 (277)
T d1xbba_ 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V----TAMLEKGERMGC---------PAGCP 236 (277)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTTCCCCC---------CTTCC
T ss_pred CceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---H----HHHHHcCCCCCC---------CcccC
Confidence 899999999999999999999999999999997 899996543221 1 111111111111 11123
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
..+.+|+.+||+.||++|||+++|++.|+.
T Consensus 237 ~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 237 REMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 458889999999999999999999988865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-49 Score=348.37 Aligned_cols=239 Identities=21% Similarity=0.274 Sum_probs=194.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+++. .+|+.||||++........+.+.+|+.+|+.++||||+++++++.+++.+++|||||++|+|.+++...
T Consensus 39 fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~- 117 (350)
T d1koaa2 39 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE- 117 (350)
T ss_dssp TEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCT-
T ss_pred CeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhh-
Confidence 899999995 589999999997776666788999999999999999999999999999999999999999999988543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC--CCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH--EMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+|||++..+.... ......||+.
T Consensus 118 -~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~ 190 (350)
T d1koaa2 118 -HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAE 190 (350)
T ss_dssp -TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTT
T ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCccc
Confidence 335999999999999999999999998 999999999999964 5789999999998865332 2334578999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||++.+..++.++|||||||++|+|++|..||....... ........ ... . . ..........+.
T Consensus 191 Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~-~~~-~-~----~~~~~~~s~~~~ 257 (350)
T d1koaa2 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSC-DWN-M-D----DSAFSGISEDGK 257 (350)
T ss_dssp TCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHT-CCC-S-C----CGGGGGCCHHHH
T ss_pred ccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-CCC-C-C----cccccCCCHHHH
Confidence 999999999999999999999999999999999996442221 11111111 000 0 0 001111223588
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~ 260 (308)
+||.+||+.||++|||++|+++-
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCChhHCcCHHHHhcC
Confidence 89999999999999999999973
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-50 Score=345.18 Aligned_cols=237 Identities=20% Similarity=0.227 Sum_probs=175.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+++. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+++.+++|||||++++|.+++..
T Consensus 22 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~- 100 (307)
T d1a06a_ 22 FSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE- 100 (307)
T ss_dssp GGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-
T ss_pred CeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc-
Confidence 799999996 579999999997553 23345678999999999999999999999999999999999999999999854
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC---CCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN---HEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
...+++..+..++.||+.||+|||++| |+||||||+||++. +++.+||+|||++....... ......||
T Consensus 101 --~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT 172 (307)
T d1a06a_ 101 --KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGT 172 (307)
T ss_dssp --CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------------------
T ss_pred --ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeC
Confidence 335999999999999999999999998 99999999999995 57889999999998654322 12335789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+.|+|||++.+..++.++|||||||++|+|++|..||....... ......... . .. . ..........
T Consensus 173 ~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~-~-~~-~----~~~~~~~s~~ 239 (307)
T d1a06a_ 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAE-Y-EF-D----SPYWDDISDS 239 (307)
T ss_dssp CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHTTC-C-CC-C----TTTTTTSCHH
T ss_pred ccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHhccC-C-CC-C----CccccCCCHH
Confidence 99999999999999999999999999999999999996432221 111111111 0 00 0 0011112235
Q ss_pred HHHHHhhcccCCCCCCCCHHHHHH
Q 021771 236 FIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+.+|+.+||+.||++|||++|+++
T Consensus 240 ~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 240 AKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHHhc
Confidence 888999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-49 Score=348.69 Aligned_cols=244 Identities=19% Similarity=0.219 Sum_probs=196.9
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+|+. .+|+.||||++........+.+.+|+.+|+.++||||++++++|.+++.+++|||||++++|.+++...
T Consensus 42 fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~- 120 (352)
T d1koba_ 42 FGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE- 120 (352)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT-
T ss_pred CeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhc-
Confidence 899999995 689999999997766666678899999999999999999999999999999999999999998877442
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeC--CCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLN--HEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||++..+.... ......+++.
T Consensus 121 -~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~ 193 (352)
T d1koba_ 121 -DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAE 193 (352)
T ss_dssp -TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGG
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCccc
Confidence 345999999999999999999999998 99999999999998 67889999999999875432 2334568999
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||++.+..++.++|||||||++|+|++|..||....... ........ ... . ...........+.
T Consensus 194 y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~-~~~-~-----~~~~~~~~s~~~~ 260 (352)
T d1koba_ 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRC-DWE-F-----DEDAFSSVSPEAK 260 (352)
T ss_dssp GCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHHC-CCC-C-----CSSTTTTSCHHHH
T ss_pred ccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhC-CCC-C-----CcccccCCCHHHH
Confidence 999999999999999999999999999999999996443221 11111111 000 0 0011111223588
Q ss_pred HHHhhcccCCCCCCCCHHHHHHH--hhcCC
Q 021771 238 HIGLLCVQADSADRPTMSSVVVM--LASDT 265 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~~--L~~~~ 265 (308)
+||.+||+.||++|||++|+++- +....
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 89999999999999999999873 54443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=341.90 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=191.8
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTR 80 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 80 (308)
||.||+|+.++++.||||+++.. ....+.+.+|+.++++++|+||+++++++.+ +..++|||||++|+|..++....
T Consensus 30 fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~- 106 (285)
T d1fmka3 30 FGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGET- 106 (285)
T ss_dssp SCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHH-
T ss_pred CeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcc-
Confidence 89999999988889999999644 4456789999999999999999999999865 56789999999999998875432
Q ss_pred ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCccC
Q 021771 81 SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYMA 160 (308)
Q Consensus 81 ~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 160 (308)
...+++..++.++.||+.||+|||++| ++||||||+|||++.++.+||+|||+++........ ......++..|+|
T Consensus 107 ~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~a 182 (285)
T d1fmka3 107 GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTA 182 (285)
T ss_dssp HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSC
T ss_pred cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-eeccccccccccC
Confidence 235899999999999999999999998 999999999999999999999999999876433222 2233467899999
Q ss_pred chhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHHHH
Q 021771 161 PEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIHIG 240 (308)
Q Consensus 161 PE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (308)
||++.+..++.++||||+||++|+|++|+.|+....... .... . ....... ..+......+.+|+
T Consensus 183 PE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~---~-i~~~~~~---------~~~~~~~~~l~~li 247 (285)
T d1fmka3 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLD---Q-VERGYRM---------PCPPECPESLHDLM 247 (285)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH---H-HHTTCCC---------CCCTTSCHHHHHHH
T ss_pred hHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHH---H-HHhcCCC---------CCCcccCHHHHHHH
Confidence 999999999999999999999999999766653322211 0111 1 1111111 11112234588899
Q ss_pred hhcccCCCCCCCCHHHHHHHhhcCCCCCCCCC
Q 021771 241 LLCVQADSADRPTMSSVVVMLASDTVTLPQPT 272 (308)
Q Consensus 241 ~~cl~~~p~~RPs~~eil~~L~~~~~~~~~~~ 272 (308)
.+||+.||++|||+++|++.|+......+++.
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~ 279 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence 99999999999999999999998766554433
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-50 Score=344.52 Aligned_cols=232 Identities=28% Similarity=0.413 Sum_probs=187.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+|+. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.+++..++|||||.++++..++.
T Consensus 28 fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~ 107 (309)
T d1u5ra_ 28 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV 107 (309)
T ss_dssp SSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH
T ss_pred CeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHH
Confidence 899999995 689999999987543 2334568899999999999999999999999999999999999999987664
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||++..... .....||+
T Consensus 108 ~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~ 175 (309)
T d1u5ra_ 108 HK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTP 175 (309)
T ss_dssp HT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCG
T ss_pred hC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCc
Confidence 32 35999999999999999999999998 99999999999999999999999999976432 22356899
Q ss_pred CccCchhhcc---CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 157 GYMAPEYAME---GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 157 ~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
.|+|||++.+ ..++.++|||||||++|+|++|..||...... ........ ........ .. ..
T Consensus 176 ~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~-~~~~~~~~----~~----~s 240 (309)
T d1u5ra_ 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ-NESPALQS----GH----WS 240 (309)
T ss_dssp GGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH-SCCCCCSC----TT----SC
T ss_pred cccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-CCCCCCCC----CC----CC
Confidence 9999998864 45889999999999999999999998643221 11111111 11111111 11 12
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..+.+|+.+||+.||++|||++|+++
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 35888999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=338.24 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=185.1
Q ss_pred CCccEEeeeCCC-----CEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLADG-----KEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||.||+|++++. ..||||++... .......+.+|+.+|++++||||+++++++.+....++|||||.++++.++
T Consensus 20 fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~ 99 (283)
T d1mqba_ 20 FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 99 (283)
T ss_dssp SSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHH
T ss_pred CeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhh
Confidence 899999997532 36999998654 334456788999999999999999999999999999999999999999888
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccceee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRIV 153 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~ 153 (308)
+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......
T Consensus 100 ~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~ 174 (283)
T d1mqba_ 100 LREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174 (283)
T ss_dssp HHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----------------C
T ss_pred hhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCC
Confidence 75533 35899999999999999999999997 999999999999999999999999999876433221 2223346
Q ss_pred cccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 154 GTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 154 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
|+..|+|||++.+..++.++|||||||++|+|++++.|+...... ..+. .....+... ..+....
T Consensus 175 gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~----~~i~~~~~~---------~~~~~~~ 239 (283)
T d1mqba_ 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM----KAINDGFRL---------PTPMDCP 239 (283)
T ss_dssp CCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH----HHHHTTCCC---------CCCTTCB
T ss_pred CCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHH----HHHhccCCC---------CCchhhH
Confidence 788999999999999999999999999999999976654322111 0111 111111111 1111223
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 240 ~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 4588899999999999999999999999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=335.85 Aligned_cols=237 Identities=22% Similarity=0.279 Sum_probs=191.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC------cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS------GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+.+++|||||++|+|.+
T Consensus 23 fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~ 102 (293)
T d1jksa_ 23 FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102 (293)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccc
Confidence 899999996 689999999986432 2346789999999999999999999999999999999999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC----CeeeecccceeeeCCCCCcccc
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM----NPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~----~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++ .+||+|||++........ .
T Consensus 103 ~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~ 173 (293)
T d1jksa_ 103 FLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 173 (293)
T ss_dssp HHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---C
T ss_pred hhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhhcCCCcc---c
Confidence 98653 35999999999999999999999998 99999999999998776 499999999988653322 2
Q ss_pred ceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 150 NRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
....+++.|+|||++.+..++.++|||||||++|+|++|..||....... ...... .... . ......
T Consensus 174 ~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~-~~~~-~-----~~~~~~ 240 (293)
T d1jksa_ 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANVS-AVNY-E-----FEDEYF 240 (293)
T ss_dssp SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH-TTCC-C-----CCHHHH
T ss_pred cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HHHHHH-hcCC-C-----CCchhc
Confidence 23467899999999999889999999999999999999999996432221 111110 1000 0 000111
Q ss_pred HHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 230 AAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
......+.+||.+||+.||++|||++|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112345888999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=339.32 Aligned_cols=234 Identities=19% Similarity=0.210 Sum_probs=192.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||||++.+. .....+.+.+|+.+|+.++||||+++++++.+++.+++|||||++|+|.+++.
T Consensus 18 fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~ 97 (337)
T d1o6la_ 18 FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97 (337)
T ss_dssp SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhh
Confidence 799999995 68999999999654 33456788899999999999999999999999999999999999999999986
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++........ ......||+
T Consensus 98 ~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~ 169 (337)
T d1o6la_ 98 RE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTP 169 (337)
T ss_dssp HH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECG
T ss_pred cc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCH
Confidence 53 34899999999999999999999998 99999999999999999999999999987543222 233467999
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|.+||....... ....... ... .. +.....++
T Consensus 170 ~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~-~~~-~~---------p~~~s~~~ 232 (337)
T d1o6la_ 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILM-EEI-RF---------PRTLSPEA 232 (337)
T ss_dssp GGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CCC-CC---------CTTSCHHH
T ss_pred HHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhc-CCC-CC---------CccCCHHH
Confidence 9999999999999999999999999999999999996543321 1111111 111 11 11122357
Q ss_pred HHHHhhcccCCCCCCCC-----HHHHHH
Q 021771 237 IHIGLLCVQADSADRPT-----MSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RPs-----~~eil~ 259 (308)
.+||.+||+.||++|++ ++|+++
T Consensus 233 ~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 233 KSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHHhhccCCchhhcccccccHHHHHc
Confidence 88999999999999995 788875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=337.10 Aligned_cols=248 Identities=19% Similarity=0.246 Sum_probs=185.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc-----cHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ-----GLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|+. .+|+.||||+++..... ....+.+|+.+|+.++||||+++++++.++++.++|||||.++++..+
T Consensus 11 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~ 90 (299)
T d1ua2a_ 11 FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII 90 (299)
T ss_dssp TEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHH
T ss_pred CeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhh
Confidence 899999995 57999999998644221 234688999999999999999999999999999999999988877766
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
.. ....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......... .....|
T Consensus 91 ~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~g 162 (299)
T d1ua2a_ 91 KD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVV 162 (299)
T ss_dssp TT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCC
T ss_pred hh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc--ccceec
Confidence 53 3345899999999999999999999998 999999999999999999999999999765433222 223468
Q ss_pred ccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh---ccccccc--------ccc
Q 021771 155 TYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC---EGEALEL--------MEP 222 (308)
Q Consensus 155 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--------~~~ 222 (308)
|+.|+|||++.+ ..++.++|||||||++|+|++|.+||......... ....+... ...+... ...
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp CCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred ChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccchhhhhcc
Confidence 999999998865 46799999999999999999999998654322111 00000000 0000000 000
Q ss_pred ccc---ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 223 VLK---QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 223 ~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
... .........++.+|+.+||+.||++|||++|+|+
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000 0001112346889999999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=334.11 Aligned_cols=237 Identities=17% Similarity=0.240 Sum_probs=190.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||+||++.. .+|+.||||+++... .....+.+|+.+|+.++||||++++++|.+++.+++|||||++++|.+++...
T Consensus 18 fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~- 95 (321)
T d1tkia_ 18 FGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS- 95 (321)
T ss_dssp SEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS-
T ss_pred CeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhc-
Confidence 899999996 579999999996553 33467889999999999999999999999999999999999999999998543
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC--CCeeeecccceeeeCCCCCccccceeecccC
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE--MNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..+..++.||+.||+|||++| |+||||||+|||++.+ ..+||+|||++...... .......+++.
T Consensus 96 -~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~---~~~~~~~~t~~ 168 (321)
T d1tkia_ 96 -AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPE 168 (321)
T ss_dssp -SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGG
T ss_pred -CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC---Ccccccccccc
Confidence 235999999999999999999999998 9999999999999854 47999999999876432 22334578899
Q ss_pred ccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHH
Q 021771 158 YMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFI 237 (308)
Q Consensus 158 y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (308)
|+|||...+..++.++|||||||++|+|++|..||....... ......... . .. . .........++.
T Consensus 169 y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~-~-~~-~----~~~~~~~s~~~~ 235 (321)
T d1tkia_ 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAE-Y-TF-D----EEAFKEISIEAM 235 (321)
T ss_dssp GSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTC-C-CC-C----HHHHTTSCHHHH
T ss_pred cccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCC-C-CC-C----hhhccCCCHHHH
Confidence 999999999999999999999999999999999996543221 111111110 0 00 0 000011223578
Q ss_pred HHHhhcccCCCCCCCCHHHHHH
Q 021771 238 HIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 238 ~li~~cl~~~p~~RPs~~eil~ 259 (308)
+|+.+||+.||++|||+.|+++
T Consensus 236 ~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 236 DFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHhc
Confidence 8999999999999999999997
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-47 Score=335.80 Aligned_cols=254 Identities=19% Similarity=0.212 Sum_probs=201.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+++. .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+....++||||+.+++|..++.
T Consensus 54 fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~ 133 (350)
T d1rdqe_ 54 FGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133 (350)
T ss_dssp SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred CcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHh
Confidence 899999996 58999999998643 33456778999999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.+|.+||+|||++...... .....||+
T Consensus 134 ~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~ 202 (350)
T d1rdqe_ 134 RI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTP 202 (350)
T ss_dssp HH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECG
T ss_pred hc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCcc
Confidence 43 35999999999999999999999998 999999999999999999999999999886432 22357899
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||...... ......... .. . .+.....++
T Consensus 203 ~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~-~~-~---------~p~~~s~~~ 265 (350)
T d1rdqe_ 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSG-KV-R---------FPSHFSSDL 265 (350)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-CC-C---------CCTTCCHHH
T ss_pred ccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHhcC-CC-C---------CCccCCHHH
Confidence 999999999999999999999999999999999999643221 111111111 10 0 011122358
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHH--HhhcC------CCCCCCCCCCCcccCccC
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVV--MLASD------TVTLPQPTEPAFSVGRNV 282 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~--~L~~~------~~~~~~~~~p~~~~~~~~ 282 (308)
.+||.+||+.||++|+ |+++|++ .+... ...+++|-.|......+.
T Consensus 266 ~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~ 324 (350)
T d1rdqe_ 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDT 324 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCC
T ss_pred HHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCcchh
Confidence 8899999999999994 8999985 23222 234566666665544433
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.7e-48 Score=333.11 Aligned_cols=231 Identities=22% Similarity=0.267 Sum_probs=190.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+++. .+|+.||||+++.. .....+.+.+|+.+|+.++||||+++++++.+++.+++|||||.+++|..++.
T Consensus 17 fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~ 96 (316)
T d1fota_ 17 FGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 96 (316)
T ss_dssp SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred CcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccc
Confidence 799999996 67999999998643 23456788999999999999999999999999999999999999999999885
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeeccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTY 156 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 156 (308)
.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++...... .....||+
T Consensus 97 ~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~ 165 (316)
T d1fota_ 97 KS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTP 165 (316)
T ss_dssp HT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCT
T ss_pred cc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcc
Confidence 43 34888899999999999999999998 999999999999999999999999999886432 22357899
Q ss_pred CccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHH
Q 021771 157 GYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKF 236 (308)
Q Consensus 157 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (308)
.|+|||++.+..++.++|||||||++|+|++|..||...... .......... . . .+.....++
T Consensus 166 ~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~~-~-~---------~p~~~s~~~ 228 (316)
T d1fota_ 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNAE-L-R---------FPPFFNEDV 228 (316)
T ss_dssp TTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHCC-C-C---------CCTTSCHHH
T ss_pred cccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHcCC-C-C---------CCCCCCHHH
Confidence 999999999989999999999999999999999999643222 1111111111 0 0 011112358
Q ss_pred HHHHhhcccCCCCCCC-----CHHHHHH
Q 021771 237 IHIGLLCVQADSADRP-----TMSSVVV 259 (308)
Q Consensus 237 ~~li~~cl~~~p~~RP-----s~~eil~ 259 (308)
.+++.+||+.||++|+ |++++++
T Consensus 229 ~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 229 KDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp HHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 8899999999999996 8999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-48 Score=334.41 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=195.5
Q ss_pred CCccEEeeeC------CCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+|+.+ +++.||||+++... ....+.+.+|+.+|+.++||||+++++++.+.+..+++|||+.+++|.+
T Consensus 26 fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~ 105 (301)
T d1lufa_ 26 FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 105 (301)
T ss_dssp SCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred CeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHH
Confidence 8999999853 46789999997553 3345679999999999999999999999999999999999999999999
Q ss_pred HhhcCCC---------------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeee
Q 021771 74 FLFDSTR---------------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKIS 132 (308)
Q Consensus 74 ~l~~~~~---------------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~ 132 (308)
++..... ...+++..+..++.|++.||+|||+++ ++||||||+|||++.++.+||+
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~ 182 (301)
T d1lufa_ 106 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIA 182 (301)
T ss_dssp HHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred HHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEc
Confidence 9864321 234888999999999999999999997 9999999999999999999999
Q ss_pred cccceeeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCC-cCCCccccccccchhHHHHHhh
Q 021771 133 DFGMARIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK-KNTGFYLSELGQSLLSYTWKLW 211 (308)
Q Consensus 133 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~-~p~~~~~~~~~~~~~~~~~~~~ 211 (308)
|||++..+.............++..|+|||.+.+..++.++|||||||++|+|+++. +||....... .... .
T Consensus 183 DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e------~~~~-v 255 (301)
T d1lufa_ 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE------VIYY-V 255 (301)
T ss_dssp CCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHH-H
T ss_pred cchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH------HHHH-H
Confidence 999998664433333334456788999999999999999999999999999999986 5665443221 1111 1
Q ss_pred hcccccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 212 CEGEALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
..+..... .... ..++.+|+.+||+.+|++|||+.||++.|+...
T Consensus 256 ~~~~~~~~-----p~~~----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 256 RDGNILAC-----PENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HTTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HcCCCCCC-----Cccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11222111 1112 235888999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=327.02 Aligned_cols=236 Identities=27% Similarity=0.371 Sum_probs=182.7
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEe-CCeEEEEEEecCCCChhhHhhcCC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-ENESLLIYEYMPNKSLDVFLFDST 79 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~ 79 (308)
||.||+|++ .|+.||||+++.. ...+.+.+|++++++++||||+++++++.+ ++.+++||||+++|+|.+++...
T Consensus 20 fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~- 95 (262)
T d1byga_ 20 FGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR- 95 (262)
T ss_dssp SCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH-
T ss_pred CeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc-
Confidence 899999998 5789999999643 345789999999999999999999999865 45689999999999999998653
Q ss_pred CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCcc
Q 021771 80 RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGYM 159 (308)
Q Consensus 80 ~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~ 159 (308)
....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++...... .....++..|+
T Consensus 96 ~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~ 167 (262)
T d1byga_ 96 GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWT 167 (262)
T ss_dssp HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTS
T ss_pred CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCC
Confidence 2335899999999999999999999997 999999999999999999999999999865322 22235678999
Q ss_pred CchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHHHHH
Q 021771 160 APEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLKFIH 238 (308)
Q Consensus 160 aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (308)
|||.+.+..++.++|||||||++|+|++ |.+||....... +... ...+..... +......+.+
T Consensus 168 aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~~~~~~---------~~~~~~~~~~ 231 (262)
T d1byga_ 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYKMDA---------PDGCPPAVYE 231 (262)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTTCCCCC---------CTTCCHHHHH
T ss_pred ChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCCCCC---------CccCCHHHHH
Confidence 9999999999999999999999999998 677775442221 1111 111111111 1112235888
Q ss_pred HHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 239 IGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 239 li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
|+.+||+.||++|||+.+|++.|+..
T Consensus 232 li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 232 VMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 99999999999999999999999754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=333.84 Aligned_cols=242 Identities=25% Similarity=0.409 Sum_probs=186.7
Q ss_pred CCccEEeee-CCCC----EEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGK----EIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|++ .+|+ +||+|++... +....+.+.+|+.+|++++||||+++++++.++ ..+++++++.+++|.++
T Consensus 22 fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~ 100 (317)
T d1xkka_ 22 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDY 100 (317)
T ss_dssp SEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHH
T ss_pred CeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccc
Confidence 899999996 4555 5888888644 445677899999999999999999999999875 56788899999999888
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeec
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVG 154 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 154 (308)
+... ...+++..++.++.||+.||+|||+++ |+||||||+||+++.++.+||+|||++................|
T Consensus 101 ~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g 175 (317)
T d1xkka_ 101 VREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175 (317)
T ss_dssp HHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------C
T ss_pred cccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccccccccccccccc
Confidence 7653 345899999999999999999999997 99999999999999999999999999987654444333444568
Q ss_pred ccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHH
Q 021771 155 TYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAEL 233 (308)
Q Consensus 155 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
|..|+|||++.+..++.++|||||||++|+|++ |.+||+....... .... ..+.... .+....
T Consensus 176 t~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~i----~~~~~~~---------~p~~~~ 239 (317)
T d1xkka_ 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSIL----EKGERLP---------QPPICT 239 (317)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHHH----HHTCCCC---------CCTTBC
T ss_pred CccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----HcCCCCC---------CCcccC
Confidence 999999999999999999999999999999998 7888865433221 1111 1111110 111122
Q ss_pred HHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 234 LKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 234 ~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
..+.+|+.+||+.||++|||+.||++.|+..
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 3588899999999999999999999887654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-47 Score=324.24 Aligned_cols=237 Identities=22% Similarity=0.275 Sum_probs=189.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcc---------cHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQ---------GLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~ 69 (308)
||+||+++. .+|+.||||++...... ..+.+.+|+.+|++++ ||||+++++++.+++..++|||||+++
T Consensus 16 ~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g 95 (277)
T d1phka_ 16 SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG 95 (277)
T ss_dssp SEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred CeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCc
Confidence 799999995 68999999998654211 2346788999999997 999999999999999999999999999
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccc
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
+|.+++... ..+++..+..++.||+.||+|||++| |+||||||+||+++.++.+||+|||++........ .
T Consensus 96 ~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~ 166 (277)
T d1phka_ 96 ELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---L 166 (277)
T ss_dssp BHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---B
T ss_pred hHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeEccCCCc---e
Confidence 999999643 35999999999999999999999998 99999999999999999999999999998754322 2
Q ss_pred ceeecccCccCchhhcc------CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhccccccccccc
Q 021771 150 NRIVGTYGYMAPEYAME------GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPV 223 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (308)
....|+..|+|||.+.+ ..++.++||||+||++|+|++|..||....... ......... . ..
T Consensus 167 ~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~~~~i~~~~-~-~~---- 234 (277)
T d1phka_ 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIMSGN-Y-QF---- 234 (277)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHTC-C-CC----
T ss_pred eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------HHHHHHhCC-C-CC----
Confidence 33578999999998864 346789999999999999999999997543221 111111111 1 00
Q ss_pred ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 224 LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...........+.+|+.+||+.||++|||++||++
T Consensus 235 -~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 235 -GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00011122345888999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-48 Score=326.62 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=180.9
Q ss_pred CCccEEeeeCC----CCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLAD----GKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|++.. +..||||.++.. .....+.+.+|+.+|++++||||+++++++.+ +..++|||||++++|.+++
T Consensus 20 fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~ 98 (273)
T d1mp8a_ 20 FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL 98 (273)
T ss_dssp SSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHH
T ss_pred CcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhh
Confidence 89999998642 456889988654 34446779999999999999999999999964 5789999999999999987
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ...+++..++.++.||+.||.|||+++ ++||||||+||+++.++.+||+|||++..+...... ......++
T Consensus 99 ~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt 172 (273)
T d1mp8a_ 99 QVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLP 172 (273)
T ss_dssp HHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------------------CC
T ss_pred hcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecC
Confidence 543 335899999999999999999999998 999999999999999999999999999876433222 23334678
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELL 234 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
+.|+|||++.+..++.++|||||||++|+|++ |.+||....... +. ... ..+..... +.....
T Consensus 173 ~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~---~~i-~~~~~~~~---------~~~~~~ 236 (273)
T d1mp8a_ 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---GRI-ENGERLPM---------PPNCPP 236 (273)
T ss_dssp GGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HHH-HTTCCCCC---------CTTCCH
T ss_pred cccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HH---HHH-HcCCCCCC---------CCCCCH
Confidence 89999999999999999999999999999987 788886543321 11 111 11111111 111234
Q ss_pred HHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 235 KFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 235 ~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.+.+|+.+||+.||++|||++||++.|+..
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 588899999999999999999999988753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=331.12 Aligned_cols=238 Identities=19% Similarity=0.186 Sum_probs=185.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcC-CCcCccceeeeEEe----CCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLE----ENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|+. .+|+.||||+++.. ..+.+|+.++.++ +||||++++++|.+ +..+++|||||++|+|.++
T Consensus 25 fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~ 99 (335)
T d2ozaa1 25 NGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 99 (335)
T ss_dssp SCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHH
Confidence 899999995 68999999998532 5677899887654 79999999999976 4568999999999999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC---CCCeeeecccceeeeCCCCCccccce
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH---EMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~---~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
+... ....+++..++.++.||+.||+|||++| |+||||||+||+++. ++.+||+|||++........ ...
T Consensus 100 i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~ 172 (335)
T d2ozaa1 100 IQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTT 172 (335)
T ss_dssp HHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCC
T ss_pred HHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCCCc---ccc
Confidence 9653 2346999999999999999999999998 999999999999985 45699999999987653322 233
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..|++.|+|||++.+..++.++|||||||++|+|++|..||............ ........ ..........
T Consensus 173 ~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~---~~~i~~~~------~~~~~~~~~~ 243 (335)
T d2ozaa1 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQ------YEFPNPEWSE 243 (335)
T ss_dssp CSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS------SSCCTTHHHH
T ss_pred ccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---HHHHhcCC------CCCCCccccc
Confidence 57899999999999989999999999999999999999999644322111000 00000000 0000111122
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...++.+||.+||+.||++|||+.|+++
T Consensus 244 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 244 VSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 3456889999999999999999999997
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-47 Score=325.89 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=186.4
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC----eEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN----ESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~ 72 (308)
||+||+++. .+|+.||||+++... ....+.+.+|+.+|+.++||||+++++++.... ..++|||||++++|.
T Consensus 20 fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~ 99 (277)
T d1o6ya_ 20 MSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR 99 (277)
T ss_dssp SEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHH
T ss_pred CeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEeh
Confidence 799999995 689999999997543 334567889999999999999999999998654 378999999999999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCC-ccccce
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQS-EANTNR 151 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~-~~~~~~ 151 (308)
.++... ..+++..++.++.||+.||+|||++| |+||||||+||+++.++..+++|||.+........ ......
T Consensus 100 ~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 173 (277)
T d1o6ya_ 100 DIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173 (277)
T ss_dssp HHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC-----------
T ss_pred hhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcccccccccccc
Confidence 888543 35999999999999999999999998 99999999999999999999999999876543322 222334
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
..||+.|+|||++.+..++.++|||||||++|+|++|.+||...... .............. ......
T Consensus 174 ~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~~~~-------~~~~~~ 240 (277)
T d1o6ya_ 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPP-------SARHEG 240 (277)
T ss_dssp -----TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCG-------GGTSSS
T ss_pred ccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCCCCC-------chhccC
Confidence 57899999999999989999999999999999999999999643221 11112221111110 000111
Q ss_pred HHHHHHHHHhhcccCCCCCCC-CHHHHHHHhhc
Q 021771 232 ELLKFIHIGLLCVQADSADRP-TMSSVVVMLAS 263 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RP-s~~eil~~L~~ 263 (308)
....+.++|.+||+.||++|| |++++++.|..
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 223588899999999999999 89999988764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=325.76 Aligned_cols=257 Identities=21% Similarity=0.253 Sum_probs=188.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+++.+++||||+.++.+......
T Consensus 15 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~ 94 (298)
T d1gz8a_ 15 YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS 94 (298)
T ss_dssp SSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT
T ss_pred CeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhh
Confidence 899999995 689999999996442 33467889999999999999999999999999999999999976544443322
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++....... .......|+..
T Consensus 95 --~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~ 167 (298)
T d1gz8a_ 95 --ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLW 167 (298)
T ss_dssp --TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCT
T ss_pred --cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc--ccceeecccce
Confidence 2345999999999999999999999998 9999999999999999999999999998764332 22333578999
Q ss_pred ccCchhhccCc-ccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh---cc---ccc---c---cccccc
Q 021771 158 YMAPEYAMEGL-FSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC---EG---EAL---E---LMEPVL 224 (308)
Q Consensus 158 y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~---~---~~~~~~ 224 (308)
|+|||++.... ++.++|||||||++|+|++|..||........ ......... .. ... . ......
T Consensus 168 y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T d1gz8a_ 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244 (298)
T ss_dssp TCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCC
T ss_pred eeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhcccccccccccccccccc
Confidence 99999877654 57899999999999999999999964432210 000000000 00 000 0 000000
Q ss_pred cc---cchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH--hhcCCCC
Q 021771 225 KQ---SCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM--LASDTVT 267 (308)
Q Consensus 225 ~~---~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~--L~~~~~~ 267 (308)
.. ........++.+|+.+||+.||++|||++|+++- ++....+
T Consensus 245 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 00 0011223468889999999999999999999974 5554333
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=320.69 Aligned_cols=242 Identities=27% Similarity=0.354 Sum_probs=185.2
Q ss_pred CCccEEeeeC--CC--CEEEEEEeccC---CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA--DG--KEIAVKRLSRT---SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+|+.. ++ ..||||+++.. .....+.+.+|+.+|+.++||||+++++++.++ ..++|||||+++++.+
T Consensus 21 fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~ 99 (273)
T d1u46a_ 21 FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLD 99 (273)
T ss_dssp -CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHH
T ss_pred CeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhh
Confidence 8999999853 33 36899988654 334456889999999999999999999999764 6789999999999998
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-ccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~ 152 (308)
++... ...+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 100 ~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~ 174 (273)
T d1u46a_ 100 RLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174 (273)
T ss_dssp HHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC----
T ss_pred hhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCcc
Confidence 87653 335999999999999999999999997 999999999999999999999999999987544322 222334
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccccccccccccccchHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAA 231 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ............... ...
T Consensus 175 ~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~~~~-----~~~---- 239 (273)
T d1u46a_ 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLPR-----PED---- 239 (273)
T ss_dssp -CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCCC-----CTT----
T ss_pred ccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCCCCC-----ccc----
Confidence 56789999999999999999999999999999997 89998643222 111122111111111 111
Q ss_pred HHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 232 ELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 232 ~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
....+.+|+.+||+.||++|||+.||++.|.+
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 12358889999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=331.02 Aligned_cols=245 Identities=27% Similarity=0.386 Sum_probs=195.3
Q ss_pred CCccEEeee------CCCCEEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL------ADGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
||.||+|++ .+++.||||+++.. .......+.+|+.+++.+ +||||+++++++.+.+..++|||||++++|.
T Consensus 36 fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~ 115 (311)
T d1t46a_ 36 FGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115 (311)
T ss_dssp SEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHH
T ss_pred CeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHH
Confidence 899999974 35779999999754 344556788999999999 6999999999999999999999999999999
Q ss_pred hHhhcCC---------------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 73 VFLFDST---------------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 73 ~~l~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
+++.... ....+++..+..++.||+.||+|||+++ ++||||||+||+++.++.++++|||.+
T Consensus 116 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~ 192 (311)
T d1t46a_ 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLA 192 (311)
T ss_dssp HHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGG
T ss_pred HHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchh
Confidence 9986542 1235889999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCC-cCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK-KNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................+++.|+|||.+.+..++.++|||||||++|+|++++ +||....... ........+..
T Consensus 193 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~------~~~~~i~~~~~ 266 (311)
T d1t46a_ 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFYKMIKEGFR 266 (311)
T ss_dssp SCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------HHHHHHHHTCC
T ss_pred eeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCC
Confidence 8765444444445567899999999999999999999999999999999855 4453332211 11111111111
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhc
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLAS 263 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~ 263 (308)
. ..+......+.+||.+||+.||++|||+++|+++|+.
T Consensus 267 ~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 267 M---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred C---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 1111123458899999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=328.88 Aligned_cols=245 Identities=29% Similarity=0.401 Sum_probs=195.2
Q ss_pred CCccEEeeeCC--------CCEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCC
Q 021771 1 MESCLQGKLAD--------GKEIAVKRLSRTS-GQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 1 ~g~v~~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 70 (308)
||.||+|+... +..||||+++... ......+.+|...+.++ +||||+++++++.++...++|||||++|+
T Consensus 26 fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~ 105 (299)
T d1fgka_ 26 FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 105 (299)
T ss_dssp --CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred CcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCc
Confidence 89999998532 3479999997653 34456788899999888 79999999999999999999999999999
Q ss_pred hhhHhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccce
Q 021771 71 LDVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMA 137 (308)
Q Consensus 71 L~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~ 137 (308)
|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 106 l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~ 182 (299)
T d1fgka_ 106 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLA 182 (299)
T ss_dssp HHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCC
T ss_pred HHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhh
Confidence 9999965431 245899999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHh-CCcCCCccccccccchhHHHHHhhhcccc
Q 021771 138 RIFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIIS-GKKNTGFYLSELGQSLLSYTWKLWCEGEA 216 (308)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (308)
................++..|+|||.+.+..++.++||||||+++|+|++ |.+||....... .......+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-------~~~~i~~~~~ 255 (299)
T d1fgka_ 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFKLLKEGHR 255 (299)
T ss_dssp CCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHTTCC
T ss_pred ccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-------HHHHHHcCCC
Confidence 87755444444445578889999999999999999999999999999997 678876443321 1111112111
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
... ... ....+.+|+.+||+.||++|||+.||++.|+..
T Consensus 256 ~~~-----p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 256 MDK-----PSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp CCC-----CSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-----Ccc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 111 223588999999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=330.32 Aligned_cols=234 Identities=22% Similarity=0.285 Sum_probs=187.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccC---CcccHHHHHHHHHHHh-cCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT---SGQGLQEFKNEVTLIA-KLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||+||+|+. .+|+.||||++... .....+.+..|..++. .++||||+++++++.+++..++|||||++|+|.+++
T Consensus 15 fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i 94 (320)
T d1xjda_ 15 FGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 94 (320)
T ss_dssp SSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred CcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHh
Confidence 899999996 58999999999643 2344556667777665 689999999999999999999999999999999999
Q ss_pred hcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecc
Q 021771 76 FDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
... ..+++..+..++.||+.||+|||++| ++||||||+|||++.++.+||+|||++....... .......||
T Consensus 95 ~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt 166 (320)
T d1xjda_ 95 QSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGT 166 (320)
T ss_dssp HHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSC
T ss_pred hcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc--ccccccCCC
Confidence 653 34899999999999999999999998 9999999999999999999999999998654332 223345789
Q ss_pred cCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHHHHH
Q 021771 156 YGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAELLK 235 (308)
Q Consensus 156 ~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
+.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ... . ... .....
T Consensus 167 ~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~-~~~-~-----~p~----~~s~~ 229 (320)
T d1xjda_ 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRM-DNP-F-----YPR----WLEKE 229 (320)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHH-CCC-C-----CCT----TSCHH
T ss_pred CCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH------HHHHHHc-CCC-C-----CCc----cCCHH
Confidence 99999999999999999999999999999999999996543221 1111111 100 0 011 11234
Q ss_pred HHHHHhhcccCCCCCCCCHH-HHHH
Q 021771 236 FIHIGLLCVQADSADRPTMS-SVVV 259 (308)
Q Consensus 236 l~~li~~cl~~~p~~RPs~~-eil~ 259 (308)
+.+|+.+||+.||++|||+. ++++
T Consensus 230 ~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 230 AKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHHhcccCCCCCcCHHHHHHh
Confidence 88899999999999999996 7763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=328.68 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=183.5
Q ss_pred CCccEEeeeC------CCCEEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCC-eEEEEEEecCCCCh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEEN-ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L 71 (308)
||.||+|+.. +++.||||+++.. .......+..|...+.++ +|+||+.+++++.+.+ .+++|||||++|+|
T Consensus 26 fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L 105 (299)
T d1ywna1 26 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 105 (299)
T ss_dssp SCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBH
T ss_pred CeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcH
Confidence 8999999853 3568999998654 334456677888888777 5899999999887654 58999999999999
Q ss_pred hhHhhcCCC-------------ccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeeccccee
Q 021771 72 DVFLFDSTR-------------SVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMAR 138 (308)
Q Consensus 72 ~~~l~~~~~-------------~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~ 138 (308)
.+++..... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~ 182 (299)
T d1ywna1 106 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLAR 182 (299)
T ss_dssp HHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC-----
T ss_pred HHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchh
Confidence 999965421 235889999999999999999999997 9999999999999999999999999998
Q ss_pred eeCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCC-cCCCccccccccchhHHHHHhhhccccc
Q 021771 139 IFGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK-KNTGFYLSELGQSLLSYTWKLWCEGEAL 217 (308)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (308)
...............||+.|+|||++.+..++.++||||+||++|+|+++. +||....... ........+...
T Consensus 183 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------~~~~~~~~~~~~ 256 (299)
T d1ywna1 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRM 256 (299)
T ss_dssp -CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHHHHHHTCCC
T ss_pred hccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCCCC
Confidence 765444444444567899999999999999999999999999999999875 5675432221 111111111111
Q ss_pred ccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 218 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
.. +......+.+|+.+||+.||++|||++||++.|+..
T Consensus 257 ~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 257 RA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 111223588899999999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.2e-47 Score=333.04 Aligned_cols=235 Identities=23% Similarity=0.228 Sum_probs=184.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC---cccHHHHH---HHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS---GQGLQEFK---NEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||.||+++. .+|+.||||++.... ......+. .++.+++.++||||+++++++.+++.+++|||||++++|.+
T Consensus 17 fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~ 96 (364)
T d1omwa3 17 FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHY 96 (364)
T ss_dssp SCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHH
Confidence 899999996 579999999986431 22223333 34677778889999999999999999999999999999999
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIV 153 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 153 (308)
++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||++..+.... .....
T Consensus 97 ~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~ 166 (364)
T d1omwa3 97 HLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 166 (364)
T ss_dssp HHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCC
T ss_pred HHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccc
Confidence 98653 34889999999999999999999998 9999999999999999999999999998765332 23357
Q ss_pred cccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 154 GTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 154 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........+ ..... ..... .... .
T Consensus 167 GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~~~~--~~~~~-----~~~~----~ 232 (364)
T d1omwa3 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTL--TMAVE-----LPDS----F 232 (364)
T ss_dssp SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH---HHHSS--SCCCC-----CCSS----S
T ss_pred cccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcc--cCCCC-----CCCC----C
Confidence 8999999999865 5689999999999999999999999975433221111 11100 00000 0011 1
Q ss_pred HHHHHHHHhhcccCCCCCCCC-----HHHHHH
Q 021771 233 LLKFIHIGLLCVQADSADRPT-----MSSVVV 259 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs-----~~eil~ 259 (308)
...+.+||.+||+.||++||| ++|+++
T Consensus 233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 235888999999999999999 788884
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=324.38 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=191.6
Q ss_pred CCccEEeeeCCC----CEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEe-CCeEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKLADG----KEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE-ENESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~~~g----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|++.++ ..||||+++.. +....+.+.+|+++|++++||||+++++++.+ ++..++|||||++++|.++
T Consensus 40 fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~ 119 (311)
T d1r0pa_ 40 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119 (311)
T ss_dssp TEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHH
T ss_pred CeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhh
Confidence 899999996432 25899998643 45566789999999999999999999999876 4578999999999999998
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcc--cccee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEA--NTNRI 152 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~ 152 (308)
+... ....++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......... .....
T Consensus 120 ~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~ 194 (311)
T d1r0pa_ 120 IRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194 (311)
T ss_dssp HHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCS
T ss_pred hccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccc
Confidence 8653 334778889999999999999999997 9999999999999999999999999998765432221 22234
Q ss_pred ecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchHHH
Q 021771 153 VGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVAAE 232 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
.|+..|+|||.+....++.++||||||+++|+|++|+.||....... ..... ...+.... .... .
T Consensus 195 ~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~----i~~g~~~~-----~p~~----~ 259 (311)
T d1r0pa_ 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY----LLQGRRLL-----QPEY----C 259 (311)
T ss_dssp SCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCCCC-----CCTT----C
T ss_pred cccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCCCCC-----Cccc----C
Confidence 67899999999999999999999999999999999888765432221 11111 11111111 0111 1
Q ss_pred HHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCCC
Q 021771 233 LLKFIHIGLLCVQADSADRPTMSSVVVMLASDTV 266 (308)
Q Consensus 233 ~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~~ 266 (308)
...+.+|+.+||+.||++|||+.||++.|+....
T Consensus 260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 260 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2358889999999999999999999999987643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-47 Score=326.78 Aligned_cols=243 Identities=28% Similarity=0.383 Sum_probs=187.9
Q ss_pred CCccEEeeeC-CCC--EEEEEEeccC-CcccHHHHHHHHHHHhcC-CCcCccceeeeEEeCCeEEEEEEecCCCChhhHh
Q 021771 1 MESCLQGKLA-DGK--EIAVKRLSRT-SGQGLQEFKNEVTLIAKL-QHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFL 75 (308)
Q Consensus 1 ~g~v~~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 75 (308)
||.||+|+++ +|. .||||++... .....+.+.+|+++|+++ +||||+++++++.+++.+++||||+++|+|.+++
T Consensus 23 fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l 102 (309)
T d1fvra_ 23 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 102 (309)
T ss_dssp GCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHH
T ss_pred CcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHH
Confidence 8999999964 454 4677877544 344566799999999999 6999999999999999999999999999999998
Q ss_pred hcC-------------CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 76 FDS-------------TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 76 ~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
... .....+++..+..++.||+.||.|||+++ ++||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~ 179 (309)
T d1fvra_ 103 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV 179 (309)
T ss_dssp HTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCE
T ss_pred hhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccccccccccc
Confidence 653 22356899999999999999999999997 99999999999999999999999999976432
Q ss_pred CCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCc-CCCccccccccchhHHHHHhhhccccccccc
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKK-NTGFYLSELGQSLLSYTWKLWCEGEALELME 221 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (308)
. .......++..|+|||.+.+..++.++|||||||++|+|++|.. ||....... .... ...+....
T Consensus 180 ~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~------~~~~-i~~~~~~~--- 246 (309)
T d1fvra_ 180 Y---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEK-LPQGYRLE--- 246 (309)
T ss_dssp E---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHH-GGGTCCCC---
T ss_pred c---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH------HHHH-HHhcCCCC---
Confidence 2 11223457889999999999999999999999999999999764 564332221 1111 11111111
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
.+......+.+|+.+||+.||++|||++||++.|+...
T Consensus 247 ------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 247 ------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp ------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11112345888999999999999999999999887653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=318.84 Aligned_cols=254 Identities=24% Similarity=0.287 Sum_probs=186.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC----eEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN----ESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~ 76 (308)
||.||+|++ +|+.||||+++... ......+.|+..+..++||||+++++++.+.+ ..++|||||++|+|.++++
T Consensus 16 fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~ 93 (303)
T d1vjya_ 16 FGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 93 (303)
T ss_dssp SSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH
T ss_pred CeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHh
Confidence 899999987 68899999985432 21222334555566789999999999998654 5799999999999999996
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCC-----CCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc--ccc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDS-----RLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--ANT 149 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g-----~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--~~~ 149 (308)
.. .+++..++.++.|++.+|+|+|+.+ +.+|+||||||+|||++.++.+||+|||++......... ...
T Consensus 94 ~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~ 169 (303)
T d1vjya_ 94 RY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169 (303)
T ss_dssp HC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC--
T ss_pred cC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccc
Confidence 42 4889999999999999999999731 124999999999999999999999999999887543322 123
Q ss_pred ceeecccCccCchhhccC------cccccccchhhhHHHHHHHhCCcCCCccccccccc--------hhHHHHHhhhccc
Q 021771 150 NRIVGTYGYMAPEYAMEG------LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQS--------LLSYTWKLWCEGE 215 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~--------~~~~~~~~~~~~~ 215 (308)
....||+.|+|||++.+. .++.++|||||||++|+|++|..||+......... ...........
T Consensus 170 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 247 (303)
T d1vjya_ 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE-- 247 (303)
T ss_dssp --CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT--
T ss_pred cceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhc--
Confidence 345789999999988754 36789999999999999999998875433221110 11111111111
Q ss_pred cccccccccc-ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 216 ALELMEPVLK-QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 216 ~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
...++.+. ..........+.+|+.+||+.||++|||+.||++.|+..
T Consensus 248 --~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 248 --QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp --SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred --cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 11111111 112334556788999999999999999999999998754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.8e-46 Score=319.80 Aligned_cols=248 Identities=22% Similarity=0.303 Sum_probs=186.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+|+.++|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+++..+++|+++.++.+..+...
T Consensus 15 fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~- 93 (286)
T d1ob3a_ 15 YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC- 93 (286)
T ss_dssp TEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS-
T ss_pred CcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhh-
Confidence 799999999999999999996542 33467899999999999999999999999999999999999988777766532
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccCc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYGY 158 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 158 (308)
...+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||.+........ ......++..|
T Consensus 94 --~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y 166 (286)
T d1ob3a_ 94 --EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWY 166 (286)
T ss_dssp --TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTT
T ss_pred --cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchh
Confidence 345999999999999999999999997 99999999999999999999999999987643322 22334678899
Q ss_pred cCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhc---cc---ccc---------cccc
Q 021771 159 MAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCE---GE---ALE---------LMEP 222 (308)
Q Consensus 159 ~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~~---------~~~~ 222 (308)
+|||.+.+. .++.++|||||||++|+|++|+.||........ .......... .. ... ....
T Consensus 167 ~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (286)
T d1ob3a_ 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEP 243 (286)
T ss_dssp CCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCC
T ss_pred hhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhhhhhcccccccccC
Confidence 999988764 568999999999999999999999965432211 0000000000 00 000 0000
Q ss_pred cccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 223 VLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
.............+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 244 LPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001111112345788999999999999999999984
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=324.57 Aligned_cols=245 Identities=24% Similarity=0.373 Sum_probs=196.1
Q ss_pred CCccEEeeeC------CCCEEEEEEeccC-CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKLA------DGKEIAVKRLSRT-SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 73 (308)
||+||+|.++ +++.||||+++.. .......+.+|+.++++++||||+++++++..+...++|||||++|+|.+
T Consensus 33 fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~ 112 (308)
T d1p4oa_ 33 FGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 112 (308)
T ss_dssp SSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred CeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHH
Confidence 8999999863 3678999999654 33445678899999999999999999999999999999999999999999
Q ss_pred HhhcCC-------CccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc
Q 021771 74 FLFDST-------RSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE 146 (308)
Q Consensus 74 ~l~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~ 146 (308)
++.... ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 113 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~ 189 (308)
T d1p4oa_ 113 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 189 (308)
T ss_dssp HHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCE
T ss_pred HHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcce
Confidence 886432 1234788899999999999999999997 999999999999999999999999999876544333
Q ss_pred cccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCC-cCCCccccccccchhHHHHHhhhccccccccccccc
Q 021771 147 ANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGK-KNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLK 225 (308)
Q Consensus 147 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
.......+++.|+|||.+.+..++.++||||+|+++|+|++|. +||....... .. .....+.....
T Consensus 190 ~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------~~-~~i~~~~~~~~------ 256 (308)
T d1p4oa_ 190 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VL-RFVMEGGLLDK------ 256 (308)
T ss_dssp EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------HH-HHHHTTCCCCC------
T ss_pred eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------HH-HHHHhCCCCCC------
Confidence 3344456889999999999999999999999999999999985 6665432221 11 11111111111
Q ss_pred ccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 226 QSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 226 ~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
+......+.+|+.+||+.+|++|||+++|++.|+..
T Consensus 257 ---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 257 ---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111223588899999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=315.61 Aligned_cols=226 Identities=21% Similarity=0.310 Sum_probs=180.8
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCc------ccHHHHHHHHHHHhcCC--CcCccceeeeEEeCCeEEEEEEecCC-CC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSG------QGLQEFKNEVTLIAKLQ--HKNLVRLFGCCLEENESLLIYEYMPN-KS 70 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~ 70 (308)
||+||+|+. .+|+.||||++..... .....+.+|+.+|++++ ||||+++++++.+++..++||||+.+ ++
T Consensus 17 fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~ 96 (273)
T d1xwsa_ 17 FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD 96 (273)
T ss_dssp TEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEE
T ss_pred CeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcch
Confidence 899999995 6899999999864321 12234668999999996 89999999999999999999999975 57
Q ss_pred hhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCC-CCeeeecccceeeeCCCCCcccc
Q 021771 71 LDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHE-MNPKISDFGMARIFGGNQSEANT 149 (308)
Q Consensus 71 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~-~~~kl~dfg~~~~~~~~~~~~~~ 149 (308)
+.+++.. ...+++..++.++.||+.||+|||++| |+||||||+||+++.+ +.+||+|||++....... .
T Consensus 97 l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~ 166 (273)
T d1xwsa_ 97 LFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----Y 166 (273)
T ss_dssp HHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----B
T ss_pred HHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccceeccccc----c
Confidence 7777744 335999999999999999999999998 9999999999999854 789999999998754322 2
Q ss_pred ceeecccCccCchhhccCcc-cccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 150 NRIVGTYGYMAPEYAMEGLF-SVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 150 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .. ... . .....
T Consensus 167 ~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------~~-~~~--~----~~~~~ 227 (273)
T d1xwsa_ 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------IR-GQV--F----FRQRV 227 (273)
T ss_dssp CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------HH-CCC--C----CSSCC
T ss_pred cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------------hh-ccc--C----CCCCC
Confidence 33568999999999887654 67799999999999999999999643211 00 000 0 11111
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..++.+|+.+||+.||++|||++|+++
T Consensus 228 ----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 228 ----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 235888999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=316.12 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=180.9
Q ss_pred CCccEEeee-CC-CCEEEEEEeccCC--cccHHHHHHHHHHHhcC---CCcCccceeeeEEe-----CCeEEEEEEecCC
Q 021771 1 MESCLQGKL-AD-GKEIAVKRLSRTS--GQGLQEFKNEVTLIAKL---QHKNLVRLFGCCLE-----ENESLLIYEYMPN 68 (308)
Q Consensus 1 ~g~v~~~~~-~~-g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~ 68 (308)
||+||+++. ++ ++.||||++.... ......+.+|+.+|+.+ +||||++++++|.. ....+++||++++
T Consensus 20 fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~ 99 (305)
T d1blxa_ 20 YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ 99 (305)
T ss_dssp TEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSC
T ss_pred CeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccC
Confidence 899999986 44 6678999986432 22334556777777666 79999999999863 2467999999988
Q ss_pred CChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccc
Q 021771 69 KSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEAN 148 (308)
Q Consensus 69 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 148 (308)
+.+...... ....+++..++.++.|++.||+|||++| |+||||||+|||++.++.+||+|||++..... ...
T Consensus 100 ~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~---~~~ 171 (305)
T d1blxa_ 100 DLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMA 171 (305)
T ss_dssp BHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCG---GGG
T ss_pred Cchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhcc---ccc
Confidence 776554433 3345899999999999999999999998 99999999999999999999999999876432 223
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH-----Hhhhcc-ccc-cc--
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW-----KLWCEG-EAL-EL-- 219 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~-----~~~~~~-~~~-~~-- 219 (308)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||................ ..+... ... ..
T Consensus 172 ~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 251 (305)
T d1blxa_ 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 251 (305)
T ss_dssp GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSC
T ss_pred CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhc
Confidence 344678999999999999999999999999999999999999996543221110000000 000000 000 00
Q ss_pred -ccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 220 -MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 220 -~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
................+.+|+.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 252 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000111112345788999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=319.02 Aligned_cols=249 Identities=21% Similarity=0.196 Sum_probs=181.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCccceeeeEEeC------CeEEEEEEecCCCChhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE------NESLLIYEYMPNKSLDV 73 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~ 73 (308)
||+||+|+. .+|+.||||++..... ...+|+.+|++++|+||++++++|... .++++|||||+++.+..
T Consensus 33 fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~ 108 (350)
T d1q5ka_ 33 FGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108 (350)
T ss_dssp TEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHH
T ss_pred CeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHH
Confidence 899999996 5799999999965432 234799999999999999999998542 35789999998765555
Q ss_pred HhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCcccccee
Q 021771 74 FLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 74 ~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+.........+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++..+..... ....
T Consensus 109 l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~ 182 (350)
T d1q5ka_ 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSY 182 (350)
T ss_dssp HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSC
T ss_pred HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccc
Confidence 4433334456999999999999999999999998 99999999999999775 799999999987653322 2234
Q ss_pred ecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhH--------HHHHhhh----ccccccc
Q 021771 153 VGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLS--------YTWKLWC----EGEALEL 219 (308)
Q Consensus 153 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~--------~~~~~~~----~~~~~~~ 219 (308)
.|+..|+|||.+.+ ..++.++|||||||++|+|++|..||............. ....... .......
T Consensus 183 ~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 262 (350)
T d1q5ka_ 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 262 (350)
T ss_dssp CSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCC
T ss_pred cccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcccccc
Confidence 68899999998765 578999999999999999999999996543321100000 0000000 0000000
Q ss_pred ccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 220 MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...............++.+|+.+||+.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000011112335888999999999999999999995
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=311.31 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=183.2
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe--------CCeEEEEEEecCCC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE--------ENESLLIYEYMPNK 69 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~ 69 (308)
||+||+|+. .+|+.||||++... ......++.+|+.+|+.++|+||+++++++.. .+..++|||||.++
T Consensus 23 fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~ 102 (318)
T d3blha1 23 FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD 102 (318)
T ss_dssp SSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEE
T ss_pred CeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCC
Confidence 899999996 68999999998544 33455778899999999999999999999865 34579999999877
Q ss_pred ChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc--c
Q 021771 70 SLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE--A 147 (308)
Q Consensus 70 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~--~ 147 (308)
.+.... .....+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||++..+...... .
T Consensus 103 ~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~ 176 (318)
T d3blha1 103 LAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176 (318)
T ss_dssp HHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CC
T ss_pred ccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccc
Confidence 666554 23345899999999999999999999998 999999999999999999999999999876533221 1
Q ss_pred ccceeecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccc--------cc
Q 021771 148 NTNRIVGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEA--------LE 218 (308)
Q Consensus 148 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 218 (308)
......||+.|+|||++.+. .++.++||||+||++|+|++|+.||........................ ..
T Consensus 177 ~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 256 (318)
T d3blha1 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYE 256 (318)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC----
T ss_pred cccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhh
Confidence 22234689999999988764 6889999999999999999999999654332211111111000000000 00
Q ss_pred ccccccccc-chH------HHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 219 LMEPVLKQS-CVA------AELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 219 ~~~~~~~~~-~~~------~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
.+....... ... .....+++|+.+||+.||++|||++|+++-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 257 KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp ---CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000 011 112357789999999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=309.19 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=183.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEeCC------eEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN------ESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L 71 (308)
||+||+|+. .+|+.||||++... .....+.+.+|+.+|+.++||||++++++|...+ .+++||||| +.+|
T Consensus 31 fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l 109 (346)
T d1cm8a_ 31 YGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL 109 (346)
T ss_dssp --CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEH
T ss_pred CeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccH
Confidence 899999995 57999999999654 3334567889999999999999999999998654 469999999 6677
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
..+... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+|++|||++....... ..
T Consensus 110 ~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~ 177 (346)
T d1cm8a_ 110 GKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TG 177 (346)
T ss_dssp HHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CS
T ss_pred HHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCCcc-----cc
Confidence 777633 35999999999999999999999998 9999999999999999999999999998764332 23
Q ss_pred eecccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHH-----Hhhhc----------cc
Q 021771 152 IVGTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTW-----KLWCE----------GE 215 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~-----~~~~~----------~~ 215 (308)
..++..|+|||.+.+ ..++.++|||||||++|+|++|..||................ ..+.. ..
T Consensus 178 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (346)
T d1cm8a_ 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257 (346)
T ss_dssp SCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH
T ss_pred ccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhcc
Confidence 467899999998876 457899999999999999999999996543221100000000 00000 00
Q ss_pred ccccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 216 ALELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
..+...... ..........+.+||.+||+.||++|||++|+|+-
T Consensus 258 ~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 258 LPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp SCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 00111122357889999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=313.27 Aligned_cols=252 Identities=19% Similarity=0.191 Sum_probs=184.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC-cccHHHHHHHHHHHhcCCCcCccceeeeEEeCC----eEEEEEEecCCCChhhH
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS-GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEEN----ESLLIYEYMPNKSLDVF 74 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~ 74 (308)
||+||+|+. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.... ..+++++++.+++|.++
T Consensus 21 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~ 100 (345)
T d1pmea_ 21 YGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL 100 (345)
T ss_dssp CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHH
T ss_pred CeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhh
Confidence 899999985 689999999996543 344567889999999999999999999987643 23444556668999999
Q ss_pred hhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCc-cccceee
Q 021771 75 LFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSE-ANTNRIV 153 (308)
Q Consensus 75 l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~ 153 (308)
+... .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++......... .......
T Consensus 101 l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 173 (345)
T d1pmea_ 101 LKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173 (345)
T ss_dssp HHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCC
T ss_pred hhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecccc
Confidence 8542 4899999999999999999999998 999999999999999999999999999876433222 2233456
Q ss_pred cccCccCchhhcc-CcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhh-----cc----------ccc
Q 021771 154 GTYGYMAPEYAME-GLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWC-----EG----------EAL 217 (308)
Q Consensus 154 ~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-----~~----------~~~ 217 (308)
|++.|+|||++.. ..++.++||||+||++|+|++|..||.................... .. ...
T Consensus 174 gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (345)
T d1pmea_ 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLP 253 (345)
T ss_dssp SCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSC
T ss_pred ccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCC
Confidence 8999999998754 5678899999999999999999999965432211100000000000 00 000
Q ss_pred ccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 218 ELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
...... ..........++.+|+.+||+.||++|||++|+|+-
T Consensus 254 ~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 254 HKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCCCC-HHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCCC-HHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 000001112358899999999999999999999963
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.6e-43 Score=301.16 Aligned_cols=248 Identities=15% Similarity=0.166 Sum_probs=192.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCC-cCccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQH-KNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||+||+|+. .+|+.||||++..... ...+.+|++.++.++| +|++.+++++.++...++||||+ +++|.+++...
T Consensus 18 fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~ 94 (293)
T d1csna_ 18 FGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC 94 (293)
T ss_dssp SCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred CeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhh
Confidence 899999995 5799999998865432 2456789999999975 89999999999999999999999 67998888653
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC-----CCCeeeecccceeeeCCCCCc-----cc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH-----EMNPKISDFGMARIFGGNQSE-----AN 148 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~-----~~~~kl~dfg~~~~~~~~~~~-----~~ 148 (308)
. ..++..++..++.|++.+|+|||++| |+||||||+||+++. ++.+||+|||+++.+...... ..
T Consensus 95 ~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~ 169 (293)
T d1csna_ 95 G--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169 (293)
T ss_dssp T--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCC
T ss_pred c--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecc
Confidence 3 35899999999999999999999998 999999999999974 567999999999987533221 12
Q ss_pred cceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccc
Q 021771 149 TNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSC 228 (308)
Q Consensus 149 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.........................++ ....
T Consensus 170 ~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l-----~~~~ 244 (293)
T d1csna_ 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL-----CAGF 244 (293)
T ss_dssp CCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-----TTTS
T ss_pred cCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh-----cCCC
Confidence 33457899999999999999999999999999999999999999755444322221111111111111111 1111
Q ss_pred hHHHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcCC
Q 021771 229 VAAELLKFIHIGLLCVQADSADRPTMSSVVVMLASDT 265 (308)
Q Consensus 229 ~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~~ 265 (308)
+.++.+++..|++.+|++||+++.+.+.|+...
T Consensus 245 ----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 245 ----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp ----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 234788888999999999999999988877653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-43 Score=302.21 Aligned_cols=247 Identities=18% Similarity=0.202 Sum_probs=183.6
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcC-ccceeeeEEeCCeEEEEEEecCCCChhhHhhcC
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKN-LVRLFGCCLEENESLLIYEYMPNKSLDVFLFDS 78 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 78 (308)
||.||+|+. .+|+.||||++...... ..+..|+++++.++|++ |+.+..++.+++..++||||+. +++...+...
T Consensus 20 fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~ 96 (299)
T d1ckia_ 20 FGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFC 96 (299)
T ss_dssp SSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT
T ss_pred CcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhhc
Confidence 899999995 67999999988654322 35788999999998766 5555666677888999999994 5666655443
Q ss_pred CCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCC---CCCeeeecccceeeeCCCCCc-----cccc
Q 021771 79 TRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNH---EMNPKISDFGMARIFGGNQSE-----ANTN 150 (308)
Q Consensus 79 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~---~~~~kl~dfg~~~~~~~~~~~-----~~~~ 150 (308)
...+++..+..++.|++.||+|||++| |+||||||+|||++. +..++|+|||++..+...... ....
T Consensus 97 --~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 171 (299)
T d1ckia_ 97 --SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171 (299)
T ss_dssp --TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCC
T ss_pred --cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccC
Confidence 235999999999999999999999998 999999999999864 446999999999987543221 1233
Q ss_pred eeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccchH
Q 021771 151 RIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCVA 230 (308)
Q Consensus 151 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
...||+.|+|||.+.+..++.++|||||||++|+|++|..||.......................... ....
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--- 243 (299)
T d1ckia_ 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV-----LCKG--- 243 (299)
T ss_dssp SCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH-----HTTT---
T ss_pred CcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH-----hccC---
Confidence 45789999999999998999999999999999999999999976544433222211111110100000 0011
Q ss_pred HHHHHHHHHHhhcccCCCCCCCCHHHHHHHhhcC
Q 021771 231 AELLKFIHIGLLCVQADSADRPTMSSVVVMLASD 264 (308)
Q Consensus 231 ~~~~~l~~li~~cl~~~p~~RPs~~eil~~L~~~ 264 (308)
....+.+++.+||+.+|++||++++|.+.|+..
T Consensus 244 -~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 244 -YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 123588888999999999999999998888754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=301.74 Aligned_cols=249 Identities=21% Similarity=0.241 Sum_probs=187.7
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEEEEecCCCChhhHhhc
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFD 77 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 77 (308)
||+||+|+. .+|+.||||+++... .....++.+|+.+|+.++||||+++++++.+....++|++++.++++..++..
T Consensus 15 fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~ 94 (292)
T d1unla_ 15 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC 94 (292)
T ss_dssp SSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT
T ss_pred CeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccc
Confidence 899999995 689999999986443 33467889999999999999999999999999999999999999988887743
Q ss_pred CCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccceeecccC
Q 021771 78 STRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRIVGTYG 157 (308)
Q Consensus 78 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 157 (308)
...+++..+..++.|++.||+|||++| |+||||||+|||++.++.+||+|||.+......... .....++..
T Consensus 95 ---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~ 166 (292)
T d1unla_ 95 ---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLW 166 (292)
T ss_dssp ---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGG
T ss_pred ---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccc
Confidence 345889999999999999999999997 999999999999999999999999999886543222 222356778
Q ss_pred ccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcc---cc---cccc---------c
Q 021771 158 YMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEG---EA---LELM---------E 221 (308)
Q Consensus 158 y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~---------~ 221 (308)
|+|||.+.+. .++.++|||||||++|+|++|+.||........ ............ .. .... .
T Consensus 167 ~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T d1unla_ 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244 (292)
T ss_dssp GCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCT
T ss_pred hhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhcccccccccccc
Confidence 9999988765 468999999999999999999998633221110 001000000000 00 0000 0
Q ss_pred ccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 222 PVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
..............+.+|+.+||+.||++|||++|+|+
T Consensus 245 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000111122345788999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=305.75 Aligned_cols=259 Identities=21% Similarity=0.279 Sum_probs=196.5
Q ss_pred CCccEEeee----CCCCEEEEEEeccC----CcccHHHHHHHHHHHhcCCC-cCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL----ADGKEIAVKRLSRT----SGQGLQEFKNEVTLIAKLQH-KNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~----~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
||+||+++. .+|+.||||+++.. .....+.+.+|+.+|++++| |||+++++++.+....+++|||+.+++|
T Consensus 37 fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L 116 (322)
T d1vzoa_ 37 YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 116 (322)
T ss_dssp TEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred CeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHH
Confidence 899999974 25899999998643 22345678899999999976 8999999999999999999999999999
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.+++.... .+++..+..++.||+.||+|||+++ ++||||||+||+++.++.+||+|||++..+....... ...
T Consensus 117 ~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~-~~~ 189 (322)
T d1vzoa_ 117 FTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYD 189 (322)
T ss_dssp HHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG-GCG
T ss_pred HHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhccccccc-ccc
Confidence 99986543 4788999999999999999999997 9999999999999999999999999998765332222 233
Q ss_pred eecccCccCchhhccC--cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHhhhcccccccccccccccch
Q 021771 152 IVGTYGYMAPEYAMEG--LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKLWCEGEALELMEPVLKQSCV 229 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
..|++.|++||.+.+. .++.++|||||||++|+|++|..||...........+. .... .... ..+
T Consensus 190 ~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~-~~~~----------~~~ 256 (322)
T d1vzoa_ 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRIL-KSEP----------PYP 256 (322)
T ss_dssp GGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHH-HCCC----------CCC
T ss_pred cccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhcc-cCCC----------CCc
Confidence 4688999999988654 46789999999999999999999997654433221111 1111 0000 011
Q ss_pred HHHHHHHHHHHhhcccCCCCCCC-----CHHHHHH--Hhhc------CCCCCCCCCCCCcccC
Q 021771 230 AAELLKFIHIGLLCVQADSADRP-----TMSSVVV--MLAS------DTVTLPQPTEPAFSVG 279 (308)
Q Consensus 230 ~~~~~~l~~li~~cl~~~p~~RP-----s~~eil~--~L~~------~~~~~~~~~~p~~~~~ 279 (308)
......+.+|+.+||+.||++|| |++|+++ .++. ....+++|..|..+..
T Consensus 257 ~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~~~ 319 (322)
T d1vzoa_ 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDE 319 (322)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCC-
T ss_pred ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCCCC
Confidence 12234588899999999999999 4889885 2322 2245566766765443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5e-43 Score=305.25 Aligned_cols=244 Identities=18% Similarity=0.248 Sum_probs=182.5
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeC--CeEEEEEEecCCCChhhHhh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEE--NESLLIYEYMPNKSLDVFLF 76 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~ 76 (308)
||+||+|+. .+|+.||||+++.. ..+.+.+|+.+|+.++ ||||++++++|... ...++|||||.+++|..+.
T Consensus 48 fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~- 123 (328)
T d3bqca1 48 YSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY- 123 (328)
T ss_dssp SEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-
T ss_pred CeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-
Confidence 899999996 68999999998643 3467889999999996 99999999999854 4689999999999987654
Q ss_pred cCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCC-CeeeecccceeeeCCCCCccccceeecc
Q 021771 77 DSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEM-NPKISDFGMARIFGGNQSEANTNRIVGT 155 (308)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 155 (308)
..+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||++........ .....+|
T Consensus 124 -----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t 192 (328)
T d3bqca1 124 -----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVAS 192 (328)
T ss_dssp -----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSC
T ss_pred -----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccC
Confidence 24899999999999999999999998 99999999999998765 589999999987653322 2334678
Q ss_pred cCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchh--HH-----HHHhhhcc--c----cccc--
Q 021771 156 YGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLL--SY-----TWKLWCEG--E----ALEL-- 219 (308)
Q Consensus 156 ~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~--~~-----~~~~~~~~--~----~~~~-- 219 (308)
..|+|||.+.+. .++.++||||+||++|+|++|..||............ .. ........ . ....
T Consensus 193 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 272 (328)
T d3bqca1 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 272 (328)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCC
T ss_pred ccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcc
Confidence 999999988765 5789999999999999999999998654332111000 00 00000000 0 0000
Q ss_pred ------ccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 220 ------MEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 220 ------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
...............++.+||.+||+.||++|||++|+|+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001111112345888999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=306.16 Aligned_cols=248 Identities=21% Similarity=0.219 Sum_probs=178.1
Q ss_pred CCccEEeee-CCCCEEEEEEeccC--CcccHHHHHHHHHHHhcCCCcCccceeeeEEe------CCeEEEEEEecCCCCh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRT--SGQGLQEFKNEVTLIAKLQHKNLVRLFGCCLE------ENESLLIYEYMPNKSL 71 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L 71 (308)
||+||+|+. .+|+.||||++... .......+.+|+.+|+.++||||++++++|.. ..++|+|||||.++.+
T Consensus 30 fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~ 109 (355)
T d2b1pa1 30 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 109 (355)
T ss_dssp -CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH
T ss_pred CeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH
Confidence 799999996 57999999999754 23345678899999999999999999999964 3678999999977655
Q ss_pred hhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCccccce
Q 021771 72 DVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNR 151 (308)
Q Consensus 72 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 151 (308)
.... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.++++|||++...... .....
T Consensus 110 ~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~---~~~~~ 177 (355)
T d2b1pa1 110 QVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTP 177 (355)
T ss_dssp HHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------------
T ss_pred Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccccc---ccccc
Confidence 4432 23889999999999999999999998 999999999999999999999999998765422 22333
Q ss_pred eecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhH----------------HHHHhhhcc-
Q 021771 152 IVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLS----------------YTWKLWCEG- 214 (308)
Q Consensus 152 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~----------------~~~~~~~~~- 214 (308)
..+|..|+|||++.+..++.++||||+||++|+|++|..||............. .........
T Consensus 178 ~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (355)
T d2b1pa1 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257 (355)
T ss_dssp ---CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSC
T ss_pred ccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCc
Confidence 467899999999999999999999999999999999999996443221100000 000000000
Q ss_pred -----ccccccccc-c--cccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHHH
Q 021771 215 -----EALELMEPV-L--KQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVVM 260 (308)
Q Consensus 215 -----~~~~~~~~~-~--~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~~ 260 (308)
......... . ..........++.+|+.+||+.||++|||++|+|+-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 0 011123345678999999999999999999999843
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=305.45 Aligned_cols=246 Identities=23% Similarity=0.249 Sum_probs=179.3
Q ss_pred CCccEEeee-CCCCEEEEEEeccCC--cccHHHHHHHHHHHhcCCCcCccceeeeEEeC-----CeEEEEEEecCCCChh
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTS--GQGLQEFKNEVTLIAKLQHKNLVRLFGCCLEE-----NESLLIYEYMPNKSLD 72 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~ 72 (308)
||+||+|+. .+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++... ...+++|+++.+++|.
T Consensus 31 fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~ 110 (348)
T d2gfsa1 31 YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 110 (348)
T ss_dssp TSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHH
T ss_pred CeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchh
Confidence 899999995 689999999997543 33456788999999999999999999998643 3346667778899999
Q ss_pred hHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCCCCCcccccee
Q 021771 73 VFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGGNQSEANTNRI 152 (308)
Q Consensus 73 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 152 (308)
+++.. ..+++..+..++.||+.||+|||++| |+||||||+|||++.++.+|++|||++..... .....
T Consensus 111 ~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~ 178 (348)
T d2gfsa1 111 NIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGY 178 (348)
T ss_dssp HHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSS
T ss_pred hhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc-----ccccc
Confidence 98843 35999999999999999999999998 99999999999999999999999999876432 22334
Q ss_pred ecccCccCchhhccC-cccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHH-----hhhc----------ccc
Q 021771 153 VGTYGYMAPEYAMEG-LFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWK-----LWCE----------GEA 216 (308)
Q Consensus 153 ~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~-----~~~~----------~~~ 216 (308)
.|+..|+|||...+. .++.++|||||||++|+|++|..||................. .... ...
T Consensus 179 ~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (348)
T d2gfsa1 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258 (348)
T ss_dssp CHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTS
T ss_pred cccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhc
Confidence 678899999987664 568899999999999999999999965432211111100000 0000 000
Q ss_pred cccccccccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 217 LELMEPVLKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
........ ..........+.+||.+||+.||++|||++|+|+
T Consensus 259 ~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 259 TQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCCCCCH-HHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCCcch-hhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000 0000112245788999999999999999999997
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-37 Score=270.60 Aligned_cols=250 Identities=17% Similarity=0.181 Sum_probs=178.0
Q ss_pred CCccEEeee-CCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-----------CcCccceeeeEEe--CCeEEEEEEec
Q 021771 1 MESCLQGKL-ADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-----------HKNLVRLFGCCLE--ENESLLIYEYM 66 (308)
Q Consensus 1 ~g~v~~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~~~--~~~~~lv~e~~ 66 (308)
||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++.. ....+++|+++
T Consensus 26 fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~ 104 (362)
T d1q8ya_ 26 FSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 104 (362)
T ss_dssp SEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEEC
T ss_pred CeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeec
Confidence 799999995 68999999999644 233467788999988875 4789999988764 34667777776
Q ss_pred CCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchh-CCCCceeecCCCCCceEeCCCCC------eeeecccceee
Q 021771 67 PNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHE-DSRLKIIHRDLKASNVLLNHEMN------PKISDFGMARI 139 (308)
Q Consensus 67 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~g~~~i~H~di~p~nilv~~~~~------~kl~dfg~~~~ 139 (308)
..+..............+++..+..++.||+.||+|||+ .| |+||||||+|||++.++. ++++|||.+..
T Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~ 181 (362)
T d1q8ya_ 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 181 (362)
T ss_dssp CCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEE
T ss_pred ccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeecccccc
Confidence 555443333333445568999999999999999999998 66 999999999999986654 89999999987
Q ss_pred eCCCCCccccceeecccCccCchhhccCcccccccchhhhHHHHHHHhCCcCCCccccccccchhHHHHHh---------
Q 021771 140 FGGNQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVLLLEIISGKKNTGFYLSELGQSLLSYTWKL--------- 210 (308)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~--------- 210 (308)
.... .....++..|+|||++.+..++.++||||+||++++|++|+.||..................
T Consensus 182 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~ 256 (362)
T d1q8ya_ 182 YDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256 (362)
T ss_dssp TTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCH
T ss_pred cccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCH
Confidence 5422 22346889999999999888999999999999999999999998654332211111110000
Q ss_pred ------------hhccccccccccc----------ccccchHHHHHHHHHHHhhcccCCCCCCCCHHHHHH
Q 021771 211 ------------WCEGEALELMEPV----------LKQSCVAAELLKFIHIGLLCVQADSADRPTMSSVVV 259 (308)
Q Consensus 211 ------------~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~RPs~~eil~ 259 (308)
+........+... ............+.+|+.+||++||++|||++|+|+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000000000 011223456678999999999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=8.5e-22 Score=156.98 Aligned_cols=158 Identities=18% Similarity=0.117 Sum_probs=110.4
Q ss_pred CCccEEeeeCCCCEEEEEEeccCCc------------------ccHHHHHHHHHHHhcCCCcCccceeeeEEeCCeEEEE
Q 021771 1 MESCLQGKLADGKEIAVKRLSRTSG------------------QGLQEFKNEVTLIAKLQHKNLVRLFGCCLEENESLLI 62 (308)
Q Consensus 1 ~g~v~~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 62 (308)
||+||+|+..+|+.||||++..... ........|+..+.++.|.+++..+++.. .+++
T Consensus 13 ~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~----~~lv 88 (191)
T d1zara2 13 ESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG----NAVL 88 (191)
T ss_dssp SEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET----TEEE
T ss_pred ceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC----CEEE
Confidence 7999999988999999998743210 01123456888999999999988876532 3799
Q ss_pred EEecCCCChhhHhhcCCCccccChHHHHHHHHHHHHHHHhchhCCCCceeecCCCCCceEeCCCCCeeeecccceeeeCC
Q 021771 63 YEYMPNKSLDVFLFDSTRSVQLDWKRRISIINGIARGLLYLHEDSRLKIIHRDLKASNVLLNHEMNPKISDFGMARIFGG 142 (308)
Q Consensus 63 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~~~~ 142 (308)
|||+++..+.. ++...+..++.|++.+++|||++| |+||||||+|||+++++ ++|+|||.+.....
T Consensus 89 me~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG~a~~~~~ 154 (191)
T d1zara2 89 MELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGE 154 (191)
T ss_dssp EECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCTTCEETTS
T ss_pred EEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECCCcccCCC
Confidence 99998765432 344556789999999999999998 99999999999999754 89999999977532
Q ss_pred CCCccccceeecccCccCchhhccCcccccccchhhhHH
Q 021771 143 NQSEANTNRIVGTYGYMAPEYAMEGLFSVKSDVFSFGVL 181 (308)
Q Consensus 143 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 181 (308)
.....-...... .-.+ .....++.++|+||+.--
T Consensus 155 ~~~~~~l~rd~~----~~~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 155 EGWREILERDVR----NIIT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp TTHHHHHHHHHH----HHHH-HHHHHHCCCCCHHHHHHH
T ss_pred CCcHHHHHHHHH----HHHH-HHcCCCCCcccHHHHHHH
Confidence 211100000000 0011 113557888999997643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=2.8e-08 Score=81.29 Aligned_cols=128 Identities=14% Similarity=0.097 Sum_probs=87.5
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCChhhHhhcCCCc
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSLDVFLFDSTRS 81 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 81 (308)
.||+.. .+++.+++|+...........+..|...+..+. +--+.+++.+..+++..++||++++|.++.......
T Consensus 29 ~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~--- 104 (263)
T d1j7la_ 29 KVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--- 104 (263)
T ss_dssp EEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---
T ss_pred cEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc---
Confidence 467654 367778899886554444556788888888775 444678888888888899999999998876544211
Q ss_pred cccChHHHHHHHHHHHHHHHhchhC-------------------------------------------------------
Q 021771 82 VQLDWKRRISIINGIARGLLYLHED------------------------------------------------------- 106 (308)
Q Consensus 82 ~~~~~~~~~~~~~qi~~~l~~lH~~------------------------------------------------------- 106 (308)
.....++.++++.++.||+.
T Consensus 105 -----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 179 (263)
T d1j7la_ 105 -----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKP 179 (263)
T ss_dssp -----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCC
T ss_pred -----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCC
Confidence 11222344455555555531
Q ss_pred -CCCceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 107 -SRLKIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 107 -g~~~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
....++|+|+.+.||++++++..-|+||+.+..
T Consensus 180 ~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 180 EEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 011378999999999999776567999987754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.35 E-value=1.5e-06 Score=70.28 Aligned_cols=67 Identities=15% Similarity=0.162 Sum_probs=48.9
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCC--CcCccceeeeEEeCCeEEEEEEecCCCChh
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ--HKNLVRLFGCCLEENESLLIYEYMPNKSLD 72 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 72 (308)
.||+....+|..+++|...... ...+..|...|+.+. .-.+.+++.+..+++..++||++++|.++.
T Consensus 26 ~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 26 AVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp EEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred eEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 4677777788889999764332 234677888887774 333677888888888899999999886653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.73 E-value=5.2e-05 Score=63.43 Aligned_cols=67 Identities=9% Similarity=0.043 Sum_probs=45.3
Q ss_pred ccEEeeeCCCCEEEEEEeccCCcccHHHHHHHHHHHhcCCCcCc--ccee-----eeEEeCCeEEEEEEecCCCC
Q 021771 3 SCLQGKLADGKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQHKNL--VRLF-----GCCLEENESLLIYEYMPNKS 70 (308)
Q Consensus 3 ~v~~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~-----~~~~~~~~~~lv~e~~~~~~ 70 (308)
.||..+..+|..+++|+.... ....+++..|...+..|...++ +..+ ..+..+...+.++++++|..
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred eeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 488888889999999987533 3345778889998888852222 1111 22344566788999987643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.65 E-value=0.00021 Score=61.24 Aligned_cols=29 Identities=24% Similarity=0.363 Sum_probs=25.7
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.++|||+++.|||+++++ ++++||.++..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 499999999999998765 89999988866
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.24 E-value=0.0005 Score=58.83 Aligned_cols=54 Identities=15% Similarity=0.230 Sum_probs=35.5
Q ss_pred CCEEEEEEeccCCcccHHHHHHHHHHHhcCC-CcCccceeeeEEeCCeEEEEEEecCCCCh
Q 021771 12 GKEIAVKRLSRTSGQGLQEFKNEVTLIAKLQ-HKNLVRLFGCCLEENESLLIYEYMPNKSL 71 (308)
Q Consensus 12 g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 71 (308)
++.+++++.- . ........+|..+++.+. +.-.+++++++.+ .+|+||++|..+
T Consensus 74 ~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 74 PNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3566666653 3 233445678999999885 4334577777653 588999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.58 E-value=0.0044 Score=50.79 Aligned_cols=30 Identities=30% Similarity=0.319 Sum_probs=26.2
Q ss_pred ceeecCCCCCceEeCCCCCeeeecccceee
Q 021771 110 KIIHRDLKASNVLLNHEMNPKISDFGMARI 139 (308)
Q Consensus 110 ~i~H~di~p~nilv~~~~~~kl~dfg~~~~ 139 (308)
.++|+|+.++||+++.+...-++||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhcccccceeEeccccccc
Confidence 499999999999999887678999998754
|